<SEC-DOCUMENT>0000912057-19-000051.txt : 20190227
<SEC-HEADER>0000912057-19-000051.hdr.sgml : 20190227
<ACCEPTANCE-DATETIME>20190215161038
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000912057-19-000051
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20190215
<PUBLIC-REL-DATE>20190227
DATE AS OF CHANGE:		20190219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genfit S.A.
		CENTRAL INDEX KEY:			0001757064
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-02371
		FILM NUMBER:		19611609

	BUSINESS ADDRESS:	
		STREET 1:		PARC EURASANTE
		STREET 2:		885, AVENUE EUGENE AVINEE
		CITY:			LOOS
		STATE:			I0
		ZIP:			59120
		BUSINESS PHONE:		33 3 20 16 4000

	MAIL ADDRESS:	
		STREET 1:		PARC EURASANTE
		STREET 2:		885, AVENUE EUGENE AVINEE
		CITY:			LOOS
		STATE:			I0
		ZIP:			59120
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg10701_table_of_contents">  TABLE OF CONTENTS</A> <BR>
<A HREF="#fa10701_index_to_consolidated_financial_statements">  INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</A><BR></font>
</P>

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;">


<FONT SIZE=1><B>As confidentially submitted to the Securities and Exchange Commission on February&nbsp;15, 2019.</B></FONT>


</P>

<P ALIGN="CENTER" style="font-family:times;">


<FONT SIZE=1><B>This draft registration statement has not been publicly filed with the Securities and Exchange Commission and<BR>
all information herein remains strictly confidential.

 </B></FONT>

</P>

<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><B> Registration Statement No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=1><B> &nbsp;<BR>  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=1><B> <div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT SIZE=1><B>Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>FORM F-1<BR>  </B></FONT><FONT SIZE=1><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF&nbsp;1933  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>GENFIT&nbsp;S.A.<BR>  </B></FONT><FONT SIZE=1>(Exact name of registrant as specified in its charter) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>France</B></FONT><FONT SIZE=1><BR>
(State or other jurisdiction of<BR>
incorporation&nbsp;or&nbsp;organization)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B> 2836</B></FONT><FONT SIZE=1><BR>
(Primary Standard Industrial<BR>
Classification Code Number)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B> Not applicable</B></FONT><FONT SIZE=1><BR>
(I.R.S. Employer<BR>
Identification Number)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Parc Eurasant&eacute;<BR>
885, avenue Eug&egrave;ne Avin&eacute;e<BR>
59120 Loos, France<BR>
+33 3 20 16 4000<BR>  </B></FONT><FONT SIZE=1>(Address, including zip code, and telephone number, including<BR>
area code, of registrant's principal executive offices) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>(Name,
address, including zip code, and telephone number, including area code, of agent for service) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="14pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="14pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="14pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Copies to:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B>Marc A. Recht<BR>
Brian F. Leaf<BR>
Katie A. Kazem<BR>
Cooley&nbsp;LLP<BR>
500 Boylston Street<BR>
Boston, MA 02116<BR>
+1&nbsp;617&nbsp;937 2300</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Bertrand S&eacute;n&eacute;chal<BR>
Linklaters&nbsp;LLP<BR>
25 rue de Marignan<BR>
75008 Paris, France<BR>
+33 1 56 43 56 43</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Mitchell S. Bloom<BR>
Edwin M. O'Connor<BR>
Markus Bauman<BR>
Goodwin Procter&nbsp;LLP<BR>
100 Northern Avenue<BR>
Boston, MA 02210<BR>
+1&nbsp;617&nbsp;570 1000</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Linda Hesse<BR>
Florent Bouyer<BR>
Jones Day<BR>
2, rue Saint-Florentin<BR>
75001 Paris, France<BR>
+33 1 56 59 39 39</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Approximate date of commencement of proposed sale to the public:<BR>
As soon as practicable after this registration statement becomes effective.  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act,
check the following box.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>


<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this Form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>


<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&nbsp;405 of the Securities Act of 1933. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Emerging
growth company&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT> </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an emerging growth company that prepares its financial statements in accordance with U.S.&nbsp;GAAP, indicate by check mark if the registrant has elected not
to use the extended transition period for complying with any new or revised financial accounting standards&#134; provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities
Act.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>CALCULATION OF REGISTRATION FEE  </B></FONT></P>

<div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="55%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:3pt;text-indent:-3pt;"><FONT SIZE=1> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>TITLE OF EACH CLASS OF SECURITIES<BR>
TO BE REGISTERED(1)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>PROPOSED MAXIMUM<BR>
AGGREGATE OFFERING<BR>
PRICE(2)(3)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>AMOUNT OF<BR>
REGISTRATION FEE(4)</B></FONT><BR></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:3pt;text-indent:-3pt;"><FONT SIZE=1><B> </B></FONT><FONT SIZE=1>Ordinary shares, &euro;0.25 nominal value per share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT"  ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;"><p style="font-family:times;margin-left:3pt;text-indent:-3pt;"> &nbsp;</TD>
</TR>
</TABLE></DIV>


<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>All
of the offered ordinary shares will be in the form of American Depositary Shares, or ADSs, in the U.S. offering, with each ADS representing one ordinary share.
ADSs issuable upon deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form&nbsp;F-6.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Includes
ordinary shares (which may be in the form of ADSs) that the underwriters have the option to purchase. See "Underwriting."
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Includes
ordinary shares that are being offered in a private placement in Europe and other countries outside of the United States, but which may be resold from time
to time in the United States in transactions requiring registration under the Securities Act of 1933, as amended, or the Securities Act, or an exemption therefrom. The total number of ordinary shares
in the U.S. offering and the European private placement is subject to reallocation between them.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Estimated
solely for the purpose of computing the amount of the registration fee pursuant to Rule&nbsp;457(o) under the Securities Act based on an estimate of the
proposed maximum offering price.  </FONT></DD></DL>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=1><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall
file&nbsp;a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as
amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission acting pursuant to said Section&nbsp;8(a), may
determine.</B></FONT></P>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="25%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="25%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>&#134;</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards
Codification after April&nbsp;5, 2012. </FONT></DD></DL>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=1>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p>
 <P style="font-family:times;"><FONT SIZE=1><div
style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=200572,FOLIO='blank',FILE='DISK124:[18ZFA1.18ZFA10701]BA10701A.;51',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#FF4040" SIZE=2><B>The information contained in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any
jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;">


<FONT COLOR="#FF4040" SIZE=1><B>SUBJECT TO COMPLETION, DATED FEBRUARY&nbsp;15, 2019</B></FONT>


</P>

<P style="font-family:times;"><FONT SIZE=2><B>PROSPECTUS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary Shares<BR>
(Including Ordinary Shares in the Form of American Depositary Shares)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>
<IMG SRC="g388375.jpg" ALT="LOGO" WIDTH="297" HEIGHT="73">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B> &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per Ordinary Share  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per American Depositary Share  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are offering an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in a global offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are offering&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in the form of American Depositary Shares, or ADSs, in the United States, referred to herein as the U.S. offering. Each ADS represents
the right to receive one ordinary share and the ADSs may be evidenced by American Depositary Receipts, or ADRs. </FONT></P>


<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are concurrently offering&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in Europe and countries outside of the United States in a private placement, referred to herein as the European private
placement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This is our initial public offering of our ADSs in the United States. We have applied to list our ADSs on the Nasdaq Global Market under the symbol "GNFT." Our ordinary shares are
listed on Euronext Paris under the symbol "GNFT." The final offering price per ADS in U.S. dollars and the corresponding offering price per ordinary share in euros will be determined through
negotiations between us and the representatives of the underwriters, and by reference to the prevailing market prices of our ordinary shares on Euronext Paris after taking into account market
conditions and other factors. On February&nbsp;14, 2019, the last reported sale price of our ordinary shares on Euronext Paris was &euro;17.99 per ordinary share, equivalent to a price of
$20.61 per ADS, assuming an exchange rate of &euro;0.8729 per U.S. dollar, the exchange rate on December&nbsp;31, 2018.

 </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
closings of the U.S. offering and the European private placement, which are together referred to as the global offering, will occur simultaneously. The total number of ordinary
shares (including in the form of ADSs) in the U.S. offering and the European private placement is subject to reallocation between these offerings as permitted under applicable laws and regulations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are an "emerging growth company" as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced public company
reporting requirements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Investing in the ordinary shares and ADSs involves a high degree of risk. See "Risk Factors" beginning on
page&nbsp;12 of this prospectus.  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=1><B>Neither the Securities and Exchange Commission nor any U.S. state or other securities commission has approved or
disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="44%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>PER ORDINARY<BR>
SHARE</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>PER ADS</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>TOTAL</B></FONT><BR></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1><B> </B></FONT><FONT SIZE=1>Initial public offering price</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Underwriting commissions(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Proceeds to us, before expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"> &nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>We
refer you to "Underwriting" beginning on page&nbsp;220 of this prospectus for additional information regarding underwriting compensation. </FONT></DD></DL>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have granted an option to the underwriters, exercisable within 30&nbsp;days from the date of the underwriting agreement, to purchase up to an aggregate of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
additional ADSs and/or ordinary shares in the global offering to be sold to the several underwriters at the applicable offering price. If the underwriters exercise this option in full, the total
underwriting commissions payable by us will be &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) and the total proceeds to us, before expenses,
will be &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;). </FONT></P>

<P style="font-family:times;"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters expect to deliver the ADSs to purchasers in the U.S. offering on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019 through the book-entry facilities of The
Depository Trust Company. The
underwriters expect to deliver the ordinary shares to purchasers in the European private placement on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019 through the book-entry
facilities of Euroclear France. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=4><B>SVB Leerink</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=4>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=4><B> Barclays</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=1>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=4><B>Bryan, Garnier&nbsp;&amp;&nbsp;Co.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=4>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=4><B> Natixis</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=1>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=4><B>Roth Capital Partners</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=4>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=4><B> H.C. Wainwright&nbsp;&amp;&nbsp;Co.</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=1>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=1>
The date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=304152,FOLIO='blank',FILE='DISK124:[18ZFA1.18ZFA10701]BC10701A.;97',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="BG10701A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg10701_table_of_contents"> </A></FONT> <FONT SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
<A NAME="BG10701_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->

<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#bi10701_exchange_rate_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2> EXCHANGE RATE INFORMATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#bi10701_exchange_rate_information"><FONT SIZE=2>i</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#bi10701_market,_industry_and_other_data"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MARKET, INDUSTRY AND OTHER DATA</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#bi10701_market,_industry_and_other_data"><FONT SIZE=2>ii</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#bi10701_trademarks_and_service_marks"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>TRADEMARKS AND SERVICE MARKS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#bi10701_trademarks_and_service_marks"><FONT SIZE=2>ii</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ca10701_prospectus_summary"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROSPECTUS SUMMARY</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ca10701_prospectus_summary"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ck10701_risk_factors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RISK FACTORS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ck10701_risk_factors"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cu10701_special_note_regarding_forward-looking_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cu10701_special_note_regarding_forward-looking_statements"><FONT SIZE=2>67</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cu10701_use_of_proceeds"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>USE OF PROCEEDS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cu10701_use_of_proceeds"><FONT SIZE=2>69</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cu10701_dividend_policy"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DIVIDEND POLICY</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cu10701_dividend_policy"><FONT SIZE=2>71</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cu10701_capitalization"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CAPITALIZATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cu10701_capitalization"><FONT SIZE=2>72</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cw10701_dilution"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DILUTION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cw10701_dilution"><FONT SIZE=2>74</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cw10701_selected_consolidated_financial_data"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SELECTED CONSOLIDATED FINANCIAL DATA</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cw10701_selected_consolidated_financial_data"><FONT SIZE=2>77</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cy10701_management_s_discussion_and_an__man03466"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cy10701_management_s_discussion_and_an__man03466"><FONT SIZE=2>79</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cz10701_business"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BUSINESS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cz10701_business"><FONT SIZE=2>96</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#de10701_management"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MANAGEMENT</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de10701_management"><FONT SIZE=2>149</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#di10701_certain_relationships___di102226"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di10701_certain_relationships___di102226"><FONT SIZE=2>166</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#di10701_principal_shareholders"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PRINCIPAL SHAREHOLDERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di10701_principal_shareholders"><FONT SIZE=2>169</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk10701_description_of_share_capital"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DESCRIPTION OF SHARE CAPITAL</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk10701_description_of_share_capital"><FONT SIZE=2>171</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do10701_limitations_affecting___do102210"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>LIMITATIONS AFFECTING SHAREHOLDERS OF A FRENCH COMPANY</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do10701_limitations_affecting___do102210"><FONT SIZE=2>197</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do10701_description_of_american_depositary_shares"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DESCRIPTION OF AMERICAN DEPOSITARY SHARES</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do10701_description_of_american_depositary_shares"><FONT SIZE=2>198</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dq10701_shares_and_adss_eligible_for_future_sale"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SHARES AND ADSs ELIGIBLE FOR FUTURE SALE</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dq10701_shares_and_adss_eligible_for_future_sale"><FONT SIZE=2>207</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dq10701_material_united_states_federal__mat02698"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MATERIAL UNITED STATES FEDERAL INCOME AND FRENCH TAX CONSIDERATIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dq10701_material_united_states_federal__mat02698"><FONT SIZE=2>209</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ds10701_enforcement_of_civil_liabilities"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ENFORCEMENT OF CIVIL LIABILITIES</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ds10701_enforcement_of_civil_liabilities"><FONT SIZE=2>219</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ds10701_underwriting"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>UNDERWRITING</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ds10701_underwriting"><FONT SIZE=2>220</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#du10701_expenses_relating_to_the_global_offering"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXPENSES RELATING TO THE GLOBAL OFFERING</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#du10701_expenses_relating_to_the_global_offering"><FONT SIZE=2>229</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#du10701_legal_matters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>LEGAL MATTERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#du10701_legal_matters"><FONT SIZE=2>230</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#du10701_experts"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXPERTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#du10701_experts"><FONT SIZE=2>230</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#du10701_where_you_can_find_more_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#du10701_where_you_can_find_more_information"><FONT SIZE=2>231</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#fa10701_index_to_consolidated_financial_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#fa10701_index_to_consolidated_financial_statements"><FONT SIZE=2>F-1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>


<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>For investors outside the United States: Neither we nor any of the underwriters have done anything that would permit the global offering or possession or
distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this
prospectus must inform themselves about, and observe any restrictions relating to, the global offering of the ADSs and ordinary shares and the distribution of this prospectus outside the United
States.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are incorporated in France, and a majority of our outstanding securities are owned by non-U.S. residents. Under the rules of the Securities and Exchange Commission, or SEC, we are
currently eligible for treatment as a "foreign private issuer." As a foreign private issuer, we will not be required to file periodic reports and financial statements with the SEC as frequently or as
promptly as domestic registrants whose securities are registered under the Securities Exchange Act of 1934, as amended, or the Exchange Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
financial statements included in this prospectus are presented in euros and, unless otherwise specified, all monetary amounts are in euros. All references in this prospectus to "$,"
"US$," "U.S.$," "U.S. dollars," "dollars" and "USD" mean U.S. dollars and all references to "&euro;" and "euros," mean euros, unless otherwise noted. Throughout this prospectus, references
to ADSs mean ADSs or ordinary shares represented by such ADSs, as the case may be. </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=681957,FOLIO='blank',FILE='DISK124:[18ZFA1.18ZFA10701]BG10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_bi10701_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bi10701_exchange_rate_information"> </A>
<A NAME="toc_bi10701_1"> </A></FONT> <FONT SIZE=2><B>  EXCHANGE RATE INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth, for each period indicated, the low and high exchange rates for euros expressed in U.S. dollars, the exchange
rate at the end of such period and the average of such exchange rates on the last day of each month during such period, based on the noon buying rate of the Federal Reserve Bank of New York for the
euro. As used in this prospectus, the term "noon buying rate" refers to the rate of exchange for the euro, expressed in U.S. dollars per euro, as certified by the Federal Reserve Bank of New York for
customs purposes. The exchange rates set forth below demonstrate trends in exchange rates, but the actual exchange rates used throughout this prospectus may vary. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=17 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>YEAR ENDED DECEMBER 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2013 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>High</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3816</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3927</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1516</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2041</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2488</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Low</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2774</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2101</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.0524</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.0375</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.0416</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rate at end of period</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3779</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2101</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.0859</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.0552</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.2022</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1456</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Average rate per period</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.3297</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1096</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1072</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1396</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.1817</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table sets forth, for each of the last six months for which such information is available, the high and low exchange rates for euros expressed in U.S. dollars and the
exchange rate at the end of the month based on the noon buying rate as described above. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AUGUST<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SEPTEMBER<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>OCTOBER<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>NOVEMBER<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DECEMBER<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>JANUARY<BR>
2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>High</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1720</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1773</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1594</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1459</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1456</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1524</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Low</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1332</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1566</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1332</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1281</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1300</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1322</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Rate&nbsp;at&nbsp;end&nbsp;of period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1596</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1622</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1332</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1323</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1456</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1454</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
December&nbsp;31, 2018, the noon buying rate of the Federal Reserve Bank of New York for the euro was &euro;1.00&nbsp;= $1.1456. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February&nbsp;8, 2019, the noon buying rate of the Federal Reserve Bank of New York for the euro was &euro;1.00&nbsp;= $1.1326.


</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise indicated, currency translations in this prospectus reflect the December&nbsp;31, 2018 exchange rate. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>i</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=335040,FOLIO='i',FILE='DISK124:[18ZFA1.18ZFA10701]BI10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_bi10701_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bi10701_market,_industry_and_other_data"> </A>
<A NAME="toc_bi10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  MARKET, INDUSTRY AND OTHER DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our
general expectations and market position, market opportunity and market size estimates, is based on information from independent industry analysts, third-party sources and management estimates.
Management estimates are derived from publicly available information released by independent industry analysts and third-party sources, as well as data from our internal research, and are based on
assumptions made by us based on such data and our knowledge of such industry and market, which we believe to be reasonable. In addition, while we believe the market opportunity information included in
this prospectus is generally reliable and is based on reasonable assumptions, such data involves risks and uncertainties and is subject to change based on various factors, including those discussed
under the heading "Risk Factors." These and other factors could cause our future performance to differ materially from our assumptions and estimates. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bi10701_trademarks_and_service_marks"> </A>
<A NAME="toc_bi10701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  TRADEMARKS AND SERVICE MARKS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"GENFIT," the GENFIT logo and other trademarks or service marks of GENFIT&nbsp;S.A. appearing in this prospectus are the property of
GENFIT&nbsp;S.A. or its subsidiaries. Solely for convenience, the trademarks, service marks and trade names referred to in this prospectus are listed
without the &reg; and&nbsp;&#153; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under
applicable law, their right thereto. All other trademarks, trade names and service marks appearing in this prospectus are the property of their respective owners. We do not intend to use or display
other companies' trademarks and trade names to imply any relationship with, or endorsement or sponsorship of us by, any other companies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>ii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=115357,FOLIO='ii',FILE='DISK124:[18ZFA1.18ZFA10701]BI10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ca10701_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ca10701_prospectus_summary"> </A>
<A NAME="toc_ca10701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROSPECTUS SUMMARY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>The following summary highlights information contained elsewhere in this prospectus and does not contain all of the
information you should consider before investing in our ordinary shares (including ordinary shares in the form of ADSs). You should read the entire prospectus carefully, including "Risk Factors" and
our financial statements and the related notes appearing elsewhere in this prospectus. You should carefully consider, among other things, the matters discussed in the sections of this prospectus
titled "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" before making an investment decision. Unless otherwise indicated, "GENFIT," "the company,"
"our company," "we," "us" and "our" refer to GENFIT&nbsp;S.A. and its consolidated subsidiaries.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic solutions targeting metabolic and
liver-related diseases where there is considerable unmet medical need. We are a leader in the field of nuclear receptor-based drug discovery with a rich history and strong scientific heritage spanning
almost two decades. We are evaluating our most advanced drug candidate, elafibranor, in a pivotal Phase&nbsp;3 clinical trial as a potential treatment for nonalcoholic steatohepatitis, or NASH, and
in a Phase&nbsp;2 clinical trial as a potential treatment for primary biliary cholangitis, or PBC. In December&nbsp;2018, we announced positive preliminary results from our Phase&nbsp;2 clinical
trial in PBC. Our drug discovery efforts are based on selecting appropriate nuclear receptors as targets and utilizing rational drug design to optimize our drug candidates. A key differentiator of our
development strategy is our NASH biomarker-based diagnostic program, in which we are developing a new </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostic, or IVD, test to identify
patients with NASH who may be appropriate candidates for drug therapy. In January 2019, we entered into a license agreement with LabCorp to allow them to deploy our IVD test in the clinical research
space. Our scientific and clinical expertise, translational disease-driven approach and strong bioinformatics capabilities have allowed us to build a scientific platform through which we discover and
develop our drug candidates and diagnostic tools. We believe elafibranor, if approved, has the potential to become a first-line treatment as a monotherapy and the backbone of combination regimens. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH
is a liver disease that affects millions of people and for which there are currently no approved therapies. NASH is characterized by an accumulation of fat, inflammation and
degeneration of hepatocytes, and may ultimately lead to life-threatening conditions like cirrhosis, liver failure or liver cancer requiring liver transplant. The global market for the treatment of
NASH is growing rapidly and is projected to reach $20&nbsp;billion by 2025. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes our drug candidate and diagnostic development pipeline. We have retained worldwide rights to all of our programs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g268398.jpg" ALT="GRAPHIC" WIDTH="526" HEIGHT="232">
  </B></FONT></P>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=6,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=9264,FOLIO='1',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elafibranor,
a dual agonist of the nuclear receptors PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>, is currently in Phase&nbsp;3
development for the treatment of NASH. In our Phase&nbsp;2b clinical trial, elafibranor achieved resolution of NASH without worsening of fibrosis, which is the primary endpoint of our ongoing global
Phase&nbsp;3 clinical trial. In our Phase&nbsp;2b clinical trial, elafibranor achieved resolution of NASH without worsening of fibrosis, which has been defined by the FDA for drug registration and
is the primary endpoint of our ongoing global Phase&nbsp;3 clinical trial. However, we did not achieve statistical significance on the pre-specified primary endpoint of our Phase&nbsp;2b clinical
trial, which was based on an outdated definition of resolution of NASH. We have already achieved the enrollment necessary to perform an interim cohort analysis and expect to report interim results by
the end of 2019. We believe these results, if positive, could support accelerated approval from the U.S. Food and Drug Administration, or FDA, and conditional approval from the European Medicines
Agency, or EMA, as early as 2020. Elafibranor has received fast track designation from the FDA for the treatment of NASH. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also developing elafibranor for the treatment of PBC, a chronic, progressive liver disease that leads to inflammation and scarring of the small bile ducts in the liver. Although a
relatively rare disease mainly affecting women, PBC can develop into cirrhosis and other serious liver complications. There is currently no cure for PBC, and the two drugs approved for the treatment
of PBC are limited by drug intolerance, lack of patient response and safety issues. Based on our clinical data in NASH, we believe elafibranor's unique mechanism of action can provide benefits for
patients with PBC without significant side effects, such as the serious liver injury or death and pruritis that have been associated with approved PBC treatments. In December 2018, we announced
positive preliminary results from our Phase&nbsp;2 clinical trial evaluating elafibranor for the treatment of PBC. Elafibranor met the primary endpoint of the trial, which was the change at week 12
in serum alkaline phosphatase, or ALP, from baseline, with statistical significance compared to placebo in both doses evaluated. Elafibranor also achieved with high statistical significance when
compared to placebo, the composite endpoint of ALP and bilirubin. That endpoint, which has been used for drug registration, is defined as (1)&nbsp;ALP less than 1.67 times the upper limit of normal,
or ULN, (2)&nbsp;total bilirubin within normal limits and (3)&nbsp;a reduction of ALP of more than 15%. Based on these positive results, we plan to advance our PBC program into Phase&nbsp;3
development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH
is a silent disease. Patients often have no symptoms until the first signs of liver failure, and the lack of an accurate, non-invasive diagnosis tool contributes to under-diagnosis.
Currently, liver biopsy is the standard for diagnosis, and variation in clinical practice and physician reluctance lead to under-diagnosis. Our blood-based IVD test is a novel, standalone diagnostic
that we believe can address the urgent need for a non-invasive, cost-effective, accessible and validated test to identify NASH patients who may be appropriate candidates for drug intervention, thereby
decreasing the need for liver biopsy. We believe our IVD test has the potential to benefit patients, improve overall clinical care and facilitate the identification of NASH patients to be treated. We
anticipate marketing our IVD test first as a laboratory developed test, or LDT, in&nbsp;2019, and then submitting our IVD test for FDA marketing authorization in&nbsp;2020. In January 2019, we
entered into a license agreement with LabCorp to allow them to deploy our IVD test in the clinical research space. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also advancing a clinical-stage program based on drug repositioning to develop an anti-fibrotic drug. Our lead drug candidate in this program, nitazoxanide, or NTZ, is an approved
anti-parasitic agent. In December 2018, we announced the initiation of an investigator-initiated Phase&nbsp;2 proof-of-concept trial to evaluate NTZ for the treatment of NASH patients with
significant fibrosis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
TGFTX1 preclinical program is focused on the discovery and development of innovative drug candidates targeting ROR<FONT FACE="SYMBOL">g</FONT>t, a nuclear receptor
involved in certain inflammatory and autoimmune diseases. We are currently conducting pre-IND studies for a topical treatment of mild to moderate psoriasis. </FONT></P>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=7,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=333379,FOLIO='2',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
current chief executive officer co-founded our company in 1999 and our shares have been listed on Euronext Paris first on Alternext and then on the regulated market under the symbol
"GNFT" since 2006. We are led by an executive team and board of directors with deep experience at leading biotech companies, large pharmaceutical companies and academic institutions. We have over 150
employees at our offices in Lille and Paris, France and Cambridge, Massachusetts. The chair of our scientific advisory board, Bart Staels, is a co-founder of our company and a world-renowned expert in
nuclear receptors. Our scientific advisory board is comprised of internationally recognized key opinion leaders in the field of metabolic and inflammatory diseases, with a particular focus on the
liver and gastroenterology. We believe the expertise of our leadership and the strength of our relationships within the academic and clinical communities are critical to our ability to execute on our
mission as we progress our development pipeline. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strengths  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe the following strengths will allow us to continue to build upon our leadership position in drug and diagnostic development for
metabolic and liver-related diseases and achieve our goal of commercializing our drug and diagnostic candidates:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>Our lead product candidate, elafibranor, is in Phase&nbsp;3 development for the treatment of NASH, an indication for
which there are no approved drugs today, but which presents significant market opportunity.</B></FONT><FONT SIZE=2> In April 2018, we announced that we had achieved the recruitment goal of 1,000
patients for the interim cohort in our global Phase&nbsp;3 clinical trial being conducted in 25 countries. We expect to report the results of our interim cohort analysis by the end of 2019, which,
if positive, could support accelerated approval from the FDA and conditional approval from the EMA as early as 2020. If approved, we believe elafibranor could be among the first FDA-approved therapies
shown to achieve resolution of NASH without worsening of fibrosis. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>We recently announced positive preliminary results from our Phase&nbsp;2 clinical trial of elafibranor for the
treatment of PBC and plan to commence Phase&nbsp;3 development.</B></FONT><FONT SIZE=2> In December 2018, we announced that elafibranor met the primary endpoint of our Phase&nbsp;2 clinical trial,
which was the change at week 12 in serum ALP from baseline. Compared to placebo, treatment with 80 mg and 120 mg elafibranor resulted in mean decrease from baseline of &#150;52% and
&#150;44%, respectively, each with high statistical significance. With respect to the composite endpoint, the elafibranor 80 mg and 120 mg treatment groups achieved with high statistical
significance mean response rates of 67% and 79%, respectively, as compared to 6.7% for the placebo group. We plan to advance our PBC program into Phase&nbsp;3 development in 2019. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>Elafibranor's results on NASH resolution, its good tolerability and lack of demonstrated safety concerns make it
well-positioned among late-stage NASH programs.</B></FONT><FONT SIZE=2> We believe elafibranor has a favorable tolerability profile based on the results of our Phase&nbsp;1 and Phase&nbsp;2
trials. Also, in our Phase&nbsp;2b clinical trial, we observed elafibranor's ability to resolve NASH without the worsening of fibrosis, which is the primary endpoint of our ongoing global
Phase&nbsp;3 clinical trial, while also showing a decrease in cardiovascular risk factors, an important observation considering the close link between NASH and cardiometabolic disease, and one that
has not been reported in other drugs in Phase&nbsp;3 development for NASH. Elafibranor is, to our knowledge, the only drug currently permitted to be developed for the treatment of children with
NASH. We hold over 350 patents and patent applications relating to elafibranor, and the patent covering the use of elafibranor for the treatment of NASH does not expire until 2030, without taking into
account any extensions.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> We are a recognized leader in the NASH
field.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We are actively involved in the NASH stakeholder community, as a member of the steering committee and co-leader of a working group of The
Liver Forum. We also participate in academic consortia, such as the biomarkers </FONT></DD></DL>
</UL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=8,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=236055,FOLIO='3',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>consortia
in the United States and Europe, and work with patient advocacy groups including the Global Liver Institute, American Liver Forum and the European Liver Patient Association. We also
spearhead disease awareness through The NASH Education Program, which is a Genfit public health initiative. These programs provide us with insight from the key stakeholders in NASH and our leadership
position enables us to establish credibility with and convey these insights to regulators and payors. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>Our diagnostic program has the potential to expand market opportunity through better patient identification and
stratification.</B></FONT><FONT SIZE=2> Our IVD test is designed to identify NASH patients who may be appropriate candidates for drug intervention. We believe that broad adoption of our non-invasive,
accessible test, if validated and authorized for marketing, could not only help solve the problem of NASH under-diagnosis, but also provide physicians with a tool to identify patients who would
benefit from treatment with elafibranor or any other appropriate drug. Our license agreement with LabCorp allows for the deployment of our IVD test in the clinical research space through its central
laboratories, which we believe will provide expanded access to, and further validation of our IVD test and generate new biological insights on NASH disease pathogenesis.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Our pipeline extends beyond
elafibranor.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;In December 2018, we announced the initiation of an investigator-initiated Phase&nbsp;2 proof-of-concept trial to evaluate NTZ for
the treatment of NASH patients with significant fibrosis. If this Phase&nbsp;2 trial demonstrates anti-fibrotic activity in these patients, we plan to develop NTZ as a combination therapy with
elafibranor as part of our strategy in NASH, in addition to development as a standalone monotherapy in fibrotic diseases. Our TGFTX1 program is in preclinical development in certain inflammatory and
autoimmune diseases.</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B>Our experienced team is comprised of industry leaders in metabolic and liver-related diseases.</B></FONT><FONT SIZE=2>
We believe that the breadth of experience and accomplishments of our management team, board of directors and scientific advisory board, combined with our broad network of established relationships
with leaders in the industry and medical community, provide us with unique insights into drug development and commercialization, and have allowed us to bring together top researchers to build
interdisciplinary research and development teams. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our goal is to become a leader in the development of innovative therapies and diagnostics in metabolic and liver-related diseases. The key
elements of our strategy to achieve this goal include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Obtain regulatory approval for, and commercialize, elafibranor for the treatment of NASH. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Rapidly advance the clinical development of elafibranor for the treatment of PBC. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Complete development and prepare for potential commercialization of our NASH IVD test. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Advance other drug candidates in our pipeline, both alone and in combination with elafibranor. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Actively manage our development pipeline and opportunistically enter into strategic collaborations.</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Increase public awareness of NASH through The NASH Education Program. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Risk Factors  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An investment in our ordinary shares (including ordinary shares in the form of ADSs) involves a high degree of risk. Any of the factors set
forth under "Risk Factors" may limit our ability to successfully execute our business strategy. You should carefully consider all of the information set forth </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=9,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=358161,FOLIO='4',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_5"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">


<P style="font-family:times;"><FONT SIZE=2>in
this prospectus and, in particular, should evaluate the specific factors set forth under "Risk Factors" in deciding whether to invest in our securities. Among these important risks are the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We have never generated profits from product sales. Currently, we have no products approved for commercial sale, and to date we have not
generated any revenue from product sales. As a result, our ability to reduce our losses and reach profitability is unproven, and we may never achieve or sustain profitability. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our ability to be profitable in the future will depend on our ability to obtain marketing approval for and commercialize our product
candidates, particularly our lead product candidate, elafibranor. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We will require substantial additional funding to commercialize our products, if approved, which may not be available to us on acceptable
terms, or at all, and, if not so available, may require us to delay, limit, reduce or cease our operations. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We are developing our lead product candidate, elafibranor for the treatment of NASH, a condition for which no drug has yet been commercialized
and for which there is little clinical experience. As a result, our development approach involves new endpoints and methodologies. There is risk that the outcome of our clinical trials will not be
favorable or that, even if favorable, regulatory authorities may not find the results of our clinical trials to be sufficient for marketing approval. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Clinical failure can occur at any stage of clinical development. The results of earlier clinical trials are not necessarily predictive of
future results and any product candidate we, or our potential future collaborators advance through clinical trials may not have favorable results in later clinical trials or receive regulatory
approval. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> If we are unable to establish sales, marketing and distribution capabilities for our product candidates, whether it be via an internal
infrastructure or an arrangement with a commercial partner, we may not be successful in commercializing those product candidates if and when they are approved. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our failure to maintain certain tax benefits applicable to French biopharmaceutical companies may adversely affect our results of operations. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our ability to compete may decline if we do not adequately protect our proprietary rights. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The rights of shareholders in companies subject to French corporate law differ in material respects from the rights of shareholders of
corporations incorporated in the United States.</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> As a foreign private issuer, we are exempt from a number of rules under the U.S. securities laws and are permitted to file less information
with the SEC than a U.S. company. This may limit the information available to holders of ADSs and ordinary shares. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Implications of Being an Emerging Growth Company  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We qualify as an "emerging growth company" as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As an emerging
growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions
include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the ability to present only two years of audited financial statements in addition to any required interim financial statements and
correspondingly reduced disclosure in management's discussion and analysis of financial condition and results of operations in the registration statement for the global offering of which this
prospectus forms&nbsp;a part; </FONT></DD></DL>
</UL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=10,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=810648,FOLIO='5',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_6"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> exemption from the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act of 2002;
and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to the extent that we no longer qualify as a foreign private issuer, (1)&nbsp;reduced disclosure obligations regarding executive compensation
in our periodic reports and proxy statements and (2)&nbsp;exemptions from the requirements of holding a non-binding advisory vote on executive compensation, including golden parachute compensation. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may take advantage of these provisions for up to five years or such earlier time that we no longer qualify as an emerging growth company. We would cease to be an emerging growth
company if we have more than $1.07&nbsp;billion in total annual gross revenue, have more than $700&nbsp;million in market value of our capital stock held by non-affiliates or issue more than
$1.0&nbsp;billion of non-convertible debt over a three-year period. We may choose to take advantage of some but not all of these reduced burdens. For example, we have presented only two years of
audited financial statements and only two years of related Management's Discussion and Analysis of Financial Condition and Results of Operations disclosure in this prospectus, and have taken advantage
of the exemption from auditor attestation on the effectiveness of our internal control over financial reporting. To the extent that we take advantage of these reduced burdens, the information that we
provide shareholders may be different than you might obtain from other public companies in which you hold equity interests. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. Since
International Financial Reporting Standards make no distinction between public and private companies for purposes of compliance with new or revised accounting standards, the requirements for our
compliance as a private company and as a public company are the same. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Implications of Being a Foreign Private Issuer  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are also considered a "foreign private issuer" under U.S. securities laws. In our capacity as a foreign private issuer, we are exempt from
certain rules under the Securities Exchange Act of&nbsp;1934, as amended, or the Exchange Act, that impose certain disclosure obligations and procedural requirements for proxy solicitations under
Section&nbsp;14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and "short-swing" profit recovery provisions of Section&nbsp;16
of the Exchange Act and the rules under the Exchange Act with respect to their purchases and sales of our securities. Moreover, we are not required to file periodic
reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. In addition, we are not required to comply with
Regulation&nbsp;FD, which restricts the selective disclosure of material information. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We will remain a foreign private issuer until such time that more than 50% of our
outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (1)&nbsp;the majority of our executive officers or directors are U.S. citizens or
residents; (2)&nbsp;more than 50% of our assets are located in the United States; or (3)&nbsp;our business is administered principally in the United States. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have taken advantage of certain reduced reporting and other requirements in this prospectus. Accordingly, the information contained herein may be different from the information you
receive from other public companies in which you hold equity securities. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Information  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We were incorporated as a French </FONT><FONT SIZE=2><I>soci&eacute;t&eacute; anonyme</I></FONT><FONT SIZE=2>, or&nbsp;S.A.,
on September&nbsp;21, 1999. Our principal executive offices are located at Parc Eurasant&eacute;, 885 avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos, France. We </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=11,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=405948,FOLIO='6',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_7"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;"><FONT SIZE=2>are
registered at the Register of Commerce and Companies of Lille M&eacute;tropole (</FONT><FONT SIZE=2><I>Registre du commerce et des
soci&eacute;t&eacute;s</I></FONT><FONT SIZE=2>) under the number&nbsp;424&nbsp;341&nbsp;907. In July 2003, we incorporated our wholly owned U.S. subsidiary, Genfit
Corp. Our other wholly owned subsidiary, Genfit Pharmaceuticals SAS, was incorporated in France in December&nbsp;2011. In 2006, we completed the initial public offering of our ordinary shares on
Alternext market of Euronext in Paris and were transferred to the regulated market
of Euronext Paris in 2014. Our telephone number at our principal executive offices is +33&nbsp;3&nbsp;20&nbsp;16&nbsp;40&nbsp;00. Our agent for service of process in the United States is
Corporation Service Company, located at 1180&nbsp;Avenue of the Americas, Suite&nbsp;210, New York, NY&nbsp;10036. Our website address is www.genfit.com. The reference to our website is an
inactive textual reference only and information contained in, or that can be accessed through, our website or any other website cited in this prospectus is not part of this prospectus. </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=12,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=189711,FOLIO='7',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_8"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ca10701_the_global_offering"> </A>
<A NAME="toc_ca10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  THE GLOBAL OFFERING    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2> Global offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares offered by us, consisting of ordinary shares in the form of ADSs offered in the U.S. offering and ordinary
shares offered in the European private placement. The closings of the U.S. offering and the European private placement will occur simultaneously. The total number of ordinary shares (including in the form of ADSs) in the U.S. offering and European
private placement is subject to reallocation between these offerings as permitted under applicable laws and regulations.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>U.S. offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs, each representing one ordinary share</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>European private placement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Offering price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The offering price is expected to be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, or &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share,
the closing price of our ordinary shares on Euronext Paris on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019. The final offering price per ADS in
U.S. dollars and the corresponding offering price per ordinary share in euros will be determined by reference to the prevailing market prices of our ordinary shares on Euronext Paris after taking into account market conditions and other
factors.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ordinary shares (including ordinary shares in the form of ADSs) to be outstanding after the global offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Option to purchase additional ADSs and/or ordinary shares in the global offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>We have agreed to issue, at the option of the underwriters, within 30&nbsp;days after the date of the underwriting agreement, up to an aggregate
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs and/or ordinary shares.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>American Depositary Shares</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Each ADS represents one ordinary share, nominal value &euro;0.25 per share. Purchasers of ADSs in the U.S. offering will have the rights of an ADS holder as provided in the deposit agreement among us, the depositary and
all holders and beneficial owners of ADSs issued thereunder. To better understand the terms of the ADSs, purchasers of ADSs should carefully read the section in this prospectus titled "Description of American Depositary Shares." We also encourage
purchasers of ADSs to read the deposit agreement, which is filed as an exhibit to the registration statement of which this prospectus forms a part.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Depositary</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Bank of New&nbsp;York Mellon</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Use of proceeds</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>We estimate that we will receive net proceeds from the global offering of approximately &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), based on an assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, or
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share, the closing price of our ordinary shares on Euronext Paris
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019, after deducting estimated underwriting commissions and estimated offering expenses payable by us. We intend to use the net proceeds from the
global offering, together with our existing resources, to:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>prepare for the potential
commercialization of elafibranor in NASH by building out our commercial infrastructure;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT SIZE=2>
</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=13,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=684417,FOLIO='8',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<A NAME="page_ca10701_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>complete our ongoing
Phase&nbsp;3 clinical development of elafibranor for the treatment of NASH through to, at least, the submission of an NDA to the FDA and EMA and the launch of the Phase&nbsp;4 clinical trial;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>conduct a global
Phase&nbsp;3 clinical trial of elafibranor for the treatment of PBC;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>advance the commercial
development of our IVD test to identify NASH patients through the launch of the LDT and completion of the work required to obtain regulatory approval for our IVD kit;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>advance our research
program on the use of elafibranor as a potential backbone for combination therapies in order to launch two proof-of-concept studies; and</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the remainder for working
capital and for general corporate purposes.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>See "Use of Proceeds" for more information.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dividend policy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>We do not expect to pay any dividends on the ordinary shares or ADSs in the foreseeable future.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk factors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>You should read the "Risk Factors" section of this prospectus for a discussion of factors to consider carefully before deciding to invest in the ordinary shares or ADSs.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proposed Nasdaq Global Market symbol for our ADSs</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>"GNFT"</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Euronext Paris trading symbol for our ordinary shares</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>"GNFT"</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of ordinary shares (including ordinary shares in the form of ADSs) that will be outstanding after the global offering is based on 31,183,921 ordinary shares outstanding as of
December&nbsp;31, 2018 and excludes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 548,882 new&nbsp;ordinary shares issuable upon the exercise of redeemable share warrants (BSAAR), share warrants (BSA), free shares and stock
options granted but not exercised as of December&nbsp;31, 2018 at a weighted average exercise price of &euro;19.72 ($22.59) per new ordinary share based on the exchange rate in effect as
of December&nbsp;31, 2018 (this weighted average exercise price does not include the 83,726 new&nbsp;ordinary shares issuable upon the vesting of outstanding free shares that may be issued for
free with no exercise price paid); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 200,066 ordinary shares reserved for future issuance under our share-based compensation plans and other delegations of authority from our
shareholders; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 9,000,000&nbsp;ordinary shares reserved to date pursuant to a delegation of authority from our shareholders for share capital increases by us
through rights issuances and public or private offerings. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise noted, the information in this prospectus assumes no exercise by the underwriters of their option to purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs and/or ordinary
shares
in the global offering. </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=14,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=184064,FOLIO='9',FILE='DISK124:[18ZFA1.18ZFA10701]CA10701A.;57',USER='JTAYLORA',CD='15-FEB-2019;13:10' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cc10701_1_10"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cc10701_summary_consolidated_financial_data"> </A>
<A NAME="toc_cc10701_1"> </A></FONT> <FONT SIZE=2><B>  SUMMARY CONSOLIDATED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following summary consolidated statement of operations data for the years ended December&nbsp;31, 2017 and the summary consolidated
statement of financial position data as of December&nbsp;31, 2018 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our audited consolidated
financial statements have been prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB, as of and for the
years ended December&nbsp;31, 2017 and 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
historical results are not necessarily indicative of the results that may be expected in the future. You should read this summary consolidated financial data together with our
consolidated financial statements and related notes beginning on page&nbsp;F-1 of this prospectus, as well as the sections of this prospectus titled "Exchange Rate Information," "Selected
Consolidated Financial Data" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Consolidated Statement of Operations Data:  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros, except loss per share data)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Revenues and other income</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,737</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,425 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenues and other income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,856</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,494 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Operating expenses and other operating income (expenses)</U></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research&nbsp;and development expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(67,024</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General&nbsp;and administrative expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,793</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(162</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(56,695</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(69,484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>642</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,096</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(11,118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(10,391</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss before tax</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(59,148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79,875</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,420</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>354 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and diluted loss per share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1.79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>In
the context of the preparation of its 2018 consolidated financial statements, the Company restated the financial statements previously published for the 2017 fiscal
year under IFRS. These changes do not affect the cash position or the operating results, and are mainly related to the application of IFRS to deferred taxes on the OCEANE bonds issued in
October&nbsp;2017. The corrections lead mainly to a decrease in the consolidated net loss of &euro;2.9&nbsp;million. More information is provided in Note&nbsp;2.3 of our consolidated
financial statements.  </FONT></DD></DL>
 </DIV>

 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=15,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=886593,FOLIO='10',FILE='DISK124:[18ZFA1.18ZFA10701]CC10701A.;41',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cc10701_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Consolidated Statement of Financial Position Data:  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(in thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As<BR>
Adjusted(1)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>207,240</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>229,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total shareholders' equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,939</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total non-current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>169,291</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,248</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>208,539</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities and shareholders' equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>229,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
as adjusted summary condensed consolidated statement of financial position data reflects our issuance and sale of ADSs and ordinary shares in the global offering
at an assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, the closing price of our ordinary shares on Euronext Paris
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, corresponding to
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement (assuming an exchange rate of &euro;1.00&nbsp;= $1.1456), after deducting estimated underwriting
commissions and estimated offering expenses payable by us.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
as adjusted summary condensed consolidated statement of financial position data is illustrative only and will change based on the actual offering price, the
actual number of ordinary shares (including ordinary shares in the form of ADSs) offered by us and other terms of the global offering determined at pricing. The as adjusted information is unaudited
and is not derived from our audited financial statements. Each &euro;1.00 ($1.1456) increase or decrease in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering would
increase or decrease the as adjusted amount of each of cash and cash equivalents, total assets and total shareholders' equity by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming that the number of ordinary shares offered by us (including ordinary shares in the form of ADSs), as set forth on the cover page of this prospectus,
remains
the same and after deducting underwriting commissions and estimated offering expenses payable by us. Subject to applicable law, we may also increase or decrease the number of ordinary shares
(including ordinary shares in the form of ADSs) we are offering. Each increase or decrease of 1,000,000 ordinary shares (including ordinary shares in the form of ADSs) offered by us would increase or
decrease the as adjusted amount of each of cash and cash equivalents, total assets and total shareholders' equity by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million),
assuming that the assumed offering price remains the same, and after deducting estimated underwriting commissions and estimated offering expenses payable by us.  </FONT></DD></DL>
 </DIV>

 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=16,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=406023,FOLIO='11',FILE='DISK124:[18ZFA1.18ZFA10701]CC10701A.;41',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ck10701_1_12"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ck10701_risk_factors"> </A>
<A NAME="toc_ck10701_1"> </A></FONT> <FONT SIZE=2><B>  RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>Investing in our ordinary shares (including ordinary shares in the form of ADSs) involves a high degree of risk. You
should carefully consider the risks and uncertainties described below, together with all of the other information in this prospectus, including our consolidated financial statements and related notes,
before deciding whether to purchase our securities. If any of the following risks are realized, our business, financial condition, operating results and prospects could be materially and adversely
affected. In that event, the market price of our securities could decline, and you could lose part or all of your investment.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to our Financial Position and Capital Needs  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have never generated profits from product sales. Currently, we have no products approved for commercial
sale, and to date we have not generated any revenue from product sales. As a result, our ability to reduce our losses and reach profitability is unproven, and we may never achieve or sustain
profitability.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although we were profitable in our early years of development, as a result of profits from our co-research alliances with certain pharmaceutical
companies, we have not been profitable in the past 10&nbsp;years and we have never generated profits from product sales. We do not expect to be profitable in the foreseeable future. We have incurred
net losses in each of the past eleven years, including a net loss of &euro;79.5&nbsp;million for the year ended December&nbsp;31, 2018. Our revenue and other income result principally
from tax credits, including research tax credits, in France, and, until June&nbsp;30, 2018, nominal revenues from the sublease of a portion of our corporate headquarters to a third party.
Historically, we have also received funding from co-research alliances with other pharmaceutical companies, although we do not currently have any such alliances in place. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have devoted substantially all of our resources to our research and development efforts relating to our drug candidates and diagnostic program, in which we are developing a new </FONT> <FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostic, or
IVD, test to identify patients with nonalcoholic steatohepatitis, or NASH, who may be appropriate candidates for drug therapy,
including conducting clinical trials of our drug candidates, providing general and administrative support for our operations, protecting our intellectual property and engaging in activities to prepare
for the potential commercialization of our drug candidates and IVD test. We do not yet have any products approved for sale and have not generated any revenues from product sales. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expect to continue to incur losses for the foreseeable future, and we expect these losses to increase as we continue our development of, and seek regulatory approvals for elafibranor,
which is our lead drug candidate, our other drug candidates and our IVD test. We also expect to incur losses as we prepare for and begin the commercialization of any approved products, and add
infrastructure and personnel in the United States, Europe and other territories to support our product development and commercialization efforts and operations as a public company in both France and
the United States. We anticipate that any such losses could be significant for the next several years as we continue our pivotal Phase&nbsp;3 clinical trial of elafibranor, referred to as the
RESOLVE-IT trial, in NASH, launch a Phase&nbsp;3 clinical trial of elafibranor in primary biliary cholangitis, or PBC, and finalize other planned activities for regulatory approval of elafibranor in
NASH. In parallel with our potential commercialization of elafibranor, we also plan to seek U.S. Food and Drug Administration, or FDA, marketing authorization of our IVD test. During the regulatory
development process for elafibranor and our IVD test, our expenses could increase if we are required by the FDA or the European Medicines Agency, or EMA, to perform studies or trials in addition to
those currently expected, or if
there are any delays in completing our clinical trials or the development of any of our product candidates. We also anticipate that we will continue to increase our product development, scientific,
commercial and administrative personnel significantly and expand our facilities and infrastructure in the United States, France and other countries as part of our longer-term growth strategy. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=17,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=799281,FOLIO='12',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our ability to be profitable in the future will depend on our ability to obtain marketing approval for and
commercialize our product candidates, particularly our lead product candidate, elafibranor.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to be profitable in the future will depend on our ability to obtain marketing approval for and commercialize our product candidates,
particularly our lead product candidate, elafibranor. We may not be successful in our efforts to obtain such approval and to commercialize our products. Obtaining marketing approval will require us to
be successful in a range of challenging activities, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> obtaining positive results in our pivotal Phase&nbsp;3 RESOLVE-IT trial for elafibranor in NASH and our other trials of elafibranor in PBC; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> regulatory bodies determining that our Phase&nbsp;3 clinical data in NASH are sufficient, without further clinical data, to support an
application for approval, whether or not conditional or accelerated; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> obtaining approval to market elafibranor for the treatment of NASH, PBC and other indications and patient populations; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> obtaining positive results in our formal validation studies required to commercialize our IVD test; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> expanding our manufacturing of commercial supply for elafibranor; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> establishing sales, marketing and distribution capabilities to effectively market and sell elafibranor in the United States, Europe and in
other territories; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> market acceptance by patients and the medical community of elafibranor; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> market acceptance by patients and the medical community of our IVD test as a diagnostic complement to liver biopsy; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> negotiating and securing coverage and adequate reimbursement from third-party payors for elafibranor and our IVD test;
and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> expanding our contract manufacturing for the commercial supply of elafibranor. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are conducting pre-commercial activities, such as patient profiling, intended to better understand how physicians care for NASH patients. NASH is a disease with no approved drug
therapy. As such, there is significant uncertainty in the degree of market acceptance elafibranor will have among NASH patients and their healthcare providers as well as third-party payors. Even if we
receive marketing approvals for elafibranor to treat NASH and commence our commercial launch, we may not be able to
generate significant revenues in the near term. We cannot foresee if elafibranor will ever be accepted as a therapy in NASH eventually resulting in sustained revenues and it may take the passage of a
significant amount of time to generate significant sustained revenues even if elafibranor becomes accepted as a therapy in NASH. NASH is currently an under-diagnosed disease, and we believe that our
non-invasive IVD test will facilitate the diagnosis and identification of NASH patients who may be well suited for drug therapy. If our IVD test does not obtain marketing authorization, we may not be
able to reach enough NASH patients to successfully generate significant revenues. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
elafibranor, our IVD test or any of our other product candidates fails in clinical trials or does not gain regulatory approval, or if elafibranor, our IVD test or any of our other
product candidates do not achieve market acceptance, we may never become profitable. Our net losses have had, and will continue to have, an adverse effect on our shareholders' equity and working
capital. Because of the numerous risks and uncertainties associated with pharmaceutical and diagnostic product development and commercialization, we are unable to accurately predict the timing or
amount of increased expenses </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=18,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=405736,FOLIO='13',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>or
when, or if, we will be able to achieve profitability. The amount of future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenues. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We will require substantial additional funding to commercialize our products, if approved, which may not be
available to us on acceptable terms, or at all, and, if not so available, may require us to delay, limit, reduce or cease our operations.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are currently advancing elafibranor through clinical development for multiple indications and other drug candidates through preclinical
development. Additionally, we are also planning formal validation studies of our IVD test in preparation for submitting the test for marketing authorization. Developing pharmaceutical and diagnostic
products, including conducting preclinical studies and clinical trials, along with obtaining necessary validation, is expensive. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to obtaining regulatory approval of any of our drug candidates or our IVD test, we expect to incur significant commercialization expenses for product sales, marketing,
manufacturing and distribution. We anticipate incurring significant expenses as we prepare for the potential commercialization of elafibranor in NASH, including significant expenses relating to our
sales, marketing and distribution capabilities and increasing our drug manufacturing activities. We also anticipate incurring significant expenses in connection with our planned commercialization of
our IVD test, along with an increase in our product development, scientific, commercial and administrative personnel and expansion of our facilities and infrastructure in the United States, France and
other
countries. We also expect to incur additional costs associated with operating as a public company in the United States and further plan on expanding our operations in the United States, Europe and in
other territories. We will continue to require substantial additional capital in connection with our continuing operations, including continuing our clinical development and pre-commercialization
activities. Because successful development of our drug candidates and diagnostic program are uncertain, we are unable to estimate the actual funds required to complete the research and development and
commercialization of our products under development. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The terms of our convertible bonds require us to meet certain operating covenants, and if we fail to comply
with those covenants the bondholders would be able to accelerate our repayment obligations. Additionally, the conversion of some or all of our bonds into ordinary shares would dilute the ownership
interests of existing shareholders.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2017, we issued bonds convertible and/or exchangeable into new and/or existing ordinary shares due October&nbsp;16, 2022, for a
nominal amount of &euro;180.0&nbsp;million, or 6,081,081 bonds that would convert into 6,081,081 new ordinary shares if such bonds were settled into new ordinary shares in the event of
conversion. The bonds bear interest at a nominal rate of 3.5% payable semi-annually in arrears on April&nbsp;16 and October&nbsp;16 of each year with a first interest payment date of
April&nbsp;16, 2018. Our ability to repay the bonds at maturity depends in part on our future performance, which is subject to the success of our research and development programs and future
operations, as well as on economic, financial and competitive factors that are beyond our control. In addition, we may incur additional debt in the future, some of which may be secured debt. Even if
we are permitted by the terms and conditions of the convertible bonds to incur additional debt or to take other measures with regard to the incurrence of new debt, the terms of the bonds could reduce
our ability to repay new debts at maturity. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
agreement governing the bonds contains customary negative covenants and events of default. The negative covenants include restrictions on creating other liens on our assets,
incurring certain additional indebtedness and engaging in certain mergers or acquisitions. If we default under the agreement governing the bonds, the bondholders may accelerate all of our repayment
obligations, which would significantly harm our business and prospects and could cause the price of our ordinary shares to decline. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=19,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=896685,FOLIO='14',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finally,
the conversion of some or all of our currently outstanding convertible bonds into ordinary shares would dilute the ownership interests of existing shareholders. Any sales in the
public market of the ordinary shares issuable upon such conversion or any anticipated conversion of our convertible bonds into ordinary shares could adversely affect prevailing market prices of our
ordinary shares. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to the Discovery and Development of and Obtaining Regulatory Approval for Our Product
Candidates  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We cannot be certain that elafibranor or any of our other product candidates will receive regulatory
approval, and without regulatory approval, we will not be able to market our product candidates.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are developing elafibranor in several clinical trials, including a pivotal Phase&nbsp;3 clinical trial, RESOLVE-IT, for the treatment of
NASH that, if successful, we believe could support regulatory approval, and a Phase&nbsp;2 clinical trial for the treatment of PBC. In parallel, we are also developing our IVD test to identify
patients with NASH who may be appropriate candidates for drug therapy. Our business currently depends substantially on the successful development and commercialization of elafibranor. Our ability to
generate revenue related to product sales will depend on the successful development and regulatory approval of elafibranor for the treatment of NASH and other indications, our IVD test and our other
product candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
currently have no products approved for sale and we cannot guarantee that we will ever have marketable products. The development of drug candidates and diagnostic tests and issues
relating to their approval and marketing are subject to extensive regulation by the FDA in the United States, the European Union and EMA in Europe and regulatory authorities in other countries, with
regulations differing from country to country. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will not be permitted to market our drug candidates in the United States or Europe until we receive approval of a New Drug Application, or NDA, from the FDA or a marketing
authorization application, or MAA, from the European Commission (based on the positive opinion of the EMA), respectively. We have not submitted any marketing applications for any of our product
candidates. NDAs and MAAs must include extensive preclinical and clinical data and supporting information to establish the drug candidate's safety and effectiveness for each desired indication. NDAs
and MAAs must also include significant information regarding the chemistry, manufacturing and controls for the drug. Obtaining approval of a NDA or a MAA is a lengthy, expensive and uncertain process,
and we may not be successful in obtaining approval. We have received a fast track designation from the FDA for the development of elafibranor for the treatment of NASH. While the fast track
designation for elafibranor in NASH permits close and regular contact between us and the FDA, the FDA and the EMA review processes can take more than one year to complete and approval is never
guaranteed. If we submit a NDA to the FDA, the FDA must decide whether to accept or reject the submission for filing, before even reviewing the scientific basis. Regulators of other jurisdictions,
such as the EMA, have their own procedures for approval of drug candidates. Even if a drug is approved, the FDA or the
EMA, as the case may be, may limit the indications for which the drug may be marketed, require extensive warnings on the drug labeling or require expensive and time-consuming clinical trials or
reporting as conditions of approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
RESOLVE-IT trial began in the first quarter of 2016 and is expected to enroll approximately 2,000 patients at approximately 270 sites throughout the world. Considering the importance
of NASH in terms of public health, we can submit an NDA to the FDA for accelerated approval under Subpart&nbsp;H and to the EMA for conditional approval on the basis of an interim analysis of the
surrogate endpoint in the first 1,000 patients after 72&nbsp;weeks of treatment. In addition, we evaluated elafibranor for the treatment of PBC in a Phase&nbsp;2 clinical trial and recently
announced preliminary results. We cannot predict whether our ongoing or future trials and studies will be successful or whether regulators will agree with our conclusions regarding the preclinical
studies and clinical trials we </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=20,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=157021,FOLIO='15',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>have
conducted to date. In NASH, following discussion with the FDA, and based on elafibranor achieving, in our Phase&nbsp;2b trial, resolution of NASH without worsening of fibrosis, which is the
FDA-recommended primary endpoint for our Phase&nbsp;3 trial, we elected to proceed to a Phase&nbsp;3 study without conducting additional Phase&nbsp;2 studies after not achieving statistical
significance on our prespecified endpoints in our Phase&nbsp;2b trial. We cannot predict whether regulators will agree with the conclusions from, or request additional clinical data following, our
Phase&nbsp;3 NASH study to support an application for marketing approval. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similarly,
we will not be permitted to market our IVD test until it is authorized for marketing by the FDA in the United States and receives CE Mark approval in Europe. We have not
submitted any marketing applications for our IVD test and, as with approval of our drug candidates, the process for obtaining marketing authorization of diagnostic candidates is lengthy, uncertain and
expensive. We plan to initially offer our IVD test as an LDT for use in clinical research in order to provide additional evidence of its clinical utility. LDTs have generally been considered to be
tests that are intended for clinical use and that are designed, manufactured and used within a single laboratory. There can be no assurance that FDA will continue to exercise enforcement discretion
over LDTs, or that the FDA will agree with our characterization of the test as an LDT. Should the FDA not agree with our characterization of the IVD test as a LDT, the IVD test may be subject to
additional regulatory requirements for clinical use including pre-market review and post-market regulatory requirements, and we may not be permitted to continue to market our test as an LDT pending
clearance of the IVD. We may be subject to fines, penalties, and removal of the LDT from the market, which could further result in lost revenues, damage to our reputation, and delays in the validation
of the IVD. In the United States, IVD tests are regulated as medical devices. The Federal Food, Drug, and Cosmetic Act, or the FDCA, and its implementing regulations, and other federal and state
statutes and regulations govern, among other things, medical device design and development, preclinical and clinical testing, premarket clearance or approval, registration and listing, manufacturing,
labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market surveillance. To be commercially distributed in the United States, medical devices must receive
from the FDA prior to marketing, unless subject to an exemption, approval of a premarket approval application, or PMA, for most Class&nbsp;III
devices, clearance of a 510(k) premarket notification, or classification pursuant to a </FONT><FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> submission. A clinical trial is almost always required to
support a PMA application and is sometimes required for 510(k) clearance. All clinical studies of medical devices must be conducted in compliance with any applicable FDA and Institutional Review Board
requirements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
can be no assurance that a diagnostic test will be classified as a Class&nbsp;II medical device, and even if it is, there can be no assurance that it will receive marketing
authorization from the FDA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
parallel with the FDA approval process for our IVD test, we are progressing towards submitting a data package which would enable CE marking and associated marketing approval in key
European markets during 2020. As with the United States approval process, the CE marking process in the European Economic Area, or the EEA, can be lengthy and expensive. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulatory
authorities in countries outside of the United States and Europe also have requirements for approval of drug candidates and diagnostics with which we must comply prior to
marketing in those countries. Obtaining regulatory approval for marketing of a drug candidate or diagnostic in one country does not ensure that we will be able to obtain regulatory approval in any
other country. In addition, delays in approvals or rejections of marketing applications in the United States, Europe or other countries may be based upon many factors, including regulatory requests
for additional analyses, reports, data, preclinical studies and clinical trials, regulatory questions regarding different interpretations of data and results, changes in regulatory policy during the
period of product development and the emergence of new information regarding our product candidates or other products. Also, regulatory approval for any of our product candidates may be withdrawn. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=21,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=626599,FOLIO='16',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are unable to obtain approval from the FDA, the EMA or other regulatory agencies for elafibranor, our IVD test and our other product candidates, or if, subsequent to approval, we
are unable to successfully commercialize elafibranor, our IVD test or our other product candidates, we will not be able to generate sufficient revenue to become profitable or to continue our
operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are developing our lead product candidate, elafibranor for the treatment of NASH, a condition for which no
drug has yet been commercialized and for which there is little clinical experience. As a result, our development approach involves new endpoints and methodologies. There is risk that the outcome of
our clinical trials will not be favorable or that, even if favorable, regulatory authorities may not find the results of our clinical trials to be sufficient for marketing approval.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are focused on developing therapeutics for the treatment of NASH, a disease for which there are currently no approved treatments. As a
result, the design and conduct of clinical trials for these diseases and other indications we may pursue will be subject to increased risk. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA and EMA generally require two pivotal clinical trials to approve an NDA or MAA. Furthermore, for full approval of an NDA or MAA, the FDA or EMA, respectively, require a
demonstration of efficacy based on a clinical benefit endpoint. The FDA can grant accelerated approval for a new drug if it complies with the following criteria: (1)&nbsp;it treats a serious
condition, (2)&nbsp;it provides a meaningful advantage over available therapies and (3)&nbsp;it demonstrates an effect on an endpoint reasonably likely to predict clinical benefit. Our pivotal
Phase&nbsp;3 RESOLVE-IT clinical trial of elafibranor in NASH incorporates a surrogate endpoint that may serve as the basis for an NDA filing for accelerated approval by the FDA in the United States
and conditional approval by the EMA in Europe. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similarly,
the EMA may give a positive opinion for conditional marketing authorization based on interim clinical data for a medicinal product for human use if (1)&nbsp;the risk-benefit
balance of the product is positive, (2)&nbsp;it is likely that the applicant will be in a position to provide the required comprehensive clinical trial data, (3)&nbsp;unmet medical needs will be
fulfilled and (4)&nbsp;the benefit to public health of the immediate availability on the market of the medicinal product outweighs the risk inherent in the fact that additional data are still
required. Specific obligations, including with respect to the completion of ongoing or new studies, and with respect to the collection of pharmacovigilance data, may be specified in the conditional
marketing authorization. Conditional marketing authorizations are valid for one year, and may be renewed annually, if the risk-benefit balance remains positive, and after an assessment of the need for
additional or modified conditions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the results of our interim cohort analysis in our pivotal Phase&nbsp;3 RESOLVE-IT clinical trial are positive, the FDA may grant accelerated approval, and the EMA may grant
conditional approval, for elafibranor in the treatment of NASH. However, there can be no assurance that our interim results will be positive and even if results from our interim results are highly
significant and we believe reasonably likely to predict clinical benefit, the FDA and EMA may not accept the results of such trial as sufficiently significant to grant accelerated or conditional
approval of elafibranor for NASH, without obtaining additional clinical data. In addition, even if we obtain accelerated or conditional marketing approval for our product candidate, elafibranor in
NASH on the basis of an interim analysis, like all companies using the Subpart&nbsp;H and conditional approval pathway, we must continue the RESOLVE-IT trial post-marketing in order to demonstrate
the efficacy of elafibranor on clinical benefit based on a composite endpoint of clinical outcomes, which include all-cause mortality, the progression to cirrhosis, and a full list of
cirrhosis-related events such as liver transplantation, Model for End-Stage Liver Disease, or MELD score <FONT FACE="SYMBOL">&#179;</FONT>15, and
hepatocellular carcinoma, or HCC, on the full trial population, with the goal of obtaining full marketing approval. Depending on the outcome, the FDA or EMA could revoke the previously granted
approval, and additional clinical data to submit for marketing approval may be required. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=22,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=108558,FOLIO='17',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
we have obtained fast track designation from the FDA for elafibranor in the treatment of NASH, which permits more frequent contact between us and the FDA, the final
acceptability of these regulatory pathways (accelerated or conditional approval) for elafibranor for the treatment of NASH will depend upon the clinical results from the RESOLVE-IT trial and the
review by the FDA and EMA of our applications. As a result, we may face difficulty in designing an acceptable registration strategy around RESOLVE-IT or any other trials in different subpopulations of
NASH patients. It may be expensive and time consuming to conduct and complete additional preclinical studies and clinical trials that the FDA, EMA and other regulatory authorities may require us to
perform. As such, any requirement by the FDA, EMA or other regulatory authorities that we conduct additional preclinical studies or clinical trials could materially and adversely affect our business,
financial condition and results of operations. Furthermore, even if we receive regulatory approval of elafibranor for the treatment of NASH, the labeling for our product candidates in the United
States, Europe or other countries in which we have received or seek approval may include limitations that could impact the commercial success of our product candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
the successful commercialization of elafibranor depends in part on our ability to obtain regulatory approval to market our IVD test. NASH is currently an under-diagnosed
disease, and we believe that our non-invasive IVD test will reduce barriers to entry for elafibranor by facilitating the diagnosis and identification of NASH patients who may be well suited for drug
therapy. If our IVD test does not obtain marketing authorization, we may not be able to generate significant revenues even if such diagnostic were to be marketed as a laboratory developed test, or
LDT. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have obtained fast track designation from the FDA for elafibranor in the treatment of NASH and we may seek
to avail ourselves of such mechanisms to expedite the development or approval of our other drug candidates in the future, but such mechanisms may not actually lead to a faster development or
regulatory review or approval process.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 2014, the FDA granted fast track designation for elafibranor in the treatment of NASH. We may also seek fast track designation for our other
drug candidates, and we may seek priority review or accelerated approval for elafibranor or any other drug candidate we may pursue in the future. The FDA's fast track program is designed to facilitate
the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions, and that demonstrate the potential to address unmet medical needs. The fast
track designation for elafibranor in
NASH permits more frequent contact between us and the FDA. Even though elafibranor has received fast track designation for the treatment of NASH, and even if we do obtain fast track or priority review
designation or pursue an accelerated approval pathway in elafibranor or our other drug candidates in the future, we may not experience a faster development process, review or approval compared to
conventional FDA procedures. Additionally, the FDA may withdraw a particular designation, including our fast track designation for the development of elafibranor in the treatment of NASH, if it
believes that the designation is no longer supported by data from our clinical development program. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


A breakthrough therapy designation by the FDA for a drug candidate may not lead to a faster development or
regulatory review or approval process, and it may not increase the likelihood that a drug candidate will receive marketing approval.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may seek a breakthrough therapy designation for elafibranor in PBC or any other drug candidate we may pursue in the future. A breakthrough
therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence
indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. For drugs that are designated as breakthrough therapies,
interaction and communication between the FDA and the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=23,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=786218,FOLIO='18',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_19"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>sponsor
can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designation
as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe a drug candidate meets the criteria for designation as a breakthrough therapy,
the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a breakthrough therapy designation for a drug candidate may not result in a faster development
process, review or approval compared to conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more drug candidate qualifies as a breakthrough
therapy, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If the FDA does not conclude that certain of our product candidates satisfy the requirements for the
Section&nbsp;505(b)(2) regulatory approval pathway, or if the requirements for such product candidates under Section&nbsp;505(b)(2) are not as we expect, the approval pathway for those product
candidates may likely take significantly longer, cost significantly more and entail significantly greater complications and risks than anticipated, and in either case may not be successful.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are currently conducting a clinical-stage program based on drug repositioning to develop an anti-fibrotic drug candidate, nitazoxanide, or
NTZ, for which we may seek FDA approval through the Section&nbsp;505(b)(2) regulatory pathway. The Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman Act,
added Section&nbsp;505(b)(2) to the FDCA. Section&nbsp;505(b)(2) permits the filing of an NDA where at least some of the information required for approval comes from trials that were not conducted
by or for the applicant and for which the applicant has not obtained a right of reference. Section&nbsp;505(b)(2), if applicable to us under the FDCA, would allow an NDA we submit to the FDA to rely
in part on data in the public domain or the FDA's prior conclusions regarding the safety and effectiveness of approved compounds, which could expedite the development program for our product
candidates by potentially decreasing the amount of clinical data that we would need to generate in order to obtain FDA approval. The Phase&nbsp;2 clinical trial of NTZ in NASH-induced fibrosis was
allowed on the basis of the existing FDA evaluations of safety in the currently-approved indication, which is a hallmark of the Section&nbsp;505(b)(2) regulatory pathway. As we progress the clinical
program, we plan to initiate such discussions with the FDA. If the FDA does not allow us to pursue the Section&nbsp;505(b)(2) regulatory pathway as we anticipated, we may need to conduct additional
clinical trials, provide additional data and information and meet additional standards for regulatory approval. Even if we are allowed to pursue the Section&nbsp;505(b)(2) regulatory pathway, we
cannot assure you that our product candidates will receive the requisite approvals for commercialization. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the pharmaceutical industry is highly competitive, and Section&nbsp;505(b)(2) NDAs are subject to special requirements designed to protect the patent rights of sponsors of
previously approved drugs that are referenced in a Section&nbsp;505(b)(2) NDA. These requirements may give rise to patent litigation and mandatory delays in approval of our NDAs for up to
30&nbsp;months or longer depending on the outcome of any litigation. It is not uncommon for a manufacturer of an approved product to file&nbsp;a citizen petition with the FDA seeking to delay
approval of, or impose additional approval requirements for, pending competing products. If successful, such petitions can significantly delay, or even prevent, the approval of the new product.
However, even if the FDA ultimately denies such a petition, the FDA may substantially delay approval while it considers and responds to the petition. In addition, even if we are able to utilize the
Section&nbsp;505(b)(2) regulatory pathway, there is no guarantee this would ultimately lead to accelerated product development or earlier approval. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
even if our product candidates are approved under Section&nbsp;505(b)(2), the approval may be subject to limitations on the indicated uses for which the products may be
marketed or to other conditions of approval, or may contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the products. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=24,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=529653,FOLIO='19',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Delays in the commencement, enrollment and completion of clinical trials could result in increased costs to
us and delay or limit our ability to obtain regulatory approval for elafibranor and our other product candidates.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delays in the commencement, enrollment and completion of clinical trials could increase our product development costs or limit the regulatory
approval of our drug candidates and IVD test. We currently have underway a number of trials including our pivotal Phase&nbsp;3 RESOLVE-IT clinical study of elafibranor in NASH. We may also be
required to conduct additional clinical trials of elafibranor, our other drug candidates or our IVD test. In the past, we have experienced some delays in enrollment in our clinical trials. We continue
to work towards expanding our overall elafibranor development program with additional trials and studies, including in pediatric patients, and we plan on conducting additional development activities
in other diseases. The results from these trials may not be available when we expect or we may be required to conduct additional clinical trials or preclinical studies not currently planned to receive
approval for elafibranor as a treatment for the relevant indication. In addition, our clinical programs are subject to a number of variables and contingencies, such as the results of other trials,
patient enrollments or regulatory interactions that may result in a change in timing. As such, we do not know whether any future trials or studies in elafibranor or our other product candidates will
begin on time or will be completed on schedule, if at all. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
commencement, enrollment and completion of clinical trials can be delayed or suspended for a variety of reasons, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to demonstrate sufficient safety and efficacy to obtain regulatory approval to commence a clinical trial; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to validate test methods to support quality testing of the drug substance and drug product; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to determine dosing and clinical trial design; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to obtain sufficient funds required for a clinical trial or lack of adequate funding to continue the clinical trial due to unforeseen
costs or other business decisions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our inability to enter into collaborations relating to the development and commercialization of our product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to reach agreements on acceptable terms with prospective contract research organizations, or CROs, and trial sites, the terms of
which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> clinical holds, other regulatory objections to commencing or continuing a clinical trial or the inability to obtain regulatory approval to
commence a clinical trial in countries that require such approvals; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> discussions with the FDA, EMA or other non-U.S. regulators regarding the scope or design of our clinical trials, which may occur at various
times, including subsequent to the initiation of the clinical trial; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> governmental or regulatory delays and changes in regulatory requirements, policy and guidelines, including mandated changes in the scope or
design of clinical trials or requests for supplemental information with respect to clinical trial results; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> varying interpretations of our data, and regulatory commitments and requirements by the FDA, EMA and similar regulatory agencies; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to identify and maintain a sufficient number of trial sites, many of which may already be engaged in other clinical trial programs,
including some that may be for the same indications targeted by our product candidates; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=25,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=778359,FOLIO='20',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_ck10701_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the delay in receiving results from or the failure to achieve the necessary results in other clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to obtain approval from institutional review boards, or IRBs, to conduct a clinical trial at their respective sites; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> lack of effectiveness of product candidates during clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> suspension or termination by a data and safety monitoring board, or DSMB, that is overseeing the clinical trial; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> changes in the standard of care on which a clinical development plan was based, which may require new or additional trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our failure to conduct clinical trials in accordance with regulatory requirements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> severe or unexpected drug-related adverse effects experienced by patients or any determination that a clinical trial presents unacceptable
health risks; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a breach of the terms of any agreement with, or for any other reason by, current or future collaborators that have responsibility for the
clinical development of any of our product candidates, or investigators leading clinical trials on our product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to timely manufacture or deliver sufficient quantities of the product candidate required for preclinical studies or clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> difficulty identifying, recruiting and enrolling patients to participate in clinical trials for a variety of reasons, including meeting the
enrollment criteria for our trial, the rarity of the disease or condition, the rarity of the characteristics of the population being studied, the nature of the protocol, the risks of procedures that
may be required as part of the trial, such as a liver biopsy, the availability of effective treatments for the relevant disease and the eligibility criteria for the clinical trial, and competition
from other clinical trial programs for the same indications as our product candidates; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to retain enrolled patients after a clinical trial is underway. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
example, our RESOLVE-IT trial is a large and complex Phase&nbsp;3 clinical trial in 2,000 patients, in a disease without any approved therapies and the diagnosis of which generally
involves invasive
procedures such as liver biopsies. Additionally, there are a number of companies developing product candidates for the treatment of NASH, and, as a result, there may be increased competition for
enrolling patients in clinical trials involving the treatment of NASH. Furthermore, if one of our competitors' products is approved by the FDA or another regulatory body for the treatment of NASH
before elafibranor is approved, we may experience difficulties enrolling patients in our clinical trials and retaining patients in any of our existing clinical trials. While we announced the
completion of enrollment of the first approximately 1,000 patients in the interim analysis cohort in April 2018, and continuously evaluate and implement a variety of options to complete enrollment as
quickly as possible, there can be no assurance that we will be able to enroll and retain a sufficient number of patients or complete the interim analysis and trial on a timely basis. As we engage in
other large and complicated trials and trials in advanced disease populations, we may experience a number of complications that may negatively affect our plans or our development programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
we have not had difficulties in the past retaining patients after enrollment in our clinical trials, changes in the treatment of NASH, such as the approval of a drug therapy for
the treatment of NASH by one of our competitors, could result in difficulties retaining or enrolling patients in our clinical trials. Any difficulty retaining patients may in the future delay or
produce negative or inconclusive results from our clinical trials, and we or our collaborators may decide, or regulators may require us, to conduct additional clinical trials or preclinical studies.
Any delay or compromises with respect to the validity of our clinical trials may have a material adverse effect on our business or decrease our competitive position relative to other biotechnology or
pharmaceutical companies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, if we are required to conduct additional clinical trials or other preclinical studies of our product candidates beyond those contemplated, our ability to obtain regulatory
approval of these product candidates and generate revenue from their sales would be similarly harmed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=26,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=567089,FOLIO='21',FILE='DISK124:[18ZFA1.18ZFA10701]CK10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cm10701_1_22"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Clinical failure can occur at any stage of clinical development. The results of earlier clinical trials are
not necessarily predictive of future results and any product candidate we or our potential future collaborators advance through clinical trials may not have favorable results in later clinical trials
or receive regulatory approval.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical failure can occur at any stage of our clinical development. Clinical trials may produce negative or inconclusive results, and we may
decide, or regulators may require us, to conduct additional clinical trials or preclinical studies. In addition, data obtained from trials and studies are susceptible to varying interpretations, and
regulators may not interpret our data as favorably as we do, which may delay, limit or prevent regulatory approval. Success in preclinical studies and early clinical trials does not ensure that
subsequent clinical trials will generate the same or similar results or otherwise provide adequate data to demonstrate the efficacy and safety of a product candidate. A number of companies in the
pharmaceutical industry, including those with greater resources and experience than us, have suffered significant setbacks in Phase&nbsp;3 clinical trials and at other stages of clinical
development, even after seeing promising results in earlier clinical trials. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
our Phase&nbsp;2b clinical trial of elafibranor in NASH, GOLDEN-505, achieved resolution of NASH without worsening of fibrosis, which is the FDA-recommended primary endpoint
of our ongoing Phase&nbsp;3 RESOLVE-IT clinical trial, this was not the original endpoint for our Phase&nbsp;2b trial. Despite the results of our retrospective analysis of the Phase&nbsp;2b
results to correct for baseline severity and site heterogeneity by a standardized statistical analysis, we cannot assure you that our RESOLVE-IT trial will achieve positive results with this
Phase&nbsp;3 endpoint, and regulators may request additional clinical data to support regulatory approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the design of a clinical trial can determine whether its results will support approval of a product and flaws in the design of a clinical trial may not become apparent until
the clinical trial is well-advanced. We may be unable to design and execute a clinical trial to support regulatory approval. Further, clinical trials of potential products often reveal that it is not
practical or feasible to continue development efforts. If elafibranor or our other product candidates are found to be unsafe or lack efficacy for any indication, we will not be able to obtain
regulatory approval for them, and our prospects and business may be materially and adversely affected. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
elafibranor or our other product candidates are found to be unsafe or lack efficacy, we will not be able to obtain regulatory approval for them and our business would be harmed. For
example, if the results of our Phase&nbsp;3 RESOLVE-IT trial of elafibranor do not achieve the primary efficacy endpoints or demonstrate expected safety, the prospects for approval of elafibranor
would be materially and adversely affected. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
some instances, there can be significant variability in safety and/or efficacy results between different trials of the same product candidate due to numerous factors, including
changes or differences in trial protocols, patient distribution by clinical investor site, standards of care across sites, differences in composition of the patient populations, adherence to the
dosing regimen and other trial protocols and the rate of dropout among clinical trial participants. We do not know whether any Phase&nbsp;2, Phase&nbsp;3 or other clinical trials we or any of our
collaborators may conduct will demonstrate consistent or adequate efficacy and safety to obtain regulatory approval to market our product candidates. If we are unable to bring any of our current or
future product candidates to market, or to acquire any marketed, previously approved products, our ability to create long-term shareholder value will be limited. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=27,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=63204,FOLIO='22',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in regulatory requirements, guidance from regulatory authorities or unanticipated events during our
clinical trials of our product candidates could necessitate changes to clinical trial protocols or additional clinical trial requirements, which would result in increased costs to us and could delay
our development timeline.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in regulatory requirements, FDA guidance or guidance from the EMA or other European or foreign regulatory authorities, or unanticipated
events during our clinical trials, may force us to amend clinical trial protocols or to otherwise alter the regulatory approval or clearance process and timeline for our drug candidates and/or our IVD
test. Regulatory authorities could also impose additional clinical trial requirements. Amendments to our clinical trial protocols would require resubmission to the FDA, EMA, national clinical trial
regulators and IRBs for review and approval, which may adversely impact the cost, timing or successful completion of a clinical trial. If we experience delays completing, or if we terminate, any of
our clinical trials, or if we are required to conduct additional clinical trials, the commercial prospects for our product candidates may be harmed and our ability to generate product revenue will be
delayed. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We depend on third-party contractors for a substantial portion of our operations and may not be able to
control their work as effectively as if we performed these functions ourselves.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our supervision, we outsource substantial portions of our operations to third-party service providers, including preclinical studies and
clinical trials, collection and analysis of data and manufacturing of our drug candidates and IVD test. In particular, we subcontract the design and/or conduct of our clinical trials to CROs, as well
as the manufacturing of our active ingredients and therapeutic units to contract manufacturing organizations, or CMOs, especially with regard to our Phase&nbsp;3 RESOLVE-IT trial. We also contract
with external investigators and other specialized services providers, for example with respect to certain statistical analyses, to perform services such as carrying out and supervising, and
collecting, analyzing and formatting of data for our trials. Although we are involved in the design of the protocols for these trials and in monitoring them, we do not control all the stages of test
performance and cannot guarantee that the third parties will fulfill their contractual and regulatory obligations. In particular, a contractor's failure to comply with protocols or regulatory
constraints, or repeated delays by a contractor, could compromise the development of our products or result in liability for us. Such events could also inflate the product development costs borne by
us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
strategy means that we do not directly control certain key aspects of our product development, such as:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the quality of the product manufactured; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the delivery times for therapeutic units (pre-packaged lots specifically labeled for a given clinical trial); </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the clinical and commercial quantities that can be supplied; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compliance with applicable laws and regulations. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
our development activities or clinical trials conducted in reliance on third parties may be delayed, suspended, or terminated if:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the third parties do not devote a sufficient amount of time or effort to our activities or otherwise fail to successfully carry out their
contractual duties or to meet regulatory obligations or expected deadlines; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we replace a third party; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the quality or accuracy of the data obtained by third parties is compromised due to their failure to adhere to clinical protocols, regulatory
requirements, or for other reasons. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=28,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=908181,FOLIO='23',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
generally would not have the ability to control the performance of third parties in their conduct of development activities. In the event of a default, bankruptcy or shutdown of, or a
dispute with, a third party, we may be unable to enter into a new agreement with another third party on commercially acceptable terms. Further, third-party performance failures may increase our
development costs, delay our ability to obtain regulatory approval, and delay or prevent the commercialization of our product candidates. In addition, our third-party agreements usually contain a
clause limiting such third party's liability, such that we may not be able to obtain full compensation for any losses we may incur in connection with the third party's performance failures. While we
believe that there are numerous alternative sources to provide these services, in the event that we seek such alternative sources, we may not be able to enter into replacement arrangements without
incurring delays or additional costs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We rely entirely on third parties for the manufacturing of our drug candidates and IVD test for preclinical
studies and clinical trials, including one manufacturer for the active ingredient in elafibranor and another manufacturer for the therapeutic units of elafibranor used in our clinical trials. Our
business could be harmed if those third parties fail to provide us with sufficient quantities of drug product, or fail to do so at acceptable quality levels or prices.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not intend to manufacture the drug products or IVD test that we plan to sell. We currently have agreements with a contract manufacturer
for the production of the active pharmaceutical ingredients and the formulation of sufficient quantities of drug product for our preclinical studies and clinical trials that we plan to conduct prior
to and after seeking regulatory approval. We rely on one supplier for the active ingredient in elafibranor and another manufacturer for the therapeutic units of elafibranor used in our clinical
trials. If either of those contract manufacturers should cease to provide services to us for any reason, we likely would experience delays in advancing our clinical trials while we identify and
qualify one or more replacement suppliers and we may be unable to obtain replacement supplies on terms that are favorable to us. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
we believe that our current inventory and drugs in production at various levels of the production chain are sufficient for our needs on a short-term basis, a failure at both of the
storage sites of the therapeutic units used for the RESOLVE-IT study would be critical. We are also in the process of qualifying one or more back-up suppliers for our active ingredient and therapeutic
units; however, we may not be able to enter into additional long-term commercial supply agreements for elafibranor with other third-party manufacturers on terms sufficiently advantageous to us. We do
not have agreements for long-term supplies of any of our other product candidates. We currently obtain these supplies and services from our third-party contract manufacturers on a purchase order
basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
the facilities used by any contract manufacturer to manufacture elafibranor or any of our other product candidates must be the subject of a satisfactory inspection before
the FDA, the EMA or the regulators in other jurisdictions that approve the product candidate manufactured at that facility. We are completely dependent on these third-party manufacturers for
compliance with the requirements of U.S. and non-U.S. regulators for the manufacture of our finished products. If our manufacturers cannot successfully manufacture material that conform to our
specifications and current good manufacturing practice requirements of any governmental agency whose jurisdiction to which we are
subject, our products or product candidates will not be approved or, if already approved, may be subject to recalls or other enforcement action. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reliance
on third-party manufacturers entails risks to which we would not be subject if we manufactured the products or product candidates,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the possibility that we are unable to enter into or renew a manufacturing agreement with a third party to manufacture elafibranor or our
product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the possible breach of the manufacturing agreements by the third parties because of factors beyond our control; and </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=29,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=619131,FOLIO='24',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_25"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the possibility of termination or nonrenewal of the agreements by the third parties before we are able to arrange for a qualified replacement
third-party manufacturer. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of these factors could cause the delay of approval or disruption of commercialization of our products or product candidates, cause us to incur higher costs, prevent us from
commercializing our products and product candidates successfully or disrupt the supply of our products after commercial launch. Furthermore, if any of our contract manufacturers fail to deliver the
required commercial quantities of finished product on acceptable commercial terms and we are unable to find one or more replacement manufacturers capable of production at substantially equivalent
cost, volume and quality and on a timely basis, we would likely be unable to meet demand for our products and could lose potential revenue. It may take several years to establish an alternative source
of supply and to have any such new source approved by the government agencies that regulate our products. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have entered, and may in the future enter into, collaboration agreements with third parties for the
development and eventual commercialization of our product candidates, which may affect our ability to generate revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have limited experience in product development and may seek to enter into collaborations with third parties for the development and potential
commercialization of our early stage and preclinical product candidates, particularly those candidates outside of our main therapeutic areas of interest. In January 2019, we entered into a license
agreement with LabCorp to allow them to deploy our IVD test in the clinical research space. Should we seek to collaborate with additional third parties with respect to our development programs, we may
not be able to locate a suitable collaborator and may not be able to enter into an agreement on commercially reasonable terms or at all. Even if we succeed in securing collaborators for the
development and commercialization of our product candidates, we have limited control over the amount and timing that our collaborators may dedicate to the development or commercialization of our
product candidates. These collaborations pose a number of risks, including that the collaborators may:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> not have sufficient resources or decide not to devote the necessary resources due to internal constraints such as budget limitations, lack of
human resources, or a change in strategic focus; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> believe our intellectual property is not valid or is unenforceable or the product candidate infringes on the intellectual property rights of
others; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> dispute their responsibility to conduct development and commercialization activities pursuant to the applicable collaboration, including the
payment of related costs or the division of any revenues; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> decide to pursue a competitive product developed outside of the collaboration arrangement; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> not be able to obtain, or believe they cannot obtain, the necessary regulatory approvals; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> delay the development or commercialization of our product candidates in favor of developing or commercializing another party's product
candidate. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thus,
collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. For example, although we have entered into a
license agreement with LabCorp to use our IVD test for clinical research purposes, LabCorp is under no obligation to do so and may choose not to further develop and deploy the test. There is no
guarantee that our collaboration with LabCorp will result in widespread clinical or commercial use of our IVD test. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Some
collaboration agreements may be terminated without cause on short notice. Once a collaboration agreement is signed, it may not lead to commercialization of a product candidate. We
also face competition in seeking out collaborators. If we are unable to secure new collaborations that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=30,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=713046,FOLIO='25',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_26"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>achieve
the collaborator's objectives and meet our expectations, we may be unable to advance our product candidates and may not generate meaningful revenues. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Due to our limited resources and access to capital, our strategic decisions with respect to the development
of certain product candidates may affect the development or timing of our business prospects.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because we have limited resources and access to capital to fund our operations, we must decide which product candidates to pursue and the amount
of resources to allocate to each. As such, we are currently primarily focused on the development of elafibranor for the treatment of NASH and PBC, and the parallel development of our IVD test for
identifying NASH patients who may be appropriate candidates for drug therapy. Our decisions concerning the allocation of research, collaboration, management and financial resources toward particular
compounds, programs, product candidates or therapeutic areas may not lead to the development of viable commercial products and may divert resources away from more promising opportunities. We may not
choose the right product
candidates or programs to develop, or may be required to collaborate with third parties to advance a particular product candidate at terms that are less than optimal to us. If we make incorrect
determinations regarding the market potential of our product candidates or misread trends in the pharmaceutical industry, our business prospects could be harmed. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our product candidates may have undesirable side effects which may delay or prevent marketing approval, or,
if approval is received, require our product candidates to be taken off the market, require them to include safety warnings or otherwise limit their sales.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While we have not observed any significant side effects in our product candidates to date, unforeseen side effects from any of our product
candidates could arise either during clinical development or, if approved, after the approved product has been marketed. If severe side effects were to occur, or if elafibranor or one of our other
product candidates is shown to have other unexpected characteristics, we may need to either restrict our use of such product to a smaller population or abandon our development of elafibranor for NASH,
PBC and other potential indications. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, our product candidates are being developed as potential treatments for severe, life-threatening diseases and, as a result, our trials will necessarily be conducted in a
patient population that will be more prone than the general population to exhibit certain disease states or adverse events. For example, NASH patients may suffer from other co-morbidities such as
diabetes, cardiovascular disease and obesity that may increase the likelihood of certain adverse events. It may be difficult to discern whether certain events or symptoms observed during our trials
were due to our product candidates or some other factor, resulting in our company and our development programs being negatively affected even if such events or symptoms are ultimately determined to be
unlikely related to our drugs and drug candidates. We further cannot assure you that additional or more severe adverse side effects with respect to elafibranor will not develop in future clinical
trials or commercial use, which could delay or preclude regulatory approval of elafibranor or limit its commercial use. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we or others later identify undesirable or unacceptable side effects caused by our products or product candidates:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> regulatory authorities may require the addition of labeling statements, specific warnings, a contraindication or field alerts to physicians and
pharmacies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may be required to change instructions regarding the way the product is administered, conduct additional clinical trials or change the
labeling of the product; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may be subject to limitations on how we may promote the product; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> sales of the product may decrease significantly; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=31,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=671839,FOLIO='26',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_27"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> regulatory authorities may require us to take our approved product off the market; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may be subject to litigation or product liability claims; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our reputation may suffer. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to the Commercialization of Our Drug Candidates and Diagnostic Test  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Even if we successfully complete clinical trials of our product candidates, those candidates may not be
commercialized successfully for other reasons.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even if we successfully complete clinical trials for one or more of our product candidates and obtain relevant regulatory approvals or
clearance, those candidates may not be commercialized for other reasons, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> being subject to proprietary rights held by others; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> failing to obtain or otherwise manufacture commercial supply of our approved products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> failing to obtain clearance from regulatory authorities on the manufacturing of our products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> failing to establish sales, marketing and distribution capabilities to effectively market and sell elafibranor and our IVD test in the United
States, Europe and other territories; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> having adverse side effects that make their use less desirable; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> difficulties in negotiating and securing coverage and adequate reimbursement, or the failure to do so, from third-party payors for elafibranor,
our IVD test or any of our other drug candidates, if approved or cleared; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> inability to secure market acceptance by patients and the medical community of elafibranor, our IVD test or any of our other drug candidates,
if approved or cleared; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> failing to compete effectively with products or treatments commercialized by competitors; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> failing to show that the long-term benefits of our products exceed their risks. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Even if approved, our product candidates may not achieve broad market acceptance among physicians, patients
and healthcare payors, and as a result our revenues generated from their sales may be limited.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The commercial success of elafibranor, our IVD test or our other drug candidates, if approved or cleared, will depend upon their acceptance
among the medical community, including physicians, healthcare payors and patients. Given that no products are currently approved for the treatment of NASH, we do not know the degree to which
elafibranor will be accepted as a therapy, if approved. There are, however, a number of products being developed by other companies for the treatment of NASH, and elafibranor may compete with these
products for market acceptance in the future, if any of them are approved. Additionally, we cannot be assured that our IVD test will be accepted by the medical community as a means of identifying NASH
patients who may be appropriate candidates for drug intervention, and even if our IVD test is used, a physician may still order a liver biopsy to confirm the diagnosis. The degree of market acceptance
of elafibranor, our IVD test and any of our other drug candidates that may be approved will depend on a number of factors, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> changes in the standard of care or availability of alternative therapies at similar or lower costs for the targeted indications for any of our
product candidates, such as competitors' product candidates for the treatment of NASH or an alternative to liver biopsy for the diagnosis of NASH; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> limitations in the approved clinical indications or patient populations for our product candidates; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=32,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=110959,FOLIO='27',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_28"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> demonstrated clinical safety and efficacy compared to other products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> limitations or warnings, including boxed warnings, contained in our drug candidates' FDA- or EMA-approved labeling; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> in the case of elafibranor, our ability to access the under-diagnosed NASH market; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> lack of significant adverse side effects; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> sales, marketing and distribution support; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> availability of coverage and adequate reimbursement from managed care plans and other third-party payors; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> timing of market introduction and perceived effectiveness of competitive products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the degree of cost-effectiveness; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> availability of alternative therapies at similar or lower cost, including generics and over-the-counter products; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the extent to which our product candidates are approved for inclusion on formularies of hospitals and managed care organizations; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether our drug candidates are designated under physician treatment guidelines for the treatment of the indications for which we have received
regulatory approval; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> adverse publicity about our product candidates or favorable publicity about competitive products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> convenience and ease of administration of our product candidates; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> potential product liability claims. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
our product candidates are approved, but do not achieve an adequate level of acceptance by physicians, patients, the medical community and healthcare payors, sufficient revenue may
not be generated from these products and we may not become or remain profitable. In addition, efforts to educate the medical community and third-party payors on the benefits of our product candidates
may require significant resources and may never be successful. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to establish sales, marketing and distribution capabilities for our product candidates,
whether it be via an internal infrastructure or an arrangement with a commercial partner, we may not be successful in commercializing those product candidates if and when they are approved.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have no sales, marketing or distribution experience and if we are unable to establish sales, marketing and distribution capabilities, we may
not be successful in commercializing our product candidates if and when they are approved. To develop internal sales, distribution and marketing capabilities, we have already begun to invest
significant amounts of financial and management resources, and we will continue to do so, even prior to any confirmation that elafibranor or any of our other product candidates will be approved. In
particular, if elafibranor obtains marketing authorization in NASH and/or PBC, we may decide to market elafibranor in certain territories by ourselves, and/or market it in other territories in
collaboration with one or more pharmaceutical partner and/or specialized local distributor. Additionally, in connection with the development of our IVD test, we entered into a license agreement with
LabCorp to allow them to deploy the test in the clinical research space. If we decide to market any of our products ourselves, we would need to develop our own sales and marketing capabilities. For
elafibranor or any other product candidates where we decide to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=33,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=219390,FOLIO='28',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>perform
sales, marketing and distribution functions ourselves or through third parties, we could face a number of additional risks, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we or our third-party sales collaborators may not be able to attract and build an effective marketing or sales force; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our sales personnel may be unable to obtain access to physicians or persuade adequate numbers of physicians to prescribe any future products; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the cost of securing or establishing a marketing or sales force may exceed the revenues generated by any products; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our direct sales and marketing efforts may not be successful. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are unable to establish our own sales, marketing and distribution capabilities and decide to enter into arrangements with third parties to perform these services, our revenue and
our profitability, if any, are likely to be lower than if we were to sell, market and distribute any products that we develop ourselves. Additionally, such collaboration agreements with partners may
limit our control over the marketing of our products and expose us to a number of risks, including the risk that the partner will not prioritize the marketing of the product candidate or diagnostic
test candidate or does not provide sufficient resources for its commercialization. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may form or seek strategic alliances or enter into licensing or co-marketing arrangements in the future to
commercialize our approved drugs or diagnostic products, and we may not realize the benefits of such arrangements.  </I></B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may enter into licensing arrangements with third parties that we believe will complement or augment our commercialization efforts,
particularly with respect to elafibranor and our IVD test. For example, in January 2019, we entered into a license agreement with LabCorp to allow them to deploy our IVD test in the clinical research
space. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing shareholders or
disrupt our management and business. Our likely collaborators include, in the case of elafibranor, large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and
biotechnology companies, or, in the case of our IVD test, a major global diagnostic company. If we enter into any such arrangements with any third parties, we will likely have limited control over the
amount and timing of resources that our collaborators dedicate to the
development or commercialization of elafibranor or any other product candidate. Our ability to generate revenues from these arrangements will depend on our collaborators' abilities to successfully
perform the functions assigned to them in these arrangements. We cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies
such transaction.

</FONT>

</P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collaborations
involving elafibranor, our IVD test or any of our other drug candidates pose the following risks to us:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators may not perform their obligations as expected; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators may not pursue commercialization or may elect not to continue or renew commercialization programs based on changes in the
collaborator's strategic focus or available funding or external factors such as an acquisition that diverts resources or creates competing priorities; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=34,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=649185,FOLIO='29',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<A NAME="page_cm10701_1_30"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product
candidate if the collaborators believe that competitive products are more likely to be successfully commercialized under terms that are more economically attractive than ours; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a collaborator with marketing and distribution rights to one or more product candidates may not commit sufficient resources to the marketing
and distribution of any such product candidate; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to
invite litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> disputes may arise between the collaborators and us that result in the delay or termination of the commercialization of our product candidate
or that result in costly litigation or arbitration that diverts management attention and resources; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may lose certain valuable rights under circumstances identified in our collaborations, including if we undergo a change of control; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or
commercialization of the applicable product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators may learn about our discoveries and use this knowledge to compete with us in the future; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> there may be conflicts between different collaborators that could negatively affect those collaborations and potentially others; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the number and type of our collaborations could adversely affect our attractiveness to future collaborators or acquirers; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaboration agreements may not lead to commercialization of our product candidate in the most efficient manner or at all. If a present or
future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our commercialization program under such collaboration could be delayed, diminished or
terminated; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> collaborators may be unable to obtain the necessary marketing approvals. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
future collaboration partners fail to develop or effectively commercialize elafibranor, our IVD test or any other drug candidate for any of these reasons, such product candidate may
not be cleared for sale and our sales of such product candidate, if approved, may be limited, which would have an adverse effect on our operating results and financial condition. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Any of our product candidates for which we obtain marketing approval will be subject to ongoing regulation
and could be subject to post-marketing restrictions or withdrawal from the market. Furthermore, we may be subject to substantial penalties if we fail to comply with regulatory requirements or
experience unanticipated problems with our products following approval.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even if we receive regulatory approval for a product candidate, this approval may carry conditions that limit the market for the product or put
the product at a competitive disadvantage relative to alternative therapies. For instance, a regulatory approval may limit the indicated uses for which we can market a product or the patient
population that may utilize the product, or may be required to carry a warning, such as a boxed warning, in its labeling and on its packaging. Products with boxed warnings are subject to more
restrictive advertising regulations than products without such warnings. These restrictions could make it more difficult to market any product candidate effectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=35,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=668494,FOLIO='30',FILE='DISK124:[18ZFA1.18ZFA10701]CM10701A.;31',USER='JTAYLORA',CD='15-FEB-2019;09:22' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_co10701_1_31"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally, any of our product candidates for which we obtain marketing approval, as well as the manufacturing processes, post-approval studies and measures,
labeling, advertising and promotional activities for such products, among other things, will be subject to continual requirements of and review by the EMA, FDA and other regulatory authorities. These
requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, requirements relating to manufacturing, quality control, quality
assurance and corresponding maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approved
drugs that are manufactured or distributed in the United States pursuant to FDA approvals are subject to pervasive and continuing regulation by the EMA and the FDA, including,
among other things, requirements relating to recordkeeping, periodic reporting, drug sampling and distribution, advertising and promotion and reporting of adverse experiences with the drug. After
approval, most changes to the approved drug, such as adding new indications or other labeling claims and some manufacturing and supplier changes are subject to prior FDA review and approval. There
also are continuing, annual program user fee requirements for marketed drugs, as well as new application fees for certain supplemental applications. Once approval is granted, the FDA may issue
enforcement letters or withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the drug reaches the market. Corrective action could
delay drug distribution and require significant time and financial expenditures. Later discovery of previously unknown
problems with a drug, including adverse effects of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to
the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a risk
evaluation and mitigation strategy, or REMS. REMS can include medication guides, communication plans for healthcare professionals, and elements to assure safe use. Elements to assure safe use can
include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries.
The requirement for a REMS can be costly to establish and can materially affect the potential market and profitability of the drug. In addition, even if we obtain accelerated or conditional marketing
approval for our product candidate, elafibranor in NASH on the basis of an interim analysis, like all companies using the Subpart&nbsp;H and conditional approval pathway, we must continue the
RESOLVE-IT trial post-marketing in order to demonstrate the efficacy of elafibranor on clinical benefit based on a composite endpoint of clinical outcomes. Depending on the outcome, the FDA or EMA
could revoke the previously granted approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
potential consequences include, among other things:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> restrictions on the marketing or manufacturing of the drug, suspension of the approval, complete withdrawal of the drug from the market or
product recalls; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fines, warning letters or holds on post-approval clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation of drug approvals; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> drug seizure or detention, or refusal to permit the import or export of drugs; or</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> injunctions or the imposition of civil or criminal penalties. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA strictly regulates marketing, labeling, advertising and promotion of drugs that are placed on the market. Drugs may be promoted only for the approved indications and in
accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to
have improperly promoted off-label uses may be subject to significant liability, including civil, criminal and administrative penalties. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=36,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=929228,FOLIO='31',FILE='DISK124:[18ZFA1.18ZFA10701]CO10701A.;32',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_co10701_1_32"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similarly,
if our IVD test is authorized for marketing in the United States, the test will be subject to quality system regulation, or QSR, labeling regulations, registration and
listing, the Medical Device Reporting regulation which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a
way that would likely cause or contribute to a death or serious injury if it were to recur and the Reports of Corrections and Removals regulation which requires manufacturers to report recalls and
field actions to the FDA if initiated to reduce a risk to health posed by the device or to remedy a violation of the FDCA. The FDA enforces these requirements by inspection and market surveillance. If
the FDA finds a violation, it can institute a wide variety of enforcement actions, ranging from an untitled or public warning letter to more severe sanctions such as fines, injunctions and civil
penalties; recall or seizure of products; operating restrictions and partial suspension or total shutdown of production; refusing requests for 510(k) clearance or PMA approval of new products;
withdrawing 510(k) clearance or PMAs already granted; and criminal prosecution. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accordingly,
assuming we receive marketing approval for one or more of our product candidates, we and our collaborators will continue to expend time, money and effort in all areas of
regulatory compliance. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Government restrictions on pricing and reimbursement, as well as other healthcare payor cost-containment
initiatives, may negatively impact our ability to generate revenues even if we obtain regulatory approval to market a product.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to successfully commercialize any of our product candidates, if approved, also will depend in part on the extent to which coverage
and adequate reimbursement for these products and related treatments will be available from third-party payors, including government authorities, such as Medicare and Medicaid in the United States,
private health insurers and health maintenance organizations. These third-party payors determine which medications they will cover and establish reimbursement levels. Assuming we obtain coverage for a
given product by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments
that patients find unacceptably high. Patients who are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on third-party payors to reimburse
all or part of the costs associated with their prescription drugs. Patients are unlikely to use our products unless coverage is provided and reimbursement is adequate to cover all or a significant
portion of the cost of our products. Therefore, coverage and adequate reimbursement is critical to new product acceptance. Coverage decisions may depend upon clinical and economic standards that
disfavor new drug products when more established or lower cost therapeutic alternatives are already available or subsequently become available. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Third-party
payors are developing increasingly sophisticated methods of controlling healthcare costs, such as by limiting coverage and the amount of reimbursement for particular
medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices as a condition of coverage, are using restrictive formularies
and preferred drug lists to leverage greater discounts in competitive classes, and are challenging the prices charged for medical products. In addition, in the United States, federal programs impose
penalties on drug manufacturers in the form of mandatory additional rebates and/or discounts if commercial prices increase at a rate greater than the Consumer Price Index-Urban, and these rebates
and/or discounts, which can be substantial, may impact our ability to raise commercial prices. Further, no uniform policy requirement for coverage and reimbursement for drug products exists among
third-party payors in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods
and approval process apart from Medicare determinations. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination
process is often a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=37,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1045923,FOLIO='32',FILE='DISK124:[18ZFA1.18ZFA10701]CO10701A.;32',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_co10701_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>time-consuming
and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate
reimbursement will be applied consistently or obtained in the first instance. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
continuing efforts of third-party payors of healthcare costs to contain or reduce costs of healthcare may negatively affect our commercialization prospects,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to set a price we believe is fair for our products, if approved; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to obtain and maintain market acceptance by the medical community and patients; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to generate revenues and achieve profitability; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the availability of capital. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
ability to obtain an acceptable reimbursement rate for our drugs from third-party payors will be determined in the coming years, in particular at the end of the development of
elafibranor in NASH, which is our most advanced drug candidate. We cannot be sure that coverage and reimbursement will be available for any potential product candidate that we may commercialize and,
if reimbursement is available, what the level of reimbursement will be. Since no drug has yet been commercialized in NASH, we are currently working internally on market access and pricing, but cannot
predict the conditions of elafibranor's future reimbursement. However, because negotiations with the payors are traditionally based on the results (intermediate, or otherwise) of Phase&nbsp;3
clinical trials, which are not expected to be available for elafibranor in NASH before the end of 2019, as of the date of this prospectus, we have only had preliminary discussions with the
organizations concerned. Coverage and reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. If coverage and reimbursement are not
available or reimbursement is available only to limited levels, we may not successfully commercialize any product candidate for which we obtain marketing approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the United States, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, ACA, is significantly
impacting the provision of, and payment for, healthcare. With regard to pharmaceutical products specifically, the ACA, among other things, expanded and increased industry rebates for drugs covered
under Medicaid programs and made changes to the coverage requirements under the Medicare prescription drug benefit. Some of the provisions of the ACA have yet to be implemented, and there have been
judicial and Congressional challenges to certain aspects of the ACA, as well as recent efforts by the Trump administration to repeal or replace certain aspects of the ACA. Since January&nbsp;2017,
President Trump has signed two Executive Orders and other directives designed to delay the implementation of certain provisions of the ACA or otherwise circumvent some of the requirements for health
insurance mandated by the ACA. On June&nbsp;14, 2018, the U.S. Court of Appeals for the Federal Circuit ruled that the federal government was not required to pay more than $12&nbsp;billion in ACA
risk corridor payments to third-party payors who argued were owed to them. Plaintiffs were denied a rehearing, but retain the right to appeal to the U.S.&nbsp;Supreme Court. The effects of this gap
in reimbursement on third-party payors, the viability of the ACA marketplace, providers, and potentially our business, are not yet known. In addition, the Centers for Medicare&nbsp;&amp; Medicaid
Services, or CMS, recently promulgated regulations that will give states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces,
which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrently,
Congress has considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, it has
enacted laws that modify certain provisions of the ACA, such as removing penalties, starting January&nbsp;1, 2019, for not complying with the ACA's individual mandate to carry health insurance,
delaying the implementation of certain ACA-mandated fees, and increasing the point-of-sale discount that is owed by pharmaceutical </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=38,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=383779,FOLIO='33',FILE='DISK124:[18ZFA1.18ZFA10701]CO10701A.;32',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_co10701_1_34"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>manufacturers
who participate in Medicare Part&nbsp;D. On December&nbsp;14, 2018, a U.S. District Court Judge in the Northern District of Texas, ruled that the individual mandate is a critical and
inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Cuts and Jobs Act, the remaining provisions of the ACA are invalid as well. While the Trump Administration and
CMS have both stated that the ruling will have no immediate effect, it is unclear how this decision, subsequent appeals, if any, and other efforts to repeal and replace the ACA will impact the ACA and
our business. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, both the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012 have instituted, among other things, mandatory reductions in Medicare payments to certain
providers. Additional legislative proposals to reform healthcare and government insurance programs, along with the trend toward managed healthcare in the United States, could influence the purchase of
medicines and reduce coverage and/or reimbursement of our product candidates, if approved. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
recently, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Such scrutiny has resulted in several
recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing
and manufacturer patient programs, reduce the costs of drugs under Medicare and reform government program reimbursement methodologies for drug products. Additionally, the Trump administration released
a "Blueprint" to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal
healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers. Additionally, on January&nbsp;31,
2019, Office of Inspector General of the U.S. Department of Health and Human Services proposed modifications to federal Anti-Kickback Statute safe harbors which, among other things, may affect rebates
paid by manufacturers to Medicare Part&nbsp;D plans, the purpose of which is to further reduce the cost of drug products to consumers. While any proposed measures will require additional
authorization to become effective, Congress and the Trump administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. At the
state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement
constraints, discounts,
restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, at both the federal and state levels in the United States, as well as
internationally, may result in more rigorous coverage criteria and lower reimbursement, and in additional downward pressure on the price that we receive for any approved product candidate. Any
reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other
healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our drugs. Moreover, we cannot predict what healthcare reform initiatives may be adopted in
the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
some non-U.S. countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. In addition, in some non-U.S. markets, the pricing of prescription drugs
is subject to government control and reimbursement may in some cases be unavailable. The requirements governing drug pricing vary widely from country to country. For example, the European Union
provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal
products for human use. A member state may approve a specific price for the medicinal product, may refuse to reimburse a product at the price set by the manufacturer or may instead adopt a system of
direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement
limitations for </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=39,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=966106,FOLIO='34',FILE='DISK124:[18ZFA1.18ZFA10701]CO10701A.;32',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_co10701_1_35"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>biopharmaceutical
products will allow favorable reimbursement and pricing arrangements for elafibranor or any of our other product candidates that may be approved. Historically, biopharmaceutical
products launched in the European Union do not follow price structures of the United States and generally tend to have significantly lower prices. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failures to reimburse our IVD test, if commercialized, or changes in reimbursement rates by third-party
payors and variances in reimbursement rates could materially and adversely affect our revenues and could result in significant fluctuations in our revenues.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to commercialize our IVD test also will depend in part on the extent to which coverage and adequate reimbursement for this test will
be available from third-party payors, such as government health administration authorities, private health insurers and other organizations. Insurance coverage and reimbursement rates for diagnostic
tests are uncertain, subject to change and
particularly volatile during the early stages of a newly commercialized diagnostic test. It is uncertain as to what extent third-party payors will provide coverage for our IVD test, if commercialized.
We will also likely experience volatility in the coverage and reimbursement of the IVD test due to contract negotiation with third-party payors and implementation requirements. The reimbursement
amounts we receive from third-party payors will vary from payor to payor, and, in some cases, the variation is material. Third-party payors have increased their efforts to control the cost,
utilization and delivery of healthcare services. These measures have resulted in reduced payment rates and decreased utilization for the diagnostic test industry. From time to time, Congress has
considered and implemented changes to the Medicare fee schedules in conjunction with budgetary legislation, and pricing for tests covered by Medicare is subject to change at any time. Reductions in
the reimbursement rate provided by third-party payors may occur in the future. Reductions in the price at which our IVD test is reimbursed could have a material adverse effect on our revenues. If we
and our collaborators are unable to establish and maintain broad coverage and adequate reimbursement for our IVD test or if third-party payors change their coverage or reimbursement policies with
respect to the IVD test, our revenues could be materially and adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our future growth depends, in part, on our ability to penetrate international markets, where we would be
subject to additional regulatory burdens and other risks and uncertainties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our future profitability will depend on our ability to commercialize our product candidates in the United States, Europe and other territories
around the world. If we commercialize our product candidates in international markets, we would be subject to additional risks and uncertainties, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> economic weakness, including inflation, or political instability in particular economies and markets; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the burden of complying with complex and changing non-U.S. regulatory, tax, accounting and legal requirements, many of which vary between
countries; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> different medical practices and customs in non-U.S. countries affecting acceptance in the marketplace; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> tariffs and trade barriers; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> other trade protection measures, import or export licensing requirements or other restrictive actions by U.S. or other governments; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> longer accounts receivable collection times; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> longer lead times for shipping; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=40,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=699422,FOLIO='35',FILE='DISK124:[18ZFA1.18ZFA10701]CO10701A.;32',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_co10701_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> workforce uncertainty in countries where labor unrest is common; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> language barriers for technical training; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> reduced protection of intellectual property rights in some countries outside the United States, and related prevalence of generic alternatives
to therapeutics; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> foreign currency exchange rate fluctuations and currency controls; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> differing reimbursement landscapes globally; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> uncertain and potentially inadequate reimbursement of our products; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the interpretation of contractual provisions governed by laws outside the United States in the event of a contract dispute. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales
of our products outside the United States could also be adversely affected by the imposition of governmental controls, political and economic instability, trade restrictions and
changes in tariffs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Adverse market and economic conditions may exacerbate certain risks associated with commercializing our
product candidates.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Future sales of our product candidates, if they are approved, will be dependent on purchasing decisions of and reimbursement from government
health administration authorities, distributors and other organizations. As a result of adverse conditions affecting the global economy and credit and financial markets, including disruptions due to
political instability or otherwise, these organizations may defer purchases, may be unable to satisfy their purchasing or reimbursement
obligations, or may delay payment for elafibranor or any of our product candidates that are approved for commercialization in the future. In addition, there have been concerns for the overall
stability and suitability of the euro as a single currency given the economic and political challenges facing individual Eurozone countries. Continuing deterioration in the creditworthiness of
Eurozone countries, the withdrawal of one or more member countries from the European Union, or the failure of the euro as a common European currency or an otherwise diminished value of the euro could
materially and adversely affect our future product revenue from European sales of our products. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to the Production and Manufacturing of Our Product Candidates  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The manufacturing facilities of our third-party manufacturers are subject to significant government
regulations and approvals. If our third-party manufacturers fail to comply with these regulations or maintain these approvals, our business will be materially harmed.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not currently and do not intend in the future to manufacture the products we intend to sell. We outsource the manufacturing of our
products to third parties, who are, in turn, subject to ongoing regulation and periodic inspection by the EMA, FDA and other regulatory bodies to ensure compliance with current Good Manufacturing
Practices, or cGMP. Any failure to follow and document their adherence to such cGMP regulations or other regulatory requirements may lead to significant delays in the availability of products for
commercial sale or clinical trials, may result in the termination of or a hold on a clinical trial, or may delay or prevent filing or approval of marketing applications for our products. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Failure
to comply with applicable regulations could also result in the EMA, FDA or other applicable regulatory authorities taking various actions,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> levying fines and other civil penalties; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> imposing consent decrees or injunctions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> requiring us to suspend or put on hold one or more of our clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> suspending or withdrawing regulatory approvals; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=41,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=478825,FOLIO='36',FILE='DISK124:[18ZFA1.18ZFA10701]CO10701A.;32',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cq10701_1_37"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> delaying or refusing to approve pending applications or supplements to approved applications; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> requiring us or our third-party manufacturers to suspend manufacturing activities or product sales, imports or exports; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> requiring us to communicate with physicians and other customers about concerns related to actual or potential safety, efficacy, and other
issues involving our products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> mandating product recalls or seizing products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> imposing operating restrictions; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> seeking criminal prosecutions. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of the foregoing actions could be detrimental to our reputation, business, financial condition or operating results. Furthermore, our key suppliers may not continue to be in
compliance with all applicable regulatory requirements, which could result in our failure to produce our products on a timely basis and in the required quantities, if at all. In addition, before any
additional products would be considered for marketing approval in the United States, Europe or elsewhere, our suppliers will have to pass an audit by the applicable regulatory agencies. We are
dependent on our suppliers' cooperation and ability to pass such audits, and the audits and any audit remediation may be costly. Failure to pass such audits by us or any of our suppliers would affect
our ability to commercialize our product candidates in the United States, Europe or elsewhere. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our production costs may be higher than we currently estimate.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We contract to have our product candidates manufactured according to manufacturing best practices applicable to drugs for clinical trials and to
specifications approved by the applicable regulatory authorities. If any of our products are found to be non-compliant, we would be required to have the product manufactured again, which would entail
additional costs and may prevent delivery of the product to patients on time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
risks inherent in the production process may have the same effect, such as:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> contamination of the controlled atmosphere area; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> unusable premises and equipment; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> new regulatory requirements requiring a partial and/or extended stop to the production unit to meet the requirements; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> unavailable qualified personnel; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> power failure of extended duration; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> logistical error. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, a rise in the cost of raw material or in direct or indirect energy rates, a shortage of raw material used to make our product candidates may increase or stopped product
manufacturing and increase logistical costs. Any of these risks, should they occur, could disrupt our activities and compromise our financial position, results, reputation or growth. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Operations  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may encounter difficulties in managing our growth, which could disrupt our operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2018, we had 148 full-time employees, and we expect to increase our number of employees and the scope of our
operations. To manage our anticipated development and expansion, including the potential commercialization of our product candidates in Europe, the United States and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=42,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=620549,FOLIO='37',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>other
territories, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel.
Also, our management may need to divert a disproportionate amount of its attention away from its day-to-day activities and devote a substantial amount of time to managing these development activities.
Due to our limited resources, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our
infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The physical expansion of our operations may
lead to significant costs and may divert financial resources from other projects, such as the development of our product candidates. If our management is unable to effectively manage our expected
development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not be able to implement our business strategy. Our
future financial performance and our ability to commercialize our product candidates, if approved, and compete effectively will depend, in part, on our ability to effectively manage the future
development and expansion of our company. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We depend on qualified management personnel and our business could be harmed if we lose key personnel and
cannot attract new personnel.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our success depends to a significant degree upon the technical and management skills of our co-founders, scientific advisers, senior management
team, including, in particular, Jean-Fran&ccedil;ois Mouney, our chairman and chief executive officer, and Dean Hum, our chief operating officer. The loss of the services of
Messrs.&nbsp;Mouney or Hum would likely have a material adverse effect on us. Our success also will depend upon our ability to attract and retain additional qualified scientific, management,
marketing, technical, and sales executives and personnel. We compete for key personnel against numerous companies, including larger, more established companies with significantly greater financial
resources than we possess. There can be no assurance that we will be successful in attracting or retaining such personnel, and the failure to do so could harm our operations and our growth prospects. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our failure to maintain certain tax benefits applicable to French biopharmaceutical companies may adversely
affect our results of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a French biopharmaceutical company, we have benefited from certain tax advantages, including, for example, the French Research Tax Credit, or
CIR (</FONT><FONT SIZE=2><I>Cr&eacute;dit d'Imp&ocirc;t Recherche</I></FONT><FONT SIZE=2>), which is a French tax credit aimed at stimulating research and development. The CIR can be
offset against French corporate income tax due and the portion in excess, if any, may be refunded. The CIR is calculated based on our claimed amount of eligible research and development expenditures
in France and represented &euro;7.3&nbsp;million for the year ended December&nbsp;31, 2018. We believe, due to the nature of our business operations, that we will continue to be
eligible to receive the CIR tax credit. However, if the French Parliament decides to eliminate, or to reduce the scope or the rate of, the CIR benefit, either of which it could decide to do at any
time, our results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
French tax authorities, with the assistance of the Research and Higher Education Ministry, may audit each research and development program in respect of which a CIR benefit has been
claimed and assess whether such program qualifies in its view for the CIR benefit. In 2014, we were subject to such an audit, at the end of which, the French tax authorities questioned part of the CIR
benefit received by us as a result of certain of our expenditures incurred in 2010. The audit continued for our 2011 and 2012 CIR returns. We received proposed adjustments in December 2014 (for the
2010 CIR) and in December 2015 (for the 2011 and 2012 CIR). This tax audit was also extended to the 2014 CIR as part of a documentary audit, the purpose of which was to determine whether we were
acting as a sub-contractor in our collaborative research alliances with companies in the pharmaceutical industry, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=43,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=234144,FOLIO='38',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_39"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>which
would reduce the basis on which the CIR is computed. The French tax authorities contend that in these alliances we were acting as a sub-contractor. However, we have disputed this finding.
Although the tax authorities have partially granted some of our arguments, it is possible that the CIR tax audit may lead to a challenge of the CIR for the years audited and to potential penalties.
The audits could, therefore, have an adverse effect on our results of operations and our financial position. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our business may be exposed to foreign exchange risks.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although the majority of our operations are denominated in euros, an increasing portion of our expenses are denominated in U.S. dollars,
including expenses resulting from clinical trials and amounts paid to our wholly owned subsidiary, Genfit Corp., and growing expenses in U.S.&nbsp;dollars incurred by Genfit&nbsp;S.A.
Additionally, as we expand our operations and conduct clinical trials in the United States, we will incur expenses in U.S. dollars and will be required to enter into additional contracts denominated
in other foreign currencies. As a result, we are exposed to foreign currency exchange risk as our results of operations and cash flows are subject to fluctuations in foreign currency exchange rates.
We currently engage in hedging transactions to protect against uncertainty in future exchange rates between particular foreign currencies and the euro. If our currency exposure were to increase, we
would put in place additional hedging instruments. We cannot predict the impact of foreign currency fluctuations, and foreign currency fluctuations in the future may adversely affect our financial
condition, results of operations and cash flows. The ADSs being sold in the U.S. offering will be quoted in U.S. dollars on the Nasdaq Global Market, while our ordinary shares (including those being
sold in the European private placement and the underlying ordinary shares of the ADSs being sold in the U.S. offering) trade in euros on the Euronext Paris exchange. Our financial statements are
prepared in euros. Therefore, fluctuations in the exchange rate between the euro and the U.S. dollar will also affect, among other matters, the value of our ordinary shares and ADSs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may use hazardous chemicals and biological materials in our business. Any claims relating to improper
handling, storage or disposal of these materials could be time-consuming and costly.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our research and development processes for our product candidates and biomarker candidates involve the controlled use of hazardous materials,
including chemicals and biological materials. We cannot eliminate the risk of accidental contamination or discharge and any resultant injury from these materials. During their work, our researchers
come into contact with a number of potentially dangerous substances, including in particular (1)&nbsp;genetically modified organisms, or GMO, the safety of which is overseen by the Ministry in
charge of Research with the assistance of High Council for Biotechnologies (or the </FONT><FONT SIZE=2><I>Haut Conseil des Biotechnologies</I></FONT><FONT SIZE=2>), (2)&nbsp;animals used for
experimentation, the authorization of which is overseen by the local pr&eacute;fet with the assistance of the local Department for the Protection of People, or DDPP (for </FONT> <FONT SIZE=2><I>Direction d&eacute;partementale de la protection des
populations</I></FONT><FONT SIZE=2>) and (3)&nbsp;human samples. This research is subject to application for
authorization from the competent authorities, in particular the National Drug and Health Product Authority, or ANSM (for </FONT><FONT SIZE=2><I>Autorit&eacute; Nationale de
S&eacute;curit&eacute; du M&eacute;dicament et des produits de sant&eacute;</I></FONT><FONT SIZE=2>) to assess the usefulness of the research, ensure that patients have
been properly informed, and assess the management of information obtained from the sampling. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may be subject to fines or sued for any injury or contamination resulting from our use or the use by third parties of these materials, and our liability may exceed any insurance
coverage and our total assets, and we may also suffer reputational harm. French and U.S. federal, state, local or foreign laws and regulations govern the use, manufacture, storage, handling and
disposal of these hazardous
materials and specified waste products, as well as the discharge of pollutants into the environment and human health and safety matters. Compliance with health, safety and/or environmental laws and
regulations may be expensive and may impair our research and development efforts. If we fail to comply with these requirements, we could incur substantial costs, including civil or criminal fines and
penalties, clean-up costs or capital expenditures for control equipment or operational changes necessary </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=44,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=419672,FOLIO='39',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>to
achieve and maintain compliance. Furthermore, we could face the rejection, suspension or withdrawal of regulatory approval for our drugs. In addition, we cannot predict the impact on our business
of new or amended health, safety and/or environmental laws or regulations or any changes in the way existing and future laws and regulations are interpreted and enforced. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Product liability and other lawsuits could divert our resources, result in substantial liabilities and reduce
the commercial potential of our product candidates.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The risk that we may be sued on product liability claims is inherent in the development and commercialization of biopharmaceutical and
diagnostic products that are intended to be tested and evaluated on humans in an initial phase, then commercialized. Side effects of, or manufacturing defects in, products that we develop could result
in the deterioration of a patient's condition, injury or even death. For example, our liability could be sought after by patients participating in the clinical trials in the context of the development
of the therapeutic products tested and unexpected side effects resulting from the administration of these products. Once a product is approved for sale and commercialized, the likelihood of product
liability lawsuits increases. Criminal or civil proceedings might be filed against us by patients, regulatory authorities, biopharmaceutical companies and any other third party using or marketing our
products. These actions could include claims resulting from acts by our partners, service providers and subcontractors, over which we have little or no control. These lawsuits may divert our
management from pursuing our business strategy and may be costly to defend. In addition, if we are held liable in any of these lawsuits, we may incur substantial liabilities and may be forced to limit
or forgo further commercialization of the affected products. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
maintain product liability insurance coverage for our clinical trials at levels which we believe are appropriate for our clinical trials and at levels granted by insurers to
biopharmaceutical companies like us. Nevertheless, our insurance coverage may be insufficient to reimburse us for any expenses or losses we may suffer. In addition, in the future, we may not be able
to obtain or maintain sufficient insurance coverage at an acceptable cost or to otherwise protect against potential product or other legal or administrative liability claims by us or our
collaborators, licensees or subcontractors, which could prevent or inhibit the commercial production and sale of any of our product candidates that receive regulatory approval. Product liability
claims could also harm our reputation, which may adversely affect our ability to commercialize our products successfully. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our internal information technology systems, or those of our third-party contractors or consultants, may fail
or suffer security breaches, which could result in a material disruption of our product development programs.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Despite the implementation of security measures, our internal information technology systems and those of our third-party contractors and
consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. If such an event were to occur and
cause interruptions in our operations, it could result in a material disruption of our programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the ordinary course of our business, we collect and store sensitive data, including, among other things, legally protected patient health information, personally identifiable
information about our employees, intellectual property and proprietary business information. We manage and maintain our applications and data utilizing on-site systems and outsourced vendors. These
applications and data encompass a wide variety of business critical information, including research and development information, commercial information and business and financial information. Because
information systems, networks and other technologies are critical to many of our operating activities, shutdowns or service disruptions at our company or vendors that provide information systems,
networks or other services to us pose increasing risks. Such disruptions may be caused by events such as computer hacking, phishing attacks, ransomware, dissemination of computer viruses, worms and
other destructive or disruptive software, denial of service attacks and other malicious activity, as well as power outages, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=45,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=165703,FOLIO='40',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_41"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>natural
disasters (including extreme weather), terrorist attacks or other similar events. Such events could have an adverse impact on us and our business, including loss of data and damage to
equipment and data. In addition, system redundancy may be ineffective or inadequate, and our disaster recovery planning may not be sufficient to cover all eventualities. Significant events could
result in a disruption of our operations, damage to our reputation or a loss of revenues. In addition, we may not have adequate insurance coverage to compensate for any losses associated with such
events. For example, the loss of clinical trial data for our product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce
the lost data. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
could be subject to risks caused by misappropriation, misuse, leakage, falsification or intentional or accidental release or loss of information maintained in the information systems
and networks of our company and our vendors, including personal information of our employees and patients, and company and vendor confidential data. In addition, outside parties may attempt to
penetrate our systems or those of our vendors or fraudulently induce our personnel or the personnel of our vendors to disclose sensitive information in order to gain access to our data and/or systems.
We may experience threats to
our data and systems, including malicious codes and viruses, phishing and other cyber-attacks. The number and complexity of these threats continue to increase over time. If a material breach of our
information technology systems or those of our vendors occurs, the market perception of the effectiveness of our security measures could be harmed and our reputation and credibility could be damaged.
We could be required to expend significant amounts of money and other resources to repair or replace information systems or networks. In addition, we could be subject to regulatory actions and/or
claims made by individuals and groups in private litigation involving privacy issues related to data collection and use practices and other data privacy laws and regulations, including claims for
misuse or inappropriate disclosure of data, as well as unfair or deceptive practices. Although we develop and maintain systems and controls designed to prevent these events from occurring, and we have
a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and
efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of
our information systems to vendors, engage in more electronic transactions with payors and patients, and rely more on cloud-based information systems, the related security risks will increase and we
will need to expend additional resources to protect our technology and information systems. In addition, there can be no assurance that our internal information technology systems or those of our
third-party contractors, or our consultants' efforts to implement adequate security and control measures, will be sufficient to protect us against breakdowns, service disruption, data deterioration or
loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage attacks or insider threat attacks which
could result in financial, legal, business or reputational harm. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Use of social media may materially and adversely impact our reputation.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unauthorized communications, such as press releases or posts on social media, purported to be issued by us, may contain information that is
false or otherwise damaging and could have an adverse impact on the price of our securities. Negative or inaccurate posts or comments about us, our research and development programs, and our directors
or officers could seriously damage our reputation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, our employees and partners may use social media and mobile technologies inappropriately, for which we may be held liable, or which could lead to breaches of data security,
loss of trade secrets or other intellectual property or public disclosure of sensitive information. Such uses of social media and mobile technologies could have a material adverse effect on our
reputation, business, financial condition and results of operations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=46,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=905340,FOLIO='41',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_42"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may acquire businesses or products, or form strategic alliances, in the future, and we may not realize the
benefits of such acquisitions.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our current growth strategy includes potentially in-licensing rights to drug candidates in clinical development, and in the future, we may
acquire companies or technologies facilitating or enabling us to access to new medicines, new research projects, or new geographical areas, or enabling us to express synergies with our existing
operations. If such acquisitions occur in the future, we may not be able to identify appropriate targets or make acquisitions under satisfactory conditions, in particular, satisfactory price
conditions. In addition, we may be unable to obtain the financing for these acquisitions on favorable terms, which could require us to finance these acquisitions using our existing cash resources that
could have been allocated to other purposes. If we acquire businesses with promising markets or technologies, we may not be able to realize the benefit of acquiring such businesses if we are unable to
successfully integrate them with our existing operations and company culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new products resulting from a
strategic alliance or acquisition that delay or prevent us from realizing their expected benefits or enhancing our business. We cannot assure you that, following any such acquisition, we will achieve
the expected synergies to justify the transaction. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Legal and Other Compliance Matters  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to healthcare laws and regulations that may require substantial compliance efforts and could
expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings, among other penalties.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Healthcare providers, physicians and others will play a primary role in the recommendation and prescription of our products, if approved. Our
business operations in the United States and our arrangements with clinical investigators, healthcare providers, consultants, third party payors and patients expose us to broadly applicable federal
and state fraud and abuse and other healthcare laws. These laws may impact, among other things, our research, proposed sales, marketing and education programs of our product candidates that obtain
marketing approval. Restrictions under applicable U.S. federal, state and non-U.S. healthcare laws and regulations include, but are not limited to, the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting,
offering, receiving or providing remuneration, including any kickback, bribe or rebate, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an
individual for, or the purchase or lease, order or recommendation of, any item, good, facility or service, for which payment may be made under federal healthcare programs such as Medicare and
Medicaid; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> U.S. federal civil and criminal false claims laws and civil monetary penalties laws, including the civil False Claims Act, which impose
criminal and civil penalties, including those from civil whistleblower or qui tam actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented,
claims for payment that are false or fraudulent or making a false statement to avoid, decrease, or conceal an obligation to pay money to the federal government; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the U.S. federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional federal criminal statutes that
impose criminal and civil liability for, among other things, executing or attempting to execute a scheme to defraud any healthcare benefit program or knowingly and willingly falsifying, concealing or
covering up a material fact or making false statements relating to healthcare matters; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=47,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=695756,FOLIO='42',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_43"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and its implementing regulations, which
impose certain requirements on covered entities and their business associates that perform functions or activities that involve HIPAA Protected Health Information on their behalf, including mandatory
contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> U.S. federal transparency requirements under the Physician Payments Sunshine Act, enacted as part of the ACA, that require applicable
manufacturers of covered drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid, or the Children's Health Insurance Program, with specific exceptions,
to track and annually report to the CMS payments and other transfers of value provided to physicians and teaching hospitals, and certain ownership and investment interests held by physicians or their
immediate family members; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> analogous state or non-U.S. laws and regulations, such as state anti-kickback and false claims laws, which may apply to items or services
reimbursed by any third-party payor, including commercial insurers, state marketing and/or transparency laws applicable to manufacturers that may be broader in scope than the federal requirements,
state laws that require biopharmaceutical companies to comply with the biopharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal
government, and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect
as HIPAA, thus complicating compliance efforts; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering
of anything of value, directly or indirectly, to any foreign official, political party, or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the
individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company
to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal
accounting controls for international operations. Activities that violate the FCPA, even if they occur wholly outside the United States, can result in criminal and civil fines, imprisonment,
disgorgement, oversight, and debarment from government contracts. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, some state laws require pharmaceutical companies to comply with the pharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance
promulgated by the federal government and require manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing
expenditures and pricing information. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ensuring
that our business arrangements with third parties comply with applicable healthcare laws and regulations will likely be costly. It is possible that governmental authorities will
conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our
operations were found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may
be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from government funded healthcare programs, such as
Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these
laws, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could substantially disrupt our operations. If the physicians or
other </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=48,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=432693,FOLIO='43',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_44"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>providers
or entities with whom we expect to do business are found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including
exclusions from government funded healthcare programs. Although an effective compliance program can mitigate the risk of investigation and prosecution for violations of these laws, the risks cannot be
entirely eliminated. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security, and fraud laws may prove costly. Any action against us for violation of these
laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management's attention from the operation of our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to laws and regulations related to data privacy, both in the United States and the European
Union.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA,
as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and its respective implementing regulations imposes certain requirements on covered entities relating
to the privacy, security, and transmission of certain individually identifiable health information, known as protected health information. Among other things, HITECH, through its implementing
regulations, makes HIPAA's security standards and certain privacy standards directly applicable to business associates, defined as a person or organization, other than a member of a covered entity's
workforce, that creates, receives, maintains, or transmits protected health information on behalf of a covered entity for a function or activity regulated by HIPAA. HITECH also strengthened the civil
and criminal penalties that may be imposed against covered entities, business associates, and individuals, and gave state attorneys general new authority to file civil actions for damages or
injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys' fees and costs associated with pursuing federal civil actions. In addition, other federal and state laws may govern
the privacy and security of health and other information in certain circumstances, many of which differ from each other in significant ways and may not be preempted by HIPAA, thus complicating
compliance efforts. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
collection and use of personal health data in the European Union had previously been governed by the provisions of the Data Protection Directive, which has been replaced by the
General Data
Protection Regulation, or GDPR, which became effective on May&nbsp;25, 2018. The GDPR imposes strict requirements on controllers and processors of personal data, including special protections for
"sensitive information" which includes health and genetic information of data subjects residing in the EU. GDPR grants individuals a number of rights as data subjects, including the opportunity to
object to the processing of their personal information and the right to request deletion of personal information in certain circumstances. It also provides a right for the data subject to obtain the
portability of its personal data in certain cases, including when processing of the personal data is based on consent, and provides the individual with an express right to seek legal remedies in the
event the individual believes his or her rights have been violated. Further, the GDPR imposes strict rules on the transfer of personal data out of the European Union to the United States or other
regions that have not been deemed to offer "adequate" privacy protections. Failure to comply with the requirements of the GDPR and the related national data protection laws of the European Union
Member States, which may deviate slightly from the GDPR, especially in respect of the processing of personal data concerning health, may result in fines of up to 4% of global revenues, or
&euro;20,000,000, whichever is greater. As a result of the implementation of the GDPR, we may be required to put in place additional mechanisms ensuring compliance with the new data
protection rules. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is significant uncertainty related to the manner in which data protection authorities will seek to enforce compliance with GDPR. For example, it is not clear if the authorities
will conduct random audits of companies doing business in the EU, or if the authorities will wait for complaints to be filed by individuals who claim their rights have been violated. Enforcement
uncertainty and the costs </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=49,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=390260,FOLIO='44',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_45"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>associated
with ensuring GDPR compliance be onerous and adversely affect our business, financial condition, results of operations and prospects. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our employees may engage in misconduct or other improper activities, including violating applicable
regulatory standards and requirements or engaging in insider trading, which could significantly harm our business.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with
legal requirements or the requirements of FDA, EMA and other government regulators, provide accurate information to applicable government authorities, comply with fraud and abuse and other healthcare
laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business
arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and
regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could
also involve the improper use of, including trading on,
information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. In connection with the global offering, we intend to reinforce our
Code of Business Conduct and Ethics, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may be ineffective in
controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If
any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the
imposition of significant fines or other sanctions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Intellectual Property  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to obtain and maintain sufficient patent protection for our product candidates, or if the
scope of the patent protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and our ability to commercialize our product candidates
successfully may be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect
to our proprietary product candidates. If we do not adequately protect our intellectual property, competitors may be able to erode or negate any competitive advantage we may have, which could harm our
business and ability to achieve profitability. To protect our proprietary position, we file patent applications in the United States and abroad related to our novel product candidates that are
important to our business. The patent application and approval process is expensive and time-consuming. We may not be able to file and prosecute all necessary or desirable patent applications at a
reasonable cost or in a timely manner. </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may not have been the first to make the inventions covered by pending patent applications or issued patents; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may not have been the first to file patent applications for our product candidates or the compositions we developed or for their uses; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> others may independently develop identical, similar or alternative products or compositions and uses thereof; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our disclosures in patent applications may not be sufficient to meet the statutory requirements for patentability; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=50,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=261522,FOLIO='45',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_46"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any or all of our pending patent applications may not result in issued patents; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we may not seek or obtain patent protection in countries that may eventually provide us a significant business opportunity; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> any patents issued to us may not provide a basis for commercially viable products, may not provide any competitive advantages, or may be
successfully challenged by third parties; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our compositions and methods may not be patentable; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> others may design around our patent claims to produce competitive products which fall outside of the scope of our patents; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> others may identify prior art or other bases which could invalidate our patents. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until patent issues from such applications.
Because the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, our patents or pending patent applications may be challenged in the courts or patent
offices in the United States and abroad. For example, we may be subject to a third party preissuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or become involved in
post-grant review procedures, oppositions, derivations, reexaminations, inter partes review or interference proceedings, in the United States or elsewhere, challenging our patent rights or the patent
rights of others. An adverse determination in any such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which
could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. In
addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such
candidates are commercialized. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Obtaining
and maintaining a patent portfolio entails significant expense and resources. Part of the expense includes periodic maintenance fees, renewal fees, annuity fees, various other
governmental fees on patents and/or applications due in several stages over the lifetime of patents and/or applications, as well as the cost associated with complying with numerous procedural
provisions during the patent application process. We may not choose to pursue or maintain protection for particular inventions. In addition, there are situations in which failure to make certain
payments or noncompliance with certain requirements in the patent process can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights
in the relevant jurisdiction. If we choose to forgo patent protection or allow a patent application or patent to lapse purposefully or inadvertently, our competitive position could suffer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us or
otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner. Our
competitors may also seek approval to market their own products similar to or otherwise competitive with our products. Alternatively, our competitors may seek to market generic versions of any
approved products by submitting Abbreviated New Drug Applications, or ANDAs, to the U.S. Food and Drug Administration, or FDA, in which they claim that patents owned or licensed by us are invalid,
unenforceable or not infringed. In these circumstances, we may need to defend or assert our patents, or both, including by filing lawsuits alleging patent infringement. In any of these types of
proceedings, a court or other agency with jurisdiction may find our patents invalid or unenforceable, or that our
competitors are competing in a non-infringing manner. Thus, even if we have valid and enforceable patents, these patents still may not provide protection against competing products or processes
sufficient to achieve our business objectives. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=51,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=618758,FOLIO='46',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_47"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal
actions to enforce our patent rights can be expensive and may involve the diversion of significant management time. In addition, these legal actions could be unsuccessful and could
also result in the invalidation of our patents or a finding that they are unenforceable. We may or may not choose to pursue litigation or other actions against those that have infringed or are
currently infringing our patent rights, or used them without authorization, due to the associated expense and time commitment of monitoring these activities. If we fail to protect or to enforce our
intellectual property rights successfully, our competitive position could suffer, which could harm our results of operations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if we have or obtain patents covering our product candidates or compositions, we may still be prevented from making, using, selling, offering for sale, or importing our product
candidates or technologies because of the patent rights of others. Others may have filed, and in the future may file, patent applications covering compositions or products that are similar or
identical to ours. These filings could materially affect our ability to develop our product candidates or sell our products if approved. Because patent applications can take many years to issue and
are not published for a period of time after filing, there may be currently pending applications unknown to us that may later result in issued patents that our product candidates or compositions may
infringe. These patent applications may have priority over patent applications filed by us. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which
could be expensive, time consuming and unsuccessful and issued patents covering our product candidates could be found invalid or unenforceable if challenged in court.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we initiate legal proceedings against a third party to enforce a patent covering one of our product candidates or technologies, the defendant
could counterclaim that the patent covering one of our product candidates or technologies is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging
invalidity and unenforceability of an asserted patent or patents are commonplace. Grounds for a validity challenge include alleged failures to meet any of several statutory requirements, including
lack of novelty, obviousness, written description or non-enablement. Grounds for unenforceability assertions include allegations that someone connected with prosecution of the patent withheld relevant
information from the USPTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside
the context of litigation. Such mechanisms include re-examination, post-grant review and/or inter partes review and equivalent proceedings in foreign
jurisdictions, such as, opposition proceedings. Such proceedings could result in revocation or amendment of our patents in such a way that they no longer cover our product candidates or competitive
products. Similarly, we may initiate proceedings before the Patent Trial and Appeal Board, or PTAB, of the USPTO, such as post grant review, or PGR, derivation, or inter partes review, against patents
granted to third parties. For example, NTZ, which we are evaluating as an anti-fibrotic in an investigator-initiated Phase&nbsp;2 clinical trial, has been commercialized by Romark for use as an
anti-parasitic drug. We have a number of granted U.S. patents covering the use of NTZ as an anti-fibrotic in certain organs, including in the liver for the treatment of liver fibrosis consecutive to
NASH. Romark has an allowed U.S. patent application which claims the use of NTZ in liver fibrosis. This may prevent or delay us from obtaining issued patents with similar claims in the U.S. and if
granted, may prompt additional proceedings in the USPTO against such patent or against other third party applications or patents or consider the need or benefit of entering into a license agreement
with such third party or parties in order to exploit such patent alone or together with Romark or such other third party or parties. In the event that we do not prevail or the settlement terms with
the adverse party are unfavorable, or we are unable to reach an agreement on terms sufficiently favorable to us, our ability to market our product candidates may be affected. The outcome following
legal assertions of invalidity and unenforceability in the PTAB or the federal courts is unpredictable. With respect to validity, for example, we cannot be certain that there is no invalidating prior
art, of which we and the patent examiner were unaware during prosecution. If a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=52,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=518753,FOLIO='47',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_48"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>defendant
were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our product candidates. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if we establish infringement, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may not be an
adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation in the United States, there is a risk that some of our
confidential information could be compromised by disclosure during litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or
developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our common stock. Moreover, there can be no
assurance that we will have sufficient financial or other resources to file and pursue such infringement claims in the federal courts, which typically last for years before they are concluded. Even if
we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a
result of the proceedings. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Biopharmaceutical patents and patent applications involve highly complex legal and factual questions, which,
if determined adversely to us, could negatively impact our patent position.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The patent positions of biopharmaceutical companies can be highly uncertain and involve complex legal and factual questions. The interpretation
and breadth of claims allowed in some patents covering biopharmaceutical compositions may be uncertain and difficult to determine, and are often affected materially by the facts and circumstances that
pertain to the patented compositions and the related patent claims. The standards of the USPTO are evolving and could change in the future. Consequently, we cannot predict the issuance and scope of
patents with certainty. Patents, if issued, may be challenged, invalidated or circumvented. U.S. patents and patent applications may also be subject to derivation or interference proceedings, and U.S.
patents may be subject to reexamination proceedings, post-grant review and/or inter partes review in the USPTO. Foreign patents may be subject also to opposition or comparable proceedings in the
corresponding foreign patent office, which could result in either loss of the patent or denial of the patent application or loss or reduction in the scope of one or more of the claims of the patent or
patent application. In addition, such interference, reexamination, post-grant review, inter partes review and opposition proceedings may be costly. Accordingly, rights under any issued patents may not
provide us with sufficient protection against competitive products or processes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, changes in or different interpretations of patent laws in the United States and foreign countries may permit others to use our discoveries or to develop and commercialize
our technology and products without providing any compensation to us, or may limit the number of patents or claims we can obtain. The laws of some countries do not protect intellectual property rights
to the same extent as U.S. laws and those countries may lack adequate rules and procedures for defending our intellectual property rights. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we fail to obtain and maintain patent protection and trade secret protection for our product candidates, we could lose our competitive advantage and competition we face would
increase, reducing any potential revenues and adversely affecting our ability to attain or maintain profitability. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are sued for infringing intellectual property rights of third parties, such litigation could be costly
and time consuming and could prevent or delay us from developing or commercializing our product candidates.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our commercial success depends, in part, on our ability to develop, manufacture, market and sell our product candidates and use our technologies
without infringing the intellectual property and other proprietary rights of third parties. If any third-party patents or patent applications are found to cover our product candidates or their methods
of use, we may not be free to manufacture or market our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=53,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=765192,FOLIO='48',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_49"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>product
candidates as planned without obtaining a license, which may not be available on commercially reasonable terms, or at all. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is a substantial amount of intellectual property litigation in the biotechnology and pharmaceutical industries, and we may become party to, or threatened with, litigation or other
adversarial proceedings regarding intellectual property rights with respect to our product candidates, including interference proceedings before the USPTO. Third parties may assert infringement claims
against us based on existing or future intellectual property rights. The outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance. The
pharmaceutical and biotechnology industries have produced a significant number of patents, and it may not always be clear to industry participants, including us, which patents cover various types of
products or methods of use. The coverage of patents is subject to interpretation by the courts, and the interpretation is not always uniform. If we were sued for patent infringement, we would need to
demonstrate that our product candidates, products or methods either do not infringe the patent claims of the relevant patent or that the patent claims are invalid or unenforceable, and we may not be
able to do this. Proving invalidity is difficult. For example, in the United States, proving invalidity requires a showing of clear and convincing evidence to overcome the presumption of validity
enjoyed by issued patents. Even if we are successful in these proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel could be diverted in
pursuing these proceedings, which could significantly harm our business and operating results. In addition, we may not have sufficient resources to bring these actions to a successful conclusion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are found to infringe a third party's intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the
infringing product candidate or product. Alternatively, we may be required to obtain a license from such third party in order to use the infringing technology and continue developing, manufacturing or
marketing the infringing product candidate. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be
non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could, in certain circumstances, be found liable for monetary damages, including treble
damages and attorneys' fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of
our business operations, which could materially harm our business. Claims may also be made that we have misappropriated the confidential information or trade secrets of third parties could have a
similar negative impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Developments in patent law in the United States and in other jurisdictions could have a negative impact on
our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress, the USPTO or similar foreign authorities may change the
standards of patentability and any such changes could have a negative impact on our business. In addition, the Leahy-Smith America Invents Act, or the America Invents Act, which was signed into law in
2011, includes a number of significant changes to U.S. patent law. These changes include a transition from a "first-to-invent" system to a "first-to-file" system, changes to the way issued patents are
challenged, and changes to the way patent applications are disputed during the examination process. In certain areas, these changes may favor larger and more established companies that have greater
resources to devote to patent application filing and prosecution. The USPTO has developed new regulations and procedures to govern the full implementation of the America Invents Act, and many of the
substantive changes to patent law associated with the America Invents Act, and, in particular, the first-to-file provisions, became effective on March&nbsp;16, 2013. Substantive changes to patent
law associated with the America Invents Act, or any </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=54,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=85546,FOLIO='49',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_50"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>subsequent
U.S. legislation regarding patents, may affect our ability to obtain patents, and if obtained, to enforce or defend them. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances for diagnostic method claims and "gene patents" (see, two
landmark Supreme Court cases, </FONT><FONT SIZE=2><I>Mayo Collaborative v. Prometheus Laboratories</I></FONT><FONT SIZE=2> ("Prometheus"), and </FONT><FONT SIZE=2><I>Association for Molecular
Pathology v. Myriad Genetics</I></FONT><FONT SIZE=2> ("Myriad")). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
view of the Supreme Court decisions in Prometheus, Myriad, and </FONT><FONT SIZE=2><I>Alice Corp. Pty.&nbsp;Ltd. v. CLS Bank Int'l</I></FONT><FONT SIZE=2> ("Alice Corp."), as well
as other federal appellate cases, we cannot guarantee that our efforts to seek patent protection for our tools and biomarkers will be successful. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we do not obtain protection under the Hatch-Waxman Amendments and similar non-U.S. legislation for
extending the term of patents covering each of our product candidates, our business may be materially harmed.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such
candidates might expire before or shortly after such candidates are commercialized. We expect to seek extensions of patent terms for certain patents in the United States and, if available, in other
countries where we are prosecuting patents and seeking approval of various products. Depending upon the timing, duration and conditions of FDA marketing approval of our product candidates, one or more
of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of&nbsp;1984, referred to as the Hatch-Waxman Amendments;
similarly, selected patents outside the U.S., may be eligible for supplementary protection certificate, or SPC, under corresponding legislation in Europe and several other countries. Depending upon
the circumstances, the Hatch-Waxman Amendments permit a patent term extension of up to five years for a patent covering an approved product as compensation for effective patent term lost during
product development and the FDA regulatory review process. However, we may not receive an extension if we fail to apply within applicable deadlines, fail to apply prior to expiration of relevant
patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. If we are unable to obtain patent term extension or the term of any
such extension is less than we request, the period during which we can enforce our patent rights for that product will be shortened. If this occurs, our competitors may be able to take advantage of
our investment in development and clinical trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to protect the confidentiality of our trade secrets, our business and competitive position
would be harmed.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to patent protection, because we operate in the highly technical field of development of therapies, we rely in part on trade secret
protection in order to protect our proprietary technology and processes. However, trade secrets are difficult to protect. We have entered into confidentiality and intellectual property assignment
agreements with our employees, consultants, outside scientific collaborators, sponsored researchers, and other advisors. These agreements generally require that the other party keep confidential and
not disclose to third parties all confidential information developed by the party or made known to the party by us during the course of the party's relationship with us. These agreements also
generally provide that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, these agreements may not be honored and may not effectively
assign intellectual property rights to us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such measures may not,
for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=14,SEQ=55,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=949801,FOLIO='50',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_51"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>provide
adequate protection for our proprietary information. Our security measures may not prevent an employee or consultant from misappropriating our trade secrets and providing them to a competitor,
and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can
be difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets. Trade secrets may be
independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or
misappropriated, or if any such information was independently developed by a competitor, our competitive position could be harmed. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We will not seek to protect our intellectual property rights in all jurisdictions throughout the world and we
may not be able to adequately enforce our intellectual property rights even in the jurisdictions where we seek protection.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filing, prosecuting and defending patents on our product candidates in all countries and jurisdictions throughout the world would be
prohibitively expensive, and our intellectual property rights in some countries outside the United States and Europe could be less extensive than those in the United States and Europe, assuming that
patent rights are obtained in the United States. Competitors may use our technologies in jurisdictions where we do not pursue and obtain patent protection to develop their own products and further,
may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States and Europe. These products may compete with our
products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. Even if we pursue and obtain issued patents in particular
jurisdictions, our patent claims or other intellectual property rights may not be effective or sufficient to prevent third parties from so competing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as the federal and state laws in the United States. Many companies have
encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, particularly in developing countries,
do not favor the enforcement of patents and other intellectual property protection, especially those relating to biopharmaceuticals or biotechnologies. This could make it difficult for us to stop the
infringement of our patents, if obtained, or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent
owner must grant licenses to third parties for certain products. In addition, many countries limit the enforceability of patents against third parties, including government agencies or government
contractors. In these countries, patents may provide limited or no benefit. Patent protection must ultimately be sought on a country-by-country basis, which
is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain countries, and we will not have the benefit of patent protection
in such countries. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceedings
to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our
patents at risk of being invalidated or interpreted narrowly, could put our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail
in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, changes in the law and legal decisions by courts in the United
States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of intellectual property. Accordingly, our efforts to enforce our intellectual
property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=15,SEQ=56,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=373980,FOLIO='51',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_52"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Third parties may assert ownership or commercial rights to inventions we develop.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Third parties may in the future make claims challenging the inventorship or ownership of our intellectual property. We have written agreements
with collaborators that provide for the ownership of intellectual property arising from our collaborations. These agreements provide that we must negotiate certain commercial rights with collaborators
with respect to joint inventions or inventions made by our collaborators that arise from the results of the collaboration. In some instances, there may not be adequate written provisions to address
clearly the resolution of intellectual property rights that may arise from collaboration. If we cannot successfully negotiate sufficient ownership and commercial rights to the inventions that result
from our use of a third-party collaborator's materials where required, or if disputes otherwise arise with respect to the intellectual property developed with the use of a collaborator's samples, we
may be limited in our ability to capitalize on the market potential of these inventions. In addition, we may face claims by third parties that our agreements with employees, contractors, or
consultants obligating them to assign intellectual property to us are ineffective, or in conflict with prior or competing contractual obligations of assignment, which could result in ownership
disputes regarding intellectual property we have developed or will develop and interfere with our ability to capture the commercial value of such inventions. Litigation may be necessary to resolve an
ownership dispute, and if we are not successful, we may be precluded from using certain intellectual property, or may lose our exclusive rights in that intellectual property. Either outcome could have
an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential
information or misappropriated trade secrets.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors
or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, and no such claims against us
are currently pending, we may be subject to claims that we or our employees, consultants or independent contractors have used or disclosed intellectual property, including trade secrets or other
proprietary information, of a former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying
monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a
distraction to management and other employees. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


A dispute concerning the infringement or misappropriation of our proprietary rights or the proprietary rights
of others could be time-consuming and costly, and an unfavorable outcome could harm our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is significant litigation in the biopharmaceutical industry regarding patent and other intellectual property rights. While we are not
currently subject to any pending intellectual property litigation, and are not aware of any such threatened litigation, we may be exposed to future litigation by third parties based on claims that our
product candidates, technologies or activities infringe the intellectual property rights of others. If our development activities are found to infringe any such patents, we may have to pay significant
damages or seek licenses to such patents. A patentee could prevent us from using the patented drugs or compositions. We may need to resort to litigation to enforce a patent issued to us, to protect
our trade secrets, or to determine the scope and validity of third-party proprietary rights. From time to time, we may hire scientific personnel or consultants formerly employed by other companies
involved in one or more areas similar to the activities conducted by us. Either we or these individuals may be subject to allegations of trade secret misappropriation or other similar claims as a
result of prior affiliations. If we become involved in litigation, it could consume a substantial portion of our managerial and financial resources, regardless of whether we win or lose. We may not be
able to afford the costs of litigation. Any adverse ruling or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=16,SEQ=57,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=899173,FOLIO='52',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cq10701_1_53"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>perception
of an adverse ruling in defending ourselves against these claims could have a negative impact on our cash position. Any legal action against us or our collaborators could lead
to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> payment of damages, potentially treble damages, if we are found to have willfully infringed a party's patent rights; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> injunctive or other equitable relief that may effectively block our ability to further develop, commercialize, and sell products; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> us having to enter into license arrangements that may not be available on commercially acceptable terms, if at all. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of these outcomes could hurt our cash position and financial condition and our ability to develop and commercialize our product candidates. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If our trademarks and trade names are not adequately protected, we may not be able to build name recognition
in our markets of interest.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be
infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we will need to build name recognition by potential partners or customers in our markets
of interest. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to the Global Offering, Ownership of Our Ordinary Shares and ADSs and Our Status as a
Non-U.S. Company with Foreign Private Issuer Status  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


There has been no market for our ADSs prior to the U.S. offering and an active and liquid market for our
securities may fail to develop, which could harm the market price of our ADSs.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although our ordinary shares have been traded on Euronext Paris since April 2014, there has been no public market on a U.S. national securities
exchange for our ADSs or our ordinary shares in the United&nbsp;States. Although we anticipate our ADSs will be approved for listing on the Nasdaq Global Market, an active trading market for our
ADSs may never develop or be sustained following the U.S. offering. The offering price of our ADSs will be determined through negotiations between us and the underwriters based on a number of factors.
This offering price may not be indicative of the market price of our ADSs or ordinary shares after the global offering. In the absence of an active trading market for our ADSs or ordinary shares,
investors may not be able to sell their ADSs at or above the offering price or at the time that they would like to sell. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The market price of our equity securities may be volatile, and purchasers of our ordinary shares or ADSs
could incur substantial losses.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The market price for our ADSs and ordinary shares may be volatile. The stock market in general and the market for biopharmaceutical companies in
particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, investors may not be able to sell
their ADSs or ordinary shares at or above the price originally paid for the security. The market price for our ADSs and ordinary shares may be influenced by many factors,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> actual or anticipated fluctuations in our financial condition and operating results; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> actual or anticipated changes in our growth rate relative to our competitors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> competition from existing products or new products that may emerge; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=17,SEQ=58,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=53218,FOLIO='53',FILE='DISK124:[18ZFA1.18ZFA10701]CQ10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cs10701_1_54"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations, or capital
commitments; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> failure to meet or exceed financial estimates and projections of the investment community or that we provide to the public; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> issuance of new or updated research or reports by securities analysts; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fluctuations in the valuation of companies perceived by investors to be comparable to us; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> share price and volume fluctuations attributable to inconsistent trading volume levels of our shares; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> additions or departures of key management or scientific personnel; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> lawsuits threatened or filed against us, disputes or other developments related to proprietary rights, including patents, litigation matters,
and our ability to obtain patent protection for our technologies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> changes to coverage policies or reimbursement levels by commercial third-party payors and government payors and any announcements relating to
coverage policies or reimbursement levels; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> announcement or expectation of additional debt or equity financing efforts; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> sales of our ordinary shares or ADSs by us, our insiders or our other shareholders; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> general economic and market conditions. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
and other market and industry factors may cause the market price and demand for our ordinary shares and ADSs to fluctuate substantially, regardless of our actual operating
performance, which may limit or prevent investors from readily selling their ordinary shares or ADSs and may otherwise negatively affect the liquidity of the trading market for our ordinary shares and
ADSs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we do not achieve our projected development and commercialization goals in the timeframes we announce and
expect, our business will be harmed and the price of our securities could decline as a result.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We sometimes estimate for planning purposes the timing of the accomplishment of various scientific, clinical, regulatory and other product
development objectives. These milestones may include our expectations regarding the commencement or completion of scientific studies, clinical trials, the submission of regulatory filings, or
commercialization objectives. From time to time, we may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing clinical trial, the initiation of other
clinical programs, receipt of marketing approval, or a commercial launch of a product. The achievement of many of these milestones may be outside of our control. All of these milestones are based on a
variety of assumptions which may cause the timing of achievement of the milestones to vary considerably from our estimates, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our available capital resources or capital constraints we experience; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the rate of progress, costs and results of our clinical trials and research and development activities, including the extent of scheduling
conflicts with participating clinicians and collaborators, and our ability to identify and enroll patients who meet clinical trial eligibility criteria; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our receipt of approvals by the EMA, FDA and other regulatory agencies and the timing thereof; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> other actions, decisions or rules issued by regulators; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=59,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=490762,FOLIO='54',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to access sufficient, reliable and affordable supplies of compounds and raw materials used in the manufacture of our product
candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the efforts of our collaborators with respect to the commercialization of our products; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the securing of, costs related to, and timing issues associated with, product manufacturing as well as sales and marketing activities. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we fail to achieve announced milestones in the timeframes we expect, the commercialization of our product candidates may be delayed, our business and results of operations may be
harmed, and the trading price of the ordinary shares and ADSs may decline as a result. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


After the completion of the global offering, we may be at an increased risk of securities class action
litigation.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Historically, securities class action litigation has often been brought against a company following a decline in the market price of its
securities. This risk is especially relevant for us because biotechnology and biopharmaceutical companies have experienced significant share price volatility in recent years. If we were to be sued, it
could result in substantial costs, which could be
insufficiently covered by insurance, and a diversion of management's attention and resources, which could harm our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have broad discretion in the use of the net proceeds from the global offering and may use them in ways
with which you do not agree and in ways that may not increase the value of your investment.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our management will have broad discretion in the application of the net proceeds that we receive from the global offering. We may spend or
invest these proceeds in a way with which our shareholders and ADS holders disagree. The failure by our management to apply these funds effectively could harm our business and financial condition.
Pending their use, we may invest the net proceeds from the global offering in a manner that does not produce income or that loses value. These investments may not yield a favorable return to our
investors. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If securities or industry analysts do not publish research or publish inaccurate or unfavorable research
about our business, the price of our ordinary shares and ADSs and their trading volume could decline.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The trading market for our ADSs and ordinary shares depends in part on the research and reports that securities or industry analysts publish
about us or our business. If no or few securities or industry analysts cover our company, the trading price for our ADSs and ordinary shares would be negatively impacted. If one or more of the
analysts who covers us downgrades our equity securities or publishes incorrect or unfavorable research about our business, the price of our ordinary shares and ADSs would likely decline. If one or
more of these analysts ceases coverage of our company or fails to publish reports on us regularly, or downgrades our securities, demand for our ordinary shares and ADSs could decrease, which could
cause the price of our ordinary shares and ADSs or their trading volume to decline. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We do not currently intend to pay dividends on our securities and, consequently, your ability to achieve a
return on your investment will depend on appreciation in the price of our ordinary shares and ADSs. In addition, French law may limit the amount of dividends we are able to distribute.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have never declared or paid any cash dividends on our ordinary shares and do not currently intend to do so for the foreseeable future. We
currently intend to invest our future earnings, if any, to fund our growth. Therefore, you are not likely to receive any dividends on your ordinary shares or ADSs for the foreseeable future and the
success of an investment in ordinary shares or ADSs will depend upon any future appreciation in its value. Consequently, investors may need to sell all or part of their holdings of ordinary shares or
ADSs after price appreciation, which may never
occur, as the only way to realize any future gains on their investment. There is no guarantee that the ordinary shares </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=60,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=393228,FOLIO='55',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_56"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>or
ADSs will appreciate in value or even maintain the price at which our shareholders have purchased them. Investors seeking cash dividends should not purchase our ADSs or ordinary shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further,
under French law, the determination of whether we have been sufficiently profitable to pay dividends is made on the basis of our statutory financial statements prepared and
presented in accordance with accounting standards applicable in France. In addition, payment of dividends may subject us to additional taxes under French law. Please see the section of this prospectus
titled "Description of Share Capital&#151;Key Provisions of Our Bylaws and French Law Affecting Our Ordinary Shares&#151;Rights, Preferences and Restrictions Attaching to Ordinary Shares
(Articles&nbsp;11, 12, 32, 40 and 41 of the Bylaws)" for further details on the limitations on our ability to declare and pay dividends and the taxes that may become payable by us if we elect to pay
a dividend. Therefore, we may be more restricted in our ability to declare dividends than companies not based in France. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, exchange rate fluctuations may affect the amount of euros that we are able to distribute, and the amount in U.S. dollars that our shareholders receive upon the payment of
cash dividends or other distributions we declare and pay in euros, if any. These factors could harm the value of our ADSs, and, in turn, the U.S. dollar proceeds that holders receive from the sale of
our ADSs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If you purchase ordinary shares or ADSs in the global offering, you will experience substantial and immediate
dilution.  </I></B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you purchase ordinary shares or ADSs in the global offering, you will experience substantial and immediate dilution of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ADS and &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in net tangible book value as of December&nbsp;31, 2018, after giving effect to the global offering at an assumed offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, which is the midpoint of the price range set forth on the cover page of this prospectus, corresponding to
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary
share in the European private placement (assuming an exchange rate of &euro;1.00=$1.1456), because the price that you pay will be substantially greater than the net tangible book value per
ADS or ordinary share, as applicable, that you acquire. This dilution is due in large part to the fact that our earlier investors paid substantially less than the offering price when they purchased
their ordinary shares. You will experience additional dilution upon exercise of any outstanding warrants to purchase ordinary shares or if we otherwise issue additional ordinary shares or ADSs below
the offering price.
For a further description of the dilution that you will experience immediately after the global offering, see the section of this prospectus titled "Dilution."

 </FONT>

</P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Future sales, or the possibility of future sales, of a substantial number of our ADSs or ordinary shares
could adversely affect the price of our ADSs and ordinary shares.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Future sales of a substantial number of our ADSs or ordinary shares, or the perception that such sales will occur, could cause a decline in the
market price of our ADSs and/or ordinary shares. Based upon the number of shares outstanding as of December&nbsp;31, 2018, after giving effect to the closing of the global offering, we will have
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares outstanding (including ordinary shares in the form of ADSs), assuming the underwriters do not exercise their option to
purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs and/or
ordinary shares. ADSs and ordinary shares issued and sold in the global offering may be resold in the public market immediately without restriction, unless purchased by our affiliates. A significant
portion of these ordinary shares and ADSs will be subject to the lock-up agreements described in "Shares and ADSs Eligible for Future Sale" and "Underwriting." If, after the end of such lock-up
agreements, these shareholders or ADS holders sell substantial amounts of ordinary shares or ADSs in the public market, or the market perceives that such sales may occur, the market price of our ADSs
or ordinary shares and our ability to raise capital through an issuance of equity securities in the future could be adversely affected. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=61,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=270596,FOLIO='56',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_57"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The rights of shareholders in companies subject to French corporate law differ in material respects from the
rights of shareholders of corporations incorporated in the United States.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a French company with limited liability. Our corporate affairs are governed by our bylaws and by the laws governing companies
incorporated in France. The rights of shareholders and the responsibilities of members of our board of directors are in many ways different from the rights and obligations of shareholders in companies
governed by the laws of U.S. jurisdictions. For example, in the performance of its duties, our board of directors is required by French law to consider the interests of our company, its shareholders,
its employees and other stakeholders, rather than solely our shareholders and/or creditors. It is possible that some of these parties will have interests that are different from, or in addition to,
your interests as a shareholder or holder of ADSs. See the sections of this prospectus titled "Management&#151;Corporate Governance Practices" and "Description of Share Capital." </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


U.S. investors may have difficulty enforcing civil liabilities against our company and directors and senior
management and the experts named in this prospectus.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain members of our board of directors and senior management and certain experts named in this prospectus are non-residents of the United
States, and all or a substantial portion of our assets and the assets of such persons are located outside the United States. As a result, it may not be possible to serve process on such persons or us
in the United States or to enforce judgments obtained in U.S. courts against them or us based on civil liability provisions of the securities laws of the United States. Additionally, it may be
difficult to assert U.S. securities law claims in actions originally instituted outside of the United States. Courts outside the United States may refuse to hear a U.S. securities law claim because
non-U.S. courts may not be the most appropriate forums in which to bring such a claim. Even if a court outside the United States agrees to hear a claim, it may determine that the law of the
jurisdiction in which the non-U.S. court resides, and not U.S. law, is applicable to the claim. Further, if U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a
fact, which can be a time-consuming and costly process, and certain matters of procedure would still be governed by the law of the jurisdiction in which the non-U.S. court resides. In particular,
there is some doubt as to whether French courts would recognize and enforce certain civil liabilities under U.S. securities laws in original actions or judgments of U.S. courts based upon these civil
liability provisions. In addition, awards of punitive damages in actions brought in the United States or elsewhere may be unenforceable in France. An award for monetary damages under the U.S.
securities laws would be considered punitive if it does not seek to compensate the claimant for loss or damage suffered but is intended to punish the defendant. French law provides that a shareholder,
or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a corporation in the corporation's interest if it fails to bring such legal action itself. If so,
any damages awarded by the court are paid to the corporation and any legal fees relating to such action may be borne by the relevant shareholder or the group of shareholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
enforceability of any judgment in France will depend on the particular facts of the case as well as the laws and treaties in effect at the time. The United States and France do not
currently have a treaty providing for recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. See the section of this prospectus titled "Enforcement
of Civil Liabilities." </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our bylaws and French corporate law contain provisions that may delay or discourage a takeover attempt.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions contained in our bylaws and French corporate law could make it more difficult for a third party to acquire us, even if doing so might
be beneficial to our shareholders. In addition, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>57</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=62,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=949428,FOLIO='57',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_58"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>provisions
of our bylaws impose various procedural and other requirements, which could make it more difficult for shareholders to effect certain corporate actions. These provisions include the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> under French law, the owner of 95% of voting rights of a public company listed on a regulated market in a Member State of the European Union or
in a state party to the European Economic Area, or EEA, Agreement, including from the main French stock exchange, has the right to force out minority shareholders following a tender offer made to all
shareholders; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> under French law, certain foreign investments in companies incorporated under French laws are subject to the prior authorization from the
French Minister of the Economy, where all or part of the target's business and activity relate to a strategic sector, such as energy, transportation, public health, telecommunications, etc.; see the
section of this prospectus titled "Limitations Affecting Shareholders of a French Company;" </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a merger (i.e.,&nbsp;in a French law context, a share for share exchange following which our company would be dissolved into the acquiring
entity and our shareholders would become shareholders of the acquiring entity) of our company into a company incorporated in the European Union would require the approval of our board of directors as
well as a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a merger of our company into a company incorporated outside of the European Union would require 100% of our shareholders to approve it; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> under French law, a cash merger is treated as a share purchase and would require the consent of each participating shareholder; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our shareholders have granted and may grant in the future our board of directors broad authorizations to increase our share capital or to issue
additional ordinary shares or other securities, such as warrants, to our shareholders, the public or qualified investors, including as a possible defense following the launching of a tender offer for
our shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our shareholders have preferential subscription rights on a pro rata basis on the issuance by us of any additional securities for cash or a
set-off of cash debts, which rights may only be waived by the extraordinary general meeting by a two-thirds majority vote of our shareholders or on an individual basis by each shareholder; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our board of directors has the right to appoint directors to fill a vacancy created by the resignation or death of a director, subject to the
approval by the shareholders of such appointment at the next shareholders' meeting, which prevents shareholders from having the sole right to fill vacancies on our board of directors; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our board of directors can be convened by our chairman, including upon request from our managing director, if any, or, when no board meeting
has been held for more than two consecutive months, from directors representing at least one-third of the total number of directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our board of directors meetings can only be regularly held if at least half of the directors attend either physically or by way of
videoconference or teleconference enabling the directors' identification and ensuring their effective participation in the board's decisions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our shares are registered or bearer, if the legislation so permits, according to the shareholder's choice; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approval of at least a majority of the votes held by shareholders present, represented by a proxy, or voting by mail at the relevant ordinary
shareholders' general meeting is required to remove directors with or without cause; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>58</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=63,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=679797,FOLIO='58',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_59"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> advance notice is required for nominations to the board of directors or for proposing matters to be acted upon at a shareholders' meeting,
except that a vote to remove and replace a director can be proposed at any shareholders' meeting without notice; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our bylaws can be changed in accordance with applicable French laws and regulations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the crossing of certain thresholds has to be disclosed and can impose certain obligations; see the sections of this prospectus titled "Rights,
Preferences and Restrictions Attaching to Ordinary Shares (Articles&nbsp;9, 11, 12, 32, 40 and, 41of the Bylaws)&#151;Requirements for Holdings Exceeding Certain Percentages" and "Declaration
of Crossing of Ownership Thresholds (Article&nbsp;11 of the Bylaws);" </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> transfers of shares shall comply with applicable insider trading rules and regulations and, in particular, with the Market Abuse Directive and
Regulation dated April&nbsp;16, 2014; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> pursuant to French law, the sections of our Bylaws relating to the number of directors and election and removal of a director from office, may
only be modified by a resolution adopted by two-thirds of the votes of our shareholders present, represented by a proxy or voting by mail at the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You may not be able to exercise your right to vote the ordinary shares underlying your ADSs.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of ADSs may exercise voting rights with respect to the ordinary shares represented by the ADSs only in accordance with the provisions of
the deposit agreement. The deposit agreement provides that, upon receipt of notice of any meeting of holders of our ordinary shares, the depositary will fix a record date for the determination of ADS
holders who shall be entitled to give instructions for the exercise of voting rights. Upon timely receipt of notice from us, if we so request, the depositary shall distribute to the holders as of the
record date (1)&nbsp;the notice of the meeting or solicitation of consent or proxy sent by us and (2)&nbsp;a statement as to the manner in which instructions may be given by the holders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchasers
of ADSs in the U.S. offering may instruct the depositary of their ADSs to vote the ordinary shares underlying their ADSs. Otherwise, purchasers of ADSs in the U.S. offering
will not be able to exercise voting rights unless they withdraw the ordinary shares underlying the ADSs they hold. However, a holder of ADSs may not know about the meeting far enough in advance to
withdraw those ordinary shares. If we ask for a holder of ADSs' instructions, the depositary, upon timely notice from us, will notify him or her of the upcoming vote and arrange to deliver our voting
materials to him or her. We cannot guarantee to any holder of ADSs that he or she will receive the voting materials in time to ensure that he or she can instruct the depositary to vote his or her
ordinary shares or to withdraw his or her ordinary shares so that he or she can vote them. If the depositary does not receive timely voting instructions from a holder of ADSs, it may give a proxy to a
person designated by us to vote the ordinary shares underlying his or her ADSs. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the
manner of carrying out voting instructions. This means that a holder of ADSs may not be able to exercise his or her right to vote, and there may be nothing he or she can do if the ordinary shares
underlying his or her ADSs are not voted as he or she requested. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Purchasers of ADSs are not holders of our ordinary shares.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A holder of ADSs will not be treated as one of our shareholders and will not have direct shareholder rights. French law governs our shareholder
rights. The depositary will be the holder of the ordinary shares underlying ADSs held by purchasers of ADSs in the U.S. offering. Purchasers of ADSs in the U.S. offering will have ADS holder rights.
The deposit agreement among us, the depositary and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>59</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=64,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=886435,FOLIO='59',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_60"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>purchasers
of ADSs in the U.S. offering, as ADS holders, and all other persons directly and indirectly holding ADSs, sets out ADS holder rights, as well as the rights and obligations of the
depositary. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
double voting right is attached to each registered share which is held in the name of the same shareholder for at least two years. However, the ordinary shares underlying our ADSs will
not be entitled to double voting rights as the depositary will hold the shares underlying our ADSs in bearer form. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The right as a holder of ADSs to participate in any future preferential subscription rights or to elect to
receive dividends in shares may be limited, which may cause dilution to the holdings of purchasers of ADSs in the U.S. offering.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;According to French law, if we issue additional securities for cash, current shareholders will have preferential subscription rights for these
securities on a pro rata basis unless they waive those rights at an extraordinary meeting of our shareholders by a two-thirds majority vote or individually by each shareholder. However, ADS holders
will not be entitled to exercise or sell such rights unless we register the rights and the securities to which the rights relate under the Securities Act or an exemption from the registration
requirements is available. In addition, the deposit agreement provides that the depositary will not make rights available to purchasers of ADSs in the U.S. offering unless the distribution to ADS
holders of both the rights and any related securities are either registered under the Securities Act or exempted from registration under the Securities Act. Further, if we offer holders of our
ordinary shares the option to receive dividends in either cash or shares, under the deposit agreement the depositary may require satisfactory assurances from us that extending the offer to holders of
ADSs does not require registration of any securities under the Securities Act before making the option available to holders of ADSs. We are under no obligation to file&nbsp;a registration statement
with respect to any such rights or securities or to endeavor to cause such a registration statement to be declared effective. Moreover, we may not be able to establish an exemption from registration
under the Securities Act. Accordingly, ADS holders may be unable to participate in our rights offerings or to elect to receive dividends in shares and may experience dilution in their holdings. In
addition, if the depositary is unable to sell rights that are not exercised or not distributed or if the sale is not lawful or reasonably practicable, it will allow the rights to lapse, in which case
you will receive no value for these rights. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Purchasers of ADSs in the U.S. offering may be subject to limitations on the withdrawal of the underlying
ordinary shares.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Temporary delays in the cancellation of ADSs and withdrawal of the underlying ordinary shares may arise because the depositary has closed its
transfer books or we have closed our transfer books, the transfer of ordinary shares is blocked to permit voting at a shareholders' meeting or we are paying a dividend on our ordinary shares. In
addition, a holder of ADSs may not be able to cancel his or her ADSs and withdraw the underlying ordinary shares when he or she owes money for fees, taxes and similar charges and when it is necessary
to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary shares or other deposited securities. See the section of this
prospectus titled "Description of American Depositary Shares." </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;">


<FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement,
which could result in less favorable outcomes to the plaintiffs in any such action.

  </I></B></FONT>

</P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The deposit agreement governing the ADSs representing our ordinary shares provides that, to the fullest extent permitted by law, ADS holders
waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S.
federal securities laws.

</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>60</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=65,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=74214,FOLIO='60',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_61"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in
accordance with the applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities
laws has not been finally adjudicated by the United States Supreme Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the
laws of the State of New York, which govern the deposit agreement, by a federal or state court in the City of New York, which has non-exclusive jurisdiction over matters arising under the deposit
agreement. In determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider whether a party knowingly, intelligently and voluntarily waived the
right to a jury trial. We believe that this is the case with respect to the deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before
entering into the deposit agreement.

</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you or any other holders or beneficial owners of ADSs bring a claim against us or the depositary in connection with matters arising under the deposit agreement or the ADSs, including
claims under federal securities laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and
discouraging lawsuits against us and the depositary. If a lawsuit is brought against either or both of us and the depositary under the deposit agreement, it may be heard only by a judge or justice of
the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have, including results that could be less
favorable to the plaintiffs in any such action.

</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nevertheless, if this jury trial waiver provision is not permitted by applicable law, an action could proceed under the terms of the deposit agreement with a jury trial. No condition,
stipulation or provision of the deposit agreement or ADSs serves as a waiver by any holder or beneficial owner of ADSs or by us or the depositary of compliance with any substantive provision of the
U.S. federal securities laws and the rules and regulations promulgated thereunder.

 </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


As a foreign private issuer, we are exempt from a number of rules under the U.S. securities laws and are
permitted to file less information with the SEC than a U.S. company. This may limit the information available to holders of ADSs and our ordinary shares.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a foreign private issuer, as defined in the SEC's rules and regulations and, consequently, we are not subject to all of the disclosure
requirements applicable to public companies organized within the United States. For example, we are exempt from certain rules under the Securities Exchange Act of 1934, as amended, or the Exchange
Act, that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations applicable to a security registered under the Exchange Act,
including the U.S. proxy rules under Section&nbsp;14 of the Exchange Act. In addition, our officers and directors are exempt from the reporting and "short-swing" profit recovery provisions of
Section&nbsp;16 of the Exchange Act and related rules with respect to their purchases and sales of our securities. Moreover, while we currently make annual and semi-annual filings with respect to
our listing on Euronext Paris and expect to file financial reports on an annual and semi-annual basis, we will not be required to file periodic reports and financial statements with the SEC as
frequently or as promptly as U.S. public companies and will not be required to file quarterly reports on Form&nbsp;10-Q or current reports on Form&nbsp;8-K under the Exchange Act. Accordingly,
there will be less publicly available information concerning our company than there would be if we were not a foreign private issuer. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>61</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=66,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=955886,FOLIO='61',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_62"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


As a foreign private issuer, we are permitted and we expect to follow certain home country practices in
relation to corporate governance matters that differ significantly from Nasdaq's corporate governance standards. These practices may afford less protection to shareholders than they would enjoy if we
complied fully with the corporate governance standards of the Nasdaq Global Market.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a foreign private issuer listed on the Nasdaq Global Market, we will be subject to Nasdaq's corporate governance standards. However, Nasdaq
rules provide that foreign private issuers are permitted to follow home country corporate governance practices in lieu of Nasdaq's corporate governance standards as long as notification is provided to
Nasdaq of the intention to take advantage of such exemptions. We intend to rely on exemptions for foreign private issuers and follow French corporate governance practices in lieu of Nasdaq's corporate
governance standards, to the extent possible. Certain corporate governance practices in France, which is our home country, may differ significantly from Nasdaq corporate governance standards. For
example, as a French company, neither the corporate laws of France nor our bylaws require a majority of our directors to be independent and we can include non-independent directors as members of our
remuneration committee, and our independent directors are not required to hold regularly scheduled meetings at which only independent directors are present. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also exempt from provisions set forth in Nasdaq rules which require an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than
one-third of the outstanding voting stock. Consistent with French law, our bylaws provide that a quorum requires the presence of shareholders having at least (1)&nbsp;20% of the shares entitled to
vote in the case of an ordinary shareholders' general meeting or at an extraordinary shareholders' general meeting where shareholders are voting on a capital increase by capitalization of reserves,
profits or share premium, or (2)&nbsp;25% of the shares entitled to vote in the case of any other extraordinary shareholders' general meeting. If a quorum is not present, the meeting is adjourned.
There is no quorum requirement when an ordinary general meeting is reconvened, but the reconvened meeting may consider only questions which were on the agenda of the adjourned meeting. When an
extraordinary general meeting is reconvened, the quorum required is 20% of the shares entitled to vote, except where the reconvened meeting is considering capital increases through capitalization of
reserves, profits or share premium. For these matters, no quorum is required at the reconvened meeting. If a quorum is not present at a reconvened meeting requiring a quorum, then the meeting may be
adjourned for a maximum of two months. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a foreign private issuer, we are required to comply with Rule&nbsp;10A-3 of the Exchange Act, relating to audit committee composition and responsibilities. Under French law, the
audit committee may only have an advisory role and appointment of our statutory auditors, in particular, must be decided by the shareholders at our annual meeting. Therefore, our shareholders may be
afforded less protection than they otherwise would have under Nasdaq's corporate governance standards applicable to U.S. domestic issuers. For an overview of our corporate governance practices, see
"Management&#151;Corporate Governance Practices." </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are an "emerging growth company" under the JOBS Act and will be able to avail ourselves of reduced
disclosure requirements applicable to emerging growth companies, which could make our ADSs less attractive to investors.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are an "emerging growth company," as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and we intend to take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies," including not being required to comply with
the auditor attestation requirements of Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, and exemptions from the requirements of holding a nonbinding advisory vote
on executive compensation and shareholder approval of any golden parachute payments not previously approved. In addition, Section&nbsp;107 of the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>62</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=67,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=153568,FOLIO='62',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_63"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>JOBS
Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section&nbsp;7(a)(2)(B) of the Securities Act of 1933, as amended, or the
Securities Act, for complying with new or revised accounting standards. We will not take advantage of the extended transition period provided under Section&nbsp;7(a)(2)(B) of the Securities Act for
complying with new or revised accounting standards. Since IFRS makes no distinction between public and private companies for purposes of compliance with new or revised accounting standards, the
requirements for our compliance as a private company and as a public company are the same. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot predict if investors will find our ADSs less attractive because we may rely on these exemptions. If some investors find our ADSs less attractive as a result, there may be a
less active trading market for our ADSs and the price of our ADSs may be more volatile. We may take advantage of these reporting exemptions until we are no longer an emerging growth company. We will
remain an emerging growth company until the earliest of (1)&nbsp;the last day of the fiscal year in which we have total annual gross revenue of $1.07&nbsp;billion or more; (2)&nbsp;the last day
of our fiscal year following the fifth anniversary of the date of the completion of the global offering; (3)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in nonconvertible
debt during the previous three years; and (4)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the SEC. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may lose our foreign private issuer status in the future, which could result in significant additional
cost and expense.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While we currently qualify as a foreign private issuer, the determination of foreign private issuer status is made annually on the last business
day of an issuer's most recently completed second fiscal quarter and, accordingly, the next determination will be made with respect to us on June&nbsp;30, 2019. In the future, we would lose our
foreign private issuer status if we fail to meet the requirements necessary to maintain our foreign private issuer status as of the relevant determination date. We will remain a foreign private issuer
until such time that more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (1)&nbsp;the majority of our executive
officers or directors are U.S. citizens or residents; (2)&nbsp;more than 50% of our assets are located in the United States; or (3)&nbsp;our business is administered principally in the United
States. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly more than costs we incur as a foreign private issuer. If we are not a
foreign private issuer, we will be required to file periodic reports and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and extensive in certain respects
than the forms available to a foreign private issuer. We would be required under current SEC rules to prepare our financial statements in accordance with U.S.&nbsp;GAAP, rather than IFRS, and modify
certain of our policies to comply with corporate governance practices associated with U.S. domestic issuers. Such conversion of our financial statements to U.S.&nbsp;GAAP would involve significant
time and cost. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements on U.S. stock exchanges that are available to foreign private issuers such as
the ones described herein and exemptions from procedural requirements related to the solicitation of proxies. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes to U.S. and non-U.S. tax laws could materially adversely affect our company.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;22, 2017, the Tax Cuts and Jobs Act was signed into law and significantly revised the Internal Revenue Code of 1986, as
amended, or the Code. The Tax Cuts and Jobs Act, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35%
to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted earnings (except for certain small businesses), implementation of a "base erosion anti-abuse tax" which
requires U.S. corporations to make an alternative determination of taxable income without regard to tax deductions for certain payments to affiliates, taxation of certain non-U.S. corporations'
earnings considered to be "global intangible low taxed income" (also referred to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>63</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=68,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=206623,FOLIO='63',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_64"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>as
"GILTI"), repeal of the alternative minimum tax, or AMT, for corporations and changes to a taxpayer's ability to either utilize or refund the AMT credits previously generated, changes to the
limitation on deductions for certain executive compensation particularly with respect to the removal of the previously allowed performance based compensation exception, changes in the attribution
rules relating to shareholders of certain "controlled foreign corporations", limitation of the deduction for net operating losses to 80% of current year taxable income and elimination of net operating
loss carrybacks, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important
exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits. Notwithstanding
the reduction in the U.S. corporate income tax rate, the overall impact of the Tax Cuts and Jobs Act is uncertain and our business and financial condition could be adversely affected. The impact of
the Tax Cuts and Jobs Act on holders of our ordinary shares or ADSs is also uncertain and could be adverse. For example, recent changes in U.S. federal income tax law resulting in additional taxes
owed by U.S. holders (as defined below under "Material United States Federal Income Tax and French Tax Considerations&#151;Material U.S. Federal Income Tax Considerations") under the new GILTI
tax rules or related to "controlled foreign corporations" may discourage U.S. investors from owning or acquiring 10% or greater of our outstanding ordinary shares or ADSs, which other shareholders may
have viewed as beneficial or may otherwise negatively impact the trading price of our ordinary shares or ADSs. We are unable to predict what federal tax law may be proposed or enacted in the future or
what effect such changes would have on our business, but such changes, to the extent they are brought into tax legislation, regulations, policies or practices, could affect our effective tax rates in
the future in countries where we have operations and have an adverse effect on our overall tax rate in the future, along with increasing the complexity, burden and cost of tax compliance. We urge our
shareholders to consult with their legal and tax advisors with respect to this legislation and the potential tax consequences of investing in or holding our ordinary shares or ADSs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are a passive foreign investment company, there could be adverse U.S. federal income tax consequences
to U.S. holders.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based on our analysis of our income, assets, activities and market capitalization, we believe that we were not classified as a passive foreign
investment company, or PFIC, for the taxable year ending December&nbsp;31, 2018 and we believe that we will not be classified as a PFIC for the taxable year ending December&nbsp;31, 2019; however,
there can be no assurance that we will not be considered a PFIC for any future taxable year. Under the Code, a non-U.S. company will be considered a PFIC for any taxable year in which (1)&nbsp;75%
or more of its gross income consists of passive income or (2)&nbsp;50% or more of the average quarterly value of its assets consists of assets that produce, or are held for the production of,
passive income. For purposes of these tests, passive income includes dividends, interest, gains from the sale or exchange of investment property and certain rents and royalties. In addition, for
purposes of the above calculations, a non-U.S. corporation that directly or indirectly owns at least 25% by value of the shares of another corporation is treated as if it held its proportionate share
of the assets and received directly its proportionate share of the income of such other corporation. If we are a PFIC for any taxable year during which a U.S. holder (as defined below under
"Material United States Federal Income Tax and French Tax Considerations&#151;Material U.S. Federal Income Tax Considerations") holds our ordinary shares or ADSs, we will continue to be treated
as a PFIC with respect to such U.S. holder in all succeeding years during which the U.S. holder owns the ordinary shares or ADSs, regardless of whether we continue to meet the PFIC test described
above, unless the U.S. holder makes a specified election once we cease to be a PFIC. If we are classified as a PFIC for any taxable year during which a U.S. holder holds our ordinary shares or ADSs,
the U.S. holder may be subject to adverse tax consequences regardless of whether we continue to qualify as a PFIC, including ineligibility for any preferred tax rates on capital gains or on actual or
deemed dividends, interest charges on certain taxes </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>64</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=69,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=964403,FOLIO='64',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_65"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>treated
as deferred, and additional reporting requirements. For further discussion of the PFIC rules and the adverse U.S. federal income tax consequences in the event we are classified as a PFIC, see
the section of this prospectus titled "Material United States Federal Income Tax and French Tax Considerations&#151;Material U.S. Federal Income Tax Considerations". </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If a United States person is treated as owning at least 10% of our ordinary shares, such holder may be
subject to adverse U.S. federal income tax consequences.  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If a U.S. holder is treated as owning, directly, indirectly or constructively, at least 10% of the value or voting power of our ordinary shares
or ADSs, such U.S. holder may be treated as a "United States shareholder" with respect to each "controlled foreign corporation" in our group, if any. Our group currently includes one U.S. subsidiary
and, therefore, under current law our non-U.S. subsidiaries should be treated as controlled foreign corporations, regardless of whether we are treated as a controlled foreign corporation. A United
States shareholder of a controlled foreign corporation may be required to annually report and include in its U.S. taxable income its pro rata share of "Subpart&nbsp;F income," "global intangible
low-taxed income" and investments in U.S. property by controlled foreign corporations, regardless of whether we make any distributions. An individual that is a United States shareholder with respect
to a controlled foreign corporation generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder that is a U.S. corporation.
Failure to comply with controlled foreign corporation reporting obligations may subject a United States shareholder to significant monetary penalties. We cannot provide any assurances that we will
furnish to any United States shareholder information that may be necessary to comply with the reporting and tax paying obligations applicable under the controlled foreign corporation rules of the
Code. U.S. holders should consult their tax advisors regarding the potential application of these rules to their investment in our ordinary shares or ADSs. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We must maintain effective internal control over financial reporting, and if we are unable to do so, the
accuracy and timeliness of our financial reporting may be adversely affected, which could hurt our business, lessen investor confidence and depress the market price of our securities.  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a public company, we must maintain effective internal control over financial reporting in order to accurately and timely report our results
of operations and financial condition. In addition, as a public company listed in the United States, the Sarbanes-Oxley Act will require, among other things, that we assess the effectiveness of our
internal control over financial reporting at the end of each fiscal year. Depending on the success of our listing in the U.S .market, we may have to start reporting under Section&nbsp;404 of the
Sarbanes Oxley Act as early as for the year ending December&nbsp;31, 2020 and the filing of our second annual report on Form&nbsp;20-F with the SEC. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
rules governing the standards that must be met for our management to assess our internal control over financial reporting pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act are
complex and require significant documentation, testing and possible remediation. These stringent standards require that our audit committee be advised and regularly updated on management's review of
internal control over financial reporting. We are in the process of designing, implementing, and testing the internal control over financial reporting required to comply with this obligation. This
process is time-consuming, costly, and complicated. In addition, our independent registered public accounting firm will be required to attest to the effectiveness of our internal controls over
financial reporting beginning with our annual report following the date on which we are no longer an "emerging growth company," which may be up to five fiscal years following the date of the global
offering. Our management may not be able to effectively and timely implement controls and procedures that adequately respond to the increased regulatory compliance and reporting requirements that will
be applicable to us as a public company listed in the United States. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>65</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=70,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=594167,FOLIO='65',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cs10701_1_66"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the audit of our consolidated financial statements as of and for the year ended December&nbsp;31, 2018, our independent registered public accounting firm identified
a control deficiency in our internal control over financial reporting that constituted a material weakness in our internal control over financial reporting. As defined in the standards established by
the U.S. Public Company Accounting Oversight Board, a material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable
possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
independent registered public accounting firm identified the material weakness attributable to our lack of expertise regarding complex and unusual IFRS accounting treatment for our
convertible bonds and their associated deferred tax impacts. As such, our controls over financial reporting were not
designed or operating effectively, and as a result there was an error in our previously issued financial statements for the year ended December&nbsp;31, 2017 that required us to restate our
financial statements for that year. Additional information describing this matter is included in Note&nbsp;2.3 to our consolidated financial statements contained in this prospectus. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have historically retained the services of an external consultant to assist us with complex and unusual IFRS accounting treatment, such as in the case of our convertible bonds. In an
effort to remediate our material weakness, we intend to engage additional personnel, both internal and external, with appropriate training, as well as to redesign our supervision controls, including
with respect to the documentation of assumptions used and the development of accounting positions, and to reassess the necessary qualifications for any external consultants. There can be no assurance
that we will be successful in pursuing these measures or that these measures will significantly improve or remediate the material weakness described above. There is also no assurance that we have
identified all of our material weaknesses or that we will not in the future have additional material weaknesses. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we fail to remediate the material weakness or to meet the demands that will be placed upon us as a public company, including the requirements of the Sarbanes-Oxley Act, we may be
unable to accurately report our financial results, or report them within the timeframes required by law or stock exchange regulations. Failure to comply with Section&nbsp;404 of the Sarbanes-Oxley
Act could also potentially subject us to sanctions or investigations by the SEC or other regulatory authorities. There is no assurance that we will be able to remediate the material weakness in a
timely manner, or at all, or that in the future, additional material weaknesses will not exist or otherwise be discovered. If our efforts to remediate the material weakness identified are not
successful, or if other material weaknesses or other deficiencies occur, our ability to accurately and timely report our financial position could be impaired, which could result in our failure to meet
our reporting obligations in a timely manner under the Exchange Act, additional restatements of our consolidated financial statements, a decline in our stock price, suspension or delisting of our
common stock from the Nasdaq Global Market, and could adversely affect our reputation, results of operations and financial condition. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>66</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=71,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=484494,FOLIO='66',FILE='DISK124:[18ZFA1.18ZFA10701]CS10701A.;34',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cu10701_1_67"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cu10701_special_note_regarding_forward-looking_statements"> </A>
<A NAME="toc_cu10701_1"> </A></FONT> <FONT SIZE=2><B>  SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus, particularly the sections of this prospectus titled "Prospectus Summary," "Risk Factors," "Management's Discussion and Analysis
of Financial Condition and Results of Operations" and "Business," contains forward-looking statements. All statements other than present and historical facts and conditions contained in this
prospectus, including statements regarding our future results of operations and financial position, business strategy, plans and our objectives for future operations, are forward-looking statements.
When used in this prospectus, the words "anticipate," "believe," "can," "could," "estimate," "expect," "intend," "is designed to," "may," "might," "plan," "potential," "predict," "objective,"
"should," or the negative of these and similar expressions identify forward-looking statements. Forward-looking statements include, but are not limited to, statements
about:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our plans to develop and commercialize elafibranor, our IVD test and our other drug candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the initiation, timing, progress and results of our preclinical studies and clinical trials, including the timing of availability of data from
our clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to successfully expand and advance our pipeline of drug candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the timing of our planned regulatory filings; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the timing of and our ability to obtain and maintain regulatory approvals; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the clinical utility and market acceptance of our drug candidates and IVD test; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the potential clinical utility of our product candidates and their potential advantages over existing therapies as well as those in
development; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to establish and maintain manufacturing and supply arrangements for our product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the ability of third parties with whom we contract to successful conduct, supervise and monitor clinical trials for our product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the effects of increased competition as well as innovations by new and existing competitors in our industry; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our ability to maintain, protect and enhance our intellectual property rights and propriety technologies and to operate our business without
infringing the intellectual property rights and proprietary technology of third parties; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our estimates regarding future revenues, expenses and needs for additional financing; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our expected use of proceeds of the global offering; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> other risks and uncertainties, including those listed under the caption "Risk Factors." </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
should refer to the section of this prospectus titled "Risk Factors" for a discussion of important factors that may cause our actual results to differ materially from those expressed
or implied by our
forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking
statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a
representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. We undertake no obligation to publicly update any
forward-looking </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>67</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=72,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=348959,FOLIO='67',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cu10701_1_68"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>statements,
whether as a result of new information, future events or otherwise, except as required by law. The Private Securities Litigation Reform Act of 1995 and Section&nbsp;27A of the Securities
Act do not protect any forward-looking statements that we make in connection with the global offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus is a
part with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. We qualify all of our
forward-looking statements by these cautionary statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>68</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=73,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=662837,FOLIO='68',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cu10701_1_69"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cu10701_use_of_proceeds"> </A>
<A NAME="toc_cu10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  USE OF PROCEEDS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We estimate that we will receive net proceeds from the global offering of approximately &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming an offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, the closing price of our ordinary
shares on Euronext Paris on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
corresponding to
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement (assuming an exchange rate of &euro;1.00&nbsp;=&nbsp;$1.1456), after deducting underwriting
commissions and estimated offering expenses payable by us, and assuming no exercise of the underwriters' option to purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs and/or ordinary shares. If the
underwriters
exercise in full their option to purchase additional ADSs and/or ordinary shares in the global offering, we estimate that we will receive net proceeds from the global offering of approximately
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming an offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, the closing price of our ordinary shares on Euronext
Paris on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
corresponding to &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement (assuming an exchange rate of &euro;1.00&nbsp;= $1.1456), after deducting
underwriting commissions and estimated offering expenses payable by us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
&euro;1.00 ($1.1456) increase or decrease in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering would increase or decrease our net proceeds from
the global offering by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming the number of ordinary shares offered by us
(which may be in the form of ADSs), as set forth on the
cover page of this prospectus, remains the same and after deducting underwriting commissions and estimated offering expenses payable by us. Subject to applicable law, we may also increase or decrease
the number of ordinary shares (including ordinary shares in the form of ADSs) we are offering. An increase or decrease of 1,000,000 ordinary shares (including ordinary shares in the form of ADSs)
offered by us in the global offering would increase or decrease the net proceeds to us by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming that the assumed offering price
remains the same and after deducting underwriting commissions and estimated offering expenses payable by us. The actual net proceeds payable to us will adjust based on the actual number of ordinary
shares (including ordinary shares in the form of ADSs) offered by us in the global offering, the actual offering price and other terms of the global offering determined at pricing. We currently expect
to use the net proceeds from the global offering as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to prepare for the potential commercialization of elafibranor in NASH by building out
our commercial
infrastructure; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to complete our ongoing Phase&nbsp;3 clinical development of
elafibranor for the treatment of NASH through to,
at least, the submission of an NDA to the FDA and EMA and the launch of the Phase&nbsp;4 clinical trial; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to conduct and complete our planned global Phase&nbsp;3 clinical
trial of elafibranor for the treatment of PBC; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to advance the commercial development of our IVD test to identify
NASH patients through the launch of the LDT and
completion of the work required to obtain regulatory approval for our IVD kit; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to advance our research program on the use of elafibranor as a
potential backbone for combination therapies in
order to launch two proof-of-concept studies; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the remainder for working capital and for general corporate purposes. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
with the expected net proceeds from the global offering, and depending on our ability to generate sufficient revenues from the future potential commercialization of our drug
candidates and IVD test, we may need to raise additional capital in the future to develop and commercialize our drug candidates and IVD test, including future clinical trials that may be required by
regulatory authorities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>69</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=74,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=694745,FOLIO='69',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cu10701_1_70"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>We
have based these estimates on assumptions that may prove to be incorrect, and we could use our available capital resources sooner than we currently expect. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
expected use of the net proceeds from the global offering represents our intentions based upon our current plans and business conditions. As of the date of this prospectus, we
cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of the global offering or the amounts that we will actually spend on the uses set forth
above. The amounts and timing of our actual expenditures and the extent of clinical development may vary significantly depending on numerous factors, including the progress of our development efforts,
the status of and results from preclinical studies and any ongoing clinical trials or clinical trials we may commence in the future, as well as any collaborations that we may enter into with third
parties for our drug candidates and any unforeseen cash needs. As a result, our future financing needs remain uncertain and our management will retain broad discretion over the allocation of the net
proceeds from the global offering. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pending
our use of the net proceeds from the global offering, we intend to invest the net proceeds in a variety of capital preservation investments, including short-term,
investment-grade, interest-bearing instruments. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>70</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=75,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=829479,FOLIO='70',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cu10701_1_71"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cu10701_dividend_policy"> </A>
<A NAME="toc_cu10701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  DIVIDEND POLICY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have never declared or paid any dividends on our ordinary shares. We do not anticipate paying cash dividends on our equity securities in the
foreseeable future and intend to retain all available funds and any future earnings for use in the operation and expansion of our business, given our state of development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the requirements of French law and our bylaws, dividends may only be distributed from our distributable profits, plus any amounts held in our available reserves which are
reserves other than legal and statutory and revaluation surplus. See the section of this prospectus titled "Description of Share Capital&#151;Key Provisions of Our Bylaws and French Law
Affecting Our Ordinary Shares&#151;Rights, Preferences and Restrictions Attaching to Ordinary Shares (Articles&nbsp;11, 12, 32, 40 and 41 of the Bylaws)" for further details on the
limitations on our ability to declare and pay dividends. Dividend distributions, if any in the future, will be made in euros and converted into U.S. dollars with respect to the ADSs, as provided in
the deposit agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>71</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=76,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=378653,FOLIO='71',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cu10701_1_72"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cu10701_capitalization"> </A>
<A NAME="toc_cu10701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  CAPITALIZATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth our cash and cash equivalents and capitalization as of December&nbsp;31,
2018:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> on an actual basis; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> on an as adjusted basis to reflect (i)&nbsp;the issuance and sale of (a)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs in the U.S. offering at an assumed
offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, the closing price of our ordinary shares on Euronext Paris
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and (b)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in the European private
placement at an assumed offering price of &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (assuming an exchange rate of &euro;1.00&nbsp;= $1.1456), after deducting estimated
underwriting commissions and estimated offering expenses payable by us and (ii)&nbsp;the application of net proceeds from the global offering described under "Use of Proceeds." </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
capitalization following the global offering will be adjusted based on the actual offering price and other terms of the global offering determined at pricing, including the amount by
which actual offering expenses are higher or lower than estimated. The table should be read in conjunction with the information contained in "Use of Proceeds," "Selected Consolidated Financial Data"
and "Management's Discussion and Analysis of Financial Condition and Results of Operations," as well as our consolidated financial statements and the related notes included elsewhere in this
prospectus. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="162pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="70pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As Adjusted(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>207,240</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total debt, including current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>169,593</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shareholders' equity:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share capital, nominal value &euro;0.25 per share; 31,183,921 shares issued and outstanding,
actual;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,796</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share premium net of treasury shares</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>250,824</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(158,167</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Currency translation adjustment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total shareholders' equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,939</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total capitalization</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>190,532</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Each
&euro;1.00 ($1.1456) increase or decrease in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, the closing price of our
ordinary shares on Euronext Paris
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, corresponding to
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement, would increase or decrease each of as
adjusted total shareholders' equity and as adjusted total capitalization by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming that the number of ordinary
shares offered by us (including ordinary shares in the form of ADSs), as set forth on the cover page of this prospectus, remains the same and after deducting underwriting commissions and estimated
offering expenses payable by us. Subject to applicable law, we may also increase or decrease the number of ordinary shares (including ordinary shares in the form of ADSs) we are offering. Each
increase or decrease of 1,000,000 ordinary shares (including ordinary shares in the form of ADSs) offered by us would increase or decrease each of as adjusted total shareholders' equity and as
adjusted total capitalization by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming that the assumed offering
price remains the same, and after deducting
underwriting commissions and estimated offering expenses payable by us. Each increase of 1,000,000 ordinary shares (including ordinary shares in the form of ADSs) offered by us together with an
associated &euro;1.00 ($1.1456) </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>72</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=77,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=472096,FOLIO='72',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cu10701_1_73"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>increase
in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, the closing price of our ordinary shares on Euronext Paris
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, corresponding to
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement, would increase each of as adjusted total shareholders' equity and as adjusted total capitalization by
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), after deducting underwriting commissions and estimated offering
expenses payable by us. Each decrease of 1,000,000
ordinary shares (including ordinary shares in the form of ADSs) offered by us together with an associated &euro;1.00 ($1.1456) decrease in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ADS in the U.S. offering, the closing price of our ordinary shares on Euronext Paris
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, corresponding to
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private
placement, would decrease each of as adjusted total shareholders' equity and as adjusted total capitalization by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million),
after deducting underwriting commissions and estimated offering expenses payable by us. The as adjusted information discussed above is illustrative only and will change based on the actual offering
price, the actual number of ordinary shares offered by us (including ordinary shares in the form of ADSs), and other terms of the global offering determined at pricing. All conversions of euros to
U.S. dollars in this note assume an exchange rate of &euro;1.00&nbsp;= $1.1456, the exchange rate in effect on December&nbsp;31, 2018.  </FONT></P>

</UL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of ordinary shares (including ordinary shares in the form of ADSs) that will be outstanding after the global offering is based on 31,183,921 ordinary shares outstanding as of
December&nbsp;31, 2018 and excludes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 548,882 new ordinary shares issuable upon the exercise of redeemable share warrants (BSAAR), share warrants (BSA), free shares and stock
options granted but not exercised as of December&nbsp;31, 2018 at a weighted average exercise price of &euro;19.72 ($22.59) per new ordinary share based on the exchange rate in effect as
of December&nbsp;31, 2018 (this weighted average exercise price does not include the 83,726 new ordinary shares issuable upon the vesting of outstanding free shares that may be issued for free with
no exercise price paid); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 200,066 ordinary shares reserved for future issuance under our share-based compensation plans and other delegations of authority from our
shareholders; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 9,000,000 ordinary shares reserved to date pursuant to a delegation of authority from our shareholders for share capital increases by us
through rights issuances and public or private offerings. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise noted, the information in this prospectus assumes no exercise by the underwriters of their option to purchase additional ordinary shares (which may be in the form of
ADSs). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>73</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=78,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=65607,FOLIO='73',FILE='DISK124:[18ZFA1.18ZFA10701]CU10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cw10701_1_74"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cw10701_dilution"> </A>
<A NAME="toc_cw10701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  DILUTION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you invest in our ADSs or ordinary shares in the global offering, your ownership interest will be diluted to the extent of the difference
between the offering price per ADS or ordinary share paid by purchasers in the global offering and the as adjusted net tangible book value per ADS or ordinary share, as applicable, after completion of
the global offering. Our net tangible book value as of December&nbsp;31, 2018 was &euro;20.1&nbsp;million ($23.02&nbsp;million), or &euro;0.64 per ordinary share
(equivalent to $0.74 per ADS), based on the exchange rate in effect as of December&nbsp;31, 2018. Net tangible book value per ordinary share is determined by dividing (1)&nbsp;our total assets
less our intangible assets and our total liabilities by (2)&nbsp;the number of ordinary shares outstanding as of December&nbsp;31, 2018, or 31,183,921 ordinary shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
giving effect to our sale of (i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs in the U.S. offering at an assumed offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, the closing price of our ordinary shares
on Euronext Paris on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and (ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in the
European private placement at an assumed offering price of &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary
share
(assuming the December&nbsp;31, 2018 exchange rate of &euro;1.00&nbsp;= $1.1456) and after deducting estimated underwriting commissions and estimated offering expenses payable by us,
and the application of the estimated net proceeds from the global offering as described under "Use of Proceeds," our as adjusted net tangible book value at December&nbsp;31, 2018 (based on the
exchange rate in effect as of December&nbsp;31, 2018) would have been &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million),
 or &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ordinary share (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS). This represents an immediate increase in net tangible book value of
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS) to existing shareholders and an immediate dilution in net tangible book value of &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
ordinary share (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS)
to new investors, or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table illustrates this dilution to new investors on a per ordinary share and per ADS basis: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="138pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Per Ordinary<BR>
Share </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Per ADS </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Assumed offering price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Historical net tangible book value per ordinary share or ADS as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Increase in net tangible book value per ordinary share or ADS attributable to new investors participating in the global offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>As adjusted net tangible book value per ordinary share or ADS after the global offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dilution in as adjusted net tangible book value per ordinary share or ADS to new investors participating in the global offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
dilution information discussed above is illustrative only and will change based on the actual offering price and other terms of the global offering determined at pricing. Each
&euro;1.00 ($1.1456) increase or decrease in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, the closing price of our ordinary shares on Euronext Paris on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, corresponding to &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement (assuming the
December&nbsp;31, 2018 exchange rate), would increase or
decrease our as adjusted net tangible book value by &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), or
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share
(equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), and the dilution to new investors participating in the global offering would be
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), assuming that the number of ordinary shares offered by us (including ordinary shares in the form of ADSs), as set forth on the cover page of this prospectus, remains
the
same, and after deducting estimated underwriting commissions and estimated offering expenses payable by us. Subject </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>74</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=79,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=704242,FOLIO='74',FILE='DISK124:[18ZFA1.18ZFA10701]CW10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cw10701_1_75"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>to
applicable law, we may also increase or decrease the number of ordinary shares (including ordinary shares in the form of ADSs) we are offering. An increase of 1,000,000 ordinary shares (including
ordinary shares in the form of ADSs) offered by us would increase the as adjusted net tangible book value by approximately &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), or &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), and the dilution to new investors participating in the global
offering would be &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), assuming that the assumed offering
price remains the same, and after deducting estimated
underwriting commissions and estimated offering expenses payable by us. Similarly, a decrease of 1,000,000 ordinary shares (including ordinary shares in the form of ADSs) offered by us would decrease
the as adjusted net tangible book value by approximately &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), or
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share
(equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), and the dilution to new investors participating in the global offering would be
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), assuming that the assumed offering price remains the same, and after deducting estimated underwriting commissions and estimated offering expenses payable by us. The as
adjusted information discussed above is illustrative only and will change based on the actual offering price, the actual number of ordinary shares offered by us (including ordinary shares in the form
of ADSs), and other terms of the global offering determined at pricing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the underwriters exercise their option to purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs and/or ordinary shares in full, the as adjusted net tangible book value after the global offering
would be &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), the increase in the as adjusted net tangible
book value to existing shareholders would be
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS), and the dilution to new investors participating in the
global offering would be
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share (equivalent to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table sets forth, as of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, on the as adjusted basis described above, consideration paid to us in
cash for ordinary shares (including ordinary shares in the
form of ADSs) purchased from us by our existing shareholders and by new investors participating in the global offering based on an assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS, the closing
price
of our ordinary shares on Euronext Paris on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(assuming an exchange rate of &euro;1.00&nbsp;= $1.1456), and before deducting underwriting commissions and estimated
offering
expenses payable by us. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Ordinary Shares<BR>
Purchased(1) </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
Consideration </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Average<BR>
Price Per<BR>
Ordinary<BR>
Share </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Average<BR>
Price<BR>
Per ADS </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Existing shareholders</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>New investors</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Including
ordinary shares in the form of ADSs.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
&euro;1.00 ($1.1456) increase or decrease in the assumed offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS in the U.S. offering, which is the midpoint of the price range set
forth on the cover page of this prospectus, corresponding to &euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ordinary share in the European private placement (assuming the December&nbsp;31, 2018 exchange rate
of &euro;1.00&nbsp;= $1.1456), would increase or decrease the total consideration paid by new investors participating in the global offering by
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million ($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million), assuming that the number of ordinary shares offered by us (including
ordinary shares in the form of ADSs), as set
forth on the cover page of the prospectus, remains the same and before deducting estimated underwriting commissions and estimated offering expenses payable by us. Subject to applicable law, we may
also increase or decrease the number of ordinary shares (including ordinary shares in the form of ADSs) we are offering. Each increase or decrease in 1,000,000 ordinary shares (including ordinary
shares in the form of ADSs) offered by us would increase or decrease the total consideration paid by new investors participating in the global offering by
&euro;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>75</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=80,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=915166,FOLIO='75',FILE='DISK124:[18ZFA1.18ZFA10701]CW10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cw10701_1_76"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million),
assuming that the assumed offering price remains the same and before deducting underwriting commissions and estimated offering expenses payable by us. The as
adjusted information discussed above is illustrative only and will change based on the actual offering price, the actual number of ordinary shares offered by us (including ordinary shares in the form
of ADSs) and other terms of the global offering determined at pricing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
table above assumes no exercise of the underwriters' option to purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ADSs and/or ordinary shares in the global offering. If the underwriters exercise
their option to purchase additional ADSs and/or ordinary shares in full, the number of ordinary shares (including ordinary shares in the form of ADSs) held by the existing shareholders after the
global offering would be reduced to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of ordinary shares (including ordinary shares in the form of ADSs) outstanding after the global offering, and the number of
ordinary shares (including ordinary shares in the form of ADSs) held by new investors participating in the global offering would increase to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of ordinary shares
(including ordinary shares in the form of ADSs) outstanding after the global offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
tables and calculations above are based on the number of ordinary shares (including ordinary shares in the form of ADSs) that will be outstanding after the global offering, which is
based on 31,183,921 ordinary shares outstanding as of December&nbsp;31, 2018 and excludes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 548,882&nbsp;new ordinary shares issuable upon the exercise of redeemable share warrants (BSAAR), share warrants (BSA), free shares and stock
options granted but not exercised as of December&nbsp;31, 2018 at a weighted average exercise price of &euro;19.72 ($22.59) per new ordinary share based on the exchange rate in effect as
of December&nbsp;31, 2018 (this weighted average exercise price does not include the 83,726 new ordinary shares issuable upon the vesting of outstanding free shares that may be issued for free with
no exercise price paid); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 200,066 ordinary shares reserved for future issuance under our share-based compensation plans and other delegations of authority from our
shareholders; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 9,000,000 ordinary shares reserved to date pursuant to a delegation of authority from our shareholders for share capital increases by us
through rights issuances and public or private offerings. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>76</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=81,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=476006,FOLIO='76',FILE='DISK124:[18ZFA1.18ZFA10701]CW10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cw10701_1_77"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cw10701_selected_consolidated_financial_data"> </A>
<A NAME="toc_cw10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  SELECTED CONSOLIDATED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following selected consolidated statement of operations data for the years ended December&nbsp;31, 2017 and 2018 and selected consolidated
statement of financial position data as of December&nbsp;31, 2017 and 2018 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our audited
consolidated financial statements have been prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB, as of
and for the years ended December&nbsp;31, 2017 and 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following selected consolidated financial data for the years and as of the dates indicated are qualified by reference to and should be read in conjunction with our consolidated
financial statements and related notes beginning on page&nbsp;F-1 of this prospectus, as well as the sections titled "Management's Discussion and Analysis of Financial Condition and Results of
Operations" and "Exchange Rate Information" included elsewhere in this prospectus. Our historical results and the results for the year ended December&nbsp;31, 2018 are not necessarily indicative of
our results to be expected for any future period. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selected Consolidated Statement of Operations Data:  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands, except loss per share data)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Revenues and other income</U></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>118</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,737</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,425 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenues and other income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,856</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,494 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><U>Operating expenses and other operating income (expenses)</U></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research&nbsp;and development expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(67,024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General&nbsp;and administrative expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(162</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(56,695</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(69,484</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>642</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,096</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11,118</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,453</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(10,391</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss before tax</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,148</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,875</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax benefit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,420</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>354 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and diluted loss per share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.79</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2.55</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(*)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>In
the context of the preparation of its 2018 consolidated financial statements, the Company restated the financial statements previously published for the 2017
fiscal year under IFRS. These changes do not affect the cash position or the operating results, and are mainly related to the application of IFRS to deferred taxes on the OCEANE bonds issued in
October 2017. The corrections lead mainly to a decrease in the consolidated net loss of &euro;2.9&nbsp;million. More information is provided in Note 2.3 to our consolidated financial
statements.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>77</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=82,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=299455,FOLIO='77',FILE='DISK124:[18ZFA1.18ZFA10701]CW10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cw10701_1_78"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selected Consolidated Statement of Financial Position Data:  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(in thousands of euros)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>273,820</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>207,240</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,183</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>229,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total shareholders' equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>101,457</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,939</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total non-current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>164,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>169,291</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>27,106</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,248</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>191,726</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>208,539</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities and shareholders' equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,183</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>229,478</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>78</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=83,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1027444,FOLIO='78',FILE='DISK124:[18ZFA1.18ZFA10701]CW10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cy10701_1_79"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cy10701_management_s_discussion_and_an__man03466"> </A>
<A NAME="toc_cy10701_1"> </A></FONT> <FONT SIZE=2><B>  MANAGEMENT'S DISCUSSION AND ANALYSIS OF<BR>  FINANCIAL CONDITION AND RESULTS OF OPERATIONS    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>You should read the following discussion and analysis of our financial condition and results of operations together with
our consolidated financial statements and the related notes included elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this
prospectus, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result
of many factors, including those factors set forth in the "Risk Factors" section of this prospectus, our actual results could differ materially from the results described in or implied by these
forward-looking statements.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Our audited consolidated financial statements have been prepared in accordance with IFRS, as issued by the IASB, as of and for the years ended December&nbsp;31,
2017 and 2018.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic solutions targeting metabolic and
liver-related diseases where there is considerable unmet medical need. We are a leader in the field of nuclear receptor-based drug discovery with a rich history and strong scientific heritage spanning
almost two decades. We are evaluating our most advanced drug candidate, elafibranor, in a pivotal Phase&nbsp;3 clinical trial as a potential treatment for nonalcoholic steatohepatitis, or NASH, and
as a potential treatment for primary biliary cholangitis, or PBC. In December 2018, we announced positive preliminary results from our Phase 2 clinical trial in PBC. Our drug discovery efforts are
based on selecting appropriate nuclear receptors as targets and utilizing rational drug design to optimize our drug candidates. A key differentiator of our development strategy is our NASH
biomarker-based diagnostic program, in which we are developing a new </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostic, or IVD, test to identify patients with NASH who may be
appropriate candidates for drug therapy. Our scientific and clinical expertise, translational disease-driven approach and strong bioinformatics capabilities have allowed us to build a scientific
platform through which we discover and develop our drug candidates and diagnostic tools. We believe elafibranor, if approved, has the potential to become a first-line treatment as a monotherapy and
the backbone of combination regimens. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elafibranor,
a dual agonist of the nuclear receptors PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>, is currently in Phase&nbsp;3
development for the treatment of NASH. In our Phase&nbsp;2b clinical trial, elafibranor achieved resolution of NASH without worsening of fibrosis, which is the primary endpoint of our ongoing global
Phase&nbsp;3 clinical trial. We have already achieved the enrollment necessary to perform an interim cohort analysis and expect to report interim results by the end of 2019. We believe these
results, if positive, could support accelerated approval from the U.S. Food and Drug Administration, or FDA, and conditional approval from the European Medicines Agency, or EMA, as early as 2020.
Elafibranor has received fast track designation from the FDA for the treatment of NASH. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also developing elafibranor for the treatment of PBC, a chronic, progressive liver disease that leads to inflammation and scarring of the small bile ducts in the liver. Although a
relatively rare disease mainly affecting women, PBC can develop into cirrhosis and other serious liver complications. There is currently no cure for PBC, and the two drugs approved for the treatment
of PBC are limited by drug intolerance, lack of patient response and safety issues. Based on our clinical data, we believe elafibranor's unique mechanism of action can provide benefits for patients
with PBC without significant side effects, such as the serious liver injury or death and pruritis that have been associated with approved PBC treatments. In December 2018, we announced positive
preliminary results from our Phase&nbsp;2 clinical trial of elafibranor for the treatment of PBC. Elafibranor met the primary endpoint of the trial, which was the change at week 12 in serum alkaline
phosphatase, or ALP, from baseline, with statistical significance compared to placebo in both doses evaluated. Elafibranor also achieved with high </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>79</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=84,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=610602,FOLIO='79',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_80"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>statistical
significance compared to placebo, the composite endpoint of ALP and bilirubin. That endpoint, which has been used for drug registration, is defined as (1)&nbsp;ALP less than 1.67 times
the upper limit of normal, or ULN, (2)&nbsp;total bilirubin within normal limits and (3)&nbsp;a reduction of ALP of more than 15%. Based on these positive results, we plan to advance our PBC
program into Phase&nbsp;3 development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH
is a silent disease. Patients often have no symptoms until the first signs of liver failure, and the lack of an accurate, non-invasive diagnosis tool contributes to under-diagnosis.
Currently, liver biopsy is the standard for diagnosis, and variation in clinical practice and physician reluctance lead to under-diagnosis. Our blood-based IVD test is a novel, standalone diagnostic
that we believe can address the urgent need for a non-invasive, cost-effective, accessible and validated test to identify NASH patients who may be appropriate candidates for drug intervention, thereby
decreasing the need for liver biopsy. We believe our IVD test has the potential to benefit patients, improve overall clinical care and greatly reduce barriers to entry for innovative therapies like
elafibranor by facilitating the diagnosis and identification of NASH patients to be treated. We anticipate submitting our IVD test for FDA marketing authorization in&nbsp;2020. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also conducting a clinical-stage program based on drug repositioning to develop an anti-fibrotic drug. Our lead drug candidate in this program, nitazoxanide, or NTZ, is an
approved anti-parasitic agent that has shown promising activity against fibrosis in our preclinical disease models. An investigator-initiated Phase&nbsp;2 proof-of-concept trial to evaluate NTZ for
the treatment of NASH patients with significant fibrosis began in December&nbsp;2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
TGFTX1 preclinical program is focused on the discovery and development of innovative drug candidates targeting ROR<FONT FACE="SYMBOL">g</FONT>t, a nuclear receptor
involved in certain inflammatory and autoimmune diseases. We are currently conducting pre-IND studies for a potential topical treatment of mild to moderate psoriasis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have never generated any revenues from product sales. We do not expect to generate material revenue from product sales unless and until we successfully complete clinical development
of, obtain marketing approval for and commercialize our drug candidates and IVD test. Clinical development, regulatory approval and commercial launch of a product candidate can take several years and
are subject to significant uncertainty. Historically, we have financed our operations and growth through issuances of share capital and convertible bonds, through conditional advances and subsidies
from BPI France and from research tax credits. In 2006, we completed the initial public offering of our ordinary shares on the Alternext market of Euronext in Paris and transferred to the Euronext
Paris in April 2014. Between&nbsp;2010 and&nbsp;2016, we raised a total of over &euro;220&nbsp;million in gross proceeds from the issuance of ordinary shares. In October 2017, we
issued &euro;180&nbsp;million in convertible bonds. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
our inception, we have incurred significant operating losses. Our net loss was &euro;79.5&nbsp;million for the year ended December&nbsp;31, 2018. We expect to incur
significant expenses and substantial operating losses over the next several years as we continue our research and development efforts and advance the clinical development of elafibranor, as well as
our IVD test and our other drug candidates, in the United States, Europe and elsewhere. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financial Operations Overview  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue and Other Income  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During the years ended December&nbsp;31, 2017 and 2018, our revenue of &euro;0.1&nbsp;million in each period consisted primarily
of revenue from the sublease of a portion of our corporate headquarters in Loos, France. We terminated this sublease effective as of June&nbsp;30, 2018 and do not expect to receive any further
sublease revenue. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>80</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=85,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=611630,FOLIO='80',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_81"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not expect to receive any revenue from any of our product candidates until we obtain regulatory approval and commercialize such products, or until we potentially enter into
collaborative agreements with third parties for the development and commercialization of such candidates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
other income results principally from the research tax credits. We expect to continue to be eligible for these tax credits and subsidies for so long as we incur eligible expenses. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


CIR Research Tax Credit  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We benefit from a tax credit known as </FONT><FONT SIZE=2><I>Cr&eacute;dit d'Imp&ocirc;t Recherche</I></FONT><FONT SIZE=2>, or
CIR, which is granted by French tax authorities to encourage companies to conduct technical and scientific research. Companies demonstrating that they have expenses that meet the required criteria,
including research expenses located in France or within the European Union or in another state that is a party to the agreement in the European Economic Area that has concluded a tax treaty with
France that contains an administrative assistance clause, receive a tax credit that can be used against the payment of French corporate income tax due for the fiscal year in which the expenses were
incurred and the three fiscal years thereafter, or, as applicable, can be reimbursed for the excess portion. The expenses taken into account for the calculation of the CIR only involve certain
eligible research and development expenses. The subcontracting expenses are limited to an amount equal to &euro;10&nbsp;million. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
main characteristics of the CIR are the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the CIR results in a cash inflow from the tax authorities paid to us as we are not subject to corporate income tax; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a company's corporate income tax liability does not limit the amount of the CIR&#151;a company which meets certain criteria in terms of
sales, headcount or assets to be considered a small/mid size company and that does not pay any corporate income tax can request cash payment of the research tax credit;
and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the CIR is not included in the determination of the corporate income tax. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have concluded that the CIR meets the definition of a government grant as defined in IAS&nbsp;20, </FONT><FONT SIZE=2><I>Accounting for Government Grants and Disclosure of
Government Assistance</I></FONT><FONT SIZE=2>, and, as a result, it has been classified as other income within operating income in our statement of operations. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


CICE Tax Credit  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We also recognize income relating to the </FONT><FONT SIZE=2><I>Cr&eacute;dit d'imp&ocirc;t pour la
comp&eacute;titivit&eacute; et l'emploi</I></FONT><FONT SIZE=2>, or CICE, which is a tax credit implemented by French tax authorities to enhance the competitiveness of businesses
through the promotion of certain activities and employment. In 2017, the tax credit was equal to 7% of wages paid to employees during the year in respect of salaries that do not exceed 2.5 times the
French minimum wage. For 2018, the applicable tax credit was equal to 6% of eligible wages. We use this tax credit to finance the increases in our headcount and to purchase scientific equipment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Aide &agrave; L'embauche Grant  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize income related to </FONT><FONT SIZE=2><I>l'aide &agrave; l'embauche,</I></FONT><FONT SIZE=2> a subsidy granted in 2017 by
French tax authorities to companies with less than 250 employees which hire new employees whose wages do not exceed 1.3 times the French minimum wage. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>81</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=86,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=389456,FOLIO='81',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_82"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Expenses  </I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We engage in substantial research and development efforts to develop our drug and diagnostic candidates. Research and development expenses
include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> raw materials and consumables, such as lab supplies, used in research and development activities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fees and costs paid to third parties, such as clinical research organizations and scientific advisors, for clinical trial and other research
and development activities, including services subcontracted to research partners for technical or regulatory reasons; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> employee-related costs and costs related to external employees seconded to us for clinical development and information technology; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> grants to The NASH Education Program for the year 2017 (primarily for the purpose of the creation of a NASH patient registry in particular to
increase understanding of the prevalence and natural history of NASH/NAFLD, and the development of co-morbidities historically linked to NASH/NAFLD, which information is to be used as part of the
efforts to collect RWE (Real World Evidence) data to better address the needs of the patients; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> intellectual property fees related to the filing of patents. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development activities are central to our business model. Drug candidates in later stages of clinical development generally have higher development costs than those in
earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials, such as our global Phase&nbsp;3 clinical trial of elafibranor for the
treatment of NASH. We expect that our research and development expenses will continue to increase in the foreseeable future as we initiate clinical trials for certain drug candidates, pursue later
stages of clinical development of other drug candidates and progress the development of our diagnostic test. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
generally do not track our research and development expenses by product candidate. However, the substantial majority of our direct expenses incurred, such as for contract research
organizations, or CROs, and other contracted research and development activities, as well as raw materials, relate to elafibranor, our lead drug candidate. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General and Administrative Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> employee-related costs for executive, business development, intellectual property, finance, legal and human resources and communications
functions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> facility-related costs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> grants to The NASH Education Program for 2018, primarily to support the creation of the first International NASH Day; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fees for third-party providers of administrative services, including press relations and communication services, security and reception and
recruiting; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> intellectual property fees for the registration and maintenance of our patents. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
anticipate that our general and administrative expenses will increase in the future as we grow our support functions for the expected increase in our research and development
activities and the potential commercialization of our drug and diagnostic candidates. We also anticipate increased expenses associated with being a public company in the United States, including costs
related to audit, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>82</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=87,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=760126,FOLIO='82',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_83"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>legal,
regulatory and tax-related services associated with maintaining compliance with U.S. exchange listing and SEC requirements, director and officer insurance premiums, and investor relations
costs. In particular, we will need to incur additional accounting expenses to comply with the Sarbanes-Oxley Act of 2002 in the United States that will require us to test the effectiveness of our
internal controls over financial reporting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financial Income (Expense)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial income relates primarily to interest income received from cash and cash equivalents deposits. Our cash and cash equivalents have been
deposited primarily in cash accounts and term deposit accounts with short maturities and therefore generate only a modest amount of interest income. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
expense relates primarily to interest expense on our outstanding convertible bonds as well as interest expense for bank loans and equipment leases. We also incur foreign
exchange gains and losses related to our purchases of services in U.S. dollars, which amounts are recorded as financial income or expense. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Results of Operations for the Years Ended December&nbsp;31, 2017 and 2018  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our results of operations for the years ended December&nbsp;31, 2017 and 2018 are summarized in the table below. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD NOWRAP  VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Revenues and other income</B></FONT><FONT SIZE=2>

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

</FONT>
</DIV></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,737</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,425 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenues and other income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,856</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,494 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD NOWRAP  VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Operating expenses and other operating income (expenses)</B></FONT><FONT SIZE=2>


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

</FONT>
</DIV></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(67,024</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,793</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(162</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(56,695</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(69,484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>642</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,096</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(11,118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(10,391</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss before tax</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(59,148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79,875</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,420</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>354 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Net loss </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(55,728</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(79,521</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(*)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>In
the context of the preparation of its 2018 consolidated financial statements, the Company restated the financial statements previously published for the 2017
fiscal year under IFRS. These changes do not affect the cash position or the operating results, and are mainly related to the application of IFRS to deferred taxes on the OCEANE bonds issued in
October&nbsp;2017. The corrections lead mainly to a decrease in the consolidated net loss of &euro;2.9&nbsp;million. More information is provided in Note 2.3 of our consolidated
financial statements.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>83</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=88,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=210459,FOLIO='83',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_84"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue of &euro;118,000 and &euro;69,000 during the years ended December&nbsp;31, 2017 and 2018, respectively, was
primarily the result of our subleasing a part of our corporate headquarters in Loos, France. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income for the years ended December&nbsp;31, 2017 and 2018 consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIR tax credit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,295</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CICE tax credit and other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>171</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>130</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other government grants and subsidies</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>6,737</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>7,425</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Expenses  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The tables below summarize our operating expenses for the years ended December&nbsp;31, 2017 and 2018. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Year Ended December&nbsp;31, 2017  </I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Operating expenses<BR>
and other operating<BR>
income (expenses)<BR>
(in thousands of<BR>
euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Raw<BR>
materials&nbsp;&amp;<BR>
consumables<BR>
used </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Contracted<BR>
research&nbsp;&amp;<BR>
development<BR>
activities<BR>
conducted<BR>
by third<BR>
parties </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employee<BR>
expenses </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Other expenses<BR>
(maintenance, fees,<BR>
travel, taxes) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Depreciation,<BR>
amortization&nbsp;&amp;<BR>
impairment<BR>
charges </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gain / (loss)<BR>
on disposal of<BR>
property,<BR>
plant&nbsp;&amp;<BR>
equipment </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,117</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(35,088</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7,915</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7,973</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,095</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(112</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,491</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,374</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(437</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>68</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(63,550</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(2,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(35,095</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(13,406</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(11,280</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(1,532</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(8</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>84</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=89,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=723641,FOLIO='84',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_85"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Year Ended December&nbsp;31, 2018  </I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Operating expenses<BR>
and other operating<BR>
income (expenses)<BR>
(in thousands of<BR>
euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Raw<BR>
materials&nbsp;&amp;<BR>
consumables<BR>
used </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Contracted<BR>
research&nbsp;&amp;<BR>
development<BR>
activities<BR>
conducted<BR>
by third<BR>
parties </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employee<BR>
expenses </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Other expenses<BR>
(maintenance, fees,<BR>
travel, taxes) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Depreciation,<BR>
amortization&nbsp;&amp;<BR>
impairment<BR>
charges </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gain/(loss)<BR>
on disposal of<BR>
property,<BR>
plant&nbsp;&amp;<BR>
equipment </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(67,024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,724</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(47,659</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,431</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(6,502</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,707</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(130</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,194</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,738</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>272</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(162</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(164</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(76,979</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(1,855</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(47,662</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(13,625</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(12,403</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(1,435</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>2</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses totaled &euro;54.2&nbsp;million, or 85% of our total operating expenses, for the year ended
December&nbsp;31, 2017. These expenses consisted primarily of &euro;35.1&nbsp;million in contracted research and development activities conducted by third parties, the substantial
majority of which were incurred in connection with the advancement of our RESOLVE-IT Phase&nbsp;3 clinical trial of elafibranor for the treatment of NASH. We also incurred
&euro;7.9&nbsp;million of employee-related expenses, consisting of wages, salaries, social security and pension costs and share-based compensation paid to employees in research and
development functions. Other expenses of &euro;8.0&nbsp;million consisted primarily of maintenance and other facility costs, as well as employee travel expenses and third-party fees
incurred for seconded employees in research and development functions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development expenses totaled &euro;67.0&nbsp;million, or 87% of our total operating expenses, for the year ended December&nbsp;31, 2018. These expenses
consisted primarily of &euro;47.7&nbsp;million in contracted research and development conducted by third parties, the substantial majority of which were incurred in connection with the
progression of our RESOLVE-IT Phase&nbsp;3 clinical trial of elafibranor for the treatment of NASH and the increase in contracted research and development expenses resulting from the progression of
the research and development program pipeline, of which the majority related to expenses for the phase 3 elafibranor trial in NASH, and to a lesser extent, the phase 2 trial of elafibranor in PBC and
the launch of the phase 2 trial of nitazoxanide. The increase of &euro;12.6&nbsp;million over the prior year reflects the advancement of these clinical trials. We also incurred
&euro;9.4&nbsp;million of employee-related expenses, consisting of wages, salaries, social security and pension costs and share-based compensation paid to employees in research and
development functions and patents. This increase of &euro;1.5&nbsp;million of employee-related expenses over the prior year was primarily due to the expansion of our workforce in the
research and development functions. Other expenses of &euro;6.5&nbsp;million consisted primarily of maintenance and other facility costs, as well as employee travel expenses and
third-party fees incurred for seconded employees in research and development functions. The decrease of &euro;1.5&nbsp;million from the prior year was primarily the result of our
contribution to The NASH Education Program in 2018 being classified as general and administrative expense instead of research and development expense. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>85</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=90,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=174129,FOLIO='85',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_86"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General and Administrative Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses totaled &euro;9.4&nbsp;million, or 15% of our total operating expenses, for the year ended
December&nbsp;31, 2017. These expenses consisted primarily of &euro;5.5&nbsp;million of employee-related expenses, consisting of wages, salaries, social security and pension costs and
share-based compensation paid to employees in general and administrative functions, and as well as &euro;3.4&nbsp;million in costs and fees for third-party service providers. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General
and administrative expenses totaled &euro;9.8&nbsp;million, or 13% of our total operating expenses, for the year ended December&nbsp;31, 2018. These expenses
consisted primarily of &euro;5.7&nbsp;million of costs and fees for third-party service providers, as well as &euro;4.2&nbsp;million of employee-related expenses, consisting
of wages, salaries, social security and pension costs and share-based compensation paid to employees in general and administrative functions. The increase of &euro;2.4&nbsp;million in
other expenses was primarily the result of increases and fees and expenses in the preparation for the commercialization of elafibranor in NASH, in communication expenses, including the support to the
creation of the first International NASH Day in conjunction with The NASH Education Program and expenses related to maintenance of equipment at our corporate headquarters. During the year ended
December&nbsp;31, 2018, we also donated &euro;1&nbsp;million to The NASH Education Program. The decrease of &euro;1.3&nbsp;million in employee-related expenses over the
prior year period was primarily due to the exceptional 2017 bonuses not replicated in 2018. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financial Income (Expense)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our net financial income (expense) for the year ended December&nbsp;31, 2017 was &euro;(2.5)&nbsp;million, consisting primarily
of &euro;(2.3)&nbsp;million of interest expense on our convertible bonds and bank loans and a &euro;(0.8)&nbsp;million net foreign currency exchange rate loss resulting from
the translation of U.S. dollars generated by the operations of our U.S. subsidiary and subcontractors into euros, offset in part by &euro;0.4&nbsp;million of interest income on our cash
and cash equivalents and &euro;0.2&nbsp;million of other financial income. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
net financial income (expense) for the year ended December&nbsp;31, 2018 was &euro;(10.4)&nbsp;million, consisting primarily of &euro;11&nbsp;million of
interest expense on our convertible bonds and bank loans, offset partially by &euro;0.4&nbsp;million in other financial income and &euro;0.2&nbsp;million in interest income.
The increase in interest expense was due to our convertible bonds, issued in October 2017, having been outstanding for the full
year ended December&nbsp;31, 2018. The change in financial expenses is related to the interest on the OCEANEs, mainly due to interest payments at a rate of 3.5% and the accretion of the discounting
of the bond debt at an effective interest rate of 7.29%. The accretion of bond debt consists of bringing the amount of the debt component of the bond issue to the amount that will be repaid (or
converted) at maturity, by the recognition of a theoretical annual interest expense resulting from the accretion over the period of an amount equivalent to the equity component at an effective
interest rate. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidity and Capital Resources  </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2017 and 2018, we had &euro;273.8&nbsp;million and &euro;207.2&nbsp;million, respectively,
in cash and cash equivalents. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
our inception, we have financed our operations primarily through the issuance of new ordinary shares and bonds convertible into new ordinary shares in public offerings and private
financing transactions. In 2006, we completed the initial public offering of our ordinary shares on the Alternext market of Euronext in Paris. The listing of our ordinary shares was transferred to the
regulated market of Euronext Paris in 2014. Between 2010 and 2016, we raised a total of over &euro;220.0&nbsp;million in gross proceeds from the issuance of additional ordinary shares for
cash. In October 2017, we issued &euro;180.0&nbsp;million in bonds convertible into new ordinary shares or exchangable for existing ordinary shares. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>86</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=91,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=815400,FOLIO='86',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_87"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also financed our operations through historical collaborative research alliances, as well as research tax credits and subsidies granted by various public institutions, such as BPI
France Institutions. We also entered into conditional and repayable advances agreements with governmental entities and had a liability of &euro;3.4&nbsp;million and
&euro;3.2&nbsp;million associated with these types
of arrangements as of December&nbsp;31, 2017 and 2018, respectively. We also entered into loans with commercial banks and had an outstanding balance of &euro;3.5&nbsp;million and
&euro;4.0&nbsp;million in bank loans as of December&nbsp;31, 2017 and 2018, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
we continue to develop, and potentially commercialize, our drug candidates and diagnostic solutions in the coming years, we will likely continue relying on some or all of these
sources of financing, as well as potential milestone payments and royalties that may result from licensing agreements for our drug candidates, diagnostic solutions and results of our research
programs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Flows  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The table below summarizes our cash flows for the years ended December&nbsp;31, 2017 and 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows used in operating activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(49,856</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(56,081</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows used in investing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,948</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,986</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows provided by (used in) financing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>174,348</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(6,514</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>121,544</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(66,580</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Activities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used in operating activities was &euro;49.9&nbsp;million and &euro;56.1&nbsp;million for the years ended
December&nbsp;31, 2017 and 2018, respectively. With respect to the 2017 period, this amount primarily resulted from our net loss of &euro;55.7&nbsp;million, driven largely by our
significant research and development efforts during the period, adjusted by &euro;0.6&nbsp;million in non-cash expenses and other adjustments and by &euro;5.3&nbsp;million in
net cash flows from changes in working capital. With respect to the 2018 period, this amount primarily resulted from our net loss of &euro;79.5&nbsp;million, again driven largely by our
significant research and development efforts as we progressed our Phase&nbsp;3 clinical trial of elafibranor in NASH and our Phase&nbsp;2 clinical trial of elafibranor in PBC, adjusted by
&euro;13.0&nbsp;million in non-cash expenses and other adjustments of &euro;10.3&nbsp;million in net cash flows from changes in working capital. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Investing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used in investing activities was &euro;2.9&nbsp;million and &euro;4.0&nbsp;million for the years ended
December&nbsp;31, 2017 and 2018, respectively, and consisted primarily of equipment and other capital purchases and in 2018, acquisition of financial instruments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by financing activities was &euro;174.3&nbsp;million for the year ended December&nbsp;31, 2017 and consisted of
gross proceeds of &euro;180.0&nbsp;million from our issuance of convertible bonds in October 2017, partially offset by bank fees, net repayments under bank loans, conditional advances,
capital leases and interest paid. For the 2018 period, cash used in financing activities was &euro;6.5&nbsp;million, which consisted primarily of &euro;6.4&nbsp;million in
interest paid on our convertible bonds and &euro;2.0&nbsp;million in repayments of loans and borrowings, partially offset by &euro;1.8&nbsp;million in proceeds from new loans
and borrowings. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>87</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=92,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=16430,FOLIO='87',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_88"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating and Capital Expenditure Requirements  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since our inception, we have incurred significant operating losses. Our net loss was &euro;55.7&nbsp;million for the year ended
December&nbsp;31, 2017 and &euro;79.5&nbsp;million for the year ended December&nbsp;31, 2018. We expect to incur significant expenses and substantial operating losses over the next
several years as we continue our research and development efforts and advance the clinical development of elafibranor, as well as our IVD test and our other drug candidates, in the United States,
Europe and elsewhere. Our net losses may fluctuate significantly from quarter to quarter and year to year, depending on the timing of our clinical trials and our expenditures on other research and
development activities. We anticipate that our expenses will increase substantially in connection with our ongoing activities, as we: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> initiate and conduct our planned preclinical studies and clinical trials of our drug candidates, including our ongoing pivotal Phase&nbsp;3
clinical trial of elafibranor for the treatment of NASH and our planned clinical trials of elafibranor for the treatment of PBC; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> continue and complete the validation and development of our IVD test for NASH; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> continue the research and development of our other drug candidates, including planned and future preclinical studies and clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> seek to discover and develop additional drug candidates and explore combination therapies for our existing drug candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> seek regulatory approval for our IVD test and any drug candidates that successfully complete clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> assist with the scale-up of our subcontractors' manufacturing capabilities in order to support the launch of additional clinical trials and the
commercialization of our drug candidates, if approved; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> establish a sales and marketing infrastructure for the commercialization of our drug candidates, if approved, in certain geographies, either on
our own or in partnership with a third party; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> maintain, expand and protect our intellectual property portfolio; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> hire additional clinical, quality control and scientific personnel; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> add operational, financial and management information systems and personnel, including personnel to support our product development and
commercialization efforts and our operations as a public company listed in the United States. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
present and future funding requirements will depend on many factors, including, among other things:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the size, progress, timing and completion of our clinical trials of elafibranor and our other current or future product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the number of potential new product candidates we identify and decide to develop; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the costs involved in filing patent applications and maintaining and enforcing patents or defending against claims of infringement raised by
third parties; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the time and costs involved in obtaining regulatory approval for our product candidates and any delays we may encounter as a result of evolving
regulatory requirements or adverse results with respect to any of these product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> selling and marketing activities undertaken in connection with the anticipated commercialization of elafibranor and our other current or future
product candidates, including other product </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>88</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=93,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1017963,FOLIO='88',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_89"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>candidates
in preclinical development, together with the costs involved in the creation of an effective sales and marketing organization; and</FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the amount of revenues, if any, we may derive either directly, or in the form of royalty payments from any future potential collaboration
agreements. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
more information as to the risks associated with our future funding needs, see the section of this prospectus titled "Risk Factors." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Until
such time that we can generate substantial revenue from product sales, we expect to finance these expenses and our operating activities through a combination of our existing
liquidity and the proceeds of the global offering. If we are unable to generate revenue from product sales in accordance with our expected timeframes, we will need to raise additional capital through
the issuance of our shares, through other equity or debt financings or through collaborations with other companies. However, we may be unable to raise additional funds or enter into other funding
arrangements when needed on favorable terms, or at all, which would have a negative impact on our financial condition and could force us to delay, limit, reduce or terminate our development programs
or commercialization efforts or grant others rights to develop or market drug candidates that we would otherwise prefer to develop and market ourselves. Our ability to successfully transition to
profitability will be dependent upon achieving a level of revenues adequate to support our cost structure. We cannot assure you that we will ever be profitable or generate positive cash flow from
operating activities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
it is difficult to predict future liquidity requirements, we believe that our existing cash and cash equivalents as of December&nbsp;31, 2018 will be sufficient to fund our
operations for at least the next 12&nbsp;months. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Contractual Obligations  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table discloses aggregate information about our material contractual obligations and the periods in which payments are due as of
December&nbsp;31, 2018. Future events could cause actual payments and timing of payments to differ from the contractual cash flows set forth below. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Contractual obligations<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
1&nbsp;year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>1 to 3<BR>
years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>3 to 5<BR>
years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>More than<BR>
5&nbsp;years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Refundable and conditional advances</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Convertible bonds</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,312</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>159,176</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>160,489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,319</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,047</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>598</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equipment leases</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>520</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,048</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pension and employee benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,085</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,085</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,095</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>160,108</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,314</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>170,678 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating leases</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,213</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,426</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>836</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>316</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,791 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total contractual obligations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,374</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>160,944</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,630</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>175,469 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
nominal amount of the convertible loan of &euro;180.0&nbsp;million is due in less than 4&nbsp;years. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
enter into contracts in the normal course of business with CROs and contract manufacturing organizations, or CMOs, for clinical trials, preclinical studies and clinical manufacturing,
and with vendors for precommercial activities, research and development activities, research supplies and other services and products for operating purposes. These contracts generally provide for
termination upon notice. Such agreements are cancelable contracts and are not included in the contractual obligations in the foregoing table. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>89</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=94,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=430336,FOLIO='89',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_90"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also make donations to The NASH Education Program, the endowment fund of which we are a sponsor. Such donations are at our discretion, and we are not contractually obligated to make
any such donation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
for the year ended December&nbsp;31, 2018, our board of directors approved a maximum grant of &euro;1.6&nbsp;million primarily to support the creation of the
first International NASH Day, while also continuing to contribute funds to patient registry, our contribution was limited to &euro;959 to The NASH Education Program during the year. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the year 2019, our board of directors approved a grant of an amount of &euro;200 to the Nash Education Program. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Subsidies and Refundable and Conditional Advances  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have received financial assistance from Banque Publique d'Investissement, or BPI France, and other governmental organizations in connection
with the development of our product candidates. BPI France's mission is to provide assistance and support to emerging French enterprises to facilitate the development and commercialization of
innovative technologies. Such funding, in the form of refundable and conditional advances, is intended to finance our research and development efforts and the recruitment of specific personnel. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
account for non-refundable subsidies as other income ratably over the duration of the funded project. Funds received in the form of refundable advances are recognized as financial
liabilities, as we are obligated to reimburse BPI France for such refundable advances in cash based on a repayment schedule if specified conditions are met. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2017, we had outstanding four repayable advances from BPI France with an aggregate remaining balance of &euro;3.4&nbsp;million. As of
December&nbsp;31, 2018, we had outstanding one repayable advance with an amount of &euro;3.2 million. This advance, in an amount of &euro;3.2&nbsp;million, is a conditional
advance we received in our capacity as leader of a research consortium initiated in 2008 called IT-DIAB that is following patients at risk for Type&nbsp;2 diabetes. The program ended on
December&nbsp;31, 2014. The conditional advance is not refundable except in the event of success. In the event of technical or commercial success of the consortium's activities, defined as the sale
of related drugs or diagnostic devices developed using research results, we would be required to repay the advance, plus an additional specified amount, based on a percentage of any revenues generated
from the licensing of such products over a 10-year period. The maximum amount that we would be required to pay under this arrangement would be &euro;14.8&nbsp;million, inclusive of the
&euro;3.2&nbsp;million advance to be repaid. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Convertible Bonds  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2017, we issued convertible bonds for gross proceeds of &euro;180.0&nbsp;million. The convertible bonds carry a fixed
interest rate of 3.5%, with an effective interest rate of 7.3%, payable semi-annually in arrears in April and October, and have a maturity date in October 2022. Beginning in November 2020, we may, at
our option, redeem the bonds prior to maturity in the event that our share price exceeds a specified amount for a 20-day trading period. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Bank Loans  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2017 and 2018, we had borrowed under multiple bank loans primarily intended to finance the acquisition of scientific and
information technology equipment. The total principal amount outstanding was &euro;3.5&nbsp;million and &euro;4.0&nbsp;million as of December&nbsp;31, 2017 and 2018,
respectively. These bank loans carry fixed interest rates of between 0.36% and 2.0% and are generally payable over periods ranging from three to five years from the original date of the loan. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>90</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=95,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=487611,FOLIO='90',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_91"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Leases  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases consist of real estate leases for our offices located in Loos and Paris, France and in Cambridge, Massachusetts. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equipment Leases  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time we enter into lease agreements for scientific equipment that contain a purchase option and are considered financial leases.
Amounts in the table above represent minimum principal payments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pension and Employee Benefits  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;French law requires payment of a lump sum retirement indemnity to employees based on years of service and annual compensation at retirement.
Benefits do not vest prior to retirement. The amount presented in the table above represents the present value of estimated future benefits to be paid, applying a number of assumptions, including
dates of expected retirement, life expectancies, salary growth rates and a discount rate. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Off-Balance Sheet Arrangements  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During the periods presented, we did not and do not currently have any off-balance sheet arrangements as defined under Securities and Exchange
Commission, or SEC, rules, such as relationships with other entities or financial partnerships, which are often referred to as structured finance or special purpose entities, established for the
purpose of facilitating financing transactions that are not required to be reflected on our statements of financial position. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Critical Accounting Policies and Judgments and Estimates  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our consolidated financial statements are prepared in accordance with IFRS as issued by IASB. Some of the accounting methods and policies used
in preparing our consolidated financial statements under IFRS are based on complex and subjective assessments by our management or on estimates based on past experience and assumptions deemed
realistic and reasonable based on
the circumstances concerned. The actual value of our assets, liabilities and shareholders' equity and of our accumulated deficit could differ from the value derived from these estimates if conditions
change and these changes had an impact on the assumptions adopted. See Note&nbsp;2 to our consolidated financial statements for a description of our significant accounting policies. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Accounting Pronouncements  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Adopted as of January&nbsp;1, 2018  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We adopted the following new standards, interpretations and amendments to standards, including any consequential amendments to other standards,
with a date of initial application as of January&nbsp;1, 2018:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRS&nbsp;9 </FONT><FONT SIZE=2><I>Financial Instruments</I></FONT><FONT SIZE=2>. The IASB issued the final version of IFRS&nbsp;9
Financial Instruments in July 2014. IFRS&nbsp;9 is effective for annual periods beginning on or after January&nbsp;1, 2018, with early adoption permitted. We applied IFRS&nbsp;9 initially on
January&nbsp;1, 2018 and will not restate comparative information for prior periods. The first application of IFRS&nbsp;9 did not have a material impact on our consolidated financial statements. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRS&nbsp;15 </FONT><FONT SIZE=2><I>Revenue from Contracts with Customers</I></FONT><FONT SIZE=2> establishes a comprehensive framework for
determining whether, how much and when revenue is recognized. It replaces existing revenue recognition guidance, including IAS&nbsp;18 Revenue, IAS&nbsp;11 Construction Contracts, IFRIC&nbsp;13 </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>91</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=96,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=553199,FOLIO='91',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_92"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>Customer
Loyalty Programmes, IFRIC&nbsp;15 Agreements for the Construction of Real Estate, IFRIC&nbsp;18 Transfers of Assets from Customers and SIC 31 Barter Transactions Involving Advertising
Services. IFRS&nbsp;15 is effective for the annual periods beginning on or after January&nbsp;1, 2018, with early adoption permitted. The standard establishes a five-step model that will apply to
revenue earned from a contract with a customer. Extensive disclosures will be required, including disaggregation of total revenue, information about performance obligations, changes in contract asset
and liability account balances between periods and key judgements and estimates. The first application of IFRS&nbsp;15 did not have a material impact on our consolidated financial statements. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Classification and Measurement of Share-based Payment Transactions (Amendments to IFRS&nbsp;2) issued on June&nbsp;20, 2016 covers three
accounting areas: the measurement of cash-settled share based payments; the classification of share-based payments settled net of tax withholdings; and the accounting for a modification of a
share-based payment from cash-settled to equity-settled. The amendments are effective for annual periods commencing on or after January&nbsp;1, 2018. As a practical simplification, the amendments
can be applied prospectively so that prior periods do not have to be restated. Retrospective, or early application is permitted if companies have the required information. The amendments did not have
a material impact on our consolidated financial statements. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRIC&nbsp;22 </FONT><FONT SIZE=2><I>Foreign currency transactions and Advance consideration</I></FONT><FONT SIZE=2> issued on
December&nbsp;8, 2016, clarifies the transaction date to be used to determine the exchange rate for translating foreign currency transactions involving an advance payment or receipt. The
interpretation is effective for annual periods beginning on or after January&nbsp;1, 2018, with earlier adoption permitted. The amendments did not have a material impact on our consolidated
financial statements. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
adoption of these standards, interpretations and amendments to standards did not have a material impact on our consolidated financial statements as of and for the year ended
December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Not Yet Adopted  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A number of new standards, amendments to standards and interpretations were not yet effective for the years ended December&nbsp;31, 2017 or
2018 and have not been applied in preparing our consolidated financial statements:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRS&nbsp;16 </FONT><FONT SIZE=2><I>Leases,</I></FONT><FONT SIZE=2> published on January&nbsp;13, 2016, makes a distinction between a
service contract and a lease based on whether the contract conveys the right to control the use of an identified asset and introduces a single, on-balance sheet lease accounting model for lessees. A
lessee recognizes a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. There are optional exemptions for
short term leases and leases of low value items. Lessor accounting remains similar to the current standard&#151;i.e.&nbsp;lessors continue to classify leases as finance or operating leases.
For lessors, there is little change to the existing accounting in IAS&nbsp;17 Leases. IFRS&nbsp;16 replaces existing leases guidance including IAS&nbsp;17 Leases, IFRIC&nbsp;4 Determining
whether an Arrangement contains a Lease, SIC-15 Operating Leases-Incentives and SIC-27 Evaluating the Substance of Transactions Involving the Legal Form of a Lease. The standard is effective for
annual periods beginning on or after January&nbsp;1, 2019. Early adoption is permitted for entities that apply IFRS&nbsp;15 Revenue from Contracts with Customers at or before the date of initial
application of IFRS&nbsp;16. We will adopt IFRS&nbsp;16 as of January&nbsp;1, 2019. An assessment of the impact of IFRS&nbsp;16 has not been finalized to date, but we expect that the most
significant impact will be that we will recognize new assets and liabilities for our operating leases. In addition, the nature and recognition of expenses related to those leases will change as
IFRS&nbsp;16 replaces the straight-line operating lease </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>92</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=14,SEQ=97,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=749898,FOLIO='92',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_93"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>


<P style="font-family:times;"><FONT SIZE=2>expense
with a depreciation charge for right-of-use assets and interest expense on lease liabilities. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Annual improvements to IFRS's 2015-2017 Cycle, issued on December&nbsp;12, 2017, covers the following minor amendments: </FONT> <FONT SIZE=2>
<BR><BR></FONT>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRS&nbsp;3 </FONT><FONT SIZE=2><I>Business Combinations: </I></FONT><FONT SIZE=2>the amendments clarify that a company
remeasures its previously held interest in a joint operation when it obtains control of the business;  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRS&nbsp;11 </FONT><FONT SIZE=2><I>Joint Arrangements: </I></FONT><FONT SIZE=2>the amendments clarify that a company does not
remeasure its previously held interest in a joint operation when it obtains joint control of the business;  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IAS&nbsp;12 </FONT><FONT SIZE=2><I>Income Taxes: </I></FONT><FONT SIZE=2>the amendments clarify that a company accounts for all
income tax consequences of dividend payments consistently with the transactions that generated the distributable profits&#151;i.e.&nbsp;in profit or loss, OCI or equity;
and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IAS&nbsp;23 </FONT><FONT SIZE=2><I>Borrowing Costs: </I></FONT><FONT SIZE=2>the amendments clarify that a company treats as
part of general borrowings any borrowing originally made to develop an asset when the asset is ready for its intended use or sale. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD></DL>
</DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> IFRIC&nbsp;23 </FONT><FONT SIZE=2><I>Uncertainty over Income Tax Treatments </I></FONT><FONT SIZE=2>issued on June&nbsp;7, 2017, clarifies
how to apply the recognition and measurement requirements in IAS&nbsp;12 when there is uncertainty over income tax treatments. In such a circumstance, an entity shall recognize and measure its
current or deferred tax asset or liability applying the requirements in IAS&nbsp;12 based on taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates determined
applying this Interpretation. An entity is required to assume that a tax authority with the right to examine and challenge tax treatments will examine those treatments and have full knowledge of all
related information. Detection risk is not considered in the recognition and measurement of uncertain tax treatments. The entity should measure the impact of the uncertainty using the method that best
predicts the resolution of the uncertainty; either the most likely amount method or the expected value method. The interpretation is effective for annual periods beginning on or after
January&nbsp;1, 2019, with earlier adoption permitted. The amendments are not expected to have a material impact on our consolidated financial statements. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Amendments to IAS&nbsp;19: </FONT><FONT SIZE=2><I>Plan Amendment, Curtailment or Settlement</I></FONT><FONT SIZE=2>. This amendment to
IAS&nbsp;19, applicable for fiscal years beginning on January&nbsp;1, 2019, clarified the assumptions to use for the remeasurement and the effect on the requirements regarding the asset ceiling
when a plan amendment, curtailment or settlement occurs. The amendments are not expected to have a material impact on our consolidated financial statements. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Quantitative and Qualitative Disclosures about Market Risk  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Foreign Currency Exchange Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We use the euro as our functional currency and the majority of our operations are denominated in euros. However, a portion of our operating
expenses is denominated in U.S. dollars, and as result we may be exposed to foreign currency risk. For the year ended December&nbsp;31, 2018, these expenses totaled $9.6&nbsp;million based on the
exchange rate in effect at December&nbsp;31, 2018, or less than 10% of our total operating expenses for the year. As a result, an adverse 10% change in the exchange rate for the U.S. dollar against
the euro would have resulted in a foreign exchange rate loss of approximately &euro;1.0&nbsp;million for the year. For the year ended December&nbsp;31, 2018, we realized a foreign
exchange rate loss of &euro;26, although any such historical gains or losses do not predict the future impact of exchange rate risk. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>93</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=15,SEQ=98,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=369064,FOLIO='93',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_94"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the future, and in particular with respect our clinical trials, we might need to manage an increasing number of transactions denominated in currencies other than the euro or
indirectly exposed to currency risk, which will increase our overall exposure to this risk. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2018, we considered the implementation of appropriate hedging arrangements without ultimately using any such arrangements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not currently have material revenues in dollars or any currency other than euros. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Interest Rate Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are exposed to interest rate risk related to our cash and cash equivalents. We had cash and cash equivalents of
&euro;207.2&nbsp;million as of December&nbsp;31, 2018, which consisted of bank accounts and short-term deposits. These interest-earning instruments carry a degree of interest rate risk;
however, historical fluctuations in interest income have not been significant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
had net outstanding debt of &euro;160.5&nbsp;million as of December&nbsp;31, 2018 in the form of convertible loans, which loans accrue interest at a fixed rate of 3.5%
and for which the gross amount is &euro;180,000. We also had outstanding at December&nbsp;31, 2018 a total of &euro;3.2&nbsp;million in conditional advances from BPI France,
&euro;1.9&nbsp;million of obligations under finance leases and &euro;4.0&nbsp;million of loans from commercial banks. The advances from BPI France are generally non-interest
bearing or carry interest at fixed rates, and the bank loans all carry fixed interest rates. In the ordinary course of business, we may enter into contractual arrangements to reduce our exposure to
interest rate risks. We do not believe that a 10% change in interest rates would have a significant impact on our consolidated financial statements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Credit Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that the credit risk related to our cash and cash equivalents is not significant in light of the quality of the financial
institutions at which such funds are held. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


JOBS Act Exemptions and Foreign Private Issuer Status  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We qualify as an "emerging growth company" as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging
growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. This includes an exemption from the auditor attestation
requirement in the
assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002. We may take advantage of this exemption for up to five years or such earlier time that we are no
longer an emerging growth company. We will cease to be an emerging growth company if we have more than $1.07&nbsp;billion in total annual gross revenue, have more than $700.0&nbsp;million in
market value of our ordinary shares held by non-affiliates or issue more than $1.0&nbsp;billion of non-convertible debt over a three-year period. We may choose to take advantage of some but not all
of these provisions that allow for reduced reporting and other burdens. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will not take advantage of the extended transition period provided under Section&nbsp;7(a)(2)(B) of the Securities Act of&nbsp;1933, as amended, for complying with new or revised
accounting standards. Since IFRS makes no distinction between public and private companies for purposes of compliance with new or revised accounting standards, the requirements for our compliance as a
private company and as a public company are the same. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
consummation of the global offering, we will report under the Securities Exchange Act of 1934, as amended, or the Exchange Act, as a non-U.S. company with foreign private issuer
status. Even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>94</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=16,SEQ=99,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=239490,FOLIO='94',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_cy10701_1_95"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>issuer
under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under
the Exchange Act; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for
insiders who profit from trades made in a short period of time; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form&nbsp;10-Q containing unaudited financial and
other specified information, or current reports on Form&nbsp;8-K, upon the occurrence of specified significant events; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Regulation&nbsp;FD, which regulates selective disclosures of material information by issuers. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>95</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=17,SEQ=100,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=130390,FOLIO='95',FILE='DISK124:[18ZFA1.18ZFA10701]CY10701A.;80',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_cz10701_1_96"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cz10701_business"> </A>
<A NAME="toc_cz10701_1"> </A></FONT> <FONT SIZE=2><B>  BUSINESS    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic
solutions targeting metabolic and liver-related diseases where there is considerable unmet medical need. We are a leader in the field of nuclear receptor-based drug discovery with a rich history and
strong scientific heritage spanning almost two decades. We are evaluating our most advanced drug candidate, elafibranor, in a pivotal Phase&nbsp;3 clinical trial as a potential treatment for
nonalcoholic steatohepatitis, or NASH, and as a potential treatment for primary biliary cholangitis, or PBC. In December 2018, we announced positive
preliminary results from our Phase 2 clinical trial in PBC. Our drug discovery efforts are based on selecting appropriate nuclear receptors as targets and utilizing rational drug design to optimize
our drug candidates. A key differentiator of our development strategy is our NASH biomarker-based diagnostic program, in which we are developing a new </FONT><FONT SIZE=2><I>in&nbsp;vitro  </I></FONT><FONT SIZE=2>diagnostic, or IVD, test to identify
patients with NASH who may be appropriate candidates for drug therapy. Our scientific and clinical expertise, translational disease-driven
approach and strong bioinformatics capabilities have allowed us to build a scientific platform through which we discover and develop our drug candidates and diagnostic tools. We believe elafibranor,
if approved, has the potential to become a first-line treatment as a monotherapy and the backbone of combination regimens. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH
is a liver disease that affects millions of people and for which there are currently no approved therapies. NASH is characterized by an accumulation of fat, inflammation and
degeneration of hepatocytes, and may ultimately lead to life-threatening conditions like cirrhosis, liver failure or liver cancer requiring liver transplant. The global market for the treatment of
NASH is growing rapidly and is projected to reach $20&nbsp;billion by 2025. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elafibranor,
a dual agonist of the nuclear receptors PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>, is currently in Phase&nbsp;3
development for the treatment of NASH. In our Phase&nbsp;2b clinical trial, elafibranor achieved resolution of NASH without worsening of fibrosis, which is the primary endpoint of our ongoing global
Phase&nbsp;3 clinical trial. We have already achieved the enrollment necessary to perform an interim cohort analysis and expect to report interim results by the end of 2019. We believe these
results, if positive, could support accelerated approval from the U.S. Food and Drug Administration, or FDA, and conditional approval from the European Medicines Agency, or EMA, as early as 2020.
Elafibranor has received fast track designation from the FDA for the treatment of NASH. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also developing elafibranor for the treatment of PBC, a chronic, progressive liver disease that leads to inflammation and scarring of the small bile ducts in the liver. Although a
relatively rare disease mainly affecting women, PBC can develop into cirrhosis and other serious liver complications. There is currently no cure for PBC, and the two drugs approved for the treatment
of PBC are limited by drug intolerance, lack of patient response and safety issues. Based on our clinical data, we believe elafibranor's unique mechanism of action can provide benefits for patients
with PBC without significant side effects, such as the serious liver injury or death and pruritis that have been associated with approved PBC treatments. In December 2018, we announced positive
preliminary results from our Phase&nbsp;2 clinical trial evaluating elafibranor for the treatment of PBC. Elafibranor met the primary endpoint of the trial, which was the change at week 12 in serum
alkaline phosphatase, or ALP, from baseline, with statistical significance compared to placebo in both doses evaluated. Elafibranor also achieved with high statistical significance compared to
placebo, the composite endpoint of ALP and bilirubin. That endpoint, which has been used for drug registration, is defined as (1)&nbsp;ALP less than 1.67 times the upper limit of normal, or ULN,
(2)&nbsp;total bilirubin within normal limits and (3)&nbsp;a reduction of ALP of more than 15%. Based on these positive results, we plan to advance our PBC program into Phase&nbsp;3 development. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>96</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=101,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=640071,FOLIO='96',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_97"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH
is a silent disease. Patients often have no symptoms until the first signs of liver failure, and the lack of an accurate, non-invasive diagnosis tool contributes to under-diagnosis.
Currently, liver biopsy is the standard for diagnosis, and variation in clinical practice and physician reluctance lead to under-diagnosis. Our blood-based IVD test is a novel, standalone diagnostic
that we believe can address the urgent need for a non-invasive, cost-effective, accessible and validated test to identify NASH patients who may be appropriate candidates for drug intervention, thereby
decreasing the need for liver biopsy. We believe our IVD test has the potential to benefit patients, improve overall clinical care and facilitate the identification of NASH patients to be treated. We
anticipate marketing our IVD test first as a laboratory-developed test, or LDT, in 2019, and then submitting our IVD test for FDA marketing authorization in 2020. In January 2019, we entered into a
license agreement with LabCorp to allow them to deploy our IVD test in the clinical research space. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also advancing a clinical-stage program based on drug repositioning to develop an anti-fibrotic drug. Our lead drug candidate in this program, nitazoxanide, or NTZ, is an approved
anti-parasitic agent that has shown promising activity against fibrosis in our preclinical disease models. See "Nitazoxanide Program for the Treatment of Fibrosis&#151;Preclinical and Clinical
Program." In December 2018, we announced the initiation of an investigator-initiated Phase&nbsp;2 proof-of-concept trial to evaluate NTZ for the treatment of NASH patients with significant or severe
fibrosis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
TGFTX1 preclinical program is focused on the discovery and development of innovative drug candidates targeting ROR<FONT FACE="SYMBOL">g</FONT>t, a nuclear receptor
involved in certain inflammatory and autoimmune diseases. We are currently conducting pre-IND studies for a topical treatment of mild to moderate psoriasis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes our drug candidate and diagnostic development pipeline. We have retained worldwide rights to all of our programs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g849928.jpg" ALT="GRAPHIC" WIDTH="666" HEIGHT="294">
  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
current chief executive officer co-founded our company in 1999 and our shares have been listed on the Euronext Paris under the symbol "GNFT" since 2006. We are led by an executive
team and board of directors with deep experience at leading biotech companies, large pharmaceutical companies and academic institutions. We have over 150&nbsp;employees at our offices in Lille and
Paris, France and Cambridge, Massachusetts. The chair of our scientific advisory board, Bart Staels, is a co-founder of our company and a world-renowned expert in nuclear receptors. Our scientific
advisory board is comprised of internationally recognized key opinion leaders in the field of metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. We believe
the expertise of our leadership and the strength of our relationships within the academic and clinical communities are critical to our ability to execute on our mission as we progress our development
pipeline. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>97</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=102,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=427115,FOLIO='97',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_98"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strengths  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe the following strengths will allow us to continue to build upon our leadership position in drug and diagnostic development for
metabolic and liver-related diseases and achieve our goal of commercializing our drug and diagnostic candidates: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Our lead product candidate, elafibranor, is in Phase&nbsp;3 development for the
treatment of NASH, an indication for which there are no approved drugs today, but which presents significant market opportunity.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;In April 2018,
we announced that we had achieved the recruitment goal of 1,000 patients for the interim cohort in our global Phase&nbsp;3 clinical trial being conducted in 25 countries. We expect to report the
results of our interim cohort analysis by the end of 2019, which, if positive, could support accelerated approval from the FDA and conditional approval from the EMA as early as 2020. If approved,
elafibranor has the potential to be the first FDA-approved therapy to achieve resolution of NASH without worsening of fibrosis that could also have the benefit of addressing cardiovascular risk
factors.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> We recently announced positive preliminary results from our Phase&nbsp;2 clinical
trial of elafibranor for the treatment of PBC and plan to commence Phase&nbsp;3 development.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;In December 2018, we announced that elafibranor
met the primary endpoint of our Phase&nbsp;2 clinical trial, which was the change at week 12 in serum ALP from baseline. Compared to placebo, treatment with 80 mg and 120 mg elafibranor resulted in
mean decrease from baseline of &#150;52% and &#150;44%, respectively, each with high statistical significance. With respect to the composite endpoint, the elafibranor 80 mg and
120 mg treatment groups achieved with high statistical significance mean response rates of 67% and 79%, as compared to 6.7% for the placebo group. We plan to advance our PBC program into
Phase&nbsp;3 development in 2019.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Elafibranor's results on NASH resolution, its good tolerability and lack of demonstrated
safety concerns make it well-positioned among late-stage NASH programs.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We believe elafibranor has a favorable tolerability profile based on the
results of our Phase&nbsp;1 and Phase&nbsp;2 trials. Also, in our Phase&nbsp;2b clinical trial, we observed elafibranor's ability to resolve NASH without the worsening of fibrosis, which is the
primary endpoint of our ongoing global Phase&nbsp;3 clinical trial. We also observed a decrease in cardiovascular risk factors, an important observation considering the close link between NASH and
cardiometabolic disease, and one that has not been reported in other drugs in Phase&nbsp;3 development for NASH. Elafibranor is, to our knowledge, the only drug currently permitted to be developed
for the treatment of children with NASH. We hold over 350&nbsp;patents and patent applications relating to elafibranor, and the patent covering the use of elafibranor for the treatment of NASH does
not expire until&nbsp;2030, without taking into account any extensions.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> We are a recognized leader in the NASH
field.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We are actively involved in the NASH stakeholder community, as a member of the steering committee and co-leader of a working group of The
Liver Forum. We also participate in academic consortia, such as the biomarkers consortia in the United States and Europe, and work with patient advocacy groups including the Global Liver Institute,
American Liver Forum and the European Liver Patient Association. We also spearhead disease awareness through The NASH Education Program, which is a Genfit public health initiative. These programs
provide us with insight from the key stakeholders in NASH and our leadership position enables us to establish credibility with and convey these insights to regulators and payors.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Our diagnostic program has the potential to expand market opportunity through better
patient identification and stratification.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;Our IVD test is designed to identify NASH patients who may be appropriate candidates for drug
intervention. We believe that broad adoption of our non-invasive, accessible test, if validated and authorized for marketing, could not only help solve the problem of NASH under-diagnosis, but also
provide physicians with a tool to identify </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>98</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=103,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=603808,FOLIO='98',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_99"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>patients
who would benefit from treatment with elafibranor or any other appropriate drug. In January 2019, we entered into a license agreement with LabCorp to allow them to deploy our IVD test in the
clinical research space.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Our pipeline extends beyond
elafibranor.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;In December 2018, we announced the initiation of an investigator-initiated Phase&nbsp;2 proof-of-concept trial to evaluate NTZ for
the treatment of NASH patients with significant or severe fibrosis. If this Phase&nbsp;2 trial demonstrates anti-fibrotic activity in these patients, we plan to develop NTZ as a combination therapy
with elafibranor as part of our strategy in NASH, in addition to development as a standalone monotherapy in fibrotic diseases. Our TGFTX1 program is in preclinical development in certain inflammatory
and autoimmune diseases. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Our experienced team is comprised of industry leaders in metabolic and liver-related
diseases.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We believe that the breadth of experience and accomplishments of our management team, board of directors and scientific advisory board,
combined with our broad network of established relationships with leaders in the industry and medical community, provide us with unique insights into drug development and commercialization, and have
allowed us to bring together top researchers to build interdisciplinary research and development teams. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our goal is to become a leader in the development of innovative therapies and diagnostics in metabolic and liver-related diseases. The key
elements of our strategy to achieve this goal include: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Obtain regulatory approval for, and commercialize, elafibranor for the treatment of
NASH.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We are currently conducting our Phase&nbsp;3 registrational trial, RESOLVE-IT, evaluating the efficacy and safety of a once-daily 120 mg
dose of elafibranor in patients with NASH and fibrosis. We expect to enroll approximately 2,000 patients in this double-blind, placebo-controlled trial and in April 2018, we announced that we had
achieved the recruitment goal of 1,000 patients necessary for the interim cohort analysis. We plan to announce results from our interim analysis at the end of 2019 and, if positive, use these results
to support an accelerated regulatory approval pathway (Subpart&nbsp;H) in the United States and conditional approval in Europe. If approved, we may decide to market elafibranor for NASH in certain
territories on our own and in other territories in collaboration with one or more pharmaceutical partners or specialized local distributors.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Rapidly advance the Phase&nbsp;3 clinical development of elafibranor for the treatment
of PBC.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We are advancing clinical development of elafibranor for the treatment of adult patients with PBC who have had inadequate response to
ursodeoxycholic acid, or UDCA. In December 2018, we announced positive preliminary results from our Phase&nbsp;2 clinical trial evaluating elafibranor for the treatment of PBC. We plan to discuss
our clinical development program with the FDA and to advance our PBC program into Phase&nbsp;3 development in 2019.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Complete development and prepare for potential commercialization of our NASH IVD
test.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;In 2017, we began the product and regulatory development phases for our novel, blood-based IVD test designed to identify patients with NASH
who may be appropriate candidates for drug therapy and to offer an attractive means of decreasing the need for liver biopsies. We will initially market the test as an LDT in 2019 and then seek to
obtain FDA marketing authorization of our IVD test in 2020 in parallel with commercialization of elafibranor. We believe that, if validated and authorized for marketing, our non-invasive, blood-based
and accessible IVD test can easily integrate into routine clinical care for the comprehensive management of NASH. We are currently in discussions with multiple global diagnostic partners to discuss
worldwide commercialization of our IVD test. Our license agreement with LabCorp allows for the deployment of our IVD test in the clinical research space through its central </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>99</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=104,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=129905,FOLIO='99',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_100"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>laboratories
which we believe will provide expanded access to, and further validation of our IVD test and generate new biological insights on NASH disease pathogenesis.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Advance other drug candidates in our pipeline, both alone and in combination with
elafibranor.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;In addition to developing our other drug candidates to independently target metabolic and liver-related diseases, we believe
elafibranor's unique approach in targeting PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT> creates opportunities to explore combination therapies, either
with our other drug candidates, third-party drug candidates or approved drugs. In our development program for fibrotic diseases, we have chosen to initially advance NTZ into Phase&nbsp;2 clinical
development. In December 2018, we announced the initiation of an investigator-initiated Phase&nbsp;2 proof-of-concept trial to evaluate NTZ for the treatment of fibrosis in NASH patients with
significant or severe fibrosis. We believe NTZ could be developed as an anti-fibrotic monotherapy and as combination therapy with elafibranor. We also plan to explore opportunities to expand the use
of elafibranor through combination therapies such as with farnesoid X receptor, or FXR, agonists, Acetyl-CoA Carboxylase, or ACC, inhibitors and our drug candidate NTZ as part of our strategy in NASH. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Actively manage our development pipeline and opportunistically enter into strategic
collaborations.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;We plan to continue to strengthen our development pipeline by in-licensing rights to drug candidates in Phase&nbsp;1 or
Phase&nbsp;2 clinical development in our therapeutic areas of interest. We may sign a licensing agreement or co-marketing agreement with one or more pharmaceutical laboratories with the financial
capacity and specific expertise to successfully conduct clinical trials and bring drugs to market. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Increase public awareness of NASH through The NASH Education
Program.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;The NASH Education Program, a public health initiative we created in 2016, is dedicated to the development and funding of NASH awareness
and education activities aimed at the medical community and the general public. We believe that this program, through the production and dissemination of essential medical knowledge, can increase
early diagnosis of NASH patients and provide physicians and patients with critical information about diagnostic and therapeutic solutions. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Drug Candidates and Diagnostic Development Programs  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NASH&#151;A Silent, Serious and Widespread Disease with No Approved Treatments  </I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH is a silent disease, meaning patients have no symptoms until first signs of liver failure appear, and is notably under-diagnosed. With no
approved drug treatments, NASH can lead to life-threatening conditions like cirrhosis, liver failure, liver cancer and death. NASH is the second leading indication for liver transplantation in the
United States, behind hepatitis C, but is also the most rapidly growing indication and is expected to eventually become the primary cause. A study published in the </FONT><FONT SIZE=2><I>Journal of
Hepatology</I></FONT><FONT SIZE=2> estimates that there were approximately 17.3&nbsp;million adults with NASH in the United States in 2016 and projects that this number will grow to approximately
27.0&nbsp;million by 2030; in the five major European markets, France, Germany, Italy, Spain and the United Kingdom, these numbers were estimated to be 12.6&nbsp;million in 2016 and
18.3&nbsp;million by 2030. NASH is a critical public health concern and an area with high unmet medical need. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are developing our lead drug candidate, elafibranor, for the treatment of NASH, a severe form of non-alcoholic fatty liver disease, or NAFLD. NAFLD is the buildup of fat in the liver,
called hepatic steatosis, that is not caused by alcohol consumption. As the disease progresses, the liver is exposed to chronic inflammation and liver cell degradation (manifested as hepatocyte
"ballooning"). A patient has NASH when the three components&#151;steatosis, inflammation and damage&#151;are all present. Without treatment, NASH leads to fibrosis, which is the
accumulation of non-functional scar tissue, as the body </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=105,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=871577,FOLIO='100',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_101"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>tries
to heal itself. Because the accumulation of scar tissue leads to tissue remodeling, development of fibrosis leads to progressive loss of liver function which may ultimately lead to
life-threatening conditions like cirrhosis, liver failure or liver cancer. Approximately 20% of NASH patients will go on to develop cirrhosis, and almost half of patients with cirrhosis will develop
liver failure. Studies show that NASH patients have a 10&nbsp;times greater risk of dying from a liver-related disorder than the general population. In addition to its serious effects on the liver,
NASH multiplies the risk of a patient developing cardiovascular problems, such as myocardial infarction, stroke and peripheral vascular accident, which also contribute to higher mortality rates in
NASH patients. In fact, cardiovascular disease is the leading cause of death in NASH patients. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following image depicts the progression of a normal liver through the development of NASH and its eventual consequences. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g426701.jpg" ALT="GRAPHIC" WIDTH="436" HEIGHT="276">
  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Causes, Diagnosis and Assessment of NASH  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although experts are still studying the multiple possible causes, it is generally accepted that NASH is a consequence of high-sugar, high-fat
diets and insufficient physical exercise. As such, the disease is closely associated with metabolic disorders and NASH patients can have some or all of the following disorders: obesity, type&nbsp;2
diabetes, hyperglycemia and abnormal levels of triglycerides and cholesterol. As the obesity and type&nbsp;2 diabetes pandemic has increased, so too has the number of NASH cases worldwide. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Today,
the clinical standard to formally diagnose NASH and stage fibrosis in a patient suspected of having NASH is the liver biopsy. When a liver biopsy shows steatosis, ballooned cells
and inflammation, with or without fibrosis, the patient is diagnosed with NASH. Physicians use various scoring scales to assess the extent of disease severity and fibrosis in NASH
patients:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The NAFLD Activity Score, or NAS, provides a numerical score and assesses the severity of the disease for patients who have NASH. The NAS
includes three sub-score components&#151;steatosis&nbsp;(0-3), hepatocellular ballooning (0-2) and inflammation (0-3).</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The NASH Clinical Research Network fibrosis staging system ranks a patient's level of fibrosis on a scale of&nbsp;F0 to&nbsp;F4. No
fibrosis is&nbsp;F0; mild, significant and severe fibrosis is&nbsp;F1, F2 and&nbsp;F3, respectively, and cirrhosis is&nbsp;F4. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
histological spectrum of NAFLD is quite large and both NAS and fibrosis stage can be used to define a patient's risk of developing cirrhosis, liver failure, liver cancer, liver
transplant and liver death. The presence of NASH is the underlying cause of fibrosis, and fuels the fibrosis progression </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>101</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=106,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=65097,FOLIO='101',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_102"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>from
stage to stage. Not surprisingly, the higher the fibrosis stage, the more advanced the disease, the greater the risk of developing major liver complications. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
the natural history of the disease is not fully understood, a consensual definition of a NASH patient at risk of liver complications has emerged. According to this definition, a
patient presenting with active NASH (NAS<FONT FACE="SYMBOL">&#179;</FONT>4) and significant fibrosis (F<FONT FACE="SYMBOL">&#179;</FONT>2) should be considered "at risk" and may
be an appropriate candidate for drug intervention. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Market Opportunity  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The treatment of NASH is an urgent public health challenge. Despite the growing burden of NASH on public health systems resulting from high
prevalence and morbidities and mortality associated with the disease, there are currently no FDA-approved therapies for the treatment of NASH. Existing drugs have been tested off-label for assessing
potential efficacy on NASH and liver fibrosis but have failed because of lack of efficacy, unacceptable side effects or both. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
the global epidemic of obesity fuels NAFLD prevalence, NASH has become one of the most common liver disorders. Global Data estimates the NASH market in the seven major markets
(France, Germany, Italy, Japan, Spain, the United Kingdom and the United States) at approximately $143&nbsp;million as of&nbsp;2017, with the potential to reach up to $18.3&nbsp;billion
by&nbsp;2026. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Solution: Elafibranor for the Treatment of NASH  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our two-pronged strategy for developing solutions for NASH patients consists of developing our drug candidate elafibranor as a first-line
treatment for patients with NASH and developing an IVD test to aid in the diagnosis of at-risk NASH patients. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elafibranor
(previously known as GFT505) is a dual-agonist acting simultaneously on two nuclear receptors, PPAR<FONT FACE="SYMBOL">a</FONT> and
PPAR<FONT FACE="SYMBOL">d</FONT>, that control expression of key genes of inflammation, lipid metabolism, glucose metabolism and insulin sensitivity, oxidative stress and fibrosis. These
two receptors play an important role in numerous processes involved in the development of NASH and its co-morbidities, as outlined below. </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The activation of PPAR<FONT FACE="SYMBOL">a</FONT> as well as PPAR<FONT FACE="SYMBOL">d</FONT> confer anti-inflammatory
activities through the repression of independent and complementary pathways. Thus, the dual activation of PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT> is
thought to be advantageous over single agonism of either of the targets alone. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT> in the liver increase mitochondrial
<FONT FACE="SYMBOL">b</FONT>-oxidation which can lead to fatty acid degradation, or catabolism, and the decrease of liver fat. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The activation of PPAR<FONT FACE="SYMBOL">a</FONT> decreases oxidative stress, which occurs in part through the upregulation of
anti-oxidant genes. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> PPAR<FONT FACE="SYMBOL">a</FONT> activation leads to a beneficial cardioprotective lipid profile which includes a decrease in total
cholesterol, remnant cholesterol, LDL-cholesterol and triglycerides, and an increase in HDL-cholesterol. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The activation of PPAR<FONT FACE="SYMBOL">d</FONT> increases insulin sensitivity, which can occur in part by its activity to
increase mitochondrial function and energy expenditure. This increased insulin sensitivity improves glucose homeostasis, lowers the elevated plasma free fatty acid levels associated with obesity and
decreases hyperinsulinemia, which in turn decreases lipogenesis. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> PPAR<FONT FACE="SYMBOL">a</FONT> activation has shown a beneficial effect on the microvasculature. It is reasonable to hypothesize
that this effect would also be operative in the liver, reducing inflammation and improving vascular activity in NASH patients. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>102</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=107,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=518467,FOLIO='102',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_103"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The combined activation of PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>, leading to decreased
inflammation, oxidative stress, liver fat and insulin resistance, has a beneficial impact on the liver as is evidenced by the activity of elafibranor to decrease markers of liver dysfunction,
including alanine aminotransferase, or ALT, aspartate aminotransferase, or AST, and gamma-glutamyl transferase, or GGT. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
important distinction between elafibranor and some of the other third-party programs targeting PPARs in NASH is that elafibranor does not have any pharmacological
PPAR<FONT FACE="SYMBOL">g</FONT> activity as shown by studies in disease models and in clinical trials. Elafibranor has not shown the unwanted side effects most commonly associated with
PPAR<FONT FACE="SYMBOL">g</FONT> activation, such as weight gain, edema, and fluid retention, which are associated with increased risk of heart failure. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH
is closely associated with obesity and type&nbsp;2 diabetes and is considered to be the liver manifestation of the metabolic syndrome. Similarly to many metabolic diseases such as
type&nbsp;2 diabetes, NASH is a multifaceted disease with multiple components, including insulin resistance, inflammation, oxidative stress, increased liver fat and dyslipidemia. A therapeutic
intervention that can address multiple NASH components may provide optimal clinical benefit and have the best probability to attain the histological endpoints required for drug registration for the
treatment of NASH patients. We believe that with its unique mechanism of action, by activating both PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>,
elafibranor has the potential to modulate many of the key hallmarks of NASH, and, if approved, could be well-positioned as a first-line treatment as a monotherapy and the backbone of combination
regimens. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Clinical Program for Elafibranor in the Treatment of NASH  </I></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RESOLVE-IT&#151;Our Pivotal Phase&nbsp;3 Clinical Trial  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based on the results obtained in our Phase&nbsp;2b clinical trial of elafibranor in treating NASH patients, we are currently evaluating
elafibranor for the treatment of NASH in a global pivotal Phase&nbsp;3 clinical trial, RESOLVE-IT. The trial began in the first quarter of 2016 and is expected to enroll approximately 2,000 patients
at approximately 250 sites throughout the world. We plan to perform an interim analysis of the first 1,000 enrolled patients after 72&nbsp;weeks of treatment in order to evaluate the efficacy of
elafibranor, based on a single primary histological endpoint, resolution of NASH without worsening of fibrosis, as a basis for accelerated marketing approval from the FDA and conditional marketing
approval from the EMA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RESOLVE-IT
is a randomized, double-blind, placebo-controlled (2:1) Phase&nbsp;3 clinical trial enrolling patients with NASH (NAS <FONT FACE="SYMBOL">&#179;</FONT>4) and
fibrosis (F2 or F3, stages at which fibrosis is significant but has not yet reached cirrhosis). Patients will receive either elafibranor 120 mg or placebo once daily. The primary endpoint at the
interim analysis, which will be performed on the interim cohort comprised of the first 1,000 patients enrolled and after a 72&nbsp;weeks of treatment, is the proportion of elafibranor-treated
patients achieving NASH resolution without worsening of fibrosis as compared to placebo. This will be done by comparing a patient's liver biopsy at the end of the 72&nbsp;week treatment period with
their initial liver biopsy. The trial also has a key secondary histological endpoint, fibrosis improvement without the worsening of NASH, which we believe may be included in the drug label if this
endpoint is met and if elafibranor receives approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
April 2018, we announced that we had achieved enrollment of the first 1,000 patients in the interim cohort. The Subpart&nbsp;H approval pathway we are pursuing requires us to
continue the trial through the extension period for all 2,000 patients, at which time the full patient population will be evaluated for a composite endpoint of clinical outcomes. The trial will also
evaluate improvement of cardiometabolic profiles in patients treated with elafibranor versus patients treated with placebo. Throughout the duration of the trial, the safety is continuously monitored
by the Data Safety Monitoring Board, or DSMB, an independent committee that provides recommendations on continuation of the trial. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>103</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=108,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=942327,FOLIO='103',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_104"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the recruitment, we focused on the balanced distribution of treatments across all sites and countries, based on stratification according to gender, presence of diabetes and
disease severity. We have enrolled patients in more than 250 sites across North America, Europe, Australia, Latin America, Turkey and South Africa. Interim baseline data on the initial cohort show
that the patients recruited into the trial to date have the expected metabolic co-morbidities which include type&nbsp;2 diabetes, hypertension, dyslipidemia and obesity. Thus, the baseline
characteristics of the trial population are consistent with the expected associated risk factors for patients with NASH and fibrosis. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Four
pre-planned safety reviews of the data have been already performed by the DSMB. In each of the reviews, including the most recent one in December 2018, the DSMB has recommended
continuation of the trial without any modification after analysis of the safety data set, including adverse events and laboratory data. This recommendation, taking into account an increasing number of
patients exposed to treatment for longer periods of time, is consistent with our observations in previous Phase&nbsp;1 and Phase&nbsp;2 clinical trials that support elafibranor's favorable
tolerability profile and lack of demonstrated safety concerns. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expect to report data from the interim cohort analysis by the end of 2019. If the results of the interim analysis are positive, we expect to apply for accelerated approval from the
FDA and conditional marketing approval from the EMA in 2020. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


GOLDEN-505&#151;Our Phase&nbsp;2b Clinical Trial  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The efficacy and safety of elafibranor, to date, has been evaluated in an extensive preclinical program which included multiple disease models.
Prior to our GOLDEN-505 Phase&nbsp;2b clinical trial in NASH patients, our Phase&nbsp;2a program in elafibranor included trials performed in
different populations of metabolic disease patients, including patients with atherogenic dyslipidemia, prediabetes or type&nbsp;2 diabetes. In these Phase&nbsp;2a trials, we observed that
treatment with elafibranor promoted a cardioprotective lipid profile, promoted glucose homeostasis, increased insulin sensitivity, was anti-inflammatory and decreased markers of liver injury. Each of
these activities are important targets in the treatment of NASH patients and we believe the combined multiple activity profile of elafibranor observed in the Phase&nbsp;2a trials warranted its
further clinical development in a Phase&nbsp;2b trial. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2012, a consensus definition of NASH resolution had not yet been adopted by regulatory authorities or the medical community and little was known about the target NASH population to be
included in clinical trials. As a result, we designed the GOLDEN-505 trial with the input of key opinion leaders and the FDA to identify the therapeutic dose for elafibranor and the most appropriate
NASH population for drug therapy. For this purpose, GOLDEN-505 enrolled a patient population covering almost the entire histological spectrum of NASH (from NAS=3 to NAS=8 and fibrosis stage
from&nbsp;F0 to&nbsp;F3). Patients with fibrosis stage&nbsp;F4 were excluded, as this would indicate that the patient had already progressed to cirrhosis. This trial, which began in&nbsp;2012,
was one of the largest interventional trials and first true international study ever conducted in NASH, enrolling 276&nbsp;patients, 274 of whom were treated, at 56&nbsp;sites throughout the
United States and seven countries in Europe. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patients
were enrolled if they had NASH defined as NAS<FONT FACE="SYMBOL">&#179;</FONT>3 with at least one point in steatosis, ballooning and inflammation scores, and fibrosis
stage from F0 to F3. Patients were divided into three treatment groups, receiving either elafibranor 80 mg, elafibranor 120 mg or placebo once daily for 52&nbsp;weeks. The primary endpoint of the
trial was to evaluate the efficacy of elafibranor doses compared to placebo on reversal of NASH without worsening of fibrosis. We also evaluated the effect of elafibranor on secondary endpoints
including changes in NAS, morphometric parameters, insulin resistance, cardiovascular risk parameters and safety markers. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>104</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=109,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=617953,FOLIO='104',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<A NAME="page_cz10701_1_105"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Efficacy Results  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Topline results were announced in March 2015 and detailed results were presented at the 2015 American Association for the Study of Liver
Diseases, or AASLD, Annual Meeting. Complete results of the trial were published in the peer-reviewed </FONT><FONT SIZE=2><I>Gastroenterology</I></FONT><FONT SIZE=2> journal. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
the end of the 52-week treatment period, there was no difference between the elafibranor arms and placebo according to the protocol-defined definition of the primary endpoint. We
conducted a post hoc analysis of the data using a definition recommended by the FDA for use as the primary endpoint in our Phase&nbsp;3 trial. Applying this definition to our Phase&nbsp;2b data,
elafibranor 120&nbsp;mg resolved NASH without the worsening of fibrosis in the intent-to-treat population, defined as all patients who took at least one treatment: 19% of patients receiving
elafibranor 120 mg experienced NASH resolution without worsening of fibrosis, compared to only 12% in the placebo group, a statistically significant difference. The following table shows the
percentage of patients in the placebo and elafibranor 120 mg groups who reached NASH resolution without the worsening of fibrosis, broken down by the patient's NAS. The elafibranor 80 mg group did not
perform better than placebo using the FDA-recommended definition of the primary endpoint. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cz10701_percentage_of_patients_with_na__per05485"> </A>
<A NAME="toc_cz10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Percentage of Patients with NASH Resolution without Worsening of Fibrosis<BR>  (Primary Endpoint of Trial (FDA recommended post hoc definition))    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g601849.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="256">
  </B></FONT></P>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>P-value represents the statistical significance between two groups. A p-value &#60;0.05 denotes significant
difference and means that there is &#60; 5% likelihood that the observed results occurred by chance. The p-values in the table are comparisons between the elafibranor 120&nbsp;mg and
placebo groups. The p-values comparing the elafibranor 80&nbsp;mg and placebo groups each exceeded 0.05, meaning that such results were not statistically significant. </FONT></DD></DL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The statistical difference between the elafibranor and the placebo groups increased with the extent of initial histological lesions. In the
subpopulation of patients with active NASH&nbsp;(NAS<FONT FACE="SYMBOL">&#179;</FONT>4), 19% of patients receiving elafibranor 120 mg experienced NASH resolution, compared to only 9% in
the placebo group, with a
p-value of 0.013. In the subpopulation of patients with active NASH (NAS<FONT FACE="SYMBOL">&#179;</FONT>4) and fibrosis (F<FONT FACE="SYMBOL">&#179;</FONT>1), these results
increased to 20% and 11% in the elafibranor 120 mg group and placebo group, respectively, with a p-value of 0.009. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>105</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=110,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=828148,FOLIO='105',FILE='DISK124:[18ZFA1.18ZFA10701]CZ10701A.;59',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_da10701_1_106"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, we conducted a post hoc analysis to take into account differences in the standard of care across centers and baseline severity. In patients recruited
in centers with at least one patient with active NASH (NAS<FONT FACE="SYMBOL">&#179;</FONT>4) in the three treatment arms of the trial, 26% in the elafibranor 120 mg group, compared to 5%
in the placebo group (p=0.02), experienced resolution of NASH without worsening of fibrosis. We believe this analysis provides a good assessment of the efficacy of elafibranor, taking into account the
caveats of the Phase&nbsp;2b trial design which recruited patients with mild disease and too low of a NAS (NAS=3) and included trial centers which did not have patients from each of the study arms
present. Of the 274 patients enrolled and treated (the intent-to-treat population) in the Phase&nbsp;2b trial, 40 patients had mild disease, defined as a NAS=3. In these patients with mild disease,
there was an unexpectedly high placebo response rate, which we believe might have led to a lack of treatment effect in the pre-specified primary outcome assessment. The current practice for drug
development in NASH, including in our ongoing RESOLVE-IT trial, is now to include only those patients with moderate or severe disease, defined by a NAS equal to or greater than 4. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Importantly,
patients who achieved NASH resolution when treated with elafibranor ("responders") experienced a parallel decrease in fibrosis score compared to elafibranor patients who did
not achieve NASH resolution ("non-responders"), as depicted in the figure below. Although the trial was not designed for anti-fibrotic endpoints, we believe it provided proof-of-concept of an
anti-fibrotic effect.
This correlation between improvement in NASH activity and regression of fibrosis fits with the treatment paradigm that NASH resolution predicts long-term beneficial effects on prevention of negative
clinical outcomes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da10701_fibrosis_change_from_baseline___fib02957"> </A>
<A NAME="toc_da10701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Fibrosis Change from Baseline<BR>  in Elafibranor 120 mg Responders v. Non-Responders    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g581856.jpg" ALT="GRAPHIC" WIDTH="241" HEIGHT="196">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patients
treated with elafibranor experienced improvement in circulating markers of liver dysfunction such as ALT, GGT and alkaline phosphatase, or ALP. The charts below show the changes
in ALT, GGT and ALP from baseline over the course of the treatment period of the trial. These results were published in </FONT><FONT SIZE=2><I>Gastroenterology</I></FONT><FONT SIZE=2> in 2016. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>106</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=111,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=924600,FOLIO='106',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_107"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g312628.jpg" ALT="GRAPHIC" WIDTH="447" HEIGHT="324">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g861211.jpg" ALT="GRAPHIC" WIDTH="447" HEIGHT="324">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>107</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=112,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=17388,FOLIO='107',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_108"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g770745.jpg" ALT="GRAPHIC" WIDTH="447" HEIGHT="292">
  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in our evaluation of the secondary endpoints, we observed therapeutic activity of elafibranor 120 mg on the following cardiometabolic risk factors associated with NASH,
which we believe is commensurate with elafibranor providing a beneficial cardiometabolic profile: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Improved levels of plasma lipids and lipoproteins.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The charts below show the changes from baseline in triglycerides, LDL cholesterol
and HDL
cholesterol for each arm during the trial. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g780818.jpg" ALT="GRAPHIC" WIDTH="442" HEIGHT="289">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>108</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=113,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=489390,FOLIO='108',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_109"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g54160.jpg" ALT="GRAPHIC" WIDTH="583" HEIGHT="207">
  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Improved insulin sensitivity and glucose metabolism in diabetic patients.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following charts show the effects of elafibranor compared
to placebo on
a number of insulin sensitivity and glucose metabolism measures observed during the trial. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g498650.jpg" ALT="GRAPHIC" WIDTH="412" HEIGHT="295">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g347371.jpg" ALT="GRAPHIC" WIDTH="412" HEIGHT="285">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>109</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=114,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=372460,FOLIO='109',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_110"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anti-inflammatory effects.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following chart shows changes from baseline in fibrinogen and haptoglobin, two measures of inflammation,
during the
trial. In this chart, elafibranor 80 mg is noted as "GFT-80" and elafibranor 120 mg is noted as "GFT-120." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g37047.jpg" ALT="GRAPHIC" WIDTH="433" HEIGHT="396">
  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
results were published in </FONT><FONT SIZE=2><I>Gastroenterology</I></FONT><FONT SIZE=2> in 2016. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Safety Results  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Periodic safety reviews were conducted throughout the Phase&nbsp;2b clinical trial by the DSMB. These reviews did not generate any comments or
additional requests highlighting the overall safety profile of elafibranor. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the GOLDEN-505 trial, elafibranor was well tolerated at both dose levels. Over the 52-week treatment period, frequency of adverse events, or AEs, were similar between the treatment
groups, including placebo, and the majority of the AEs were mild in intensity. During the trial, 4 patients in the elafibranor groups experienced possibly treatment related SAEs. In the elafibranor
80mg group, three SAEs occured in one patient experiencing ataxia, fasciulation and tremor on the same day. A second patient, who had a preexisting risk profile for miscarriage, experienced a
spontaneous abortion. In the elafibranor 120 mg group, one patient experienced mild acute pancreatitis. This patient had a historical cholecystectomy, was suspected of related biliary pancreatitis at
the time of the adverse event, suffered from numerous concurrent conditions and was on confounding concurrent medications. A second patient was diagnosed with Parkinson's disease, deemed possibly
treatment related by the investigator, although it was deemed not treatment related by the sponsor due to risk factors such as patient's age&nbsp;(76), sex (male) and family history of tremors
(patient's father). Additionally, four patients in the placebo group experienced possibly treatment related SAEs (renal cancer, breast cancer, bladder cancer and pancreatic cancer). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, there were no cardiac events, signals on cancer or deaths in the elafibranor treatment groups. Body weight remained stable. A statistically significant mild increase in
creatinine of approximately five percent was observed in the elafibranor treatment group. An increase in creatinine </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>110</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=115,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=347048,FOLIO='110',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_111"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>is
a known and generally reversible effect of elafibranor and other PPAR agonists, like fenofibrate, which has been on the market for decades. Several long-term studies with fenofibrate (DAIS, FIELD,
ACCORD) have shown the preservation of renal function. This was illustrated by the rapid reversal of the observed increase in creatinine upon stopping treatment, which, even after several years of
treatment, decreased to levels below those observed in the placebo groups, which is indicative of a renoprotective effect of PPAR agonist treatment. The most common adverse events were of
gastrointestinal nature and of mild intensity, such as abdominal pain, transit disorders, nausea and vomiting, were similar between treatment groups. No safety concerns of elafibranor emerged from
this trial. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Prior Clinical Trials and Preclinical Studies  </I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


</I></FONT><FONT SIZE=2><U>Phase 2a Clinical Trials</U> </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have also completed five Phase&nbsp;2a clinical trials which were exploratory in nature to assess safety, type of efficacy and magnitude of efficacy of elafibranor
in patients suffering from specific cardiometabolic disorders also frequently observed in NASH patients. These trials, involving an aggregate of 297 randomized patients assessed a variety of endpoints
not specifically related to efficacy in NASH. However, we believe the results provided a scientific and clinical rationale for positioning of elafibranor as a suitable NASH therapeutic through our
observations of:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> reduced markers of liver injury; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> reduced markers of inflammation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> improved glucose metabolism and insulin sensitivity; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> improved levels of plasma lipids and lipoproteins. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
all five Phase&nbsp;2a clinical trials, we observed a favorable tolerability profile and did not demonstrate any safety concerns of elafibranor. Below are summaries of these five
Phase 2a clinical trials. </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-207-1 was a Phase&nbsp;2a, randomized, placebo-controlled, double-blind, two-parallel group clinical trial in patients presenting with
Frederickson Type&nbsp;IIB dyslipidemia (high triglycerides and low HDL-cholesterol). In this trial, we evaluated a once-daily oral treatment of elafibranor 30 mg in 24 patients compared to a
placebo group of 13 patients over the course of 28&nbsp;days. We evaluated reduction in serum triglycerides and increases in HDL-cholesterol levels, as well as improvements in other related lipid
markers. We observed that patients in the elafibranor treatment group experienced a decrease in triglycerides of 8.72%, an increase in HDL-cholesterol of 5.35%, a decrease in non-HDL-cholesterol of
4.65% and a decrease in LDL-cholesterol of 4.28%, each as compared to placebo. We also observed favorable trends in corresponding apolipoproteins, which are proteins that bind lipids to form
lipoproteins. In the patients treated with elafibranor 30 mg, we observed good tolerability. No SAEs were reported and no subjects withdrew from the trial. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-208-3 was a Phase&nbsp;2a, randomized, placebo-controlled, double-blind, two-parallel group clinical trial in patients with
atherogenic dyslipidemia (high triglycerides and low HDL-cholesterol). In this trial, we evaluated a once-daily oral treatment of elafibranor 80 mg in 63 patients compared to a placebo group of 31
patients over the course of 28&nbsp;days. We evaluated reduction in serum triglycerides, increases in HDL-cholesterol levels and improvement in other lipid makers. We observed significant beneficial
effects in the elafibranor group compared to the placebo group, including a reduction in serum triglycerides of 16.67% (p=0.008), an increase in HDL-cholesterol of 7.77% (p=0.004), and statistically
significant reductions in pro-atherogenic lipoproteins, each as compared to placebo. In patients treated with </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>111</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=116,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=747233,FOLIO='111',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_112"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>elafibranor,
we observed good tolerability. No SAEs were reported and no subjects withdraw from the trial due to adverse events. The results of this clinical trial were published in </FONT> <FONT SIZE=2><I>Diabetes Care</I></FONT><FONT SIZE=2> in 2011.
</FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-209-4 was a Phase&nbsp;2a, randomized, placebo-controlled, double-blind, two-parallel group clinical trial in patients with abdominal
obesity and presenting with impaired fasting glucose and/or impaired glucose tolerance. In this trial, we evaluated a once-daily oral treatment of elafibranor 80 mg in 23 patients compared to a
placebo group of 24 patients over the course of 35&nbsp;days. We evaluated improvement in markers of glucose metabolism and lipid profile. We observed significant beneficial effects in the
elafibranor group compared to the placebo group on changes in glucose homeostasis, including a reduction in fasting insulin of 24.8% (p=0.005), a reduction in fasting plasma glucose of 5.2% (p=0.01)
and a reduction on the insulin resistance index of 31.4% (p=0.001). With respect to changes in plasma lipids and associated proteins, patients in the elafibranor group experienced significant
improvements over placebo, including a decrease in triglycerides of 24.8% (p&#60;0.001), an increase in HDL-cholesterol of 9.3% (p=0.009), a decrease in non-HDL-cholesterol of 13.3%
(p&#60;0.001), a decrease in total cholesterol of 8.7% (p&#60;0.001) and statistically significant decreases in corresponding apolipoproteins. Additionally, in the elafibranor
group we observed significant impact on markers of liver injury and inflammation compared to placebo, including a decrease in GGT of 15.1% (p=0.004), a decrease in ALP of 24.5%
(p&#60;0.001), a decrease in fibrinogen of 10.0% (p=0.01) and a decrease in haptoglobin of 15.8% (p=0.008). In patients treated with elafibranor, we observed good tolerability. There was
one SAE in the elafibranor group that was deemed to be unrelated to treatment. No adverse events led to discontinuation of elafibranor treatment. The results of this clinical trial were published in </FONT> <FONT SIZE=2><I>Diabetes
Care</I></FONT><FONT SIZE=2> in 2011. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-210-5 was a Phase&nbsp;2a, randomized, placebo-controlled, double-blind, two-parallel group clinical trial in drug-naive patients with
type&nbsp;2 diabetes. In this trial, we evaluated the efficacy of once daily oral treatment of elafibranor 80 mg in 50 patients compared to a placebo group of 47 patients over a period of
12&nbsp;weeks. We evaluated changes in HbA1c, fasting glucose, fasting insulin, HOMA-IR and other parameters measured during an oral glucose tolerance test. Patients in the elafibranor group
experienced significant improvements from baseline, including a decrease in HbA1c of 0.31% (p=0.01). Patients experienced a decrease in fasting insulin of 2.02 mlU/L and a decrease in the HOMA-IR
score of 1.10. In the elafibranor treatment group, but not in the placebo group, parameters derived from the oral glucose tolerance test were also significantly improved compared to baseline, like
glucose AUC of &#150;42.5 mg/dL (p=0.001) and a decrease in insulin AUC of 10.5 mlU/L (p=0.009) and a decrease in free fatty acid AUC of 0.17 mmol/L h (p&#60;0.001), but not in
the placebo group. Favorable trends persisted when comparing these glucose homeostasis marker changes between the two groups but were not statistically significant. Highly significant improvements
over placebo were obtained on plasma lipids including a decrease in triglycerides of 0.60 mmol/L (p&#60;0.001), a decrease in LDL-cholesterol of 0.37&nbsp;mmol/L (p=0.002), a decrease in
total cholesterol of 0.47 mmol/L (p=0.001), a decrease in non-HDL-cholesterol of 0.53 mmol/L (p&#60;0.001), and decreases in corresponding apolipoproteins (p&#60;0.001). Finally,
significant effects could be seen over placebo on inflammatory markers like HsCRP (p=0.004), haptoglobin (p&#60;0.0001), and on liver markers GGT (p&#60;0.001) and ALP
(p&#60;0.001). In the trial, one patient experienced four SAEs deemed unrelated to treatment leading to premature treatment discontinuation. Another patient experienced an AE of mild to
moderate intensity, which was judged not related to treatment with elafibranor, led to study drug discontinuation. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-210-6 was a randomized, single-blind, placebo-controlled, crossover clinical trial in 22 male patients with insulin resistance and
abdominal obesity. In this trial, we evaluated the efficacy of once daily oral treatment of elafibranor 80 mg over the course of eight weeks on </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>112</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=117,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=143459,FOLIO='112',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_113"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>insulin
resistance using the hyperinsulinemic euglycemic glucose clamp procedure. This gold-standard technique allows assessment of the hepatic response to low dose of insulin and peripheral tissues
response to high dose of insulin. In patients treated with elafibranor, we observed significantly improved hepatic response to a low dose of insulin compared to placebo. Similarly, the response of
peripheral tissues was significantly increased compared to placebo. In addition, compared to placebo, patients treated with elafibranor experienced a significantly improved plasma lipid profile,
including a decrease in serum triglycerides of 21% (p=0.003), a decrease in total cholesterol of 9.2% (p=0.004), a decrease in LDL-cholesterol of 13.2% (p=0.001) and statistically significant
decreases in corresponding apolipoproteins. In addition, patients treated with elafibranor showed improvement in inflammation markers such as haptoglobin or fibrinogen and liver markers such as ALT
(&#150;20%, p=0.004), GGT (&#150;30.4%, p=0.003) or ALP (&#150;19.3%, p&#60;0.001). In patients treated with elafibranor, we observed good tolerability. No
SAEs related to treatment with elafibranor occurred and no AE led to discontinuation of elafibranor treatment. The results of this clinical trial were published in </FONT><FONT SIZE=2><I>Diabetes
Care</I></FONT><FONT SIZE=2> in 2013. </FONT></P>

</UL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Most
of these Phase&nbsp;2a clinical trial results have been reported in two publications in a peer-reviewed journal, </FONT><FONT SIZE=2><I>Diabetes Care</I></FONT><FONT SIZE=2>.
Notably, in a trial using the gold standard method for measuring sensitivity to insulin, we showed that in patients with insulin resistance, elafibranor was able to increase insulin sensitivity of the
liver and muscles. Knowing the essential role of insulin resistance in development of NASH, this Phase&nbsp;2a trial was decisive for the decision to launch a biopsy-based Phase&nbsp;2b trial in
NASH patients. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


 </I></FONT><FONT SIZE=2><U>Phase 1 Clinical Trials</U> </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
date, the elafibranor Phase&nbsp;1 program to assess the safety and tolerability as well as pharmacokinetic profile of elafibranor comprises 12 clinical trials
performed in single Phase&nbsp;1 clinical research centers. This Phase&nbsp;1 program has included a total of over 600 volunteers including more than 500 healthy lean subjects, 60 healthy
overweight or obese subjects and 12 subjects with type&nbsp;2
diabetes. Among them, more than 400 were included in elafibranor treated groups and more than 150 in placebo or comparator treated groups. Below is a brief summary of these Phase&nbsp;1 clinical
trials:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-106-1 was a placebo-controlled trial conducted in a total of 56 healthy volunteers (44 subjects in the elafibranor treatment group and
12 subjects in the placebo group) to assess the safety and the pharmacokinetic profile of elafibranor after single administrations at ascending doses of 10, 20, 30, 50 and 70 mg under fasting and fed
conditions. No subject withdrew from the trial and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-106-2 was conducted in a total of 48 healthy volunteers (36 patients in the elafibranor treatment group and 12 patients in the placebo
group) to assess the safety and pharmacokinetic profile of elafibranor after repeated administration for 14&nbsp;days at ascending doses of 5, 10, 20 and 30 mg. No subject withdrew from the trial
and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-108-3 was conducted in a total of 12 healthy volunteers, all treated with elafibranor, to compare safety and pharmacokinetics of two
different formulations after single administration at 10 mg. No subject withdrew from the trial and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-108-4 was a placebo-controlled trial conducted in a total of 64 healthy volunteers (48 subjects in the elafibranor treatment group and
16 subjects in the placebo group) to assess the safety and pharmacokinetic profile of elafibranor after single administration of ascending doses of 100 and 120 mg and after repeated administration of
ascending doses of 40, 60, 80 and 100&nbsp;mg for 14&nbsp;days. No subject withdrew from the trial. One SAE was reported at the 120 mg dose level but was not deemed related to elafibranor. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>113</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=118,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=583102,FOLIO='113',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_114"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-109-5 was an open label trial conducted in a total of 28 healthy volunteers, all treated with elafibranor, to assess potential drug-drug
interaction between elafibranor at 80 mg for 14&nbsp;days with simvastatin at 20 mg. One non-treatment related AE led to discontinuation and one non-treatment related SAE occurred prior to any
administration of elafibranor. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-109-6 was conducted in a total of 30 healthy volunteers (20 subjects in the elafibranor treatment group and 10 subjects in the
comparator group) to assess potential drug-drug pharmacodynamic interaction between repeated administration of elafibranor at 100 mg for 14&nbsp;days and single administration of sitagliptin at the
end of the treatment period. No subject withdrew from the trial and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-111-7 was conducted in 24 healthy subjects, all treated with elafibranor, and in 60 overweight/obese subjects (45 subjects treated with
elafibranor and 15 subjects in the placebo group) and in 12 type&nbsp;2 diabetic subjects (9 subjects treated with elafibranor and 3 subjects in the placebo group). Our objectives in this trial were
to (i)&nbsp;compare pharmacokinetic profile of two formulations of elafibranor at 120 mg after single administration in male and female healthy lean volunteers (open label phase), (ii)&nbsp;to
assess safety and tolerability and pharmacokinetic profile of single administration of ascending doses of 180, 240 and 300 mg in overweight/obese otherwise healthy volunteers (double-blind, placebo
controlled); (iii)&nbsp;to assess safety and tolerability and pharmacokinetic profile of repeated administration for 14&nbsp;days of ascending doses of 120, 180 and 240 mg in overweight/obese
otherwise healthy volunteers (double-blind, placebo controlled); and (iv)&nbsp;to assess safety and tolerability after multiple oral doses in patients with Type 2 diabetes. No subject withdrew from
the trial and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-112-8 was an open label trial conducted in a total of 19 healthy volunteers, all treated with elafibranor, to assess potential drug-drug
interaction between elafibranor at 120 mg for 13&nbsp;days with Warfarin 15 mg. No subject withdrew from the trial and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-113-9 was a double-blind trial conducted in a total of 176 healthy volunteers (89 subjects in the elafibranor group, 42 subjects in the
placebo group and 45 subjects in the positive control group) to assess the effects of repeated administration for 14&nbsp;days of elafibranor at 120mg and 300 mg on QT/QTc interval. No subject
withdrew from the trial and no SAEs were reported. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-114-10 was an open label trial conducted in 6 healthy volunteers, all treated with elafibranor, to assess excretion balance and
metabolic profile of elafibranor after single administration of 14C-labelled elafibranor at 120 mg. No subject withdrew from the trial and no SAEs were reported. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-115-11 was an open label trial conducted in a total of 25 healthy volunteers, all treated with elafibranor, to assess potential
drug-drug interaction between elafibranor at 180 mg for 14&nbsp;days with atorvastatin 40 mg. No subject withdrew from the trial and no SAEs were reported. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> GFT505-115-12 was an open label trial conducted in a total of 25 healthy volunteers, all treated with elafibranor, to assess dose linearity of
pharmacokinetic parameters after single administration of elafibranor (120, 180 and 240 mg) and time dependency of pharmacokinetic parameters and repeated administration of elafibranor for
16&nbsp;days. Eight subjects withdrew from the trial due to AEs and no SAEs were reported. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
date, we believe that the results from our Phase&nbsp;1 program of elafibranor support a favorable tolerability profile up to 300 mg (which is 3-4 times higher than expected
therapeutic doses of 80 mg/day and 120 mg/day), both under fed and fasting conditions, either after single administration or after repeated administration for at least 14&nbsp;days (from 10 mg/day
to 300 mg/day) in healthy, overweight/obese or diabetic volunteers. In this range of doses, no SAE related to elafibranor was reported. None of these Phase&nbsp;1 trials revealed any serious safety
signals and, notably, a 14-day regulatory cardiac </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>114</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=119,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=507598,FOLIO='114',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_115"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>safety
study did not reveal an effect on QT/QTc, which is a measure of cardiac safety risk, at the high dose of 300 mg per day. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adverse
events were all of mild to moderate intensity with no apparent imbalance over placebo or comparator groups. Most of them resolved before study end. They consisted mainly of
gastrointestinal disorders (diarrhea, abdominal pain, flatulence, constipation, vomiting, dyspepsia). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
no clinically relevant changes were detected in biochemical and hematological parameters, vital signs (including arterial pressure) or electrocardiogram. There was no
evidence of dose-related clinically potentially significant abnormalities (CPSA) and/or clinically potentially significant changes (CPSC). </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


 </I></FONT><FONT SIZE=2><U>Animal Models and Toxicology Studies</U> </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several
animal models have been used to assess efficacy of elafibranor on NASH resolution, liver fibrosis and comorbidities like dyslipidemia, type&nbsp;2 diabetes or
atherosclerosis. Results have been published in peer-review journals, including </FONT><FONT SIZE=2><I>Hepatology</I></FONT><FONT SIZE=2>, and/or presented at multiple international scientific
meetings. Recently, we observed elafibranor's effect on liver cancer prevention and development in two mouse models. In the first mouse model, the effect of elafibranor was evaluated in mice that had
been fed a diet that induced NASH and hepatocellular carcinoma, or HCC, referred to as the "CD/FF diet." The mice were divided into three groups: one group of eight mice received a "regular" diet, one
group of seven mice received the CD/FF diet and one group of four mice received the CD/FF diet plus elafibranor at a dose of 30 mg/kg/day. At week 36, all of the mice that had received the CD/FF diet
alone developed NASH and grade 3 fibrosis. In contrast, among the mice that received elafibranor, none developed NASH and all only developed grade 1 fibrosis. At the end of the study, we evaluated
nodules present in the mice. All of the mice in the group that had received the CD/FF diet alone had between six to eight nodules present in their livers. In contrast, nodules were only present in
half of the mice that were administered elafibranor, and even those only had one or two nodules. Liver sections from the mice were analyzed to determine the presence of tumors and whether any tumors
were benign or malignant. In the group that received the CD/FF diet alone, 86% had developed at least one malignant lesion, whereas no tumor lesions&#151;malignant or benign&#151;were
observed in the group that received elafibranor. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the second mouse model, NASH and HCC were induced in mice through administration of the CD/FF diet for 19&nbsp;weeks, following DEN (carcinogen) injection at 14&nbsp;days post
partum. The mice were divided into two groups&#151;one group of six mice received the CD/FF diet alone and one group of seven mice received the CD/FF diet and, only for the last eight weeks of
treatment, began to receive elafibranor at a dose of 30 mg/kg/day, once histological NASH lesions had already developed. A group of three mice that received a "regular" diet and no DEN injection was
kept as comparator. Liver sections from the mice were analyzed to determine the presence of tumors and whether any tumors were benign or malignant. In the group that had received the CD/FF diet alone,
half developed at least one HCC lesion. In contrast, in the group that received elafibranor for the last eight weeks of treatment, only 28% developed at least one HCC lesion. None of the mice on the
"regular" diet had benign or malignant lesions. Also in this study, we measured the concentration of alpha fetoprotein, or AFP, a commonly used cancer marker, in the mice serum. In the group that had
received the CD/FF diet alone, AFP serum concentration was significantly increased compared to that seen in healthy mice, whereas in the group that received elafibranor, AFP serum concentration was
reduced by 47% as compared to the group receiving CD/FF alone, a result that was statistically significant with a p-value of less than 0.01. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have also evaluated elafibranor in numerous regulatory toxicology studies in animals, with up to two years of treatment in rats and mice and up to one year of high-dose treatment in
monkeys. These studies did not reveal any major signs of toxicity relevant to humans. In all animal studies, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>115</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=120,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=16706,FOLIO='115',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_116"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>elafibranor
did not cause weight gain, peripheral edema or increase heart weight which are side effects typically associated with drugs acting on PPAR<FONT FACE="SYMBOL">g</FONT>. This
confirmed selectivity of elafibranor for the two other forms of PPARs: PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Regulatory Pathway for Treatment of NASH  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In February 2014, the FDA granted fast track designation to elafibranor for the treatment of NASH. If the results of the interim analysis of our
Phase&nbsp;3 clinical trial are positive, we plan to apply for accelerated marketing approval from the FDA under Subpart&nbsp;H and conditional approval from the EMA in 2020. Like all companies
using the Subpart&nbsp;H and conditional approval pathway, we must continue the trial post-marketing in order to demonstrate the efficacy of elafibranor on clinical benefit within the full 2,000
patient population. We will evaluate a composite endpoint of clinical outcomes which include all-cause mortality, the progression to cirrhosis, and a full list of cirrhosis-related events such as
liver transplantation, Model for End-Stage Liver Disease, or MELD score <FONT FACE="SYMBOL">&#179;</FONT>15, and hepatocellular carcinoma, or HCC, on the full trial population, with the
goal of obtaining full marketing approval. The Phase&nbsp;3 trial will remain blinded, and all patients will be maintained under treatment and followed until the occurrence of a pre-defined number
of progressions to clinical outcomes. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pediatric NASH  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As prevalence of obesity in children has increased, NAFLD has become a growing health concern in this population. A study published in 2016
estimates that NAFLD affects approximately 10-20% of the general pediatric population, with approximately 25% of these children
progressing to NASH, and that within the next 10&nbsp;years, pediatric NAFLD is expected to become the most prevalent cause of liver pathology, liver failure and indication for liver transplantation
in childhood and adolescence in the Western world. In the United States, the prevalence of NAFLD in children is estimated to be approximately 10%. Thus, regulatory agencies strongly encourage parallel
development of drugs to treat this specific population. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2016, we initiated the first juvenile toxicology studies of elafibranor in rats as part of our Pediatric Investigation Plan, or PIP, in the treatment of NAFLD/NASH following
agreement on our PIP from the EMA. In January 2018, we received agreement from the FDA on our Pediatric Study Plan, or PSP, after which we announced the official launch of the NASH pediatric program
with elafibranor. We plan to begin enrolling patients in a Phase&nbsp;2 clinical trial in 2019 to evaluate the pharmacokinetic and pharmacodynamic properties of elafibranor in children. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NASH Combination Therapies with Elafibranor  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH is a complex and multifaceted disease and several drug classes with complementary mechanisms of action may be required for optimal
management of NASH, liver fibrosis and comorbidities. Therefore, there is an increasing need for therapies based on drug combinations. To address this need, we are also evaluating combination therapy
approaches combining elafibranor with molecules being developed in our other programs, molecules already marketed in other indications and certain molecules currently being developed by others for the
treatment of NASH, with the goal of treating the largest possible number of NASH patients. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the International Liver Congress in Amsterdam in 2017, we presented data on the therapeutic complementarity of elafibranor and an FXR agonist illustrating the potential for new
combination treatments with elafibranor for the optimal care of NASH patients. We evaluated elafibranor in combination with obeticholic acid, or OCA, an FXR agonist, in a preclinical rat model. In
this study, a total of 90 rats were divided into several groups of 10, with a control group receiving a "normal" diet and the rest receiving a CDAA/c diet. Of the rats receiving the CDAA/c diet
designed to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>116</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=121,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=604814,FOLIO='116',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_117"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>induce
fibrosis, mice received either elafibranor alone (in doses of either 1, 3 or 10 mg/kg/day), OCA (in doses of either 10 or 30 mg/kg/day) or a combination of one of the three elafibranor doses
plus OCA 10 mg/kg/day. At the end of the 12-week study period, the rat livers were analyzed for levels of liver fibrosis and hepatic collagen, a biochemical measure of fibrosis. Notably, significant
reduction in fibrosis was observed in all rats that were given elafibranor of any dose level. In contrast, a significant
reduction in fibrosis was only achieved by the rats receiving OCA at the higher 30 mg/kg/day dose level. In this study we observed a synergistic effect of elafibranor and OCA on fibrosis in the rats
receiving combination therapy even at the low doses of elafibranor. Fibrosis was reduced by 71% and 81% in the groups receiving elafibranor 1 mg/kg/day plus OCA 10 mg/kg/day and elafibranor
3&nbsp;mg/kg/day plus OCA 10 mg/kg/day, respectively. Rats administered with combination therapy also had significant decreases in hepatic collagen compared to decreases observed in the mice
receiving only elafibranor or OCA alone. We believe this synergistic effect, even at submaximal doses, supports the potential of our combination therapy approach. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
April 2018, we presented data at the European Association for the Study of the Liver, or EASL, International Liver Congress from studies of combination therapy with elafibranor in
which NTZ had a synergistic effect in primary human stellate cells and in a model of NASH with fibrosis. In this mouse model, a total of 39 mice were divided into five groups&#151;one group of
4 mice received a "normal" diet, one group of 12 mice received only a diet designed to promote lipid accumulation and result in liver fibrosis, referred to as a CDAA/c diet, one group of eight mice
received the CDAA/c diet plus elafibranor 1 mg/kg/day, one group of eight mice received the CDAA/c diet plus NTZ 100 mg/kg/day and the final group of seven mice received the CDAA/c diet plus
elafibranor 1 mg/kg/day plus NTZ 100 mg/kg/day. At the end of the 12-week study period, the mice livers were analyzed for levels of liver fibrosis and hepatic collagen. The mice in the combination
therapy group experienced a statistically significant attenuation of liver fibrosis of 52% (range of 25% to 63%), compared to 36% in the group receiving only elafibranor (range of 18% to 47%) and 27%
in the group receiving only NTZ (range of &#150;4% to 53%), each as compared to the CDAA/c only group. Similarly, in the combination therapy group, hepatic collagen was reduced by 41%
(ranging from 26% to 56%), compared to 22% in the group receiving only elafibranor (ranging from 11% to 33%) and 23% in the group receiving only NTZ (ranging from 13% to 34%), each as compared to the
CDAA/c only group. Altogether, these findings indicate that NTZ may be a good candidate for a NASH combination therapy with elafibranor, thus establishing the rationale for proof-of-concept studies in
patients with NASH and advanced fibrosis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finally,
at the annual meeting of the AASLD in San Francisco in November 2018, we presented new data on anti-NASH treatment combinations, using elafibranor as backbone, in </FONT> <FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> and </FONT><FONT SIZE=2><I>in
vivo</I></FONT><FONT SIZE=2> NASH models, associating it with an ACC inhibitor. In this study, mice were divided
into five groups&#151;one group of four mice received a "normal" diet, one group of 12 mice received the CD/FF diet alone, one group of eight mice received the CD/FF diet plus elafibranor
1&nbsp;mg/kg/day, one group of eight mice received the CD/FF diet plus GS-0976, an ACC inhibitor product candidate being developed by Gilead Sciences,&nbsp;Inc., at 10 mg/kg/day and the final
group received the CD/FF diet plus elafibranor 1&nbsp;mg/kg/day plus GS-0976 at a dose of 10 mg/kg/day. At the end of the eight-week study, the mice livers were analyzed for NAS and levels of
hepatic triglycerides, an indicator of advancing liver disease. As compared to the group that received only the CD/FF diet, the groups receiving either elafibranor or GS-0976 alone showed subtle and
non-significant decreases in NAS (3% and 9%, respectively) and hepatic triglycerides (6% and 2%, respectively). However, the group of mice that received the CD/FF diet and the combined therapy of
elafibranor and GS-0976 showed statistically significant (p&#60;0.05) decreases in both NAS (33%) and hepatic triglycerides (64%). These results suggest the potential of elafibranor, in
combination with an ACC inhibitor, in reducing liver fat. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>117</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=122,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=134052,FOLIO='117',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_118"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


IVD Test for the Diagnosis of NASH  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As part of our strategy to address the unmet needs in NASH, we have advanced a diagnostic program based on the in-house discovery that specific
microRNA, or miRNA, which are short non-coding RNA molecules that are master regulators of many biological processes, are expressed at different levels in patients with NASH. This discovery kicked off
a multi-year effort that has resulted in the development of what we target to be the first validated diagnostic test to identify patients with NASH who may be appropriate candidates for treatment. In
January 2019, we entered into a license agreement with LabCorp to allow them to deploy our IVD test in the clinical research space. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Circulating Biomarkers and miRNA  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biomarkers are characteristics of the body that can be objectively measured and correlate to a biological state or condition. Circulating
biomarkers are biological molecules, such as proteins, DNA or RNA, found in body fluids such as cerebrospinal fluid, blood or urine that modulate with disease. A single circulating biomarker or a
panel of different markers can be used to not only identify but also monitor the evolution of disease. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MicroRNAs,
or miRNAs, represent a class of small non-coding RNA whose principal function is the regulation of the expression of target genes by acting on the stability and the
translation of their messenger RNA, or mRNA. miRNAs play an essential role in many cell functions, such as development, proliferation, differentiation, cell-cycle arrest and apoptosis, or cell death.
Multiple studies have shown a close association between circulating levels of miRNA and the development and progression of several cancers and have highlighted an important role for miRNAs in the
regulation of human liver development and pathophysiology. Because miRNAs are released from cells in response to stress, they can be detected in most biological fluids, including blood. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
our inception, we have developed a recognized expertise in transcriptomics, which is the study of the RNA transcripts in cells. We initially focused this expertise on mRNA and have
expanded in recent years to the study of specific miRNAs. We have developed methods for the extraction and rapid and
reliable measurement of miRNA in samples of blood, serum or plasma. In our miRNA biomarker research program, we use advanced technologies, such as next generation sequencing, or NGS, which allows us
to perform sequencing of millions of small fragments of DNA in parallel. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Today's Challenges in Diagnosing NASH  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NASH is a silent, asymptomatic disease. Patients with NASH are often unaware of their disease until their condition progresses to more serious
and life-threatening stages. The identification of patients with NASH and early fibrosis is a key area of major unmet need since medical intervention at this stage can help prevent or attenuate
adverse clinical outcomes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
liver biopsy is the clinical standard to formally diagnose NASH and assess the stage of fibrosis in a patient suspected of having NASH. However, the liver biopsy is an invasive
procedure that presents a number of limitations, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> pain, discomfort and bleeding; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> potential mortality; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> high cost; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> low levels of patient acceptance. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, there are a limited number of specialists who are able to perform and interpret liver biopsies when considering the anticipated increase in clinical cases over the next
10&nbsp;years. Furthermore, there are roughly 1,000 to 2,000 practicing hepatologists in the United States, which limits the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>118</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=123,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=987202,FOLIO='118',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_119"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>availability
of the liver biopsy procedure to adequately diagnose these patients. As such there is a clear unmet need and market opportunity for the development of non-invasive diagnostics in NASH. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
FDA-cleared diagnostic tests indicated for NASH exist and the currently available diagnostics are either general tools for the management of chronic liver disease patients, such as
FibroScan or Magnetic Resonance Elastography, or are not widely accessible, such as MRI-based technologies. The following table depicts some of the currently available diagnostic approaches for NAFLD
and liver fibrosis, including their benefits and limitations: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=1><B>NAFLD</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><B> Liver Fibrosis</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:24pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=1> </font> <font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:42pt;"><font size=1></FONT><FONT
SIZE=1><B>Ultrasound</B></FONT><FONT SIZE=1></font> <p align=left style="font-family:times;margin-top:0pt;margin-left:0pt;"> <font size=1> </FONT><FONT SIZE=1> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1>
&#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Adequate for detection of fatty liver in patients at risk of NAFLD </FONT><FONT SIZE=1> </font> <p align=left
style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Low accuracy for mild steatosis </FONT><FONT SIZE=1>  </font> <p
align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Low cost and wide availability </FONT><FONT SIZE=1>
</font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:24pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:42pt;"><font size=1></FONT><FONT SIZE=1><B>MRI</B></FONT><FONT SIZE=1> </font> <p
align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>High performance in detecting low grade of steatosis
</FONT><FONT SIZE=1> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Low availability, high
costs and long exam time, potentially limiting use in daily medical practice</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:24pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=1> </font> <font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:42pt;"><font size=1></FONT><FONT SIZE=1><B>Ultrasound
Elastography (Fibroscan, ElastQ)</B></FONT><FONT SIZE=1></font> <p align=left style="font-family:times;margin-top:0pt;margin-left:0pt;"> <font size=1> </FONT><FONT SIZE=1> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1>
&#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Diagnostic performances for F3 and F4 are good but limited when F&#60;3 </FONT><FONT SIZE=1> </font> <p align=left
style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Limited to specialist's office </FONT><FONT SIZE=1>  </font> <p
align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:24pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:42pt;"><font size=1></FONT><FONT SIZE=1><B>MRE</B></FONT><FONT SIZE=1> </font> <p align=left
style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Potential for detecting F&#60;3 </FONT><FONT SIZE=1> </font> <p
align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Low availability, high costs, long exam time </FONT><FONT
SIZE=1> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:24pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:42pt;"><font size=1></FONT><FONT SIZE=1><B>Fibrosis scores (NASH FibroSure and
equivalent scores)</B></FONT><FONT SIZE=1> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT
SIZE=1>Diagnostic performances are good for F3 and F4 but degrade when F&#60;3 </FONT><FONT SIZE=1> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-10pt;margin-left:41pt;"><font size=1> &#149;</font></p> <p align=left
style="font-family:times;margin-top:0pt;margin-left:59pt;"><font size=1></FONT><FONT SIZE=1>Not validated in large cohorts of NAFLD/NASH patients in intended use NAFLD</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Therefore,
there is a high unmet need for a validated, highly-specific test to identify patients with NASH and fibrosis as an alternative to the liver biopsy for use in the clinical
research and clinical care settings. We believe our diagnostic test, if validated and approved for marketing, may directly address this clinical gap. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Solution: IVD Test Based on Our Biomarker Algorithm  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aware of the challenges associated with diagnosing NASH, we initiated a program to combine our technical expertise in informatics, machine
learning and next-generation sequencing with access to our extensive NASH clinical biobank, including cohorts from our GOLDEN-505 and RESOLVE-IT clinical trials, in addition to cohorts from academic
partnerships, to pursue the discovery of novel biomarkers that may hold the key in developing a novel diagnostic test in NASH. In 2015, we reached a key milestone with the discovery that two miRNA
biomarkers, miR-200a and miR-34a, were differentially expressed in patients with NASH and early fibrosis. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
then, we have further refined the diagnostic test and have ultimately found four unique biomarkers that we believe provide the best overall diagnostic performance:
alpha-2-macroglobulin, chitinase-3-like protein 1, hemoglobin A1c, and microRNA-34a. Our diagnostic test combines the results from these four independent assays through a single proprietary algorithm,
referred to as NIS4, to assist in identifying patients with both NASH and significant fibrosis who should be considered for therapeutic intervention with elafibranor or any other suitable therapeutic.
We intend to market our IVD test, if it receives marketing authorization, as a standalone diagnostic with the potential to enable a non-invasive, accessible and validated alternative to the liver
biopsy to benefit patients, improve overall clinical care and greatly reduce barriers to entry for innovative therapies like elafibranor. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Using
data from our elafibranor development program, we have assessed the predictive value of our IVD test in samples from 687 patients, representing a merged cohort comprising 220
patients from our GOLDEN-505 Phase&nbsp;2b clinical trial and the first 467 patients screened in our RESOLVE-IT Phase&nbsp;3 clinical trial. In testing our IVD test, we utilized the initial liver
biopsy and blood sample from each patient. We compared the results of our IVD test on the blood sample to the patient's initial liver biopsy to evaluate whether our IVD test was an accurate predictor
of the patient's levels of NASH and fibrosis. We tested our IVD test's ability to sort patients with NAS<FONT FACE="SYMBOL">&#179;</FONT>4 and
F<FONT FACE="SYMBOL">&#179;</FONT>2 from patients with </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>119</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=14,SEQ=124,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=562476,FOLIO='119',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_120"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>NAS&#60;4
or F&#60;2 in this cohort of prospectively enrolled patients suspected of NASH. This was determined using the AUROC, or Area Under Receiver Operating Characteristic,
curve, a type of analysis that gives an overall performance metric of a diagnostic test based on its ability to correctly identify those with the disease, or sensitivity, and its ability to correctly
rule out those without the disease, or specificity. The AUROC is expressed as a ratio of these two measures, with the maximum score being 1.0. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
IVD test outperformed currently available blood-based biomarkers when assessed in a head-to-head comparison from 687 patients with a full set of biochemical parameters. As depicted
in the figure below, our IVD test, labeled as NIS4, achieved an AUROC&nbsp;= 0.83 (95% CI&nbsp;0.7965&nbsp;-&nbsp;0.8557), compared to the following currently available biomarkers: the Fib-4
Index (FIB4), the NAFLD Fibrosis Score (NFS), the Enhanced Liver Fibrosis Score (ELF), the Fatty Liver Index Score (FLI), the BARD Score (BARD), the AST to Platelet Ratio Score (APRI) and the
FibroTest. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g363639.jpg" ALT="GRAPHIC" WIDTH="424" HEIGHT="420">
  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
assessment of the NIS4 IVD test results based on fibrosis stage (F0-F4) or NAS category (0-1, 2-3, 4-5 or &gt;6) revealed significant differences between fibrosis stages
(p&#60;0.0001 for all comparisons) and NAS categories (p&#60;0.01 for all categories). We believe that these observations demonstrate that NIS4, our IVD test, has the potential
to be used in medical practice, as well as in a clinical research setting, to accurately identify patients with NASH (NAS<FONT FACE="SYMBOL">&#179;</FONT>4) and significant fibrosis
(F<FONT FACE="SYMBOL">&#179;</FONT>2). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Regulatory and Commercial Strategy  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We began communications with the FDA in 2017 to discuss potential regulatory pathways for our IVD test. Based on these discussions, we are using
blood samples and liver biopsy results from patients enrolled in our clinical trials of elafibranor conducted to date in order to provide support for the potential validation of our test. By applying
our IVD test to a patient's blood sample, and then comparing the IVD test result to that patient's liver biopsy result, we can assess whether our IVD test is accurate in diagnosing patients with NASH
and significant fibrosis who should be considered for therapeutic intervention. We are currently finalizing the analytical and clinical study designs which are required prior to initiating formal
validation studies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>120</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=15,SEQ=125,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=33804,FOLIO='120',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_121"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2019, we entered into a license agreement with LabCorp for development and deployment in the clinical research space as a laboratory developed test, or LDT. We believe this
agreement will provide expanded access to, and further validation of our IVD test which should be supportive in our plans to seek marketing authorization from the FDA. Initially, we will limit the use
of the LDT for use in clinical research studies. LabCorp will serve as a central lab partner, processing samples and providing test results. LabCorp is permitted and accredited, and will be
responsible for submitting the LDT for any validation that may be required under applicable state and federal laws. We believe that leveraging the capabilities of a large diagnostic company will allow
for early test adoption, result in third-party publications and provide additional evidence of the clinical utility of our IVD test. We plan to use these benefits to further support the next stage of
our commercial strategy, which is to first have the FDA grant our request for marketing of the IVD at a single site and then expand the IVD test to multi-site use through a second marketing
authorization for use in routine clinical care. With the assistance of a partner, we plan to produce IVD test kits and commercialize the kit-based tests in the United States, which is a prerequisite
for enabling our multi-site strategy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
parallel, we are progressing towards submitting a data package to the EMA to enable CE marking and associated marketing approval in key European markets during 2020. In Europe, if
approved, we plan to sell our kit-based IVD tests through a distributor or commercial partner to independent, smaller laboratories, as there are fewer large central laboratories in these regions. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Elafibranor for the Treatment of PBC  </I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


About PBC  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PBC is an autoimmune disease resulting from progressive destruction of the small bile ducts inside the liver. When liver bile ducts are
destroyed, the bile which normally would travel to the small intestines to aid in digestion and elimination of waste instead accumulates in the liver, contributing to inflammation and fibrosis. PBC is
believed to be an autoimmune disease in which a person's immune system is overactive and attacks normal, healthy bile duct cells. The following graphic depicts the distinction between normal bile
ducts and those that have been destroyed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="da10701_primary_biliary_cholangitis"> </A>
<A NAME="toc_da10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Primary Biliary Cholangitis    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g963328.jpg" ALT="GRAPHIC" WIDTH="376" HEIGHT="349">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>121</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=16,SEQ=126,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1029026,FOLIO='121',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_122"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PBC
is a disease with a global prevalence of approximately 40 cases per 100,000. However, that prevalence is increasing; in the United States, the prevalence of PBC increased from 21.7
to 39.2 per 100,000 from 2006 through 2014. Women are much more likely to be affected by PBC than men, and the incidence increases after the age of 50. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
initial symptoms of PBC are general fatigue and pruritus, which is itchy skin; other potentially associated symptoms include dry eyes, dry mouth and jaundice. However, approximately
60% of patients are asymptomatic when the disease is diagnosed. PBC is diagnosed based on blood tests revealing the presence of anti-mitochondrial antibodies, or AMAs, and high levels of the liver
enzyme ALP. Cirrhosis is not generally advanced at the time of PBC diagnosis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Left
untreated, PBC typically leads to cirrhosis, liver failure and the need for liver transplantation. In the absence of treatment, the 10-year survival of asymptomatic patients is
estimated to be between 50 and 70%, with a median survival of 16&nbsp;years. Among symptomatic patients, median survival in the absence of treatment is only seven to eight years. PBC is believed to
be responsible for 2-3% of deaths by cirrhosis. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitations of Current Treatment Options  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is currently no cure for PBC, although there are medications that work to slow its progression. For many years, ursodiol, a drug
containing ursodeoxycholic acid, or UDCA, was the only drug approved by the FDA for the treatment of PBC. UDCA is a naturally occurring bile acid that is normally produced in the liver by healthy
cells. Ursodiol, administered orally, is designed to help move bile through the liver and into the intestines. Although ursodiol is effective in more than 50% of patients, up to 40% of patients do not
respond or respond poorly to treatment and an additional 5-10% of patients are unable to tolerate the drug. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
May 2016, the FDA approved obeticholic acid, marketed as Ocaliva by Intercept Pharmaceuticals,&nbsp;Inc., for the treatment of PBC in combination with UDCA in adults with an
inadequate response to UDCA, or as a single therapy in adults unable to tolerate UDCA. In September 2017, following the death of 19 PBC patients being treated with Ocaliva, the FDA published a safety
announcement for Ocaliva, indicating that some patients with moderate to severe decreases in liver function had been incorrectly dosed, resulting in an increased risk of serious liver injury and
death. The FDA also indicated that Ocaliva may also be associated with liver injury in some patients with mild disease who are receiving the correct dose. In February 2018, the FDA had a Boxed Warning
added to the Ocaliva label, the most severe warning required to be included in labeling by the FDA. Concerns remain over pruritus and serious liver injury or liver death caused by administration of
Ocaliva. In its Phase&nbsp;3 clinical trial, severe pruritus was reported in 23% of patients in the Ocaliva 10 mg dose cohort and in 19% of patients in the Ocaliva titration cohort, in which dosing
was initiated at 5 mg and titrated up to 10 mg based on clinical response, compared to 7% of patients in the placebo group. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accordingly,
we believe there is still a significant medical need for new therapies, as current treatments either are ineffective for a large portion of PBC patients, cause significant
side effects or include safety risks. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Solution: Elafibranor for the Treatment of PBC  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that elafibranor has the potential to offer a therapeutic solution that can be effective in treating PBC while also maintaining a
favorable tolerability profile and lack of demonstrated safety concerns. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Targeting
PPAR receptors has shown multiple beneficial activities, including the reduction of bile acid synthesis, improved detoxification of bile in the bile duct and anti-inflammatory
activity. In third- </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>122</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=17,SEQ=127,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=396188,FOLIO='122',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_123"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>party
clinical trials, drugs targeting PPAR receptors resulted in a significant decrease in ALP and improved biochemical profiles and pruritus in PBC patients. Patients with PBC often have elevated
ALP, and studies have shown a correlation between elevated ALP levels and increased risk of adverse patient outcomes. We have observed elafibranor's effect in lowering ALP levels in our clinical
trials, including our Phase 2 clinical trial in PBC. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Clinical Program for Elafibranor in the Treatment of PBC  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In December 2018, we announced positive preliminary results, including achievement of the primary endpoint and the composite endpoint, from our
Phase&nbsp;2 multi-center, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of elafibranor after 12&nbsp;weeks of treatment in patients with PBC and
inadequate response to UDCA. The trial was conducted at multiple clinical centers in the United States and in three European countries and enrolled a total of 45 patients. The patients were randomized
into one of three treatment arms, receiving either elafibranor 80 mg, elafibranor 120 mg or placebo. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
primary objective of the trial was to determine the effect of daily oral administration of elafibranor on ALP in these patients, based on relative change from baseline serum ALP
levels compared to placebo. In addition to assessing the tolerability and safety of elafibranor in patients with PBC, secondary endpoints included assessment of elafibranor 80 mg and 120 mg as
compared to placebo on several outcome measures, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> composite endpoint composed of ALP and bilirubin, with response defined as (1)&nbsp;ALP less than 1.67 times the upper limit or normal, or
ULN, (2)&nbsp;total bilirubin within normal limits and (3)&nbsp;a reduction of ALP of more than 15%; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> changes in patients' risk scores as measured by several PBC risk scoring systems (Paris I and II, Toronto I and II and UK-PBC); </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> change from baseline in pruritis, as measured by a 5-D itch scale and visual analogue scale; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> change from baseline in quality of life, as measured by PBC-40, a patient-derived questionnaire. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the preliminary results published in December 2018, we observed that the mean decrease in ALP in both of the elafibranor treatment groups showed statistically significant improvement
compared to placebo. In the elafibranor 80 mg and 120 mg treatment groups mean decreases in ALP were 48% (n=15) and 41% (n=14), respectively whereas the mean ALP increased by 3% (n=15) in the placebo
group. When adjusted for placebo, the treatment effect of the elafibranor 80 mg and 120 mg treatment groups was a mean decrease in ALP of 52% (p&#60;0.001) and 44%
(p&#60;0.001), respectively. Based on these results, elafibranor achieved the primary endpoint of the trial with high statistical significance. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elafibranor
also achieved with high statistical significance the composite endpoint of ALP and bilirubin, with response defined as (1)&nbsp;ALP less than 1.67 times the upper limit of
normal, or ULN, (2)&nbsp;total bilirubin within normal limits and (3)&nbsp;a reduction of ALP of more than 15%. The elafibranor 80 mg and
120 mg treatment groups achieved mean response rates of 67% (p=0.001) and 79% (p&#60;0.001), respectively, as compared to 6.7% in the placebo group. This composite endpoint was the primary
endpoint in the Phase&nbsp;3 clinical trial of Ocaliva that led to its FDA marketing approval. In a three-month Phase&nbsp;2 clinical trial of Ocaliva, treatment with Ocaliva 10 mg resulted in a
mean response rate of 23%, compared to a placebo response rate of 10%, on this composite endpoint. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patients
treated with elafibranor showed improvement in other PBC markers such as gamma-glutamyl transferase and metabolic markers such as total cholesterol, low-density lipoprotein-C,
and triglycerides. Improvement in pruritus was observed and will be confirmed in a study of longer duration. Treatment with elafibranor was generally well tolerated, with a similar number of patients
experiencing adverse events in the drug treatment and placebo arms of the trial, with the most common </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>123</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=18,SEQ=128,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=347455,FOLIO='123',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<A NAME="page_da10701_1_124"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>adverse
events being of a gastrointestinal nature and of mild or moderate intensity, and included nausea, fatigue and headache. Two patients experienced serious adverse events, of which only one was
considered as possibly drug-related. The latter patient suffered from two preexisting auto-immune diseases (PBC and myasthenia gravis) and during the trial presented with a third auto-immune disease
(auto-immune hepatitis, or AIH). This diagnosis was made in a patient with poly-auto-immune diseases, and AIH consecutive to PBC or AIH-PBC overlap syndrome are not uncommon, occurring in up to 2.5%
and 14% of PBC patients, respectively. While this factor and/or other concomitant medications could be considered as confounding factors, a causal relationship to study drug could not be excluded. The
other patient experienced an SAE deemed unrelated to treatment with elafibranor and withdrew from the trial after only one daily dose. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on these preliminary results, we plan to advance our PBC program into Phase&nbsp;3 development in 2019. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nitazoxanide Program for the Treatment of Fibrosis  </I></B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


About Fibrosis  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are developing NTZ for the treatment of liver fibrosis. Progressive liver fibrosis can result from chronic liver injury of any etiology,
including viral infection, alcoholic liver disease and NASH. Multiple studies have demonstrated that patients with NASH are at higher risk for adverse liver-related outcomes, with the degree of
fibrosis contributing most significantly to this increased risk. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cirrhosis
is the terminal stage of progressive liver fibrosis, which results in over 1&nbsp;million deaths annually worldwide. Lethal complications of cirrhosis include functional
liver failure, portal hypertension-induced variceal bleeding, ascites, hepatic encephalopathy, systemic bacterial infection and liver cancer, especially HCC. Annual direct and indirect costs for the
care of cirrhosis exceed $12&nbsp;billion in the United States alone, and there is an urgent need for anti-fibrotic drugs to prevent progression towards hepatic decompensation and the associated
morbidity and mortality. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approved
therapies directly targeting and reversing advanced fibrosis are still lacking, but clinical studies have indicated that liver fibrosis and even cirrhosis can be regressed by
therapeutic intervention aimed at the primary disease etiology. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Solution: Repositioning of Nitazoxanide  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The identification of NTZ is the result of our research program designed to discover novel anti-fibrotic molecules with a priority given to
liver fibrosis. Our strategy to target fibrosis is based on the use of a phenotypic screening approach combined with the use of a compound library composed of FDA-approved drugs. The phenotypic method
does not rely on knowledge of the identity of a specific drug target or a hypothesis about its role in a disease, but rather focuses on the modulation of a disease-linked phenotype. In our model, we
evaluated the compounds for their capacity to interfere with the activation of quiescent hepatic stellate cells into myofibroblasts, which are the major fibrogenic cell type in the liver. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
screening of FDA-approved drugs, and investigation of drug candidate profiles in medical literature, we identified NTZ, currently commercialized and prescribed in the United
States and in several other countries as an anti-parasitic, as a potent anti-fibrotic agent that we believe can be repurposed for the treatment of fibrosis. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>124</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=19,SEQ=129,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=555282,FOLIO='124',FILE='DISK124:[18ZFA1.18ZFA10701]DA10701A.;102',USER='JTAYLORA',CD='15-FEB-2019;13:35' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_db10701_1_125"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pre-clinical and Clinical Development Program  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As part of our pre-clinical program, we have studied NTZ in disease models and in human fibroblasts from different organs. Fibroblasts are cells
in connective tissues that, when activated, play a significant role in the development of fibrosis. In April 2017, we presented the results of this research supporting the potential efficacy of NTZ in
two disease models of liver fibrosis at the EASL International Liver Congress. In these two </FONT><FONT SIZE=2><I>in vivo</I></FONT><FONT SIZE=2> models, we observed that administration of NTZ
significantly attenuated liver fibrosis development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have also studied NTZ in two mouse models. In the first mouse model, we observed the effect of NTZ administration on mice that had been exposed to a toxin that causes liver damage and
fibrosis. The mice were divided into four groups&#151;a group of six mice that received a placebo, a group of nine mice that received the toxin alone, a group of 10 mice that received the toxin
plus NTZ at a dose of 32&nbsp;mg/kg/day and a group of 10 mice that received the toxin plus NTZ at a dose of 104
mg/kg/day. After six weeks, we measured fibrosis by percentage of surface area on a slide from tissue that was fibrotic. The cohort that received NTZ 32&nbsp;mg/kg/day had their observed liver
fibrosis as measured by histological evaluation reduced by an average of 30.3% (p&#60;0.001) (ranging from 10% to 53%) and the cohort that received NTZ&nbsp;104&nbsp;mg/kg/day had their
liver fibrosis reduced by an average of 24.7% (p&#60;0.01) (ranging from 1% to 43%), in each case as compared to the cohort that received the toxin alone. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the second mouse model, we observed the effect of NTZ administration on mice that had been fed a CDAA/c diet. The mice were divided into four groups&#151;a group of four mice
that received a "normal" diet as the control group, a group of 12 mice that received the CDAA/c diet alone, a group of eight mice that received the CDAA/c diet plus NTZ at a dose of 26.3 mg/kg/day and
a group of eight mice that received the CDAA/c diet plus NTZ at a dose of 78.1 mg/kg/day. After 12&nbsp;weeks, we measured fibrosis by percentage of surface area on a slide of liver tissue that was
fibrotic. The cohort that received NTZ 26.3 mg/kg/day did not have a statistically significant reduction in liver fibrosis as compared to placebo, but the cohort that received NTZ 78.1 mg/kg/day had
their liver fibrosis reduced by an average of 27.4% (p&#60;0.001) (ranging from &#150;4% to 53%) as compared to placebo. In this same study, we also observed that the cohort that
received NTZ 78.1 mg/kg/day had their liver collagen accumulation reduced by 22.9% (p&#60;0.001) (ranging from 12% to 34%) compared to the placebo group. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2018, we announced the start of an investigator-initiated single-center, open-label trial to evaluate the safety and efficacy of nitazoxanide in patients with NASH-induced
Stage&nbsp;2 or Stage&nbsp;3 fibrosis. The primary objective of the study is to evaluate the safety and tolerability of NTZ in patients with NASH-induced stage 2 or stage 3 fibrosis. Secondary
objectives of this proof-of-concept trial include evaluating the anti-fibrotic effect of NTZ by several approaches, including a method to quantify hepatic fibrogenesis flux rates. Using heavy water
labeling, de novo collagen-associated protein synthesis will be determined through Fractional Synthesis Rate of circulating proteins at baseline and at the end of treatment to assess the effect of
daily oral administration of NTZ. Other non-invasive methods, including MRE and FibroScan, will be used to evaluate the liver stiffness changes after NTZ treatment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


TGFTX1 Program for the Treatment of IL-17-Dependent Autoimmune Diseases  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have designed our TGFTX1 preclinical program to allow us to identify and develop drug candidates for the treatment of certain IL-17-dependent
autoimmune diseases, including psoriasis and certain inflammatory respiratory conditions such as neutrophilic asthma, chronic obstructive pulmonary disease, or COPD, or asthma-COPD overlap syndromes.
Psoriasis is a chronic and debilitating autoimmune disease that affects approximately 125&nbsp;million people globally, or 2 to 3% of the total population, and approximately 80% of psoriasis
patients suffer from a mild-to-moderate form of the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>125</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=130,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=936112,FOLIO='125',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_126"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>disease.
Beyond the physical manifestations, psoriasis can have a significant impact on a patient's quality of life, often with profound psychosocial consequences. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are three major forms of therapy: topical, phototherapy and systemic therapy. The treatment options are based on psoriasis severity. Recent advances in biologic agents have
considerably expanded the treatment options, however, the prices of these newer treatments are higher than traditional systemic medications. Topical therapy remains the standard of care for treatment
of mild-to-moderate disease and the biological agents are typically reserved for the small population of psoriasis patients with the most severe disease. The available topical therapies include the
use of corticosteroids and vitamin D analogues, as monotherapies or in combinations. Although these treatments are still the standard of therapy for mild-to-moderate psoriasis, there are considerable
side effects that have been documented. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IL-17
is produced by inflammatory lymphocytes upon the activation of ROR<FONT FACE="SYMBOL">g</FONT>t, a key transcription factor that controls the function of IL-17-secreting
lymphocytes. Recent data suggest that ROR<FONT FACE="SYMBOL">g</FONT>t inhibition may be a straightforward and efficient way to curb exacerbated immune responses caused by IL17. In our
TGFTX1 program, we have identified novel ROR<FONT FACE="SYMBOL">g</FONT>t antagonists. One of our proprietary molecules is a potent and selective
ROR<FONT FACE="SYMBOL">g</FONT>t antagonist that inhibits IL-17 release from human primary Th17 lymphocytes. This topical drug candidate improved both disease score, as measured by the
Psoriasis Area and Severity Index, or PASI, and skin histology in a mouse model of psoriasis and complies with a target product profile for topically delivered drugs. In this mouse model, we
pre-treated a group of 10&nbsp;mice with TGFTX1 for three days before applying a skin irritant, and treated another group of 10 mice with the skin irritant alone for a period of eight days. We
assessed the severity of inflammation daily and then at the end of the study analyzed the skin samples to evaluate changes in psoriasis using a PASI score and measuring epidermal thickness. The group
of 10&nbsp;mice pre-treated with TGFTX1 had significant decreases in PASI score (40%, p&#60;0.001), epidermal thickness score (41%, p&#60;0.001) and in a direct measure of
epidermal layer thickness (33%, p&#60;0.001), compared to the group of 10&nbsp;mice given the skin irritant alone. We have also completed several regulatory pre-IND studies of this drug
candidate that are required for topically administered agents. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
parallel, we are developing a different ROR<FONT FACE="SYMBOL">g</FONT>t drug candidate to treat certain inflammatory lung conditions, such as severe neutrophilic asthma,
COPD and asthma-COPD overlap syndrome, conditions in which pathologic actions of IL-17 are postulated. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
further these programs, we plan to leverage the expertise of specialized pharmaceutical companies with already established franchises in dermatology and/or respiratory diseases
through collaborations or other strategic alliances that we may enter into in the future. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Competition  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We operate in a highly competitive sector. Several companies are working on technologies, therapeutic targets or drug or biomarker candidates
that aim to treat or diagnose the same diseases or identify the same patient population as our product candidates. While we believe that our drug candidates and diagnostic solutions, combined with our
expertise and know-how, provide us with competitive advantages, we face potential competition from various sources, including pharmaceutical and biotechnology companies, as well as from academic
institutions, governmental agencies and public and private research institutions. We anticipate that we will face intense and increasing competition as new drugs and therapies enter the market and
advanced technologies become available. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NASH  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are currently no approved drugs for the treatment of NASH; however, the NASH market has been attracting increasing interest from larger
pharmaceutical companies over recent years. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>126</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=131,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=473638,FOLIO='126',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_127"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are aware of three other companies that are also in Phase&nbsp;3 development of a drug candidate for the treatment of NASH:</FONT></P>


<UL>
<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Gilead Sciences,&nbsp;Inc., which has an ongoing Phase&nbsp;3 trial of its drug candidate selonsertib targeting fibrosis only in patients
with level F3 fibrosis due to NASH, but which recently announced that in its Phase&nbsp;3 trial of selonsertib, in patients with level F4 fibrosis due to NASH, selonsertib did not meet the
pre-specified week 48 primary endpoint of one stage or greater histologic improvement in fibrosis without worsening of NASH; </FONT><FONT SIZE=2>

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Intercept Pharmaceuticals,&nbsp;Inc., which is in Phase&nbsp;3 development of its drug candidate obeticholic acid, or OCA, an FXR agonist
for the treatment of NASH, that is currently approved for the treatment of PBC under the name Ocaliva; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Allergan&nbsp;plc, following its acquisition of Tobira Therapeutics,&nbsp;Inc., which is developing its drug candidate cenicriviroc for the
treatment of NASH. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also aware of other companies that have drug candidates in earlier stages of development, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Madrigal Pharmaceuticals,&nbsp;Inc., which has completed Phase&nbsp;2 clinical trials of its drug candidate MGL-3196, a thyroid hormone
receptor, or THR, <FONT FACE="SYMBOL">b</FONT>-selective agonist, for the treatment of NASH and which has announced plans to initiate a Phase&nbsp;3 clinical program; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> NGM Biopharmaceuticals, Inc., which is in Phase&nbsp;2 development of its drug candidate NGM282, an engineered variant of the human hormone
known as FGF19 for the treatment of NASH; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Inventiva&nbsp;S.A., which is in Phase&nbsp;2 development of its drug candidate lanifibranor, a drug targeting
PPAR<FONT FACE="SYMBOL">a</FONT>, PPAR<FONT FACE="SYMBOL">d</FONT> and PPAR<FONT FACE="SYMBOL">g</FONT> for the treatment of both NASH and systemic sclerosis; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Novartis AG, which is currently in Phase&nbsp;2 development of its candidate emricasan. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to these drug candidates in development, we also may compete with approved drugs in other indications which could be used off-label for the treatment of NASH. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to our IVD test in development to use blood-based biomarkers to identify patients with NASH who we believe could benefit from treatment with elafibranor, there are a number
of clinical tools available for the management of chronic liver disease patients, but there are no validated diagnostic tests for NASH available on the market today that are an alternative to an
invasive liver biopsy procedure. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


PBC  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UDCA was approved by the FDA to treat PBC in 1997 and remained the only approved treatment for PBC until 2016, when Ocaliva was approved by the
FDA and EMA for the treatment of PBC in combination with UDCA in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA. Although Ocaliva has been the subject
of continued safety concerns with respect to pruritus and serious liver injury or death, leading to the FDA issuing a Boxed Warning in 2018, elafibranor would compete with these drugs already approved
for the treatment of PBC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are aware of other companies developing drug candidates for the treatment of PBC with whom we would also compete, including CymaBay&nbsp;Therapeutics,&nbsp;Inc., Zydus Cadila,
Enanta Pharmaceuticals,&nbsp;Inc. and Eisai&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to these approved drugs and drug candidates in development, we also may compete with approved drugs in other indications which could be used off-label for the treatment of
PBC. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>127</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=132,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=807284,FOLIO='127',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_128"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that elafibranor's differentiated mechanism of action in targeting PPAR<FONT FACE="SYMBOL">a</FONT> and PPAR<FONT FACE="SYMBOL">d</FONT>, the positive
efficacy results from our Phase&nbsp;2b clinical trial in NASH and our Phase 2 clinical trial in PBC and the favorable tolerability profile and demonstrated lack of safety concerns observed to date
in clinical trials together suggest the potential for elafibranor to have competitive advantages over approved drugs and drug candidates in development by our competitors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;However,
many of our competitors, either alone or with their strategic collaborators, have substantially greater financial, technical and human resources than we do. Accordingly, our
competitors may be more successful than we are in obtaining approval for their drug candidates and achieving widespread market acceptance and may render our drug candidates, such as elafibranor,
obsolete or non-competitive. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated among a smaller number of our competitors.
These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical study sites and patient registration for clinical studies, as
well as in acquiring technologies complementary to, or necessary for, our programs. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
anticipate that we will face intense and increasing competition as new drugs and therapies enter the market and advanced technologies become available. We expect any drugs that we
develop and commercialize to compete on the basis of, among other things, efficacy, safety, delivery, price and the availability of reimbursement from government and other third-party payors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
commercial opportunity could be reduced or eliminated if our competitors develop and commercialize drugs that are safer, more effective, have fewer or less severe side effects, are
more convenient or are less expensive or better reimbursed than any drugs that we may commercialize. Our competitors also may obtain FDA, EMA or other regulatory approval for their drugs more rapidly
than we may obtain approval for ours, which could result in our competitors establishing a strong market position for either the product or a specific indication before we are able to enter the
market. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Manufacturing and Supply  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not have any manufacturing facilities or personnel. We currently rely, and expect to continue to rely, on third parties for the
manufacturing of our drug candidates for preclinical and clinical testing, as well as for commercial manufacturing if our drug candidates receive marketing approval. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to our lead drug candidate, elafibranor, we use one supplier for the active ingredient and another manufacturer for the therapeutic units used in our clinical trials.
Although we could use a substitute company in the event of failure or breach of these two manufacturers, we may face challenges in finding new suppliers within an acceptable timeframe or under
commercially reasonable conditions. To mitigate this risk, we have performed an evaluation of the expected elafibranor manufacturing delays and costs in the event of a disaster at the supplier of the
active ingredient or at the manufacturer of therapeutic units. Based on the results of this evaluation, we believe that given the current inventory and drugs in production at various levels of the
production chain, which is sufficient to supply our ongoing clinical trials, the short-term failure of one of these manufacturers would not be critical. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to our IVD test, we have entered into a license agreement with LabCorp to further develop and manufacture the test for clinical research use within IVD regulatory
requirements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Intellectual Property  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our intellectual property is critical to our business, which we strive to protect by obtaining and maintaining patent protection in territories
throughout the world for our drug and biomarker candidates, innovative methods and tools, production methods and other inventions that are important </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>128</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=133,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=50792,FOLIO='128',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_129"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>to
our business. We also rely on trade secrets to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
commercial success depends in part upon obtaining and maintaining patent protection and trade secret protection of our current and future drug and biomarker candidates and the
methods used to develop and manufacture them, as well as successfully defending these patents against third-party challenges. Our ability to stop third parties from making, using, selling, offering
for sale in the United Sates or importing into the United States, our products depends on the extent to which we have rights under valid and enforceable patents or trade secrets that cover these
activities. We cannot guarantee that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we
guarantee that any of our existing patents or any patents that may be granted to us in the future will be commercially useful in protecting our drug and biomarker candidates, discovery programs and
processes from competitors. Furthermore, our patents may be challenged, circumvented, or invalidated by third parties. Because patent applications in
the United States and certain other jurisdictions are maintained in secrecy for 18&nbsp;months or potentially even longer, and since publication of discoveries in the scientific or patent literature
often lags behind actual discoveries, we cannot be certain of the priority of inventions covered by our pending patent applications. For this and more comprehensive risks related to our intellectual
property, please see "Risk Factors&#151;Risks Relating to Our Intellectual Property." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Patents  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of January&nbsp;1, 2019, we own or have rights to 28 issued U.S. patents, over 450 issued foreign patents, and 11 pending U.S.
applications, and over 135 pending foreign patent applications. Our patent portfolio contains 41 different patent families, which are made up of over 600 patents and patents applications. Eighteen of
our patent families relate to our lead product candidate, elafibranor. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Elafibranor  </I></B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our patent portfolio for elafibranor, a molecule synthesized by us, includes issued patents and pending patent applications directed to
compositions of matter, manufacturing methods, and methods of use. As of January&nbsp;1, 2019, we own 3 U.S. patents directed to the composition of matter of elafibranor, which are expected to
expire in 2024, without taking a patent term extension into account. We also have counterpart patents in various countries and regions, including Australia, Brazil, Canada, China, Europe, Israel and
Japan.

 </FONT>

</P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, we own 6 U.S. patents and 1 pending U.S. application directed to the treatment of liver diseases, including NASH, and using elafibranor. The granted patents and the pending
patent applications, if issued, are expected to expire in 2030 and 2031, without taking a patent term extension into account. We also have counterpart patents granted in various countries or regions,
including, Australia, Canada, China, Europe, Israel, and Japan. In addition, we own 1 U.S. patent application directed to the treatment of PBC, which, if issued, is expected to expire in 2037, without
taking a patent term extension into account. We also have counterpart pending patent applications in various countries or regions, including Australia, Canada, Europe, Israel, China, and Japan. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, we own 2 U.S. patents directed to the method of preparing elafibranor, which are expected to expire in 2024 and 2031. We also have counterpart patents granted in various
countries and regions, including Canada, China, Europe, and Israel. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to these patents and pending applications, we are also pursuing additional patents directed to specific forms of elafibranor, and combinations with other pharmaceutical
compounds. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>129</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=134,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=640259,FOLIO='129',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_130"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Diagnostic Tools and Biomarkers  </I></B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of January&nbsp;1, 2019, we own 2 U.S. patent applications and 4 International patent applications designating the United States directed
to the diagnosis of NASH using certain biomarkers. The U.S. application, if issued, would be expected to expire in 2036, and U.S. patent applications based on the corresponding International
applications, if filed and issued, would be expected to expire in 2037-2038.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Programs  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are pursuing patent protection for various molecules developed by our laboratories including molecules in our TGFTX1 program for the
discovery of drug candidates relating to RORyt. In addition, we are pursuing patent protection directed to our repositioning of nitazoxanide for treating cholestatic and fibrotic disease. As of
January&nbsp;1, 2019, 4 U.S. patents have been granted to us for the use of NTZ in the treatment of different fibrotic diseases and 2 U.S. patent applications are pending. These patents and patent
applications, if granted, would be expected to expire in 2037. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Patent Term Extension (PTE)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States, the term of a patent covering an FDA-approved drug may be eligible for a patent term extension (PTE) under the
Hatch-Waxman Act as compensation for the loss of patent term during the FDA regulatory review process. This extended coverage period, PTE, can only be obtained provided we apply for and receive a
marketing authorization for a product. The
period of extension may be up to five years beyond the expiration of the patent, but cannot extend the remaining term of a patent beyond a total of 14&nbsp;years from the date of product approval.
Only one patent among those eligible for an extension may be extended. In Europe, Supplementary Protection Certificates (SPC) may also be available to patents, which would be available by applying to
the member states. However, there is no guarantee that the applicable authorities, including the FDA, will agree with our assessment of whether such extensions should be granted, and even if granted,
the length of such extensions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Know-How and Trade Secrets  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to patent protection, we also rely on trade secret protection of our proprietary information that is not amenable to, or that we do
not consider appropriate for, patent protection. However, trade secrets can be difficult to protect. Although we take steps to protect our proprietary information, including restricting access to our
premises (we seek to preserve the integrity and confidentiality of our data, trade secrets and know-how by maintaining physical security of our premises and physical and electronic security of our
information technology systems) and our confidential information, as well as entering into agreements with our employees, consultants, advisors, and potential collaborators, that prohibit the
disclosure of confidential information, and require disclosure and assignment to us of ideas, developments, discoveries and inventions important to our business. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Government Regulation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our drug candidates must be approved by the FDA through the NDA process before they may be legally marketed in the United States and by the
European Commission following a positive opinion provided by the EMA through the MAA process for a drug falling within the scope of the Centralized procedure or by a national Competent Authority
through other MAA processes (National Procedure, Mutual Recognition or Decentralized procedure) before they may be legally marketed in the European Union. Our drug candidates will be subject to
similar requirements in other countries prior to marketing in those countries. The process of obtaining regulatory approvals and the compliance with applicable federal, state, local and foreign
statutes and regulations require the expenditure of substantial time and financial resources. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>130</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=135,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=531588,FOLIO='130',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_131"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


United States Government Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or the FDCA, and its implementing regulations. The
process of obtaining regulatory approvals and compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial
resources. Failure to comply with the applicable U.S. requirements at any time during the drug development process, approval process or after approval may subject an applicant and/or sponsor to a
variety of administrative or judicial sanctions, including imposition of a clinical hold, refusal by the FDA to approve applications, withdrawal of an approval, import/export delays, issuance of
warning letters and other types of enforcement letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government
contracts, restitution, disgorgement of profits, or civil or criminal investigations and penalties brought by the FDA and the Department of Justice or other governmental entities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
clinical testing, manufacturing, labeling, storage, distribution, record keeping, advertising, promotion, import, export and marketing, among other things, of our drug candidates are
governed by extensive regulation by governmental authorities in the United States and other countries. The FDA, under the FDCA, regulates pharmaceutical products in the United States. The steps
required before a drug may be approved for marketing in the United States generally include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the FDA's good laboratory practice, or
GLP, regulations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the submission to the FDA of an IND application for human clinical testing, which must become effective before human clinical trials commence; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approval by an independent institutional review board, or IRB, representing each clinical site before each clinical trial may be initiated; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the drug for each indication and
conducted in accordance with good clinical practices, or GCP; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> preparation and submission to the FDA of an NDA; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> FDA acceptance, review and approval of the NDA, which might include an Advisory Committee review; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> satisfactory completion of an FDA inspection of the manufacturing facilities at which the drug, or components thereof, are made to assess
compliance with current good manufacturing practices, or cGMPs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> satisfactory completion of FDA audits of clinical trial sites to assure compliance with GCPs and the integrity of the clinical data; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> agreement for compliance with any post-approval requirements, including Risk Evaluation and Mitigation Strategies, or REMS, and post-approval
studies required by the FDA. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
testing and approval process requires substantial time, effort and financial resources, and the receipt and timing of any approval is uncertain. The FDA may suspend clinical trials
at any time on various grounds, including a finding that the subjects or patients are being exposed to an unacceptable health risk. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preclinical and Human Clinical Trials in Support of an NDA  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preclinical studies include laboratory evaluations of the drug candidate, as well as </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2>
and animal studies to assess the potential safety and efficacy of the drug candidate. The conduct of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>131</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=136,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=640504,FOLIO='131',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_132"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>preclinical
studies is subject to federal regulations and requirements including GLP regulations. The results of the preclinical studies, together with manufacturing information and analytical data,
among other things, are submitted to the FDA as part of the IND, which must become effective before human clinical trials may commence. The IND will become effective automatically 30&nbsp;days after
receipt by the FDA, unless the FDA raises concerns or questions about the conduct of the trials as outlined in the IND prior to that time and places a clinical hold on the IND. In this case, the IND
sponsor and the FDA must resolve any outstanding concerns before clinical trials can proceed. The FDA may nevertheless initiate a clinical hold after the 30&nbsp;days if, for example, significant
public health risks arise. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical
trials involve the administration of the drug candidate to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include the
requirement that all research subjects provide their informed consent in writing for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other
things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol
amendments must be submitted to the FDA as part of the IND. Each clinical trial must be reviewed and approved by an IRB at each of the sites at which the trial will be conducted. The IRB will
consider, among other things, ethical factors, the safety of human subjects and the possible liability of the institution. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical
trials are typically conducted in three sequential phases prior to approval, but the phases may overlap or be combined. These phases generally include the following: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2><I>Phase&nbsp;1.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;Phase&nbsp;1 clinical trials represent the initial introduction of a drug candidate into human subjects, frequently
healthy volunteers. In Phase&nbsp;1, the drug candidate is usually tested for safety, including adverse effects, dosage tolerance, absorption, distribution, metabolism, excretion and
pharmacodynamics. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>Phase&nbsp;2.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;Phase&nbsp;2 clinical trials usually involve studies in a limited patient population to (1)&nbsp;evaluate the efficacy
of the drug candidate for specific indications, (2)&nbsp;determine dosage tolerance and optimal dosage and (3)&nbsp;identify possible adverse effects and safety risks. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>Phase&nbsp;3.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;If a drug candidate is found to be potentially effective and to have an acceptable safety profile in Phase&nbsp;2
clinical trials, the clinical trial program will be expanded to Phase&nbsp;3 clinical trials to further demonstrate clinical efficacy, optimal dosage and safety within an expanded patient population
at geographically dispersed clinical trial sites. </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Post-approval
trials, sometimes referred to as Phase&nbsp;4 clinical trials, may be conducted after approval to gain additional experience from the treatment of patients in the
intended therapeutic indication and to document a clinical benefit in the case of drugs approved under accelerated approval regulations, or when otherwise requested by the FDA in the form of
post-market requirements or commitments. Failure to promptly conduct any required Phase&nbsp;4 clinical trials could result in enforcement action or withdrawal of approval. Companies that conduct
certain clinical trials also are required to register them and post the results of completed clinical trials on a government-sponsored database, such as ClinicalTrials.gov in the United States, within
certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Submission and Review of an NDA  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The results of preclinical studies and clinical trials, together with detailed information on the drug's manufacture, composition, quality,
controls and proposed labeling, among other things, are submitted to the FDA in the form of an NDA, requesting approval to market the drug for one or more indications. The application must be
accompanied by a significant user fee payment, which typically increases annually, although waivers may be granted in limited cases. The FDA conducts a preliminary review of all NDAs within the first
60&nbsp;days after submission, before accepting them for filing, to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>132</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=137,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=146769,FOLIO='132',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_133"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>determine
whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the application must be
resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. The FDA has substantial discretion in the approval process and
may refuse to file or approve any application or decide that the data is insufficient for approval and require additional preclinical, clinical or other studies. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Once
an NDA has been accepted for filing, the FDA sets a user fee goal date that informs the applicant of the specific date by which the FDA intends to complete its review. This goal
date is typically 10&nbsp;months from the date that the FDA accepts the filing. The review process can be extended by FDA requests for additional information or clarification. The FDA reviews NDAs
to determine, among other things, whether the proposed drug is safe and effective for its intended use, and whether the drug is being manufactured in accordance with cGMPs to assure and preserve the
drug's identity, strength, quality and purity. Before approving an NDA, the FDA typically will inspect the facilities at which the drug is manufactured and will not approve the drug unless the
manufacturing facilities comply with cGMPs. Additionally, the FDA will typically inspect one or more clinical trial sites for compliance with GCP and integrity of the data supporting safety and
efficacy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the approval process, the FDA also will determine whether a REMS is necessary to assure the safe use of the drug. REMS can include medication guides, communication plans for
healthcare professionals, and elements to assure safe use, or ETASU. ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under
certain circumstances, special monitoring and the use of patent registries. If the FDA concludes a REMS is needed, the sponsor of the application must submit a proposed REMS, and the FDA will not
approve the application without an approved REMS, if required. A REMS can substantially increase the costs of obtaining approval. The FDA may also convene an advisory committee of external experts to
provide input on certain review issues relating to risk, benefit and interpretation of clinical trial data. The FDA may delay approval of an NDA if applicable regulatory criteria are not satisfied
and/or the FDA requires additional testing or information. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the basis of the FDA's evaluation of the NDA and accompanying information, including the results of the inspection of the manufacturing facilities and clinical trial sites, the FDA
will issue either an approval of the NDA or a Complete Response Letter, detailing the deficiencies in the submission and the additional testing or information required for reconsideration of the
application. Even with submission of this additional information, the FDA may ultimately decide that the application does not satisfy the regulatory criteria for approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the FDA approves a new drug, it may limit the approved indications for use of the drug. It may also require that contraindications, warnings or precautions be included in the drug
labeling, such as a special warning, known as a boxed warning, to highlight a particular safety risk. In addition, the FDA may call for post-approval studies, including Phase&nbsp;4 clinical trials,
to further assess the drug's safety after approval. The agency may also require testing and surveillance programs to monitor the drug after commercialization, or impose other conditions, including
distribution restrictions or other risk management mechanisms, including REMS, to help ensure that the benefits of the drug outweigh the potential risks. The FDA may prevent or limit further marketing
of a drug based on the results of post-market studies or surveillance programs. After approval, many types of changes to the approved drug, such as adding new indications, manufacturing changes and
additional labeling claims, are subject to further testing requirements and FDA review and approval. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fast Track and Breakthrough Designations  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The FDA is authorized to designate certain drugs for expedited programs if they are intended to address an unmet medical need in the treatment
of a serious or life-threatening disease or condition. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>133</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=138,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=824559,FOLIO='133',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_134"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>These
programs are fast track designation, breakthrough therapy designation and priority review designation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may designate a drug for fast track designation if it is intended, whether alone or in combination with one or more other drugs, for the treatment of a serious or
life-threatening disease or condition, and it demonstrates the potential to address unmet medical needs for such a disease or condition. For fast track designated drugs, sponsors may have a higher
number of interactions with the FDA. In addition, the FDA may review sections of the NDA for a fast track designated drug on a rolling basis before the complete application is submitted. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may designate a drug for breakthrough designation if the drug is intended to treat a serious condition and that preliminary clinical evidence indicates that the drug may
demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies. The feature of this program allows the same advantages of the fast track designation, but also
intensive FDA guidance to promote efficient development and FDA organizational commitment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accelerated Approval Pathway  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The FDA may grant accelerated approval, under Subpart&nbsp;H of 21 CFR Part&nbsp;314, to a drug for a serious or life-threatening condition
that provides meaningful therapeutic advantage to patients over existing treatments based upon a determination that the drug has an effect on a surrogate endpoint that is reasonably likely to predict
clinical benefit. The FDA may also grant accelerated approval for such a condition when the drug has an effect on an intermediate clinical endpoint that can be measured earlier than an effect on
irreversible morbidity or mortality, or IMM, and that is
reasonably likely to predict an effect on IMM or other clinical benefit, taking into account the severity, rarity or prevalence of the condition and the availability or lack of alternative treatments.
Drugs granted accelerated approval must meet the same statutory standards for safety and effectiveness as those granted traditional approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to
predict clinical benefit, but is not itself a measure of clinical benefit. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. An intermediate clinical
endpoint is a measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug, such as an effect on IMM. The FDA has limited experience with
accelerated approvals based on intermediate clinical endpoints, but has indicated that such endpoints generally may support accelerated approval where the therapeutic effect measured by the endpoint
is not itself a clinical benefit and basis for traditional approval, if there is a basis for concluding that the therapeutic effect is reasonably likely to predict the ultimate clinical benefit of a
drug. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
accelerated approval pathway is most often used in settings in which the course of a disease is long and an extended period of time is required to measure the intended clinical
benefit of a drug, even if the effect on the surrogate or intermediate clinical endpoint occurs rapidly. Thus, accelerated approval has been used extensively in the development and approval of drugs
for treatment of a variety of cancers in which the goal of therapy is generally to improve survival or decrease morbidity and the duration of the typical disease course requires lengthy and sometimes
large trials to demonstrate a clinical or survival benefit. The benefit of accelerated approval derives from the potential to receive approval based on surrogate endpoints sooner than possible for
trials with clinical or survival endpoints, rather than deriving from any explicit shortening of the FDA approval timeline, as is the case with priority review. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
accelerated approval pathway is usually contingent on a sponsor's agreement to conduct, in a diligent manner, confirmatory studies to verify and describe the drug's clinical benefit.
As a result, a drug candidate approved on this basis is subject to rigorous post-marketing compliance requirements, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>134</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=139,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=708756,FOLIO='134',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_135"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>including
the completion of Phase&nbsp;4 or post-approval clinical trials to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or confirm a clinical
benefit during post-marketing studies, would allow the FDA to initiate expedited proceedings to withdraw approval of the drug. All promotional materials for drug candidates approved under accelerated
regulations are subject to prior review by the FDA. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Post-Approval Requirements  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In additional to the post-approval requirements specific to an accelerated approval pathway, there are other post-approval requirements whatever
the registration pathway. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approved
drugs that are manufactured or distributed in the United States pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other
things, requirements relating to recordkeeping, periodic reporting, drug sampling and distribution, advertising and promotion and reporting of adverse experiences with the drug. After approval, most
changes to the approved drug, such as adding new indications or other labeling claims and some manufacturing and supplier changes are subject to prior FDA review and approval. There also are
continuing, annual program user fee requirements for marketed drugs, as well as new application fees for certain supplemental applications. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including Phase&nbsp;4 clinical
trials, and surveillance programs to further assess and monitor the drug's safety and effectiveness after commercialization. The FDA may also require a REMS, which could involve requirements for,
among other things, medication guides, special trainings for prescribers and dispensers, patient registries, and elements to assure safe use. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state agencies, and are subject to
periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. The FDA has promulgated specific requirements for drug cGMPs. Changes to the manufacturing
process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and
impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money,
and effort in the area of production and quality control to maintain cGMP compliance. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Once
an approval is granted, the FDA may issue enforcement letters or withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems
occur after the drug reaches the market. Corrective action could delay drug distribution and require significant time and financial expenditures. Later discovery of previously unknown problems with a
drug, including AEs&nbsp;of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling
to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other
potential consequences include, among other things:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> restrictions on the marketing or manufacturing of the drug, suspension of the approval, complete withdrawal of the drug from the market or
product recalls; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fines, warning letters or holds on post-approval clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation of drug approvals; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>135</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=140,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=452833,FOLIO='135',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_db10701_1_136"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> drug seizure or detention, or refusal to permit the import or export of drugs; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> injunctions or the imposition of civil or criminal penalties. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA strictly regulates marketing, labeling, advertising and promotion of drugs that are placed on the market. Drugs may be promoted only for the approved indications and in
accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to
have improperly promoted off-label uses may be subject to significant liability, including investigation by federal and state authorities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Section&nbsp;505(b)(2) NDAs  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As an alternative path to FDA approval for modifications to formulations or uses of drugs previously approved by the FDA, an applicant may
submit an NDA under Section&nbsp;505(b)(2) of the FDCA. Section&nbsp;505(b)(2) was enacted as part of the Hatch-Waxman Amendments. A Section&nbsp;505(b)(2) NDA is an application that contains
full reports of investigations of safety and effectiveness, but where at least some of the information required for approval comes from studies not conducted by, or for, the applicant and for which
the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted. This type of application permits reliance for such approvals on literature
or on an FDA finding of safety, effectiveness or both for an approved drug product. As such, under Section&nbsp;505(b)(2), the FDA may rely, for approval of an NDA, on data not developed by the
applicant. The FDA may also require companies to perform additional studies or measurements, including clinical trials, to support the change from the approved branded reference drug. The FDA may then
approve the new product candidate for the new indication sought by the 505(b)(2) applicant. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pediatric Exclusivity and Pediatric Use  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Hatch-Waxman Amendments, the FDA may not approve a generic (abbreviated NDA) until any applicable period of non-patent exclusivity for
the reference listed drug has expired. The FDCA provides a period of five years of non-patent exclusivity for a new drug containing a new chemical entity. For the purposes of this provision, a new
chemical entity, or NCE, is a drug that contains no active moiety that has previously been approved by the FDA in any other NDA. An active moiety is the molecule or ion responsible for the
physiological or pharmacological action of the drug substance. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDCA also provides for a period of three years of exclusivity if the NDA includes reports of one or more new clinical investigations, other than bioavailability or bioequivalence
studies, that were conducted by or for the applicant and are essential to the approval of the application. This three-year exclusivity period often protects changes to a previously approved drug
product, such as a new dosage form, route of administration, combination or indication. Three-year exclusivity would be available for a drug product that contains a previously approved active moiety,
provided the statutory requirement for a new clinical investigation is satisfied. Unlike five-year NCE exclusivity, an award of three-year exclusivity does not block the FDA from accepting abbreviated
NDAs seeking approval for generic versions of the drug as of the date of approval of the original drug product. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the Pediatric Research Equity Act of 2003, as amended, an NDA or supplement thereto must contain data that are adequate to assess the safety and effectiveness of the drug for the
claimed
indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the drug is safe and effective. Sponsors must also submit
pediatric study plans prior to the assessment data. Those plans must contain an outline of the proposed pediatric study or studies the applicant plans to conduct, including study objectives and
design, any deferral or waiver requests and other information required by regulation. The applicant, the FDA, and the FDA's internal review committee must then review the information submitted,
consult with each other and agree upon a final plan. The FDA or the applicant may request an amendment to the plan at any time. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>136</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=141,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=869332,FOLIO='136',FILE='DISK124:[18ZFA1.18ZFA10701]DB10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dc10701_1_137"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the
drug for use in adults, or full or partial waivers from the pediatric data requirements if certain criteria are met. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pediatric
exclusivity is another type of non-patent marketing exclusivity in the United States and, if granted, provides for the attachment of an additional six months of marketing
protection to the term of any existing regulatory exclusivity, including the non-patent marketing and orphan exclusivity. This six-month exclusivity may be granted if an NDA sponsor submits pediatric
data that fairly respond to a written request from the FDA for such data. The data do not need to show the drug to be effective in the pediatric population studied; rather, if the clinical trial is
deemed to fairly respond to the FDA's request, the additional protection is granted. If reports of FDA-requested pediatric studies are submitted to and accepted by the FDA within the statutory time
limits, whatever statutory or regulatory periods of exclusivity or patent protection cover the drug are extended by six months. This is not a patent term extension, but it effectively extends the
regulatory period during which the FDA cannot approve another application. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FDA Regulation of In Vitro Diagnostics  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the FDCA, </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostics are regulated as medical devices. In the United States, the
FDCA and its implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, preclinical and clinical testing,
premarket clearance or approval, registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market surveillance. Unless
an exemption applies, diagnostic tests require marketing clearance or approval from the FDA prior to commercial distribution. The two primary types of FDA marketing authorization applicable to a
medical device are premarket notification, also called 510(k) clearance, and premarket approval, or PMA approval; however, other devices may be commercialized after the FDA grants a </FONT> <FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> request.
</FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Device Classification  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the FDCA, medical devices are classified into one of three classes&#151;Class&nbsp;I, Class&nbsp;II or
Class&nbsp;III&#151;depending on the degree of risk associated with each medical device and the extent of control needed to provide reasonable assurances with respect to safety and
effectiveness. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class&nbsp;I
devices are those for which safety and effectiveness can be reasonably assured by adherence to a set of regulations, referred to as General Controls, which require
compliance with the applicable portions of the FDA's Quality System Regulation, or QSR, facility registration and product listing, reporting of adverse events and malfunctions, and appropriate,
truthful and non-misleading labeling and promotional materials. Most Class&nbsp;I products are exempt from the premarket notification requirements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class&nbsp;II
devices are those that are subject to the General Controls, as well as Special Controls, which can include performance standards, guidelines and post market surveillance.
Most Class&nbsp;II devices are subject to premarket review and clearance by the FDA. Premarket review and clearance by the FDA for Class&nbsp;II devices is accomplished through the 510(k)
premarket notification process. Under the 510(k) process, the manufacturer must submit to the FDA a premarket notification, demonstrating that the device is "substantially equivalent," as defined in
the statute, to either:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a device that was legally marketed prior to May&nbsp;28, 1976, the date upon which the Medical Device Amendments of 1976 were enacted, or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> another commercially available, similar device that was cleared through the 510(k) process. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
be "substantially equivalent," the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate
device or have </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>137</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=142,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=737464,FOLIO='137',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_138"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>different
technological characteristics and not raise different questions of safety or effectiveness than the predicate device. Clinical data are sometimes required to support substantial equivalence. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
a 510(k) notice is submitted, the FDA determines whether to accept it for substantive review. If it lacks necessary information for substantive review, the FDA will refuse to
accept the 510(k) notification. If it is accepted for filing, the FDA begins a substantive review. If the FDA agrees that the device is substantially equivalent, it will grant clearance to
commercially market the device. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


The PMA Process  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the FDA determines that the device is not "substantially equivalent" to a predicate device, or if the device is classified into
Class&nbsp;III by operation of law, the device sponsor must then fulfill the much more rigorous premarketing requirements of the PMA process, or seek classification of the device through the </FONT> <FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2>
process by submitting a </FONT><FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> request. A manufacturer can also submit a direct </FONT> <FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> request if the manufacturer is unable to identify an appropriate
predicate device and the new device or new use of the device presents a
moderate or low risk. In response to a </FONT><FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> request, FDA may classify the device into class&nbsp;I or II. When FDA grants a </FONT> <FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> request, the device
is granted marketing authorization and further can serve as a predicate for future devices of that type, including for
510(k)s. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class&nbsp;III
devices include devices deemed by the FDA to pose the greatest risk such as life-supporting or life-sustaining devices, or implantable devices, in addition to those
deemed not substantially equivalent following the 510(k) process. The safety and effectiveness of Class&nbsp;III devices cannot be reasonably assured solely by the General Controls and Special
Controls described above. Therefore, these devices are subject to the PMA application process, which is generally more costly and time consuming than the 510(k) process. Through the PMA application
process, the applicant must submit data and information demonstrating reasonable assurance of the safety and effectiveness of the device for its intended use to the FDA's satisfaction. Accordingly, a
PMA application typically includes, but is not limited to, extensive technical information regarding device design and development, pre-clinical and clinical study data, manufacturing information,
labeling and financial disclosure information for the clinical investigators in device studies. The PMA application must provide valid scientific evidence that demonstrates to the FDA's satisfaction
reasonable assurance of the safety and effectiveness of the device for its intended use. Overall, the FDA review of a PMA application generally takes between one and three years, but may take
significantly longer. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Laboratory-developed Tests  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LDTs have generally been considered to be tests that are intended for clinical use and that are designed, manufactured and used within a single
laboratory. The FDA takes the position that it has the authority to regulate such tests as devices under the FDCA. The FDA has historically exercised enforcement discretion, meaning FDA has not
enforced premarket review or other applicable FDA requirements with respect to LDTs. In addition, the New York State Department of Health, or NYSDOH, separately approves certain LDTs offered to New
York State patients. The laboratory partner to whom we license our technology will be responsible for obtaining the requisite approvals for our LDT in New York, and maintaining CLIA-certification and
state clinical laboratory licenses, where applicable. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
October&nbsp;3, 2014, the FDA issued two draft guidance documents regarding oversight of LDTs. These draft guidance documents proposed more active oversight over LDTs. The draft
guidance documents have been the subject of considerable controversy, and in November 2016, the FDA announced that it would not be finalizing the 2014 draft guidance documents. On January&nbsp;13,
2017, the FDA issued a discussion paper which laid out elements of a possible revised future LDT regulatory framework, but did not establish any regulatory requirements. The FDA's efforts to regulate
LDTs have </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>138</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=143,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=547408,FOLIO='138',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_139"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>prompted
the drafting of legislation governing diagnostic products and services, including LDTs. Congress or FDA may still act to provide further direction on the regulation of LDTs. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


European Union Regulation for Drug Development and Registration  </I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pre-clinical and Clinical Development  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the European Union, our drug candidates are also subject to extensive regulatory requirements. As in the United States, medicinal products
can only be marketed if a marketing authorization from the competent regulatory agencies has been obtained. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similar
to the United States, the various phases of preclinical and clinical research in the European Union are subject to significant regulatory controls. Although the EU Clinical
Trials Directive 2001/20/EC has sought to harmonize the European Union clinical trials regulatory framework, setting out common rules for the control and authorization of clinical trials in the
European Union, the EU Member States have transposed and applied the provisions of the Directive differently. This has led to significant variations in the Member State regimes. To improve the current
system, Regulation (EU)&nbsp;No 536/2014 on clinical trials on medicinal products for human use, which repealed Directive&nbsp;2001/20/EC, was adopted on April&nbsp;16, 2014 and published in the
European Official Journal on May&nbsp;27, 2014. The Regulation aims at harmonizing and streamlining the clinical trials authorization process, simplifying adverse event reporting procedures,
improving the supervision of clinical trials, and increasing their transparency. Although the Regulation entered into force on June&nbsp;16, 2014, it will not be applicable until six months after
the full functionality of the IT portal and database envisaged in the Regulation is confirmed. This is not expected to occur until mid-2020. Until then the Clinical Trials Directive 2001/20/EC will
still apply. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the current regime, before a clinical trial can be initiated it must be approved in each of the EU Member States where the trial is to be conducted by two distinct bodies: the
National Competent Authority, or NCA, and one or more Ethics Committees, or ECs. Under the current regime all suspected unexpected serious adverse reactions, or SUSARs, to the investigated drug that
occur during the clinical trial have to be reported to the NCA and ECs of the Member State where they occurred. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


European Union Drug Review and Approval  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the European Economic Area, or EEA (which is currently still comprised of the 28 Member States of the European Union plus Norway, Iceland and
Liechtenstein, with the United Kingdom scheduled to leave the European Union as of March&nbsp;29, 2019), medicinal products can only be commercialized after obtaining a Marketing Authorization, or
MA. Marketing Authorizations may be granted either centrally (EU MA) or nationally (National MA). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
EU MA is issued centrally by the European Commission through the Centralized Procedure, based on the opinion of the CHMP of the EMA and is valid throughout the entire territory of
the EEA. The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan medicinal products, and medicinal products containing a new active
substance indicated for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes, auto-immune and viral diseases. The Centralized Procedure is optional for products containing a new active
substance not yet authorized in the EEA, or for products that constitute a significant therapeutic, scientific or technical innovation or which are in the interest of public health in the European
Union. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;National
MAs are issued nationally by the competent authorities of the Member States of the EEA and only cover their respective territory. National MAs are available for products not
falling within the mandatory scope of the Centralized Procedure. We do not foresee that any of our current </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>139</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=144,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=551136,FOLIO='139',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_140"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>drug
candidates will be suitable for a National MA as they fall within the mandatory criteria for the Centralized Procedure. Therefore, our drug candidates should be approved through EU MAs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the above-described procedures, before granting the MA, the EMA or the competent authorities of the Member States of the EEA make an assessment of the risk-benefit balance of the
product on the basis of scientific criteria concerning its quality, safety and efficacy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Also,
pursuant to Regulation (EC) No 1901/2006, all applications for marketing authorization for new medicines must include the results of studies as described in a pediatric
investigation plan agreed between regulatory authorities and the applicant, unless the medicine is exempt because of a deferral or waiver. Before the EMA is able to begin its assessment of an EU MA
application, it will validate that the applicant has complied with the agreed pediatric investigation plan. The applicant and the
EMA may, where such a step is adequately justified, agree to modify a pediatric investigation plan to assist validation. Modifications are not always possible; may take longer to agree than the period
of validation permits; and may still require the applicant to withdraw its marketing authorization application and to conduct additional non-clinical and clinical studies. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Orphan Drugs  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the European Union, Regulation (EC) No 141/2000, as amended, states that a drug will be designated as an orphan drug if its sponsor can
establish:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> that it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting not more
than five in ten thousand persons in the European Union when the application is made, or that it is intended for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or
serious and chronic condition in the European Union and that without incentives it is unlikely that the marketing of the drug in the European Union would generate sufficient return to justify the
necessary investment; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> that there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the
European Union or, if such method exists, that the drug will be of significant benefit to those affected by that condition. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulation
(EC) No 847/2000 sets out further provisions for implementation of the criteria for designation of a drug as an orphan drug. An application for the designation of a drug as an
orphan drug must be submitted at any stage of development of the drug but before filing of a MA application. A MA for an orphan drug may only include indications designated as orphan. For non-orphan
indications treated with the same active pharmaceutical ingredient, as a separate MA has to be sought. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an EU MA in respect of an orphan drug is granted pursuant to Regulation (EC) No 726/2004, regulatory authorities will not, for a period of usually 10&nbsp;years, accept another
application for a MA, or grant a MA or accept an application to extend an existing MA, for the same therapeutic indication, in respect of a similar drug. This period may however be reduced to six
years if, at the end of the fifth year, it is established, in respect of the drug concerned, that the criteria for orphan drug designation are no longer met, in other words, when it is shown on the
basis of available evidence that the product
is sufficiently profitable not to justify maintenance of market exclusivity. The exclusivity period may increase to 12&nbsp;years if, among other things, the MAA includes the results of studies from
an agreed pediatric investigation plan. Notwithstanding the foregoing, a MA may be granted, for the same therapeutic indication, to a similar drug if:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the holder of the MA for the original orphan drug has given its consent to the second applicant; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the holder of the MA for the original orphan drug is unable to supply sufficient quantities of the drug; or </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>140</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=145,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=476939,FOLIO='140',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_141"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the second applicant can establish in the application that the second drug, although similar to the orphan drug already authorized, is safer,
more effective or otherwise clinically superior. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regulation
(EC) No 847/2000 lays down definitions of the concepts 'similar drug' and 'clinical superiority'. Other incentives available to orphan drugs in the European Union include
financial incentives such as a reduction of fees or fee waivers and protocol assistance. Orphan drug designation does not shorten the duration of the regulatory review and approval process. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


In Vitro Diagnostics  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The regulations on in-vitro diagnostics (IVD) are currently harmonized through the Directive&nbsp;98/79/EC on in vitro diagnostic medical
devices (the IVD Directive). The IVD Directive
requires a conformity assessment by the person placing the product on the market under its name (the legal manufacturer), confirming the performance of an IVD. The IVD Directive will be replaced by
Regulation (EU)&nbsp;2017/746 on in vitro diagnostic medical devices (IVDR). The IVDR shall apply from May&nbsp;26, 2022, with certain exceptions for earlier application and transitional periods
for later application. The IVDR in many instances results in an upclassification of IVD, which means that the conformity assessment previously carried out by the legal manufacturer may have to be
confirmed by a notified body. Notified bodies are companies designated by competent authorities of a EU Member State to review and confirm an IVD conformity assessment. The rules for the conformity
assessment are tightened themselves. Furthermore, a Unique Device Identification (UDI) will be required, as well as a performance evaluation report and tightened vigilance and market surveillance
requirements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other European Regulatory Matters  </I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


French Regulatory Framework on Clinical Trials  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the European Union, the regulation governing clinical trials is currently based on Directive&nbsp;2001/20/EC of April&nbsp;4, 2001
relative to the implementation of good clinical practices in the conduct of clinical trials on medicinal products for human use. Each Member State of the European Union had to transpose this Directive
into national law, which resulted in Member States adapting it to their own regulatory framework. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
France, for example, Directive No.&nbsp;2001/20/EC has been implemented by Act Law 2004-806 of August&nbsp;9, 2004 regarding the public health policy and Decree 2006-477 of
April&nbsp;26, 2006, modifying the section of the Public Health Code, or PHC, on biomedical research. Law No.&nbsp;2012-300 of March&nbsp;5, 2012, or the "Loi Jard&eacute;," related to
biomedical research involving human subjects, and French Order No.&nbsp;2016-800 related to clinical trials of medicinal products for human use have recently adapted French law to the new provisions
of Regulation No.&nbsp;536/2014 of the European Parliament and of the Council of April&nbsp;16, 2014 related to clinical trials of medicinal products for human use, which repealed Directive
2001/20/EC. Law 2004-806 abolishes the prior notification procedure introduced by the Law Huriet-S&eacute;rusclat of December&nbsp;20, 1988. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
framework imposed by Directive 2001/20/EC is in the process of being replaced by a new framework set forth in Regulation No.&nbsp;536/2014 of the European Parliament and of the
Council of April&nbsp;16, 2014 related to clinical trials of medicinal products for human use, which repealed Directive&nbsp;2001/20/EC. For practical purposes, full implementation of Regulation
No.&nbsp;536/2014 depends
on the development of a fully functional EU&nbsp;clinical trials portal and database, which is currently estimated to start operating in 2020. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
France, the main legislative and regulatory texts relating to the conduct of clinical trials are mainly codified in the French Public Health Code (Articles&nbsp;L. 1121-1 to L.
1126-12 and Articles&nbsp;R.&nbsp;1121-1 to R.&nbsp;1125-26). In addition, other regulations apply to such clinical trials such as Data Protection regulations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>141</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=146,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=695775,FOLIO='141',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_142"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
France, Article&nbsp;L. 1121-4 of the Public Health Code establishes a system of prior authorization for interventional clinical trial on human beings. This authorization is granted
by the French Medicines Agency, or ANSM, provided that the competent Ethics Committee issued a favorable opinion. In addition, clinical trials require a prior favorable opinion from an ethics
committee. Non-interventional clinical trials are only subject to approval by the competent ethic committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
Article&nbsp;L. 1123-7 of the Public Health Code, the Ethics Committee shall assess whether the conditions in which the trial will be conducted are valid. This assessment should
be based on whether: adequate protection is offered to individuals, in particular to participants; adequate information is provided to the participants and appropriate procedure is in place to obtain
their informed consent; the project is relevant; the benefits/risks assessment is satisfactory; the objectives of the trial are adequate to the means implemented; the qualification of the
investigator(s) is satisfactory; the conditions and amount of patients' indemnification is appropriate; and the method for recruiting participants is adequate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
ANSM, after submission of the complete file containing not only information on the clinical protocol, but also specific product data and its quality control, as well as results of
preclinical studies, may inform the sponsor that it objects to the implementation of the research. The sponsor can then modify the contents of its research project and submit this amended or
supplemented request to the ANSM; this procedure may not, however, be applied more than once. If the sponsor does not alter the content of its request, the request is considered rejected. Under
Article&nbsp;R. 1123-38 of the Public Health Code, the time limit for the examination of a request for authorization cannot exceed 60&nbsp;days from the receipt of the complete file. As of
October&nbsp;15, 2018, sponsors of clinical trials may volunteer for a Fast Track procedure, established by ANSM, to obtain expedite processing of their application, which may reduce the examination
to a maximum of 40&nbsp;days (for innovative treatments) or a maximum of 25&nbsp;days (for known molecules). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finally,
under Article&nbsp;L. 1123-11, in the event of risk to public health or if the ANSM considers that the conditions in which the research is implemented no longer correspond to
the conditions indicated in
the request for authorization or does not comply with the provisions of the Public Health Code, it may at any time request changes to procedures for the realization of research, and suspend or ban
this research. The decision of November&nbsp;24, 2006 sets the rules for Good Clinical Practice, or GCPs, for clinical trials on medicines for human use as referred to in Article&nbsp;L. 1121-3 of
the Public Health Code. GCPs aim to ensure both the reliability of data arising from clinical trials and the protection of the persons participating in these clinical trials. GCPs apply to all
clinical trials, including pharmacokinetics, bioavailability and bioequivalence studies in healthy volunteers as well as Phase&nbsp;2 to Phase&nbsp;4 clinical trials. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Protection of Clinical Trial Subjects in France  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under French law, a clinical trial may be undertaken only if (1)&nbsp;it is based on the latest stage of scientific knowledge and on
sufficient preclinical testing, (2)&nbsp;the foreseeable risk incurred by the subjects is outweighed by the benefit expected for these persons or the interest of the research, (3)&nbsp;it aims at
expanding scientific knowledge and the means possible to improve the human condition and (4)&nbsp;the research was designed to reduce the pain, inconveniences, fear and other predictable
inconvenience connected to the disease or to the research, by taking into account in particular the degree of maturity of minors and the capacity of understanding of adults unable to express an
informed consent. All these conditions must be fulfilled in order to start a clinical trial. A clinical trial may be undertaken under the following technical conditions: (a)&nbsp;under the direction
and the supervision of a qualified physician and (b)&nbsp;under adapted material and technical conditions, compatible with the rigorous imperatives of science and the safety of the clinical trial
subjects. Two documents must be provided to clinical trial subjects before the conduct of the trial. First, the patient must receive a patient information sheet which must contain in particular a
description of the objective, the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>142</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=147,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1041047,FOLIO='142',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_143"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>methodology
and the time period of the research, as well as a description of the alternative treatments, the number of subjects expected to take part in the study, the anticipated benefits, the
constraints and the foreseeable risks resulting from the administration of the products that are the object of the clinical trials but also the favorable opinion of the ethics committee and the
authorization of the ANSM, and information on processing of personal data. The information communicated must be summarized in a written document delivered to the patient prior to any administration of
products by the investigator or a physician. Second, the patient must confirm his or her agreement to participate in the clinical study by signing an informed consent form. For each study, patient
information must include a right to refuse to participate and to withdraw consent at any time and by any means without further consequences or prejudice. A clinical trial on a minor may be undertaken
only if, in particular, the informed consent of the parents or legal representative has been obtained. Furthermore, a clinical trial on adults under guardianship requires the informed consent of the
adult's legal representative. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, personal data collected during clinical trials should be declared in simplified form to the French Data Protection Agency (</FONT><FONT SIZE=2><I>Commission Nationale de
l'Informatique et des Libert&eacute;s</I></FONT><FONT SIZE=2>, or </FONT><FONT SIZE=2><I>CNIL</I></FONT><FONT SIZE=2>) pursuant to a reference methodology (MR-001 for interventional studies
where the consent of the patient is necessary and MR-003 for certain non-interventional studies where the information of the patient is required). As a principle, patients have a right to access and
rectify their personal data pursuant to Law 78-17 of January&nbsp;6, 1978 on Personal Data, as amended. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
sponsor of a clinical trial is also responsible for subscribing to a mandatory insurance policy, in order to provide for the indemnification of all unfavorable consequences of the
clinical trial on the patients subject to such trials, pursuant to Article&nbsp;L. 1121-10 of the Public Health Code. The guaranties cannot amount to less than EUR 1.000.000 per victim and EUR
6.000.000 per research protocol. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer of Values to Health Care Professionals  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The French Public Health Code provides for two sets of requirements regarding the transfer of values by health care companies to health care
professionals:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Transparency or Sunshine regime, set out by Article&nbsp;L.1453-1 of the Public Health Code, requires companies manufacturing or
marketing health care products (medicinal products, medical devices, etc.) in France to publicly disclose (mainly on a specific public website available at:
https://www.entreprises-transparence.sante.gouv.fr) the advantages and fees paid to healthcare professionals amounting to 10&nbsp;euros or above, as well as the agreements concluded with the latter,
along with detailed information about each agreement (the precise subject matter of the agreement, the date of signature of the agreement, its end date, the total amount paid to the healthcare
professional, etc.). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Anti-Gift regime, regarding the general prohibition of payments from pharmaceutical and device manufacturers to healthcare professionals (Article&nbsp;L.1453-3 of the French Public
Health Code), except in certain circumstances in particular scientific research, speaker fees and hospitality provided in the course of scientific event. The Anti-Gift regime is in the process of
being modified by the implementation of the provisions of Ordinance n&deg; 2017-49 of January&nbsp;19, 2017 through regulations which are scheduled to be adopted by the end of 2018. The new
regime will include a prior declaration or prior authorization procedure for the transfers of values which do not fall under the above-mentioned prohibition. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Significant uncertainty exists in the United States as to the coverage and reimbursement status of any drug candidates for which we obtain
regulatory approval. Sales of our products will depend, in part, on the extent to which our products, once approved, will be covered and reimbursed by third-party payors, such as government health
programs, commercial insurance and managed healthcare </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>143</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=148,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=190689,FOLIO='143',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_144"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>organizations.
These third-party payors are increasingly reducing reimbursement levels for medical products and services. The process for determining whether a third-party payor will provide coverage
for a drug product typically is separate from the process for setting the price of a drug product or for establishing the reimbursement rate that a payor will pay for the drug product once coverage is
approved. Third-party payors may limit coverage to specific drug products on an approved list, also known as a formulary, which might not include all of the approved drugs for a particular indication. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
secure coverage and reimbursement for any product candidate that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the
medical necessity and cost-effectiveness of the product candidate, in addition to the costs required to obtain FDA or other comparable regulatory approvals. Whether or not we conduct such studies, our
drug candidates may not be considered medically necessary or cost-effective. A third-party payor's decision to provide coverage for a drug product does not imply that an adequate reimbursement rate
will be approved. Further, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. One payor's
determination to provide coverage for a product does not assure that other payors will also provide coverage, and adequate reimbursement, for the product. Third-party reimbursement may not be
sufficient to enable us to realize an appropriate return on our investment in product development. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are developing an </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostic test for the identification of NASH patients to treat, initially as an LDT. Our collaborators who
develop the LDT will not seek or receive third-party reimbursement for the LDT because it will only be used in clinical research. Once we have been granted authorization to commercialize our IVD under
FDA's device authorities, we or our collaborators will likely seek coverage and reimbursement from third party payors, including Medicare and Medicaid. We, or our collaborators, will be required to
obtain coverage and reimbursement for this test separate and apart from the coverage and reimbursement we seek for our product candidates, once approved. There is significant uncertainty regarding our
ability to obtain coverage and adequate reimbursement in the United States for this test for the same reasons applicable to our product candidates. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of drugs have been a focus in this effort. The United States federal
government, state legislatures and foreign governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement, utilization
management and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing
controls and measures, could further limit our net revenue and results. Decreases in third-party reimbursement for our drug candidates or a decision by a third-party payor to not cover our drug
candidates could reduce physician usage of the drug candidates and could have a material adverse effect on our sales, results of operations and financial condition. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in some foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from
country to country. For example, the European Union provides options for its Member States to restrict the range of medicinal products for which their national health insurance systems provide
reimbursement and to control the prices of medicinal products for human use. A Member State may approve a specific price for the medicinal product or it may instead adopt a system of direct or
indirect controls on the profitability of the company placing the medicinal product on the market. For example, in France, effective market access will be supported by agreements with hospitals and
products may be reimbursed by the Social Security Fund. The price of medicines is negotiated with the Economic Committee for Health Products, or CEPS. There can be no assurance that any country that
has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>144</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=149,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=764995,FOLIO='144',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_145"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>arrangements
for any of our drug candidates. Historically, products launched in the European Union do not follow price structures of the United States and generally prices tend to be significantly
lower. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Healthcare Reform  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and
proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to
profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in
healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the
pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, ACA, enacted in the United States in March
2010, has already had, and is expected to continue to have, a significant impact on the healthcare industry. The ACA has expanded coverage for the uninsured while at the same time containing overall
healthcare costs. With regard to pharmaceutical products, among other things, the ACA expanded and increased industry rebates for drugs covered under Medicaid programs and made changes to the coverage
requirements under the Medicare Part&nbsp;D program. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
its enactment there have been judicial and Congressional challenges to certain aspects of the ACA, as well as recent efforts by the Trump administration to repeal or replace
certain aspects of the ACA. Since January 2017, President Trump has signed two Executive Orders and other directives designed to delay the implementation of certain provisions of the ACA or otherwise
circumvent some of the requirements for health insurance mandated by the ACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the ACA. While
Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the ACA such as removing penalties, starting January&nbsp;1, 2019, for not complying
with the ACA's individual mandate to carry health insurance, delaying the implementation of certain ACA-mandated fees, and increasing the point-of-sale discount that is owed by pharmaceutical
manufacturers who participate in Medicare Part&nbsp;D. In July 2018, the Centers for Medicare and Medicaid Services, or CMS, published a final rule permitting further collections and payments to and
from certain ACA-qualified health plans and health insurance issuers under the Affordable Care Act risk adjustment program in response to the outcome of federal district court litigation regarding the
method CMS uses to determine this risk adjustment. On December&nbsp;14, 2018, a U.S. District Court Judge in the Northern District of Texas, ruled that the individual mandate is a critical and
inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Cuts and Jobs Act, the remaining provisions of the ACA are invalid as well. While the Trump Administration and
CMS have both stated that the ruling will have no immediate effect, it is unclear how this decision, subsequent appeals, and other efforts to repeal and replace the ACA will impact the ACA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, on August&nbsp;2, 2011, the Budget Control Act of
2011 among other things, created measures for spending reductions by Congress. Specifically, the Joint Select Committee on Deficit Reduction was created to recommend to Congress proposals in spending
reductions. The Joint Select Committee on Deficit Reduction did not achieve a targeted deficit reduction of at least $1.2 trillion for the years 2012 through 2021, thereby triggering the legislation's
automatic reduction to several government programs. This includes aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, started in April 2013 and which, due to subsequent
legislative amendments, including the BBA, will stay in effect through 2027 unless additional Congressional action is taken. Additionally, on January&nbsp;2, 2013, President Obama signed into law
the American Taxpayer Relief Act </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>145</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=150,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=246482,FOLIO='145',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_146"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>of
2012, or the ATRA. The ATRA, among other things, reduced Medicare payments to several providers and increased the statute of limitations period for the government to recover overpayments to
providers from three to five years. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recently,
there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Such scrutiny has resulted in several recent
U.S.&nbsp;Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between
pricing and manufacturer patient programs, reduce the cost of drugs under Medicare and reform government program reimbursement methodologies for drug products. At the federal level, the Trump
administration's budget proposal for fiscal year 2019 contains further drug price control measures that could be enacted during the 2019 budget process or in other future legislation, including, for
example, measures to permit Medicare Part&nbsp;D plans to negotiate the price of certain drugs under Medicare Part&nbsp;B, to allow some states to negotiate drug prices under Medicaid, and to
eliminate cost sharing for generic drugs for low-income patients. Additionally, the Trump administration released a "Blueprint" to lower drug prices and reduce out of pocket costs of drugs that
contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their
products and reduce the out of pocket costs of drug products paid by consumers. Additionally, on January&nbsp;31, 2019, Office of Inspector General of the U.S. Department of Health and Human
Services proposed modifications to federal Anti-Kickback Statute safe harbors which, among other things, may affect rebates paid by manufacturers to Medicare Part&nbsp;D plans, the purpose of which
is to further reduce the cost of drug products to consumers. Although a number of these, and other proposed measures will require additional authorization to become effective, Congress and the Trump
administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. At the state level, legislatures have increasingly passed
legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and
marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
on May&nbsp;30, 2018, the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain
investigational new drug products that have completed a Phase&nbsp;I clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek
treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products
available to eligible patients as a result of the Right to Try Act. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other U.S. Healthcare Laws and Compliance Requirements  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our business operations in the United States and our arrangements with clinical investigators, healthcare providers, consultants, third-party
payors and patients expose us to broadly applicable federal and state fraud and abuse and other healthcare laws. These laws may impact, among other things, our research, and if approved, proposed
sales, marketing and education programs of our drug candidates. The laws that may affect our ability to operate include, among others:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting,
receiving, offering or paying remuneration (including any kickback, bribe or rebate), directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an
individual for, or the purchase, lease, order, or recommendation of, an item, good, facility or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>146</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=151,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=515375,FOLIO='146',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_147"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> federal civil and criminal false claims laws and civil monetary penalty laws, including the federal civil False Claims Act, which can be
enforced by private individuals through civil whistleblower or qui tam actions, which prohibits individuals and entities from, among other things, knowingly presenting, or causing to be presented,
claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent, or making a false statement or record material to payment of a false claim or avoiding,
decreasing, or concealing an obligation to pay money to the federal government, including for example, providing inaccurate billing or coding information to customers or promoting a product off-label; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional federal criminal statutes that
prohibit knowingly and willfully executing or attempting to execute a scheme to defraud any healthcare benefit program, knowingly and willfully embezzling or stealing from a healthcare benefit
program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willingly falsifying, concealing or covering up a material fact or making materially false
statements, fictitious, or fraudulent statements in connection with the delivery of or payment for healthcare benefits, items, or services; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the federal Physician Payments Sunshine Act, enacted as part of the ACA, which requires applicable manufacturers of drugs, devices, biologics
and medical supplies for which payment is available under Medicare, Medicaid, or the Children's Health Insurance Program, with specific exceptions, to track and annually report to CMS payments and
other transfers of value provided to physicians and teaching hospitals and certain ownership and investment interests held by physicians and their immediate family members; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations,
which imposes certain requirements on certain healthcare providers, health plans, and healthcare clearinghouses, known as covered entities, and their business associates, which are individuals and
entities that perform functions or activities on behalf of covered entities that involve protected health information, relating to the privacy, security and transmission of protected health
information; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> State and foreign equivalents of each of the above federal laws and regulations, such as: state anti-kickback and false claims laws which may
apply to items or services reimbursed by any third-party payor, including commercial insurers; state marketing and/or transparency laws applicable to manufacturers that may be broader in scope than
the federal requirements; state laws that require biopharmaceutical companies to comply with the biopharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance
promulgated by the federal government; state and local laws that require the registration of pharmaceutical sales representatives; and state and/or foreign laws governing the privacy and security of
health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect as HIPAA, thus complicating compliance efforts. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
ACA broadened the reach of the federal fraud and abuse laws by, among other things, amending the intent requirement of the U.S. federal Anti-Kickback Statute and certain federal
criminal healthcare fraud statutes. Pursuant to the statutory amendment, a person or entity no longer needs to have actual knowledge of these statutes or specific intent to violate them in order to
have committed a violation. In addition, the ACA provides that the government may assert that a claim including items or
services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act or the civil monetary penalties
laws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Efforts
to ensure that our business arrangements with third parties comply with applicable healthcare laws involves substantial costs. It is possible that governmental authorities will
conclude that our business practices may not comply with current or future statutes, regulations or case law involving </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>147</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=152,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=22442,FOLIO='147',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dc10701_1_148"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>applicable
fraud and abuse or other healthcare laws. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject
to, for example, significant administrative, civil, and/or criminal penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, individual
imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity
agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations. If the physicians or other healthcare providers or
entities with whom we expect to do business are found to be not in compliance with applicable laws, they may be subject to administrative, civil, and/or criminal sanctions, including exclusions from
government funded healthcare programs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2018, we had 148 employees. Of these employees, 100 were engaged in research and development activities and 48 were
engaged in administration and management, which includes business development, finance, investor relations, information systems, human resources and legal. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Of
these 148 employees, 138 were employed by Genfit&nbsp;S.A. and seven were employed by our U.S.&nbsp;subsidiary, Genfit Corp. Employees employed by Genfit Corp. were mainly based
in our Cambridge, Massachusetts office. Of the 138 employees employed by Genfit&nbsp;S.A., 130 were based at our corporate headquarters in Loos and 8 were based in our Paris office. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of our employees is subject to a collective bargaining agreement. We consider our relationship with our employees to be good. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Facilities  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our corporate headquarters are located in Loos, France, where we lease approximately 5,500&nbsp;square meters of office space. We have begun
construction of an extension to the building to provide approximately 1,000 additional square meters of office space, and we expect this extension to be completed in the second half of 2019. The lease
for our Loos headquarters continues through March 2022. We also lease office space in Paris, France and, for our U.S. subsidiary, Genfit Corp., in Cambridge, Massachusetts. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that our existing facilities, including the extension to our corporate headquarters in Loos, France, are adequate for our near-term needs, and we believe that suitable
additional or alternative office and manufacturing space will be available as required in the future on commercially reasonable terms. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Legal Proceedings  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations, including those
described in Note&nbsp;23 of our consolidated financial statements for the year ended December&nbsp;31, 2018 included in this prospectus. Other than the legal proceeding related to the research
tax credit described elsewhere in this prospectus, we are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our
business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>148</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=153,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=70221,FOLIO='148',FILE='DISK124:[18ZFA1.18ZFA10701]DC10701A.;36',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_de10701_1_149"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="de10701_management"> </A>
<A NAME="toc_de10701_1"> </A></FONT> <FONT SIZE=2><B>  MANAGEMENT    <BR>    </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Senior Management and Directors  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information concerning our senior management and directors as of February&nbsp;1, 2019: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="218pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position(s) </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Senior Management</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Fran&ccedil;ois Mouney(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Executive Officer and Chairman of the Board</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dean Hum, Ph.D</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>56</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Operating Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nathalie Huitorel</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>57</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Executive Vice President and Chief Financial and Administrative Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pascal Prigent</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Executive Vice President, Marketing and Commercial Development</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Christophe Marcoux</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Strategy Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Laurent Lannoo</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Corporate Secretary, Director of Legal Affairs</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Non-Employee Directors</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Xavier Guille des&nbsp;Buttes(2)(3)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>77</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Vice-Chairman of the Board</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine Larue, Ph.D(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anne-H&eacute;l&egrave;ne Monsellato(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fr&eacute;d&eacute;ric Desdouits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Florence S&eacute;journ&eacute;(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Philippe Moons(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Member
of the Nomination and Compensation Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Member
of the Audit Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Chairman
of the Nomination and Compensation Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Chair
of the Audit Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
representative of Biotech Avenir SAS, the legal entity that holds this board seat.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Senior Management  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B><I>Jean-Fran&ccedil;ois Mouney</I></B></FONT><FONT SIZE=2> has served as our Chief Executive Officer since September
1999 and as Chairman of our board of directors since June 2017. Mr.&nbsp;Mouney served as Chairman of our Executive Board from September 1999 to June 2017, when we changed our management structure.
He co-founded Genfit in 1999 after having been actively involved in the incubation of the company since 1997. Prior to this, he founded, managed and developed several companies specializing in
high-performance materials, particularly in the aeronautical industry. In 1992, he founded M&amp;M, a consultancy firm specializing in health economics. He was responsible for carrying out a feasibility
study for the economic development agency, Eurasant&eacute;, within the field of health and biology in Nord-Pas-de-Calais region of France and was appointed Chief Executive Officer of this
agency. He has continued to serve in this role since its launch in 1995. Mr.&nbsp;Mouney has also served as Deputy Chairman of the "Nutrition, Health and Longevity" research hub between 2008 and
2016 and as an Advisor to the Banque de France since 2008. Mr.&nbsp;Mouney is a graduate of ESCP-Europe Business School, and holds a master degree in Economics from the University of Lille. He is
also chairman of the board of directors of our wholly owned subsidiary, Genfit&nbsp;Corp., chairman of the Management Committee of our wholly owned subsidiary Genfit Pharmaceuticals SAS, and
chairman of the board of directors of The NASH Education Program. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>149</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=154,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=21422,FOLIO='149',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_150"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Dean Hum, Ph.D</I></B></FONT><FONT SIZE=2> has served as our Chief Operating Officer since September 2018 and prior to that served as our Chief Scientific Officer
since 2000 and as a member of our former Executive Board from May&nbsp;2014 until the change in management and administration in June 2017. He earned a Ph.D in Biochemistry from McGill University in
Montreal in 1990. He is an expert in the regulation of gene expression and nuclear receptors associated with endocrine and cardiometabolic diseases. Prior to becoming a Professor at Laval University
in Quebec from&nbsp;1994 to&nbsp;2000, Dr.&nbsp;Hum held a research position at the University of California in San Francisco from&nbsp;1990 to&nbsp;1994. Dr.&nbsp;Hum coordinates our
research and development activities with our Chief Executive Officer and in close collaboration with our other scientific officers and project managers. He is also a member of the board of directors
of our wholly
owned subsidiary, Genfit&nbsp;Corp., and a member of the Management Committee of our wholly owned subsidiary Genfit Pharmaceuticals SAS. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Nathalie Huitorel</I></B></FONT><FONT SIZE=2> has served as our Executive Vice President and Chief Financial and Administrative Officer since October 2007 and as a
member of our former Executive Board until the change in management and administration in June 2017. From 1997 to 2007, she was Chief Financial and Administrative Officer for MS Composites, a company
specializing in high-performance composite materials. She is a graduate of the SKEMA Business School (School of Management in Lille, France). At Genfit, she oversees the financial management controls,
purchasing, human resources department and general services. She is also a member of the board of directors of our wholly owned subsidiary, Genfit&nbsp;Corp., the Management Committee of Genfit
Pharmaceuticals SAS and a member of the board of directors and Treasurer of The NASH Education Program since its inception. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Pascal Prigent</I></B></FONT><FONT SIZE=2> has served as our Executive Vice President, Marketing and Development since May 2018. Prior to that, he served as Vice
President of Marketing&#151;U.S. Vaccines for GlaxoSmithKline USA from April 2014 to November 2017. Prior to this, he was Vice President and General Manager of GlaxoSmithKline Romania from
January 2011 to March 2014. He also served in various roles at Eli Lilly and its affiliates from 1996 through January 2011. Mr.&nbsp;Prigent is a graduate of Reims Management School, now known as
NEOMA Business School, in Reims, France and earned his MBA from INSEAD in Fontainebleau, France. He has also served as a member of the board of directors and Corporate Secretary of The NASH Education
Program since July&nbsp;2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Jean-Christophe Marcoux</I></B></FONT><FONT SIZE=2> has served as our Chief Strategy Officer since 2016, after joining our company in 2015 to play a
cross-disciplinary role regarding tactical, strategic and operational matters. He is an engineer and graduated from INSA Lyon in France, having spent part of his time at the University of Leeds in
England. In addition, he also holds a degree in Strategic Management and Economic Intelligence from EGE in France. From 2000 to 2015, he led international projects and programs in a variety of
industrial sectors, in particular in Europe and Asia, and with clients and colleagues in the United States. In 2012, he joined IQVIA (formerly known as IMS Health, and later Quintiles IMS), a global
information and technology services company for clients in the healthcare industry, where he led projects in healthcare systems, such as patient longitudinal studies, forecasting, targeting,
profiling, prospective analyses, digital healthcare and innovation. He was also a member of the board of directors and Corporate Secretary of The NASH Education Program from its inception in 2017
until mid-2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Laurent Lannoo</I></B></FONT><FONT SIZE=2> has served as our Corporate Secretary and Director of Legal Affairs since 2008. From 2005 to 2008, he served in various
roles at the Coeur et Art&egrave;res foundation, including as chairman of its executive board from 2007 to 2008 and as corporate secretary from 2005 to 2006. Prior to that, from 1996 to 2005,
he was in charge of finance and administration for Eurasant&eacute;, the public agency for the economic development of healthcare activities in the Nord-Pas de Calais region of France. He
began his professional career at M&amp;M, a consulting firm, in 1994, becoming partner in 1996. Mr.&nbsp;Lannoo graduated from Lille Law School with a degree in Business Law. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>150</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=155,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=797436,FOLIO='150',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_151"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B><I>Xavier Guille des Buttes</I></B></FONT><FONT SIZE=2> served as member of our former Supervisory Board since 2006 and has
served as a member of our board of directors since June 2017. Mr.&nbsp;Guille des Buttes was educated at the Ecole Sup&eacute;rieure des Sciences Commerciales d'Angers, the Institut de
gestion pr&eacute;visionnelle et de contr&ocirc;le de gestion, and has spent his entire career in the pharmaceutical industry. He has held a number of executive positions for more
than 30&nbsp;years, particularly in the French subsidiary of the German Group Schering AG, where, from 1974 to 2006, he successively held the positions of Marketing Director, General Manager of the
Pharmaceutical Division and Chairman of the board of directors. As a member of our former Supervisory Board from October 2006, he chaired the Supervisory Board from April 2008 to June 2017, when he
became Vice-Chairman of our Board of Directors following the change in administration and management. In addition to his responsibilities at Genfit, he also serves as director of several private
companies. Mr.&nbsp;Guille des&nbsp;Buttes also chairs the Foundation of the Catholic University of Lille. He is also vice chairman of the NASH Education Program. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Catherine Larue, Ph.D</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since 2017. Since 2012, Dr.&nbsp;Larue has been CEO of the
Integrated Biobank of Luxembourg (IBBL), where she leads the development of the bio banking strategy and new initiatives in the field of personalized medicine. She also served as interim CEO of the
Luxembourg Institute of Health (LIH), a biomedical research institute, between 2016 and 2017. Prior to joining the IBBL, Dr.&nbsp;Larue piloted Genfit's biomarker program until 2012.
Dr.&nbsp;Larue began her career as team leader at Sanofi at the Montpellier, France based research and development center in the cardiovascular research department. She later joined Sanofi
Diagnostics Pasteur, as Director of Research and Development and then spent 11&nbsp;years at the Bio-Rad group, holding different management positions. She participated in the discovery of several
innovative biomarkers and the commercialization of dozens of diagnostic products. Dr.&nbsp;Larue holds a doctorate in experimental biology and an accreditation to direct research (Habilitation
&agrave; Diriger la Recherche, or HDR) from the University of Rouen, a University Degree in clinical oncology from the University of Paris VI and an executive MBA from St.&nbsp;John's
University (New York). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Anne-H&eacute;l&egrave;ne Monsellato</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors and the chair of our Audit Committee
since 2017. Ms.&nbsp;Monsellato has been a Certified Public Accountant in France since 2008 and received a board member certification from IFA Sciences Po (French Association of Directors)
in&nbsp;2014. She graduated from EM Lyon in 1990 with a degree in Business Management. Since May 2015, she has been an independent director, the Chairman of the Audit and Risk Committee and a member
of the Corporate Governance and Nomination Committee of Euronav, a Belgian crude oil tanker company listed on the New York Stock Exchange and Euronext Brussels. In addition, she serves as the Vice
President and Treasurer of the Mona Bismarck American Center for Art and Culture, a U.S. public foundation based in New York. From 2005 until 2013, Ms.&nbsp;Monsellato served as a Partner with
Ernst&nbsp;&amp; Young (now EY), Paris, after having served as Auditor/Senior, Manager and Senior Manager for the firm starting in 1990. During her time at EY, she gained extensive experience in cross
border listing transactions, in particular with the United States, internal control and risk management, and was involved with several companies in the pharmaceutical and biotechnology sector.
Ms.&nbsp;Monsellato is an active member of the IFA since 2013. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Fr&eacute;d&eacute;ric Desdouits</I></B></FONT><FONT SIZE=2> served as member of our former Supervisory Board since 2014 and has served as a member of
our board of directors since our change in management and administration in June 2017. Mr.&nbsp;Desdouits is Managing Director of Uetikon (Lahr, Germany), a member of the Novacap group in Ecully,
France. Prior to joining Novacap in October 2017, he was head of Business Development, Acquisition and Market Intelligence at Pierre Fabre Group since 2011, and North American Pharma Director from
January 2016. He was also a member of the pharmaceuticals executive board and of the development products board. Prior to joining Pierre Fabre, from 2004 to 2011, Mr.&nbsp;Desdouits was Managing
Partner at Bionest Partners, a consulting and transaction firm based in Paris and New York </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>151</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=156,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=795581,FOLIO='151',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_152"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>specializing
in healthcare and biotechnology. From 2007 to 2011, he was the founding Managing Partner of Bionest Partners Finance, a boutique specialized in value strategy and fund raising for
emerging bio-companies. Between 1997 and 2004, Mr.&nbsp;Desdouits was a partner in charge of Pharmaceutical and Biotechnology sectors at Exane BNP-Paribas, an investment company. Prior to that,
Mr.&nbsp;Desdouits worked in research from 1996 to 1997 at GlaxoWellcome in France (now GSK), as a consultant for Hoechst in the USA from 1995 to 1997 and was a Ph.D student from 1992 to 1995 with a
grant from Rh&ocirc;ne-Poulenc in France (now Sanofi). Between 2010 and 2011, he was a member of the Pre-Phase&nbsp;III DPU Blood&nbsp;&amp; Vessels board at Sanofi Aventis (now Sanofi) in
Chilly-Mazarin, France. Mr.&nbsp;Desdouits is a member of the supervisory board of CiToxLab. Between 2008 and 2011, Mr.&nbsp;Desdouits was a board member at Exonhit Therapeutics (now Diaxonhit
Therapeutics) and member of the Mergers and Acquisitions subcommittee, and from 2015 to 2017, was an observer on the Orphelia Pharma Board of Directors. Mr.&nbsp;Desdouits graduated from Ecole
Polytechnique (Palaiseau, France), obtained a M.S. in pharmacology and a Ph.D in Neurosciences at University Paris VI and Coll&egrave;ge de France and studied from 1994 to 1996 at the
Rockefeller University in New York. He is a CEFA (Certified European Financial Analyst) and Certified in Global Management from INSEAD. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Florence S&eacute;journ&eacute;</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since June 2017 as representative of SAS
Biotech Avenir. She was a member of our former Supervisory Board from 1999 until the change in our management and administration in June 2017. Ms.&nbsp;S&eacute;journ&eacute;
co-founded our company and served as our chief operating officer, business development director, industrial alliances coordinator and member of our former Executive Board from 1999 to 2008. Since
2008, she has been the chairwoman of Da Volterra, a clinical-stage biotechnology company. From 1997 to 1999, she was in charge of the biopharmaceutical sector for Eurasant&eacute;, the
economic development agency. Ms.&nbsp;S&eacute;journ&eacute; graduated from the Ecole des Mines of Paris with a degree in Biotechnology and holds a master's degree in Pharmacy from
the University of Illinois in Chicago. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Philippe Moons</I></B></FONT><FONT SIZE=2> served as member of our former supervisory board since 2015 and has served as a member of our board of directors since June
2017. Mr.&nbsp;Moons graduated from the Institut Catholique des Arts et M&eacute;tiers de Lille and received an MBA from the Ecole des Hautes Etudes Commerciales du Nord (EDHEC), and began
his career as a business engineer at Delattre Leviver, part of the Creusot-Loire Group, a French industrial Group. In 1989, he joined Finorpa, a venture capital and growth capital company, operating
under the aegis of the Group "Charbonnage de France" in the Nord-Pas-de-Calais region of France. Between 2006 and&nbsp;2015, he was in charge at Finorpa of supporting and financing several companies
in their early-stage activities or development phases, in particular in the fields of biology and health. Mr.&nbsp;Moons was a member of the executive board of Finovam, a regional venture capital
company, established in 2014 to strengthen the emergence and provide seed capital to innovative businesses, primarily technological projects in the Nord-Pas-de-Calais region, until&nbsp;2015. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Composition  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Until June 2017, our company had a two-tier corporate governance system: an executive board
(</FONT><FONT SIZE=2><I>directoire</I></FONT><FONT SIZE=2>) was responsible for managing the company and a supervisory board (</FONT><FONT SIZE=2><I>conseil de surveillance</I></FONT><FONT SIZE=2>)
oversaw and advised the executive board. We have now established a board of directors. Our board of directors currently consists of seven members, none of which are citizens or residents of the United
States. As permitted by French law, one of our directors, SAS Biotech Avenir, is a legal entity. This entity has designated an individual, Florence S&eacute;journ&eacute;, to represent
it and to act on its behalf at meetings of our board of directors. Ms.&nbsp;S&eacute;journ&eacute; has the same responsibilities to us and to our shareholders as she would have if
she had been elected to our board of directors in her individual capacity. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
French law and our bylaws, our board of directors must be comprised of between three and 18&nbsp;members. Since January&nbsp;1, 2017, the number of directors of each gender may
not be less than 40%. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>152</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=157,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=459734,FOLIO='152',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_153"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Any
appointment made in violation of this limit that is not remedied within six months of this appointment will be null and void. Within these limits, the number of directors is determined by our
shareholders. Directors are appointed, reappointed to their position, or removed by the company's ordinary general meeting, and in particular, any appointment which remedies a violation of the 40%
gender limit must be ratified by our shareholders at the next ordinary general meeting. Their term of office, in accordance with our bylaws, is five years. Directors chosen or appointed to fill a
vacancy must be elected by our board of directors for the remaining duration of the current term of the vacant
director. The appointment must then be ratified at the next shareholders' general meeting. In the event the board of directors would be comprised of less than three directors as a result of a vacancy
or removal, the remaining directors shall immediately convene a shareholders' general meeting to elect one or several new directors so there are at least three directors serving on the board of
directors, in accordance with French law. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table sets forth the names of our directors, the years of their initial appointment as directors of our board or our former supervisory board or our former executive board
and the expiration dates of their current term. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="79pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>CURRENT<BR>
POSITION </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>YEAR OF<BR>
INITIAL<BR>
APPOINTMENT </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>TERM<BR>
EXPIRATION<BR>
YEAR </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Fran&ccedil;ois Mouney</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chairman</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1999</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Xavier Guille des Buttes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Vice Chairman</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2006</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SAS Biotech Avenir represented by Florence S&eacute;journ&eacute;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2010</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fr&eacute;d&eacute;ric Desdouits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine Larue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anne-H&eacute;l&egrave;ne Monsellato</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Philippe Moons</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
member of the former executive board of our company and was subsequently appointed as a member of our board of directors at our combined general meeting in June
2017 and elected as chairman and chief executive officer of our company.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
member of the former supervisory board and was subsequently appointed as a member of our board of directors at our combined general meeting in June 2017 and
elected as vice chairman.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Biotech
Avenir SAS was appointed to the former supervisory board for the first time on incorporation of the company on September&nbsp;15, 1999.
Ms.&nbsp;S&eacute;journ&eacute; has been its permanent representative since 2010, first to the former supervisory board and later to the board of directors of our company.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
member of the former supervisory board and was subsequently appointed as a member of our board of directors at our combined general meeting in June
2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
member of the former supervisory board and was subsequently appointed as a member of our board of directors at our combined general meeting in June 2017. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Independence  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a foreign private issuer, under the listing requirements and rules of the Nasdaq Global Market, we are not required to have independent
directors on our board of directors, except to the extent that our audit committee is required to consist of independent directors, subject to certain phase-in schedules. Nevertheless, our board of
directors has undertaken a review of the independence of the directors and considered whether any director has a material relationship with us that could compromise his or her ability to exercise
independent judgment in carrying out his or her </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>153</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=158,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=402492,FOLIO='153',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_154"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>responsibilities.
Based upon information requested from, and provided by, each director concerning such director's background, employment and affiliations, including family relationships, our board of
directors determined that all of our directors, except for Jean-Fran&ccedil;ois Mouney and Florence S&eacute;journ&eacute;, as representative of Biotech Avenir, qualify as
"independent directors" as defined under applicable rules of the Nasdaq Global Market and the independence requirements contemplated by Rule&nbsp;10A-3 under the Exchange Act. In making these
determinations, our board of directors considered the current and prior relationships that each non-employee director has with our company and all other facts and circumstances that our board of
directors deemed relevant in determining their independence, including the beneficial ownership of our ordinary shares by each non-employee director and his or her affiliated entities (if any). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of the Board in Risk Oversight  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors is primarily responsible for the oversight of our risk management activities and has delegated to the audit committee the
responsibility to assist our board in this task. The audit committee also monitors our system of disclosure controls and procedures and internal control over financial reporting and reviews contingent
financial liabilities. The audit committee, among other things, examines our balance sheet commitments and risks and the relevance of risk monitoring procedures. While our board oversees our risk
management, our management is responsible for day-to-day risk management processes. Our board of directors expects our management to consider risk and risk management in each business decision, to
proactively develop and monitor risk management strategies and processes for day-to-day activities and to effectively implement risk management strategies adopted by the board of directors. We believe
this division of responsibilities is the most effective approach for addressing the risks we face. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Governance Practices  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a French </FONT><FONT SIZE=2><I>soci&eacute;t&eacute; anonyme</I></FONT><FONT SIZE=2>, we are subject to various corporate
governance requirements under French law. In addition, as a foreign private issuer listed on the Nasdaq Global Market, we will be subject to Nasdaq corporate governance listing standards. However, the
corporate governance standards provide that foreign private issuers are permitted to follow home country corporate governance practices in lieu of Nasdaq rules, with certain exceptions. We intend to
rely on these exemptions for foreign private issuers and follow French corporate governance practices in lieu of the Nasdaq corporate governance rules, which would otherwise require that (1)&nbsp;a
majority of our board of directors consist of independent directors; (2)&nbsp;we establish a nominating and corporate governance committee; and (3)&nbsp;our remuneration committee be composed
entirely of independent directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a foreign private issuer, we are required to comply with Rule&nbsp;10A-3 of the Exchange Act, relating to audit committee composition and responsibilities. Rule&nbsp;10A-3
provides that the audit committee must have direct responsibility for the nomination, compensation and choice of our auditors, as well as control over the performance of their duties, management of
complaints made, and selection of consultants. However, if the laws of a foreign private issuer's home country require that any such matter be approved by the board of directors or the shareholders,
the audit committee's responsibilities or powers with respect to such matter may instead be advisory. Under French law, the audit committee may only have an advisory role and appointment of our
statutory auditors, in particular, must be decided by the shareholders at our annual meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, Nasdaq rules require that a listed company specify that the quorum for any meeting of the holders of common stock be at least 33<SUP>1</SUP>/<SMALL>3</SMALL>% of the outstanding shares
of the company's voting stock. Consistent with French law, our bylaws provide that a quorum requires the presence of shareholders having at least (1)&nbsp;20% of the shares entitled to vote in the
case of an ordinary shareholders' general meeting or at an extraordinary shareholders' general meeting where shareholders are voting on a capital increase by capitalization of reserves, profits or
share premium, or (2)&nbsp;25% of the shares </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>154</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=159,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1018252,FOLIO='154',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_155"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>entitled
to vote in the case of any other extraordinary shareholders' general meeting. If a quorum is not present, the meeting is adjourned. There is no quorum requirement when an ordinary general
meeting is reconvened, but the reconvened meeting may consider only questions which were on the agenda of the adjourned meeting. When an extraordinary general meeting is reconvened, the quorum
required is 20% of the shares entitled to vote, except where the reconvened meeting is considering capital increases through capitalization of reserves, profits or share premium. For these matters, no
quorum is required at the reconvened meeting. If a quorum is not present at a reconvened meeting requiring a
quorum, then the meeting may be adjourned for a maximum of two months. See the section of this prospectus titled "Description of Share Capital&#151;Key Provisions of Our Bylaws and French Law
Affecting Our Ordinary Shares (Articles&nbsp;11, 12, 32, 40 and&nbsp;41 of the Bylaws)." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Committees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The board of directors has established an audit committee and a remuneration and appointments committee, which operate pursuant to rules of
procedure adopted by our board of directors. The board of directors also established in September 2017 an alliance committee to analyze potential business and corporate development opportunities that
may be available to us. Subject to available exemptions, the composition and functioning of all of our committees will comply with all applicable requirements of the French Commercial Code, the
Exchange Act, the Nasdaq Global Market and SEC rules and regulations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with French law, committees of our board of directors will only have an advisory role and can only make recommendations to our board of directors. As a result, decisions
will be made by our board of directors taking into account non-binding recommendations of the relevant board committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our audit committee assists our board of directors in its oversight of our corporate accounting and financial
reporting and submits
the selection of our statutory auditors, their remuneration and independence for approval. Ms.&nbsp;Anne-H&eacute;l&egrave;ne Monsellato, Mr.&nbsp;Xavier Guille de Buttes and
Mr.&nbsp;Philippe Moons currently serve on our audit committee. Ms.&nbsp;Monsellato is the chairperson of our audit committee. Our board has determined that each member is independent within the
meaning of the applicable listing rules and the independence requirements contemplated by Rule&nbsp;10A-3 under the Exchange Act. Our board of directors has further determined that
Ms.&nbsp;Monsellato is an "audit committee financial expert" as defined by SEC rules and regulations and that each of the members qualifies as financially sophisticated under the applicable Nasdaq
listing rules. The principal responsibility of our audit committee is to monitor the existence and efficacy of the company's financial audit and risk control procedures on an ongoing basis. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors has specifically assigned the following duties to the audit committee:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> monitoring the financial reporting process provided by the company. In this respect, it examines in particular the consistency and the
relevance of the accounting standards and methods used by the company, and the advisability of any modification of the accounting methods. Special attention is paid by the audit committee to reviewing
the accounting policies used for the valuation of significant or unusual transactions. The audit committee may make recommendations, in particular to ensure the integrity of the financial reporting
process provided by the company, control the integrity of the financial information provided by the company and, in particular, review the consistency and relevance of the accounting standards and
methods retained by the company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> monitoring of the effectiveness of the internal control and risk management systems, as well as of the internal audit, as regards the
procedures relating to the preparation and processing of accounting and financial information, without it is undermining its independence. If necessary, it alerts the board of directors in the event
of an irregularity or anomaly identified in the </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>155</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=160,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=578468,FOLIO='155',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_156"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>company's
financial statements or control procedures. The audit committee assists the board of directors in drafting the report on internal control; </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> monitoring the appointment and renewal process of the statutory auditors. For this purpose, and in accordance with the regulations, the audit
committee issues a recommendation to the board of directors on the statutory auditors proposed for appointment and / or renewal by the shareholders' general meeting; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> monitoring of the performance by the Statutory Auditors of their mission, taking into account, where appropriate, the findings and conclusions
of the </FONT><FONT SIZE=2><I>Haut conseil du commissariat aux comptes</I></FONT><FONT SIZE=2> following the audits carried out, in accordance with the regulations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> monitoring by the statutory auditors of the conditions of independence under the conditions and in the manner provided for by the regulations,
and in particular those mentioned in Article&nbsp;6 of Regulation (EU) No.&nbsp;537/2014. The audit committee takes the necessary measures to implement paragraph&nbsp;3 of Article&nbsp;4 of
this Regulation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> pre-approval of the provision of services other than the certification of the accounts by the statutory auditors in compliance with the
applicable regulations; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the regular report to the board of directors on the performance of its duties. The audit committee also reports on the results of the
certification of the financial statements, how this mission has contributed to the integrity of financial reporting and the role it has played in this process. It informs the board of directors
without delay of any difficulty encountered. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nomination and Compensation Committee.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Xavier Guille des Buttes, Dr.&nbsp;Catherine Larue and
Mr.&nbsp;Jean-Fran&ccedil;ois
Mouney currently serve on our nomination and compensation committee, which we also refer to as our remuneration and appointments committee. Mr.&nbsp;Guille des&nbsp;Buttes is the chairperson of
our remuneration and appointments committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors has specifically assigned the following duties to the remuneration and appointments committee:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> ensure the professionalism and objectivity of the appointment procedure for senior executives and corporate officers and senior management of
the company. In particular, it is in charge of making any proposal regarding the size and the desirable balance of the composition of the board of directors in view of the structure and evolution of
the shareholding of our company, as well as the requirements for good corporate governance, including the proportion of independent directors at our board of directors. Its mission is to research and
assess potential candidates as well as the opportunity to renew mandates; and reviews the future succession of our company's chairman and chief executive officer; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> assess the status of each of its board members relatives to other relations they might have with our company, which may compromise his or her
free judgment or trigger potential conflicts of interest with us; the nomination and compensation committee must also organize a procedure to select future independent members of the Board of
Directors; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> make proposals to the board of directors concerning the elements of compensation or benefits granted to senior executives, corporate officers
and senior management, including directors' attendance fees and salaries, allowances or remuneration of any kind that such persons may receive under an employment contract or company contract with our
company, the indemnities and benefits due upon termination of their employment, function or subsequent to this, the allocation of warrants or stock options or the free shares, or any form of long-term
incentive in the capital of the company. In this respect, the nomination and compensation committee assesses the scale of the compensation offered by the company in comparison with those practiced on
the market and gives its recommendations to the board of directors on the </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>156</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=161,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=589243,FOLIO='156',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_157"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>remuneration
levels and the breakdown between the various elements of the compensation, as well as the changes in compensation that may be proposed by the company to its senior management and
corporate officers. </FONT></P>

</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Code of Business Conduct and Ethics  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with the global offering, we intend to reinforce our Code of Business Conduct and Ethics, or the Code of Conduct, applicable to
all of our employees, senior management and directors. Following the closing of the global offering, the Code of Conduct will be available on our website at www.genfit.com. The audit committee of our
board of directors will be responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, senior management and directors. We expect that any
amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on our website. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation of Directors and Chief Executive Officer  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Compensation  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At our combined general meetings of shareholders held on June&nbsp;16, 2017 and June&nbsp;15, 2018, shareholders set the total annual
attendance fees (</FONT><FONT SIZE=2><I>jetons de pr&eacute;sence</I></FONT><FONT SIZE=2>) to be distributed among non-employee directors at &euro;225,000 for the period beginning
with the shareholders' general meeting of June&nbsp;15, 2018 until the next shareholders' general meeting. The following table sets forth information regarding the compensation earned by our
non-employee directors for service on our board of directors during the year ended December&nbsp;31, 2018, which consisted solely of attendance fees. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>NAME

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Fran&ccedil;ois Mouney(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Xavier Guille des Buttes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fr&eacute;d&eacute;ric Desdouits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,174</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SAS Biotech Avenir</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Philippe Moons</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>29,704</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anne-H&eacute;l&egrave;ne Monsellato</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>37,075</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine Larue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,256</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Mouney
was appointed as chairman of the board of directors by the shareholders at the Shareholders' Meeting on June&nbsp;16, 2017. Mr.&nbsp;Mouney
does not receive compensation for his service on the board of directors. His compensation for the year ended December&nbsp;31, 2018 is described in the section titled "Executive Compensation." </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Chief Executive Officer Compensation  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information regarding compensation earned by Jean-Fran&ccedil;ois Mouney, our Chief Executive Officer and
sole executive officer under French law, during the year ended December&nbsp;31, 2018. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>NAME AND PRINCIPAL POSITION

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FIXED<BR>
COMPENSATION<BR>
(&euro;) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>VARIABLE<BR>
COMPENSATION<BR>
(&euro;) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>EQUITY<BR>
AWARDS<BR>
(&euro;) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>ALL OTHER<BR>
COMPENSATION<BR>
(&euro;) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>TOTAL<BR>
(&euro;) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Fran&ccedil;ois Mouney, Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>574,361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>566,074</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>103,651</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,251,286</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
gross amount consists of &euro;534,295 in annual compensation and &euro;40,066 paid for services as a director of Genfit Corp., our wholly
owned U.S. subsidiary. </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>157</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=162,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=299042,FOLIO='157',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_de10701_1_158"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Mouney
is eligible for a gross variable compensation of &euro;566,074 for the year ended December&nbsp;31, 2017 under our Incentive Plan,
subject to approval and which was ultimately approved by the Shareholders' General Meeting of June&nbsp;18, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
amount was calculated in accordance with the IFRS2 valuation of the grant to Mr.&nbsp;Mouney of (i)&nbsp;stock options to purchase 17,000 ordinary shares and
(ii)&nbsp;3,000 free shares.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>This
amount consists of use of a company car valued at &euro;7,200.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
various component parts of the overall annual compensation of Mr.&nbsp;Mouney for his duties within the Genfit group during the fiscal year ended December&nbsp;31, 2018 are
summarized below: </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fixed Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Through his executive officer contract (</FONT><FONT SIZE=2><I>contrat de mandat social</I></FONT><FONT SIZE=2>), Mr.&nbsp;Mouney received a
gross fixed annual compensation of &euro;534,295 for the duties carried out within Genfit&nbsp;S.A. and a gross fixed annual compensation of $45,916 for the performance of his office of
chairman of the board of directors of our subsidiary, Genfit Corp., during the year ended December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Variable Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the year ended December&nbsp;31, 2018, all variable compensation linked to Mr.&nbsp;Mouney's performance was granted under the Incentive
Plan in an amount of &euro;566,074. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Incentive Plan provides that the Chairman and Chief Executive Officer's incentive bonus can represent up to 40% of the sums to be allocated under the plan; these sums vary in
accordance with the conditions for carrying out the strategic and structuring operations for our development, and which reflect the beneficiary's performance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Awards  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During the year ended December&nbsp;31, 2018, Mr.&nbsp;Mouney was granted equity awards in the form of stock options to purchase 17,000
shares and 3,000 free shares. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The benefits in kind granted to Mr.&nbsp;Mouney for the year ended December&nbsp;31, 2018 consisted of a company car valued at
&euro;7,200. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Chief Executive Officer Change of Control and Severance Benefits  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Mouney also benefits from a severance payment falling within the scope of Article&nbsp;L.225-42-1 of the French Commercial Code
equal to six months' gross compensation, calculated on the basis of the last twelve months, excluding variable compensation associated with the
implementation of the Incentive Plan, plus an additional payment of one month's gross compensation per year of service within the Company, calculated on the same basis. In accordance with
Recommendation R16 of the Middlenext Corporate Governance Code, this payment is limited to two years' gross compensation, excluding variable compensations associated with the implementation of the
Incentive Plan, paid for the last fiscal year and it would be paid if, and only if, one of the following three performance conditions is achieved at the time that his post is
terminated:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> At least one collaboration agreement or licensing agreement for the rights to use our programs and products is in force with a
biopharmaceutical group, as defined in the Incentive Plan; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> At least two of our products are in the clinical development phase; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We have changed control as part of the backing by a biopharmaceutical group, as defined in the Incentive Plan, in the two months prior to the
time that his post is terminated. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>158</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=163,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=930493,FOLIO='158',FILE='DISK124:[18ZFA1.18ZFA10701]DE10701A.;60',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dg10701_1_159"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Mouney is not subject to a non-compete clause. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date of this prospectus, the second condition has been fulfilled. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitations on Liability and Indemnification Matters  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under French law, provisions of bylaws that limit the liability of directors are ineffective. However, French law allows </FONT> <FONT SIZE=2><I>soci&eacute;t&eacute;s
anonymes</I></FONT><FONT SIZE=2> to contract for and maintain liability insurance against civil liabilities incurred by any of their
directors and officers involved in a third-party action, provided that they acted in good faith and within their capacities as directors or officers of the company. Criminal liability cannot be
indemnified under French law, whether directly by the company or through liability insurance. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have liability insurance for our directors and officers, and intend to obtain insurance coverage for liability under the Securities Act. We also intend to enter into agreements with
our directors and senior management to provide contractual indemnification. With certain exceptions and subject to limitations on indemnification under French law, these agreements will provide for
indemnification for damages and expenses including, among other things, attorneys' fees, judgments and settlement amounts incurred by any of these individuals in any action or proceeding arising out
of his or her actions in that capacity. We believe that this insurance and these agreements are necessary to attract qualified directors and members of senior management. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
of our non-employee directors may, through their relationships with their employers or partnerships, be insured against certain liabilities in their capacity as members of our
board of directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
agreements may discourage shareholders from bringing a lawsuit against our directors and senior management for breach of their fiduciary duty. These provisions also may have the
effect of reducing the likelihood of derivative litigation against directors and senior management, even though such an action, if successful, might otherwise benefit us and our shareholders.
Furthermore, a shareholder's investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these insurance agreements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Incentives  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe our ability to grant equity incentives is a valuable and necessary compensation tool that allows us to attract and retain the best
available personnel for positions of substantial responsibility, provides additional incentives to our employees, senior management and directors and promotes the success of our business. Due to
French corporate law and tax considerations, we have historically granted several different equity incentive instruments to our directors, senior management, employees and other service providers,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> redeemable share warrants (otherwise known as </FONT><FONT SIZE=2><I>bons de souscription et/ou d'acquisition d'actions
remboursables</I></FONT><FONT SIZE=2>, or BSAAR); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> share warrants (otherwise known as </FONT><FONT SIZE=2><I>bons de souscription d'actions</I></FONT><FONT SIZE=2>, or BSA), which have
historically only been granted to non-employee directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> restricted, or free, shares (otherwise known as </FONT><FONT SIZE=2><I>actions gratuites,</I></FONT><FONT SIZE=2> or AGA); and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> stock options (otherwise known as </FONT><FONT SIZE=2><I>options de souscription et/ou dachat d'actions,</I></FONT><FONT SIZE=2> or SO). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors has authority to grant these equity incentive instruments and the aggregate amount authorized to be granted under these instruments must be approved by a
two-thirds majority of the votes held by our shareholders present, represented or voting by authorized means, at the relevant extraordinary shareholders' meeting. Once approved by our shareholders,
our board of directors can </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>159</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=164,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=333665,FOLIO='159',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dg10701_1_160"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>grant
share warrants (BSA) and redeemable share warrants (BSAAR) for up to 18&nbsp;months, and restricted (free) shares (AGA) and stock options (SO) for up to 38&nbsp;months from the date of the
applicable shareholders' approval. The authority of our board of directors to grant equity incentives may be extended or increased only by extraordinary shareholders' meetings. As a result, we
typically request that our shareholders authorize new pools of equity incentive instruments at every annual shareholders' meetings. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have four share-based compensation plans for our senior management, directors and employees, the BSAAR plan, the BSA plan, the AGA plan and the SO plan. In general, redeemable share
warrants and share warrants no longer continue to vest following termination of the employment, office or service of the holder and all vested shares must be exercised within post-termination exercise
periods set forth in the grant documents. In the event of certain changes in our share capital structure, such as a consolidation or share split or dividend, French law and applicable grant
documentation provides for appropriate adjustments of the numbers of shares issuable and/or the exercise price of the outstanding warrants. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, share warrants, stock options and free shares were outstanding allowing for the purchase of an aggregate of 548,882&nbsp;ordinary shares at a weighted
average exercise price of &euro;19.72 (equal to $22.59) per ordinary share based on the exchange rate in effect as of December&nbsp;31, 2018 (this weighted average exercise price does not
include 83,726 ordinary shares issuable upon the vesting of outstanding free shares that may be issued for free with no exercise price being paid). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Redeemable Share Warrants (BSAAR)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Redeemable share warrants have been granted to our directors and employees, including Mr.&nbsp;Mouney and the two other members of the former
executive board (</FONT><FONT SIZE=2><I>directoire</I></FONT><FONT SIZE=2>) who were corporate officers at the time of their subscription. Exercise of the BSAAR is subject to the effective presence
of the beneficiary in our company or one of our French or foreign subsidiaries as an employee, officer, or through a consulting agreement at the date of receipt of the exercise request accompanied by
the payment of the exercise price. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to authorizations granted by the shareholders meetings on April&nbsp;2, 2014 and February&nbsp;24, 2015, we put in place in September 2014 and July 2016, two share warrant
plans (BSAAR 2014 and BSAAR 2016) for members of the executive board (including the current Chairman and Chief Executive Officer) and non-corporate officer
employees:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 5,901 BSAAR 2014-A, 17,822 BSAAR 2014-B and 18,711 BSAAR 2014-C were subscribed by members of the executive board during the 2014 and 2015
fiscal years; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 3,118 BSAAR 2014-A, 6,237 BSAAR 2014-B, 6,237 BSAAR 2014-C were subscribed by Mr.&nbsp;Mouney during the 2014 and 2015 fiscal years;
and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 9,299 BSAAR 2014-A, 5,416 BSAAR 2014-B, 5,568 BSAAR 2014-C, 7,200 BSAAR 2016-A and 3,600 BSAAR 2016-B were subscribed by non-corporate officer
employees. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, 833 BSAAR 2014-A and 400 BSAAR-C have been exercised by non-corporate officer employees, and no BSAAR have been exercised by corporate officers. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>160</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=165,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=966530,FOLIO='160',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dg10701_1_161"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
main terms of the BSAAR plans are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plan title


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2014-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2014-B </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2014-C </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2016-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2016-B </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Meeting date</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>February&nbsp;24, 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>February&nbsp;24, 2015</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Dates of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;22, 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;22, 2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise conditions(1)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=9 ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>1 warrant / 1.03 shares</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription periods</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From September&nbsp;19, 2014 to October&nbsp;15, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From May&nbsp;7, 2015 to May&nbsp;29, 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From July&nbsp;6, 2015 to July&nbsp;31, 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From July&nbsp;25, 2016 to July&nbsp;27, 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From July&nbsp;25, 2016 to July&nbsp;27, 2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAARs granted</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>15,200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>23,238</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>24,279</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>7,200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>3,600</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Start date for the exercise of the BSAARs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>January&nbsp;1, 2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>August&nbsp;1, 2019</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSAAR expiry date</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;15, 2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>May&nbsp;4, 2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;1, 2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;27, 2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;27, 2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSAAR issuance price</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;5.61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;5.61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;5.61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;4.60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;4.60</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSAAR exercise price per share</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Number of shares subscribed as of December&nbsp;31, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>833</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSAAR cancelled or lapsed</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>14,367</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>833</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSAAR remaining as of December&nbsp;31, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>22,155</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>23,046</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>7,200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>3,600</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercisable
in tranches of 1/3 of the BSAAR owned by the beneficiary. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Share Warrants (BSA)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share warrants have been granted to the independent members of the former supervisory board and of the board of directors and scientific
consultants. Similar to options, share
warrants entitle a holder to exercise the warrant for the underlying vested shares at an exercise price per share determined by our board of directors and at least equal to the fair market value of an
ordinary share on the date of grant. However, unlike options, the exercise price per share is fixed as of the date of implementation of the plans pursuant to which the warrants may be granted, rather
than as of the date of grant of the individual warrants. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to delegations granted by our shareholders, our board of directors, determines the recipients of the warrants, the dates of grant, the number and exercise price of the share
warrants to be granted, the number of shares issuable upon exercise and certain other terms and conditions of the share warrants, including the period of their exercisability and their vesting
schedule. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>161</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=166,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=209868,FOLIO='161',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dg10701_1_162"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, we have issued three share warrants plans as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="79pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="79pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="79pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plan title

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2014-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2014-B </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2015-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2015-B </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2017-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2017-B </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Meeting date</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>April&nbsp;2, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;16, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;16, 2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Dates of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;24, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;24, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>January&nbsp;9, 2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>January&nbsp;9, 2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;21, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;21, 2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise conditions(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>1 warrant / 1.03 shares</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>1 warrant / 1 share</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription periods</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From August&nbsp;1, 2014 to September&nbsp;15, 2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From January&nbsp;2, 2015 to February&nbsp;25, 2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From January&nbsp;20, 2015 to February&nbsp;25, 2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From July&nbsp;1, 2015 to September&nbsp;15, 2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From December&nbsp;11, 2017 to December&nbsp;26, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From July&nbsp;1, 2018 to July&nbsp;15, 2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAs granted</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>46,765</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>46,765</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>12,860</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>12,860</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>18,345</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>18,345</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Start date for the exercise of the BSAs</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;1, 2014</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>March&nbsp;1, 2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>June&nbsp;1, 2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;1, 2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;1, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;16, 2018</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSA expiry date</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>September&nbsp;30, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>February&nbsp;28, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>May&nbsp;31, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>June&nbsp;30, 2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>July&nbsp;15, 2018</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSA issuance price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;0.01</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;0.01</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;0.01</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;0.01</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;2.00</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;2.00</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>BSA exercise price per share</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;23.50</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;35.95</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;35.95</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;19.97</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;19.97</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Number of shares subscribed as of December&nbsp;31, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Warrants cancelled or lapsed</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>46,765</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Warrants remaining as of December&nbsp;31, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>46,765</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>12,860</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>12,860</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>18,345</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>18,345</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercisable
by tranches of a minimum of 2,000 BSA, or a multiple thereof, except for outstanding balance under 2,000. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Free Shares (AGA)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Free shares may be granted to any individual employed by us or by any affiliated company. Free shares may also be granted to our chairman of the
board of directors, chief executive officer (</FONT><FONT SIZE=2><I>directeur g&eacute;n&eacute;ral</I></FONT><FONT SIZE=2>) and deputy executive officers
(</FONT><FONT SIZE=2><I>directeurs g&eacute;n&eacute;ral d&eacute;l&eacute;gu&eacute;</I></FONT><FONT SIZE=2>). Currently, Mr.&nbsp;Mouney serves as both our
chairmain of the board and chief executive officer and we do not have any deputy executive officers. However, under French law, the maximum number of shares that may be granted shall not exceed 10% of
the share capital as at the date of grant of the free shares (30% if the allocation benefits all employees). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017, the board of directors granted an aggregate of 41,196 free shares to all of our employees and senior management, and in 2018, the board of directors granted them an aggregate of
37,072 free shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors has the authority to administer the free shares plans. Our board of directors determines the recipients, the dates of grant, the number of free shares to be
granted and the terms and conditions of the free shares, including the length of their vesting period (starting on the grant date, during which the beneficiary holds a right to acquire shares for free
but has not yet acquired any shares) and holding period (starting when the shares are issued and definitively acquired but may not be transferred by the recipient) within the limits determined by the
shareholders. Our shareholders have determined that the vesting period should be set by the board of directors and should not be less than two years from the date of grant and that the optimal holding
period should be set by the board of directors. From the beginning of the vesting period, the cumulated vesting and holding period should not be less than three years. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>162</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=167,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=356424,FOLIO='162',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dg10701_1_163"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board of directors has the authority to modify awards outstanding under our AGA plans, subject to the consent of the beneficiary for any modification adverse to such beneficiary. For
example, the board has the authority to release a beneficiary from the continued service condition during the vesting period after the termination of the employment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
free shares granted under our AGA plans will be definitively acquired at the end of the vesting period as set by our board of directors subject to performance conditions and
continued service during the vesting period, except if the board releases a given beneficiary from this condition upon termination
of his or her employment contract. At the end of the vesting period, the beneficiary will be the owner of the shares. However, the shares may not be sold, transferred or pledged during the holding
period. In the event of disability before the end of the vesting period, the free shares shall be definitively acquired by the beneficiary on the date of disability. In the event the beneficiary dies
during the vesting period, the free shares shall be definitively acquired at the date of the request of allocation made by his or her beneficiaries in the framework of the inheritance provided that
such request is made within six months from the date of death. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, we granted an aggregate of 107,705 free shares under the free shares plans which will vest as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="116pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>MEETING<BR>
DATE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DATE OF<BR>
ALLOCATION </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>NUMBER<BR>
OF FREE<BR>
SHARES </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>EXERCISEABLE<BR>
(SUBJECT TO<BR>
CONDITIONS)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>STOCK PRICE<BR>
ON<BR>
ALLOCATION<BR>
DATE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FREE<BR>
SHARES<BR>
VESTED </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>AGA D and S 2016-1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>June&nbsp;21, 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>December&nbsp;15, 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>20,520</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>December&nbsp;16, 2019(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>20.79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>17,484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>AGA D and S 2016-2</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;21, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>December&nbsp;15, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>December&nbsp;16, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20.79</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>AGA D and S 2017-1</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;16, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>December&nbsp;21, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>27,468</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>January&nbsp;1, 2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>21.95</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>AGA D and S 2017-2</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;16, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>December&nbsp;21, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>January&nbsp;1, 2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>21.95</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>AGA D and S 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;15, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>November&nbsp;22, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>35,800</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>January&nbsp;1, 2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20.02</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Subject
to meeting performance conditions and continued employment with us.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Subject
to meeting the conditions, the AGA 2016-1 could be definitively vested in whole or part on December&nbsp;16, 2018, with a one year holding period, or on
December&nbsp;16, 2019 without a holding condition. As of December&nbsp;31, 2018, 7,985 and 9,499 free shares were definitively vested under the AGA 2016-1 and AGA 2016-2, respectively. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Options (SO)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock options may be granted to any individual employed by us or by any affiliated company. Stock options may also be granted to our chairman of
the board of directors, chief executive officer (</FONT><FONT SIZE=2><I>directeur g&eacute;n&eacute;ral</I></FONT><FONT SIZE=2>) and deputy executive officers
(</FONT><FONT SIZE=2><I>directeurs g&eacute;n&eacute;ral d&eacute;l&eacute;gu&eacute;</I></FONT><FONT SIZE=2>). Currently, Mr.&nbsp;Mouney serves as both our
chairman of the board and chief executive officer and we do not have any deputy executive officers. In addition, incentive stock options may not be granted to owners of shares possessing 10% or more
of the share capital of our company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017 and 2018, the board of directors, using the authorizations granted to them by the extraordinary shareholders' meeting, decided to grant stock options to the members of the board
of directors, including Mr.&nbsp;Mouney, and certain senior managers. These stock options were put in place as motivation and retention instruments for the current teams, to recruit new talents
interested in
participating in our future development and include them in obtaining operational and financial objectives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
stock options allow us to continue to offer to new employees competitive packages compared to other companies in our sector, in particular U.S. companies; substantiate in shares a
portion of the total profit-sharing of employees our company, this contributing to the alignment of their interests with those of shareholders; and motivate the employees to achieve long-term
objectives, and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>163</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=168,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=705428,FOLIO='163',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dg10701_1_164"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>particularly
to retain some of them by establishing a direct link between their level of profit sharing and the evolution of the stock price. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017, the board of directors granted an aggregate of 109,250 options as part of the plan SO 2017 which will expire December&nbsp;31, 2027. In 2018, the board of directors granted an
aggregate of 139,500 options as part of the SO 2018 and SO U.S. 2018 plans, each of which will expire December&nbsp;31, 2028. Stock options issued pursuant to these plans provide the holder with the
right to purchase a specified number of ordinary shares from us at a fixed exercise price payable at the time the stock option is exercised, as determined by our board of directors. The plans
generally provide that the exercise price for any stock option will be no less than 80% of the volume weighted average price of the 20 market trading days prior to the day of the board of directors'
decision to grant the options. The vesting of the stock options is subject to performance conditions and the continued presence our company. These conditions are evaluated over a period of three years
and reflect our mid-term objectives. Incentive stock options and non-statutory stock options may be granted under the SO plans. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors has the authority to administer and interpret the SO plans. Subject to the terms and conditions of the stock option plan, our board of directors determines the
recipients, dates of grant, exercise price, number of stock options to be granted and the terms and conditions of the stock options, including the length of their vesting schedules. Our board of
directors is not required to grant stock options with vesting and exercise terms that are the same for every participant. The term of each stock option granted under the SO plans will generally be
10&nbsp;years from the date of grant. Further, stock options will generally terminate on the earlier of when the beneficiary ceases to be an employee of our company or upon certain transactions
involving our company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors has the authority to modify awards outstanding under our SO plans, subject to the written consent of the beneficiary for any modification adverse to such
beneficiary. For example, our board of directors has the authority to extend a post-termination exercise period. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
options granted under the SO plans generally may not be sold, transferred or pledged in any manner other than by will or by the laws of descent or distribution. In the event of
disability, unless otherwise resolved by our board of directors, the beneficiary's right to exercise the vested portion of his or her stock option generally terminates six months after the last day of
such beneficiary's service, but in any event no later than the expiration of the maximum term of the applicable stock options. In the event the beneficiary dies during the vesting period, then, unless
otherwise resolved by our board of directors, the beneficiary's estate or any recipient by inheritance or bequest may exercise any portion of the stock option vested at the time of the beneficiary's
death within the six months following the date of death, but in any event no later than the expiration of the maximum term of the applicable stock options. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>164</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=169,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=474072,FOLIO='164',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<A NAME="page_dg10701_1_165"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
main terms of the SO plans are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plan title

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2016-1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2016-2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2017-1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2017-2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2018 </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Meeting date</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;21, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;21, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;16, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;16, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>June&nbsp;15, 2018</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Dates of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;15, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;15, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;21, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;21, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>November&nbsp;7, 2018</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise conditions(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=9 ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>1 option / 1 share</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription periods</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From December&nbsp;15, 2016 to September&nbsp;15, 2018 or December&nbsp;15, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From December&nbsp;15, 2016 to December&nbsp;15, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From December&nbsp;6, 2017 to December&nbsp;31, 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From December&nbsp;6, 2017 to December&nbsp;31, 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>From November&nbsp;7, 2018 to December&nbsp;31, 2021</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of SOs granted</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>48,917</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>24,458</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>72,830</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>36,420</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>139,500</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Start date for the exercise of the SOs</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;16, 2019</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;16, 2019</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>January&nbsp;1, 2021</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>January&nbsp;1, 2021</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>January&nbsp;1, 2022</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>SO expiry date</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;16, 2026</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;16, 2026</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;31, 2027</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;31, 2027</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>December&nbsp;31, 2028</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>SO exercise price per share</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;15.79/&euro;21.12(2)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;15.79/&euro;21.12</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;17.91/&euro;22.54(3)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;17.91/&euro;22.54</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>&euro;16.00/&euro;21.65(4)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Number of SO exercised as of December&nbsp;31, 2018.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>SO voided or lapsed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>8,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>4,333</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>8,666</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>4,334</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>0</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>SO remaining as of December&nbsp;31, 2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>40,250</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>20,125</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>64,164</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>32,086</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>139,500</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercisable
by 1/3 of the number of options held by each beneficiary.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price at &euro;15.79 for SO 2016-1 and SO 2016-2 and &euro;21.12 for SO US 2016-1 and SO US 2016-2.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price at &euro;17.91 for SO 2016-1 and SO 2016-2 and &euro;22.54 for SO US 2016-1 and SO US 2016-2.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price at &euro;16.00 for SO 2018 and &euro;21.65 for SO US 2018. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>165</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=170,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=178184,FOLIO='165',FILE='DISK124:[18ZFA1.18ZFA10701]DG10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:23' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_di10701_1_166"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="di10701_certain_relationships___di102226"> </A>
<A NAME="toc_di10701_1"> </A></FONT> <FONT SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1, 2016, we have engaged in the following transactions with our directors, senior management and holders of more than 5% of
our outstanding voting securities and their affiliates, which we refer to as our related parties. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Arrangements with Our Chief Executive Officer  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the change in our management structure on June&nbsp;16, 2017, Mr.&nbsp;Mouney, our chief executive officer, was party to an
employment contract with us. The main obligations contained in the most recent amendments to the contract were the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fixed gross monthly salary of &euro;35,385 and the payment of a 13th&nbsp;month; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a company car, the value of which cannot exceed &euro;65,000 if purchased new; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> subscription to the French social security regime for company managers and senior executives (</FONT><FONT SIZE=2><I>r&eacute;gime de
garantie sociale des chefs d'entreprise et des dirigeants d'entreprise</I></FONT><FONT SIZE=2>, or GSC); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a non-disclosure clause; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a severance payment, in the event of termination (provided there is no evidence of severe misconduct (</FONT><FONT SIZE=2><I>faute
grave</I></FONT><FONT SIZE=2> under French law) or gross negligence (</FONT><FONT SIZE=2><I>faute lourde</I></FONT><FONT SIZE=2> under French law)), totaling six months in wages, calculated based on
the monthly wages paid over the previous 12&nbsp;months (including the 13th&nbsp;month), plus one month of his gross wages for every year he was employed by us. The amount of this severance is
capped at two years of gross compensation. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
employment contract of Mr.&nbsp;Mouney was suspended and then terminated and replaced by a corporate mandate agreement (</FONT><FONT SIZE=2><I>contrat de mandat
social</I></FONT><FONT SIZE=2>) in his capacity as our Chairman and Chief Executive Officer on June&nbsp;16, 2017. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Biotech Avenir  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biotech Avenir SAS, our holding company, holds 6.06% of our share capital and 10.79% of our voting rights. Mr.&nbsp;Mouney, the Chairman of
our board of directors and our Chief Executive Officer, is also Chairman of the Management Committee of Biotech Avenir and holds 17.1% of its share capital. Florence
S&eacute;journ&eacute;, who represents Biotech Avenir on our board of directors, is also member of the Management Committee of Biotech Avenir and holds 9.9% of its share capital. The
registered office of Biotech Avenir is located at the same address as our principal executive offices, without charge to Biotech Avenir. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


The NASH Education Program  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The NASH Education Program endowment fund was created in November 2016 at the initiative of our company to develop and finance disease awareness
activities targeting medical professionals and the general public. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to an agreement with effect from July&nbsp;1, 2016, we decided to finance the creation by Pinnacle Clinical Research of a registry of NAFLD/NASH patients, which diseases are
targeted by certain of our drug and biomarker candidates. Our goal in supporting the creation of this registry was to contribute to the improvement of scientific and medical knowledge around NAFLD and
NASH. As a result, we decided on December&nbsp;22, 2016, with effect from December&nbsp;31, 2016, to assign the benefit and obligations of this agreement to our endowment fund, The NASH Education
Program. The NASH Education Program was created on November&nbsp;3, 2016 to educate the medical community and patients on the lessons that can be learned from these patients, in accordance with its
objectives. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>166</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=171,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=715187,FOLIO='166',FILE='DISK124:[18ZFA1.18ZFA10701]DI10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;12:05' -->
<A NAME="page_di10701_1_167"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the year ended December&nbsp;31, 2017, we granted to The NASH Education Program a donation of approximately &euro;1.8&nbsp;million so that The NASH Education Program
could honor the obligations under the transfer of registry donation and carry out the other planned disease awareness activities to patients and doctors. For the year ended December&nbsp;31, 2018,
we donated &euro;959,000 to The NASH Education Program, primarily to support the creation of the first International NASH Day, which occurred in June 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registered office of The NASH Education Program is located at the same address as our principal executive offices, without charge to The NASH Education Program. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Shareholders' Agreement  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Shareholders' Agreement binds all shareholders who held equity in our company prior to the private placement we carried out before the
admission of our ordinary shares, on December&nbsp;19, 2006, to trading on the Alternext stock exchange managed by Euronext Paris. In particular, this Shareholders' Agreement grants a right of first
refusal to Biotech Avenir or to any shareholder it designates, provided said shareholder is a signatory of the Shareholders' Agreement, in the event that a shareholder who is a party to the
Shareholders' Agreement plans an off-market sale of its shares, insofar as the projected sale, plus any other sales carried out in a given year, represents at least 2% of our total share capital. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
parties to the Shareholders' Agreement that hold our shares include the Universit&eacute; de Lille, Fondation partenariale de l'Universit&eacute; de Lille, Finorpa
SCR, Biotech Avenir SAS and two of our directors Messrs.&nbsp;Mouney and Guille de Buttes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Shareholders' Agreement became effective on December&nbsp;19, 2006, and remained effective for an initial 10-year period, after which the Shareholders' Agreement was, and may
continue to be, automatically renewed for successive one-year periods. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Shareholders' Agreement was amended on January&nbsp;30, 2018 as part of the restructuring of the University of Lille, whereby on January&nbsp;1, 2018, the three universities of
Lille (the universities of Lille&nbsp;I, Lille II and Lille III)&nbsp;merged into a single university (the Universit&eacute; de Lille). In this context, the Universit&eacute; de
Lille II Droit et Sant&eacute; (now Universit&eacute; de Lille) made a donation of 200,000 ordinary shares at the end of 2017 to the foundation, Fondation partenariale de
l'Universit&eacute; de Lille, which is now one of our shareholders and a party to the Shareholders' Agreement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Related Person Transaction Policy  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We comply with French law regarding approval of transactions with related parties. Prior to the closing of the global offering, we expect to
adopt a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. The policy will
become effective immediately upon the closing of the global offering. For purposes of our policy only, a related person transaction is defined as (1)&nbsp;any transaction, arrangement or
relationship (or any series of similar transactions, arrangements or relationships) in which we and any related person are, were or will be participants in and the amount involved exceeds $120,000, or
(2)&nbsp;any agreement or similar transaction under French law which falls within the scope of Article&nbsp;L.&nbsp;225-38 of the French Commercial Code. A related person is any director, member
of senior management or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or
any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our board
of directors for review, consideration and approval or ratification. The presentation must include a description of, among other </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>167</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=172,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=154015,FOLIO='167',FILE='DISK124:[18ZFA1.18ZFA10701]DI10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;12:05' -->
<A NAME="page_di10701_1_168"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>things,
the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms
available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each
director, member of senior management and, to the extent feasible, significant shareholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of
the policy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, under our Code of Business Conduct, which we intend to adopt in connection with the global offering, our employees and directors have an affirmative responsibility to
disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
considering related person transactions, our board of directors will take into account the relevant available facts and circumstances including, but not limited
to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the risks, costs and benefits to us; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the impact on a director's independence in the event that the related person is a director, immediate family member of a director or an entity
with which a director is affiliated; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the availability of other sources for comparable services or products; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the terms available to or from, as the case may be, unrelated third parties or to or from employees generally. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
policy requires that, in determining whether to approve, ratify or reject a related person transaction, our board of directors must consider, in light of known circumstances, whether
the transaction is in, or is not inconsistent with, our best interests and those of our shareholders, as our board of directors determines in the good faith exercise of its discretion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the transactions described above were entered into prior to the adoption of the written policy, but all were approved by our board of directors to the extent required by, and in
compliance with, French law. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>168</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=173,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=813903,FOLIO='168',FILE='DISK124:[18ZFA1.18ZFA10701]DI10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;12:05' -->
<A NAME="page_di10701_1_169"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="di10701_principal_shareholders"> </A>
<A NAME="toc_di10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  PRINCIPAL SHAREHOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth, as of January&nbsp;1, 2019, information regarding beneficial ownership of our ordinary shares
by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> each person, or group of affiliated persons, known by us to beneficially own more than 5% of our ordinary shares; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> each member of our senior management; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> each of our directors; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> all of our senior management and directors as a group. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beneficial
ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared
voting or investment power of that security, including free shares that vest by March&nbsp;2, 2019, the date that is 60&nbsp;days after January&nbsp;1, 2019 and stock options and warrants that
are currently exercisable or exercisable by March&nbsp;2, 2019. Shares subject to options and warrants currently exercisable or exercisable by March&nbsp;2, 2019 are deemed to be outstanding for
computing the percentage ownership of the person holding these options or warrants and the percentage ownership of any group of which the holder is a member, but are not deemed outstanding for
computing the percentage of any other person. Shares subject to free shares and stock options are not included, as no free shares nor stock options are currently vested because the requisite
performance conditions have not been met. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with
respect to all shares shown that they beneficially own, subject to community property laws where applicable. The
information does not necessarily indicate beneficial ownership for any other purpose, including for purposes of Sections&nbsp;13(d) and 13(g) of the Securities Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our calculation of the percentage of beneficial ownership prior to the global offering is based on 31,183,921 of our ordinary shares outstanding as of January&nbsp;1, 2019. We have
based our calculation of the percentage of beneficial ownership of our ordinary shares outstanding immediately after the closing of the global offering of ordinary shares (including ordinary shares in
the form of ADSs), assuming no exercise of the underwriters' option to purchase additional ADSs and/or ordinary shares in the global offering.

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>169</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=174,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=65940,FOLIO='169',FILE='DISK124:[18ZFA1.18ZFA10701]DI10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;12:05' -->
<A NAME="page_di10701_1_170"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise indicated, the address of each beneficial owner listed in the table below is c/o&nbsp;Genfit&nbsp;S.A., Parc Eurasant&eacute;, 885, avenue
Eug&egrave;ne Avin&eacute;e, 59120 Loos, France. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Ordinary<BR>
Shares<BR>
Beneficially<BR>
Owned<BR>
Before<BR>
Global<BR>
Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percentage of<BR>
Ordinary<BR>
Shares<BR>
Beneficially Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name of Beneficial Owner

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Before<BR>
Global<BR>
Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>After<BR>
Global<BR>
Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>5% Shareholders:</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Biotech Avenir SAS(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,888,618</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Directors and Senior Management:</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Fran&ccedil;ois Mouney(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,913,920</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dean Hum, Ph.D(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nathalie Huitorel(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,858</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pascal Prigent</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jean-Christophe Marcoux(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,296</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Laurent Lannoo(6)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,545</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Xavier Guille Des Buttes(7)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine Larue, Ph.D(8)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anne-H&eacute;l&egrave;ne Monsellato(9)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fr&eacute;d&eacute;ric Desdouits(10)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,561</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Florence S&eacute;journ&eacute;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Philippe Moons(11)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,310</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All directors and senior management as a group (12 persons)(12)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,013,292</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
beneficial ownership of less than 1%


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Biotech
Avenir SAS is our holding company. Mr.&nbsp;Mouney, the Chairman of our board of directors and our Chief Executive Officer, is also the Chief Executive
Officer and Chairman of the Management Committee of Biotech Avenir and holds 17.1% of its share capital. Florence S&eacute;journ&eacute;, who represents Biotech Avenir on our board of
directors, is also a member of the Management Committee of Biotech Avenir and holds 9.9% of its share capital. Dean Hum holds 6.2% of its share capital and Laurent Lannoo, who is a member of the
Management Committee of Biotech Avenir, holds less than 0.01% of its share capital.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 1,899,884 ordinary shares, of which 1,888,618 shares are held directly by Biotech Avenir, 12,474 BSAAR share warrants that are exercisable within 60 days
of January 1, 2019 and 1,562 free shares that are exercisable within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 11 ordinary shares, 11,585 BSAAR share warrants that are exercisable within 60 days of January 1, 2019 and 1,413 free shares that are exercisable within
60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 2,879 ordinary shares, 12,474 BSAAR share warrants that are exercisable within 60 days of January 1, 2019 and 1,505 free shares that are exercisable
within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 554 ordinary shares, 2,533 BSAAR share warrants that are exercisable within 60 days of January 1, 2019 and 209 free shares that are exercisable within 60
days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 5,893 ordinary shares and 652 free shares that are exercisable within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 1,342 ordinary shares and 19,451 BSA share warrants that are exercisable within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 5,000 BSA share warrants that are exercisable within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 5,000 BSA share warrants that are exercisable within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 111 ordinary shares and 19,450 BSA share warrants that are exercisable within 60 days of January 1, 2019.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of 310 ordinary shares and 5,000 BSA share warrants that are exercisable within 60 days of January 1, 2019.



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,888,618 shares (6.1%) held directly by Biotech Avenir. </FONT>

</DD>

</DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>170</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=175,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=732154,FOLIO='170',FILE='DISK124:[18ZFA1.18ZFA10701]DI10701A.;35',USER='JTAYLORA',CD='15-FEB-2019;12:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dk10701_1_171"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dk10701_description_of_share_capital"> </A>
<A NAME="toc_dk10701_1"> </A></FONT> <FONT SIZE=2><B>  DESCRIPTION OF SHARE CAPITAL    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following description of our share capital summarizes certain provisions of our bylaws. Such summaries do not purport to be complete and are
subject to, and are qualified in their entirety by reference to, all of the provisions of our bylaws, a copy of which has been filed as an exhibit to the registration statement of which this
prospectus forms&nbsp;a part. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, our outstanding share capital consisted of a total of 31,183,921 ordinary shares, with nominal value &euro;0.25 per share. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, to the best of our knowledge, none of our outstanding ordinary shares were held by shareholders of record in the United States. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
French law, our bylaws set forth only our issued and outstanding share capital as of the date of the bylaws. Our fully diluted share capital represents all issued and outstanding
shares, as well as all potential shares which may be issued upon exercise of outstanding free shares, stock options and share warrants, as approved by our shareholders and granted by our board of
directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
closing of the global offering, based on the number of ordinary shares outstanding as of December&nbsp;31, 2018, our outstanding share capital will consist of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
ordinary shares (including ordinary shares in the form of ADSs), nominal value &euro;0.25 per share (or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if the underwriters exercise their option to purchase additional ADSs
and/or ordinary shares in the global offering in full). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reconciliation of the Shares Outstanding Prior to the Global Offering  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares outstanding at December&nbsp;31, 2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,958,904</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Number of shares issued in connection with a private placement on February&nbsp;29, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,395,890</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Number of shares issued in connection with a private placement on October&nbsp;12, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,695,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Number of shares issued in connection with a rights issuance on November&nbsp;2, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,116,643 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares outstanding at December&nbsp;31, 2016 and 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,166,437 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Number of shares issued in connection with the vesting of free shares on December&nbsp;27, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,484 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shares outstanding at December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,183,921 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


History of Securities Issuances  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From January&nbsp;1, 2016 through December&nbsp;31, 2018, the following events have changed the number and classes of our issued and
outstanding shares:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On February&nbsp;29, 2016, we issued an aggregate of 2,395,890 shares to 3 purchasers in connection with a private placement, at a purchase
price of &euro;20.70 per share. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On October&nbsp;12, 2016, we issued an aggregate of 1,695,000 shares to 18 purchasers in connection with a private placement, at a purchase
price of &euro;20.00 per share. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On November&nbsp;2, 2016, we issued an aggregate of 3,116,643 shares in connection with a rights issuance, at a purchase price of
&euro;14.30 per share. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On October&nbsp;16, 2017, we issued convertible bonds, convertible into an aggregate of 6,081,081 shares, for aggregate gross proceeds of
&euro;180.0&nbsp;million. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>171</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=176,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=29302,FOLIO='171',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_172"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2016 to December&nbsp;31, 2018, we issued BSAAR share warrants to purchase an aggregate of 11,124 shares, at a
weighted-average exercise price of &euro;23.50 per share. None of these BSAAR share warrants have been exercised or cancelled or have expired. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2016 to December&nbsp;31, 2018, we issued BSA share warrants to purchase an aggregate of 36,690 shares, at a
weighted-average exercise price of &euro;19.97 per share. None of these BSA share warrants, have been exercised or cancelled or have expired. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2016 to December&nbsp;31, 2018, we issued stock options to purchase an aggregate of 322,125 shares, at a
weighted-average exercise price of &euro;17.62 per share. Of these stock options, none have been exercised, 2,500 have been cancelled and none have expired. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2016 to December&nbsp;31, 2018, we issued free shares to purchase an aggregate of 107,705 shares upon the performance
of specified conditions. As of the date of this prospectus, 1,104 of these free shares have been cancelled and 17,484 of these free shares have vested. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Key Provisions of Our Bylaws and French Law Affecting Our Ordinary Shares  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The description below reflects the terms of our bylaws and summarizes the material rights of holders of our ordinary shares under French law.
Please note that this is only a summary and is not intended to be exhaustive. For further information, please refer to the full text of our bylaws, a copy of which has been filed as an exhibit to the
registration statement of which this prospectus forms&nbsp;a part. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Purpose (Article&nbsp;4 of the Bylaws)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our corporate purpose in France and abroad includes the research concerning the production and sale, at different stages of development, of
biological molecules and all other activities regardless of what they may be, linked to the pharmaceutical industry, and more generally, to carry out all commercial, industrial, financial, securities
or real estate transactions and operations linked directly or indirectly to its activity or capable of its facilitation. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Directors (Articles&nbsp;14-25 of the Bylaws)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Duties of the Board.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors determines the orientations of the company's activity and ensures their implementation.
Subject to the
powers expressly assigned to the general meetings, and within the limits of the corporate purpose of our company, it shall deal with all issues pertaining to the proper functioning of the company and
settle by its decisions our company's business. In relation to third parties, the company will be committed even by the actions of the board of directors which do not fall within the scope of our
company's purpose, unless it proves that the third parties knew that the action fell outside the limits of said purpose or that they could not be unaware thereof given the circumstances. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appointment and Term.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors must be composed of at least three members, but may not exceed 15 members, subject to the
dispensation
established by law in the event of merger, in which case the number may be increased to 24. In appointing and electing directors, we seek a balanced representation of women and men. The term of a
director is 5&nbsp;years, and directors may be re-elected at our annual ordinary shareholders meetings; however, a director over the age of 75 may not be appointed if such appointment would result
in the number of directors over the age of 75 constituting more than one-third of the board. The number of directors who are also our employees cannot exceed one-third of the board. Directors may be
natural persons or legal entities except for the chairman of the board who must be a natural person. Legal entities appointed to the board must designate a permanent representative. If a director dies
or resigns between annual meetings, the board may appoint a temporary director to fill the vacancy, subject to ratification at the next ordinary general </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>172</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=177,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=945651,FOLIO='172',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_173"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>meeting,
or, if such vacancy results in a number of directors below three, the board must call an ordinary general meeting to fill the vacancy. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organization.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The board of directors must elect a chairman from among the board members. The chairman must be a natural person, age 80
or younger,
and may be removed by the board at any time. The board may also elect a natural person as deputy chairman who will fulfill the functions of the Chairman in his absence and may designate one or more
non-voting board observers, whether companies or individuals, shareholders or not. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deliberations.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;At least half of the number of directors in office must be present to constitute a quorum. Decisions are made by a
majority of the
directors present or represented and, if there is a tie, the vote of the chairman will carry the decision. Meetings may be held as often as required; however, the chairman is required to call a
meeting with a determined agenda upon the request of at least one-third of the directors if the board has not met for more than two months. French law and our charter and bylaws allow directors to
attend meetings in person or, to the extent permitted by applicable law and with specified exceptions in our bylaws, by videoconference or other telecommunications means allowing them to be identified
and ensuring an effective participation in accordance with applicable laws and regulations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors' Voting Powers on Proposal, Arrangement or Contract in which any Director is Materially Interested.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Under French law, any
agreement entered
into, directly or through an intermediary, between us and any director that is not entered into in the ordinary course of our business and upon standard market terms is subject to the prior
authorization of the board of directors. The interested director cannot vote on such decision. All agreements entered into between our company and one of our director, our chief executive officer, one
of its deputy chief executive officer, an observer or a shareholder that holds over 10% of the voting rights, or further, if a legal person, a controlling company within the meaning of
article&nbsp;L.233-3 of the French Commercial Code holding over 10% of the voting rights, must be subject to prior authorization from the board of directors. The chairman will in turn gives notice
to our statutory auditors of all authorized regulated agreements and submits them to the general meeting for approval. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors' Compensation.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Director compensation for attendance at board meetings (</FONT><FONT SIZE=2><I>jetons de
pr&eacute;sence</I></FONT><FONT SIZE=2>) is determined at the annual ordinary general meeting. Independent directors have a right to a fixed
amount of compensation for their duties as director and, if applicable, as member or chair of one or more board committees and to a variable amount of compensation depending on their actual
participation at board meetings and, if applicable, committee meetings. See the section of this prospectus titled "Management&#151;Compensation of Directors and Senior
Management&#151;Director Compensation" for a description of our compensation policy for our non-employee directors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Board of Directors' Borrowing Powers.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Subject to any limitation set up by the general meeting of shareholders, there are currently no
limits imposed
on the amounts of loans or borrowings that the board of directors may approve. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors' Share Ownership Requirements.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our directors are not required to own any of our shares. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rights, Preferences and Restrictions Attaching to Ordinary Shares (Articles&nbsp;11, 12, 32, 40 and
41 of the Bylaws)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We may only distribute dividends out of our distributable profits, plus any amounts held in our reserves that the
shareholders decide to
make available for distribution, other than those reserves that are specifically required by law. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>"Distributable Profits"</I></FONT><FONT SIZE=2> consist of our statutory net profit in each fiscal year, calculated in accordance with accounting standards
applicable in France, as increased or reduced by any profit or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>173</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=178,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=374426,FOLIO='173',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_174"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>loss
carried forward from prior years, less any contributions to the reserve accounts pursuant to applicable French laws and regulations. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal Reserve.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to French law, we must allocate 5% of our statutory net profit for each year to our legal reserve fund before
dividends may
be paid with respect to that year. Funds must be allocated until the amount in the legal reserve is equal to 10% of the aggregate par value of the issued and outstanding share capital. However, it is
resumed when for any particular cause the reserve drops below 10%. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approval of Dividends.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to French law, our board of directors may propose a dividend for approval by the shareholders at the
annual ordinary
general meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
recommendation of our board of directors, our shareholders may decide to allocate all or part of any distributable profits to special or general reserves, to carry them forward to
the next fiscal year as retained earnings or to allocate them to the shareholders as dividends. However, dividends may not be distributed when our net assets are or would become as a result of such
distribution lower than the amount of the share capital plus the amount of the legal reserves which, under French law, may not be distributed to shareholders. The amount of our share capital plus the
amount of our legal reserves which may not be distributed was equal to &euro;1,035,981.50 at December&nbsp;31, 2018. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors may distribute interim dividends after the end of the fiscal year but before the approval of the financial statements for the relevant fiscal year when the interim
balance sheet, established during such year and certified by an auditor, reflects that we have earned distributable profits since the close of the last financial year, after recognizing the necessary
depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves, as required by law or the bylaws, and including any retained earnings. The amount of
such interim dividends may not exceed the amount of the profit so defined. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to French legislation, if a dividend is declared we may be required to pay a dividend tax in an amount equal to 3% of the aggregate dividend paid by us. However, the European
Court of Justice, or ECJ, has ruled that the 3% dividend tax may not be applied to redistribution of dividends we receive from our subsidiaries established in another Member State of the EU, in that
it creates double taxation of profits made within the EU as prohibited by Article&nbsp;9 of the Parent-Subsidiary directive (ECJ, 1<SUP>st</SUP>&nbsp;ch. May&nbsp;17, 2017, case C-365/16
AFEP). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distribution of Dividends.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Dividends are distributed to shareholders </FONT><FONT SIZE=2><I>pro rata</I></FONT><FONT SIZE=2> according
to their
respective holdings of shares. In the case of interim dividends, distributions are made to shareholders on the date set by our board of directors during the meeting in which the distribution of
interim dividends is approved. The actual dividend payment date is decided by the shareholders at an ordinary general
shareholders' meeting or by our board of directors in the absence of such a decision by the shareholders. Shareholders that own shares on the actual payment date are entitled to the dividend. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders
may be granted an option to receive dividends in cash or in shares, in accordance with legal conditions. The conditions for payment of dividends in cash shall be set at the
shareholders' meeting or, failing this, by the board of directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Timing of Payment.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to French law, dividends must be paid within a maximum of nine months after the close of the relevant
fiscal year, unless
extended by court order. Dividends not claimed within five years after the payment date shall be deemed to expire and revert to the French state. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voting Rights.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each share shall entitle its holder to vote and be represented in the shareholders' meetings in accordance with the
provisions of
French law and of our bylaws. Ownership of one share implies, ipso jure, adherence to our bylaws and the decisions of the shareholders' meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>174</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=179,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=893734,FOLIO='174',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_175"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, each shareholder is entitled to one vote per share at any general shareholders' meeting. Pursuant to our bylaws, however, a double voting right is attached to each registered
share which is held in the name of the same shareholder for at least two years. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
French law, treasury shares or shares held by entities controlled by us are not entitled to voting rights and do not count for quorum purposes. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rights to Share in Our Profit.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each share entitles its holder to a portion of the corporate profits and assets proportional to the
amount of share
capital represented thereby. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rights to Share in the Surplus in the Event of Liquidation.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If we are liquidated, any assets remaining after payment of the debts,
liquidation
expenses and all of the remaining obligations will first be used to repay in full the par value of our shares. Any surplus will be distributed pro rata among shareholders in proportion to the number
of shares respectively held by them, taking into account, where applicable, of the rights attached to shares of different classes. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase and Redemption of Shares.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Under French law, we may acquire our own shares. Such acquisition may be challenged on the ground
of market
abuse regulations. However, the Market Abuse Regulation&nbsp;596/2014 of April&nbsp;16, 2014 (MAR) provides for safe harbor exemptions when the acquisition is made for one of the following
purposes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to decrease our share capital, provided that such a decision is not driven by losses and that a purchase offer is made to all shareholders on a
pro rata basis, with the approval of the shareholders at an extraordinary general meeting; in this case, the shares repurchased must be cancelled within one month from the expiry of the purchase
offer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to meet obligations arising from debt securities that are exchangeable into equity instruments; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to provide shares for distribution to employees or managers under a profit-sharing, free share or share option plan; in this case the shares
repurchased must be distributed within 12&nbsp;months from their repurchase failing which they must be cancelled; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we benefit from a simple exemption when the acquisition is made under a liquidity contract complying with the general regulations of, and the
market practice accepted by the French Financial Markets Authority (AMF). </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
other purposes, and especially share buy-backs made for external growth operations in pursuance of Article&nbsp;L.225-209 of the French Commercial Code, while not forbidden, must
be pursued in strict compliance of market manipulation and insider dealing rules. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
MAR and in accordance with the General Regulations of the AMF (</FONT><FONT SIZE=2><I>R&eacute;glement G&eacute;n&eacute;ral de
l'AMF</I></FONT><FONT SIZE=2>), a corporation shall report to the competent authority of the trading value on which the shares have been admitted to trading or are traded, no later than by the end of
the seventh daily market session following the date of the execution of the transaction, all the transactions relating to the buy-back program, in a detailed form and in an aggregated form. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
such repurchase of shares may result in us holding, directly or through a person acting on our behalf, more than 10% of our issued share capital. Shares repurchased by us continue to
be deemed "issued" under French law but are not entitled to dividends or voting rights so long as we hold them directly or indirectly, and we may not exercise the preemptive rights attached to them. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sinking Fund Provisions.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our bylaws do not provide for any sinking fund provisions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liability to Further Capital Calls.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Shareholders are liable for corporate liabilities only up to the par value of the shares they hold;
they are not
liable to further capital calls. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>175</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=180,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=793203,FOLIO='175',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_176"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Requirements for Holdings Exceeding Certain Percentages.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Any individual or legal entity referred to in Articles&nbsp;L. 233-7, L. 233-9
and L.
223-10 of the French Commercial Code coming to directly or indirectly own, alone or in concert, a number of shares representing a fraction of our capital or voting rights greater than or equal to 2%
or a multiple of this percentage, must inform us of the total number of shares and voting rights and of securities giving access to the capital or voting rights that it owns immediately or over time
within a period of four trading days from the crossing of the said holding thresholds. This obligation applies when crossing each of the above-mentioned thresholds in a downward direction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, any shareholder required the above information shall inform us of its objectives it intends pursuing over the following 12&nbsp;months, when the thresholds are crossed,
either upwards or downwards, of a tenth, a fifth, or third of the capital or voting rights, including notably whether it acts alone or in
concert, it intends to continue acquiring our shares, it intends to acquire or transfer control of the company, its intended management strategy for the company. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
case of failure to declare shares or voting rights exceeding the fraction that should have been declared, such shares shall be deprived of voting rights at General Meetings of
Shareholders for any meeting that would be held until the expiry of a period of two years from the date of regularization of the notification in accordance with Article&nbsp;L. 233-14 of the French
Commercial Code, if the failure to make the declaration was recorded and if one or more shareholders holding at least 5% of the capital request it, their request being recorded in the minutes of the
General Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
requirements apply without prejudice to requirements described below under the sections of this prospectus titled "Declaration of Crossing of Ownership Thresholds
(Article&nbsp;11 of the Bylaws)" and "Form, Holding and Transfer of Shares (Articles&nbsp;13 and 15 of the Bylaws)&#151;Ownership of Shares by Non-French Persons." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Actions Necessary to Modify Shareholders' Rights  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders' rights may be modified as allowed by French law. However, the extraordinary shareholders' meeting is authorized to amend any and
all provisions of our bylaws. It may not, however, increase shareholder commitments without the prior approval of each shareholder. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Special Voting Rights of Warrant Holders  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under French law, the holders of warrants of the same class (i.e.,&nbsp;warrants that were issued at the same time and with the same rights),
including founder's warrants, are entitled to vote as a separate class at a general meeting of that class of warrant holders under certain circumstances, principally in connection with any proposed
modification of the terms and conditions of the class of warrants or any proposed issuance of preferred shares or any modification of the rights of any outstanding class or series of preferred shares. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rules for Admission to and Calling Annual Shareholders' Meetings and Extraordinary Shareholders'
Meetings (Part&nbsp;V of the Bylaws)  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Access to, Participation in and Voting Rights at Shareholders' Meetings.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The right to participate in shareholders' general meetings is
defined and
justified in accordance with the provisions of article&nbsp;R.225-85 of the French Commercial Code. For the calculation of the quorum and the majority, the shareholders participating, as the case
may be, to the shareholders' general meetings by proxy, by postal ballot, by videoconference or by any other means of telecommunication or remote data transmission are deemed present, in accordance
with applicable French laws and regulations. Each of our shareholders may vote by postal ballot or by proxy (including by electronic means) in accordance with applicable legislation, and notably by
means of a form filled in and sent to our company in the conditions set by applicable French laws and by regulations. Any shareholder may also participate in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>176</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=181,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1033400,FOLIO='176',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_177"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>and
vote at meetings by videoconference or any other means of telecommunication or electronic transmission (including by the transmission of an electronic voting form or a proxy form) allowing him/her
to be identified, under the conditions and in accordance with the procedures stipulated in the legal and regulatory provisions in force. The decision of the board of directors to use telecommunication
facilities or videoconferencing will be published in the meeting notice and the notice of summons. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Participation
in shareholders' general meetings, in any form whatsoever, is subject to registration of shares under the conditions and time limits provided for applicable French laws and
regulations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
final date for returning voting ballots by correspondence is set by the board of directors and disclosed in the notice of meeting published in the French Journal of Mandatory
Statutory Notices, or BALO </FONT><FONT SIZE=2><I>(Bulletin des Annonces L&eacute;gales Obligatoires)</I></FONT><FONT SIZE=2>. This date cannot be earlier than three days prior to the
meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
shareholder who has voted by correspondence will no longer be able to participate directly in the meeting or to be represented. In the case of returning the proxy form and the voting
by
correspondence form, the proxy form is taken into account, subject to the votes cast in the voting by correspondence form. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
shareholder may be represented at meetings by any individual or legal entity by means of a proxy form which we send to such shareholder either at the shareholder's request or at our
initiative. A shareholder's request for a proxy form must be received at the registered office at least five days before the date of the meeting. The proxy is only valid for a single meeting or for
successive meetings convened with the same agenda. It can also be granted for two meetings, one ordinary, and the other extraordinary, held on the same day or within a period of fifteen days. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
shareholder may vote by correspondence by means of a voting form, which we send to such shareholder either at the shareholder's request or at our initiative, or which we include in an
appendix to a proxy voting form under the conditions provided for by current laws and requirements. A shareholder's request for a voting form must be received at the registered office at least six
days before the date of the meeting. The voting form is also available on our website at least 21&nbsp;days before the date of the meeting. The voting form must be recorded by us three days prior to
the shareholders' meeting, in order to be taken into consideration. The voting by correspondence form addressed by a shareholder is only valid for a single meeting or for successive meetings convened
with the same agenda. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
better understand the voting rights of the ADSs, you should carefully read the section in this prospectus titled "Description of American Depositary Shares&#151;Voting Rights." </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice of Annual Shareholders' Meetings.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Shareholders' meetings are convened by our board of directors, or, failing that, by the
statutory auditors,
or by a court appointed agent or liquidator in certain circumstances. Meetings are held at our registered offices or at any other location indicated in the convening notice
(</FONT><FONT SIZE=2><I>avis de convocation</I></FONT><FONT SIZE=2>). A meeting announcement (</FONT><FONT SIZE=2><I>avis de r&eacute;union</I></FONT><FONT SIZE=2>) is published in the BALO
at least 35&nbsp;days prior to a meeting, as well as on our website at least 21&nbsp;days prior to the meeting. In addition to the particulars relative to the company, it indicates, notably, the
meeting's agenda and the draft resolutions that will be presented. The requests for recording of issues or draft resolutions on the agenda must be addressed to the company under the conditions
provided for in the current legislation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to special legal provisions, the convening notice is sent out at least 15&nbsp;days prior to the date of the meeting, by means of a notice inserted both in a legal announcement
bulletin of the registered office department and in the BALO. Further, the holders of registered shares for at least a month at the time of the insertion of the convening notice shall be summoned
individually, by regular letter (or by registered letter if they request it and include an advance of expenses) sent to their last </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>177</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=182,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=501237,FOLIO='177',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_178"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>known
address. This notice may also be transmitted by electronic means of telecommunication, in lieu of any such mailing, to any shareholder after obtaining their agreement by post or by electronic
means in accordance with legal and regulatory requirements. The latter may expressly request by post or by electronic means to the Company at least 35&nbsp;days prior to the date of the insertion of
the convening notice in a legal announcement bulletin and in the BALO that the aforementioned means of telecommunication should be replaced in the future by a mailing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
convening notice must also indicate the conditions under which the shareholders may vote by correspondence and the places and conditions in which they can obtain voting forms by
mail. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
the shareholders' meeting cannot deliberate due to the lack of the required quorum, the second meeting must be called at least ten days in advance in the same manner as used for the
first notice. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agenda and Conduct of Annual Shareholders' Meetings.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The agenda of the shareholders' meeting shall appear in the convening notice of the
meeting and
is set by the author of the notice. The shareholders' meeting may only deliberate on the items on the agenda except for the removal of directors and the appointment of their successors which may be
put to vote by any shareholder during any shareholders' meeting. Pursuant to French law and our current share capital, one or more shareholders representing 5% of our share capital may request the
inclusion of items or proposed resolutions on the agenda. Such request must be received at the latest on the 25<SUP>th</SUP>&nbsp;day preceding the date of the shareholders' meeting, and in any
event no later than the 20<SUP>th</SUP>&nbsp;day following the date of the shareholders' meeting announcement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders'
meetings shall be chaired by the Chairman of the board of directors or, in his or her absence, by a director elected for this purpose. Failing that, the meeting itself
shall elect a Chairman. Vote counting shall be performed by the two members of the meeting who are present and accept such duties, who represent, either on their own behalf or as proxies, the greatest
number of votes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary Shareholders' Meeting.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Ordinary shareholders' meetings are those meetings called to make any and all decisions that do not
amend our bylaws.
An ordinary meeting shall be convened at least once a year within six months of the end of each fiscal year in order to approve the annual and consolidated accounts for the relevant fiscal year or, in
case of postponement, within the period established by court order. Upon first notice, the meeting may validly deliberate only if the shareholders present or represented by proxy or voting by
correspondence, by videoconference or by means of telecommunication or electronic transmission in accordance with the applicable laws and regulations,
represent at least one-fifth of the shares entitled to vote. Upon second notice, no quorum is required. Decisions are made by a majority of the votes held by the shareholders present, or represented
by proxy, or voting by correspondence, by videoconference or by means of telecommunication or electronic transmission. Abstentions will have the same effect of a "no" vote. In addition, pursuant to
the AMF recommendation applicable from June&nbsp;15, 2015, French listed companies may be required to conduct a consultation of the ordinary shareholders' meeting prior to the disposal of the
majority of their assets, under certain circumstances. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extraordinary Shareholders' Meeting.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our bylaws may only be amended by approval at an extraordinary shareholders' meeting. Our bylaws
may not,
however, be amended to increase shareholder commitments without the approval of each shareholder. Subject to the legal provisions governing share capital increases from reserves, profits or share
premiums, the resolutions of the extraordinary meeting shall be valid only if the shareholders present, represented by proxy or voting by correspondence, by videoconference or by means of
telecommunication or electronic transmission represent at least one-fourth of all shares entitled to vote upon first notice, or one-fifth upon second notice. If the latter quorum is not reached, the
second meeting may be postponed to a date no later than two months after the date for which it was initially called. Decisions are made by a two-thirds </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>178</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=183,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=932465,FOLIO='178',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_179"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>majority
of the votes held by the shareholders present, represented by proxy, or voting by correspondence, by videoconference or electronic transmission. Abstentions will have the same effect of a
"no" vote. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Provisions Having the Effect of Delaying, Deferring or Preventing a Change in Control of Our Company  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions contained in our bylaws and French corporate law could make it more difficult for a third party to acquire us, even if doing so might
be beneficial to our shareholders. These provisions include the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> under French law, the owner of 95% of voting rights of a public company listed on a regulated market in a Member State of the European Union or
in a state party to the EEA Agreement, including from the main French Stock Exchange, has the right to force out minority shareholders following a tender offer made to all shareholders; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> under French law, certain foreign investments in companies incorporated under French laws are subject to the prior authorization from the
French Minister of the Economy, where all or part of the target's business and activity relate to a strategic sector, such as energy, transportation, public health, telecommunications, etc.; see the
section of this prospectus titled "Limitations Affecting Shareholders of a French Company"; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a merger (i.e.,&nbsp;in a French law context, a share for share exchange following which our company would be dissolved into the acquiring
entity and our shareholders would become shareholders of the acquiring entity) of our company into a company incorporated in the European Union would require the approval of our board of directors as
well as a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a merger of our company into a company incorporated outside of the European Union would require 100% of our shareholders to approve it; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> under French law, a cash merger is treated as a share purchase and would require the consent of each participating shareholder; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our shareholders have granted and may grant in the future our board of directors broad authorizations to increase our share capital or to issue
additional ordinary shares or other securities, such as warrants, to our shareholders, the public or qualified investors, including as a possible defense following the launching of a tender offer for
our shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our shareholders have preferential subscription rights on a pro rata basis on the issuance by us of any additional securities for cash or a
set-off of cash debts, which rights may only be waived by the extraordinary general meeting (by a two-thirds majority vote) of our shareholders or on an individual basis by each shareholder; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our board of directors has the right to appoint directors to fill a vacancy created by the resignation or death of a director, subject to the
approval by the shareholders of such appointment at the next shareholders' meeting, which prevents shareholders from having the sole right to fill vacancies on our board of directors; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our board of directors can be convened by our chairman, including upon request from our managing director, if any, or, when no board meeting
has been held for more than two consecutive months, from directors representing at least one third of the total number of directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our board of directors meetings can only be regularly held if at least half of the directors attend either physically or by way of
videoconference or teleconference enabling the directors' identification and ensuring their effective participation in the board's decisions; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>179</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=184,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=417718,FOLIO='179',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_180"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our shares are registered or bearer, if the legislation so permits, according to the shareholder's choice; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> approval of at least a majority of the votes held by shareholders present, represented by a proxy, or voting by mail at the relevant ordinary
shareholders' general meeting is required to remove directors with or without cause; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> advance notice is required for nominations to the board of directors or for proposing matters to be acted upon at a shareholders' meeting,
except that a vote to remove and replace a director can be proposed at any shareholders' meeting without notice; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our bylaws can be changed in accordance with applicable French laws and regulations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the crossing of certain thresholds has to be disclosed and can impose certain obligations; see the sections of this prospectus titled "Rights,
Preferences and Restrictions Attaching to Ordinary Shares (Articles&nbsp;11, 12, 32, 40 and 41 of the Bylaws)&#151;Requirements for Holdings Exceeding Certain Percentages" and "Declaration of
Crossing of Ownership Thresholds (Article&nbsp;11 of the Bylaws)"; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> transfers of shares shall comply with applicable insider trading rules and regulations, and in particular with the Market Abuse Directive and
Regulation dated April&nbsp;16, 2014; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> pursuant to French law, the sections of the bylaws relating to the number of directors and election and removal of a director from office may
only be modified by a resolution adopted by two-thirds of the votes of our shareholders present, represented by a proxy or voting by mail at the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Declaration of Crossing of Ownership Thresholds (Article&nbsp;11 of the Bylaws)  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Set forth below is a summary of certain provisions of the French Commercial Code applicable to us. This summary is not intended to be a complete
description of applicable rules under French law. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
individual or legal entity referred to in Articles&nbsp;L. 233-7, L. 233-9 and L. 223-10 of the French Commercial Code coming to directly or indirectly own, alone or in concert, a
number of shares representing a fraction of our capital or voting rights greater or equal to 5%, 10%, 15%, 20%, 25%, 30%, 33.33%, 50%, 66.66%, 90% and 95% shall inform us as well as the French
Financial Markets Authority (AMF) of the total number of shares and voting rights and of securities giving access to the capital or voting rights that it owns immediately or over time within a period
of four trading days from the crossing of the said holding thresholds. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
obligation applies when crossing each of the above-mentioned thresholds in a downward direction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
case of failure to declare shares or voting rights exceeding the fraction that should have been declared, such shares shall be deprived of voting rights at General Meetings of
Shareholders for any meeting that would be held until the expiry of a period of two years from the date of regularization of the notification in accordance with Article&nbsp;L. 233-14 of the French
Commercial Code. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, any shareholder crossing, alone or acting in concert, the 10%, 15%, 20% or 25% threshold shall file&nbsp;a declaration with the AMF pursuant to which it shall expose its
intention over the following 6&nbsp;months, including notably whether it intends to continue acquiring shares of the company, it intends to acquire control over the company, its intended strategy
for the company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further,
and subject to certain exemptions, any shareholder crossing, alone or acting in concert, the 30% threshold shall file&nbsp;a mandatory public tender offer with the AMF. Also,
any shareholder holding directly or indirectly a number between 30% and 50% of the capital or voting rights and who, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>180</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=185,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=377288,FOLIO='180',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_181"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>in
less than 12 consecutive months, increases his/her/its holding of capital or voting rights by at least 1% company's capital or voting rights, shall file&nbsp;a mandatory public tender offer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the provisions of Article&nbsp;11 of our bylaws, such individual or legal entity acquiring directly or indirectly, alone or in concert, a number of shares representing a
fraction of our capital or voting
rights greater than or equal to 2% or a multiple of this percentage, must inform us of the total number of shares and voting rights and securities giving access to capital and voting rights it owns
immediately or subsequently within a period of four trading days from the crossing of the said holding thresholds. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
individual or company required to provide the above information shall inform us of the objectives it intends pursuing during the next 12&nbsp;months when the thresholds are
crossed, either upwards or downwards, of a tenth, fifth or third of the capital or voting rights. This declaration specifies whether the purchaser is acting alone or in concert, if it intends stopping
its purchases or sales or continuing them, or whether it intends acquiring or transferring control of our company, requesting its nomination or that of one or more other persons, or its registration,
as a director of the Board of directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
case of failure to declare shares or voting rights exceeding the fraction that should have been declared in accordance with the provisions of Article&nbsp;11 of our bylaws, such
share shall be deprived of voting rights at General Meetings of Shareholders for any meeting that would be held until the expiry of a period of two years from the date of regularization of the
notification in accordance with Article&nbsp;L. 233-14 of the French Commercial Code, if the failure to make the declaration was recorded and if one or more shareholders holding at least 5% of the
capital request it, their request being recorded in the minutes of the General Meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Changes in Share Capital  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increases in Share Capital (Article&nbsp;7 of the Bylaws).</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to French law, our share capital may be increased only with
shareholders'
approval at an extraordinary general shareholders' meeting following the recommendation of our board of directors. The shareholders may delegate to our board of directors either the authority
(</FONT><FONT SIZE=2><I>d&eacute;l&eacute;gation de comp&eacute;tence</I></FONT><FONT SIZE=2>) or the power (</FONT><FONT SIZE=2><I>d&eacute;l&eacute;gation
de pouvoir</I></FONT><FONT SIZE=2>) to carry out any increase in share capital. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increases
in our share capital may be effected by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> issuing additional shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> increasing the par value of existing shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> creating a new class of equity securities; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> exercising the rights attached to securities giving access to the share capital. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increases
in share capital by issuing additional securities may be effected through one or a combination of the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> in consideration for cash; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> in consideration for assets contributed in kind; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> through an exchange offer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> by conversion of previously issued debt instruments; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> by capitalization of profits, reserves or share premium; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> subject to certain conditions, by way of offset against debt incurred by us. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>181</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=186,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=429651,FOLIO='181',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_182"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decisions
to increase the share capital through the capitalization of reserves, profits and/or share premium require shareholders' approval at an extraordinary general shareholders'
meeting, acting under the quorum and majority requirements applicable to ordinary shareholders' meetings. Increases effected by an increase in the par value of shares require unanimous approval of the
shareholders, unless effected by capitalization of reserves, profits or share premium. All other capital increases require shareholders' approval at an extraordinary general shareholders' meeting
acting under the regular quorum and majority requirements for such meetings. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reduction in Share Capital.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to French law, any reduction in our share capital requires shareholders' approval at an
extraordinary general
shareholders' meeting following the recommendation of our board of directors. The share capital may be reduced either by decreasing the par value of the outstanding shares or by reducing the number of
outstanding shares. The number of outstanding shares may be reduced by the repurchase and cancellation of shares. Holders of each class of shares must be treated equally unless each affected
shareholder agrees otherwise. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferential Subscription Right.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;According to French law, if we issue additional securities for cash, current shareholders will have
preferential
subscription rights to these securities on a </FONT><FONT SIZE=2><I>pro rata</I></FONT><FONT SIZE=2> basis. Preferential subscription rights entitle the individual or entity that holds them to
subscribe </FONT><FONT SIZE=2><I>pro rata</I></FONT><FONT SIZE=2> based on the number of shares held by them to the issuance of any securities increasing, or that may result in an increase of, our
share capital by means of a cash payment or a set-off of cash debts. The preferential subscription rights are transferable during the subscription period relating to a particular offering. Pursuant to
legislation that went into effect on October&nbsp;1, 2016, the preferential subscription rights will be transferable during a period starting two days prior to the opening of the subscription period
and ending two days prior to the closing of the subscription period. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
preferential subscription rights with respect to any particular offering may be waived at an extraordinary general meeting by a two-thirds vote of our shareholders or individually by
each shareholder. Our board of directors and our independent auditors are required by French law to present reports to the shareholders' meeting that specifically address any proposal to waive the
preferential subscription rights. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
current shareholders waived their preferential subscription rights with respect to the global offering at our combined general shareholders' meeting held on June&nbsp;16, 2017. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the future, to the extent permitted under French law, we may seek shareholder approval to waive preferential subscription rights at an extraordinary general shareholders' meeting in
order to authorize the board of directors to issue additional shares and/or other securities convertible or exchangeable into shares. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Form, Holding and Transfer of Shares (Articles&nbsp;9 and 10 of the Bylaws)  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form of Shares.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The shares are in registered form, until their full payment. When they are fully paid up, they may be in registered form
or bearer,
at the option of the shareholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further,
in accordance with applicable laws, we may request at any time from the central depository responsible for holding our shares, the information referred to in Article&nbsp;L.
228-2 of the French Commercial Code. Thus, we are, in particular and at any time, entitled to request the name and year of birth or, in the case of a legal entity, the name and the year of
incorporation, nationality and address of holders of securities conferring immediate or long-term voting rights at its general meetings of shareholders and the amount of securities owned by each of
them and, where applicable, the restrictions that the securities could be affected by. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holding of Shares.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In accordance with French law concerning the "dematerialization" of securities, the ownership rights of shareholders
are
represented by book entries instead of share </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>182</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=187,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=62242,FOLIO='182',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<A NAME="page_dk10701_1_183"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>certificates.
Shares issued are registered in individual accounts opened by us or any authorized intermediary, in the name of each shareholder and kept according to the terms and conditions laid down
by the legal and regulatory provisions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ownership of Shares by Non-French Persons.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Neither the French Commercial Code nor our bylaws limit the right of non-French residents or
non-French
shareholders to own or, where applicable, to vote our securities. However, non-French residents must file&nbsp;a declaration for statistical purposes with the Bank of France (Banque de France)
within twenty working days following the date of certain direct foreign investments in us, including any purchase of our ADSs. In particular, such filings are required in connection with investments
exceeding &euro;15,000,000 that lead to the acquisition of at least 10% of our share capital or voting rights or cross of such 10% threshold. Moreover, certain foreign investments in
companies incorporated under French laws are subject to the prior authorization from the French Minister of the Economy, where all or part of the target's business and activity relate to a strategic
sector, such as energy, transportation, public health, telecommunications, etc. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assignment and Transfer of Shares.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Shares are freely negotiable, subject to applicable legal and regulatory provisions. French law
notably provides
for standstill obligations and prohibition of insider trading. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;">


<FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Forum Selection Provision (Article&nbsp;44 of the Bylaws)

  </I></B></FONT>

</P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our bylaws also include a provision that applies to actions between shareholders and us and between shareholders themselves that are predicated
on French corporate law. The competent court is the Commercial Court of Lille. This provision does not apply to actions arising under U.S. federal securities laws. In addition, it is possible that a
court could find this provision in our bylaws inapplicable or unenforceable.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Securities Exercisable for Ordinary Shares  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Incentives  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See the section of this prospectus titled "Management&#151;Equity Incentives" for a description of securities granted by our board of
directors to our directors, senior management and employees. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>183</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=188,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=218851,FOLIO='183',FILE='DISK124:[18ZFA1.18ZFA10701]DK10701A.;26',USER='LBURNET',CD='15-FEB-2019;12:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dm10701_1_184"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Differences in Corporate Law  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a </FONT><FONT SIZE=2><I>soci&eacute;t&eacute; anonyme</I></FONT><FONT SIZE=2>, or&nbsp;S.A., incorporated under the
laws of France. The laws applicable to French </FONT><FONT SIZE=2><I>soci&eacute;t&eacute;s anonymes</I></FONT><FONT SIZE=2> differ from laws applicable to Delaware corporations and
their shareholders. Set forth below is a summary of certain differences between the provisions of the French Commercial Code applicable to us and the Delaware General Corporation Law relating to
shareholders' rights and protections. This summary is not intended to be a complete discussion of the respective rights and it is qualified in its entirety by reference to Delaware law and French law. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Number of Directors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Under French law, a </FONT><FONT SIZE=2><I>soci&eacute;t&eacute; anonyme</I></FONT><FONT SIZE=2> must have at least three and may have up to 18 directors. The number of directors is fixed by or in the manner provided in
the bylaws. Since January&nbsp;1, 2017, the number of directors of each gender may not be less than 40%. Any appointment made in violation of this limit that is not remedied will be null and void. The directors are appointed at the shareholders'
general meetings.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Under Delaware law, a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the bylaws.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Director Qualifications</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, a corporation may prescribe qualifications for directors under its bylaws. In addition, under French law, members of a
board of directors of a corporation may be legal entities (with the exception of the Chairman of the board of directors), and such legal entities may designate an individual to represent them and to act on their behalf at meetings of the board of
directors.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, a corporation may prescribe qualifications for directors under its certificate of incorporation or bylaws.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Removal of Directors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, directors may be removed from office, with or without cause, at any shareholders' general meeting without notice or
justification, by a simple majority vote.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, unless otherwise provided in the certificate of incorporation, directors may be removed from office, with or without
cause, by a majority stockholder vote, though in the case of a corporation whose board is classified, stockholders may effect such removal only for cause.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>184</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=189,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=906171,FOLIO='184',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_185"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vacancies on the Board of Directors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, vacancies on the board of directors resulting from death, resignation or removal, provided that at least three directors remain in office,
may be filled by a majority of the remaining directors pending ratification by the shareholders by the next shareholders' general meeting.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, vacancies on a corporation's board of directors, including those caused by an increase in the number of directors, may be filled by a
majority of the remaining directors.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Annual General Meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, the annual general meeting of shareholders shall be held at such place, on such date and at such time as decided each year
by the board of directors and notified to the shareholders in the convening notice of the annual meeting, within six months after the end of the relevant fiscal year unless such period is extended by court order.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be designated from
time to time by the board of directors or as provided in the certificate of incorporation or by the bylaws.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General Meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, general meetings of the shareholders may be called by the board of directors or, failing which, by the statutory auditors,
or by a court appointed agent (</FONT><FONT SIZE=2><I>mandataire ad hoc</I></FONT><FONT SIZE=2>) or liquidator in certain circumstances, or by the majority shareholder in capital or voting rights following a public tender offer or exchange offer or
the transfer of a controlling block on the date decided by the board of directors or the relevant person.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be
authorized by the certificate of incorporation or by the bylaws.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>185</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=190,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=277323,FOLIO='185',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_186"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Notice of General Meetings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>A meeting announcement is published in the French Journal of Mandatory Statutory Notices (BALO) at least 35&nbsp;days prior to a meeting and made available
on the website of the company at least twenty-one day prior to the meeting. Subject to limited exceptions provided by French law, additional convening notice is sent out at least fifteen days prior to the date of the meeting, by means of a notice
inserted both in a newspaper for legal notices (</FONT><FONT SIZE=2><I>journal d'annonces l&eacute;gales</I></FONT><FONT SIZE=2>) of the registered office department and in the BALO. Further, shareholders holding registered shares for at least a
month at the time latest insertions of the notices shall be summoned individually, by regular letter (or by registered letter if they request it and include an advance of expenses) sent to their last known address. This notice to registered
shareholders may also be transmitted by electronic means of telecommunication, in place of any such mailing, to any shareholder requesting it beforehand by registered letter with acknowledgment of receipt in accordance with legal and regulatory
requirements, specifying his e-mail address. When the shareholders' meeting cannot deliberate due to lack of required quorum, the second meeting must be called at least ten calendar days in advance in the same manner as used for the first
notice.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders must be given
to each stockholder entitled to vote at the meeting not less than 10 nor more than 60&nbsp;days before the date of the meeting and shall specify the place, date, hour, and purpose or purposes of the meeting.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>186</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=191,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=218355,FOLIO='186',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_187"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The notice shall specify the name of the company, its legal form, share capital, registered office address, registration number with the French Registry of
Commerce and Companies (</FONT><FONT SIZE=2><I>registre du commerce et des soci&eacute;t&eacute;s</I></FONT><FONT SIZE=2>), the place, date, hour and agenda of the meeting and its nature (ordinary and/or extraordinary meeting). The convening notice
must also indicate the conditions under which the shareholders may vote by correspondence and the places and conditions in which they can obtain voting forms by mail.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proxy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Each shareholder has the right to attend the meetings and participate in the discussions (1)&nbsp;personally, or (2)&nbsp;by granting proxy
to his/her spouse, his/her partner with whom he/she has entered into a civil union or to another shareholder or to any individual or legal entity of his choosing; or (3)&nbsp;by sending a proxy to the company without indication of the mandate, or
(4)&nbsp;by voting by correspondence, or (5)&nbsp;by videoconference or another means of telecommunication in accordance with applicable laws that allow identification. The proxy is only valid for a single meeting or for successive meetings convened
with the same agenda. It can also be granted for two meetings, one ordinary, and the other extraordinary, held on the same day or within a period of fifteen days.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, at any meeting of stockholders, a stockholder may designate another person to act for such stockholder by proxy, but no
such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>187</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=192,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=477687,FOLIO='187',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_188"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shareholder Action by Written Consent</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, shareholders' action by written consent is not permitted in a </FONT><FONT SIZE=2><I>soci&eacute;t&eacute; anonyme</I></FONT><FONT
SIZE=2>.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, a corporation's certificate of incorporation (1)&nbsp;may permit stockholders to act by written consent if such action is signed by all
stockholders, (2)&nbsp;may permit stockholders to act by written consent signed by stockholders having the minimum number of votes that would be necessary to take such action at a meeting or (3)&nbsp;may prohibit actions by written
consent.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>188</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=193,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=763460,FOLIO='188',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_189"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preemptive Rights</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, in case of issuance of additional shares or other securities for cash or set-off against cash debts, the existing shareholders have
preferential subscription rights to these securities on a </FONT><FONT SIZE=2><I>pro rata</I></FONT><FONT SIZE=2> his/her share ownership unless such rights are waived by a two-thirds majority of the votes held by the shareholders present at the
extraordinary general meeting deciding or authorizing the capital increase, voting in person or represented by proxy or voting by mail. In case such rights have not been waived by the extraordinary general meeting, each shareholder may individually
either exercise, assign or not exercise its preferential subscription rights. Since October&nbsp;1, 2016, preferential subscription rights may only be exercised two business days prior to the day on which the subscription is opened until the second
business day prior to its closing. Thus, the preferential subscription rights are transferable during the same period as their period of exercise. In accordance with French law, the period of exercise shall be no less than 5 business
days.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, unless otherwise provided in a corporation's certificate of incorporation, a stockholder does not, by operation of law, possess
preemptive rights to subscribe to additional issuances of the corporation's stock.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>189</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=194,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=767655,FOLIO='189',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_190"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sources of Dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 Under French law, dividends may only be paid by a French </FONT><FONT SIZE=2><I>soci&eacute;t&eacute; anonyme</I></FONT><FONT SIZE=2> out of "</FONT><FONT SIZE=2><I>distributable profits</I></FONT><FONT SIZE=2>" (</FONT><FONT
 SIZE=2><I>b&eacute;n&eacute;fices distribuables</I></FONT><FONT SIZE=2>) plus any distributable reserves and "</FONT><FONT SIZE=2><I>distributable premium</I></FONT><FONT SIZE=2>" that the shareholders decide to make available for distribution, other
 than those reserves that are specifically required by law. </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> "</FONT><FONT SIZE=2><I>Distributable profits</I></FONT><FONT SIZE=2>" (</FONT><FONT
 SIZE=2><I>b&eacute;n&eacute;fices distribuables</I></FONT><FONT SIZE=2>) consist of the unconsolidated net profits of the relevant corporation for each fiscal year, as increased or reduced by any profit or loss carried forward from prior
 years.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, dividends may be paid by a Delaware corporation either out of (1)&nbsp;surplus or (2)&nbsp;in case there is no surplus, out of its net
profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year, except when the capital is diminished by depreciation in the value of its property, or by losses, or otherwise, to an amount less than the aggregate
amount of capital represented by issued and outstanding stock having a preference on the distribution of assets.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>"</FONT><FONT SIZE=2><I>Distributable premium</I></FONT><FONT SIZE=2>" refers to the contribution paid by the shareholders in addition to
the par value of their shares for their subscription that the shareholders decide to make available for distribution.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Except in case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower
than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the bylaws.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Repurchase of Shares</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, a corporation may acquire its own shares. Such acquisition may be challenged on the ground of market abuse regulations.
However, the Market Abuse Regulation&nbsp;596/2014 of April&nbsp;16, 2014 (MAR) provides for safe harbor exemptions when the acquisition is made for the following purposes:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, a corporation may generally redeem or repurchase shares of its stock unless the capital of the corporation is impaired
or such redemption or repurchase would impair the capital of the corporation.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>190</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=195,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=218326,FOLIO='190',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_191"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>to decrease its share
capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction, in
which case, the shares repurchased must be cancelled within one month from the expiry of the purchase offer;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>with a view to
distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, free share or share option plan; not to exceed 10% of the share capital, in which case the shares repurchased must be distributed
within 12&nbsp;months from their repurchase failing which they must be cancelled; or</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>to meet obligations
arising from debt securities, that are exchangeable into equity instruments.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>A simple exemption is provided when the acquisition is made under a buy-back program to be authorized by the shareholders in accordance with
the provisions of Article&nbsp;L. 225-209 of the French Commercial Code and in accordance with the General Regulations of the Financial Markets Authority (AMF).</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>191</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=196,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=879060,FOLIO='191',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_192"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All other purposes, and especially share buy-backs for external growth operations by virtue of Article&nbsp;L. 225-209 of the French Commercial Code, while
not forbidden, must be pursued in strict compliance of market manipulations and insider dealing rules.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under the MAR and in accordance with the General Regulations of the AMF, a corporation shall report to the competent authority of the
trading venue on which the shares have been admitted to trading or are traded, no later than by the end of the seventh daily market session following the date of the execution of the transaction, all the transactions relating to the buy-back program,
in a detailed form and in an aggregated form.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Liability of Directors and Officers</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, the bylaws may not include any provisions limiting the liability of directors. Civil liabilities of the directors may be
sought for (1)&nbsp;an infringement of laws and regulations applicable to a company, (2)&nbsp;breach of the bylaws and (3)&nbsp;management failure.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, a corporation's certificate of incorporation may include a provision eliminating or limiting the personal liability of a
director to the corporation and its stockholders for damages arising from a breach of fiduciary duty as a director. However, no provision can limit the liability of a director for:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>any breach of the
director's duty of loyalty to the corporation or its stockholders;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>acts or omissions not in
good faith or that involve intentional misconduct or a knowing violation of law;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> intentional or negligent
payment of unlawful dividends or stock purchases or redemptions; or</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>192</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=197,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=382312,FOLIO='192',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_193"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>any transaction from which
the director derives an improper personal benefit.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Voting Rights</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>French law provides that, unless otherwise provided in the bylaws, each shareholder is entitled to one vote for each share of capital stock
held by such shareholder. As from March 2014, double voting rights are automatically granted to the shares held in registered form for more than two years, unless provided otherwise in the bylaws.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Delaware law provides that, unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote for each
share of capital stock held by such stockholder.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shareholder Vote on Certain Transactions</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 Generally, under French law, completion of a merger, dissolution, sale, lease or exchange of all or substantially all of a corporation's assets requires: </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> </FONT><FONT
 SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the approval of the board of directors;
 and </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left
 style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant shareholders' meeting or, in the case of
 a merger with a non-EU company, approval of all shareholders of the corporation.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 Generally, under Delaware law, unless the certificate of incorporation provides for the vote of a larger portion of the stock, completion of a merger, consolidation, sale, lease or exchange of all or substantially all of a corporation's assets or
 dissolution requires: </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left
 style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the approval of the board of directors; and </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> </FONT><FONT SIZE=2> </font> <p align=left
 style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>approval by the vote of the holders of a majority of the outstanding
 stock or, if the certificate of incorporation provides for more or less than one vote per share, a majority of the votes of the outstanding stock of a corporation entitled to vote on the matter.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>193</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=198,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=981773,FOLIO='193',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_194"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dissent or Dissenters' Appraisal Rights</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>French law does not provide for any such right but provides that a merger is subject to shareholders' approval by a two-thirds majority vote as stated
above.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, a holder of shares of any class or series has the right, in specified circumstances, to dissent from a merger or consolidation by
demanding payment in cash for the stockholder's shares equal to the fair value of those shares, as determined by the Delaware Chancery Court in an action timely brought by the corporation or a dissenting stockholder. Delaware law grants these
appraisal rights only in the case of mergers or consolidations and not in the case of a sale or transfer of assets or a purchase of assets for stock. Further, no appraisal rights are available for shares of any class or series that is listed on a
national securities exchange or held of record by more than 2,000 stockholders, unless the agreement of merger or consolidation requires the holders to accept for their shares anything other than:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>shares of stock of the
surviving corporation;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>shares of stock of another
corporation that are either listed on a national securities exchange or held of record by more than 2,000 stockholders;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>cash in lieu of fractional
shares of the stock described in the two preceding bullet points; or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>any combination of the
above.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>In addition, appraisal rights are not available to holders of shares of the surviving corporation in specified mergers that do not require
the vote of the stockholders of the surviving corporation.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>194</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=199,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=64555,FOLIO='194',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_195"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Standard of Conduct for Directors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>French law does not contain specific provisions setting forth the standard of conduct of a director. However, directors have a duty to act without
self-interest, on a well-informed basis and they cannot make any decision against a corporation's corporate interest (</FONT><FONT SIZE=2><I>int&eacute;r&ecirc;t social</I></FONT><FONT SIZE=2>).</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Delaware law does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary duties of directors is
generally determined by the courts of the State of Delaware. In general, directors have a duty to act without self-interest, on a well-informed basis and in a manner they reasonably believe to be in the best interest of the stockholders.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shareholder Suits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a corporation in the corporation's corporate interest if it fails to bring such legal action itself. If so,
 any damages awarded by the court are paid to the corporation and legal fees relating to such action may be borne by the relevant shareholder or the group of shareholders. </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2>
 The plaintiff must remain a shareholder through the duration of the legal action. </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> There is no other case where shareholders may initiate a derivative action to enforce a
 right of a corporation. </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> A shareholder may alternatively or cumulatively bring individual legal action against the directors, provided he has suffered distinct damages from
 those suffered by the corporation. In this case, any damages awarded by the court are paid to the relevant shareholder.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 Under Delaware law, a stockholder may initiate a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must: </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font
 size=2> </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>state that the
 plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiff's shares thereafter devolved on the plaintiff by operation of law; and </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;">
 <font size=2> </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>allege with
 particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors and the reasons for the plaintiff's failure to obtain the action; or </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font
 size=2> </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>state the reasons
 for not making the effort. </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> Additionally, the plaintiff must remain a stockholder through the duration of the derivative suit. The action will not be dismissed or
 compromised without the approval of the Delaware Court of Chancery.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>195</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=200,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=811441,FOLIO='195',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dm10701_1_196"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>FRANCE </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DELAWARE </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amendment of Certificate of Incorporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, corporations are not required to file&nbsp;a certificate of incorporation with the French Registry of Commerce and Companies (</FONT><FONT
SIZE=2><I>registre du commerce et des soci&eacute;t&eacute;s</I></FONT><FONT SIZE=2>) and only have bylaws (</FONT><FONT SIZE=2><I>statuts</I></FONT><FONT SIZE=2>) as organizational documents.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 Under Delaware law, generally a corporation may amend its certificate of incorporation if: </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> </FONT><FONT SIZE=2> </font> <p align=left
 style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>its board of directors has adopted a resolution setting forth the
 amendment proposed and declared its advisability; and </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2>
 &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>the amendment is adopted by the affirmative votes of a majority (or greater percentage as may be specified by the corporation) of the
 outstanding shares entitled to vote on the amendment and a majority (or greater percentage as may be specified by the corporation) of the outstanding shares of each class or series of stock, if any, entitled to vote on the amendment as a class or
 series.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amendment of Bylaws</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under French law, only the extraordinary shareholders' meeting is authorized to adopt or amend the bylaws.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Under Delaware law, the stockholders entitled to vote have the power to adopt, amend or repeal bylaws. A corporation may also confer, in its
certificate of incorporation, that power upon the board of directors.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Listing  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have applied to have our ADSs listed on the Nasdaq Global Market under the symbol "GNFT." Our ordinary shares are currently listed on
Euronext Paris under the symbol "GNFT." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Agent and Registrar  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BNP Paribas Securities Services is our transfer agent and registrar and currently maintains our share register for our ordinary shares. Upon the
closing of the U.S. offering, BNP Paribas Securities Services will also serve as transfer agent and registrar for our ADSs. The share register reflects only record owners of our ordinary shares.
Holders of our ADSs will not be treated as one of our shareholders and their names will therefore not be entered in our share register. The depositary, the custodian or their nominees will be the
holder of the shares underlying our ADSs. Holders of our ADSs have a right to receive the ordinary shares underlying their ADSs. For discussion on our ADSs and ADS holder rights, see "Description of
American Depositary Shares" in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>196</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=201,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=119353,FOLIO='196',FILE='DISK124:[18ZFA1.18ZFA10701]DM10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_do10701_1_197"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="do10701_limitations_affecting___do102210"> </A>
<A NAME="toc_do10701_1"> </A></FONT> <FONT SIZE=2><B>  LIMITATIONS AFFECTING SHAREHOLDERS OF A FRENCH COMPANY    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Ownership of ADSs or Shares by Non-French Residents  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the French Commercial Code nor our bylaws presently impose any restrictions on the right of non-French residents or non-French
shareholders to own and vote shares. However, non-French residents must file&nbsp;a declaration for statistical purposes with the Bank of France (</FONT><FONT SIZE=2><I>Banque de
France</I></FONT><FONT SIZE=2>) within twenty working days following the date of certain direct foreign investments in us, including any purchase of our ADSs. In particular, such filings are required
in connection with investments exceeding &euro;15,000,000 that lead to the acquisition of at least 10% of our
share capital or voting rights or cross such 10% threshold. Violation of this filing requirement may be sanctioned by five years of imprisonment and a fine of up to twice the amount of the relevant
investment. This amount may be increased fivefold if the violation is made by a legal entity. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
certain foreign investments in companies incorporated under French laws are subject to the prior authorization from the French Minister of the Economy, where all or part of the
target's business and activity relate to a strategic sector, such as energy, transportation, public health, telecommunications, etc. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Foreign Exchange Controls  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under current French foreign exchange control regulations there are no limitations on the amount of cash payments that we may remit to residents
of foreign countries. Laws and regulations concerning foreign exchange controls do, however, require that all payments or transfers of funds made by a French resident to a non-resident such as
dividend payments be handled by an accredited intermediary. All registered banks and substantially all credit institutions in France are accredited intermediaries. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Availability of Preferential Subscription Rights  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our shareholders will have the preferential subscription rights described under "Description of Share Capital&#151;Key Provisions of Our
Bylaws and French Law Affecting Our Ordinary Shares&#151;Changes in Share Capital&#151;Preferential Subscription Right." Under French law, shareholders have preferential rights to
subscribe for cash issues of new shares or other securities giving rights to acquire additional shares on a pro rata basis. Holders of our securities in the United States (which may be in the form of
shares or ADSs) may not be able to exercise preferential subscription rights for their securities unless a registration statement under the Securities Act is effective with respect to such rights or
an exemption from the registration requirements imposed by the Securities Act is available. We may, from time to time, issue new shares or other securities giving rights to acquire additional shares
(such as warrants) at a time when no registration statement is in effect and no Securities Act exemption is available. If so, holders of our securities in the United States will be unable to exercise
any preferential subscription rights and their interests will be diluted. We are under no obligation to file any registration statement in connection with any issuance of new shares or other
securities. We intend to evaluate at the time of any rights offering the costs and potential liabilities associated with registering the rights, as well as the indirect benefits to us of enabling the
exercise by holders of shares and holders of ADSs in the United States of the subscription rights, and any other factors we consider appropriate at the time, and then to make a
decision as to whether to register the rights. We cannot assure you that we will file&nbsp;a registration statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
holders of our ordinary shares in the form of ADSs, the depositary may make these rights or other distributions available to ADS holders. If the depositary does not make the rights
available to ADS holders and determines that it is impractical to sell the rights, it may allow these rights to lapse. In that case ADS holders will receive no value for them. The section of this
prospectus titled "Description of American Depositary Shares&#151;Dividends and Other Distributions" explains in detail the depositary's responsibility in connection with a rights offering. See
also "Risk Factors&#151;The right as a holder of ADSs to participate in any future preferential subscription rights or to elect to receive dividends in shares may be limited, which may cause
dilution to the holdings of purchasers of ADSs in the U.S. offering." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>197</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=202,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=130254,FOLIO='197',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_198"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="do10701_description_of_american_depositary_shares"> </A>
<A NAME="toc_do10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  DESCRIPTION OF AMERICAN DEPOSITARY SHARES    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


American Depositary Shares  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Bank of New York Mellon, as depositary, will register and deliver American Depositary Shares, or ADSs. Each ADS will represent one ordinary
share (or a right to receive one ordinary share) deposited with BNP Paribas Securities Services, as custodian for the depositary in France. Each ADS will also represent any other securities, cash or
other property that may be held by the depositary. The deposited ordinary shares together with any other securities, cash or other property held by the depositary are referred to as the deposited
securities. The depositary's office at which the ADSs will be administered and its principal executive office are located at 240 Greenwich Street, New&nbsp;York, New&nbsp;York&nbsp;10286. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
may hold ADSs either (A)&nbsp;directly (i)&nbsp;by having an American Depositary Receipt, or an ADR, which is a certificate evidencing a specific number of ADSs, registered in
your name, or (ii)&nbsp;by having uncertificated ADSs registered in your name, or (B)&nbsp;indirectly by holding a security entitlement in ADSs through your broker or other financial institution
that is a direct or indirect participant in The Depository Trust Company, or DTC. If you hold ADSs directly, you are a registered ADS holder, or an ADS holder. This description assumes you are an ADS
holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult
with your broker or financial institution to find out what those procedures are. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
holders of uncertificated ADSs will receive statements from the depositary confirming their holdings. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. French law governs shareholder rights. The depositary will be the holder of
the ordinary shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or
beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR. For
directions on how to obtain copies of those documents, see the section of this prospectus titled "Where You Can Find More Information." </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividends and Other Distributions  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How will you receive dividends and other distributions on the ordinary shares?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on ordinary
shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;After completion of the global offering, we do not expect to declare or pay any cash dividends or cash distributions on our
ordinary shares for
the foreseeable future. The depositary will convert any cash dividend or other cash distribution we pay on the ordinary shares into U.S. dollars, if it can do so on a reasonable basis and can transfer
the U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign
currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest
the foreign currency and it will not be liable for any interest. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>198</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=203,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=292661,FOLIO='198',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_199"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before
making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. See the section of this prospectus titled "Material United States
Federal Income and French Tax Considerations." The depositary will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. </FONT><FONT SIZE=2><I>If
the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some of the value of the distribution.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary Shares.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The depositary may distribute additional ADSs representing any ordinary shares we distribute as a dividend or free
distribution. The
depositary will only distribute whole ADSs. It will sell ordinary shares which would require it to deliver a fraction of an ADS (or ADSs representing those ordinary shares) and distribute the net
proceeds in the same way as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new ordinary shares. The depositary may sell a
portion of the distributed ordinary shares (or ADSs representing those ordinary shares) sufficient to pay its fees and expenses in connection with that distribution. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rights to purchase additional ordinary shares.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If we offer holders of our securities any rights to subscribe for additional ordinary
shares or any
other rights, the depositary may (i)&nbsp;exercise those rights on behalf of ADS holders, (ii)&nbsp;distribute those rights to ADS holders or (iii)&nbsp;sell those rights and distribute the net
proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the extent the depositary does not do any of those things, it will allow the rights to lapse
unexercised. </FONT><FONT SIZE=2><I>In that case, you will receive no value for them.</I></FONT><FONT SIZE=2> The depositary will exercise or distribute rights only if we ask it to and provide
satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities
or, in the case of ordinary shares, new ADSs representing the new ordinary shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. U.S.
securities laws may restrict the ability of the depositary to distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed
may be subject to restrictions on transfer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Distributions.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks
is legal,
fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does
with cash. Or, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities
(other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or
property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the depositary to distribute securities to all or certain ADS
holders, and the securities distributed may be subject to restrictions on transfer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, ordinary
shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, ordinary shares, rights or anything else to ADS
holders. </FONT><FONT SIZE=2><I>This means that you may not receive the distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to make them
available to you</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Deposit, Withdrawal and Cancellation  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How are ADSs issued?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The depositary will deliver ADSs if you or your broker deposits ordinary shares or evidence of rights to receive ordinary shares with the
custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>199</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=204,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=279460,FOLIO='199',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_200"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>appropriate
number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons that made the deposit. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How can ADS holders withdraw the deposited securities?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may surrender your ADSs to the depositary for the purpose of withdrawal. Upon payment of its fees and expenses and of any taxes or charges,
such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the ordinary shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder
designates at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not
required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited ordinary share or other security. The depositary may charge you a fee and its expenses for
instructing the custodian regarding delivery of deposited securities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How do ADS holders interchange between certificated ADSs and uncertificated ADSs?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR
and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Upon receipt by the depositary of a proper instruction from a registered
holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Rights  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How do you vote?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADS holders may instruct the depositary how to vote the number of deposited ordinary shares their ADSs represent. If we request the depositary
to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders' meeting and send or make voting materials available to you. Those materials
will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the
depositary. The depositary will try, as far as practical, subject to the laws of France and the provisions of our articles of association or similar documents, to vote or to have its agents vote the
ordinary shares or other deposited securities as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions, and, in
that case, the depositary may try to vote as you instruct, but it is not required to do so. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed or as described in the following
sentence. If we asked the depositary to solicit your instructions at least 30&nbsp;days before the meeting date but the depositary does not receive voting instructions from you by the specified date
and we confirm to the depositary that </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we wish to receive a discretionary proxy; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> as of the instruction cutoff date we reasonably do not know of any substantial shareholder opposition to the particular question; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the particular question would not be materially adverse to the interests of our shareholders, </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>then
the depositary will consider you to have authorized and directed it to give a discretionary proxy to a person designated by us to vote the number of deposited securities represented by your ADSs
as to that question. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your ordinary shares. In addition, the depositary and its
agents are not </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>200</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=205,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=196970,FOLIO='200',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_201"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>responsible
for failing to carry out voting instructions or for the manner of carrying out voting instructions. </FONT><FONT SIZE=2><I>This means that you may not be able to exercise voting rights
and there may be nothing you can do if your ordinary shares are not voted as you requested.</I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we request the Depositary to act, we
agree to give the depositary notice of any such meeting and details concerning the matters to be voted upon at least 30&nbsp;days in advance of the meeting date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
double voting right is attached to each registered share which is held in the name of the same shareholder for at least two years. However, the ordinary shares underlying our ADSs will
not be entitled to double voting rights as the depositary will hold the shares underlying our ADSs in bearer form. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of ADSs who wish to obtain double voting rights will need to surrender their ADSs at the depositary's office. The depositary will in turn deliver the ordinary shares underlying
such ADSs to you, and you must then inscribe those shares directly in registered form within the books of our transfer agent and registrar for the ordinary shares for two consecutive years in order to
be entitled to double voting rights. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Except as described above, you will not be able to exercise your right to vote unless you withdraw the ordinary shares. However, you may not know about the
shareholder meeting enough in advance to withdraw the ordinary shares.</I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>201</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=206,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=455610,FOLIO='201',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_202"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fees and Expenses  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What fees and expenses will you be responsible for paying?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the terms of the deposit agreement, the persons depositing or withdrawing ordinary shares or holders of ADSs will be required to pay
the following fees: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Persons depositing or withdrawing ordinary shares or ADS holders must pay:

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>For: </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Issuance of ADSs,
including issuances resulting from a distribution of ordinary shares or rights or other property</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> Cancellation of ADSs for
the purpose of withdrawal, including if the deposit agreement terminates</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>$.05 (or less) per ADS</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Any cash distribution to
ADS holders</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>A fee equivalent to the fee that would be payable if securities distributed to you had been ordinary shares and the ordinary shares had been deposited for
issuance of ADSs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> Distribution of
securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>$.05 (or less) per ADS per calendar year</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> Depositary
services</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Registration or transfer fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Transfer and registration
of ordinary shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw ordinary shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expenses of the depositary</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Cable and facsimile
transmissions (when expressly provided in the deposit agreement)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> Converting foreign
currency to U.S. dollars</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or ordinary shares underlying ADSs, such as stock
transfer taxes, stamp duty or withholding taxes</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>As necessary</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Any charges incurred by the depositary or its agents for servicing the deposited securities</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>As necessary</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
depositary collects its fees for delivery and surrender of ADSs directly from investors depositing ordinary shares or surrendering ADSs for the purpose of withdrawal or from
intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable
property to pay the fees. The depositary
may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them.
The depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to
pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
time to time, the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive fees and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>202</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=207,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=568418,FOLIO='202',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_203"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>expenses
for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers,
dealers, foreign currency dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
depositary may convert currency itself or through any of its affiliates and, in those cases, acts as principal for its own account and not as agent, advisor, broker or fiduciary on
behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it will retain for its own account. The revenue is based on, among other things, the difference
between the exchange rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for
its own account. The depositary makes no representation that the exchange rate used or obtained in any currency conversion under the deposit agreement will be the most favorable rate that could be
obtained at the time or that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary's obligations under the deposit agreement. The
methodology used to determine exchange rates used in currency conversions is available upon request. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Payment of Taxes  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You will be responsible for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of
your ADSs. The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until those taxes or other charges are paid. It
may apply payments owed to you or sell deposited securities represented by your American Depositary Shares to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells
deposited securities, it will, if appropriate,
reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes. Your obligation to pay taxes and
indemnify us and the depository against any tax claims will survive the transfer or surrender of your ADSs, the withdrawal of the deposited ordinary shares as well as the termination of the deposit
agreement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do by an ADS holder
surrendering ADSs and subject to any conditions or procedures the depositary may establish. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
deposited securities are redeemed for cash in a transaction that is mandatory for the depositary as a holder of deposited securities, the depositary will call for surrender of a
corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
there is any change in the deposited securities such as a sub-division, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization
affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the depositary will hold those replacement
securities as deposited securities under the deposit agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities
could not be distributed to ADS holders or for any other reason, the depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of the ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
there is a replacement of the deposited securities and the depositary will continue to hold the replacement securities, the depositary may distribute new ADSs representing the new
deposited securities or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>203</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=208,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=909897,FOLIO='203',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_204"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
there are no deposited securities underlying ADSs, including if the deposited securities are cancelled, or if the deposited securities underlying ADSs have become apparently
worthless, the depositary may call for surrender or of those ADSs or cancel those ADSs upon notice to the ADS holders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Amendment and Termination  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How may the deposit agreement be amended?  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or
increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a
substantial right of ADS holders, it will not become effective for outstanding ADSs until 30&nbsp;days after the depositary notifies ADS holders of the amendment. </FONT><FONT SIZE=2><I>At the time
an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How may the deposit agreement be terminated?  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The depositary will initiate termination of the deposit agreement if we instruct it to do so. The depositary may initiate termination of the
deposit agreement if </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 60&nbsp;days have passed since the depositary told us it wants to resign but a successor depositary has not been appointed and accepted its
appointment; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we delist our ordinary shares from an exchange on which they were listed and do not list the ordinary shares on another exchange; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> we appear to be insolvent or enter insolvency proceedings </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> there has been a replacement of deposited securities. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the deposit agreement will terminate, the depositary will notify ADS holders at least 90&nbsp;days before the termination date. At any time after the termination date, the
depositary may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, unsegregated
and without liability for interest, for the </FONT><FONT SIZE=2><I>pro rata</I></FONT><FONT SIZE=2> benefit of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell
as soon as practicable after the termination date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
the termination date and before the depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the depositary may refuse
to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind if it would interfere with the selling process. The depositary may
refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited
securities, </FONT><FONT SIZE=2><I>but</I></FONT><FONT SIZE=2>, after the termination date, the depositary is not required to register any transfer of ADSs or distribute any dividends or other
distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform any other duties under the deposit agreement except as described in this
paragraph. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>204</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=209,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=529154,FOLIO='204',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_205"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitations on Obligations and Liability  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of
the depositary. We and the depositary:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith, and the depositary will
not be a fiduciary or have any fiduciary duty to holders of ADSs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its control from performing our or
its obligations under the deposit agreement; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> are not liable if we or it exercises discretion permitted under the deposit agreement; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to
holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf
of any other person; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person;. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the depositary has no duty to make any determination or provide any information as to our tax status, or any liability for any tax consequences
that may be incurred by ADS holders as a result of owning or holding ADSs or be liable for the inability or failure of an ADS holder to obtain the benefit of a foreign tax credit, reduced rate of
withholding or refund of amounts withheld in respect of tax or any other tax benefit. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Requirements for Depositary Actions  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before the depositary will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of ordinary shares, the
depositary may require:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the
transfer of any ordinary shares or other deposited securities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer
documents. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we
think it advisable to do so. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>205</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=210,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=886657,FOLIO='205',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_do10701_1_206"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Your Right to Receive the Ordinary Shares Underlying your ADSs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADS holders have the right to cancel their ADSs and withdraw the underlying ordinary shares at any time
except:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> when temporary delays arise because: (i)&nbsp;the depositary has closed its transfer books or we have closed our transfer books;
(ii)&nbsp;the transfer of ordinary shares is blocked to permit voting at a shareholders' meeting; or (iii)&nbsp;we are paying a dividend on our ordinary shares; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> when you owe money to pay fees, taxes and similar charges; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the
withdrawal of ordinary shares or other deposited securities. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
right of withdrawal may not be limited by any other provision of the deposit agreement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Direct Registration System  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct Registration System, also referred to as DRS, and
Profile Modification System, also referred to as Profile, will apply to the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and
holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of
uncertificated ADSs, to direct the depositary to
register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS
holder to register that transfer. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand that the depositary will not determine
whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described in the paragraph above has the actual authority to
act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary's reliance on and compliance with
instructions received by the depositary through the DRS/Profile system and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Shareholder communications; inspection of register of holders of ADSs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited
securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if
we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
holder of ADSs may be required from time to time to provide certain information, including proof of taxpayer status, residence and beneficial ownership (as applicable), from time to
time and in a timely manner as we, the depositary or the custodian may deem necessary or proper to fulfill obligations under applicable law. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Jury Trial Waiver  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have
against us or the depositary arising out of or relating to our ordinary shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary
opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>206</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=211,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=371528,FOLIO='206',FILE='DISK124:[18ZFA1.18ZFA10701]DO10701A.;24',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_dq10701_1_207"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dq10701_shares_and_adss_eligible_for_future_sale"> </A>
<A NAME="toc_dq10701_1"> </A></FONT> <FONT SIZE=2><B>  SHARES AND ADSs ELIGIBLE FOR FUTURE SALE    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the U.S. offering, while our ordinary shares have been traded on Euronext Paris since April 2014 and prior to that, on the Alternext
since 2006, there has been no public market on a U.S. national securities exchange for our ADSs or ordinary shares in the United States. Future sales of ADSs in the U.S. public market after the U.S.
offering, and the availability of ADSs for future sale, could adversely affect the market price of the ADSs prevailing from time to time. As described below, a significant number of currently
outstanding ordinary shares will not be available for sale shortly after the global offering due to contractual restrictions on transfers of ordinary shares and ADSs. However, sales of substantial
amounts of our ADSs or our ordinary shares, or the perception that these sales could occur, could adversely affect prevailing market prices for the ADSs and could impair our future ability to raise
equity capital. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the number of ordinary shares outstanding on December&nbsp;31, 2018, upon completion of the global offering,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares (including ordinary shares
in the
form of ADSs) will be outstanding, assuming no outstanding warrants are exercised and assuming no exercise of the underwriters' option to
purchase additional ADSs and/or ordinary shares. All of the ADSs sold in the U.S. offering will be freely tradable without restrictions or further registration under the Securities Act, except for any
ADSs sold to our "affiliates," as that term is defined under Rule&nbsp;144 under the Securities Act. The ordinary shares held by existing shareholders are "restricted securities," as that term is
defined in Rule&nbsp;144 under the Securities Act. Restricted securities may be sold in the United States on the Nasdaq Global Market only if registered or if their resale qualifies for exemption
from registration described below under Rule&nbsp;144 or 701 promulgated under the Securities Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the lock-up and market stand-off agreements described below and the provisions of Rules&nbsp;144 and 701 under the Securities Act and French law, and assuming no exercise of the
underwriters' option to purchase additional ADSs and/or ordinary shares, these restricted securities will be available for sale in the public market 90&nbsp;days after the date of the underwriting
agreement related to this global offering, provided that shares held by our affiliates will remain subject to volume, manner of sale and other resale limitations set forth in Rule&nbsp;144 and
subject to French law, both as described below. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;144  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In general, a person who has beneficially owned restricted ordinary shares for at least six months would be entitled to sell their securities
pursuant to Rule&nbsp;144 under the Securities Act provided that (1)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90&nbsp;days
preceding, a sale and (2)&nbsp;we have been subject to the Exchange Act periodic reporting requirements for at least 90&nbsp;days before the sale. Persons who have beneficially owned restricted
ordinary shares for at least six months, but who are our affiliates at the time of, or at any time during the 90&nbsp;days preceding a sale, would be subject to additional restrictions, by which
such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> 1.0% of the number of ordinary shares then outstanding (including ordinary shares in the form of ADSs), which will equal approximately
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares immediately after the completion of the global offering based on the number of ordinary shares (including ordinary shares in the form of
ADSs) outstanding as of
December&nbsp;31, 2018 and assuming no exercise of the underwriters' option to purchase additional ADSs and/or ordinary shares; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the average weekly trading volume of our ordinary shares in the form of ADSs on the Nasdaq Global Market during the four calendar weeks
preceding the filing of a notice on Form&nbsp;144 with respect to the sale; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>207</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=212,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=9311,FOLIO='207',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_208"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>provided,
in each case, that we have been subject to the Exchange Act periodic reporting requirements for at least 90&nbsp;days before the sale. Such sales both by affiliates and by non-affiliates
must also comply with the manner of sale, current public information and notice provisions of Rule&nbsp;144. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;701  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rule&nbsp;701 under the Securities Act, as in effect on the date of this prospectus, permits resales of shares in reliance upon
Rule&nbsp;144 but without compliance with certain restrictions of Rule&nbsp;144, including the holding period requirement. Most of our employees, senior management or directors who purchased
shares under a written compensatory plan or contract may be entitled to rely on the resale provisions of Rule&nbsp;701, but all holders of Rule&nbsp;701 shares are required to wait until
90&nbsp;days after the date of this prospectus before selling their shares subject also to French law, as described below. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lock-up Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We and our senior management and directors and their affiliated entities have agreed that, without the prior written consent of SVB
Leerink&nbsp;LLC and Barclays Capital&nbsp;Inc., we and they will not, subject to customary exceptions, during the period ending 90&nbsp;days after the date of this prospectus, directly or
indirectly, sell, offer, contract or grant any option to sell, pledge or otherwise transfer or dispose of any ordinary shares, ADSs or any securities convertible into, exercisable or exchangeable for
our ordinary shares or ADSs or publicly announce an intent to do any of the foregoing. SVB Leerink&nbsp;LLC and Barclays Capital&nbsp;Inc., on behalf of the underwriters, will have discretion in
determining if and when to release any ordinary shares or ADSs subject to lock-up agreements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not currently expect any release of ordinary shares or ADSs subject to lock-up agreements prior to the expiration of the applicable lock-up periods. Upon the expiration of the
applicable lock-up periods, substantially all of the ordinary shares and ADSs subject to such lock-up restrictions will become eligible for sale, subject to the limitations described above. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


French Law  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under French law, and in particular under the General Regulation issued by the French Financial Markets Authority
(</FONT><FONT SIZE=2><I>R&eacute;glement G&eacute;n&eacute;ral de l'AMF</I></FONT><FONT SIZE=2>), as well as under Market Abuse Regulation&nbsp;596/2014 of 16&nbsp;April
2014 (MAR), any person that holds inside information shall, until such information is made public, refrain from (1)&nbsp;carrying out any transactions relating to securities issued by the company,
(2)&nbsp;recommending that another person engage in insider dealing or induce another person to engage in insider dealing, (3)&nbsp;unlawfully disclosing inside information outside of the normal
exercise of an employment, a profession or duties. The use of inside information by cancelling or amending an order concerning a financial instrument to which the information relates where the order
was placed before the person concerned possessed the inside information, shall also be considered to be insider dealing. These rules apply to all persons who hold inside information as a result of
(1)&nbsp;their status as board member, executive officer, manager, employee of the company, third parties acting on behalf of the company and having access to privileged information as party of
their professional relations with the company during the preparation or the completion of a particular transaction, such as investor services providers, lawyers or public relations agencies,
(2)&nbsp;their holding of securities in the share capital of the company, and/or (3)&nbsp;their access to information because of their employment, profession or duties or their participation in
the preparation of a financial transaction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
MAR and the General Regulation of the French Financial Markets Authority, it is also prohibited for a person to engage or attempt to engage in market manipulation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prohibited
transactions include all transactions related to securities (stocks, bonds, securities convertible, options and warrants), and, in particular, the (1)&nbsp;transfer of
securities, (2)&nbsp;exercise of options and warrants (including founder's share warrants) and exercise of any securities giving access to the capital, (3)&nbsp;transfer of free shares and
(4)&nbsp;acquisition of securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>208</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=213,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=657120,FOLIO='208',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_209"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dq10701_material_united_states_federal__mat02698"> </A>
<A NAME="toc_dq10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  MATERIAL UNITED STATES FEDERAL INCOME AND FRENCH TAX CONSIDERATIONS    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following describes material U.S. federal income tax and French tax considerations relating to the acquisition, ownership and disposition of
ADSs by a U.S. holder (as defined below). This summary addresses these tax considerations only for U.S. holders that are initial purchasers of the ADSs pursuant to the global offering and that will
hold such ADSs as capital assets (generally, property held for investment). This summary does not address all U.S. federal income tax and French tax matters that may be relevant to a particular U.S.
holder. This summary does not address tax considerations applicable to a holder of ADSs that may be subject to special tax rules including, without limitation, the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> banks, financial institutions or insurance companies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> brokers, dealers or traders in securities, currencies, commodities, or notional principal contracts; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> tax-exempt entities or organizations, including an "individual retirement account" or "Roth IRA" as defined in Section&nbsp;408 or 408A of
the Code (as defined below), respectively; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> real estate investment trusts, regulated investment companies or grantor trusts; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons that hold the ADSs as part of a "hedging," "integrated," "wash sale" or "conversion" transaction or as a position in a "straddle" for
U.S. federal income tax purposes; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> S corporations, partnerships, or other entities or arrangements classified as partnerships for U.S. federal income tax purposes; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> certain former citizens or long term residents of the United States; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons that received ADSs as compensation for the performance of services; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> persons acquiring ADSs in connection with a trade or business conducted outside of the United States, including a permanent establishment or a
fixed base in France; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> holders that own directly, indirectly, or through attribution 10% or more of the voting power or value of our ADSs and shares or, in the case
of the discussion of French tax consequences, 5% or more of the voting stock or our share capital; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> holders that have a "functional currency" other than the U.S. dollar. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of ADSs who fall within one of the categories above are advised to consult their usual tax advisor regarding the specific tax consequences which may apply to their particular
situation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purposes of this description, a "U.S. holder" is a beneficial owner of ADSs that is (or is treated as), for U.S. federal income tax
purposes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an individual who is a citizen or resident of the United States; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or
the District of Columbia; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a trust, if a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have
the authority to control all of the substantial decisions of such trust, or if such trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a partnership (or any other entity treated as a partnership for U.S. federal income tax purposes) holds ADSs, the tax consequences relating to an investment in the ADSs will depend in
part upon the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>209</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=214,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=852270,FOLIO='209',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_210"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>status
of the partner and the activities of the partnership. Such a partner or partnership should consult its tax advisor regarding the specific tax considerations of acquiring, owning and disposing
of the ADSs in its particular circumstances. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
discussion in this section is based in part upon the representations of the depositary and the assumption that each obligation in the deposit agreement and any related agreement will
be performed in accordance with its terms. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Persons considering an investment in the ADSs should consult their own tax advisors as to the particular tax consequences applicable to them relating to the
acquisition, ownership and disposition of the ADSs, including the applicability of U.S. federal, state and local tax laws, French tax laws and other non-U.S. tax laws.</B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Material French Tax Considerations  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following describes the material French income tax consequences to U.S. holders of purchasing, owning and disposing of our ADSs and, unless
otherwise noted, this discussion is the opinion of Linklaters&nbsp;LLP, our French tax counsel, insofar as it relates to matters of French tax law and legal conclusions with respect to those
matters. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
discussion does not purport to be a complete analysis or listing of all potential tax effects of the acquisition, ownership or disposition of our ADSs to any particular investor,
and does not discuss tax considerations that arise from rules of general application or that are generally assumed to be known by investors. All of the following is subject to change. Such changes
could apply retroactively and could affect the consequences described below. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
description of the French income tax and wealth tax consequences set forth below is based on the Convention Between the Government of the United States of America and the Government
of the French Republic for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital of August&nbsp;31, 1994, or the Treaty, which came into
force on December&nbsp;30, 1995 (as amended by any subsequent protocols, including the protocol of January&nbsp;13, 2009), and the tax guidelines issued by the French tax authorities in force as
of the date of this prospectus. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
discussion applies only to investors that are entitled to Treaty benefits under the "Limitation on Benefits" provision contained in the Treaty. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2011, France introduced a comprehensive set of new tax rules applicable to French assets that are held by or in foreign trusts. These rules provide inter alia for the inclusion of
trust assets in the settlor's net assets for the purpose of applying the French wealth tax, for the application of French gift and death duties to French assets held in trust, for a specific tax on
capital on the French assets of
foreign trusts not already subject to the French wealth tax and for a number of French tax reporting and disclosure obligations. The following discussion does not address the French tax consequences
applicable to securities (including ADSs) held in trusts. If ADSs are held in trust, the grantor, trustee and beneficiary are urged to consult their own tax advisor regarding the specific tax
consequences of acquiring, owning and disposing of securities (including ADSs). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S.
holders are urged to consult their own tax advisors regarding the tax consequences of the purchase, ownership and disposition of securities in light of their particular
circumstances, especially with regard to the "Limitations on Benefits" provision. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Estate and Gift Taxes  </I></B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In general, a transfer of securities by gift or by reason of death of a U.S. holder that would otherwise be subject to French gift or
inheritance tax, respectively, will not be subject to such French </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>210</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=215,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=812670,FOLIO='210',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_211"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>tax
by reason of the Convention between the Government of the United States of America and the Government of the French Republic for the Avoidance of Double Taxation and the Prevention of Fiscal
Evasion with Respect to Taxes on Estates, Inheritances and Gifts, dated November&nbsp;24, 1978, unless (1)&nbsp;the donor or the transferor is domiciled in France at the time of making the gift or
at the time of his or her death, or (2)&nbsp;the securities were used in, or held for use in, the conduct of a business through a permanent establishment or a fixed base in France. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Taxes  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Article&nbsp;235 ter ZD of the </FONT><FONT SIZE=2><I>Code g&eacute;n&eacute;ral des
imp&ocirc;ts</I></FONT><FONT SIZE=2> (French Tax Code, or FTC), purchases of shares or ADSs of a French company listed on a regulated market of the European Union or on a foreign regulated
market formally acknowledged by the French Financial Market Authority (AMF) are subject to a 0.3% French tax on financial transactions provided that, broadly, the issuer's market capitalization
exceeds 1&nbsp;billion euros as of December&nbsp;1 of the year preceding the taxation
year. The Nasdaq Global Market is not currently acknowledged by the French AMF but this may change in the future. A list of companies whose market capitalization exceeds 1&nbsp;billion euros as of
December&nbsp;1 of the year preceding the taxation year within the meaning of Article&nbsp;235 ter ZD of the FTC used to be published annually, by the French Ministry of Economy by a ministerial
decree until December 2014. It was not published by the French tax authorities, and could be amended at any time. As from such date, the list is published by the French tax authorities on an annual
basis in their official guidelines. Pursuant to regulations BOI-ANNX-000467-20181217 issued on December&nbsp;17, 2018, we are currently not included in such list. Please note that such list may be
updated from time to time, or may not be published anymore in the future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
the global offering, purchases of our securities may be subject to such tax provided that its market capitalization exceeds 1&nbsp;billion euros as of December&nbsp;1 of
the year preceding the taxation year and that the Nasdaq Global Market is acknowledged by the French AMF. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the case where Article&nbsp;235 ter ZD of the FTC is not applicable, transfers of shares issued by a French company which are listed on a regulated or organized market within the
meaning of the French Monetary and Financial Code are subject to uncapped registration duties at the rate of 0.1% if the transfer is evidenced by a written statement ("acte") executed either in France
or outside France. As ordinary shares of our company are listed on Euronext Paris, which is an organized market within the meaning of the French Monetary and Financial Code, their transfer should be
subject to uncapped registration duties at the rate of 0.1% subject to the existence of a written statement, or </FONT><FONT SIZE=2><I>acte</I></FONT><FONT SIZE=2> and provided that
Article&nbsp;235 ter ZD of the FTC is not applicable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Tax on Sale or Other Disposition  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a matter of principle, under French tax law, a U.S. holder should not be subject to any French tax on any capital gain from the sale,
exchange, repurchase or redemption by us of ordinary shares or ADSs, provided such U.S. holder is not a French tax resident for French tax purposes and has not held more than 25% of our dividend
rights, known as </FONT><FONT SIZE=2><I>"droits aux b&eacute;n&eacute;fices sociaux,"</I></FONT><FONT SIZE=2> at any time during the preceding five years, either directly or
indirectly, and, as relates to individuals, alone or with relatives (as an exception, a U.S holder resident, established or incorporated in a non-cooperative State or territory as defined in
Article&nbsp;238-0 A of the FTC should be subject to a 75% withholding tax in France on any such capital gain, regardless of the fraction of the dividend rights it holds. A law aiming at fighting
against tax fraud and adopted in October 2018 by the French Parliament expands the list of non-cooperative States or territories as defined under Article&nbsp;238-0 A of the FTC to include States
and jurisdictions on the blacklist published by the Council of the European Union and as a consequence, expands this 75% withholding tax regime to certain States and jurisdictions included in the
blacklist.) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>211</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=216,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=613442,FOLIO='211',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_212"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
application of the Treaty, a U.S. holder who is a U.S. resident for purposes of the Treaty and entitled to Treaty benefit will not be subject to French tax on any such capital gain
unless the ordinary shares or the ADSs form part of the business property of a permanent establishment or fixed base that the U.S. holder has in France. U.S. holders who own ordinary shares or ADSs
through U.S. partnerships that are not resident for Treaty purposes are advised to consult their own tax advisors regarding their French tax treatment and their eligibility for Treaty benefits in
light of their own particular circumstances. A U.S. holder that is not a U.S. resident for Treaty purposes or is not entitled to Treaty benefit (and in both cases is not resident, established or
incorporated in a non-cooperative State or territory as defined in Article&nbsp;238-0 A of the FTC) and has held more than 25% of our dividend rights, known as </FONT><FONT SIZE=2><I>"droits aux
b&eacute;n&eacute;fices sociaux,"</I></FONT><FONT SIZE=2> at any time during the preceding five years, either directly or indirectly, and, as relates to individuals, alone or with
relatives will be subject to a levy in France at the rate (1)&nbsp;of 12.8% for individuals and (2)&nbsp;corresponding to the standard corporate income tax rate set forth in Article&nbsp;219-I
of the FTC for legal persons. Special rules apply to U.S. holders who are residents of more than one country. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Taxation of Dividends  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid by a French corporation to non-residents of France are generally subject to French withholding tax at a rate of (i)&nbsp;30%
(to be aligned on the standard corporate income tax rate set forth in Article&nbsp;219-I of the FTC for fiscal years beginning as from January&nbsp;1, 2020) for payments benefiting legal persons
which are not French tax residents, and (ii)&nbsp;12.8% for payments benefiting individuals who are not French tax residents Dividends paid by a French corporation in a non-cooperative State or
territory, as defined in Article&nbsp;238-0 A of the FTC, will generally be subject to French withholding tax at a rate of 75%. The law aiming at fighting against tax fraud mentioned above expands
this 75% withholding tax regime to certain States and jurisdictions included in the blacklist of the European Union. However, eligible U.S. holders which are legal entities and entitled to Treaty
benefits under the "Limitation on Benefits" provision contained in the Treaty who are U.S. residents, as defined pursuant to the provisions of the Treaty, will not be subject to this 30% (to be
aligned on the standard corporate income tax rate set forth in Article&nbsp;219-I of the FTC for fiscal years beginning as from January&nbsp;1, 2020) or 75% withholding tax rate, but may be
subject to the withholding tax at a reduced rate (as described below). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
U.S. holders that are not individuals but are U.S. residents, as defined pursuant to the provisions of the Treaty, the requirements for eligibility for Treaty benefits, including the
reduced 5% or 15% withholding tax rates contained in the "Limitation on Benefits" provision of the Treaty, are complex, and certain technical changes were made to these requirements by the protocol of
January&nbsp;13, 2009. U.S. holders are advised to consult their own tax advisors regarding their eligibility for Treaty benefits
in light of their own particular circumstances. Dividends paid to an eligible U.S. holder may immediately be subject to the reduced rates of 5% or 15% provided
that:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> such holder establishes before the date of payment that it is a U.S. resident under the Treaty by completing and providing the depositary with
a treaty form (Form&nbsp;5000); or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the depositary or other financial institution managing the securities account in the U.S. of such holder provides the French paying agent with
a document listing certain information about the U.S. holder and its ordinary shares or ADSs and a certificate whereby the financial institution managing the U.S. holder's securities account in the
United States takes full responsibility for the accuracy of the information provided in the document. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Otherwise,
dividends paid to a U.S. holder, if such U.S. holder is a legal person, will be subject to French withholding tax at the rate of 30% (to be aligned on the standard corporate
income tax rate set forth in Article&nbsp;219-I of the FTC for fiscal years beginning as from January&nbsp;1, 2020), or 75% if paid in a non-cooperative State or territory (as defined in
Article&nbsp;238-0 A of the FTC), and then reduced at a later date to 5% or 15%, provided that such holder duly completes and provides the French tax </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>212</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=217,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=551436,FOLIO='212',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_213"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>authorities
with the treaty forms Form&nbsp;5000 and Form&nbsp;5001 before December&nbsp;31 of the second calendar year following the year during which the dividend is paid. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
qualifying pension funds and certain other tax-exempt entities are subject to the same general filing requirements as other U.S. holders except that they may have to supply
additional documentation evidencing their entitlement to these benefits. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;5000
and Form&nbsp;5001, together with instructions, will be provided by the depositary to all U.S. holders registered with the depositary. The depositary will arrange for
the filing with the French tax authorities of all such forms properly completed and executed by U.S. holders of ordinary shares or ADSs and returned to the depositary in sufficient time so that they
may be filed with the French tax authorities before the distribution in order to immediately obtain a reduced withholding tax rate.
Otherwise, the depositary must withhold tax at the full rate of 30% or 75% as applicable. In that case, the U.S. holders may claim a refund from the French tax authorities of the excess withholding
tax. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
any case, individual taxpayers who are not fiscally domiciled in France should not have to comply with these procedures if the French withholding tax applying to them is lower than
15%. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Wealth Tax  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As from January&nbsp;1, 2018, the French wealth tax </FONT><FONT SIZE=2><I>(imp&ocirc;t de solidarit&eacute; sur la
fortun</I></FONT><FONT SIZE=2>e) is repealed and replaced by the French real estate wealth tax </FONT><FONT SIZE=2><I>(imp&ocirc;t sur la fortune
immobili&egrave;re).</I></FONT><FONT SIZE=2> The scope of such new tax is narrowed to real estate assets (and certain assets determined to be real estate assets) or rights, directly or
indirectly through one or more legal entities and whose net taxable assets amount to at least &euro;1,300,000. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broadly,
subject to provisions of double tax treaties and to certain exceptions, individuals who are not residents of France for tax purposes within the meaning of Article&nbsp;4 B of
the FTC, are subject to real estate wealth tax </FONT><FONT SIZE=2><I>(imp&ocirc;t sur la fortune immobili&egrave;re)</I></FONT><FONT SIZE=2> in France in respect of the portion of
the value of their shares of our company representing real estate assets (Article&nbsp;965, 2&deg; of the FTC). Some exceptions are provided by the FTC. For instance, any participations
representing less than 10% of the share capital of an operational company and shares representing real estate for the professional use of the company considered shall not fall within the scope of the
French real estate wealth tax </FONT><FONT SIZE=2><I>(imp&ocirc;t sur la fortune immobili&egrave;re)</I></FONT><FONT SIZE=2>. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the Treaty (the provisions of which should be applicable to this new real estate wealth tax (</FONT><FONT SIZE=2><I>imp&ocirc;t sur la fortune
immobili&egrave;re</I></FONT><FONT SIZE=2>) in France), the French real estate wealth tax (</FONT><FONT SIZE=2><I>imp&ocirc;t sur la fortune
immobili&egrave;re</I></FONT><FONT SIZE=2>) will however generally not apply to shares that are held by U.S. Holders who (1)&nbsp;own, alone or with related persons, directly or indirectly,
shares in our company which give rise to less than 25% of the rights in the company's earnings, and (2)&nbsp;do not own their shares in connection with a permanent establishment or a fixed base
through which the U.S. Holder carries on business or performs personal services in France. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S.
Holders are advised to consult their usual tax advisor regarding the specific tax consequences which may apply to their particular situation with respect to such French real estate
wealth tax </FONT><FONT SIZE=2><I>(imp&ocirc;t sur la fortune immobili&egrave;re).</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Material U.S. Federal Income Tax Considerations  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This section discusses the material U.S. federal income tax considerations relating to the acquisition, ownership and disposition of ADSs by a
U.S. holder. This description does not address the U.S. federal estate, gift, or alternative minimum tax considerations, or any U.S. state, local, or non-U.S. tax considerations of the acquisition,
ownership and disposition of the ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
description is based on the U.S. Internal Revenue Code of 1986, as amended, or the Code, existing, proposed and temporary U.S. Treasury Regulations promulgated thereunder and
administrative and judicial interpretations thereof, in each case as in effect and available on the date hereof. All the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>213</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=218,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=201632,FOLIO='213',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_214"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>foregoing
is subject to change, which change could apply retroactively, and to differing interpretations, all of which could affect the tax considerations described below. There can be no assurances
that the U.S. Internal Revenue Service, or the IRS, will not take a position concerning the tax consequences of the acquisition, ownership and disposition of the ADSs or that such a position would not
be sustained by a court. We have not obtained, nor do we intend to obtain, a ruling with respect to the U.S. federal income tax considerations in the purchase, ownership or disposition of our ADSs.
Accordingly, holders should consult their own tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of acquiring, owning and disposing of the ADSs in their particular
circumstances. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
indicated below, this discussion is subject to U.S. federal income tax rules applicable to a "passive foreign investment company," or a PFIC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
discussion below assumes that the representations contained in the deposit agreement are true and that the obligations in the deposit agreement and any related agreements will be
complied with in accordance with their terms. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, and taking into account the earlier assumptions, for U.S. federal income and French tax purposes, a U.S. holder holding ADSs will be treated as the owner of the shares
represented by the ADSs. Exchanges of shares for ADSs, and ADSs for shares, generally will not be subject to U.S. federal income or to French tax. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributions.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Subject to the discussion under "</FONT><FONT SIZE=2><I>&#151;Passive Foreign Investment Company
Considerations,</I></FONT><FONT SIZE=2>" below, the gross amount of any distribution (including any amounts withheld in respect of foreign tax) actually or constructively received by a U.S. holder
with respect to ADSs will generally be taxable to the U.S. holder as a dividend to the extent of the U.S. holder's pro rata share of our current and accumulated earnings and profits as determined
under U.S. federal income tax principles. Distributions in excess of earnings and profits will generally be non-taxable to the U.S. holder to the extent of, and will be applied against and reduce, the
U.S. holder's adjusted tax basis in the ADSs. Distributions in excess of earnings and profits and such adjusted tax basis will generally be taxable to the U.S. holder as either long-term or short-term
capital gain depending upon whether the U.S. holder has held the ADSs for more than one year as of the time such distribution is received. However, since we may not calculate our earnings and profits
under U.S. federal income tax principles, it is expected that any distribution will be reported as a dividend, even if that distribution would otherwise be treated as a non-taxable return of capital
or as capital gain under the rules described above. Non-corporate U.S. holders may qualify for the preferential rates of taxation with respect to dividends on ADSs applicable to long-term capital
gains (i.e.,&nbsp;gains from the sale of capital assets held for more than one year) and qualified dividend income (as discussed below) if we are a "qualified foreign corporation" and certain other
requirements (discussed below) are met. A non-U.S. corporation (other than a corporation that is classified as a PFIC for the taxable year in which the dividend is paid or the preceding taxable year)
generally will be considered to be a qualified foreign corporation (a)&nbsp;if it is eligible for the benefits of a comprehensive tax treaty with the United States which the Secretary of Treasury of
the United States determines is satisfactory for purposes of this provision and which includes an exchange of information provision, or (b)&nbsp;with respect to any dividend it pays on ADSs which
are readily tradable on an established securities market in the United States. We have applied to list our ADSs on the Nasdaq Global Market, which is an established securities market in the United
States, and we expect the ADSs to be readily tradable on the Nasdaq Global Market. There can be no assurance that the ADSs will be considered readily tradable on an established securities market in
the United States in later years. The Company, which is incorporated under the laws of France, believes that it qualifies as a resident of France for purposes of, and is eligible for the benefits of,
the Convention between the Government of the United States of America and the Government of the French Republic for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect
to Taxes on Income and Capital, signed on August&nbsp;31, 1994, as amended and currently in force, or the U.S.-France Tax Treaty, although there can be no assurance in this regard. Further, the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>214</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=219,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=600823,FOLIO='214',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_215"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>IRS
has determined that the U.S.-France Tax Treaty is satisfactory for purposes of the qualified dividend rules and that it includes an exchange-of-information program. Therefore, subject to the
discussion under "</FONT><FONT SIZE=2><I>&#151;Passive Foreign Investment Company Considerations</I></FONT><FONT SIZE=2>," below, such dividends will generally be "qualified dividend income"
in the hands of individual U.S. holders, provided that a holding period requirement (more than 60&nbsp;days of ownership, without protection from the risk of loss, during the 121-day period
beginning 60&nbsp;days before the ex-dividend date) and certain other requirements are met. The dividends will not be eligible for the dividends-received deduction generally allowed to corporate
U.S. holders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
U.S. holder generally may claim the amount of any French withholding tax as either a deduction from gross income or a credit against its U.S. federal income tax liability. The foreign
tax credit is subject to numerous complex limitations that must be determined and applied on an individual basis. Generally, the credit cannot exceed the proportionate share of a U.S. holder's U.S.
federal income tax liability that such U.S. holder's taxable income bears to such U.S. holder's worldwide taxable income. In applying this limitation, a U.S. holder's various items of income and
deduction must be classified, under complex rules, as either "foreign source" or "U.S. source." This limitation is calculated separately with respect to specific categories of income. The amount of a
distribution with respect to the ADSs that is treated as a "dividend" may be lower for U.S. federal income tax purposes than it is for French income tax purposes, potentially resulting in a reduced
foreign tax credit for the U.S. holder. In addition, the creditability of foreign taxes could be affected by actions taken by intermediaries in the chain of ownership between the holders of ADSs and
our company if, as a result of such actions, the holders of ADSs are not properly treated as beneficial owners of the underlying ordinary shares. Each U.S. holder should consult its own tax advisors
regarding the foreign tax credit rules. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, the amount of a distribution paid to a U.S. holder in a foreign currency will be the U.S. dollar value of the foreign currency calculated by reference to the spot exchange
rate on the day the Depositary receives the distribution, regardless of whether the foreign currency is converted into U.S. dollars at that time. Any foreign currency gain or loss a U.S. holder
realizes on a subsequent conversion of foreign currency into U.S. dollars will be U.S. source ordinary income or loss. If dividends received in a foreign currency are converted into U.S. dollars on
the day they are received, a U.S. holder should not be required to recognize foreign currency gain or loss in respect of the dividend. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sale, Exchange or Other Taxable Disposition of the ADSs.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A U.S. holder will generally recognize gain or loss for U.S. federal
income tax purposes
upon the sale, exchange or other taxable disposition of ADSs in an amount equal to the difference between the U.S. dollar value of the amount realized from such sale or exchange and the U.S. holder's
adjusted tax basis in those ADSs, determined in U.S. dollars. Subject to the discussion under "</FONT><FONT SIZE=2><I>&#151;Passive Foreign Investment Company
Considerations</I></FONT><FONT SIZE=2>" below, this gain or loss will generally be a capital gain or loss. The adjusted tax basis in the ADSs generally will be equal to the cost of such ADSs. Capital
gain from the sale, exchange or other taxable disposition of ADSs by a non-corporate U.S. holder is generally eligible for a preferential rate of taxation applicable to capital gains, if the
non-corporate U.S. holder's holding period determined at the time of such sale, exchange or other taxable disposition for such ADSs exceeds one year (i.e.,&nbsp;such gain is long-term taxable gain).
The deductibility of capital losses for U.S. federal income tax purposes is subject to limitations. Any such gain or loss that a U.S. holder recognizes generally will be treated as U.S. source gain or
loss for foreign tax credit limitation purposes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
a cash basis taxpayer, units of foreign currency paid or received are translated into U.S. dollars at the spot rate on the settlement date of the purchase or sale. In that case, no
foreign currency exchange gain or loss will result from currency fluctuations between the trade date and the settlement date of such a purchase or sale. An accrual basis taxpayer, however, may elect
the same treatment required of cash basis taxpayers with respect to purchases and sales of the ADSs that are traded on an </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>215</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=220,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=64205,FOLIO='215',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_216"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>established
securities market, provided the election is applied consistently from year to year. Such election may not be changed without the consent of the IRS. For an accrual basis taxpayer who does
not make such election, units of foreign currency paid or received are translated into U.S. dollars at the spot rate on the trade date of the purchase or sale. Such an accrual basis taxpayer may
recognize exchange gain or loss based on currency fluctuations between the trade date and the settlement date. Any foreign currency gain or loss a U.S. holder realizes will be U.S. source ordinary
income or loss. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medicare Tax.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Certain U.S. holders that are individuals, estates or trusts are subject to a 3.8% tax on all or a portion of their
"net investment
income," which may include all or a portion of their dividend income and net gains from the disposition of ADSs. Each U.S. holder that is an individual, estate or trust is urged to consult its tax
advisors regarding the applicability of the Medicare tax to its income and gains in respect of its investment in the ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Passive Foreign Investment Company Considerations.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If we are classified as a PFIC in any taxable year, a U.S. holder will be
subject to special rules
generally intended to reduce or eliminate any benefits from the deferral of U.S. federal income tax that a U.S. holder could derive from investing in a non-U.S. company that does not distribute all of
its earnings on a current basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will be classified as a PFIC for U.S. federal income tax purposes in any taxable year in which, after applying certain look-through rules with respect to the income and assets of our
subsidiaries, either: (1)&nbsp;at least 75% of the gross income is "passive income" or (2)&nbsp;at least 50% of the average quarterly value of our total gross assets (which would generally be
measured by fair market value of our assets, and for which purpose the total value of our assets may be determined in part by the market value of the ADSs and our ordinary shares, which are subject to
change) is attributable to assets that produce "passive income" or are held for the production of "passive income." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Passive
income for this purpose generally includes dividends, interest, royalties, rents, gains from commodities and securities transactions, the excess of gains over losses from the
disposition of assets which produce passive income, and includes amounts derived by reason of the temporary investment of funds raised in offerings of the ADSs. If a non-U.S. corporation owns directly
or indirectly at least 25% by value of the stock of another corporation, the non-U.S. corporation is treated for purposes of the PFIC tests as owning its proportionate share of the assets of the other
corporation and as receiving directly its proportionate share of the other corporation's income. The determination of whether we are a PFIC is a fact-intensive determination made on an annual basis
and the applicable law is subject to varying interpretation. If we are classified as a PFIC in any taxable year during which a U.S. holder
owns our ordinary shares or ADSs, such U.S. holder will be subject to special tax rules discussed below and could suffer adverse tax consequences. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
market value of our assets may be determined in large part by reference to the market price of the ADSs and our ordinary shares, which is likely to fluctuate after the global
offering. Therefore, fluctuations in the market price of our ordinary shares or ADSs may result in our being a PFIC for any taxable year. In addition, the composition of our income and assets will be
affected by how, and how quickly, we use the cash proceeds from the global offering in our business. Whether we are a PFIC for any taxable year will depend on our assets and income (including whether
we receive certain non-refundable grants or subsidies and whether such amounts and reimbursements of certain refundable research tax credits will constitute gross income for purposes of the PFIC
income test) in each year, and because this is a factual determination made annually after the end of each taxable year, there can be no assurance that we will not be considered a PFIC in any taxable
year. We do not believe were characterized as a PFIC in our taxable year ending December&nbsp;31, 2018 and do not believe we will be characterized as a PFIC for our taxable year ending
December&nbsp;31, 2019; however, there can be no assurance that we will not be considered a PFIC for any future taxable year. Our U.S. counsel expresses no opinion regarding our conclusions or our
expectations regarding our PFIC status. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are classified as a PFIC in any year with respect to which a U.S. holder owns our ordinary shares or ADSs, we will continue to be treated as a PFIC with respect to such U.S. holder
in all </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>216</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=221,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=314397,FOLIO='216',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_217"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>succeeding
years during which the U.S. holder owns the ordinary shares or ADSs, regardless of whether we continue to meet the tests described above unless we cease to be a PFIC and the U.S. holder has
made a "deemed sale" election under the PFIC rules or is eligible to make and makes a mark-to-market election (as described below), with respect to all taxable years during such U.S. holder's holding
period in which we are a PFIC. If the "deemed sale" election is made, a U.S. holder will be deemed to have sold the ordinary shares or ADSs the U.S. holder holds at their fair market value as of the
date of such deemed sale and any gain from such deemed sale would be subject to the rules described below. After the deemed sale election, so long as we do not become a PFIC in a subsequent taxable
year, the U.S. holder's ordinary shares or ADSs with respect to which such election was made will not be treated as shares in a PFIC and the U.S. holder will not be subject to the rules described
below with respect to any "excess distribution" the U.S. holder receives from us or any gain from an actual sale or other disposition of the ordinary shares or ADSs. U.S. holders should consult their
tax advisors as to the possibility and consequences of making a deemed sale election if such election becomes available. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are a PFIC, and you are a U.S. holder that does not make one of the elections described above (and below in further detail), a special tax regime will apply to both (a)&nbsp;any
"excess distribution" by us to you (generally, your ratable portion of distributions in any year which are greater than 125% of the average annual distribution received by you in the shorter of the
three preceding years or your holding
period for the ADSs) and (b)&nbsp;any gain realized on the sale or other disposition of the ADSs. Under this regime, any excess distribution and realized gain will be treated as ordinary income and
will be subject to tax as if (a)&nbsp;the excess distribution or gain had been realized ratably over your holding period, (b)&nbsp;the amount deemed realized in each year had been subject to tax
in each year of that holding period at the highest marginal rate for such year (other than income allocated to the current period or any taxable period before we became a PFIC, which would be subject
to tax at the U.S. holder's regular ordinary income rate for the current year and would not be subject to the interest charge discussed below), and (c)&nbsp;the interest charge generally applicable
to underpayments of tax had been imposed on the taxes deemed to have been payable in those years. In addition, dividend distributions made to you will not qualify for the lower rates of taxation
applicable to qualified dividends discussed above under "Distributions." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
elections may alleviate some of the adverse consequences of PFIC status and would result in an alternative treatment of the ADSs. If a U.S. holder makes a mark-to-market
election, the U.S. holder generally will recognize as ordinary income any excess of the fair market value of the ADSs at the end of each taxable year over their adjusted tax basis, and will recognize
an ordinary loss in respect of any excess of the adjusted tax basis of the ADSs over their fair market value at the end of the taxable year (but only to the extent of the net amount of income
previously included as a result of the mark-to-market election). If a U.S. holder makes the election, the U.S. holder's tax basis in the ADSs will be adjusted to reflect these income or loss amounts.
Any gain recognized on the sale or other disposition of ADSs in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of
the net amount of income previously included as a result of the mark-to-market election). The mark-to-market election is available only if we are a PFIC and the ADSs are "regularly traded" on a
"qualified exchange." The ADSs will be treated as "regularly traded" in any calendar year in which more than a de minimis quantity of the ADSs are traded on a qualified exchange on at least
15&nbsp;days during each calendar quarter (subject to the rule that trades that have as one of their principal purposes the meeting of the trading requirement as disregarded). The Nasdaq Global
Market is a qualified exchange for this purpose and, consequently, if the ADSs are regularly traded, the mark-to-market election will be available to a U.S. holder. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;However,
a mark-to-market election generally cannot be made for equity interests in any lower-tier PFICs that we own, unless shares of such lower-tier PFIC are themselves "marketable."
As a result, even if a U.S. holder validly makes a mark-to-market election with respect to our ordinary shares or ADSs, the U.S. holder may continue to be subject to the PFIC rules (described above)
with respect to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>217</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=222,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=129970,FOLIO='217',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_dq10701_1_218"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>its
indirect interest in any of our investments that are treated as an equity interest in a PFIC for U.S. federal income tax purposes. U.S. holders should consult their tax advisors as to the
availability and desirability of a mark-to-market election, as well as the impact of such election on interests in any lower-tier PFICs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not currently intend to provide the information necessary for U.S. holders to make qualified electing fund elections if we were treated as a PFIC for any taxable year. U.S. holders
should consult their tax advisors to determine whether any of these elections would be available and if so, what the consequences of the alternative treatments would be in their particular
circumstances. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are determined to be a PFIC, the general tax treatment for U.S. holders described in this section would apply to indirect distributions and gains deemed to be realized by U.S.
holders in respect of any of our subsidiaries that also may be determined to be PFICs. U.S. holders should consult their tax advisors regarding the application of the PFIC rules to our subsidiaries. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a U.S. holder owns ADSs during any taxable year in which we are a PFIC, the U.S. holder generally will be required to file an IRS Form&nbsp;8621 (Information Return by a Shareholder
of a Passive Foreign Investment Company or Qualified Electing Fund) with respect to the company, generally with the U.S. holder's federal income tax return for that year. If our company were a PFIC
for a given taxable year, then you should consult your tax advisor concerning your annual filing requirements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>The U.S. federal income tax rules relating to PFICs are complex. Prospective U.S. investors are urged to consult their own tax advisers with respect to the
acquisition, ownership and disposition of the ADSs, the consequences to them of an investment in a PFIC, any elections available with respect to the ADSs and the IRS information reporting obligations
with respect to the acquisition, ownership and disposition of the ADSs.</B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Backup Withholding and Information Reporting.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;U.S. holders generally will be subject to information reporting requirements with
respect to dividends
on ADSs and on the proceeds from the sale, exchange or disposition of ADSs that are paid within the United States or through U.S.-related financial intermediaries, unless the U.S. holder is an "exempt
recipient." In addition, U.S. holders may be subject to backup withholding on such payments, unless the U.S. holder provides a taxpayer identification number and a duly executed IRS Form&nbsp;W-9 or
otherwise establishes an exemption. Backup withholding is not an additional tax, and the amount of any backup withholding will be allowed as a credit against a U.S. holder's U.S. federal income tax
liability and may entitle such holder to a refund, provided that the required information is timely furnished to the IRS. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain Reporting Requirements With Respect to Payments of Offer Price.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;U.S. holders paying more than U.S. $100,000 for the ADSs
generally may be
required to file IRS Form&nbsp;926 reporting the payment of the Offer Price for the ADSs to us. Substantial penalties may be imposed upon a U.S. holder that fails to comply. Each U.S. holder should
consult its own tax advisor as to the possible obligation to file IRS Form&nbsp;926. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign Asset Reporting.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Certain individual U.S. holders are required to report information relating to an interest in the ADSs,
subject to certain
exceptions (including an exception for shares held in accounts maintained by U.S. financial institutions) by filing IRS Form&nbsp;8938 (Statement of Specified Foreign Financial Assets) with their
federal income tax return. U.S. holders are urged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of the ADSs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>THE DISCUSSION ABOVE IS A SUMMARY OF THE MATERIAL FRENCH AND U.S. FEDERAL INCOME TAX CONSEQUENCES OF AN INVESTMENT IN OUR ADSs OR ORDINARY SHARES AND IS BASED
UPON LAWS AND RELEVANT INTERPRETATIONS THEREOF IN EFFECT AS OF THE DATE OF THIS PROSPECTUS, ALL OF WHICH ARE SUBJECT TO CHANGE, POSSIBLY WITH RETROACTIVE EFFECT. EACH PROSPECTIVE INVESTOR IS URGED TO
CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT OF AN INVESTMENT IN ADSs OR ORDINARY SHARES IN LIGHT OF THE INVESTOR'S OWN CIRCUMSTANCES.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>218</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=223,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=670310,FOLIO='218',FILE='DISK124:[18ZFA1.18ZFA10701]DQ10701A.;21',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ds10701_1_219"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ds10701_enforcement_of_civil_liabilities"> </A>
<A NAME="toc_ds10701_1"> </A></FONT> <FONT SIZE=2><B>  ENFORCEMENT OF CIVIL LIABILITIES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a corporation organized under the laws of France. All of our directors are citizens and residents of countries other than the United
States, and the majority of our assets are located outside of the United States. We have appointed an agent for service of process in the United States; however, it may be difficult for
investors:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to obtain jurisdiction over us or our non-U.S. resident officers and directors in U.S. courts in actions predicated on the civil liability
provisions of the U.S. federal securities laws; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to enforce in U.S. courts judgments obtained in such actions against us or our non-U.S. resident officers and directors; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to bring an original action in a French court to enforce liabilities based upon the U.S. federal securities laws against us or our non-U.S.
resident officers or directors; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to enforce in U.S. courts against us or our directors in non-U.S. courts, including French courts, judgments of U.S. courts predicated upon the
civil liability provisions of the U.S. federal securities laws. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nevertheless,
a final judgment for the payment of money rendered by any federal or state court in the United States based on civil liability, whether or not predicated solely upon the
U.S. federal securities laws, would be recognized and enforced in France provided that a French judge considers that this judgment meets the French legal requirements concerning the recognition and
the enforcement of foreign judgments and is capable of being immediately enforced in the United States. A French court is therefore likely to grant the enforcement of a foreign judgment without a
review of the merits of the underlying claim, only if (1)&nbsp;that judgment resulted from legal proceedings compatible with French standards of due process, (2)&nbsp;that judgment does not
contravene international public order and public policy of France and (3)&nbsp;the jurisdiction of the U.S. federal or state court has been based on principles of French private international law.
The French court would also require that the U.S. judgment is not tainted with fraud and is not incompatible with a judgment rendered by a French court in the same matter, or with an earlier judgment
rendered by a foreign court in the same matter. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, French law guarantees full compensation for the harm suffered but is limited to the actual damages, so that the victim does not suffer or benefit from the situation. Such
system excludes damages such as, but not limited to, punitive and exemplary damages. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result, the enforcement, by U.S. investors, of any judgments obtained in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities law
against us or members of our board of directors, officers or certain experts named herein who are residents of France or countries other than the United States would be subject to the above
conditions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finally,
there may be doubt as to whether a French court would impose civil liability on us, the members of our board of directors, our officers or certain experts named herein in an
original action predicated solely upon the U.S. federal securities laws brought in a court of competent jurisdiction in France against us or such members, officers or experts, respectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>219</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=224,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=272198,FOLIO='219',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_220"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ds10701_underwriting"> </A>
<A NAME="toc_ds10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  UNDERWRITING    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The global offering consists of:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an offering of a total of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in the form
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ADSs in the United States, referred to herein as the
U.S. offering; and</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a concurrent private placement of a total of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary shares in France and countries outside of the United
States, referred to
herein as the European private placement. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SVB
Leerink&nbsp;LLC and Barclays Capital&nbsp;Inc. are acting as joint global coordinators for the global offering and joint bookrunners for the U.S. offering. SVB
Leerink&nbsp;LLC and Barclays Capital&nbsp;Inc. are also acting as representatives of each of the underwriters named below. Bryan, Garnier&nbsp;&amp;&nbsp;Co. Limited and Natixis are acting as
joint bookrunners with respect to the European private placement. Roth Capital Partners,&nbsp;LLC and H.C. Wainwright&nbsp;&amp;&nbsp;Co.,&nbsp;LLC are acting as co-managers of the U.S. offering.
The underwriters and the representatives are collectively referred to as the "underwriters" and the "representatives," respectively. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms and conditions set forth in the underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has
agreed, severally and not jointly, to purchase from us, the number of ordinary shares and/or ADSs, as the case may be, set forth opposite its name below. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="78pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Underwriter

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
ADSs </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Ordinary Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SVB Leerink&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Barclays Capital Inc.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bryan, Garnier&nbsp;&amp;&nbsp;Co. Limited</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Natixis</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Roth Capital Partners,&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>H.C. Wainwright&nbsp;&amp;&nbsp;Co.,&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an underwriter defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the underwriting agreement may be
terminated. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
purchases of ADSs by the underwriters pursuant to the underwriting agreement are carried out by the underwriters agreeing, severally and not jointly, to subscribe for ordinary shares
and deposit such ordinary shares with the Depositary, receiving in return the ADSs. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to
make in respect of those liabilities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters are offering the ordinary shares and ADSs representing ordinary shares that they subscribe for pursuant to the underwriting agreement, subject to prior issue, when, as
and if issued to and accepted by them, subject to approval of legal matters by their counsel, including the validity of the ordinary shares and ADSs and the ordinary shares underlying the ADSs, and
other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officers' certificates and legal opinions. The underwriters reserve the right to withdraw, cancel
or modify offers to the public and to reject orders in whole or in part. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales
of our ordinary shares made outside of the United States may be made by the underwriters or by their affiliates. In addition, to the extent that any securities are offered by
Bryan, Garnier&nbsp;&amp;&nbsp;Co. Limited within the United States, Bryan, Garnier&nbsp;&amp;&nbsp;Co. Limited will offer and place ADSs with </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>220</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=225,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=715190,FOLIO='220',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_221"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>investors
through Bryan Garnier Securities,&nbsp;LLC, its U.S. broker-dealer affiliate. The activities of Bryan, Garnier&nbsp;&amp;&nbsp;Co. Limited in the United States will be effected only to the
extent permitted by Rule&nbsp;15a-6 under the Exchange Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Natixis
is not registered as a broker-dealer under the Exchange Act and will not engage in any offers or sales of our securities within the United States or to U.S. persons except to the
extent permitted by Rule&nbsp;15a-6 under the Exchange Act (and applicable SEC interpretive guidance issued in connection therewith) and other applicable securities laws. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Commissions  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The representatives have advised us that the underwriters propose initially to offer the ordinary shares and ADSs to the public at the initial
public offering price set forth on the cover page of this prospectus and any ordinary shares or ADSs sold to dealers at that price less a concession not in excess of &euro; per ordinary
share and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per ADS. After the initial offering of the ordinary shares and ADSs, the public offering price, concession or any other term of the offering may be changed by the
representatives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table shows the per share and total public offering price, underwriting commissions and proceeds before expenses to us. The information assumes either no exercise or full
exercise by the underwriters of their option to purchase additional ordinary shares and/or ADSs. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="147pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="147pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Per ADS </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Per Ordinary Share </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Without<BR>
Option To<BR>
Purchase<BR>
Additional<BR>
ADSs<BR>
and/or<BR>
Ordinary<BR>
Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Without<BR>
Option To<BR>
Purchase<BR>
Additional<BR>
ADSs<BR>
and/or<BR>
Ordinary<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Without<BR>
Option<BR>
To<BR>
Purchase<BR>
Additional<BR>
ADSs </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>With<BR>
Option<BR>
To<BR>
Purchase<BR>
Additional<BR>
ADSs </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Without<BR>
Option<BR>
To<BR>
Purchase<BR>
Additional<BR>
Ordinary<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>With<BR>
Option<BR>
To<BR>
Purchase<BR>
Additional<BR>
Ordinary<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Offering price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Underwriting commissions</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds to us, before expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
estimate expenses payable by us in connection with the global offering, other than the underwriting commissions referred to above, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. We also have
agreed to reimburse the underwriters for up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for their FINRA counsel fee. In accordance with FINRA Rule&nbsp;5110, this reimbursed fee is deemed underwriting compensation for
the
global offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Option to Purchase Additional Ordinary Shares and/or ADSs  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have granted an option to the underwriters, exercisable for 30&nbsp;days after the date of this prospectus, to purchase up to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional ordinary shares and/or
ADSs at the public offering price, less the underwriting commissions. If the underwriters exercise this option, each underwriter will be obligated,
subject to conditions contained in the underwriting agreement, to purchase a number of additional ordinary shares and/or ADSs proportionate to that underwriter's initial amount reflected in the above
table. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


No Sales of Similar Securities  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We, our senior management and directors and certain of our existing security holders have agreed not to sell or transfer any of our ordinary
shares or securities convertible into or
exchangeable or exercisable for our ordinary shares, which includes ADSs, for 90&nbsp;days after the date of this prospectus without first obtaining the written consent of SVB Leerink&nbsp;LLC and
Barclays Capital&nbsp;Inc. on behalf of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>221</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=226,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=111348,FOLIO='221',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_222"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>the
underwriters. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> offer, pledge, sell or contract to sell any of our ordinary shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> sell any option or contract to purchase any of our ordinary shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> purchase any option or contract to sell any of our ordinary shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> grant any option, right or warrant for the sale of any of our ordinary shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> otherwise dispose of or transfer any of our ordinary shares; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> request or demand that we file&nbsp;a registration statement related to any of our ordinary shares;
or</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> enter into any swap or other agreement or any transaction that transfers, in whole or in part, the economic consequence of ownership of any of
our ordinary shares, whether any such swap, agreement or transaction is to be settled by delivery of ordinary shares or other securities, in cash or otherwise. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
lock-up provision applies to our ordinary shares and to securities convertible into or exchangeable or exercisable for our ordinary shares, which includes ADSs. It also applies to
our ordinary shares owned now or acquired later by the person executing the agreement or for which the person executing the agreement later acquires the power of disposition. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Exchange Listing  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have applied to list the ADSs on The Nasdaq Global Market, under the symbol "GNFT." Our ordinary shares are listed on Euronext Paris under
the symbol "GNFT." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Determination of Offering Price  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before the global offering, there has been no public market for the ADSs. The initial public offering price will be determined through
negotiations between us and the representatives and by reference to the prevailing market prices of our ordinary shares on Euronext Paris after taking into account market conditions and other factors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
active trading market for the ADSs may not develop. It is also possible that after the global offering, the ADSs will not trade in the public market at or above the initial public
offering price. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters do not expect to sell more than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the ADSs in the aggregate to accounts over which they exercise discretionary authority. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stamp Taxes  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you purchase ordinary shares and/or ADSs offered in this prospectus, you may be required to pay stamp taxes and other charges under the laws
and practices of the country of purchase, in addition to the offering price listed on the cover page of this prospectus. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Price Stabilization, Short Positions and Penalty Bids  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Until the distribution of the ordinary shares and ADSs is completed, SEC rules may limit underwriters and selling group members from bidding for
and purchasing ordinary shares and ADSs. However, the representatives may engage in transactions that stabilize the price of the ordinary shares and ADSs, such as bids or purchases to peg, fix or
maintain that price. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the global offering, the underwriters may purchase and sell ordinary shares and ADSs in the open market. These transactions may include short sales, purchases on the
open market to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>222</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=227,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=649482,FOLIO='222',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_223"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>cover
positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of ordinary shares and ADSs than they are required to purchase
in the global offering. "Covered" short sales are sales made in an amount not greater than the underwriters' option described above. The underwriters may close out any covered short position by either
exercising their option or purchasing ordinary shares and/or ADSs in the open market. In determining the source of ordinary shares and/or ADSs to close out the covered short position, the underwriters
will consider, among other things, the price of ordinary shares and/or ADSs available for purchase in the open market as compared to the price at which they may purchase ordinary shares and/or ADSs
through the option granted to them. "Naked" short sales are sales in excess of such option. The underwriters must close out any naked short position by purchasing ordinary shares and/or ADSs in the
open market. A naked short position is more likely to be created if the underwriters are
concerned that there may be downward pressure on the price of the ordinary shares and/or ADSs in the open market after pricing that could adversely affect investors who purchase in the global
offering. Stabilizing transactions consist of various bids for or purchases of ordinary shares and/or ADSs made by the underwriters in the open market prior to the closing of the global offering. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the
representatives have repurchased ordinary shares and/or ADSs sold by or for the account of such underwriter in stabilizing or short covering transactions. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similar
to other purchase transactions, the underwriters' purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of the ordinary
shares and/or ADSs or preventing or retarding a decline in the market price of the ordinary shares and/or ADSs. As a result, the price of the ordinary shares and/or ADSs may be higher than the price
that might otherwise exist in the open market. The underwriters may conduct these transactions on The Nasdaq Global Market, Euronext Paris, in the over-the-counter market or otherwise. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of
the ordinary shares and/or ADSs. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once
commenced, will not be discontinued without notice. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Electronic Distribution  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with the global offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such
as e-mail. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Relationships  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The underwriters and certain of their affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Some of the
underwriters and certain of their
affiliates may in the future engage in investment banking and other commercial dealings in the ordinary course of business with us and our affiliates, for which they may in the future receive
customary fees, commissions and expenses. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in the ordinary course of their business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities
may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views
in respect of such securities or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>223</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=228,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=881042,FOLIO='223',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_224"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>financial
instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selling Restrictions  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in the European Economic Area  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a "Relevant Member State"),
with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State, no offer of any securities which are the subject of the global offering
contemplated by this prospectus may be made to the public in that Relevant Member State other than: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>A.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>to
any legal entity which is a qualified investor as defined in the Prospectus Directive;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>B.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>to
fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive,
subject to obtaining the prior consent of the representatives; or
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>C.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>in
any other circumstances falling within Article&nbsp;3(2) of the Prospectus Directive, </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>provided
that no such offer of securities shall require the Company or the representatives to publish a prospectus pursuant to Article&nbsp;3 of the Prospectus Directive or supplement a prospectus
pursuant to Article&nbsp;16 of the Prospectus Directive. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
person in a Relevant Member State who initially acquires any securities or to whom any offer is made will be deemed to have represented, acknowledged and agreed that it is a
"qualified investor" within the meaning of the law in that Relevant Member State implementing Article&nbsp;2(1)(e) of the Prospectus Directive. In the case of any ADSs being offered to a financial
intermediary as that term is used in Article&nbsp;3(2) of the Prospectus Directive, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the ADSs
acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may
give rise to an offer of any securities to the public other than their offer or resale in a Relevant Member State to qualified investors as so defined or in circumstances in which the prior consent of
the representatives has been obtained to each such proposed offer or resale. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We,
the representatives and each of our and the representatives' and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and
agreements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
prospectus has been prepared on the basis that any offer of securities in any Relevant Member State will be made pursuant to an exemption under the Prospectus Directive from the
requirement to publish a prospectus for offers of securities. Accordingly, any person making or intending to make an offer in that Relevant Member State of the securities which are the subject of the
global offering contemplated in this prospectus may only do so in circumstances in which no obligation arises for the company or any of the underwriters to publish a prospectus pursuant to
Article&nbsp;3 of the Prospectus Directive in relation to such offer. Neither the company nor the underwriters have authorized, nor do they authorize, the making of any offer of the securities in
circumstances in which an obligation arises for the company or the underwriters to publish a prospectus for such offer. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purpose of the above provisions, the expression "an offer to the public" in relation to any securities in any Relevant Member State means the communication in any form and by any
means of
sufficient information on the terms of the offer and the securities to be offered so as to enable an investor to decide to purchase or subscribe the securities, as the same may be varied in the
Relevant Member State by any measure implementing the Prospectus Directive in the Relevant Member State and the expression "Prospectus Directive" means Directive 2003/71/EC as amended or superseded </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>224</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=229,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=125795,FOLIO='224',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_225"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>(including
the 2010 PD Amending Directive, to the extent implemented in the Relevant Member States) and includes any relevant implementing measure in the Relevant Member State and the expression "2010
PD Amending Directive" means Directive 2010/73/EU. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


MiFID II Product Governance  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any person offering, selling or recommending the securities (a "distributor") should take into consideration the manufacturers' target market
assessment; however, a distributor subject to Directive&nbsp;2014/65/EU on markets in financial instruments, as amended is responsible for undertaking its own target market assessment in respect of
the securities (by either adopting or refining the manufacturers' target market assessment) and determining appropriate distribution channels. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in the United Kingdom  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may
only be directed at persons who are "qualified investors" (as defined in the Prospectus Directive) (1)&nbsp;who have professional experience in matters relating to investments falling within
Article&nbsp;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), and/or (2)&nbsp;who are high net worth companies (or persons to whom
it may otherwise be lawfully communicated) falling within Article&nbsp;49(2)(a) to (d)&nbsp;of the Order (all such persons together being referred to as "relevant persons") or otherwise in
circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the Financial Services and Markets Act 2000. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it as basis for taking any action. In the United
Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Canada  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The securities may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument&nbsp;45-106 Prospectus Exemptions or subsection&nbsp;73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument&nbsp;31-103
Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the
prospectus requirements of applicable securities laws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto)
contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province or territory for particulars of these rights or consult with a
legal advisor. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to section&nbsp;3A.3 of National Instrument&nbsp;33-105 Underwriting Conflicts (NI&nbsp;33-105), the underwriters are not required to comply with the disclosure
requirements of NI&nbsp;33-105 regarding underwriter conflicts of interest in connection with the global offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Australia  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and
Investments Commission ("ASIC") in relation to the global offering. This prospectus does not constitute a prospectus, product disclosure statement or other </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>225</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=230,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=981132,FOLIO='225',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_226"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>disclosure
document under the Corporations Act 2001 (the "Corporations Act"), and does not purport to include the information required for a prospectus, product disclosure statement or other
disclosure document under the Corporations Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
offer in Australia of the securities may only be made to persons (the "Exempt Investors") who are "sophisticated investors" (within the meaning of section&nbsp;708(8) of the
Corporations Act), "professional investors" (within the meaning of section&nbsp;708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section&nbsp;708 of
the Corporations Act so that it is lawful to offer the securities without disclosure to investors under Chapter&nbsp;6D of the Corporations Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
securities applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12&nbsp;months after the date of allotment under the global
offering, except in circumstances where disclosure to investors under Chapter&nbsp;6D of the Corporations Act would not be required pursuant to an exemption under section&nbsp;708 of the
Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter&nbsp;6D of the Corporations Act. Any person acquiring the securities must observe
such Australian on-sale restrictions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
prospectus contains general information only and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not
contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their
needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Hong Kong  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The securities have not been offered or sold, and will not be offered or sold, in Hong Kong by means of any document, other than (a)&nbsp;to
"professional investors" as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&nbsp;in other circumstances which do not result in
the document being a "prospectus" as defined in the Companies Ordinance (Cap. 32)&nbsp;of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No
advertisement, invitation or document relating to the securities has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or
elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than
with respect to the securities which are or are intended to be
disposed of only to persons outside Hong Kong or only to "professional investors" as defined in the Securities and Futures Ordinance and any rules made under that Ordinance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Japan  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The securities have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as
amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for re-offering or resale, directly or indirectly, in
Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect
at the relevant time. For the purposes of this paragraph, "Japanese Person" shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Qatar  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The securities described in this prospectus have not been, and will not be, offered, sold or delivered, at any time, directly or indirectly in
the State of Qatar in a manner that would constitute a public offering. This prospectus has not been, and will not be, registered with or approved by the Qatar </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>226</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=231,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=13840,FOLIO='226',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_227"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Financial
Markets Authority or Qatar Central Bank and may not be publicly distributed. This prospectus is intended for the original recipient only and must not be provided to any other person. This
prospectus is not for general circulation in the State of Qatar and may not be reproduced or used for any other purpose. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Singapore  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other
document or material in connection with the offer or sale, or invitation for subscription or purchase, of the securities may not be circulated or distributed, nor may the securities be offered or
sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (1)&nbsp;to an institutional investor under
Section&nbsp;274 of the Securities and Futures Act, Chapter&nbsp;289 of Singapore (the "SFA"), (2)&nbsp;to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to
Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275, of the SFA, or (3)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other
applicable provision of the SFA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where
the securities are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business of which is to hold
investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an
individual who is an accredited investor, </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>securities
(as defined in Section&nbsp;239(1) of the SFA) of that corporation or the beneficiaries' rights and interest (howsoever described) in that trust shall not be transferred within six months
after that corporation or that trust has acquired the securities pursuant to an offer made under Section&nbsp;275 of the SFA except:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to an institutional investor or to a relevant person defined in Section&nbsp;275(2) of the SFA, or to any person arising from an offer
referred to in Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> where no consideration is or will be given for the transfer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> where the transfer is by operation of law; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> as specified in Section&nbsp;276(7) of the SFA; or</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> as specified in Regulation&nbsp;32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations&nbsp;2005 of
Singapore. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in Switzerland  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange ("SIX") or on any other stock
exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss
Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in
Switzerland. Neither this document nor any other offering or marketing material relating to the securities or the global offering may be publicly distributed or otherwise made publicly available in
Switzerland. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>227</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=232,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=265191,FOLIO='227',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ds10701_1_228"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
this document nor any other offering or marketing material relating to the global offering, the Company or the securities have been or will be filed with or approved by any Swiss
regulatory authority. In particular, this document will not be filed with, and the offer of the securities will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the
offer of ADSs has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes ("CISA"). The investor protection afforded to acquirers of interests in collective
investment schemes under the CISA does not extend to acquirers of the securities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Notice to Prospective Investors in the Dubai International Financial Centre  </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority ("DFSA").
This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA
has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein
and has no responsibility for the prospectus. The securities to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities
offered should conduct their own due diligence on the securities. If you do not understand the contents of this prospectus, you should consult an authorized financial advisor. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>228</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=233,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=21627,FOLIO='228',FILE='DISK124:[18ZFA1.18ZFA10701]DS10701A.;33',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_du10701_1_229"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du10701_expenses_relating_to_the_global_offering"> </A>
<A NAME="toc_du10701_1"> </A></FONT> <FONT SIZE=2><B>  EXPENSES RELATING TO THE GLOBAL OFFERING    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the costs and expenses, other than underwriting commissions, payable in connection with the sale of ordinary
shares and ADSs in the global offering. All amounts are estimated except the SEC registration fee, the Nasdaq initial listing fee and the Financial Industry Regulatory Authority,&nbsp;Inc., or
FINRA, filing fee. Except as otherwise noted, all the expenses below will be paid by us. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>ITEM

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AMOUNT </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2> SEC registration fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FINRA filing fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nasdaq initial listing fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Legal fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounting fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Printing expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Miscellaneous fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>* </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>* </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>To
be provided by amendment.  </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>229</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=234,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=778397,FOLIO='229',FILE='DISK124:[18ZFA1.18ZFA10701]DU10701A.;25',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_du10701_1_230"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du10701_legal_matters"> </A>
<A NAME="toc_du10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  LEGAL MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the ordinary shares and ADSs and certain other matters of French law will be passed upon for us by Linklaters&nbsp;LLP,
including matters of French income tax law. Certain matters of U.S. federal law will be passed upon for us by Cooley&nbsp;LLP, Boston, Massachusetts. Legal counsel to the underwriters in connection
with the global offering are Jones Day with respect to French law and Goodwin Procter&nbsp;LLP, Boston, Massachusetts, with respect to U.S. federal law. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du10701_experts"> </A>
<A NAME="toc_du10701_3"> </A>
<BR></FONT><FONT SIZE=2><B>  EXPERTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Genfit&nbsp;S.A. at December&nbsp;31, 2017 and 2018 and for the years then ended appearing in this
registration statement have been audited by Ernst&nbsp;&amp; Young et Autres, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein and are
included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
offices of Ernst&nbsp;&amp; Young&nbsp;et Autres are located at 1-2 place des Saisons, 92400 Courbevoie, Paris La D&eacute;fense 1, France. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>230</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=235,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=847538,FOLIO='230',FILE='DISK124:[18ZFA1.18ZFA10701]DU10701A.;25',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_du10701_1_231"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du10701_where_you_can_find_more_information"> </A>
<A NAME="toc_du10701_4"> </A>
<BR></FONT><FONT SIZE=2><B>  WHERE YOU CAN FIND MORE INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have filed with the Securities and Exchange Commission a registration statement on Form&nbsp;F-1 under the Securities Act with respect to
the ordinary shares and ADSs offered in this prospectus. A related registration statement on Form&nbsp;F-6 will be filed with the Securities and Exchange Commission to register the ADSs. This
prospectus, which forms&nbsp;a part of the registration statement, does not contain all of the information included in the registration statement. Certain information is omitted and you should refer
to the registration statement and its exhibits for that information. With respect to references made in this prospectus to any contract or other document of GENFIT&nbsp;S.A., such references are not
necessarily complete and you should refer to the exhibits attached to the registration statement for copies of the actual contract or document. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
SEC maintains a website (http://www.sec.gov) that contains reports, proxy and information statements and other information regarding registrants, such us, that file electronically
with the SEC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
completion of the U.S. offering, we will be subject to the information reporting requirements of the Exchange Act applicable to foreign private issuers and under those requirements
will file reports with the SEC. Those reports may be inspected without charge at the locations described above. As a foreign private issuer, we will be exempt from the rules under the Exchange Act
related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained
in Section&nbsp;16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as
U.S. companies whose securities are registered under the Exchange Act. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
maintain a corporate website at www.genfit.com. The reference to our website is an inactive textual reference only and information contained in, or that can be accessed through, our
website or any other website cited in this prospectus is not part of this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>231</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=236,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=556092,FOLIO='231',FILE='DISK124:[18ZFA1.18ZFA10701]DU10701A.;25',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fa10701_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fa10701_index_to_consolidated_financial_statements"> </A>
<BR></FONT><FONT SIZE=2><B>  INDEX TO CONSOLIDATED FINANCIAL STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
<A NAME="FA10701_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Consolidated Financial Statements as of and for the Years Ended December&nbsp;31, 2017 and 2018</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#re1"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Report of Ernst&nbsp;&amp; Young&nbsp;et Autres, Independent Registered Public Accounting
Firm</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#re1"><FONT SIZE=2><BR>
F-2</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#fp1"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Consolidated Statements of Financial Position as of December&nbsp;31, 2017 and 2018</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#fp1"><FONT SIZE=2><BR>
F-3</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#soo1"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Consolidated Statements of Operations for the Years Ended December&nbsp;31, 2017 and 2018</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#soo1"><FONT SIZE=2><BR>
F-4</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#cl1"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Consolidated Statements of Other Comprehensive Loss for the Years Ended December&nbsp;31, 2017 and
2018</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cl1"><FONT SIZE=2><BR>
F-5</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#cf1"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Consolidated Statements of Cash Flows for the Years Ended December&nbsp;31, 2017 and 2018</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cf1"><FONT SIZE=2><BR>
F-6</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#cie1"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Consolidated Statements of Changes in Equity for the Years Ended December&nbsp;31, 2017 and
2018</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cie1"><FONT SIZE=2><BR>
F-7</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#fo10701_notes_to_the_consolidated_fina__not05168"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Notes to the Consolidated Financial Statements</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#fo10701_notes_to_the_consolidated_fina__not05168"><FONT SIZE=2><BR>
F-8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=237,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=16573,FOLIO='F-1',FILE='DISK124:[18ZFA1.18ZFA10701]FA10701A.;14',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fc10701_1_2"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="re1"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>The
Board of Directors and Shareholders<BR>
GENFIT&nbsp;S.A. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>Opinion on the Financial Statements</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have audited the accompanying consolidated statements of financial position of GENFIT&nbsp;S.A. ("the Company") as of December&nbsp;31, 2017 and 2018, the related consolidated
statements of operations, other comprehensive loss, cash flows and changes in equity for the years ended December&nbsp;31, 2017 and 2018 and the related notes to the financial statements
(collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the
Company at December&nbsp;31, 2017 and 2018 and the results of its operations and its cash flows for the years then ended, in conformity with International Financial Reporting Standards as issued by
the International Accounting Standards Board ("IFRS"). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>Restatement of 2017 financial statements</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
discussed in Note&nbsp;2.3 to the consolidated financial statements, the 2017 consolidated financial statements have been restated to correct misstatements in accordance with the
provisions of IAS&nbsp;8. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>Basis for opinion</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a
public accounting firm registered with the Public Company Accounting Oversight Board ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness
of the Company's internal control over financial reporting. Accordingly, we express no such opinion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>/s/
ERNST&nbsp;&amp; YOUNG et Autres </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>We
have served as the Company's auditors since 1999. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Paris,
France<BR>
February&nbsp;8, 2019 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=238,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=475355,FOLIO='F-2',FILE='DISK124:[18ZFA1.18ZFA10701]FC10701A.;15',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fe10701_1_3"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="fp1"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Notes </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>ASSETS</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Non-current assets</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Intangible assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>636</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>796</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property, plant and equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,324</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,764</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current trade and other receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,921</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other non-current financial assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>729</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,313 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total non-current assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,611</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,362 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Current assets</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Inventories</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current trade and other receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,955</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,794</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other current financial assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other current assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,078</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>273,820</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>207,240 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>283,572</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>218,116 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,183</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>229,478 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SHAREHOLDERS' EQUITY AND LIABILITIES</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Shareholders' equity</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share capital</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,792</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,796</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share premium</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>251,932</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>251,554</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(102,531</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(158,897</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Currency translation adjustment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total shareholders' equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>101,457</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,939 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Non-current liabilities</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current convertible loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>154,539</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>159,176</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other non-current loans and borrowings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,978</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,255</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current deferred income and revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current employee benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>936</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,085</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred tax liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,165</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,773 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total non-current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>164,620</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>169,291 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Current liabilities</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current convertible loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,329</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,312</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other current loans and borrowings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,834</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,848</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current trade and other payables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23,580</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35,974</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current deferred income and revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current provisions</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>361</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>112 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>27,106</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39,248 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total shareholders' equity and liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,183</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>229,478 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>See
Note&nbsp;2.3, "Correction of errors."  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=239,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=729974,FOLIO='F-3',FILE='DISK124:[18ZFA1.18ZFA10701]FE10701A.;23',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fg10701_1_4"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="soo1"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CONSOLIDATED STATEMENTS OF OPERATIONS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except per share data)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Notes </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Revenues and other income</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,737</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,425 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenues and other income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,856</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,494 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Operating expenses and other operating income (expenses)</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(67,024</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,793</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expense)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(162</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(56,695</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(69,484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>642</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,096</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(11,118</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,453</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(10,391</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss before tax</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(59,148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79,875</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,420</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>354 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Basic and diluted loss per share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1.79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>See
Note&nbsp;2.3, "Correction of Errors."  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=240,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=532264,FOLIO='F-4',FILE='DISK124:[18ZFA1.18ZFA10701]FG10701A.;23',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fi10701_1_5"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="cl1"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Notes </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Actuarial gains and losses net of tax</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(210</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(31</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other comprehensive income (loss) that will never be reclassified to profit or loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(210</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(31</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exchange differences on translation of foreign operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
(29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
14 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other comprehensive income (loss) that are or may be reclassified to profit or loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total other comprehensive loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,967</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,537</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>See
Note&nbsp;2.3, "Correction of Errors."  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=241,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=196663,FOLIO='F-5',FILE='DISK124:[18ZFA1.18ZFA10701]FI10701A.;23',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fk10701_1_6"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="cf1"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CONSOLIDATED STATEMENTS OF CASH FLOWS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-4pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR style="line-height:0pt;"><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="100.00%" style="font-family:times;"><div style="width:100.00%;"></div></TD>
<TD WIDTH="12.0pt" style="font-family:times;"><div style="width:12.0pt;"></div></TD>
<TD WIDTH="5.0pt" ALIGN="RIGHT" style="font-family:times;"><div style="width:5.0pt;"></div></TD>
<TD WIDTH="32.50pt" style="font-family:times;"><div style="width:32.50pt;"></div></TD>
<TD WIDTH="12.0pt" style="font-family:times;"><div style="width:12.0pt;"></div></TD>
<TD WIDTH="5.0pt" ALIGN="RIGHT" style="font-family:times;"><div style="width:5.0pt;"></div></TD>
<TD WIDTH="32.50pt" style="font-family:times;"><div style="width:32.50pt;"></div></TD>
<TD WIDTH="12pt" style="font-family:times;"><div style="width:12pt;"></div></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="white-space:nowrap;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="white-space:nowrap;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="white-space:nowrap;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="white-space:nowrap;font-family:times;"><FONT SIZE=1><B>Restated*</B></FONT><BR></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="white-space:nowrap;font-family:times;"><FONT SIZE=1>&#8203;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Cash flows from operating activities</I></B></FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Reconciliation of net loss to net cash used in operating activities</I></B></FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adjustments for:</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Amortization</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>1,226</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>1,819</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Depreciation and impairment charges</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>186</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(208</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expenses related to share-based compensation</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>278</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>787</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net result on disposal of property, plant&nbsp;&amp; equipment</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>8</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(2</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net finance expenses</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>2,296</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>10,971</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(3,420</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(354</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other non-cash items</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>17</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&#151; </FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating cash flows before change in working capital</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(55,137</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(66,507</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Decrease in inventories</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>10</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&#151;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Increase in trade receivables and other assets</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(2,106</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(724</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Increase in trade payables and other liabilities</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>7,364</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>11,056 </FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Change in working capital</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>5,268</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>10,332 </FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax paid</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>13</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>93 </FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash flows used in operating activities</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(49,856</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(56,081</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Cash flows from investment activities</I></B></FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition of property, plant&nbsp;&amp; equipment</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2><BR>
(2,800</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2><BR>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2><BR>
(2,938</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from disposal of property, plant&nbsp;&amp; equipment</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>15</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>3</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition of financial instruments and financial assets</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(163</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(1,050</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash flows used in investment activities</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(2,948</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(3,986</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Cash flows from financing activities</I></B></FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from subscription / exercise of share warrants</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2><BR>
37</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2><BR>
37</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from new loans and borrowings net of issue costs</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>177,338</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>1,800</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Repayments of loans and borrowings</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(1,655</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(2,000</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial interests paid (including finance lease)</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(1,372</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(6,351</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash flows (used in) provided by financing activities</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>174,348</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(6,514</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Increase (decrease) in cash and cash equivalents</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>121,544</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>(66,580</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents at the beginning of the period</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>152,277</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;" COLSPAN=2><FONT SIZE=2>273,820 </FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents at the end of the period</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>273,820</FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>207,240 </FONT></TD>
<TD style="white-space:nowrap;font-family:times;"><FONT SIZE=2>&#8203;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;" COLSPAN=2><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;" COLSPAN=2><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;" COLSPAN=2><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="white-space:nowrap;line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>See
Note&nbsp;2.3, "Correction of Errors."  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=242,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=264174,FOLIO='F-6',FILE='DISK124:[18ZFA1.18ZFA10701]FK10701A.;27',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fm10701_1_7"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="cie1"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (Amounts in thousands of euros, except for number of shares)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Share Capital </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Share<BR>
Capital </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Share<BR>
Premium </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Treasury<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Currency<BR>
Translation<BR>
Adjustment </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Net<BR>
Loss </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
Shareholders'<BR>
Equity </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>As of December&nbsp;31, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,166,437</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,792</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>237,305</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(127</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(68,527</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(33,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>142,797 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other comprehensive income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(210</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(239</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total comprehensive income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(210</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(29</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,967</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Allocation of prior period profit (loss)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(33,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity component of OCEANE net of deferred taxes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,312</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,312</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>278</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>278</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other movements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>As of December&nbsp;31, 2017* restated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,166,437</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,792</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>251,932</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(127</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(102,404</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>101,457 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other comprehensive income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(31</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total comprehensive income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(31</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>79,537 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Allocation of prior period profit (loss)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Capital increase**</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,484</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,201</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,201</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>787</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>787</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Treasury shares</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(603</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(603</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other movements</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>As of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,183,921</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>

<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,796</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>251,554</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(730</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(158,167</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>20,939 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>See
Note 2.3, "Correction of Errors."
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>**</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Expenses
incurred as of December&nbsp;31, 2018 in connection with the preparation of capital market transactions are deducted from equity.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=243,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=134223,FOLIO='F-7',FILE='DISK124:[18ZFA1.18ZFA10701]FM10701A.;20',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fo10701_1_8"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fo10701_notes_to_the_consolidated_fina__not05168"> </A>
<A NAME="toc_fo10701_1"> </A></FONT> <FONT SIZE=2><B><BR>  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS    <BR>    <BR>    (amounts in thousands of euros, except for numbers of shares and per share amounts)    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


1. THE COMPANY  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Founded in 1999 under the laws of France, GENFIT&nbsp;S.A. (the "Company") is a biopharmaceutical company dedicated to the discovery and development of drugs and biomarkers in
therapeutic areas of high unmet need due to the lack of effective treatments or diagnostic tools and/or due to the increasing number of patients worldwide. The Company concentrates its research and
development (R&amp;D) efforts to participate in the potential commercialization of treatment solutions and diagnostic tools to fight certain metabolic, inflammatory, autoimmune or fibrotic diseases
affecting especially the liver (such as non-alcoholic steatohepatitis, or NASH) and more generally in gastroenterology. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated financial statements of the Company include the financial statements of GENFIT&nbsp;S.A. and those of its wholly-owned subsidiaries: GENFIT CORP (U.S. subsidiary) and
GENFIT PHARMACEUTICALS SAS (French subsidiary) (together referred to as "GENFIT" or the "Group"). </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Consolidated Financial Statements of GENFIT have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting
Standards Board ("IASB") as of December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated financial statements as of and for the year ended December&nbsp;31, 2018 were prepared under the responsibility of the Board of Directors that authorized for issue
such statements on February&nbsp;4, 2019. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term IFRS includes International Financial Reporting Standards ("IFRS"), International Accounting Standards (the "IAS"), as well as the Interpretations issued by the Standards
Interpretation Committee (the "SIC"), and the International Financial Reporting Interpretations Committee ("IFRIC"). The principal accounting methods used to prepare the Consolidated Financial
Statements are described below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
financial information (unless indicated otherwise) is presented in thousands of euros (&euro;). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=244,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=832074,FOLIO='F-8',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>2.1.&nbsp;&nbsp;Changes in accounting policies and new standards or amendments  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="141pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  COLSPAN=3 ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>New or amended<BR>
policies or standards

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effective date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Potential impact on<BR>
consolidated financial<BR>
statements </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>IFRS&nbsp;15</B></FONT><FONT SIZE=2><BR>
Revenue from Contracts with Customers</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>IFRS&nbsp;15 establishes a comprehensive framework for determining whether, how much and when revenue is recognized. It replaces existing revenue recognition guidance, including IAS&nbsp;18, Revenue.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The first application of IFRS&nbsp;15 does not have an impact on the Group's consolidated financial statements.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B>IFRS&nbsp;9</B></FONT><FONT SIZE=2><BR>
Financial Instruments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>IFRS&nbsp;9, published in July 2014, replaces the existing guidance in IAS&nbsp;39, Financial Instruments: Recognition and Measurement.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The first application of IFRS&nbsp;9 does not have an impact on the Group's consolidated financial statements.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B>Amendment to IFRS&nbsp;2</B></FONT><FONT SIZE=2><BR>
Share-based payments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>This amendment to IFRS&nbsp;2 provides clarification on the valuation and modification of the plans.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>These provisions do not have a significant impact on the Group's consolidated financial statements.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B>IFRIC&nbsp;22</B></FONT><FONT SIZE=2><BR>
Foreign currency transactions and advanced consideration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>IFRIC&nbsp;22 clarifies the accounting for transactions that include the receipt or payment of advance consideration in a foreign currency.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The application of this amendment to the Group's consolidated financial statements is not expected to have a significant impact.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B>2.2.&nbsp;&nbsp;Standards, interpretations and amendments issued but not yet effective  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The paragraph below describes the standards and amendments to standards that are binding and apply starting from January&nbsp;1, 2019 or later, and indicates
GENFIT's position with respect to the future application of these texts. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=245,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=747677,FOLIO='F-9',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GENFIT
has not applied any of these texts earlier than required. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="141pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  COLSPAN=3 ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>New or amended<BR>
Standards<BR>
Text already adopted in the EU

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effective date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Potential impact on<BR>
consolidated financial<BR>
statements </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>IFRS&nbsp;16</B></FONT><FONT SIZE=2><BR>
Leases</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>IFRS&nbsp;16 aligns the accounting of simple leases to that of finance leases.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The Group plans to adopt IFRS&nbsp;16 using the modified retrospective method and to elect to apply the standard to contracts that were previously identified as leases applying IAS&nbsp;17 and IFRIC&nbsp;4. The Group also
plans to use the exemptions proposed by the standard on lease contracts for which the lease term ends within 12&nbsp;months as of the date of initial application and lease contracts for which the underlying asset is of low value. The Group is
currently identifying the related contracts (the most significant ones relating to building lease contracts) and assessing the related impact on its consolidated financial statements.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=246,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=695884,FOLIO='F-10',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_11"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="23%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="23%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="23%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="23%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  COLSPAN=3 ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Amendments to standards<BR>
Text not yet adopted in the EU

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effective date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Potential impact on<BR>
consolidated financial<BR>
statements </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>Improvements to IFRS Standards 2015&nbsp;- 2017 Cycle</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>This cycle concerns IFRS&nbsp;3, IFRS&nbsp;11, IAS&nbsp;12, and IAS&nbsp;23.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The application of this amendment to the Group's consolidated financial statements is not expected to have a significant impact.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B>IFRIC&nbsp;23</B></FONT><FONT SIZE=2><BR>
Uncertainty over income tax treatments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>IFRIC&nbsp;23 clarifies the interpretation to be applied to the determination of taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates, when there is an uncertainty over income tax
treatments under IAS&nbsp;12.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The application of this amendment to the Group's consolidated financial statements is not expected to have a significant impact.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B>Amendments to IAS&nbsp;19<BR>
Employee Benefits</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>This amendment to IAS&nbsp;19 clarified the assumptions to use for the remeasurement and the effect on the requirements regarding the asset ceiling when a plan amendment, curtailment or settlement occurs.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Applicable for fiscal years open from January&nbsp;1, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The application of this amendment to the Group's consolidated financial statements is not expected to have a significant impact.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B>2.3&nbsp;&nbsp;&nbsp;Correction of errors  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the context of the preparation of its 2018 consolidated financial statements, and in accordance with IAS&nbsp;8, the Company restated the financial
statements previously published for the 2017 fiscal year with respect to the accounting for the OCEANE issuance. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
changes do not affect the cash position or the operating results. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
changes were approved by the Board of Directors at its meeting on February&nbsp;4, 2019. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=247,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=420313,FOLIO='F-11',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_12"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table shows the impact on the statement of operations for the 2017 fiscal year, compared to previously published figures: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros,<BR>
except earnings per share data)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year ended<BR>
December&nbsp;31,<BR>
2017&#151;as<BR>
published </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Correction:<BR>
proper effective<BR>
interest rate of<BR>
convertible<BR>
loan </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Correction:<BR>
proper<BR>
accounting<BR>
under IAS&nbsp;12 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year ended<BR>
December&nbsp;31,<BR>
2017&#151;as<BR>
corrected </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>See<BR>
explanatory<BR>
note below </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Revenues and other income</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>118</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>118</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,737</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,737</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue and other income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,856</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,856</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Operating expenses and other operating income (expenses)</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(56,595</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(56,695</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>642</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>642</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,168</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,096</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>A </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financial loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,526</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,453</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss before tax</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,220</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(59,148</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income tax (expense) benefit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(384</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,804</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,420</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>B </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,604</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,804</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
corrections lead to a decrease in the net loss of &euro;2,876, bringing it to &euro;(55,728) compared to &euro;(58,604) in the previously published
accounts. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=5,SEQ=248,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=772075,FOLIO='F-12',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
accounting changes are related to: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> Correction of the
effective interest rate taken into account for the calculation of financial expenses related to the OCEANE at the transaction date of October&nbsp;16, 2017 for an amount of &euro;928 (increase of financial expenses).</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>B</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Recognition of</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>A deferred tax liability
with respect to the equity component of the OCEANE &euro;(19,960) for &euro;5,648, as a decrease of equity on October&nbsp;16, 2017 on initial recognition;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>A deferred tax liability
as of December&nbsp;31, 2017 related to the tax deduction of the OCEANE issuance costs and the difference between the effective interest rate and the portion of deductible coupon (&euro;120 net), as an increase of the financial expenses in net result
(deferred tax expense); and</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:12pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>A deferred tax asset
arising from recognizing deferred tax assets with respect to tax deductible net operating losses (NOLs) carried forward with respect to the deferred tax liabilities mentioned above, taking into account the French tax rule which limits application of
such NOLs to 50% (above one million euros) against taxable profit, and the timing of reversal of these deferred tax liabilities, for an amount of &euro;3,724 on initial recognition (deferred tax income), the use of NOLs for the period of &euro;121
(deferred tax expense) and the reversal of the previously recognized deferred tax expense as of December&nbsp;31, 2017 for &euro;321 (decrease of deferred tax expense), resulting in an aggregate amount of &euro;3,924 of reduction of deferred tax
expense (or a net deferred tax income).</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result, the net loss per share for the 2017 fiscal year decreased from &euro;1.88 to &euro;1.79. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=249,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=241943,FOLIO='F-13',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table shows the impact of the corrections of these errors in the consolidated statement of financial position at December&nbsp;31, 2017: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Shareholders' Equity and Liabilities<BR>
(in thousands of euros,<BR>
except earnings per share data)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2017&#151;as<BR>
published </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Correction:<BR>
proper effective<BR>
interest rate of<BR>
convertible<BR>
loan </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Correction:<BR>
proper<BR>
accounting<BR>
under IAS&nbsp;12 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2017&#151;as<BR>
corrected </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>See<BR>
explanatory<BR>
note below </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Shareholders' equity</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share capital</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,792</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,792</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share premium</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>257,580</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,648</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>251,932</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>C</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(102,531</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(102,531</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Currency translation adjustment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58,604</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,804</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>D </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total shareholders' equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>104,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,844</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>101,457</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Non-current liabilities</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current convertible loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>153,611</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>154,539</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>E</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other non-current loans and borrowings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,978</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,978</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current deferred income and revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-current employee benefits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>936</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>936</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred tax liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>321</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,844</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,165</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F, G </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total&#151;Non-current liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>161,848</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>928</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,844</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>164,620</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Current liabilities</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current convertible loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,329</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,329</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other current loans and borrowings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,834</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,834</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current trade and other payables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,580</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,580</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current deferred income and revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current provisions</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total&#151;Current liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>27,106</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>27,106</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total&#151;Shareholders' equity and liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>293,183</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>293,183</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
statement of financial position at December&nbsp;31, 2017 was restated due to the following changes, in particular: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>C</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The equity component of the OCEANE (&euro;19,960) determined in accordance with split accounting under IAS&nbsp;32 was decreased by the deferred tax liability recognized under IAS&nbsp;12 (&euro;5,648).</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>D</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The impact on income is the result of the elements explained in points A and B above.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>E</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The non-current part of the convertible loan (OCEANE) is increased by the financial expenses calculated with the proper application of the effective interest rate.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>F</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>The correction of the initially recognized deferred tax liabilities under IAS&nbsp;12 for &euro;1,844.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>G</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Following these corrections, the deferred tax liabilities are &euro;2,165.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=250,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=137191,FOLIO='F-14',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_15"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. BASIS OF PRESENTATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
overall impact of these corrections is a &euro;2,772 decrease in equity and an increase in non-current liabilities in the same amount. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.1.&nbsp;&nbsp;Use of estimates and judgments  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In preparing these consolidated financial statements, management makes judgments, estimates and assumptions that affect the application of accounting policies and
the reported amounts of assets and liabilities, incomes and expenses. Actual amounts may differ from these estimates. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any
future periods affected. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
estimates and underlying assumptions mainly relate to research tax credits (see Note&nbsp;3.19.2, "Research tax credit", employee benefits (see Note&nbsp;3.17, "Employee
benefits"), share-based payments (see Note&nbsp;19, "Share-based compensation"), accruals related to clinical trials (see Note 18, "Operating expenses") and convertible loans (see Note&nbsp;3.14,
"Loans and Borrowings"). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.2.&nbsp;&nbsp;Consolidation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Group controls an entity when it is exposed to variable returns from its involvement with the entity, and it has the ability to affect those returns through
its power over the entity. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group controls all the entities included in the scope of consolidation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.3.&nbsp;&nbsp;Foreign currency  </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.3.1. Foreign currency transactions  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transactions in foreign currencies are translated into the respective functional currencies of the entities of the Group at the exchange rates
applicable at the transaction dates. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the reporting date. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
resulting exchange gains or losses are recognized in the statements of operations. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.3.2. Foreign currency translation  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The assets and liabilities of foreign operations having a functional currency different from the euro are translated into euros at the closing
exchange rate. The income and expenses of foreign operations are translated into euros at the exchange rates effective at the transaction dates or using the average exchange rate for the reporting
period, unless this method cannot be applied due to significant exchange rate fluctuations. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains
and losses arising from foreign operations are recognized in the statement of other comprehensive loss. When a foreign operation is partly or fully divested, the associated share
of gains and losses recognized in the currency translation reserve is transferred to the statements of operations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=251,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=489272,FOLIO='F-15',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_16"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group presentation currency is the euro, which is also the functional currency of GENFIT&nbsp;S.A. The functional currency of GENFIT CORP is the U.S. dollar. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Ratio : 1 US dollars (USD) =&nbsp;&times;&nbsp;euros (EUR)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exchange rate at period end</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.83382</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.87336</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Average exchange rate for the period</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.88704</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.84758</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B>3.4.&nbsp;&nbsp;Intangible assets  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets mainly consist of software and operating licenses acquired by the Group. They are recognized at cost less accumulated amortization and
impairment. Amortization expense is recorded on a straight-line basis over the estimated useful lives of the intangible assets. The estimated useful lives of both software and license agreements are
between 3 and 5&nbsp;years. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>3.5.&nbsp;&nbsp;Property, plant and equipment  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment are initially recognized at cost. Cost includes expenditures that are directly attributable to the acquisition of the asset. Routine
maintenance costs are expensed as incurred. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequently,
depreciation expense is recognized on a straight-line basis over the estimated useful lives of the assets. If components of property, plant and equipment have different
useful lives, they are accounted for separately. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if appropriate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated
useful lives are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Scientific equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Between 2 and 12&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Computer equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Between 2 and 5 years</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Furniture</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Between 4 and 10 years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Vehicles</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Between 4 and 6 years</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
gain or loss on disposal of an item of property, plant and equipment is determined by comparing the proceeds from disposal with the carrying amount of the item. The net amount is
recognized in the consolidated statements of operations under the line item "Other operating income (expenses)." </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>3.6.&nbsp;&nbsp;Leases  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GENFIT is a lessee in a number of lease contracts (see Note&nbsp;6, "Property, plant and equipment"). </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.6.1. Finance leases  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, according to the terms of a lease, it appears that substantially all the risks and rewards incidental to ownership are transferred from the
lessor to the lessee, the leasing contract is qualified as a finance lease. The associated leased assets are initially recognized as an asset at their fair value or present value of the minimum lease
payments due under the contract, if this is lower, and are </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=252,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=486467,FOLIO='F-16',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>subsequently
depreciated or impaired, as necessary. The resulting financial liabilities are reported in the line items "Non-current loans and borrowings" and "Current loans and borrowings". </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.6.2. Operating leases  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A lease is classified as an operating lease if it does not transfer to the lessee substantially all the risks and rewards incidental to
ownership. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments
made under operating leases are expensed on a straight-line basis over the term of the lease. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease
incentives received such as rent-free periods or uneven lease payments are spread on a straight-line basis over the term of the lease. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.7.&nbsp;&nbsp;Impairment of tangible assets, intangible assets and goodwill  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If indicators of impairment are identified, amortizable intangible assets and depreciable tangible assets are subject to an impairment test under the provisions
of IAS&nbsp;36, </FONT><FONT SIZE=2><I>Impairment of Assets</I></FONT><FONT SIZE=2>. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company does not have any goodwill. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.8.&nbsp;&nbsp;Financial instruments  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IFRS&nbsp;9, Financial Instruments, replaces IAS&nbsp;39, Financial Instruments: Recognition and Measurement, for annual periods beginning on or after
January&nbsp;1, 2018, bringing together all three aspects of the accounting for financial instruments: (a)&nbsp;classification and measurement; (b)&nbsp;impairment; and (c)&nbsp;hedge
accounting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
first time application of IFRS&nbsp;9 had no impact on the Group's financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans
and borrowings are initially measured at fair value and subsequently recorded at amortized cost. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.9.&nbsp;&nbsp;Inventories  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company recognizes inventories of laboratory consumables in connection with its former co-research agreements. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
inventories are measured at the lower of cost and net realizable value. Cost is determined using the weighted average cost method. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.10.&nbsp;&nbsp;Trade and other receivables  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade and other receivables are recognized at fair value, which is the nominal value of invoices unless payment terms require a material adjustment for the time
value discounting effect at market interest rates. Trade receivables are subsequently measured at amortized cost. A valuation allowance for trade receivables is recognized if their recoverable amount
is less than their carrying amount. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables
are classified as current assets, except for those with a maturity exceeding 12&nbsp;months after the reporting date. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=253,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=658152,FOLIO='F-17',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fo10701_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.11.&nbsp;&nbsp;Other financial assets  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans and receivables are financial assets with fixed or determinable payments that are not listed on an active market and are valued using the amortized cost
method. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
gain or loss arising from a change in the fair value of an available-for-sale financial asset is recognized in other comprehensive income (loss) except for impairment losses and
foreign exchange gains and losses, until the financial asset is derecognized. At that time the cumulative gain or loss previously recognized in other comprehensive income (loss) is reclassified from
equity to profit or loss as a reclassification adjustment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.12.&nbsp;&nbsp;Cash and cash equivalents  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents comprise cash on hand and demand deposits, together with short-term, highly liquid investments. They are readily convertible to a known
amount of cash and thus present a negligible risk of a change in value. They also include Undertakings for Collective Investments in Transferable Securities (UCITs) whose characteristics allow them to
be classified as financial assets available for sale. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Initially
recognized at their purchase cost at the transaction date, investments are subsequently measured at fair value. Changes in fair value are recognized in net financial income
(expenses). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.13.&nbsp;&nbsp;Equity  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share capital comprises ordinary shares and ordinary shares with double voting rights classified in equity. Costs directly attributable to the issue of ordinary
shares or share options are recognized as a reduction in the share premium. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
liquidity agreement consists of a share buyback program contracted to an investment service provider. Purchases and sales of the Company's shares carried out under the contract are
recognized directly in shareholder's equity under treasury shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.14.&nbsp;&nbsp;Loans and borrowings  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial liabilities are initially recognized at fair value, net of directly attributable transaction costs, and are subsequently measured at amortized cost
using the effective interest rate method. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
accounting of the Company's financial liabilities remains largely the same as it was under IAS&nbsp;39. Similar to the requirements of IAS&nbsp;39, IFRS&nbsp;9 requires
contingent liabilities to be treated as financial instruments measured at fair value, with the changes in fair value recognized in the statement of profit or loss. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group derecognizes financial liabilities when the contractual obligations are discharged or cancelled or expire. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
bonds convertible or exchangeable into new or existing shares (OCEANE&#151;see Section&nbsp;12.1, "Breakdown of convertible loan") are recognized as follows: in accordance
with IAS&nbsp;32, </FONT><FONT SIZE=2><I>Financial Instruments&#151;Presentation</I></FONT><FONT SIZE=2>, if a financial instrument has different components the characteristics of which are
that some could be classified as liabilities and others as equity, the issuer must recognize the different components separately. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=254,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=525825,FOLIO='F-18',FILE='DISK124:[18ZFA1.18ZFA10701]FO10701A.;46',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fq10701_1_19"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts)  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The liability component is measured, at the date of issuance, at its fair value in accordance with IAS&nbsp;39, </FONT><FONT SIZE=2><I>Financial Instruments: Recognition and
Measurement</I></FONT><FONT SIZE=2> on the basis of future contractual cash flows discounted at market rates (taking into consideration the issuer's credit risk) of a debt having similar
characteristics but without having the conversion option. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
value of the conversion option is measured by the difference between the bond's issue price and the fair value of the liability component. After deduction of the portion of expenses
related to the transaction, this amount is recognized in the line item "Share premium" under shareholders' equity and is subject to a calculation of deferred tax according to IAS 12.28. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
liability component (after deduction of the portion of the expenses related to the transaction pro rata to the respective parts attributed to liability and the conversion option) is
measured at amortized cost. A non-monetary interest expense, recorded in net loss is calculated using an effective interest rate to progressively bring the debt component up to the amount which will
be repaid (or converted) at maturity. A deferred tax liability is calculated on the basis of this amount. The shareholders' equity component is not remeasured. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.15.&nbsp;&nbsp;Trade and other payables  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade and other payables are initially recognized at the fair value of the amount due. This value is usually the nominal value, due to the relatively short period
of time between the recognition of the instrument and its repayment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.16.&nbsp;&nbsp;Provisions  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions are recognized when the Group has a present obligation (legal, regulatory, contractual or constructive) as a result of a past event, for which it is
probable that an outflow of resources will be required to settle the obligation, and of which the amount can be estimated reliably. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
amount recognized as a provision is the best estimate at the reporting date of the expenditure required to settle the present obligation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions
are discounted when the time value effect is material. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.17.&nbsp;&nbsp;Employee benefits  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Group's pension schemes and other post-employment benefits consist of defined benefit plans and defined contribution plans. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.17.1. Defined benefit plans  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined benefit plans relate to French retirement benefit plans under which the Group is committed to guaranteeing a specific amount or level of
contractually defined benefits. The obligation arising from these plans is measured on an actuarial basis using the projected unit credit method. The method consists in measuring the obligation based
on a projected end-of-career salary and vested rights at the measurement date, according to the provisions of the collective bargaining agreement, corporate agreements and applicable law. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Actuarial
assumptions are performed to determine the benefit obligations. The amount of future payments is determined on the basis of demographic and financial assumptions such as
mortality, staff </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=1,SEQ=255,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=877613,FOLIO='F-19',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>turnover,
pay increases and age at retirement, and then discounted to their present value. The discount rate used is the yield at the reporting date on AA credit-rated bonds with maturity dates that
approximate the expected payments for the Group's obligations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Re-measurements
of the net defined benefit liability which comprise actuarial gains and losses are recognized immediately in the statements of other comprehensive loss. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group determines the net interest expense on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the
beginning of the annual period to the then-net defined benefit liability, taking into account any changes in the net defined benefit liability during the period as a result of contributions and
benefit payments. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.17.2.&nbsp;&nbsp;&nbsp;&nbsp;Defined contribution plans</B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
defined contribution plans, the management of plans is performed by an external organization, to which the Group pays regular contributions. Payments made by the
Group in respect of these plans are recognized as an expense for the period in the statements of operations. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.17.3.&nbsp;&nbsp;&nbsp;&nbsp;Short-term employee benefits</B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
liability is recognized for the amount expected to be paid under short-term cash bonus or profit-sharing plans if the Group has a present legal or constructive
obligation to pay the amount as a result of past service provided by the employee, and the obligation can be estimated reliably. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>3.18.&nbsp;&nbsp;Revenues</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue
recognized in 2017 and 2018 related primarily to the sublease of a part of the Group's corporate headquarters. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group has not yet entered into other contracts with customers that would fall within the scope of IFRS&nbsp;15. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.19.&nbsp;&nbsp;Other income</B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.19.1.&nbsp;&nbsp;&nbsp;&nbsp;Government grants</B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group received until 2016 various forms of government grants. This government aid is provided for and managed by French state-owned entities, and specifically "BPI
France" ("</FONT><FONT SIZE=2><I>Banque Publique d'Investissement</I></FONT><FONT SIZE=2>"), formerly named "OSEO Innovation". </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsidies
received are non-refundable. Conditional advances received are interest-free or are subject to low interest rates depending on contractual provisions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Grants related to assets</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grants
related to assets are intended to finance the purchase of long-term assets. They are presented in the statements of financial position as deferred income and
recognized in the line item "Other income" in the statements of operations on a systematic basis over the useful life of the related asset. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=256,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=271114,FOLIO='F-20',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Grants related to income</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grants
related to income are intended to finance research programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;They
are presented in the statements of financial position as deferred income and recognized in the line item "Other income" in the statements of operations as and when costs related to
the research programs are incurred. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Conditional advances related to research programs</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conditional
advances that are interest-free or subject to low interest rates are intended to finance research programs needs. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with IAS&nbsp;20, </FONT><FONT SIZE=2><I>Accounting for Government Grants and Disclosure of Government Assistance</I></FONT><FONT SIZE=2>, the advantage resulting from
interest-free or low interest rates as compared to a market interest rate is considered and accounted for as a government grant. A financial liability is recognized for proceeds received from the
advance less the grant, and interest expense is subsequently recorded under the effective interest rate method using a market interest rate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
grant portion of conditional advances is treated as a grant related to income. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
advances granted by BPI France, repayment is required in the event of commercial success. In addition, if the Group decides to stop the research program, the conditional advance may
be repayable. If a program is unsuccessful, a pre-determined amount may be repayable. The remaining amount, if any, is then considered as a grant and written off in the line item "Other income" in the
statements of operations. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


3.19.2.&nbsp;&nbsp;&nbsp;&nbsp;Research tax credit</B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Research Tax Credit ("</FONT><FONT SIZE=2><I>Cr&eacute;dit d'Imp&ocirc;t Recherche</I></FONT><FONT SIZE=2>", or "CIR") is granted to entities by
the French tax authorities in order to encourage them to conduct technical and scientific research. Entities that demonstrate that their research expenditures meet the required CIR criteria receive a
tax credit that may be used for the payment of their income tax due for the fiscal year in which the expenditures were incurred, as well as in the next three years. If taxes due are not sufficient to
cover the full amount of tax credit at the end of the three-year period, the difference is repaid in cash to the entity by the authorities. If a company meets certain criteria in terms of sales,
headcount or assets to be considered a small/mid-size company, immediate payment of the Research Tax Credit can be requested. The Group meets such criteria. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group applies for CIR for research expenditures incurred in each fiscal year and recognizes the amount claimed in the line item "Other income" in the statements of operations in the
same fiscal year. In the notes to the financial statements, the amount claimed is recognized under the heading "Research tax credit" (see Note&nbsp;7, "Trade and other receivables" and
Note&nbsp;17, "Revenue and other
income"). The CIR for fiscal years 2010, 2011, 2012 and 2014 was under audit by the tax authorities and proposed reassessments were made, which the Group has contested using the legal remedies
available to it (see Note&nbsp;23, "Litigation and contingent liabilities"). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=257,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=404253,FOLIO='F-21',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_22"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.20.&nbsp;&nbsp;Research and development costs</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
expenses are recorded in the financial statements as expenses (see Note&nbsp;18, "Operating expense"). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with IAS&nbsp;38, </FONT><FONT SIZE=2><I>Intangible Assets</I></FONT><FONT SIZE=2>, development expenses are recognized as intangible assets only if all the following
criteria are met:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Technical feasibility necessary for the completion of the development project; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Intention on the Group's part to complete the project and to utilize it; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Capacity to utilize the intangible asset; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Proof of the probability of future economic benefits associated with the asset; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Availability of the technical, financial, and other resources for completing the project; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Reliable evaluation of the expenses attributed to the intangible asset during its development. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
some of these criteria were not fulfilled, the Group did not capitalize any development costs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>3.21.&nbsp;&nbsp;Classification of operating expenses</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development expenses include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> employee-related costs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> costs related to external employees seconded to the Company (clinical development and IT); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> lab supplies and facility costs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> donations to The NASH Education Program<SUP>TM</SUP> endowment fund, in particular for the creation of patient registry; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> fees paid to scientific advisers and contracted research and development activities conducted by third parties; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> intellectual property fees corresponding to the filing of the Group's patents. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contracted
research and development activities conducted by third parties include services subcontracted to research partners for technical and/or regulatory reasons. In particular, this
includes the production of active ingredients and therapeutic units, all or a part of clinical trials and pre-clinical trials that are necessary to the development of GENFIT's drug candidates and
biomarker candidates. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General
and administrative expenses include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> employee-related costs for executive, business development, intellectual property, finance, legal and human resources and communications
functions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> facility-related costs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> legal, audit and accounting fees; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> press releases and communications firm fees; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the cost of external employees seconded to the Company (security and reception); </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=258,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=899449,FOLIO='F-22',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_23"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> other service costs (recruitment, etc.); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> grants to the endowment fund, The NASH Education Program<SUP>TM</SUP>, earmarked in particular to finance the International NASH Day; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> intellectual property fees corresponding to the maintenance of the Group's patents. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B>3.22.&nbsp;&nbsp;Share-based compensation</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
fair value of equity-settled share-based compensation granted to employees, officers, board members and consultants as determined on the grant date is recognized as a compensation
expense with a corresponding increase in equity, over the vesting period. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and
non-market performance conditions are expected to be met. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
fair values of equity-settled share-based compensation granted to employees are measured using the Black-Scholes model with respect to the share warrants (BSA) and redeemable share
warrants (BSAAR) and using the Monte Carlo model for the stock options (SO) and free shares (AGA). Measurement inputs include share price on the measurement date, the exercise price of the instrument,
expected volatility, expected maturity of the instruments, expected dividends, and the risk-free interest
rate (based on government bonds). With respect to the redeemable share warrants, service and non-market performance conditions attached to the transactions are not taken into account in determining
fair value. Regarding the stock options and free shares, market conditions are taken into account in the evaluation of the fair value for the allocation plans that provide for it. For share-based
compensation awards with non-vesting conditions, the grant date fair value of the share-based compensation is measured to reflect such conditions and there is no adjustment for differences between
expected and actual outcomes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GENFIT
may also grant equity-settled share-based compensation in exchange for services to consultants who are not considered employees. In such cases, the value of the services is
measured when they are rendered by the consultants and the share-based compensation exchanged for the services is measured at an equal amount. If the value of the services cannot be measured reliably,
then such value is measured with reference to the fair value of the equity instruments granted. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based
compensation granted to consultants consists of share warrants, some of which may be redeemed at GENFIT's discretion. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based
compensation granted to employees consists of redeemable share warrants, stock options and free shares. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>3.23.&nbsp;&nbsp;Income tax</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
tax expense (or income) comprises current tax expense (or income) and deferred tax expense (or income), as applicable. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred
taxes are recognized for all the temporary differences arising from the difference between the tax basis and the accounting basis of assets and liabilities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=5,SEQ=259,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=143218,FOLIO='F-23',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred
tax assets are recognized for unused tax losses, unused tax credits and temporary deductible differences to the extent that:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> it is probable that future taxable profit will be available against which they can be used; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if there are deferred tax liabilities for the same entity in the same tax jurisdiction on which they can be applied. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2><B>3.24.&nbsp;&nbsp;Earnings (loss) per share</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic
earnings (loss) per share are calculated by dividing profit or loss attributable to the Company's ordinary shareholders by the weighted average number of ordinary shares
outstanding during the period. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted
earnings (loss) per share are calculated by adjusting profit attributable to ordinary shareholders and the average number of ordinary shares outstanding weighted for the effects
of all potentially dilutive instruments (share warrants, redeemable share warrants, free shares, stock options and bonds convertible into new and/or existing shares). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>3.25.&nbsp;&nbsp;Operating segments</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors and Chief Executive Officer are the chief operating decision makers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors and the Chief Executive Officer oversee the operations and manage the business as one segment with a single activity; namely, the research and development of
innovative medicines, the marketing of which depends on the success of the clinical development phase. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


4. FINANCIAL RISKS MANAGEMENT  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Group may be exposed to the following risks arising from financial instruments: foreign exchange risk, interest rate risk, liquidity risk and credit risk. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>4.1.&nbsp;&nbsp;Foreign exchange risk</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date of this document, the Group's exposure to exchange rate risk is moderate because the majority of its operations are denominated in euros, with the notable exception of the
operations performed by GENFIT CORP in U.S. dollars. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the future, and in particular with respect to its clinical trials, the Group may have to manage an increasing number of transactions either denominated in other foreign currencies or
indirectly exposed to currency risk, which will increase its overall exposure to this risk. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
increase in the overall exposure of the Group to this risk will depend, in particular, on:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the currencies in which the Group receives its revenues; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the currencies chosen when agreements are entered into, such as licensing agreements, or co-marketing or co-development agreements; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the geographic location of clinical trials on drug or biomarker candidates; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=260,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=304132,FOLIO='F-24',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_25"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


4. FINANCIAL RISKS MANAGEMENT (Continued) </B></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the ability, for its co-contracting parties to indirectly transfer foreign exchange risk to the Group; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the Group's foreign exchange risk policy. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the 2017 fiscal year, the Group used specific hedging arrangements (e.g.,&nbsp;purchase of U.S. dollars and of UCITS in U.S. dollars, as well as currency forwards in U.S.
dollars). In 2018, the Group considered the implementation of appropriate certain hedging arrangements without ultimately using any such arrangements. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table shows the sensitivity of the Group's expenses in U.S. dollars to a variation of 10% of the U.S. dollar against the euro in 2017 and 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ROWSPAN=2 ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Sensitivity of the Group's expenses to a variation of +/&#150; 10% of<BR>
the U.S. dollar against the euro<BR>
(in thousands of euros or U.S. dollars, as applicable)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expenses denominated in U.S. dollars</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,993</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,613</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equivalent in euros, on the basis of 1&nbsp;euro&nbsp;= 1.1993 U.S. dollars in 2017 and 1.1456&nbsp;U.S. dollars in 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,997</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,396</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equivalent in euros, in the event of an increase of 10% of U.S. dollar vs euro</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,552</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,328</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equivalent in euros, in the event of a decrease of 10% of U.S. dollar vs euro</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,543</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,632</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the 2017 fiscal year, the impact of the operational exchange rate risk consisted of realized and unrealized foreign exchange rate losses of &euro;765, offset in part by
gains of &euro;59, and in 2018, a realized and unrealized foreign exchange rate loss of &euro;(127), offset in part by gains of &euro;101. These gains and losses are
not necessarily indicative of the future impact of exchange rate risk. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>4.2.&nbsp;&nbsp;Interest rate risk</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, the Group was only liable for governmental advances or conditional advances with no interest or interest at a fixed rate, generally below market rate, and
for fixed-rate bank loans (the only variable-rate loan was repaid in 2017). Consequently, the Group is not significantly exposed to fluctuations in interest rates for its liabilities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2017 and 2018, the Group's financial liabilities totaled &euro;164,680 and &euro;169,593, respectively, net of the equity component of the
convertible loan and debt issue costs. The Group's exposure to interest rate risk through its financial assets is also limited, since these assets are mainly euro-denominated Undertakings for the
Collective Investment of Transferable Securities (UCITs), medium-term negotiable notes or term deposits with progressive rates. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>4.3.&nbsp;&nbsp;Liquidity risk</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group's loans and borrowings mainly consist of bonds convertible or exchangeable into new or existing shares (OCEANE), government advances for research projects and bank loans. For
conditional advances, reimbursement of the principal is subject to the commercial success of the related research project. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=261,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=210843,FOLIO='F-25',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_26"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


4. FINANCIAL RISKS MANAGEMENT (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has conducted a specific review of its liquidity risk and considers that it is able to meet its future maturities. At December&nbsp;31, 2017 and 2018, the Group has
&euro;274,581 and &euro;208,553, respectively, in cash and cash equivalents and other financial assets. The Group's net cash at December&nbsp;31, 2017 and 2018, consisting of
cash and cash equivalents, less the carrying value of the OCEANEs and current and non-current financial liabilities, amounted to &euro;109,141 and &euro;37,647, respectively. The
Company believes that the Group's cash and cash equivalents and current financial instruments are sufficient to ensure its financing, in light of its current projects and obligations, for at least the
next twelve months. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Group's funds are insufficient to cover any additional financing needs, the Group would require additional financing. The conditions and arrangements for any such new financing
would depend, among other factors, on economic and market conditions that are beyond the Group's control. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>4.4.&nbsp;&nbsp;Credit risk</B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit
risk is the risk of financial loss if a customer or counterparty to a financial asset defaults on their contractual commitments. The Group is exposed to credit risk due to trade
receivables and other financial assets. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group's policy is to manage this risk by transacting with third parties with good credit standards. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


5. INTANGIBLE ASSETS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets consist mainly of office and administrative software as well as scientific software purchased by the Group. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following tables show the variations in intangible assets for the years ended December&nbsp;31, 2017 and 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Intangible assets&#151;Variations<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
January&nbsp;1,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Decrease </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Gross</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Software</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,688</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>268</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(56</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Gross</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,709</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>268</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(56</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>1,921</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Accumulated depreciation and impairment</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Software</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(298</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,264</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Accumulated depreciation and impairment</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> (1,042</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(298</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>54</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(1,285</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Net</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 668</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(29</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(2</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>636</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=262,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=592107,FOLIO='F-26',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_27"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


5. INTANGIBLE ASSETS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Intangible assets&#151;Variations<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
January&nbsp;1,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Decrease </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Gross</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Software</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>216</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(67</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,049</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other intangibles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>313</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>313 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Gross </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>1,921</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>529</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(67</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>2,384</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Accumulated depreciation and impairment</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Software</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,264</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(370</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,567</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other intangibles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Accumulated depreciation and impairment </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(1,285</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(370</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>67</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(1,588</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Net </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>636</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>159</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>796</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. PROPERTY, PLANT AND EQUIPMENT  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment (including assets held under finance lease contracts) consist of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Property, plant&nbsp;&amp; equipment&#151;<BR>
Variations<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
January&nbsp;1,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Decrease </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Reclassification </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Gross</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Buildings on non-freehold land</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Scientific equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,078</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,546</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,576</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fittings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>988</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>138</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,126</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vehicles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>82</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(44</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>99</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computer equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>211</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,954</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>317</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>357</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>In progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Gross</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 8,940</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>4,287</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(105</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>13,123</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Accumulated depreciation and impairment</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Scientific equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,438</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(673</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(5,063</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fittings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(657</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(65</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(722</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vehicles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(29</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computer equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(530</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(184</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(703</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(276</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(285</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>In progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Depreciation and impairment</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> (5,930</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(949</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>81</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(6,798</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Net</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 3,010</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>3,338</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(24</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>6,324</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=263,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1021972,FOLIO='F-27',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fq10701_1_28"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. PROPERTY, PLANT AND EQUIPMENT (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following tables show the variations in tangible assets for the years ended December&nbsp;31, 2017 and 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Property, plant and equipment&#151;<BR>
Variations<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
January&nbsp;1,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Increase </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Decrease </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Reclassification </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Gross</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Buildings on non-freehold land</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,447</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,458</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Scientific equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,576</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(235</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,879</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fittings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,126</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>443</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(43</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,531</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vehicles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>99</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>99</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computer equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,954</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(702</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,446</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>357</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>361</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>In progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>805</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(804</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Gross </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>13,123</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>2,939</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(288</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>15,774</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Accumulated depreciation and impairment</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Buildings on non-freehold land</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Scientific equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(5,063</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,142</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>218</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(5,988</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fittings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(722</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(91</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>43</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(769</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vehicles</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computer equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(703</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(216</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(915</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(285</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(292</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>In progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Depreciation and impairment </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(6,798</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(1,481</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>270</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(8,010</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Net </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>6,324</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>1,459</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(18</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>7,764</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assets
under finance lease contracts relate to scientific equipment. Their net carrying value as of December&nbsp;31, 2017 and 2018 amounted to &euro;1,895 and
&euro;1,889, respectively. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Financial commitments&#151;Operating leases</U> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease
payments for property rented under the Group's real estate operating leases for its offices in Loos, France; Paris, France; and Cambridge, Massachusetts, USA) and
the payment schedule for minimum future lease payments under these leases are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Operating lease payments&#151;group as lessee<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;for the period</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,072</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,153</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=264,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=45473,FOLIO='F-28',FILE='DISK124:[18ZFA1.18ZFA10701]FQ10701A.;29',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fs10701_1_29"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts)  </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. PROPERTY, PLANT AND EQUIPMENT (Continued)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Operating lease commitments&#151;group as lessee<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;within 1&nbsp;year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,072</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,213</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;after 1&nbsp;year but no more than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,832</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,262</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;more than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>316 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 5,197</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 4,791</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
May 2018, the Company signed an agreement with an independent third party who owns the Company's headquarters, for a building extension of approximately 1,000 square meters for a
maximum amount of &euro;2.5&nbsp;million. The expected completion date for the extension is end of the first quarter of 2019. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GENFIT
has guaranteed its rental payment obligation under the lease agreement for the headquarters in Loos in the amount of &euro;455 at December&nbsp;31, 2017 and 2018. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Financial commitments&#151;Capital leases</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
payment schedule for minimum future lease payments under capital leases is as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Finance lease<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;Within 1&nbsp;year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>439</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>539</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;After 1&nbsp;year but not more than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,404</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Minimum payments&#151;More than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total&#151;Minimum payments</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,928</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,943</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : Principal&#151;Within 1&nbsp;year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>420</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>520</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : Principal&#151;After 1&nbsp;year but not more than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,460</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,381</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : Principal&#151;More than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total&#151;Of which : Principal</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,880</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,900</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : Interest&#151;Within 1&nbsp;year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : Interest&#151;After 1&nbsp;year but not more than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>29</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : Interest&#151;More than 5&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total&#151;Of which : Interest</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 48</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 42</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=265,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=109259,FOLIO='F-29',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_30"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


7. TRADE AND OTHER RECEIVABLES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade and other receivables consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Trade and other receivables&#151;Total<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade receivables, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research tax credit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,466</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,785</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Social security costs receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>VAT receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>994</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,103</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Grants receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>340</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>361 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 9,876</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 10,284</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Trade and other receivables&#151;Current<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade receivables, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research tax credit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,295</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Social security costs receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>VAT receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>994</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,103</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Grants receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>340</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>361 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 7,955</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 8,794</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Trade and other receivables&#151;Non-current<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade receivables, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research tax credit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,921</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Social security costs receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>VAT receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Grants receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other receivables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,921</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,489</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2017 and 2018, trade receivables neither past due nor impaired amounted to &euro;49 and &euro;7, respectively. At December&nbsp;31, 2017
and 2018, past due trade receivables amounted to &euro;12 and &euro;18, respectively. At December&nbsp;31, 2017 and 2018, the part of trade receivables classified as doubtful
accounts amounted to &euro;73 and &euro;4, respectively. During the 2018 period, a majority of the trade receivables were classified as non-recoverable, in the amount of
&euro;57. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=266,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=400046,FOLIO='F-30',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_31"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


7. TRADE AND OTHER RECEIVABLES (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Research tax credit</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
research tax credit receivable as of December&nbsp;31, 2018 included:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a partial payment of the assessment (&euro;333) due to an ongoing tax audit </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the balance of the amount due for the 2014 fiscal year (&euro;1,140) </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the balance of the amount due for the 2016 fiscal year (&euro;447), the two amounts are used as partial compensation with the
assessment notices and the tax notice related to the 2014 CIR, as described in Note&nbsp;23, "Litigation and contingent liabilities". </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The amount received following the judgment in favor of the Company at the Montreuil court (&euro;432) has been deducted. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
estimated amount of &euro;7,295 for the research tax credit receivable for the year 2018 (&euro;6.545 for the year 2017) is in addition to the amounts described
above. At December&nbsp;31, 2018, other receivables mainly included VAT receivables for &euro;1,103, receivables from suppliers for &euro;235 and the CICE receivable for
&euro;122. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


8. OTHER FINANCIAL ASSETS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financial assets consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Financial assets&#151;Total<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>219</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>259</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deposits and guarantees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>274</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Liquidity contract net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>267</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>770 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 760</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,313</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="16pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Financial assets&#151;Current<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deposits and guarantees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 31</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Financial assets&#151;Non current<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>219</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>259</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deposits and guarantees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>243</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Liquidity contract</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>267</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>770 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 729</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,313</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=267,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=839254,FOLIO='F-31',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_32"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


8. OTHER FINANCIAL ASSETS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
liquidity contract consists of a share buyback program contracted to an investment service provider in order to facilitate the listing of the Group's shares. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the period, Genfit made an additional contribution of &euro;1,000 to the liquidity agreement with CM-CIC Market Solutions. As of December&nbsp;31, 2018, the liquidity
agreement had a cash balance of &euro;770. CM-CIC Market Solutions holds on behalf of Genfit, 27,911 shares, recorded as a deduction from equity. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


9. OTHER ASSETS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets of &euro;1,761 and &euro;2,078 at December&nbsp;31, 2017 and 2018, respectively, consisted of prepaid expenses related to current operating expenses.
This follows the increase in operating expenses in 2018. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


10. CASH AND CASH EQUIVALENTS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The main components of cash equivalents were:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> UCITS and interest-bearing current accounts, available immediately; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> term accounts, available within the contractual maturities or by the way of early exit; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> negotiable medium-term notes, available with a quarterly maturity or by the way of early exit. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
investments, summarized in the tables below, are short-term, highly liquid and subject to a low risk of changes in value. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Cash and cash equivalents<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Short-term deposits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>244,279</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>201,522</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash on hand and bank accounts</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>29,541</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,718 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 273,820</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 207,240</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Short-term deposits<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>UCITS</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38,052</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>29,189</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term accounts</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>138,967</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>124,316</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Negotiable medium-term notes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,150</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest-bearing current accounts</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63,110</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48,017 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 244,279</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 201,522</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


11. EQUITY  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary shares are classified under shareholders' equity. Any shareholder, regardless of nationality, whose shares are fully paid-in and registered for at least two years, is entitled
to double voting rights under the conditions prescribed by law (Article&nbsp;32 of the Company's bylaws). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=268,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1001580,FOLIO='F-32',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


11. EQUITY (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2018, 2,300,214 shares have been held for more than two years and entitle their holders to double voting rights (7.38% of the issued share capital). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Changes in share capital in 2017</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
October&nbsp;16, 2017, the Company issued bonds convertible or exchangeable into new or existing shares (OCEANEs) due October&nbsp;16, 2022 for a nominal amount
of
&euro;180,000. This transaction is recorded as a liability component and an equity component; the latter is measured at &euro;14,312 net of deferred taxes (see Note&nbsp;12.2,
"Breakdown of other loans and borrowings"). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Changes in share capital in 2018</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
December&nbsp;27, 2018, the Board of Directors of the Company determined that some of the performance conditions for the AGA D 2016-1 and all of the performance
conditions for the AGA&nbsp;S&nbsp;2016-1 were met, and therefore 17,484 ordinary shares were definitively acquired by their beneficiaries, and the share capital was increased by the nominal
amount. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. LOANS AND BORROWINGS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>12.1.&nbsp;&nbsp;Breakdown of convertible loan</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
October&nbsp;16, 2017, the Company issued 6,081,081 OCEANEs at par with a nominal unit value of &euro;29.60 per bond for an aggregate nominal amount of
&euro;180,000. The exchange or conversion premium is 30% of the reference share price of &euro;22.77. Annual nominal interest rate is a fixed 3.5% payable semi-annually in
arrears. The effective interest rate is 7.3%. The OCEANEs are due October&nbsp;16, 2022. Redemption prior to maturity is at the option of the Company from November&nbsp;6, 2020 if the arithmetic
volume-weighted average price of the Company's share price and the then-prevailing conversion ratio (over a 20-day trading period) exceeds 150% of the nominal value of the OCEANEs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2017 and 2018, the Group recorded a liability of &euro;155,868 and &euro;160,489, respectively, related to the OCEANEs net of the equity
portion and debt issue costs. Of this amount, &euro;1,329 and &euro;1,312, respectively, was classified as current and &euro;154,539 and &euro;159,176,
respectively, was classified as non-current. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
conversion of all of the convertible bonds would result in a dilution of 19.5% (expressed as a percentage of share capital). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=269,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=480137,FOLIO='F-33',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_34"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. LOANS AND BORROWINGS (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>12.2.&nbsp;&nbsp;Breakdown of other loans and borrowings</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
loans and borrowings consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Other loans&nbsp;&amp; borrowings&#151;Total<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Refundable and conditional advances</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,407</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,488</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Obligations under finance leases</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,890</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interests</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial loans and borrowings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 8,812</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 9,104</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Other loans and borrowings&#151;Current<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Refundable and conditional advances</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,209</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,319</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Obligations under finance leases</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>420</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>520</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interests</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial loans and borrowings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,834</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 1,848</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Other loans and borrowings&#151;Non current<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Refundable and conditional advances</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,279</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,645</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Obligations under finance leases</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,469</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,381</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interests</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial loans and borrowings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 6,978</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 7,255</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
financial liabilities are denominated in euros. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


12.2.1.&nbsp;&nbsp;&nbsp;&nbsp;Refundable and conditional advances</B></FONT></P>

</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>General overview</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
2006 to 2010, the Company received conditional advances from BPI France. Advances are subject to no or low interest rates and are intended to finance research
programs described in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=270,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=14738,FOLIO='F-34',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_35"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. LOANS AND BORROWINGS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Note&nbsp;3.19.1,
"Government grants". The following table summarizes advances outstanding at December&nbsp;31, 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Refundable and conditional<BR>
advances&#151;general overview<BR>
(in &euro; thousands)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
amount<BR>
allocated </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Receipts </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Repayments </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effects of<BR>
discounting </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Net book<BR>
value as of<BR>
December&nbsp;31,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE&#151;IT-DIAB</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12/23/2008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Development of a global strategy for the prevention and management of type&nbsp;2 diabetes</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE&#151;ADVANCE<BR>
N&deg;1&#151;OLNORME II&#151;1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11/24/2010</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(134</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE&#151;ADVANCE<BR>
N&deg;2&#151;OLNORME II&#151;2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11/24/2010</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(134</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE&#151;ADVANCE<BR>
N&deg;3&#151;OLNORME II&#151;3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11/24/2010</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>200</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(108</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Research of pharmaceutical entities in plant extracts for the treatment of inflammatory diseases</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 3,407</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes advances outstanding at December&nbsp;31, 2018. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Refundable and conditional<BR>
advances&#151;general overview<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
amount<BR>
allocated </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Receipts </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Repayments </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effects of<BR>
discounting </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Net book<BR>
value as of<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE&#151;IT-DIAB</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12/23/2008</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Development of a global strategy for the prevention and management of type&nbsp;2 diabetes</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Receipts and repayments of refundable and conditional advances</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the years ended December&nbsp;31, 2017 and 2018, the Group repaid &euro;166 and &euro;183, respectively, of refundable and conditional
advances. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=271,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=833030,FOLIO='F-35',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. LOANS AND BORROWINGS (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Main terms of the contracts</U> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="218pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE IT-DIAB</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>On December&nbsp;23, 2008, the Group received an advance from BPI France (the BPI France IT-DIAB) as part of a framework innovation aid agreement involving several scientific partners and for which the
Group was the lead partner. The contribution expected at each stage by each of the partners in respect of work carried out and results achieved is defined in the framework agreement. With respect to the Group, the aid consisted of a &euro;3,229
conditional advance and a &euro;3,947 non-repayable government grant.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The conditional advance is not refundable except in the event of success. The program ended on December&nbsp;31, 2014. In
the event of success, defined as the commercial spin-offs of the IT-Diab program which involves products for the treatment or diagnosis of type&nbsp;2 diabetes, in that case, the financial returns generated will be used initially to repay the
&euro;3,229 conditional advance and the agreement stipulates that the conditional advance will be regarded as repaid in full when the total payments made in this regards by the recipient, discounted at the rate of 5.19%, equal the total amount,
discounted at the same rate, of the aid paid. Any further amounts will be classified as additional payments, up to a maximum amount of &euro;14,800.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE ADVANCE N&deg;1&#151;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;OLNORME II&#151;1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>These non-interest bearing advances are repayable in full (at 100% of their nominal amount) in the event of technical and/or
commercial success.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The balance of these advances (in an amount of &euro;66) were reimbursed during 2018.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE ADVANCE N&deg;2&#151;<BR>
OLNORME II&#151;2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>These non-interest bearing advances are repayable in full (at 100% of their nominal amount) in the event of technical and/or
commercial success.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The balance of these advances (in an amount of &euro;66) were reimbursed during 2018.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE ADVANCE N&deg;3&#151;<BR>
OLNORME II&#151;3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>These non-interest bearing advances are repayable in full (at 100% of their nominal amount) in the event of technical and/or
commercial success.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The balance of these advances (in an amount of &euro;52) were reimbursed during 2018.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=272,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=431063,FOLIO='F-36',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_37"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. LOANS AND BORROWINGS (Continued) </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


12.2.2.&nbsp;&nbsp;&nbsp;&nbsp;Bank loans</B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank
loans are primarily used to finance research and laboratory equipment. Bank loans consisted of the following as of December&nbsp;31, 2017: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="70pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(amounts in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Loan date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Facility<BR>
size </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Interest<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Available<BR>
as of<BR>
December&nbsp;31,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Installments </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Outstanding<BR>
as of<BR>
December&nbsp;31,<BR>
2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>July 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>451</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cr&eacute;dit du Nord</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>June 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.36</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>525</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>April 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>December 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>264.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>217</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>October 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,050</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.80</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>945</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Banque Neuflize OBC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>June 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>252</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>June 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.80</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>377</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cr&eacute;dit du Nord</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>April 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.72</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>335</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>March 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>158</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>December 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>205</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total bank loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,488 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank
loans consisted of the following as of December&nbsp;31, 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="25%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="91" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="70" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(amounts in thousands of<BR>
euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Loan date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Facility<BR>
size </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Interest<BR>
rate </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Available<BR>
as of<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Installments </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Outstanding<BR>
as of<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>July 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>753</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cr&eacute;dit du Nord</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>June 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.36</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>376</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>April 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>695</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>December 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>265</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>164</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>October 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,050</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.80</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>735</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Banque Neuflize OBC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>June 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>84</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>June 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.80</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>277</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cr&eacute;dit du Nord</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>April 2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.72</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>236</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>March 2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BNP Paribas</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>December 2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20 quarterly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>103</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cr&eacute;dit du Nord</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>November 2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.46</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48&nbsp;monthly</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>490</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total bank loans</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 3,964</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P style="font-family:times;"><FONT SIZE=2><B>12.3.&nbsp;&nbsp;Development agreements with participation feature</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
June 2010, BPI France granted the Company a development agreement with participation feature amounting to &euro;2,300 over a 7-year period with a fixed interest rate of
4.46%. No
repayment of principal was scheduled during the first two years. The loan agreement has a provision applicable </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=273,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=583351,FOLIO='F-37',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. LOANS AND BORROWINGS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>during
the reimbursement period which provides for additional remuneration to BPI France depending on whether the Company had industrial income. This additional remuneration amounts to 0.2294% of
sales. However, this loan was repaid in its entirety in June 2017. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>12.4.&nbsp;&nbsp;Maturities of financial liabilities</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Maturity of financial liabilities<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
1&nbsp;year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
2&nbsp;years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
3&nbsp;years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
4&nbsp;years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
5&nbsp;years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>More than<BR>
5&nbsp;years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BPI FRANCE&#151;IT-DIAB</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Refundable and conditional advances</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Convertible loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160,489</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,312</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>159,176</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,964</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,319</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,105</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>942</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>544</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>54</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Obligations under finance leases</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>520</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>525</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>523</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>291</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>42</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interests</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial loans and borrowings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Other loans and borrowings</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 166,364</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 3,161</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 1,631</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 1,465</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 160,012</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 96</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 169,593</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 3,161</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 1,631</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 1,465</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 160,012</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 96</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
convertible bond results in the payment of yearly interest of &euro;6,300 and a reimbursement at par in October 2022. The nominal amount of the convertible loan of
&euro;180,000 is due in less than 4 years. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


13. TRADE AND OTHER PAYABLES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade and other payables consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Trade and other payables&#151;Total (all current)<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade payables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,053</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32,649</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Social security costs payables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,217</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,949</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Employee profit sharing</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>VAT payables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Taxes payables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>241</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>286</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other payables</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>71 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 23,580</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 35,974</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


14. PROVISIONS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At December&nbsp;31, 2017 and 2018, this line item amounted to &euro;361 and &euro;112, respectively. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=274,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=494878,FOLIO='F-38',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_39"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


14. PROVISIONS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
accruals recorded are mainly related to the research tax credit and the salary tax for 2017. See Note&nbsp;23, "Litigation and contingent liabilities". </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


15. EMPLOYEE BENEFITS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In France, pension funds are generally financed by employer and employee contributions and are accounted for as a defined contribution plan with the employer contributions recognized as
expense as incurred. The Group has no actuarial liabilities in connection with these plans. Expenses recorded for the years ended December&nbsp;31, 2017 and 2018 amounted to &euro;543 and
&euro;765, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;French
law also requires payment of a lump sum retirement indemnity to employees based on years of service and annual compensation at retirement, which are accounted for as a defined
benefit plan. Benefits do not vest prior to retirement. The Group is paying this defined benefit plan. It is calculated as the present value of estimated future benefits to be paid, applying the
projected unit credit method whereby each period of service is seen as giving rise to an additional unit of benefit entitlement, each unit being measured separately to build up the final. At
December&nbsp;31, 2017 and 2018, pension provisions recorded were &euro;936 and &euro;1,085, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
part of the measurement of the retirement indemnity to employees, the following assumptions were used for all categories of employees: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="208pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Population</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Permanent staff</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Retirement age</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>65</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Terms of retirement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Initiated by the employee</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Life expectancy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>On the basis of the INSEE table(1)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Probability of continued presence in the company at retirement age</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>On the basis of the DARES table(1)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>INSEE
is the French National Institute of Statistics; DARES is the French Bureau of Studies and Statistics  </FONT></DD></DL>
 </DIV>

 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="26pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Rate

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Salary growth rate in 2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Salary growth rate beyond 2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Discount rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.53</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
discount rates are based on the market yield at December&nbsp;31, 2017 and 2018 on high quality corporate bonds. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=275,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=434657,FOLIO='F-39',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fs10701_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


15. EMPLOYEE BENEFITS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table presents the changes in the present value of the defined benefit obligation: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Changes in the present value of the defined benefit obligation<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Defined benefit obligation as of January&nbsp;1, 2017</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 849</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current service cost</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>76</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest cost on benefit obligation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Actuarial losses on obligation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>210</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Past service costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(211</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Defined benefit obligation as of December&nbsp;31, 2017</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 936</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current service cost</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>104</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest cost on benefit obligation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Actuarial losses on obligation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Past service costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Defined benefit obligation as of December&nbsp;31, 2018 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>1,085</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
actuarial differences are mainly explained by the changes in personnel observed against the hypothesis used in the actuarial calculation. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


16. FAIR VALUE OF FINANCIAL INSTRUMENTS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following tables provide the financial assets and liabilities carrying values by category and fair values as of December&nbsp;31, 2017 and 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=20 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Carrying value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As per<BR>
statement of<BR>
financial<BR>
position </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Assets at<BR>
fair value<BR>
through<BR>
profit&nbsp;&amp; loss </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Loans&nbsp;&amp;<BR>
receivables </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Debt at<BR>
amortized<BR>
cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;3 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Assets</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deposits and guarantees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>274</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>274</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>274</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade receivables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>273,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>273,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>273,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Assets </B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>274,375</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>273,820</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>555</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>273,820</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>555</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Liabilities</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Conditional advances</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Convertible loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>155,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>155,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>155,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,488</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,488</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,488</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Obligations under finance leases</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,890</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,890</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,890</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interests</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial loans and borrowings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade payables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,053</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,053</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,053</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other payables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Liabilities </B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>183,766</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>183,766</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>180,359</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>3,407</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=276,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=440689,FOLIO='F-40',FILE='DISK124:[18ZFA1.18ZFA10701]FS10701A.;74',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fu10701_1_41"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts)  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


16. FAIR VALUE OF FINANCIAL INSTRUMENTS (Continued)  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=20 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Carrying value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As per<BR>
statement of<BR>
financial<BR>
position </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Assets at<BR>
fair value<BR>
through<BR>
profit&nbsp;&amp; loss </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Loans&nbsp;&amp;<BR>
receivables </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Debt at<BR>
amortized<BR>
cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;3 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Assets</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>259</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>259</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>259</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deposits and guarantees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade receivables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>207,240</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>207,240</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>207,240</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Assets</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 207,808</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>207,240</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>568</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>207,240</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>568</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Liabilities</I></B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Conditional advances</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Convertible loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160,489</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160,489</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>160,489</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bank loans</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,964</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,964</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,964</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Obligations under finance leases</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,900</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interests</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial loans and borrowings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Trade payables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other payables</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>71</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>71</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>71</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Liabilities</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 202,313</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>202,313</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>199,084</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>3,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


17. OTHER INCOME  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Other income<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CIR research tax credit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,545</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,295</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CICE tax credit; other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>171</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>130</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Government grants and subsidies</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>6,737</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>7,425</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
described in section&#151;Note&nbsp;23, "Litigation and contingent liabilities", the research tax credits for the fiscal years 2010, 2011, 2012 and 2014 were subject to a tax
audit and proposed reassessments were made which the Group has contested using the legal remedies available to it. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the 2017 and 2018 fiscal years, the Group recognized in other operating income &euro;170 and &euro;122, respectively, relating to the CICE
(</FONT><FONT SIZE=2><I>Cr&eacute;dit d'imp&ocirc;t pour la comp&eacute;titivit&eacute; et l'emploi</I></FONT><FONT SIZE=2>), which is a tax credit implemented to
enhance the competitiveness of businesses through the promotion of certain activities and employment. In 2017 and 2018, the tax credit was equal to 7% and 6%, respectively, of all wages paid to
employees during the year in respect of salaries that do not exceed 2.5 times the French minimum wage. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017 and 2018, this tax credit was used to finance the increase in headcount and to purchase scientific equipment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=277,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=573724,FOLIO='F-41',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fu10701_1_42"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


18. OPERATING EXPENSE  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Year Ended December&nbsp;31, 2017  </I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Operating expenses and other operating income (expenses)<BR>
(in thousands of<BR>
euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Raw<BR>
materials&nbsp;&amp;<BR>
consumables<BR>
used </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Contracted<BR>
research&nbsp;&amp;<BR>
development<BR>
activities<BR>
conducted<BR>
by third<BR>
parties </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employee<BR>
expenses </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Other expenses<BR>
(maintenance, fees,<BR>
travel, taxes) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Depreciation,<BR>
amortization&nbsp;&amp;<BR>
impairment<BR>
charges </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gain / (loss)<BR>
on disposal of<BR>
property,<BR>
plant&nbsp;&amp;<BR>
equipment </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(54,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,117</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(35,088</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7,915</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7,973</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,095</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,421</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(112</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,491</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,374</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(437</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income (expenses)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>68</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(63,550</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(2,229</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(35,095</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(13,406</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(11,280</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(1,532</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(8</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Year Ended December&nbsp;31, 2018  </I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Operating expenses and other operating income (expenses)<BR>
(in thousands of<BR>
euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Raw<BR>
materials&nbsp;&amp;<BR>
consumables<BR>
used </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Contracted<BR>
research&nbsp;&amp;<BR>
development<BR>
activities<BR>
conducted<BR>
by third<BR>
parties </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employee<BR>
expenses </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Other expenses<BR>
(maintenance, fees,<BR>
travel, taxes) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Depreciation,<BR>
amortization&nbsp;&amp;<BR>
impairment<BR>
charges </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gain / (loss)<BR>
on disposal of<BR>
property,<BR>
plant&nbsp;&amp;<BR>
equipment </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(67,024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,724</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(47,659</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,431</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(6&nbsp;502</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,707</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
&euro;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(130</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,194</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,738</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>272</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other operating income and (expenses)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(162</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(164</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(76,979</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(1,855</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(47,662</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(13,625</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(12,403</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>(1,435</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B>
<!-- -->
&euro;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>2</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development expenses take into account estimates for ongoing activities subcontracted as part of the clinical trials and not yet invoiced, on the basis of detailed
information provided by subcontractors and reviewed by the Group's internal departments. The accuracy of these estimates for some types of expenses improves with the progression of the trials and the
review of their determination methods. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017, the donation to The NASH Education Program (&euro;1,808) was classified as a research&nbsp;&amp; development expense because the 2017 donation was primarily related to
the creation of a NASH patient registry in particular to increase understanding of the prevalence and natural history of NASH/ </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=278,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=814322,FOLIO='F-42',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fu10701_1_43"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


18. OPERATING EXPENSE (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>NAFLD,
and the development of co-morbidities historically linked to NASH/NAFLD, which information is to be used as part of the efforts to collect RWE (Real World Evidence) data to better address the
needs of the patients, which information could be utilized by the Company in its research&nbsp;&amp; development efforts. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
increase in contracted research and development activities conducted by third parties in the 2018 period was primarily the result of the progression of the research and development
pipeline; and mainly operational outsourcing costs related to the Phase&nbsp;3 RESOLVE-IT clinical trial of elafibranor for the treatment of NASH and, to a lesser extent, those related to the
Phase&nbsp;2 trial of elafibranor in PBC and the launch of the Phase&nbsp;2 trial in nitazoxanide. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
increase in employee expenses is mainly due to the evolution of employee profiles (specialized and more experienced), the increase in compensation, and the increase in the number of
employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
operating expenses include costs related to facilities and their maintenance, intellectual property costs, and expenses related to the preparation of marketing of elafibranor in
NASH. In 2018, the Company's donation to The Nash Education Program endowment fund (&euro;959) was dedicated mainly to the organization of the first international NASH Day. In this context,
in 2018, the Company has classified this charge as general and administrative expenses. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>18.1.&nbsp;&nbsp;Employee expenses  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee expenses and number of employees were as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="105pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="111pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Employee expenses<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Wages and salaries</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,267</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(9,012</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Social security costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,996</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,722</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Changes in pension provision</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(104</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-based compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(278</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(13,406</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(13,625</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Average number of employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>123</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Average age of employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38&nbsp;years 4&nbsp;months</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38&nbsp;years 11&nbsp;months</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Number of employees</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>92</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Administration and management</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>125</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>148</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation is granted by the Group to employees, executive officers, board members and consultants. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based
compensation granted to employees and executive officers in 2014 through 2018 corresponds to redeemable share warrants ("</FONT><FONT SIZE=2><I>Bons de Souscriptions et/ou
d'Acquisition d'Actions</I></FONT><FONT SIZE=2>" or "BSAAR"), stock options ("SO") and free shares ("</FONT><FONT SIZE=2><I>actions gratuites</I></FONT><FONT SIZE=2>" or "AGA"). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=279,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=108919,FOLIO='F-43',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fu10701_1_44"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based
compensation granted to board members and consultants in 2014, 2015 and 2017 corresponds to share warrants ("</FONT><FONT SIZE=2><I>Bons de Souscriptions
d'Actions</I></FONT><FONT SIZE=2>" or "BSA"). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the measurement of this share-based compensation, the Group has determined that under IFRS its consultants were not equivalent to employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
these programs, holders of vested instruments are entitled to subscribe to shares of the Company at a pre-determined exercise price. All of the plans are equity settled. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
table below presents the share-based compensation for each of the programs. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
calculated </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
remaining </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation&#151;Annual expense

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSA 2014-A </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>945</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to non-executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>365</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to consultants</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>581</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSA 2014-B </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>1,045</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to non-executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>365</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to consultants</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>680</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSAAR 2014-A </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>43</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSAAR 2014-B </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>191</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>156</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSAAR 2014-C </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>189</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>154</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
calculated </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
remaining </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation&#151;Annual expense

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSA 2015-A </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>335</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to non-executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to consultants</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>157</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSA 2015-B </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>315</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to non-executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to consultants</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>138</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=280,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=910393,FOLIO='F-44',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fu10701_1_45"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
calculated </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
remaining </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation&#151;Annual expense

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSAAR 2016-A </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSAAR 2016-B </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA D 2016-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>38</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>127</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>166</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>101</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>133</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA D 2016-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>17</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>17</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>51</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>16</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>42</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA S 2016-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>44</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>151</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>197</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>44</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>151</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>197</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA S 2016-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>22</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>22</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>65</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>21</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>65</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO 2016-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>83</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>83</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>249</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>79</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>210</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO 2016-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>38</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>38</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>113</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>36</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO US 2016-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>12</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>12</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>36</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>11</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>36</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO US 2016-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>5</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>5</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>16</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>5</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=281,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=52044,FOLIO='F-45',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fu10701_1_46"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
calculated </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
remaining </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation&#151;Annual expense

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSA 2017-A </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>6</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>63</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>69</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to non-executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>43</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BSA 2017-B </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>3</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>66</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>70</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to non-executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>46</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA D 2017-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>17</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>35</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>17</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA D 2017-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>29</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>89</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>58</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>51 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA S 2017-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA S 2017-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>24</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>73</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>48</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO 2017-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>2</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>28</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>57</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>28</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO 2017-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>3</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>48</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>146</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>95</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>121</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>79 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO US 2017-1 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>3</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>6</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>3</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO US 2017-2 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>5</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>16</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>11</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=282,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=684787,FOLIO='F-46',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fu10701_1_47"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
calculated </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
remaining </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation&#151;Annual expense

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA D 2018</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>10</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>202</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>191</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>93</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>98</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>AGA S 2018</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>12</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>237</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>225</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>237</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>225</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO 2018</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>24</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>517</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>493</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>182</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>179</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>335</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>314</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>SO US 2018</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>3</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>55</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>52</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to executive officers</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Of which : expense related to employees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
calculated </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total expense<BR>
remaining </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation&#151;Annual expense

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>278</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>787</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>5,530</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>1,390</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=283,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=441554,FOLIO='F-47',FILE='DISK124:[18ZFA1.18ZFA10701]FU10701A.;52',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fw10701_1_48"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts)  </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>19.1.&nbsp;&nbsp;Share warrants (</B></FONT><FONT SIZE=2><B><I>bons de souscription d'actions</I></B></FONT><FONT SIZE=2><B> or BSA)  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The key terms and conditions related to each program are detailed in the following tables: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2014-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2014-B </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Share warrants (BSA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Consultants </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Consultants </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>04/02/2014</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>07/24/2014</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,380</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,380</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23,380</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of shares to which the BSA give right</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>24,087</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>24,081</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Share entitlement per option</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>1 warrant / 1.03 shares</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issue price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.01&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise price(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23.50&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 08/01/2014 to 09/15/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 01/02/2015 to 02/15/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 11/01/2014 to 09/30/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 03/01/2015 to 02/28/2019</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Methods of exercise</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Exercisable per tranches of a minimum number of BSA equal to 2,000 or a multiple of 2,000, except outstanding balance</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Black Scholes</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>74.9%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.40%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected life</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>4&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;valued by expert opinion(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>13.02&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of December&nbsp;31, 2014</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 08/01/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 08/01/2014 To 11/01/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 08/01/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 08/01/2014 To 12/31/2014</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>27.46&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>37.79&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>27.46&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>37.79&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>15.61&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>24.84&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>15.61&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>24.85&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of December&nbsp;31, 2015</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 08/01/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 01/01/2015 To 03/01/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>27.46&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>54.84&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>15.61&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>40.09&nbsp;&euro;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Independent
members of the Supervisory board.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price of the BSA 2014 is equal to the average, weighted by the volumes, of the closing prices of the share over five consecutive trading days from
July&nbsp;7, 2014 to July&nbsp;11, 2014, decreased by a discount of 5.00%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Valuation
of the financial instrument by independent expert opinion at the time of allocation. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=284,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=633198,FOLIO='F-48',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_49"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2015-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2015-B </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Consultants </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Consultants </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Share warrants (BSA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>04/02/2014</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>01/09/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>11,690</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>11,690</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of shares to which the BSA give right</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,225</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>6,020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,225</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>6,020</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Share entitlement per option</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>1 warrant / 1.03 shares</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issue price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.01&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise price(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>35.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 01/20/2015 to 02/25/2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/01/2015 to 09/15/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 06/01/2015 to 05/31/2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 12/01/2015 to 11/30/2019</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Methods of exercise</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Exercisable per tranches of a minimum number of BSA equal to 2,000 or a multiple of 2,000, except outstanding balance</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Black Scholes</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>74.9%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.40%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected life</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>4&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;valued by expert opinion(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>14.64&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of June&nbsp;30, 2015</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 01/09/2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 01/09/2015 To 06/01/2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 01/09/2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 01/09/2015 To 06/30/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.12&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>44.84&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.12&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>44.20&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>25.33&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>26.89&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>25.33&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>26.31&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of December&nbsp;31, 2015</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 01/09/2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/01/2015 To 12/01/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.12&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>38.09&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>25.33&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>20.80&nbsp;&euro;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Independant
members of the Supervisory board.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price of the BSA 2015 is equal to the average, weighted by the volumes, of the closing prices of the share over five consecutive trading days from
December&nbsp;3, 2014 to December&nbsp;9, 2014, decreased by a discount of 4.98%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Valuation
of the financial instrument by independent expert opinion at the time of allocation. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=285,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=634163,FOLIO='F-49',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_50"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2017-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSA 2017-B </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Consultants </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Consultants </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Share warrants (BSA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of shares to which the BSA give right</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5,845</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Share entitlement per option</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>1 warrant / 1 share</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issue price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>2.00&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise price(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>19.97&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 12/11/2017 to 12/26/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/01/2018 to 07/15/2018</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/01/2018 to 06/30/2022</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/16/2018 to 07/15/2022</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Methods of exercise</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Exercisable per tranches of a minimum number of BSA equal to 2,000 or a multiple of 2,000, except outstanding balance</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Black Scholes</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>36.4%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>35.7%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.00%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected life</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.6&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;valued by expert opinion(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3.78&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3.81&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of December&nbsp;31, 2017</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 12/11/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>22.50&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3.78&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3.81&nbsp;&euro;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Independant
members of the Board of Directors.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price of the BSA 2017 is equal to the average, weighted by the volumes, of the closing prices of the share over five consecutive trading days from
October&nbsp;20, 2017 to October&nbsp;26, 2017, decreased by a discount of 5%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Valuation
of the financial instrument by independent expert opinion at the time of allocation. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
services performed by the consultants are mainly:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to evaluate product development plans and propose, if necessary, changes to strategic or technical approaches; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to advise the Company's management and the Scientific Board in identifying strategies and selecting drug candidates, based in particular on the
scientific results obtained by the Group (new therapeutic targets, new compounds); and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> to assist and advise the Group in its alliance strategies, such as external growth-supporting synergies (acquisition of new competencies and
the purchase of operating rights, drug candidates and innovative technologies, etc.). </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=286,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=994760,FOLIO='F-50',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_51"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>19.2.&nbsp;&nbsp;Redeemable warrants (</B></FONT><FONT SIZE=2><B><I>bons de souscription et/ou d'acquisition d'actions remboursables</I></B></FONT><FONT SIZE=2><B> or
BSAAR)</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
key terms and conditions related to each program are detailed in the following tables: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2014-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2014-B </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR 2014-C </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Redeemable<BR>
share subscription warrants (BSAAR)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Members of the<BR>
Executive Board </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Members of the<BR>
Executive Board </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Members of the<BR>
Executive Board </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Shareholders meeting</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>04/02/2014</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Executive board Meeting</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>09/15/2014</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR granted</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>18,711</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>17,248</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>18,711</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>17,248</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>18,711</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>17,248</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR subscribed</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>5,901</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>9,299</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>17,822</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>5,416</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>18,711</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>5,568</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR voided</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>5,901</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8,466</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>1,083</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>833</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR exercised</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>833</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>400</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR remaining</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>17,822</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>4,333</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>18,711</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>4,335</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of shares to which the BSAAR give right</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>18,357</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>4,463</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>19,272</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>4,465</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Share entitlement per option</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>1 warrant / 1.03 shares</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issue price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>5.61&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise price(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23.50&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 09/19/2014 to 10/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 05/07/2015 to 05/29/2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/06/2015 to 07/31/2015</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 09/15/2015 to 09/15/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 09/15/2015 to 05/04/2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 09/15/2015 to 07/01/2019</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Methods of exercise</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Exercisable by fraction of a number of BSAAR equal to 1/3 of the number held by each beneficiary</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Black Scholes</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>74.9%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.40%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected life</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>4&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;valued by expert opinion(2)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>5.61&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of December&nbsp;31, 2014</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 10/10/2014 To 10/14/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 10/10/2014 To 10/14/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/19/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/19/2014</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>34.63&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>34.63&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>46.85&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.95&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>46.85&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8.44&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8.44&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11.29&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>10.61&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11.29&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>10.61&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of June&nbsp;30, 2015</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 10/10/2014 To 10/14/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 10/10/2014 To 10/14/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/19/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/19/2014</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>34.63&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>34.63&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>46.85&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.95&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>46.85&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8.44&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8.44&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11.29&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>10.61&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11.29&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>10.61&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><B>Estimation of fair value as of December&nbsp;31, 2015</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Period used for the estimation of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 10/10/2014 To 10/14/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 10/10/2014 To 10/14/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/19/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/15/2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>As of 09/19/2014</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Price of the underlying share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>34.63&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>34.63&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>46.85&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.95&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>46.85&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>43.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;according to IFRS&nbsp;2</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8.44&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>8.44&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11.29&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>10.61&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>11.29&nbsp;&euro;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>10.61&nbsp;&euro;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price of the BSAAR 2014 is equal to the average, weighted by the volumes, of the closing prices of the share over five consecutive trading days from
August&nbsp;13, 2014 to August&nbsp;19, 2014, decreased by a discount of 13.60%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Valuation
of the financial instrument by independent expert opinion at the time of allocation. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=287,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=528989,FOLIO='F-51',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_52"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR<BR>
2016-A </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>BSAAR<BR>
2016-B </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Redeemable share subscription warrants (BSAAR)


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>02/24/2015</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>07/22/2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3,600</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3,600</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of BSAAR remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3,600</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Total number of shares to which the BSAAR give right</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>7,416</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>3,708</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Share entitlement per option</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>1 warrant / 1.03 shares</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issue price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>4.60&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise price(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>23.50&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Subscription period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 07/25/2016 to 07/27/2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 01/01/2018 to 07/27/2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>From 08/01/2019 to 07/27/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Methods of exercise</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Exercisable by fraction of a number of BSAAR equal to 1/3 of the number held by each beneficiary</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>Black Scholes</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>75.4%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>0.00%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Expected life</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>4 years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Estimated fair value&#151;valued by expert opinion(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>4.60&nbsp;&euro;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Exercise
price of the BSAAR 2016 is equal to the average, weighted by the volumes, of the closing prices of the share over five consecutive trading days from
July&nbsp;15, 2014 to July&nbsp;21, 2016, decreased by a discount of 6.67%.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Valuation
of the financial instrument by independent expert opinion at the time of allocation. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exercise of the BSAAR 2016-A is subject to the following performance condition: the Group will have, at the date it receives the exercise notice accompanied by the payment of the
exercise price, the financial means to carry out its research and development programs, and at a minimum its development program for elafibranor in NASH until at least the end of 2018. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exercise of the BSAAR 2016-B is subject to the following performance condition: the Group will have published, on the date it receives the exercise notice accompanied by the exercise
price, the main results of the RESOLVE-IT clinical trial for which it is the sponsor. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=288,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=620370,FOLIO='F-52',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_53"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>19.3.&nbsp;&nbsp;Free shares (</B></FONT><FONT SIZE=2><B><I>actions gratuites attribu&eacute;es</I></B></FONT><FONT SIZE=2><B> or AGA)</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
key terms and conditions related to each program are detailed in the following tables: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA D 2016-1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA S 2016-1 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Free shares (AGA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/21/2016</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/15/2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,242</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,879</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,419</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,242</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,879</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,399</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>778</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>900</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA definitively vested</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4,480</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3,505</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9,499</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>762</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>596</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/15/2016 to 12/15/2018 or 12/15/2019</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20.79&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Members
of the Executive Board.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA D 2016-2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA S 2016-2 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Free shares (AGA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/21/2016</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/15/2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,621</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,439</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,209</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,621</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,439</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,129</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>389</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>380</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,621</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,050</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,749</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/15/2016 to 12/15/2019</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20.79&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Members
of the Executive Board.  </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=289,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=891623,FOLIO='F-53',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_54"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA D 2017-1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA S 2017-1 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Free shares (AGA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,646</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,443</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,646</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,822</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,806</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>649</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,840</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,173</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/06/2017 to 12/31/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53.7%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Chief
executive officer  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA D 2017-2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA S 2017-2 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Free shares (AGA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Exe</FONT><FONT SIZE=2><B>c</B></FONT><FONT SIZE=2>utive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,321</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,718</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,321</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,407</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>903</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>324</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,418</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,083</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/06/2017 to 12/31/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53.7%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Chief
executive officer  </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=290,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1018218,FOLIO='F-54',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>AGA 2018 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Free shares (AGA)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16,149</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,923</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16,149</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16,651</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>366</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of AGA remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16,149</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16,285</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/06/2017 to 12/31/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20.02&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>:&nbsp;&nbsp;Chief
executive officer  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
final allocation of free shares is subject to continued employment with the Group and performance conditions. These performance conditions are described in Note&nbsp;19.5, </FONT> <FONT SIZE=2><I>"Performance conditions"</I></FONT><FONT SIZE=2>.
</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=291,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=55311,FOLIO='F-55',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_56"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>19.4.&nbsp;&nbsp;Stock options (</B></FONT><FONT SIZE=2><B><I>options de souscription d'actions</I></B></FONT><FONT SIZE=2><B> or SO)</B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
key terms and conditions related to each program are detailed in the following tables: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2016-1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO US 2016-1 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Stock-options (SO)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/21/2016</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/15/2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,001</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,916</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,001</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,916</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,000</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,667</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,093</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,305</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,908</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,944</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.79&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.12&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vesting period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/15/2016 to 12/15/2019</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/16/2019 to 12/16/2026</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fair Value</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10.30&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.52&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20.79&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Members
of the Executive Board.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2016-2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO US 2016-2 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Stock-options (SO)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/21/2016</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/15/2016</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,999</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,959</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,500</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,999</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,959</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,500</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>833</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,500</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,999</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,126</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.79&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.12&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vesting period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/15/2016 to 12/15/2019</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/16/2019 to 12/16/2026</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fair Value</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10.30&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.52&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20.79&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Members
of the Executive Board.  </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=292,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=995310,FOLIO='F-56',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_57"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2017-1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO US 2017-1 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Stock-options (SO)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52,831</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,666</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52,831</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,666</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,666</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>52,831</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17.91&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22.54&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vesting period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/06/2017 to 12/31/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 01/01/2021 to 12/31/2027</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fair Value</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.32&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53.7%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Chief
executive officer  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2017-2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO US 2017-2 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Stock-options (SO)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,667</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,419</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,334</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,667</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,419</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,334</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,334</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,667</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,419</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17.91&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22.54&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vesting period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/06/2017 to 12/31/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 01/01/2021 to 12/31/2027</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fair Value</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.32&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.95&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53.7%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Chief
executive officer </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-57</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=293,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=42890,FOLIO='F-57',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fw10701_1_58"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>SO US 2018 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Share-based compensation Stock-options (SO)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Officers(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Employees </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Shareholders meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>06/16/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the decision and delegation of the Board of Directors to the CEO</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11/21/2017</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Date of the Executive board meeting</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/06/2017</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,500</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO subscribed</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,500</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO voided</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO definitively vested</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO remaining</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,500</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total number of SO exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise price</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16.00&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.65&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vesting period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 12/06/2017 to 12/31/2020</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercise period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>From 01/01/2021 to 12/31/2027</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Valuation method used</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Monte Carlo</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Fair value</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.32&nbsp;&euro;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.90&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Price of the share at the time of allocation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22.12&nbsp;&euro;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividends</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>44.1%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk-free interest rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Turnover rate</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=7 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15.00%<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>:&nbsp;&nbsp;Chief
executive officer  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Volatility
assumptions in the above tables are determined by reference to the Company's historical share price over a 3-year period prior to the grant date, adjusted for extreme and
unusual variations, if any. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
final allocation of free shares is subject to continued employment with the Group and performance conditions. These performance conditions are described in Note&nbsp;19.5, </FONT> <FONT SIZE=2><I>"Performance conditions"</I></FONT><FONT SIZE=2>.
</FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>19.5.&nbsp;&nbsp;Performance conditions</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
SO and SO US stock option plans as well as certain free share plans (AGA "D") implemented in 2016, 2017 and 2018 are subject to internal performance conditions related to the
progress of the Group's research and development programs, and to external performance conditions related to the evolution of the Company's stock price. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
other free share plans (AGA "S") are subject only to internal performance conditions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-58</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=294,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=557119,FOLIO='F-58',FILE='DISK124:[18ZFA1.18ZFA10701]FW10701A.;49',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_fy10701_1_59"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts)  </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued)  </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


19.5.1. Performance conditions of the 2016-1 and 2016-2 plans</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 </UL>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Assessment date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>SO 2016-1<BR>
SO US 2016-1<BR>
AGA D 2016-1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/15/2018<BR>
and/or<BR>
12/15/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 66<SUP>2</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated, regardless of the variation of the stock market price, in the following events: </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font
 size=2> (i) if, on the date of the Allocation Decision, one of the two ongoing or authorized clinical trials (Resolve-It, Phase&nbsp;2 in PBC) has revealed its first results and/or principal results and these results have been published;
 and</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if, on the date of the Allocation Decision, the authorization to launch at least one of the new clinical trials among the projected clinical trials has been obtained, either:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>a clinical trial with
elafibranor within a NASH subpopulation; or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>a clinical trial with
respect to fibrosis within the TGFTX4/repositioning program.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Nature of external conditions<BR> </B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>33<SUP>1</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated in proportion to the evolution of the stock market price of the Company, as follows:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if the Final Price is strictly lower than the Initial Price, the number exercisable or definitively allocated is equal to 0;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the Final Price is between (i)&nbsp;a value equal to or higher than the Initial Price and (ii)&nbsp;a value lower than the Ceiling Price, the number exercisable or definitively allocated is equal to:<BR>
[(Final Price&nbsp;/&nbsp;Initial Price)-1]&nbsp;&times;&nbsp;<SUP>1</SUP>/<SMALL>3</SMALL> of number of instruments;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if the Final Price is equal to or higher than the Ceiling Price, the number exercisable or definitively allocated is equal to the entire one-third of the instruments granted.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AGA S 2016-1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/15/2018<BR>
and/or<BR>
12/15/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The free shares will be definitively allocated upon meeting the same internal performance conditions as the SO 2016-1, SO US 2016-1 and AGA D 2016-1 plans.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-59</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=295,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=1031209,FOLIO='F-59',FILE='DISK124:[18ZFA1.18ZFA10701]FY10701A.;38',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fy10701_1_60"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>SO 2016-2<BR>
SO US 2016-2<BR>
AGA D 2016-2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/15/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>66<SUP>2</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated, regardless of the evolution of the stock market price if at least one of the three following conditions is
met:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if an application for marketing authorization for a product (elafibranor in NASH) is examined by the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA); or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the launch of at least two new clinical trials among the following are authorized by the EMA or the FDA, either:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Phase&nbsp;III clinical
trials of or which aim to record a new product (TGFTX4) or a new indication for elafibranor (PBC); or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Clinical trials with a
product in Phase&nbsp;II (Elafibranor) within a NASH subpopulation; or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if at least on licensing agreement, on one or another of Genfit's products in one or several territories, is entered into by the Company</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Nature of external conditions<BR> </B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>33<SUP>1</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated in proportion to the evolution of the stock market price, as follows:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if the Final Price is strictly lower than the Initial Price, the number exercisable or definitively allocated is equal to 0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the Final Price is between (i)&nbsp;a value equal to or higher than the Initial Price and (ii)&nbsp;a value lower than the Ceiling Price, the number exercisable or definitively allocated is equal to:<BR>
[(Final Price&nbsp;/&nbsp;Initial Price)-1]/2&nbsp;&times;&nbsp;<SUP>1</SUP>/<SMALL>3</SMALL> of number of instruments ;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if the Final Price is equal to or higher than the Ceiling Price, the number exercisable or definitively allocated is equal to the entire one-third of the instruments granted.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AGA S 2016-2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/15/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The free shares will be definitively allocated upon meeting the same internal performance conditions as the SO 2016-2, SO US 2016-2 and AGA D 2016-2 plans.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-60</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=296,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=614442,FOLIO='F-60',FILE='DISK124:[18ZFA1.18ZFA10701]FY10701A.;38',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fy10701_1_61"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


19.5.2. Performance conditions of the 2017-1 and 2017-2 plans</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 </UL>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>SO 2017-1<BR>
SO US 2017-1<BR>
AGA D 2017-1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/31/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


 66<SUP>2</SUP>/<SMALL>3</SMALL>% of the instruments will be definitively allocated, regardless of the variation of the stock market price, in the following events: </font> <p align=left style="font-family:times;margin-top:12pt;margin-left:0pt;"> <font size=2> (i) if,
 on the date of the Allocation Decision, one of the two ongoing or authorized clinical trials (Resolve-It, Phase&nbsp;2 in PBC) has revealed its first results and/or principal results and these results have been published; and</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if, on the date of the Allocation Decision, the authorization to launch at least one of the clinical trials among the projected clinical trials has been obtained, either:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>a clinical trial with
elafibranor within a NASH subpopulation; or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>a clinical trial with
respect to fibrosis with NTZ.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Nature of external conditions<BR> </B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>33<SUP>1</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated in proportion to the evolution of the stock market price of the Company, as follows:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if the Final Price is strictly lower than the Initial Price, the number exercisable or definitively allocated is equal to 0;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the Final Price is between (i)&nbsp;a value equal to or higher than the Initial Price and (ii)&nbsp;a value lower than the Ceiling Price, the number exercisable or definitively allocated is equal to:<BR>
[(Final Price&nbsp;/&nbsp;Initial Price)-1]&nbsp;&times;&nbsp;<SUP>1</SUP>/<SMALL>3</SMALL> of number of instruments;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if the Final Price is equal to or higher than the Ceiling Price, the number exercisable or definitively allocated is equal to the entire one-third of the instruments exercisable or definitively
allocated.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AGA S 2017-1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/31/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The free shares will be definitively allocated upon meeting the same internal performance conditions as the SO 2017-1, SO US 2017-1 and AGA D 2017-1 plans.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-61</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=297,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=245740,FOLIO='F-61',FILE='DISK124:[18ZFA1.18ZFA10701]FY10701A.;38',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fy10701_1_62"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>SO 2017-2<BR>
SO US 2017-2<BR>
AGA D 2017-2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/31/2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>66<SUP>2</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated, regardless of the evolution of the stock market price if at least one of the three following conditions is
met:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if an application for marketing authorization for a product (elafibranor for NASH) is examined by the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA); or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the launch of at least one clinical trial among the following is authorized by the EMA or the FDA, either:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Phase&nbsp;III clinical
trials of or which aim to record a new product (NTZ program) or a new indication for Elafibranor (PBC);</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Clinical trials with a
product in Phase&nbsp;II (Elafibranor) within a NASH subpopulation; or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if at least on licensing agreement, on one or another of Genfit's products in one or several territories, is entered into by the Company.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Nature of external conditions<BR> </B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>33<SUP>1</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively allocated in proportion to the evolution of the stock market price, as follows:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if the Final Price is strictly lower than the Initial Price, the number exercisable or definitively allocated is equal to 0</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the Final Price is between (i)&nbsp;a value equal to or higher than the Initial Price and (ii)&nbsp;a value lower than the Ceiling Price, the number exercisable or definitively allocated is equal to:<BR>
[(Final Price&nbsp;/&nbsp;Initial Price)-1]/2&nbsp;&times;&nbsp;<SUP>1</SUP>/<SMALL>3</SMALL> of number of instruments;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if the Final Price is equal to or higher than the Ceiling Price, the number exercisable or definitively allocated is equal to the entire one-third of the instruments granted.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AGA S 2017-2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/31/2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The free shares will be definitively allocated upon the same internal performance conditions as the SO 2017-2, SO US 2017-2 and AGA&nbsp;D&nbsp;2017-2 plans.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-62</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=298,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=987710,FOLIO='F-62',FILE='DISK124:[18ZFA1.18ZFA10701]FY10701A.;38',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_fy10701_1_63"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


19. SHARE-BASED COMPENSATION (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>SO 2018<BR>
SO US 2018<BR>
AGA D 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/31/2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>66<SUP>2</SUP>/<SMALL>3</SMALL>% of the instruments will be exercisable or definitively vested, and 100% of the free shares for the AGA S 2018 will be vested, regardless of the variation of the stock market price, if one
of the three following conditions is met:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if an application for marketing authorization for elafibranor for the treatment of NASH is submitted to the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA); or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if authorization to launch at least one new clinical trial among the following trials is obtained:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:0pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Phase&nbsp;III or
Phase&nbsp;II/III clinical trial evaluating a new product (NTZ); </FONT><FONT SIZE=2> </font> <p align=left style="font-family:times;margin-top:11pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left
style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Phase&nbsp;III or Phase&nbsp;II/III clinical trial evaluating elafibranor in PBC </FONT><FONT SIZE=2> </font> <p align=left
style="font-family:times;margin-top:11pt;margin-bottom:-12pt;margin-left:0pt;"><font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Phase&nbsp;III clinical trial evaluating elafibranor in a NASH
subpopulation; or</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if at least on licensing agreement, on one or another of Genfit's products in one or several territories, is entered into by the Company</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B> Nature of external conditions<BR> </B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>33<SUP>1</SUP>/<SMALL>3</SMALL>% of the Stock Options will be exercisable in proportion to the variation of the Company's stock market price as per the following breakdown:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(i) if the Final Price is strictly lower than the Initial Price, the number of the Stock Options exercisable is equal to 0;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(ii) if the Final Price is between (i)&nbsp;a value equal to or higher than the Initial Price and (ii)&nbsp;a value lower than the Ceiling Price, the number of Stock Options exercisable is equal to:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>[(Final Price / Initial Price)-1]/2&nbsp;&times;&nbsp;<SUP>1</SUP>/<SMALL>3</SMALL> of number of Stock Options;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(iii) if the Final Price is equal to or higher than the Ceiling Price, the number of Stock Options exercisable is equal to the entire one-third of the Stock Options allocated.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plans

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Evaluation date<BR>
for performance<BR>
conditions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nature of internal conditions </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AGA S 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>12/31/2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>The free shares will be definitively allocated upon the same internal performance conditions as the SO 2018, SO US 2018 and AGA&nbsp;D&nbsp;2018 plans.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-63</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=299,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=305316,FOLIO='F-63',FILE='DISK124:[18ZFA1.18ZFA10701]FY10701A.;38',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ga10701_1_64"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts)  </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


20. FINANCIAL INCOME AND EXPENSES  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="37pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Financial income and expenses<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Financial income</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>389</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>202</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign exchange gain</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>59</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>101</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>195</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>425 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Financial income</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 642</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>728</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Financial expenses</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest expenses for loans and borrowings</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,309</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(10,955</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interest expenses for financial leases</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Foreign exchange losses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(764</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(127</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other financial expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL&#151;Financial expenses</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> (3,096</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(11,118</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>FINANCIAL GAIN (LOSS)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> (2,453</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>(10,391</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>)</B></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
increase in financial expenses is mainly due to the interest payments on the OCEANEs which were issued in October 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
change in financial expenses is related to the interest on the OCEANEs, mainly due to interest payments at a rate of 3.5% and the discounting of the bond debt at an effective
interest rate of 7.29%. The discounting of bond debt consists of bringing the amount of the debt component of the bond issue to the amount that will be repaid (or converted) at maturity, by the
recognition of a theoretical annual interest expense resulting from the accretion over the period of an amount equivalent to the equity component at an effective interest rate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017 the foreign exchange result is mainly explained by a loss related to a currency forward in USD. (There was an unfavourable USD versus EUR variation). </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


21. INCOME TAX  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>21.1.&nbsp;&nbsp;Losses available for offsetting against future taxable income</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2017 and 2018, the tax loss carryforwards for the Company amounted to &euro;226,708 and &euro;(305,530), respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
carryforwards can be offset against future taxable profit within a limit of &euro;1,000 per year plus 50% of the profit exceeding this limit. Remaining unused losses will
continue to be carried forward indefinitely. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>21.2.&nbsp;&nbsp;Deferred tax assets and liabilities</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group's main sources of deferred tax assets and liabilities as of December&nbsp;31, 2017 and 2018 related to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Tax loss carryforwards: &euro;226,708 and &euro;305,530, respectively; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-64</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=300,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=759146,FOLIO='F-64',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_65"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


21. INCOME TAX (Continued) </B></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Temporary differences: </FONT> <FONT SIZE=2>
<BR><BR></FONT>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> related to the OCEANE: a net deferred tax liability for &euro;2,165 and &euro;1,773 as of
December&nbsp;31, 2017 and 2018, respectively. See Note&nbsp;2.3, "Correction of errors"; and  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> related to post-employment benefits: &euro;936 and &euro;1,085, respectively, or an impact on deferred tax
assets of &euro;262 and &euro;304, respectively. </FONT></DD></DL>
</DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than as it relates to deferred tax assets recognized based on the available deferred tax liabilities, no other deferred tax asset has been recognized as it is not probable that
taxable profit will be available to offset deductible temporary differences and tax loss carryforwards. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


22. EARNINGS (LOSS) PER SHARE  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The components of the earnings (loss) per share computation are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Earnings per share

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss for the period (in thousands of euros)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(55,728</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(79,521</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Weighted average number of ordinary shares for the period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,166,437</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>31,167,203</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss per share (in &euro;)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.79</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2.55</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Potentially
dilutive instruments were excluded from the calculation of the diluted weighted average number of shares as their effect was anti-dilutive. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


23. LITIGATION AND CONTINGENT LIABILITIES  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Dispute over research tax credit calculation</U> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Context  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During 2014, the Company was under a tax audit at the end of which the tax authorities questioned part of the Research Tax Credit (CIR) received
by the Company for 2010. The tax audit continued for the 2011 and 2012 CIR returns. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Subject matter of the dispute  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The dispute with the French tax authorities pertained mainly to collaborative research alliances with companies in the pharmaceutical industry.
The tax authorities contended that, in these alliances, the Company was acting as a sub-contractor, which should reduce the basis on which the CIR was computed by deducting amounts billed by the
Company to the other party. The Company maintained that the contracts governing the collaborative research alliances included reciprocal provisions concerning intellectual property, the shared
governance of the research programs, risk sharing, conditions governing the termination of the agreements and the terms of compensation, which demonstrated that they were not sub-contracting
agreements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-65</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=301,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=235321,FOLIO='F-65',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_66"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


23. LITIGATION AND CONTINGENT LIABILITIES (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Status of the tax audit  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company received proposed tax adjustments in December 2014 (for the 2010 CIR) and in December 2015 (for the 2011 and 2012 CIR), to which the
Company presented its observations in written letters in February 2015 and February 2016. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
the administrative appeal and the departmental meeting (</FONT><FONT SIZE=2><I>interlocution d&eacute;partementale</I></FONT><FONT SIZE=2>) held in June 2016 and
October 2016 respectively, the tax authorities partially accepted the Company's arguments. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result, the final tax adjustments on the CIRs totaled &euro;566 for 2010, &euro;623 for 2011 and &euro;285 for 2012, and an additional
&euro;5 for late filing. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
January&nbsp;27, 2017, the Company received the formal tax assessment notice for &euro;1,478 from the tax authorities, which were paid as
follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a cash payment for an amount of &euro;338; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a request for write-off with the amount withheld on its CIR receivable for 2014 (&euro;1,141), which was accepted up to
&euro;693 in August 2017; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> a request for a partial write-off with the amount due on its CIR receivable for 2016, which was accepted for &euro;447 in August
2017. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company filed two claims, on February&nbsp;15, 2017 and October&nbsp;6, 2017, contesting the aforementioned adjustments (the initial &euro;1,478 and the potential tax
adjustment on the CIR for 2014 of&nbsp;&euro;447). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
April&nbsp;5, 2018, the Administrative Court of Montreuil substantially accepted the Company's claim regarding the tax qualification of its collaborative research. On
July&nbsp;25, 2018, the Ministry of Action and Public Accounts appealed the April&nbsp;5, 2018 judgment. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
June&nbsp;28, 2018, the Administrative Court of Montreuil accepted the Company's claim on the CIR for 2014. On September&nbsp;11, 2018, following the judgment, the Company was
reimbursed by &euro;432. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company was informed on October&nbsp;28, 2018 that the Ministry of Action and Public Accounts appealed the aforementioned June&nbsp;28, 2018 judgment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Potential liability  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company, in accordance with IFRS standards, measured its potential tax liability should the tax authorities' interpretation prevail with
respect to the CIR for the years under tax audit and subsequent years. The recording and disclosure of this potential tax liability in these consolidated financial statements does not, under any
circumstances, constitute an acknowledgement of the tax authorities' arguments in this matter. Based on analyses conducted by independent third party tax experts, the Company believes that the
potential tax liability is approximately &euro;1,809 out of the aggregate &euro;20,695 in CIRs reported in the 2010 to 2015 financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Independent
of the payments made pursuant to the tax authorities' requests in the assessment notice, the amount of the potential tax liability of &euro;1,809 mentioned above
remains unchanged considering the appeal formed by the Ministry. There is no provision for this amount considering that the risk was assessed as possible rather than probable. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-66</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=302,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=147313,FOLIO='F-66',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_67"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


23. LITIGATION AND CONTINGENT LIABILITIES (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Provision  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company has accrued &euro;106 for contracts, other than joint research alliances, which could be considered as
sub-contracting for third parties that are themselves eligible for the research tax credit, and for other adjustments related to the type of tangible assets considered eligible for the CIR. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Dispute regarding social security contributions and other payments</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
an URSSAF (French social security administration) audit which began in September 2016 with respect to the 2013, 2014 and 2015 fiscal years, the Company
received in November 2016 a social security contribution reassessment for &euro;5 which the Company contested in the amount of &euro;4 before the </FONT><FONT SIZE=2><I>Tribunal
des Affaires Sociales</I></FONT><FONT SIZE=2> (Social Affairs Court). The Court is expected to rule on this case in March 2019. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


24. RELATED PARTIES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biotech Avenir SAS and The NASH Education Program<SUP>TM</SUP>, an endowment fund set up by the Company, are related parties within the meaning of IAS&nbsp;24.9. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registered office of Biotech Avenir SAS and that of The NASH Education Program<SUP>TM</SUP> are located at the same address as the Company. These domiciliations are provided
without charge. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biotech
Avenir SAS is a holding company incorporated in 2001 by the Company's founders. Most of its share capital is currently held by the four co-founders of the Company and
approximately thirteen Company employees. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jean-Fran&ccedil;ois
Mouney, the Chairman and CEO of the Company, is also the Chairman of Biotech Avenir SAS. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
December&nbsp;31, 2018, Biotech Avenir SAS held 6.06% of the share capital of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company did not carry out any transactions with Biotech Avenir in 2017 nor in 2018. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the cash contributed by the Company to the liquidity agreement put in place with CM-CIC Securities, Biotech Avenir SAS contributed shares of the Company to the liquidity
agreement. Biotech Avenir SAS withdrew from this liquidity agreement as of December&nbsp;1, 2017 in order to comply with the latest recommendations of the </FONT> <FONT SIZE=2><I>Autorit&eacute; des March&eacute;s Financiers</I></FONT><FONT SIZE=2>.
</FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
NASH Education Program<SUP>TM</SUP> endowment fund was created in November 2016 at the initiative of the Group to develop and finance disease awareness activities targeting
medical professionals and the general public. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
transactions carried out in 2017 and 2018 between the Group and The NASH Education Program<SUP>TM</SUP> and the Group's obligations with respect to The NASH Education
Program<SUP>TM</SUP> are described in Note&nbsp;26, "Commitments". </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


25. COMPENSATION OF CORPORATE OFFICERS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By resolution of the General Shareholders Meeting on June&nbsp;16, 2017, the shareholders adopted the change in mode of administration and management of the Company and elected to
change from a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-67</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=303,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=901820,FOLIO='F-67',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_68"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


25. COMPENSATION OF CORPORATE OFFICERS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>historical
two-tiered board structure (Executive Board and Supervisory Board) to a single board (Board of Directors). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result, the table below provides details of the compensation paid to the Chairman and CEO, as well as that paid to the members of the Executive Board during the first half of 2017
(prior to the change in mode of governance) and for the financial years in which the relevant amounts were recognized in the statements of operations. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Compensation paid to Officers<BR>
(in thousands of euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Short-term employee benefits (gross plus employer's social contributions paid)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,476</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,569</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Post-employment pension and medical benefits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>199</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Share-based payment transactions</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>104</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Director fees for service to Genfit Corp.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 1,763</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>1,703</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
changes in provision for pension liabilities relate to rates described in Note&nbsp;15, "Employee benefits" and the fact that the Chairman and CEO exercised his pension rights in
September 2017 retaining his position as Chairman and CEO. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Chairman and CEO is entitled to a severance payment falling within the scope of article&nbsp;L.225-42-1 of the French commercial code, equal to six months' salary, calculated on
the basis of the last 12&nbsp;months' salary (excluding payments under the Group's incentive plan) and increased by additional compensation of one months' salary per year of service with the Company
(calculated on the same basis). This severance payment is capped at 2&nbsp;years gross compensation (excluding exceptional payments under the incentive plans) paid with respect to the last fiscal
year and subject to performance conditions. This commitment (gross amount and employer charges) at December&nbsp;31, 2018 amounted to &euro;1,438. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-68</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=304,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=110208,FOLIO='F-68',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_69"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


25. COMPENSATION OF CORPORATE OFFICERS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
directors' fees and other compensation due and paid to the non executive directors are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amounts due* </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amounts paid* </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amounts due* </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amounts paid* </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>During the year ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ROWSPAN=2 ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Attendance fees and other forms of remuneration<BR>
payable to each of the non executive officer<BR>
(in euros)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017(4) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Jean-Fran&ccedil;ois MOUNEY(1)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration (outside compensation as CEO)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Xavier GUILLE DES BUTTES</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30,218</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24,688</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>53,330</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>41,311</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 30,218</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>24,688</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>53,330</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>41,311</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Charles WOLER(2)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,925</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,925</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 5,925</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>5,925</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Fr&eacute;d&eacute;ric DESDOUITS</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,627</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,258</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,174</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,113</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 13,627</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>11,258</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>21,174</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>17,113</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>BIOTECH AVENIR</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Represented by Florence S&eacute;journ&eacute;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> &#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>&#151;</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Philippe MOONS</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>18,763</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>29,704</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,345</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 18,763</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>14,023</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>29,704</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>22,345</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Anne-H&eacute;l&egrave;ne MONSELLATO(3)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>14,813</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,468</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>37,075</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24,307</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 14,813</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>10,468</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>37,075</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>24,307</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Catherine LARUE(3)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attendance fees</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,258</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,098</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,256</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,985</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other remuneration</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 11,258</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>8,098</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>21,256</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>17,985</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>TOTAL</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B> 94,602</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>74,458</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>162,539</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><B>123,061</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-69</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=305,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=810708,FOLIO='F-69',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_70"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


25. COMPENSATION OF CORPORATE OFFICERS (Continued) </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017(4) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>IFRS&nbsp;2 valuation of options granted during the financial year</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>94,875</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;<BR></FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>After
applying a required 21% withholding
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Jean-Fran&ccedil;ois
MOUNEY joined the Board of Directors on June&nbsp;16, 2017 as Chairman.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Since
the Shareholders' Meeting on June&nbsp;16, 2017, Charles WOLER is no longer a board member.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Anne-H&eacute;l&egrave;ne
MONSELLATO and Catherine LARUE were appointed to the Board of Directors by the shareholders at the June&nbsp;16, 2017
Shareholders' Meeting.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
remuneration received by Xavier GUILLE DES BUTTES, Fr&eacute;d&eacute;ric DESDOUITS, Biotech Avenir and Philippe MOONS until June&nbsp;16, 2017
was in their capacities as members of the Supervisory Board.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


26. COMMITMENTS  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Subcontracting agreements</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Group enters into contracts in the normal course of business with clinical research organizations (CROs) for clinical trials, as well as with third party vendors
for clinical and commercial supply manufacturing, commercial and precommercial activities, research and development activities and other services and products for operating purposes. The Group's
agreements generally provide for termination with specified periods of advance notice. Such agreements are generally cancelable contracts and not included in the description of the Group's contractual
obligations and commitments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Deposits and guarantees</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has guaranteed its rental payment obligation under the lease agreement for the headquarters in Loos, France in the amount of &euro;455 at
December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Lease commitments</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2016, CM-CIC Bail and the Company entered into a master agreement for leases with an option to purchase scientific equipment for a maximum amount of
&euro;2,000. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
contract was amended several times, with Amendment No.&nbsp;3 increasing the amount of this agreement to &euro;2,150, valid until June&nbsp;30, 2019. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in 2016, NatioCreditMur (BNP Paribas) and the Company entered into a master lease agreement of &euro;1,050, which was extended by amendments in 2017 and 2018
until June&nbsp;30, 2019. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Through
December&nbsp;31, 2018, the Company had drawn on &euro;2,637 under these leasing agreements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Obligations in respect of the co-ownership of intellectual property rights</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
date, the Company has not been required to license any third-party intellectual property to develop drug candidates and biomarker candidates that comprise its
portfolio of proprietary programs and products. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-70</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=306,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=551673,FOLIO='F-70',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<A NAME="page_ga10701_1_71"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> (amounts in thousands of euros, except for numbers of shares and per share amounts) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


26. COMMITMENTS (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company ensures, with regard to these programs, that the collaboration or subcontracting agreements that it is required to enter into, systematically stipulate that the results of
the research are the Company's property. This is particularly the case for research consortia, in which the Group is associated with university laboratories and other biotechnology companies. It
therefore holds all the intellectual property rights over its portfolio of proprietary programs and products. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
the other hand, the agreements signed in the framework of the Company's historical co-research alliances with partners in the pharmaceutical industry provided that the intellectual
property rights of the drug candidates developed under these alliances belonged to the partners. These agreements also provided that the Company had intellectual property rights over the innovative
technologies discovered on this occasion, even if it had to grant a royalty free and non-exclusive license to the industrial partner for the purpose of developing drug candidates discovered under the
co-research programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
date, Sanofi remains the only industrial partner likely to still have exploitation rights on a drug candidate developed as part of its historical co-research alliance with the Company
and therefore able to use on a royalty-free basis, but not exclusively, technologies developed by the Company under this program. The other historic partners have informed the Company of their
decision not to exploit or stop exploiting the results of joint research. Nevertheless, to date, Sanofi has not communicated to the Company its desire to continue the development of this program
despite the last research phase shared with the Company's teams having ended in May 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<U>Other liabilities</U> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to an agreement with effect from July&nbsp;1, 2016, the Company decided to finance the creation by Pinnacle Clinical Research of a registry of NAFLD/NASH
patients, which diseases are targeted by certain of the Company's drug and biomarker candidates. This donation, for a maximum amount of USD $1,582 is being paid over the course of the creation of the
registry on the basis of reporting periods. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's goal in supporting the creation of this registry was to contribute to the improvement of scientific and medical knowledge around NAFLD and NASH. As a result, the Company
decided on December&nbsp;22, 2016, with effect from December&nbsp;31, 2016, to assign the benefit and obligations of this agreement to its endowment fund, The NASH Education
Program<SUP>TM</SUP>. The NASH Education Program<SUP>TM</SUP> was created on November&nbsp;3, 2016 with Genfit as its sole founding member to educate the medical community and patients on the
lessons that can be learned from these patients, in accordance with its objectives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017 and 2018, the Company granted to The NASH Education Program<SUP>TM</SUP> endowment fund a donation of &euro;1,808 and &euro;959, respectively, so that
The NASH Education Program<SUP>TM</SUP> could honor its obligations under the transfer of registry donation and carry out the other planned disease awareness activities to patients and doctors and
the organization of the first International NASH Day, which took place in June 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the year 2019, our board of directors approved a grant of an amount of &euro;200 to the Nash Education Program. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


27. EVENTS AFTER THE REPORTING PERIOD  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On January&nbsp;2, 2019, GENFIT signed a licensing agreement with LabCorp, a company specialized in drug development. The agreement will expand access to Genfit's NASH liver diagnostic
test for the clinical research market. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-71</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=307,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=358665,FOLIO='F-71',FILE='DISK124:[18ZFA1.18ZFA10701]GA10701A.;40',USER='JTAYLORA',CD='15-FEB-2019;07:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><div
style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><B>GENFIT&nbsp;S.A.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary Shares<BR>
(including Ordinary Shares in the form of American Depositary Shares)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>
<IMG SRC="g388375.jpg" ALT="LOGO" WIDTH="297" HEIGHT="73">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B>PROSPECTUS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=5><B>SVB Leerink</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=5><B><BR>&nbsp;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=5><B>Barclays</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=5><B>Bryan, Garnier&nbsp;&amp;&nbsp;Co.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=5><B><BR>&nbsp;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=5><B>Natixis</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=4><B>Roth Capital Partners</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=4><B><BR>&nbsp;</B></FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=4><B>H.C. Wainwright &amp; Co.</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><B>Through and including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019 (the 25th&nbsp;day after the date of this prospectus), all dealers that effect transactions in
these securities, whether or not
participating in the global offering, may be required to deliver a prospectus. This is in addition to the dealers' obligations to deliver a prospectus when acting as underwriters and with respect to
their unsold allotments or subscriptions.</B></FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p>
 <P style="font-family:times;"><FONT SIZE=2><div
style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=308,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=268739,FOLIO='blank',FILE='DISK124:[18ZFA1.18ZFA10701]HO10701A.;16',USER='JTAYLORA',CD='15-FEB-2019;13:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A NAME="page_ja10701_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ja10701_part_ii_information_not_required_in_prospectus"> </A>
<A NAME="toc_ja10701_1"> </A></FONT> <FONT SIZE=2><B>  PART II<BR>  <BR>    INFORMATION NOT REQUIRED IN PROSPECTUS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="ja10701_item_6._indemnification_of_directors_and_officers."> </A>
<A NAME="toc_ja10701_2"> </A></FONT> <FONT SIZE=2><B>  ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under French law, provisions of bylaws that limit the liability of directors are prohibited. However, French law allows </FONT> <FONT SIZE=2><I>soci&eacute;t&eacute;s
anonymes</I></FONT><FONT SIZE=2> to contract for and maintain liability insurance against civil liabilities incurred by any of their
directors and officers involved in a third-party action, provided that they acted in good faith and within their capacities as directors or officers of the
company. Criminal liability cannot be indemnified under French law, whether directly by the company or through liability insurance. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have liability insurance for our directors and officers, and intend to obtain coverage for insurance against liability under the Securities Act. We also intend to enter into
agreements with our directors and senior management to provide contractual indemnification. With certain exceptions and subject to limitations on indemnification under French law, these agreements
will provide for indemnification for damages and expenses including, among other things, attorneys' fees, judgments and settlement amounts incurred by any of these individuals in any action or
proceeding arising out of his or her actions in that capacity. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
agreements may discourage shareholders from bringing a lawsuit against our directors and senior management for breach of their fiduciary duty. These provisions also may have the
effect of reducing the likelihood of derivative litigation against directors and senior management, even though such an action, if successful, might otherwise benefit us and our shareholders.
Furthermore, a shareholder's investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these insurance agreements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="ja10701_item_7._recent_sales_of_unregistered_securities."> </A>
<A NAME="toc_ja10701_3"> </A></FONT> <FONT SIZE=2><B>  ITEM 7.&nbsp;&nbsp;&nbsp;&nbsp;Recent Sales of Unregistered Securities.    <BR>    </B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following sets forth information regarding all unregistered securities sold since January&nbsp;1,
2016:</FONT>

</P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On February&nbsp;29, 2016, we issued an aggregate of 2,395,890 shares to 3 purchasers in connection with a private placement, at a purchase
price of &euro;20.70 per share. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On October&nbsp;12, 2016, we issued an aggregate of 1,695,000 shares to 18 purchasers in connection with a private placement, at a purchase
price of &euro;20.00 per share. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On November&nbsp;2, 2016, we issued an aggregate of 3,116,643 shares in connection with a rights issuance, at a purchase price of
&euro;14.30 per share. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> On October&nbsp;16, 2017, we issued OCEANE convertible bonds, convertible into an aggregate of 6,081,081 shares, for aggregate gross proceeds
of &euro;180.0&nbsp;million. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2015 to the date of this prospectus, we issued BSAAR share warrants to purchase an aggregate of 11,124 shares, at a
weighted-average exercise price of &euro;23.50 per share. None of these BSAAR share warrants have been exercised or cancelled or have expired. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2015 to the date of this prospectus, we issued BSA share warrants to purchase an aggregate of 63,182 shares, at a
weighted-average exercise price of &euro;26.56 per share. None of these BSA share warrants have been exercised or cancelled or have expired. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2015 to the date of this prospectus, we issued stock options to purchase an aggregate of 322,125 shares, at a
weighted-average exercise price of &euro;17.60 per share. Of these stock options, none have been exercised, 26,000 have been cancelled and none have expired. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=309,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=818249,FOLIO='II-1',FILE='DISK124:[18ZFA1.18ZFA10701]JA10701A.;25',USER='JTAYLORA',CD='15-FEB-2019;07:40' -->
<A NAME="page_ja10701_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> From January&nbsp;1, 2015 to the date of this prospectus, we issued free shares to purchase an aggregate of 107,705 shares upon the
performance of specified conditions. As of the date of this prospectus, 1,104 of these free shares have been cancelled and 17,484 of these free shares have vested. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
offers, sales and issuances of the securities described in the preceding paragraphs were exempt from registration either (a)&nbsp;under Section&nbsp;4(a)(2) of the Securities Act
and the rules and regulations promulgated thereunder (including Regulation&nbsp;D and Rule&nbsp;506), in that the transactions were between an issuer and sophisticated investors or members of its
senior executive management and did not involve any public offering within the meaning of Section&nbsp;4(a)(2), (b)&nbsp;under Regulation&nbsp;S promulgated under the Securities Act in that
offers, sales and issuances were not made to persons in the United States and no directed selling efforts were made in the United States, (c)&nbsp;under Rule&nbsp;144A under the Securities Act in
that the shares were offered and sold by the initial purchasers to qualified institutional buyers or (d)&nbsp;under Rule&nbsp;701 promulgated under the Securities Act in that the transactions were
under compensatory benefit plans and contracts relating to compensation.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="ja10701_item_8._exhibits_and_financial_statement_schedules."> </A>
<A NAME="toc_ja10701_4"> </A></FONT> <FONT SIZE=2><B>  ITEM 8.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits and Financial Statement Schedules.    <BR>    </B></FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Exhibits </FONT></DD></DL>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>EXHIBIT NO. </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>DESCRIPTION OF EXHIBIT </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2> 1.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Form of Underwriting Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Articles of Association of GENFIT S.A. (English translation)</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Form of Deposit Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Form of American Depositary Receipt (included in Exhibit&nbsp;4.1)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Form of Opinion of Linklaters&nbsp;LLP</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Summary of BSA Plans</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Summary of BSAAR Plans</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Summary of Share Options Plans</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Summary of Free Shares (AGA) Plan</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Summary of Lease Agreement (English translation)</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Subsidiaries of GENFIT S.A.</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Consent of Ernst&nbsp;&amp; Young&nbsp;et Autres</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&#134;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Form of Consent of Linklaters&nbsp;LLP (included in Exhibit&nbsp;5.1)</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><A HREF="#sig">Power of Attorney (included on signature page to the filing of this Registration Statement on Form&nbsp;F-1)</A></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>To
be filed by amendment.

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#134;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Previously
submitted.

</FONT></DD>

</DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=310,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=122793,FOLIO='II-2',FILE='DISK124:[18ZFA1.18ZFA10701]JA10701A.;25',USER='JTAYLORA',CD='15-FEB-2019;07:40' -->
<A NAME="page_ja10701_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Financial
Statement Schedules </FONT></DD></DL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
schedules have been omitted because the information required to be set forth therein is not applicable or has been included in the consolidated financial statements and notes
thereto.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><A NAME="ja10701_item_9._undertakings."> </A>
<A NAME="toc_ja10701_5"> </A></FONT> <FONT SIZE=2><B>  ITEM 9.&nbsp;&nbsp;&nbsp;&nbsp;Undertakings.    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreements certificates
in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid
by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned registrant hereby undertakes that: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;For
purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration
statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be
deemed to be part of this registration statement as of the time it was declared effective. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;For
the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a
new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </FONT></P>

</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=311,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=651829,FOLIO='II-3',FILE='DISK124:[18ZFA1.18ZFA10701]JA10701A.;25',USER='JTAYLORA',CD='15-FEB-2019;07:40' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A NAME="sig"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> SIGNATURES  </B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form&nbsp;F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Loos, France, on this
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019.

</FONT>

</P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="45%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> GENFIT&nbsp;S.A.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2><BR>
 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2> By:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Jean-Fran&ccedil;ois Mouney<BR></FONT> <FONT SIZE=2><I>Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="jc10701_power_of_attorney"> </A>
<A NAME="toc_jc10701_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Power of Attorney    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Jean-Fran&ccedil;ois Mouney,
Dean Hum and Laurent Lannoo, and each of them, as his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her
name, place and stead, in any and all capacities, to (i)&nbsp;act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this
registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule&nbsp;462(b) under the Securities Act of 1933, as amended,
together with all schedules and exhibits thereto, (ii)&nbsp;act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection
therewith, (iii)&nbsp;act on and file any supplement to any prospectus included in this registration statement or any such amendment or any subsequent registration statement filed pursuant to
Rule&nbsp;462(b) under the Securities Act of 1933, as amended, and (iv)&nbsp;take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he
or she might or could do in person, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes may lawfully do or cause to be done by virtue
thereof. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>SIGNATURE

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>TITLE

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>DATE

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Jean-Fran&ccedil;ois Mouney</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>Chief Executive Officer and Chairman of the Board of Directors<BR>
(Principal Executive Officer)</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Nathalie Huitorel</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Executive Vice President and Chief Financial and Administrative Officer<BR>
(Principal Financial and Accounting Officer)</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Xavier Guille Des Buttes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Vice-Chairman of the Board of Directors</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=312,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=95210,FOLIO='blank',FILE='DISK124:[18ZFA1.18ZFA10701]JC10701A.;20',USER='JTAYLORA',CD='15-FEB-2019;07:25' -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg10701a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>SIGNATURE

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>TITLE

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>DATE

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Catherine Larue, Ph.D</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Anne-H&eacute;l&egrave;ne Monsellato</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Fr&eacute;d&eacute;ric Desdouits</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;<BR>



<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Florence S&eacute;journ&eacute;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Philippe Moons</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="jc10701_signature_of_authorize__jc102321"> </A>
<A NAME="toc_jc10701_2"> </A>
<BR></FONT><FONT SIZE=2><B>  SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE OF REGISTRANT    <BR>    </B></FONT></P>

<P style="font-family:times;">


<FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States
of GENFIT&nbsp;S.A. has signed this registration statement on the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019.

</FONT>

</P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="49%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>GENFIT CORP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2><BR>
 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>&nbsp;&nbsp;<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT>
 </TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Jean-Fran&ccedil;ois Mouney</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Title:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> President</I></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=313,EFW="2237727",CP="GENFIT S.A.",DN="1",CHK=359455,FOLIO='blank',FILE='DISK124:[18ZFA1.18ZFA10701]JC10701A.;20',USER='JTAYLORA',CD='15-FEB-2019;07:25' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g37047.jpg
<TEXT>
begin 644 g37047.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@!!1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?4$Q!0T5"3U]&4$]?2U]"05(N15!3_]L
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M\#,Y0D5&4E24F+*XT=4FP41D9GFBM^'_Q  4 0$
M_\0 %!$!                     /_:  P# 0 "$0,1 #\ W^
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MDUR(I8.0V.I"YQG "K
M                                             ''3_?KGK_#Z1R #
MC/H^4OSX%N]6_8GGXPVWUGE1<3/H^4OSX%N]6_8GGXPVWUGE0%Q0
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MD-'+5LAUBH+.B8=NSD<9[J7AY.8N54,D5R7J8P\. 'N/='?%V6];+ )B
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MV?/G.<F,8QS&SDQS&-G.<W$%"ZP^UO0/B34O5Z-%=
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M+[E6'_&4XG_^H&B#)GCT?*;Y\@.0
M'&?1\I?GP+=ZM^Q//QAMOK/*BXF?1\N/GP+=ZM^Q//QAMOK/*@+B@      (
MY<OO<L\A?P.;"]6GXD:(Y<OO<L\A?P.;"]6GX"Z>L/M;T#XDU+U>C170H76'
MVMZ!\2:EZO1HKH                               &,337_&J\TOQ=.+
MGY5>AD[&,337_&J\TOQ=.+GY5>@&3L=1_P#W$Z^]G'^H4';'J)^081,)+2DH
M]:1L;'1KYX_D'[A)HR9-&[595=R[=+G(BW;HIE,=594Y4TR8R8QL8QG("*7
M#W'NCOB[+>ME@$Q!![LY+16K/P\TZ:MV&$L!(J*EXV3/"RC.3)'R);+-.<L7
MIF:RV&KS#9PW<9;+=Q;""Z*N2>&J0QIP@,9?:R^Y5A_QE.)__J!H@R9X]'RF
M^?(QF=K+[E6'_&4XG_\ J!H@R9X]'RF^?(#D
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MR<_8=RSE5<S5AHY(T\G)LX7%6E#M8MQ[)HX9^.[,N;N*=\A>GGRM9]'RE^?
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MBWB)Y1SWNI38-CH+U#Q\,F3X4R0F5,8R7!^[COX+GTEP;IWL8S[^,9Z /(
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MFQ@(Q@    -QWZ#^^WCS$_!50?6U0:<0W'?H/[[>/,3\%5!];5 &^6
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M+&1T:\D%X"#86-@J3!E5H^2/G*2*:9,J!E8QZ/-Z/>^7_?S#D  <9]'RE^?
MMWJW[$\_&&V^L\J+B9]'RE^? MWJW[$\_&&V^L\J N*       CER^]RSR%_
M YL+U:?B1HCER^]RSR%_ YL+U:?@+IZP^UO0/B34O5Z-%="A=8?:WH'Q)J7J
M]&BN@&#7MP/M;:.^/4]^81KDC8V[<#[6VCOCU/?F$:Y(    #J2'UOD/O![^
M2JCMCJ2'UOD/O![^2J@-2Z1^N$A^^$A^6N!TQW)'ZX2'[X2'Y:X'3     ?1
M ^A*O<(;@_&$E_5F''SOQ]$#Z$J]PAN#\827]68<!M4
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M6N!TP    'T0/H2KW"&X/QA)?U9AQ\[\?1 ^A*O<(;@_&$E_5F' ;5
M               L*^XM\<9)6^K/M(:P=*;1;M&NPC*TR"SBVI,,+9:9EB89
M8(JN@HX5<$=I%2=>5FP\RMET0BQ;]  M%":"TE6K- 72O:HH$';:K7_:I7;'
M$U:'83$17?";H%B&C]JT2<%:)H-$$$BF.8Z*)3)I'(117![-J>[U:?BH.O\
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MU/?F$:Y(V-NW ^UMH[X]3WYA&N2 "DJE_P!*_CO/_P#D8"K1252_Z5_'>?\
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M?0E7N$-P?C"2_JS#CYWX^B!]"5>X0W!^,)+^K,. VJ
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M&DBP=DP=!XDEE!LIW52=,ERJD53.,8ZXZ= %6@
M          -<3E=V=O-?=7/#8G(&KR=5;:]C]>7")UIEU=;C'NUYA[J]W581
MGB*C9]NG%+&DYV714>(D:L2_JSE=$Z#C)3P_ANQLYX.X?6-<L$O2$XY'<#JU
M7DV=A7USAG6RW&DIH&*4ECZR.5:E4TETFR1#.T$2HL3K>4I(93V^P =1@VRS
M9-&F3F4RV:MV_?,=10QO 1(EWC*+&.JIDW<ZY.J<RALY[RAC'SDV>V
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MSD>\
M  '&?1\I?GP+=ZM^Q//QAMOK/*BXF?1\I?GP+=ZM^Q//QAMOK/*@+B@
M           (O<8OU_(G\:':O^HK8E"(O<8OU_(G\:':O^HK8"4(      C]
MNG[,./?X72>IUI$@"^C'W,?,(_[I^S#CW^%TGJ=:1( OHQ]S'S /60TU%V&-
M;3$*\2D(UWXWDSM'!\)J^3N%6JW=PH0A\>&X052-WBX^J)GIUQTSGV@X*4I,
M8*0I2EQUZ%+C!<8ZYZYZ8QTQCKG.<Y_=SU'(
M                              L'R(W_ %OCS1G=MGXFU3;E:/L2D#&U
MJI6BRI.Y2$@'TXFWG']<B)5"J1+@K/PEY^=RRBVN#F,=S@Y<%SC)C^U#VG-<
M9]^;0J6L-07G:VE=BU:GQT#7]NQ;'6^P(JQ5ZNVF2D:Y:[/(0I596J1\XK'2
MT69]T<3;+#)JKA9PF@7-4[:-7[5RQ>MT7;-X@LU=M7"956[ELX3,BNW72/@Q
M%45TCG252.4Q%$SF(;&2YS@6,3XL<;$J<?7B6AM2)T50CI-2H$H-:)7%"O9%
MO+N^_#EC\,CF<2;1J^6.9')U'3=!4QN\D3H'N=4[89['TGK[<6&3WR2[T2M7
M3,?'1KYR\1]G(QF^59-(TI5G[C+99<Z29"864533PH4RA38/GV6GGB<C1FK]
M%-TBD\F;0Y31>M5F3Q(BUCE#E3=,W!".&JY<9Z*(+$*HGGS'*7/7&+A,(YA$
ML&47%LVL=&QS9LQCV#)!)LS8LFB2;=JS:-D2D1;MFR"9$4$$B%323(4A"X+C
M&!1&K?L4S\8;;ZS2H"XH                "+W&+]?R)_&AVK_J*V).+J^"
MBJMW#J^$F=3PTL=Y13N%R;N)EZX[RANG=(7KCO&SC'7'41 XC3<S*'W[[,:\
MV/0L2>_;S;8;.P*P:N>S<#84XDD?(1&#/'67:.31SCQNOAF1P9')BY\7'0)B
M      "/VZ?LPX]_A=)ZG6D2 +Z,?<Q\PC_NG[,./?X72>IUI$@"^C'W,?,
MY
M!QGT?*7Y\"W>K?L3S\8;;ZSRHN)GT?*7Y\"W>K?L3S\8;;ZSRH"XH
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M[$O(233?0;O+-Z19B]334P3)^ZH@JGWTE4CER4_7!BE"1(
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MI9XZ7<JIIHIF45<+J&Z)I)D+C."E+C& %0
M##WNCL5>+F\MF[2VS:K5N)I:]M3=@F;)F(ODHUC4<V M90691D=E<S9HU:LZ
MZHS;$(7S(RKHJA38;LBHY">,_'+7G%+3]:TGJXLWBH5A2379'L4R^GI99S+O
MUI%ZLYD'ZRRQ^^NMG":13%22(0N"$QG)LFOV
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M:IG*B:[S-8\D/X)%$$RR>5,+Y\'&:9(GAIII]>O<(0G7X>Z7!>OR].H#S
M                  !;'=.TX;1^IMB;?L458IR"UM4)NXRT/4HH\Y9I)A!,
ME'KAG!1"1TU)&37(GDC5HF?!U5,X*3!C="&"YP"V>F=H1.Z]4:[VW!1%A@(?
M8].@;E&PEMC#0UGB&D^P1?I1D_$F45/'3#'"OD\@R.H8S=PF=,W0V,EQ<P
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MBF%9@
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MSY_AQTS\'P>8<@
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MFQGIG.<],XSG&<YSG/7X//UZ8^3W@'D
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ML]?O6-K4LLG.(JYT^Z7X,>][WP>C^#WO@]X,8QCT8QCWOD^#[G[@#D
H                                                  ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g54160.jpg
<TEXT>
begin 644 g54160.jpg
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M7^:Q^UA$Z-,V,X+U)Y79Z;D2%ZAKU#X%M;!&5A27U_7+G#5ZVQCBLW%K%S5
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M(=J05% 81<;3+,Q9,T5ESK.!30:()(@95910Y2 *ISG$QAVIQQSP4$2E$2B
M&$0*41*)@ QQ A1$H&((@!C (@!BB( ( ("/<(R::9?O&?-:,59?R/&U2'N-
M[AI.:E8NDA-!6F*062;81;>/-87;R744)$L61I!5TMX5)$SHS9-)KY%,LGN.
M.:8<9UI;;/T=K>HTMAL@RF*)',K5VG5)92E!38JULZ8]!:ZE3]PD+ E.R+!$
M*THN$PHU>(R!&QF9C+%W/QQQQQQQQQQQS4.4,UU#$DYA^O6AI:G4CG#*+/$5
M("MU:7LC<+<\JMJNP&L+F,151K4$VK-*LLH]L$L9",:IQBB2BP+K()*[> >X
M /QAWXXXXXXXXYA3#X1;3]#*)^>\B<S7F%,/A%M/T,HGY[R)S->8+D_'%5S!
MCB]XJO+-S(4W(]0L5(M+)F_>13QS V>*=0\HDSE(]5!_&/!:.U3-)%BNB\9.
M2I.6RI%DB&"'U+Z>6,J-=,,W*-ROL9*!@^<M-LJ]3L^5BV6BR]UOQ7J^0;U;
M*K+5IPPFKM=)R9M%ED;2D,?,0TQ<;<2G.JO#6!_$'EO"1C*/R3>%FB/DE9.K
MT1\^/Y153R[KW5R W\J)5%#D2_S2*9? B5)+]KXO!XA,8=B<<<<<<<<<<<<X
M[^OMZ^_;O[![?C[=N_\ !W[\YXXXXXXYXF-X2B;L)A#V%+X>YA]@%#Q"4O<P
M]BAXC '<0[B =Q#3&OF<('8O$]<R[6JU<*A$V-[;(]*N7UI ,K7&NJ;<[#1I
M5.4;5BQVR#("LO6I!=B=C/ORK1ZC5=46ZRIVR6Z>.......:>SY\$]J_#!?I
M)$<C%$;>Z_:V81UUA<MWAY%V*UXHJTC!5.J4;(V4[H\AX^)B6+^PJTO%%0O%
MJ859B^=-F+VU240SKK1ZLFT7DR.#>2Y,W'^0:3E6F5W(>.;3"72DVR.3E:[9
MZZ_1DHB58G.HB*K5T@82^-!RBNT=MU03=,GK=RQ>H-WC9=!/,/$7U_M@_:_=
M>L/VOW_7\7J]?KY@5V_TECSZ>-OT7MG,^XXYZU?N0_C$?[TG(0=-G]P_KK]!
ME?TFL/)Q\<<@Q( '_*0U0>P=_P!A+?@[_?[?L@\9^KO\7)S\<<UOE_+="P1C
M.Z9@RC+O(#'N/8-S9+?.,*Y9[8XB(-F9,KR2]'Z9"V&ROV[,BH.'GN7#OE&K
M--=\X(FS;.%TL\CWR$HP9234KHK9^T;/6Y7K%]&/"H.T$W")7<;)MVDC'N03
M5*#AD_:MGK1;QMW;=%PFHD3N<<<]"3ILN==-!P@LHV4\DX(DJFH=!7MW\FL4
MAC&2/V]?@4 INWK[=N>_CCD,MK  <GZ#]P >VY:HAW#OV$-1=M>P_A#[P\F8
M7V!^ /[.<\<<<<<<<PIA\(MI^AE$_/>1.9KS"F'PBVGZ&43\]Y$YFO'',*8?
M"+:?H91/SWD3F:\<<<<<<X,8"E$P]^P (CX2F,/J#OZBE 3&$?O%* B(]@ !
M$0#FM\19=QWG?'E=RMBBR(6^@6PDBK7K(U8R\<UE48J6?P;U9LVG(Z*D@12E
M(QZV(LLR23<>0%=J99L=)939/''(,U*#:(=1[.DN1W.F54TXUG5".6L]E<5Q
MN\E\R[.QTK),JFXEU:K'R\E'TFJ,I"88PK>5>-8-B@X>J)$.0\YN......>"
MGW(?]]/^\+R#W3D_<E43Z99Y_P 166^3DXXXXXXXYI[/GP3VK\,%^DD1R@/J
M%[#9GQIK_A?$U7S-5<<8BS+I;-5?(4'5,/SF6-E9 MC@%JA)63&+&0L6,<=I
M-H&$F 2CD'^6H6S&LSI)\P@9)JT CC]$&+VS9IC:AMF7NIYNE2ZN5$TXU*PF
MU"^X$?X59IH1P\*VF%?4I*(^=.A2?G<$%PX$OECU:3&*>I(^?;X5Q+(-KBH[
M+C>^CK+D"LY9QOYSBV>A R18\7/JM7;+C1\-)JEIK,CAK#-Z@WC:>E6UMIV0
M\H1DC'+69E;).S&SIS9'^)/.UF7DT[2S),I&275=JR84^S 51H\*Z*@FW(N"
MPKE5:+J. ,04UD/"(GVOQQSUJ_<A_&(_WI.0@Z;/[A_77Z#*_I-8>3CXXY!B
M0_UD-4_D37[_ !!8SY.?CCD,^HI^X.W"]H?^C?E_U@(@/_8F7^^'KY,L/9_.
M;^T><\<" " @(=P'U" ^P0^(>07U:K5<@MCNHT]A("$AWD[LWBZ0FW<5%,(]
MS,/U-,=9W"CZ5<-&Z*L@\4</':YW+LZRQEG3E43B==4QYT<<<AGM7\)^@_\
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M?PF[#V[^KOV[<F:'L_G-_:/.>..0QUO,4-A.H* B ".R&*P !'L(B.E>K_8
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MM/ABO@[CYW:I?7G9W'%$C,E[</H2@RM'2H;G'- 6RQ0\.AJ#8\2U0T52\B4
M8VTXZ,X=DG'T^[7B[GL:])'IU8RGD[DVU8QWD?(::R;LN4]A36#9[+!7Y#BJ
M:00R7L3-Y.N3%VHN8ZYCQLLQ3!4YA223#PE+8BT8LV#9!DR;(-&;9$C=LS;)
M)MVC=!(H$310:HE(W123( $(FFF4A2@!2@   <[(  !V    ]@ '8 _F#D--
MJ_A/T'_EE*_X1=M>3++[ _ ']G.!*4W83%*80]@B #V_!W#U<^!9JE5[I#/:
M[<*[!VNOR*8I2$'98F/GX9ZD8! R3N+F&SU@X3, B IJMSE$/4(=N5-;0]%G
M3/*- R2ZURPSBW4'9.QU"9AL?;!X#A;A@^:I-NE$CMXVY3$=KE><*K7=:&6<
MJOT8RP23E@\>$;A))/62:S)QWNBIB2^8FTVCR3\IC9GCO(%QF\E88Q-BVNW:
M$J.!J=846;&P8VA'=\O-YG)F)D<A0MKR:DX</&GF$OD">C6Z'N:WCB(V\<<<
M<PIA\(MI^AE$_/>1.9KR.&:U5$ZWGPJ<#9;,9S@^.CS0E/KK>WV5ZG*FRA%K
M>X]4<N6I+*[;)/3O/<!)0[N82;*Q[%J^>N&[)Q7)T8*D?#^&I;"I*WE=_P"C
MK>KNI7)ELPSG##%+EI:NTRI4$8F&@=C,(:[WX):1)!+3X1E;IEZJ$%&!YJ]R
M2:66;0W+4,]Q.3Y[".787"<RSKN8);&MVCL7ST@X2:,HB_/*Y(MZG(NGBT=+
MHLT6LVHS5,]6B)5)D)0=*1KXB)FRD'L 8XW=;EU/7RK<;S$(8GN.3X_+E?F,
MGXZO3?*.*KWC;)DIBY2_34-18ZPVS)F$[(^Q5CB6F8^:B(BX34/<,AN&=H0>
M1,V6>\)[I^^5>/=#S'R'HO1/<OS/SCROF/NK?_\ K_E_VGG?G'EO^K?YGR/D
M_P#[3Q\V)QSQ.<J93',( 4H"81$0    [B(B(@4   [B8P@4H (F$"@(A^3?
M>2"QYU:<G:^YHRI3I2Z].+"F\N%=>M?(2(KEBG$]P,I7K)(4//F=IB0J;4]A
M::Q4="OFQ3C!U%.&M?R7.I7V^6"6<4MO4&DO^G#&F!\)8=CT([$F'\68NCT4
M01188XQ[3Z.Q12\+<ODD&U7A8I%-$"M6Q"$3(! 3;MRE#PHI 7; $*'QB'Q&
M,8X?B,(_'_Y[<%*4OW)2E_[H ']@<X4'L4![ /[=,/7ZP]:A0[_A#OW#XA !
M^]R ?2U@DZUH-K9"IR<Y,D:TR56"1LDLYG)E89"[6J1,FYDW@BX71:&="TCT
MCCX6<>@V9I=DD"!R?_''(95?_6$YP_D;:K_^..XW)F\<X$I1'N(!W ! !]A@
M ?;V,'K#O_ (<I_ZO.B^J>WV,\%'V$PY6L@/:[M_J%$QTRN+Z%LA:]?-@Z'C
MBZ5=Q9Z\ZB["[K%EI]PG(R3@'$F>-,LLTEVZ#>9C(V0:VT0->@JQ#1E>KD-%
M0$!#LF\=$04)'M(F%BH]J0$VK&,B6"+>/8-&R92IH-VK=))),H%(4 #GV>.>
M"GW(?]]/^\+R#W3D_<E43Z99Y_Q%9;Y[-RM+XC9EE3LAT*X.L%;:8/=/[!K?
MLS6(EK)6;'4X]2\$M4K9#JJ-4,F8+R*@0L)EW#4^[" N,(H5_'K0-UAZS:H7
MX^FFY<EG"2NF <_TMC@O=S!;&,4S=A%.37DZ].UZ375CZYG_  #9)!)JZR3K
MCDETU7/5K25 LY3)PK_&F2V$'>H-RV>SXY .+@H5'J=7.Q(Q3!*==Z,X\CG4
MNDU23D'+%#83) HM7#DA04613\DD!"J"82E22)W\":92S\XXXYI[/GP3VK\,
M%^DD1S\^74SD'K_ ^AL/[P]ERCZ(U2*NM:F"4%UD*@*3]AQQ/XYDJ7:X"TZ6
M;@8IE)F2B9IO)U2)?PD3>EET7\E7'#:/BI(DU^DZJ%.6L5TJC8&1RP4.!V8-
MB,P:F"-:@9L#1./B4VP(& 4@;IQ<<1#P>2(P9E(#9+(.X?'[/;_!S ;M_I+'
MGT\;?HO;.55[M0Y-*-BJ_P!2.%9G5P)?(.JZ\=2RIHM4WL2KA\9)>(POMD]A
MR-S>=O\ 6FP6:0K.5WRJ;XSW7&ZV-](HK-<91:1.C(ZQ9RZ>\F^R]TWH9'+6
MJTR_=VK)W397L#6.AX9M.+^Z<Y?^GS<IAV6OXELAW"[BQNM:)]RSP%D4SM^A
M0G^'[(^9NY&PS5O;7!FXF.3Y(P?;#S+2*F7M1O=0GHJ2J.3<2Y#AP3"QXPR_
MC>PMV-MQMD6MK*%)+56SQK-X*"C:5C#R4$_C95Y)!7[D/XQ+^])R#G35527T
M<UT514363-1UP*HD<JA!$EHL1#@!R")1$IRF*8 'N4P"4>P@(<G/QQR#$A_K
M(:I[?W$U^]?8>W[H+&?W^W;O_!W[_?[<G/QQR#'4VL,=5NGON9.2Q9,S!IKG
ME-)8L/!3EDD!,_J[Z.;^1AZY'2TPZ(#EVB+E1LP639-07?O3-V#5TY1FW'/D
M)-@SD6I716S]JW>MRO6+V,>%0=HD<HE=QTDW:2+!R"2I 79/VK9ZT5\;=TW1
M<)J)$[G''(9:W?NA.H+_ "C\5_X*]7N3-XXY#/:OX3]!_P"64K_A%VUY,LOL
M#\ ?V<YXYZU?N0_C$?[TG(0=-G]P_KK]!E?TFL/)Q\<<<PIA\(MI^AE$_/>1
M.9KS2MZD7$0?,<JUF'M><QN&XR0;S\; IVF1A%V1,J.D9=A65BG2L+V,42*^
M:02A#IR[ANG''*8CD0Y5ET*;GL3D#5>Q6S83,M@S4YE[E#OL=6BR7O&N0I9Y
MCZ3H5;FXF9DI>AYHS/)P4S9E9526FJ+<9*N2U-?B>+9U\D?X7B]V_',*8?"+
M:?H91/SWD3F:\<J*W-N]LW$S.OTP\$V*9KD$K7:_<>HAFJIO5F<MAO76XD=C
M7]?:=,M/5#Y]VP9,I&(:.P<$E,8X*3N.2"MDIN=QTH\W/M91JAC/&6G..L?U
MN'I]%HFW6F]0IU3KS%",@:S5ZW=V,1 P$+'-B)MV,5$1C1LQ8-42%30;H)D
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M*6RIL-G"RMVZ%QSSGFZ V<9 RC9DVP>28EDW3=M#U&LMSJ1U%H,+5J1#B$9
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MZ3$P$!,C<0E]G/+K;!>,Y_)CO'^6LH(0"L0D>E8/QY,Y4R5+>Z\NRB"G@*1
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M9.@+-2'$<6S2.6Z*A.-\B-+&VIU1:,20E2=V#T24RS)XTU5>YCK[2&R?)PU
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MG,U[A\8?C#CN'QA^,..X?&'XPX[A\8?C#CN'QA^,..X?&'XPX[A\8?C#G!O
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M=4YR\,+G)ZS9;N>7,:SB>)Z!4)*#D,L4G*D/F*I0*T"D8]7HEWNN6YNWM:U
MJ-FM?BH&G4@1F(ZOIRJ\J1JJ<CE&X=K9;&2QZC1WIF<=/E:D037F+\B4B38&
MRATF93-S"W*/<@*J.?"<QC&*3*O0 ?WZ7_\ I*/V'CT ']^E_P#Z2C]AX] !
M_?I?_P"DH_8>?+EJ(Y31:&;Y&NL8;W4B_++.Y\BQ'+3SU+SN-3!5JF5-Q)(>
M-FW5((K)+*D.@!E *4WU/0 W[];_ /TE'[#QZ #^_2__ -)1^P\>@ _OTO\
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MYKZW"@PC%2-O323Q?'L[!.-21(6/5B?RQ8,6:UV*V4"9)?Y*(HUCR/"2AH6
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M[7(DZYGJ1JC5$8*_6)\^-#R5!P\ZUHL$GAB)9,CN8OW];X14L,JB\4L]K?'
M^P?^'X?O<HQS?TJ;C=<IV&Q4T<$.<>7G?1;<>TQ%J;WZ&R%"-'.'=:*?*P^+
M[Y!L;![W-TMF2\)S5VNE^KT:RM[NIR2./J7;,?M[1=99S>:4.P=OX3#[1'VF
M$?O_ (?9[ ]@>H YSQR!&TFG-ASOG'"&;J)D=+$5VQ)BS:7&+/(,3#C+7F"3
MV QW%5> GJHB[5) .'=&M42SN2;&P$.T=OF3,I3 !%2'U[K9JM8-*>GE!ZU6
M.YQ%]=X\G;TNPL<)"R,"Q5K]VV"LN0JY'"QEY>=DSO(6%M;*)D7SV5?.'\@T
M<NCN7 *%<*S0UP^ ##'^[*E_F!CS=/./"4>_<I1[^WU!Z_P\@GN=/[B0<WKP
MGJM!.):)D<JQ[;+"C*&H4PBE7RR=9\V8W4;O-1+R"Q:_KRE^5M=EQZ1SD:+L
M$?1DH$2,'TPV?3L#N(>OU#W'\7<?#_.)>W?^'XN<\<^-8EY!M S3B**L>30B
M9):/*V8I2C@SY)BNHT!"-6?Q:,@L+@J8),59..3>*"5LH_9D5,Y2B#H%.[)V
M37>)F=JRWIME=Y:K>=6*R91\<T:_0E9+)E)68JU-,1O7.-I>618 9PM,4]!I
M#@5T2$1<60\(I=;1-?CCD([G;=PT=Z,,5:L8[9*:7.<4Y']\Z^M9>DKRA<J.
M$F<C359B,E'J5UC(F")#>X$*VJ;!XWLLC>)B2LCAJQJ48FK-SCCD7=T9'8F)
MUDRN_P!4$4E<]H1$.%%4/!0EI<L"+6J ;VR8B*O9).'@K-8X.CJV:9J]=EI%
MNPG+$PBXMR"Y'?FZVS<%/<D26%,12&8XP\+EI[C*B.LG1*CB&=*1N0%ZQ%J7
M!DJXKJ#6OJJM[ :0(J:";HPP* 8D80&14>;5XYP;OX3>'[KL/;\/;U?\>5[:
MBV#=V6V(W<8;,P[J/P?#Y*AF>J#A>"Q]%(.*66:R&21-'252D7-AGV;JJIXT
MEE7UQ15>-Y62DV*;QG(H358KUA7''*[MRGF[T!95)K6I]*3%!=8&N+>9K%3H
MN+YF]UW)$9F7 ODK=2)/)4XSA[)?'>#9O.1\=4*R-$L?NKE4XQ2VJ2PR,;$J
M2WP([RH^PCB)[G)FQC\RN\:TESE1C&I,D&+/(2U<CE+<V;H1CN0C$"(SAGI#
M(1C]]&H* =&/>NF9$%C[:XYI+9)MF!W@+,*.OTXC6\VACJV.,5S#BN0UN2;7
MIG#.WE<1&NV%_%P4H>1DFZ$6BE,/D(U%9ZF[>^5;MU$5(Q:G6C;RP9ZV2;9\
M9WV(Q;$M,8ML3QMOQ_C"$@G4TK!KKW^5QU;\?RSJ=EZDG(JMH55GDLKVU2$[
M&2UJCF]*JLK!5/EA7' ^P>WJ'[P^WMRIC.=FZG=1SJ\:X>JS+*.$Y39?6*3!
MV@RQ)4I.H:[/4_<[/-+BRVJ7\_MKT\B)9N;O;UPSL5<AT5H^FUUTY>HR499C
M']_?$M'?V^AE$ 1]7K[3>1 [^KV=_;V^]W[<S;F%,/A%M/T,HGY[R)S->0NS
M/O=A#"^5:3AM\XE+M=[';H*L7&-H;NHRCC#3*RV'%E1A+7E*.E+5"S47"2-E
MS;BU@S8P$78K0ZCK0>SM:^O68"P2L=KBS]23'-4RU&X=E</9V:3SO9YUK')3
M\A7:?'4FM21*IARUPN3;':E;PK&0^,[P3.N/Z_CQY)*-+7<K7(^X,;5"OG,6
ME(S8AG[%]D>Z$9/&SL["K49B^*V727,R?$EK^N=D[!,QA;NR(.&ZQVRW@6(D
MNBH8@$53$VP............X?'QQQQQQQQQQQQQQQQQQS3V?/@GM7X8+])(C
MG7UP^ ##'^[*E_F!CS=/'.! ![=P >P]P[AW[#\8?$/\/.>...<  %#L   ?
M$   ?B#G/'''8/;V]8>P?B[^WCCCGY^.I%U$=X]9=MBX4P)A9C?,9VO#^M,K
M6[JIBR[7!"I9'M.R=J0S<K;YB"D6L0I6D=9*+9EJQ'G-'.XO(1X5VZ>R#>4;
M1*W>/UC<_.V-B=U_02RR"U4LV1#6%G*W[(D ,'5,<5N1M,_3))5QKJN/[(^'
M9L&<;9,8Q2,QCZ(EK15F\;F.P \>BST[7NL!O13ZW/WO)^G%8R/#L:#&MW,!
MB^3RG29>N9?C@WGF)J*,C9\7VLTO474#J[4HRPR3Q]"R%"LUPB!;,+9%VMHK
M"WIZF9V=[,ZYXCSM(4B7QQ(9*J3>?D:1.-YYO(5R1!X]CG\=WLM<J<N^9%=L
M%EHJ84@63.<BEF4S$G?1#]A(NY$<X  #OV  [^L>P>T?C'X^<\<<X$ 'V@ ^
MH0]8=_4/M#\ _?#[_.>../;[>< 4H"(@4 $?:(  "/X1#V\YXXYQV#X@^]][
MXO9^+[WQ<PMA\(MI^AE$_/>1.9KS"F'PBVGZ&43\]Y$YFO-:9$PQB++BE:6R
MGC"@9&6IDD^F:BM>*A VE6KRTE$NH*1DJ^I-L'JD.^?0SUW%NW4>9NLX8KJ-
MU3F)X0+CZVMNOCB4J$XO@_$RLSC^Q1ENH\LICVJGDJA:82I0%"A[%6WIHLSF
M&FHNDU2KU./DF"J#MG7JU7XENJFSA8Q)KNOCCCCCCCCCCCE(W5;V!WVP9E[5
MQ;3^$N]LHLY1]@8G+M0JF+HZ\M)6Z7N5PMA#7FS2M@<U:;?59'%&2\O)94E6
M;.3BF$[1*G>7-B:RD) NQ8PYQ?U-.IW3\?5NK7?6N4RODJG:86"_612RX!SU
M7KUD;(U.U3L&7&^>']II-.K^ 8NC6_/4*RUJ7UMK249G0]OEO2V$290P-8 ^
M<Y!VWZMSK)L%CR/A:+3)=2]RN)V[^G:TY<FL8V:R4WJ%:78W5R2_M%G?V25@
M<<3FL&:<AOYZ']U6;B1@*CD2Z4RV,)",CI2A;SU2ZAV\&6MN=?L#9EUCCZ/0
M,@ZQRN1,D76OXCV&9)UC+U<E;K#2;5Q;+JE'T6F4>><U5@M3H)XXO=B>!8V,
M9,6B,G"(QSV]/CCCCCCCCCCCCCCFGL^?!/:OPP7Z21',3UXM$>VP-AM%1%X)
MT\:TXAA(FB)1$D&S(/83."CV$2B(=P >W;N #ZN;C]+XWY!]]4W^T\>E\;\@
M^^J;_:>/2^-^0??5-_M/'I?&_(/OJF_VGCTOC?D'WU3?[3QZ7QOR#[ZIO]IX
M]+XWY!]]4W^T\>E\;\@^^J;_ &GCTOC?D'WU3?[3QZ7QOR#[ZIO]IX]+XWY!
M]]4W^T\>E\;\@^^J;_:>/2^-^0??5-_M/'I?&_(/OJF_VGCTOC?D'WU3?[3S
M@;;&"/<49#^8B(!]_P"\#L ^_P#%\7Q!S@+9%AW_ ,Q(>OO_ +*7W_B_YWZ@
M#[P!V /O ''I9%]NWD9#\27?[_W_ #ON'M'V#ZO5V^Y+VY"W1@   @_]7QIH
M"/\ .(NA$?YQYSZ7QOR#[ZIO]IX]+XWY!]]4W^T\>E\;\@^^J;_:>/2^-^0?
M?5-_M/'I?&_(/OJF_P!IX]+XWY!]]4W^T\>E\;\@^^J;_:>/2^-^0??5-_M/
M'I?&_(/OJF_VGCTOC?D'WU3?[3QZ7QOR#[ZIO]IX]+XWY!]]4W^T\>E\;\@^
M^J;_ &GCTOC?D'WU3?[3QZ7QOR#[ZIO]IY\.O2;>5O\ ;5FY%B%2J%#2,"Q2
M%,)AF,AG[E BB@"7L8 [B(#W[^KMZ^;&YK169:Q61[$1PFX.*]*HYR>1(F8
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3N)7!A#]J00#L4?7V[]@[B'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g268398.jpg
<TEXT>
begin 644 g268398.jpg
M_]C_X  02D9)1@ ! 0$!1 %$  #__@ _1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?1$5614Q/4%\T0U]&3$]7+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( .@"#@,!(@ "$0$#$0'_Q  ?   !! ,! 0$!            !@<("0($
M!0$* PO_Q !X$   !@$" 00*# 8(#@P*" <! @,$!08'  @1"1(4(1,5%QDQ
M4926T]46&$%25%976)*7T=8B4U61F-(R,V%QD['7\",D)28W0D1C=X&5F:&V
M"AHG-#4X<[*UP=38-CE#14AD9GB&X2A&1V)RA+CQ*4F#I<7&Y?_$ !X! 0 !
M! ,! 0             % 0(#! 8("0<*_\0 9!$  @$# @,"!@H+"0H*"P$
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M,[L ,$D]NIFZ7_BF6_5U'17>]R2/<9X::FIZVL=W8S$)%%$DA9F) "HH)/0
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M_61(>AT=]3Y27Y\>Y7ZR)#T.J_>E-1\#MIY4AZ31TII\+:>5-_2:EO<]P_\
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MQ[E?K(D/0Z@)K]VK8[QTV:)';)*.W+=JFJ\=MF#-)1RL1 BCM\]509L6J9E
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M1H'CEB):-U(.0T;,S(?M6=R,%V)I+Q/Q+-%-!+=KC)#/$\$T;2N4DBE"+(C
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M=H:3<:S=12J PKWIK2L1N QY-1[1<7D-MFV'2K,RC!PN@5]$;3<'OFP+I=B
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M\)O1P8)VCLA>V&0PYQVCDH<>XQDP>'$R0!QX /N^YJ$+%@^%A'B#)Z(#'L1
M09NA 0%HB(" ]AZP$.L!]W6U%:+,;Q71FVVTQ);K6Z(:2F,:O)4W99'5>7M#
M.L48=@,L(T!)"C&O/>KX.'[;*MSN0G>Z72-Y!55 E:..GM;1H[A][*AD8H"2
M 7./LCFV_$EUY3'.M*87_%,/B&VUV4OO<VCRHX1V'1<^\M"<E0(=Z+:HS>,H
MVU.*[$2V4\=1L_<&\.M5Z^]N4$C,RK('8G3&]PY4-U"O9]M1J:LPCXC!TT\2
M+MEV8IRJ#/<A:I"DX73/!.</(302-TL\6[BTXKH/;"#'HKRQMXB/?,W:\-L6
M;L]QF&*SCJEX[M,I U/&F:@S]%5Q&/E AK!D5%QCYXP<WN/;N&S:YP<.]QG5
MGT- RJ8M(Y\B]>('Z0\*HW>LO*9;SE*FYIDM98"V1$O5X^IV]U?L80N0['?X
M^#A&$%6'=ZMEX9V"RSLK5&\:U=0CTDJQ3.]*?MXUFV!^UY8VHM%P6>7Q6R\&
MR4YG'(YU*T<J4PG\H2%$=9)WIU;85$:)-(FX,BOB3I+W:VIX?';[QO%5"G^'
MY%4DD+U30+M,0=D=((ZEEW!C([P1R%2)'C!?VTR7*>4RHY-OED0V^1U2Q$I'
M-[I-!CKD[WB";V4B'4XVC*\BPH+IW;IA./8ONG0M:;R4O&/&3J/D639XF5$[
M'WW<SOQQC7J#:[R3&,'7LGQ"DW2)0-N.RN61EF:,= 3"[=TG XCE'->FF\-:
MZO-.:U9T(6R-X6RP$LO$IQ\NQ<+<S)O*-[G,L4?(>-[1&TU"E9(80C"7AH6O
M9#CU6:<!"24''*I32N0'D]9U$&\N^<((Y.DLA1S!?H#>(CXV(A86*CXR90S#
M<LKU;$U0F:=2Z[$X;J)J750HE)?U11]&*G:N'K^S-T)!W$2]EEY-!><L-H0B
MHV;LT[(OY2Q.Y1P=IT+);K34,T'MG9.&(U,Q$XI:.)BM/XDK(59V;X;Q[*N"
M'00^2I9AS3ANEZI5CG]J.(.*Y)%IU-/XW5S!7J?'PK!@D:_ ^U^UT.Y':;RF
M"9,(G9L[WEYZR7NTVR8[O+[$EAI=ZSWBBHVV =;7]JZ#:;K=AND1%S,4X7C\
M*,WR*+]@Y7;*JLW39T0B@F0724 IPCT^W^[H$7SY%.R8K*FB^>I)E#:UM-X%
M32=K)IE 38,,(@4A2E 1$1$ ZQ$>(CR-@;)X3?/LX.=F\*4NY[!XF,9FZ
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M8GC9B)E8/&L;T\L_+^'/8K> [B7Q;Q:F\)M":FTQW=5N=PLM.887N%7;A35
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MGV07RK/F^Y3ACN^8_KUSV'-8W>K;1\L]>\R93[RZ][U=:/=S/7A_?I,F/@\
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MGCU[W./_ &^R1YU__P#/TTTY?$/&'YPT<0\8?G#39]SD/C_D@>H!ZK7QZA\
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MJKVV9L-:68(K0L>5JU2L:;]U-RZDL0T8P3>PC9N[:,TX5^Y+9BN"5R9;)@I
MOY$PF(5D1D9$Q$4S2,B9-N1-)NF:0>BFW21$112;IBN)&Z:(B(I)H%3(D/6F
M!=8+O7CDJ9'+QXX(DBV;)$<.W+@B39F0Z;-LD194Y4F[--10C1NF!46A%%"-
MB)$4.4T36W?@66CGBHN#:^EK'H^53U4O$U541PUI@Y9JFI_%(Q+$L_PZ4[2
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MHR1FC!6Y!N>'.Z;.VZRC0P=);*.'#7>98EWC1J*S>-H&=HY%PRC(U8L=%SK
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M4TJX6T5^Q"8(269R0ECX>5,#503B$=8&AWT,\$!*7^@231-1=J?_ ,HF0P\
M$HAKO:VHI8IT$L,D<T;%@LD3K(C%6*, Z$J2KJRM@]&!4X((UJRQ2P.8IHY(
M9%"EHY4:-U#*'4E' 8!D967(ZJ0PR"#IMNDY<_(^.O.6T_=31TG+GY'QUYRV
MG[J:<G2!+E/&YD$W1;U4Q;JN.C)+!/1PI**]@(Z$"'[/S3$Z*JFY[-^T='4(
MMV7L9@-K'45E)2[/&JJGIN9N*>,3Q0[PI4,4YC+NVET#8S@NH."PSD@I*NJW
M^*TM14[-H?D0R3;"P8J'Y:MMW!'*YQD(Q&=IQJ=)RY^1\=><MI^ZFCI.7/R/
MCKSEM/W4UUWF1*&P'@\N58;CVQDH@W9IR.)V.4AEVS:88*B+C@B[B7+QFWDD
M5A3.P7=-DG0)'72*93OW[*+9/)*1=(,H^/:KO7KUTH5%LT:-4CK.'#A8X@FD
MBBD0ZBJAQ I"%$P]0:)5TDO-Y=53R<@*T^R:-^2KJ71I=K'EAD!=2^ R@L,@
M9TDI*N+E<VEJ(^>66#F0R)SF5@C+%N4<PJY",$R0Q"G!.-('I.7/R/CKSEM/
MW4T=)RY^1\=><MI^ZFEW&R<?,,D9&*>M9%@Y XMWK)=-RV7!-0Z*@I+)&.F<
M"*IJ)GYIAYIR&*/ 2B&MT>H!_>'6965U5T971U#(ZD,K*P!5E89!5@000<$'
M(U@961F1U*LI*LK JRLIP58'!!!!!! ((P=-KTG+/NP^./.6T?=31TG+/Y'Q
MQYRVC[J:I%SWNSW%U3-V6:S7LJ3D7 P%_L<3#QJ$?6E$6$<R>F2:M4CN(-=P
M<B) YI3+K*JB'[-0P]>FE]NENC^6.P_Y,JGW>UU/NWLP/!]9[K<[34</<8R3
MVNXUMMGDAI+*87FH:F2EE>(O?(W,3/$[1EXT8H0613Y.NX%F]A;X2;W:+3>J
M;B+@B.FN]LH+I3QSUU^6>."X4L-7$DRQ\/21K*D<P60))(@<,%=U 9OH4Z3E
MG\CXX\Y;1]U-'2<L_D?''G+:/NIKYZ_;I;H_ECL/^3*I]WM'MTMT?RQV'_)E
M4^[VH_WZ/@Y^3G&OZ'8^[Y^^GZ]LE[QKPG_*;@/]/X@[O^;?T_7M^A3I.6?R
M/CCSEM'W4T=)RS^1\<><MH^ZFOGK]NENC^6.P_Y,JGW>UZ&]'=(80*7,5B$3
M"!0 (RJB(F,(%* ?UO>$1$ #]T=![-'P<G'^#?&O7'_(['W?/WT__OSO>->$
M_P _$W 8]/\ =_$'=G[F_I^HZWT7E?*YJA8BGB*@4@Q;@## 6JPMY@ _ XC'
M+.:PD@DZ_%'44(4.OB8-*L7&6>(_U'QSX1\-EM''PCXJIPU1/9\M[YS YJMI
MG;[S991*&7C'<-3!3>K/FLV\)'D<-8PR*C@[>L6 RR+=WV9LI"R+5WT=VW,W
M,,MP>^:25;I,KC?EU'E7BKJT+VCIZ!756GSJ$@IIN=S"MTE6TXJDJA#-TSFD
M)1RF=LP9.' "EJ8;V6'#*2\A_!]X3TGWM%R7X?H5EYL>#)'RC=@_,0'+IC<@
MZL,8S!+[$+BEX?&$\)/@E>#EI*9TXGKVAY4A CEYJV0IRY"&$;[MCD>0S>>]
MCI.6?R/CCSEM'W4T=)RS^1\<><MH^ZFJ*'NX'?-'/JW%N[K=DY2X-B/*U&)Q
MU%=R$LU48H29%TF3*,<N6B9HURA(<91)@)6)^E& J!%3IHU_O#W8Q3YY&2>5
M[5'R,>Y79/F+R&J[=VS=ME#).&SE!2NE41714*8BB9@ 0,'N@(".I5>R_P""
MJ'=X]P7X0Z+9*('\;M%KIMDYABJ1"W.O2;933S15 C/EF"6*8*8Y$9]VC]AA
MQU<2@M_'/@RKS) :E/$KY=ZO?3+/)2M4)XO8)-T"U4,],95S&*B&6$MS(G77
MT$])RS^1\<><MH^ZFCI.6?R/CCSEM'W4U\]?MTMT?RQV'_)E4^[VCVZ6Z/Y8
M[#_DRJ?=[6E[]'P<_)SC7]#L?=\_?3]>V0]XUX3_ )3<!_I_$'=_S;^GZ]M\
M]Z7RN:JRI3Q%1*009<1@+786\J'"39"'15G-821)Q$ !?GJ%YS;LY2\3& HJ
MT7.6>(_U'QSX1\-EM''PCXJI^;]S7SMRF[[<G-,'$9*Y8G'S!T"0.&JT95^Q
MJ@BNDY2XBG IJ )%T$E $IRCQ( "(E$Q1WQWI;I!X_[LEA+QX\>;%U,.''PB
M >QW@'#CU  < \0AU:>_1\'&/_9OC;/_ ,)8N[Y^^GZ,>?3WC7A/^4W ?Z?Q
M!W?\V_I__?G^A;L^6OR-CGSDM'W4T=GRU^1<<^<EI^ZFHC;/=Z,3FAE'X_R
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MM)ZT<-$F#P:LQ"516;K*ODUWK<ZY6ZJ*2'->X'@Y,[@9"P3ZJ*LE%SR+5LC
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MV8U""AJQ5Z_N!K]>KT:RB(*%B-B&\EA&Q,9')%19,6#1# )$FS9LF4"I))@
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M(91-N+A44$CG,5+LJHI%+V13C66VUC!]G#=QCS&55N56L4?=GF',6UO)P"N
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MK(9(<SGL$0<P533:3$V["47 [5V=G6&MHL;![ (V3QSDK^/8O@**8/&;5T!
M54.! <H)K\T#F!,Q@+V3F@8Q"";AQ$A1'F@B'N'\3R73^V.,<>/^VI8@LGTV
MDUAUVQ+7WR\I!%?]GBE.F%A9-TYD8D'/90C7SE=VR!!PLHH9Q0 "@!2@!2E
M *4     #@   =0  =0 '4 :UJJ2B<1BDIY8",F4RS<W<2D8PF%4*@<2%5(9
MP&\J5\@)MT$-RB,OMA5P5*D*(!#3\C8%>0YDR\ADE*&,.ZLD9*>1!'AGE\YH
M>,WTS_K:.:'C-],_ZVLM&M/4C@>@?7^P>K6/-#QF^F?];1S0\9OIG_6UEHTT
MP/0/K_8/5K'FAXS?3/\ K:.:'C-],_ZVLM&FF!Z!]?[!ZM?''>]I><:/99*
M3JS:XLF;I9*/M-)L56G:[.LR&#L,BP70G@>-4W!#%,+.5:,9!N<#I+M@,F)A
M1WM>LX?)C8_X:!]=:AED7=I7K)=)^9Q_LWV$8SICMZ8:Y2B[,-O=R<PD60I2
M-T)*U6"BGDIZ44X&6?R H1[0ZR@ILHUFV233%%>V7?\ S<]AGZ!>V#[@:^@K
MX.2RAC72Q[@"8W@A+)G!VL4J70LN2"5=UR.C,,%NN$OL6N9+))%<Q3Q.Q=(#
M=3*858Y$7,/#9+B/.T,2S$ %F8Y8V!>UZSA\F-C_ (:!]=:/:]9P^3&Q_P -
M ^NM5^^V7?\ S<]AGZ!>V#[@:/;+O_FY[#/T"]L'W U7]S<_C%_^HC[ORWT_
M7MQ^]7E_'*_K'_\ F]6!>UZSA\F-C_AH'UUH]KUG#Y,;'_#0/KK5?OMEW_S<
M]AGZ!>V#[@:/;+O_ )N>PS] O;!]P-/W-S^,7_ZB/N_+?3]>U[U>7\<K^L?_
M .;U8&&WG.(B !C&Q\3"!0XKP !Q$0 .(C-  !Q'K,(@ !UB(  CKZ#N39K(
M8#V_2%>RE9:36;/9L@3EO+7%KM4W<C#QCN(KT.R1ESL)ETR1D7(PJST[-!TX
M%HW<-TG*A'?9T$?CN]LN_P#FY[#/T"]L'W _GXAU]*O)68<V@;R=LSK(.5]B
M6RE*]U+(E@QU,2M;VQXCA8NRIQ,179UA.]I$JTLVB)!9G8DV<FT8F"/5>,CO
MF2+-%V#)M'W+@Z"RT_CE5654D6]8CR*:!F5I <$J]7'D94CH6()'3'E#E7"'
M@/JO!]=CQ!35-/<*A::6CC2HNDHAC6I*"20I%8(7=]J%$^$VJ'8E&.UDO [I
M^-_C_2?.VO>LM'=/QO\ '^D^=M>]9:@A8]J')9U2WN:--[.MIK:R,XNFS"[)
M/:_CQTB1C?+VPQQ73 _:T=5@=PK:I:*:R#(CDSR'8RD;,2B#6*?M7:K<N,-<
ME&C9)RM)[%\"NW$$B],M(LMF-0<PK]XTO#[&*,/"R:=&[%+S4MD>->4F#C61
M%%YB?2!%D"C51)V>&6DMC#*O>", Y%OIL$$ @@^/X.001@]<CT]/J8]TA[**
MT'L_Y?78^U\_M7Y\GUC5FO=/QO\ '^D^=M>]9:.Z?C?X_P!)\[:]ZRU71/[?
M^2:JM,97JQ[/=K$1#NU+$U7;N=J-%/-Q$C4#]CM<3.P3>B+R4/)UTP*#)LWJ
M"9TTT5'" N&W8UE$W*8NY'>&?Y#C7^U':DDZQ<:93N $VF4U9)HO7[36*5+M
MX]=''YTIMPTLUQKL4*$2=VHHM(E.B4Z2#DZ55H[<_P!BUY89*Y6VTY&X,JD=
M*_M#,%QZ2!VGH XD/916D^;I7UQ["H/9:_22/SC\UG?=/QO\?Z3YVU[UEH[I
M^-_C_2?.VO>LM5T*8"Y)-%2MHJ[2-IB9[9',Y2$%3:Q0TTG#220OZT:*[@]$
M*W9+2*F,K<Q8H/%4574HSCXQ(IGT]"(/^OBC:YR8&:',X2B;'-M3V/@S F><
MD=J6-X>&D%"N5&BZ<6[D*DBJZ.V<)*$6*=L@/ HG2[*F!C!0TML56=I+PJK@
MLS6ZF4#)VCJ:\=I! ^@]^*9XD R:*T #&2:^N [0.WVK\YR/S^JP#NGXW^/]
M)\[:]ZRT=T_&_P ?Z3YVU[UEJ-/>XN3[^8]M'_1UQ-]U-'>XN3[^8]M'_1UQ
M-]U-8MEE_";I^@TG]8?3]3TMYG$/X+9O-\85O=GXK^GU^J0\I>\2SD;(0TQ<
M<?2D3*LG,=)QK^RUITR?L'B)V[MF[;+2!TEVSE!0Z2R*A3$43.8I@$!$-(-O
M$[7VI5R((X8(1RS-'N"=.IQRN&9WXRBJ*X'=F!8%I$PO5CJ 919Q_1%3G$ X
M-IWN+D^_F/;1_P!'7$WW4T=[BY/OYCVT?]'7$WW4TV6;\)NGZ%2=WSA]/[/3
MTP20WB9@\ULX?E=5VAY*NID8*<94,UI)"GRL@'!SZG5D6VVF6.W4D>XT\.U?
M/9) 5GM,,"<A)#%#(/.:#H"G<O304*=TJ<#'64B(Q103'8-3)9LTMML>_;RC
M%3#S5^T1:(-72$A3DU&Y&$J$XS,CS78%37;3 %DD7)2@Y3>%*N57GD()6G[W
M%R??S'MH_P"CKB;[J:.]Q<GW\Q[:/^CKB;[J:;++^$W3]!I/ZP^GZGI9XI=-
MQ?VIX<WDJ6?QB?<2H502WM1DD*, D]!@#  Q(YID3%K!JV8L;M0F;)DW1:M&
MC6SUM!LU;-TRI(-VZ"4@5-%!%(A4TDDRE(F0I2E*!0 -; Y/QN("'L_I/7_[
M6U[UEJ-/>XN3[^8]M'_1UQ-]U-'>XN3[^8]M'_1UQ-]U--EE_";I^@TG]8?3
M]3TV@_$   I+,    +A6@ #'0#VKZ#H<?2/S1[R)L,V39.OEQR+8\H3:<_=[
M%)V>93B\O5!G'$DI5;L[HK%J>.<';M0/^U(G76,0O4*AO#I&][3V&?*G:OKG
MIWJG4K3<G?R>!#&(;9/L_*8HB4Q3;?,0%,40\("4:N @(>Z @ A[H:Q[WCR=
MWS*-GWZ/N'_NQJWD6,_YZY_H%)W?.']O_P QUPJ;P>66HFEJ)^"N#)9YY9)Y
MY7DJ6>6:5^9+(Y-KZL[EV8^<L3YSJ*G>T]AGRIVKZYZ=ZIT=[3V&?*G:OKGI
MWJG4J^]X\G=\RC9]^C[A_P"[&LB<G=R>*A@(GLFV@',/$0*3;WB$YA  XB/-
M+5Q-P .L1X< #K'@ ".J<BQ_OUR_0*3N^</[?_F.L?[FU@^0W!7F^WJ?X/S5
MW'U]YU%+O:>PSY4[5]<].]4Z.]I[#/E3M7UST[U3J6W>XN3[^8]M'_1UQ-]U
M-'>XN3[^8]M'_1UQ-]U-.18_W^Y?H-)W?.'U_.=/W-K!\AN"O-]O4_P?FKN/
MK[SJ%%LY./8U%5J;DHW+,RW?,H]9PU7ELRU8T:DL02@0[T&T*JN+<!'@IV-(
MYNL  HB.E$/)I[# $0'*5J 0$0X=V:GA[OB&)X@/C ?=U(F]<G7L+9U"Q.8K
M9)M<;R*,6X49KP>VO$KV727*!>8>/:C5T^SN@Z^QI]D)SN(AS@#CQ5G>X^3[
M'B/M'MH_A'_T=<2A[H^*J</WO!^]IR+'^_W+S?\ (:3N^</[?/VG3]S:P?(;
M@KS?;U/FV_-?<?7J)/>T]AGRIVKZYZ=ZIT=[3V&?*G:OKGIWJG4MN]Q<GW\Q
M[:/^CKB;[J:.]Q<GW\Q[:/\ HZXF^ZFG(L?[_<OT&D[OG#Z_G.G[FU@^0W!7
MF^WJ?X/S5W'U]YU$GO:>PSY4[5]<].]4Z.]I[#/E3M7UST[U3J6W>XN3[^8]
MM'_1UQ-]U-'>XN3[^8]M'_1UQ-]U-.18_P!_N7Z#2=WSA]?SG3]S:P?(;@KS
M?;U/\'YJ[CZ^\ZA-;.3CV-15?D7\;EF9;O6P-126ELR58\>F"K]HW4%P#6$6
M6X&26.FD)4S<'!TN=P+SC HQY-/8: F#NIVLH@)B_P!F:G )1 1#CP-$#P,4
M?<, \!#K =2(O?)U["VE5E7$5LEVNMGZ8,NP+P>VK$CZ43Y\DR(J+5L:KI@H
M)D#*D6_#*)&QEU.(@42F5W>XN3[Z_P#Z#NT?PC_Z.N)0X=8]0 %4  #Q<  .
M'@  ZM.18_W^Y?H-)W?.'U_.=/W-;!\AN"O-]O4_P?FON/KTZN+B[?\ #5(@
M\>8\L= @*O7VW8&;1&VU]1=PL<>>[DI)V>2%Q(RTDXYSJ2DG1U'+QR<RBA^:
M!"$<'NGXW^/])\[:]ZRU&GO<7)]_,>VC_HZXF^ZFCO<7)]_,>VC_ *.N)ONI
MJ[EV4?\ *;F/_P##2=WSA]/[/3TYI3QWJE@AIJ:WV*GIZ>*.&""&MJXH888E
M5(XHHTM2HD:(NU$4!57   '22W=/QO\ '^D^=M>]9:.Z?C?X_P!)\[:]ZRU&
MGO<7)]_,>VC_ *.N)ONIH[W%R??S'MH_Z.N)ONIJNRR_A-T_0:3^L/I^IZ9>
M9Q#^"V;S?&%;W9^*_I]?J>B_Y(QJZHUP;GOV.C$7K,VD<)6W1!8P2J1S@A@D
M3,9$7A60@/!T+4.D CS^P_T3FZ5263L;@DD'L_I'4F0/P;;7^;^Q#]CQDN/#
MQ<>OAPXZB1=.3IV$-:A:',;LDVLMY%" EEF*\-MLQ*\ET7:3%<[=6,:#5T^D
MOR*E*9HAV1/LJX$()R@81THD^3CY/P4TQ-L>VDB84R<X3;=,3 81YH<1,'L4
MZC"/$1#W!X^'PZ;++^$W3]!I/ZP^GZGHYG$/X+9O-\85O=GXK^GU^J3/=/QO
M\?Z3YVU[UEH[I^-_C_2?.VO>LM1I[W%R??S'MH_Z.N)ONIH[W%R??S'MH_Z.
MN)ONIILLOX3=/T&D_K#Z?J>CF<0_@MF\WQA6]V?BOZ?7ZI+=T_&_Q_I/G;7O
M66CNGXW^/])\[:]ZRU&GO<7)]_,>VC_HZXF^ZFCO<7)]_,>VC_HZXF^ZFFRR
M_A-T_0:3^L/I^IZ.9Q#^"V;S?&%;W9^*_I]?JDMW3\;_ !_I/G;7O66M*2OV
M*9B.?Q,G=:&]C9-DZCY!FXM=>.@[9/D%&KMLL3MF'.2<-U5$5"\0YQ#F#B''
M4=N]Q<GW\Q[:/^CKB;[J:TI+D].3JAH]_+R^RS9W%Q46S=2,E)2&W[$#-A'Q
M[%!1T]?/7;BKIH-6C1LBJX<N%E")(()J*J'*0AC $=F) %3="20 !0TI))QT
M ]L.I]'IZ>GI1GOY5A)264H5(<-<*PJ5P-P8&UXVD;LYZ8/7IV*)/$NS-/M;
M_4G$*AHMI+L&ZJ]GBW*RS.;C@B7S627<3ZJTR@$:5-FQ2F5'Y(A%% L0# 4$
MA)LL<9;0(Z10EVS7%G;5!I%- D7-Q9O7JW:5R@[CGKUR^L;E60F$EVK85IU\
M9S-O4FZ#=](.6Z*:16OHNR;DO\G5UK;\<[4-D-ZJSXYDVEAJ6$,*V"&<*$*F
M8Z24C%UQRU,J0JR)C)"H"I2*I'$@$53,;\9W9?R6E8E%H2R;7-BE?F6\)(65
M>)FL.8+C)-&NQ3%[*2DZJP>P*+I.'CHV,D9![)&2!FV9,'KI98B#1PHG?XO:
MMS1\V[[TR&3VOIMR[<!@R^/Y&WKG(&.F<9Z1"VTJD<RV/@X1DQM'*LF$+;$C
MC9)!9\%C&H1&4Y*!54[0 '//BG9JH=8RD1AY4KB.-%KH*V.(59KM.@.8Q %V
M2DZ9FLX8L7KQ"+?*(&?Q(.W2D6Z9K.%5#]QK3MJK*BS.-6Q\8I4BPO8Z2G(#
MV81QVTO(Q)8<K"0D7![ 9^[?(]H(<YG:SLSA=5@@LY465YYSL=3MFW)7Y">V
M6-H>U[8I<Y"FRCF$MK&KX;P;.O*U+LW3IBZC9UK&0#E>+>(/6+YFJB\31,5V
MQ>MOVYHX(DM4>3NY/!R9P1OLGV@+G9N.B.R([>L1JF:N@227%LX*G53"@X!%
M=!8450(H"2Z*@EYBR9C4:&T(Q5Y[LC+@LK4%,K $ @D&O!&001GM!'IU?#;9
M2I>"Q\(E9DEA9X96(ECE'+J(F9+/B1)5YB3(25<$JX(R X<?5]KD8_DY1JYQ
MH,C,R=7F91X[N3"1</)6FN$GE>D%5)"P.C [:/D4Y%PL02GE9,#2<P,@_.=P
M934-U@+&,,K7Z)/8\KD0N^5D5F;*W0Z@*NU$&S,ASK/)ETX,FTCV+"*C6PK=
M%BX>/CH>-1:1C!FT08" V&<FK:V:TC5]GVRZQ1[9^]BUWT'@?#4JS1DHU7L$
MBP4<L:RNB5XP7XHO&XG[*V5 4UBD. E#O!R<?)]" "&Q[:.(#U@/M=<3=8>/
M_P %-6F.SJ2&J+H".A!H:4$'IT(-P!]/[/3TV8*2X1,D]-:>&HW42<N:"HF1
ME6=Q)-LDCM ($SEI)-I D<[VR>NI+]T_&_Q_I/G;7O66CNGXW^/])\[:]ZRU
M&GO<7)]_,>VC_HZXF^ZFCO<7)]_,>VC_ *.N)ONIILLOX3=/T&D_K#Z?J>FY
MS.(?P6S>;XPK>[/Q7]/K]4ENZ?C?X_TGSMKWK+1W3\;_ !_I/G;7O66HT][B
MY/OYCVT?]'7$WW4T=[BY/OYCVT?]'7$WW4TV67\)NGZ#2?UA]/U/1S.(?P6S
M>;XPK>[/Q7]/K]4ENZ?C?X_TGSMKWK+1W3\;_'^D^=M>]9:C3WN+D^_F/;1_
MT=<3?=31WN+D^_F/;1_T=<3?=3399?PFZ?H-)_6'T_4]',XA_!;-YOC"M[L_
M%?T^OU26[I^-_C_2?.VO>LM'=/QO\?Z3YVU[UEJ-/>XN3[^8]M'_ $=<3?=3
M1WN+D^_F/;1_T=<3?=3399?PFZ?H-)_6'T_4]',XA_!;-YOC"M[L_%?T^OU2
M6[I^-_C_ $GSMKWK+1W3\;_'^D^=M>]9:C3WN+D^_F/;1_T=<3?=31WN+D^_
MF/;1_P!'7$WW4TV67\)NGZ#2?UA]/U/1S.(?P6S>;XPK>[/Q7]/K]4ENZ?C?
MX_TGSMKWK+1W3\;CX+_21_\ BRO>LM1I[W%R??S'MH_Z.N)ONIK(G)R\GZ0>
M<39!M(*/#AQ+MVQ, \!$!$.(53P<0 ?\0:ILLWX3<_T*E_K#Z?J>E>9Q#YZ6
MS^;.+A6]V?BL=_KU_/MT:-&NPNOJ.I5XUVIR>4<;1^283+^(HI!>R6>N3%7L
M9\CL+#5AI-'FLHW"9FW+/'\A6U(BOXOK\G>ESPTY*O7[ B,)&-'=H6"'*Z"O
M)[Y$BZM*7>VY.QK2*C'WBO45&<LE<SD1-T]ML!0+#69-Y'1^)7DQ6(V80R37
M&"!+7'P\@63"21!HJT9 ^7B+3LKY(Q\$06E7.;K9(&VJ7J)1C56H-VML7KCB
MGNI@S9RU<H/3/ZF[=UJ3CY!-W#RD$\=QDE&NFKIPFIT[YF_+63WD(_O]\F[0
MYK,H69K9GZ<4@C7Y%..KL.@M"M(R-8,XQ%I#U&K1+)@T;I1S&,K\4P9LT&S4
M$S1<D-V-03%60)3,2?*B5ID&[(1!R1&05 3>[,5RS,LA !PE9R_210G_ +H+
M#KT !7:>F!DY[22#J0LOL<N<<XD2L<NX,F(Z,SNTVS.IX+%;Z]#)YP<RZ+!6
MD*K6JDP[I#H<:,A8SV!9F$ ^C8AZQB7K^=<1<6_B!98%[5;)9*M)F0/)5:Q3
M]8DCM3G4;'D:Y,/81^=L=5-%4[8[Q@L9N=5%%4Z(IF412.)DRN0MN"S:X9.X
MU?)UJ5CGUK6O;Q@==CT)S=W%Y0R6M<%6@, ;C9U+TU;6(9T$PDBK(DC2.2P/
M&)%JY22?S4G)S4L[6?RLS)2,S*OW E%P_E)9ZO(R3YP)"D(*[U\Z<.EQ(0A!
M56.)"$+P*&>E2N0MXW-#*.Q#&I#=-O5O@XQD^42H! )&&([+D$H)YC*1YMHP
M>P=3T ]/0#\YUHZ^PG_8_'_$[R/_ .\;;_\ 4#&FOCVU]A/^Q^>K9WD?_P!X
MVW_Z@8UUQSCG_B%__BJ;_P"YM:5T_P#5&_\ ?C_^[4O\MN]MS?*%Y<W?'-_8
M6E"Z5^JCER$7C"+2=ZEJ1C>VPM:@W+.RFL+9&IP;"DW2*1FZZVJ2%AJCEZR.
M_FD56LHEHNW[?Y%6LTN$QUE)Q9+=)RM$:23B[4F)L\;)T?(U?RM[.I1U,Y!9
M]J[X?).1V=U)#N(]&\IS9G[&3I[5BW0CG"]RME':U6,CW8M\QS.RDZI8F<+:
M)U2,2?5EU+P5:QC*R,TZ1=VM%A#)UFK2^/$)6WR<-"$?QQ"5Z/E9DK&2CB(%
M7+NTF FXIU&4*YQ<KSVDN[M8STY$JP=+N3:E-JRJYM#"_+OT*G9(AW5&]+Q\
M9R2(JC%HE%3=?H"+,Z ?,8PQCB'*KF(B1D <F,LL2A2H$H(02$, #UZ*%4DK
MJ#&=J>3,<*I'E';]B,8\KLSC SZ  .S6Q'V#:-,&@DF-)L=H?/\ ,ETQU8;D
MXD*^WD;%;.EQK*0M%YLJMFC$;:RN#>X,9>FP1%'<[*5J0DCU>GMF4/(1C)O:
MO'[1;!5,?NBX<R9'0%WM+:$KSV2R) NE1%6K1=6)+3TFVR@\ DH]0GHI\-1E
M7;B_S=@8&N+*M24I659!HI4LZ;*Y96!4A\33*1@;M$TXN/KSB$7LC&@Q5@>&
MJZ5=K\V1#)"-:DZ0UCY&$G6LA35)AE!+/'SJ2BH0H.W9Y?:I3\38QOK^H6&:
MH$P+U[6XJ)EYVT-H6#KM/E\FSL;,1 7AS$.:/!1&/5)J2HJ*DY77<[!P:K*L
M2,RTC%4+B7C*J8[@KNV%!D8$X$C$ +*HR#CH1@*C#H6.*^4O3;."W\(]YZ88
M=>A\WVI&.W7(L->V6U"2MN.[]8#1HV ;%0F4=:+1)D;IPC2KOWLI3J0JP4*[
MCH6MJ9>?#"BH<DLC?+$W8P$D]G(F&:1LC]OU Q75Z^XG,0OIQ6JSKR:0!E*+
M28@SEHNPR4=8D%VMAC&5F92K*QL95A)L)M4SB/>H.V96S4""F$-++E;:'D::
M)*2M$R#*VB]-WLM7#N86(AI!E+V""&NV4M:1L4_$QBK^"1H#2=F5I$DO6HNR
ML(J=C' S<PQ/(?MA+<SMQI%/IZ]2;94DD59>S4> EIF5462NEGLTG&7.5>/&
M4Q,PSA5^[G[C6FSV:D*A&,Z]+W0(Y-?H"<B\;XI8*AX,8KC(2AE27!B)PWE*
M-V0<JO4]>DG3"G%K([)CX8L=NY6ZJ2 >H&<YZ#!.3T8C([+2=&H9--\.*UTX
M0ZT!>T.V\"M;UU"1U>=LH6BQA7J=GO<P^;6<Z3.L51_%3+*9 Q!L9DHEU-1M
M<?UU9C+NI!8QR2SR9'34DRBWT6C%3+5@B1_S 6>QTO5JU=(&4!(GX;49"O6N
M*768K_TRQ=](:K<[L9%#QSP31C,D;*/2<>G:?/YCT/H/;K7*,OV2D?3ZOY]=
MW(%P98\H=VOTDU=/HZCU&R6]^R8B@#UXRK,,]FG35F+E5%L#IP@Q41;BX620
M[,<G954T^<<(H0F]:OV1A*2-?HLY-LZ>PF;+D!]&SU<6CH2D0BD4F[LT \57
M;^R\_P#5)T(0;1",DR&KEA;*<QZ6 :V&9<S#Q=AB)6 G(]I+0LY&OHB7BWZ)
M'+&2BY-JJRD&#QNH IKM'C1=9LX1. D514.F8!*80TWDSA'%%@ET)V6HL"[E
MD9HE@4>BV405?29&$#&%4EP;+()S;;HE6K)#1LR1_%G4KT(Y.Q,ZBF*Z-\+T
MRJ1-$[MDD,K8 &  I7*Y.<G=N&#C*N,C5R&, [U)/F(/9V>8$=_7/3IT/73*
M8ZWGXPOD]-P:Z3ZOGCGAV#!RX51EDW\B-XN-#:5]RA$)KNHBU24I3'K^+@7:
M*AY"*?QZC5VK( _CF,EZ/;6%]IU7NT6SE8^-M<%&6!@RG&"D7+MFDJT2>-T9
M!@J)C-G1$E2@HF!U"<>!DE54C$4,FC8<QT1W$/F%7BX=Y"OX]^U<P[1NQ6.$
M;8I:W(,7"A$3G5CC6>;DY]9H D*K*NU7@G!4QA%<04'$UF(CH"!8-XN&B6J3
M&,C6A!3:,6: "5!JV2$Q@1;H$X)HHD$$T4RE23*1,A2EMF:G8DPQR1Y(P'<,
M H!SUQG);![3C!'TT8H?L%8=?.<],>OKV]IUUM>&\ _O#_%KW7@^ ?WAU@U9
MK^?'O^=.B[XMVQ2NG12ES_D0I2D=.2%* 2H< *4JH%* >X   !X #AJ(G2W?
MPMYY8[]-JU3>ULEW@W3>#N<M]0VQYLLU6LV;+U-UZPPE%DGT1-Q#Z2!1G)1K
MU,>QNF3I,.>@N3\%0O6&HO\ >_\ ?'\T?<!]7<K]NNP%OK[>M!0JU=1*RT5*
M&5JJG5E801A@P,@(8$8((!!'7LUS&&:(0PCFQ@B*($&1 00B @@MT(./S_1J
M)?2W?PMYY8[]-I3TK(%WQS;*_>J);)^J7"JRC:9KUAAY-TWD(N1:'YZ*Z0F4
M4172, F1=LG:+AA(-%5V3]LY9N%D%)&][_WQ_-'W ?5W*_;I05/DW=]-NLT#
M6$-KV78!6>E&D86<N%6=UJJPX.E (I*6&>>"9"+B&*7/<O70IKK=B3%)HU=O
M%6[5;9>X6LHXDKK>T>U@ZM54S*4QY093(0RE1@J001TP=7F:'!S-$5QU!D0@
MC Z$%L$8(R#TQ]&OJOY,WE):QO8IZE-MY8^K[B:1"IOKC66H&0BK?"MUFL>?
M(%+34.H<L4L]=-$)^".JH[JTJ];MQ4=1+Z*?N+5=00V&;#<9['<9A7Z^"%FR
M;9V[-SD[)KED5"2LTD@43I1<4DH*BT+3(9559.!@2+&'\-64E57DR\=.=3OU
M\'NS6][A4M:T=*(R? K)] WE 0&2(ON,2/EUCVAL'*CB-083-(8 1%GR0?HZ
MD=,A2<[0<D+C/72'R44#4.U 8I# ,,[ 2GE A2"' O4:5-U, _\ 61ZD_=\.
MEP'_ %C[O'W?Y]7N>#2'R2H5&B6I4YFA"$AG1C&?QIIAF  !>(N(PJ:IGR7O
MVX$.)^K\$>'4N _ZQ_C_ )_OZCM8=&C1HTTT:-&C332$R64#4J: P%, A'=1
MY4L(4?ZKQX]<F80!MU@' >/]&'@WZQ6#2Z#_ *Q_C'^?[FD-DI4J-+FE#F9D
M*4(_B9_&&F&@<9:/*'98XA%#..(B $X$'L2HD7'@"7$%R'_6/\8Z::]T:-&F
MFC1HT:::1^0@ U#N0"4I@&KSH"4\B$.0P#&N>(&EC?@QI1_MGP]30.*XC^!I
M6(_M*7_)D]WG?VH?VW]M^_[OA]W23R"H5*B7)4YFI")UB<.8SZ/-*LRE+&N3
M"9U&%(H:0;@ <5F14SBY3YR(%$3\-*Q']I2\'[63P!S0_8AX"\ YH>(. < Z
MN&FFOTT:-&FFC1HT:::-(W(M0;9!H%WHCU\M&,[I4+/4G4BW207<,&UE@W\(
MN]00= +999HD^.X22< *"ATRD6 4S&TLM-WE^F/<CXGR?CV.D$(F0O>/+M3&
M,HY375;1KRT5F4@VK]PDU.FY409KOTW*J;=1-<Z:9BI'*H)3!?$=LD;!^65=
M"'QNV88'?M\^WMQY\8U1D256CD *2 HX.<;6&&SC![">P@^CKJ 5[Y+K%EDA
MVC&H9"R!0I%O!XRB'%B:3MBL5AEU*.XM7;R7FK),VL;7)R5RCYJJMCJ.;&9O
M KXGQ4+%!U#TV.@2+/+7)YTG+$G>9N1REDEK/6K',C1X*R/7S"SV6DR$@K=B
MC9(:;GT7"[M,D/?K%4SU:236KKFGR3^NKMS,GJG,Y3C;GNDIV,,LP]<S5/WB
MRV];&2=/C!NMHJR550A<YSLU;4(*P.7BKNFPK["<G7*6Y;5,6ST?8H^>1R*L
MQ)ME%>>SVI[NV18)T&[>Q/Y<+="NI9P^G+J6+AJS$URA-HU6(@@<+,;5*P<S
M#7QO(0EK!"O90C[FTG;^L>Q5UF09\5M7D,;VA,;LL;/&S,P*4[LS Q,Y0E50
MB0$.T;A0P9]1GN9L6)5%+3*LA1653.BMRPY1E1' 39SY0K*%;.,$[$VKR-V,
MPS. RA".L@OWXW6B91QQ5W)8,T0%5J^5\KV?,4ZWEQ@[+&R5L=M[/8TV#)ZV
MEJFLWKL:5HWZ/*2DM,NFNCN3:4BBB6.W"VYB620K[VU$CJ?7XEO:[/5J+;*9
M%R<FTB)1@R4A9%.Y22=N@5FSIU9ZY&5NL+S[0D0K*/T)6MLF_&WTZTN)W/MS
MQ1:VG;6-I\2]RG8[6E.+KGQ"+^S3\G 2<RC L[4UK>3F\;%Q9Y!?'+ZZDDJG
M',FK)M&I+UIM4WKM$7)5-WLM)NPR'BNW-'LG+VTI7$;6862C[["2<?$,HAH6
MK6%PZ9.6E&A0B4I&08=MYVW"5<L.WKXU4Q\W^_-+ND8\Q>0LBL28\LI%.\8!
MR'8H1\)&S8+J&-S\-65^5NCCS3@)$5GJU95'8-\<OE@*[(,EML>Z)<)Y.DH7
MDJH9,8\C;/MYCV+!/)YAJ,-&NJQC]DKDMBU36C*_4*G=( E>I[1XDND[K;>1
M<+2U=%C!(S,2X8GFG=DV(:.;%N,*/CQU9UK<O2JS%UYQ9'C&-B%Y92-2%L+L
M\7%\&,:0QB"D@S1,KT=%--%5R[7(JY5A#?MK6XJZY+RO/US-]DQG#SUP"9@'
M5?L]AB!F8I["8?CVS9\WJTJS62&IQ=/OE78MI)$Q"*V=&Q1JA7"[DR#:!L-W
M$%C9ILYSQ!2CF\2D(OD!1(+G6$Y\L?8\FV4TL]&O*IGF%&$A>4EDZ@^3;5BQ
MKJ/E[$<P1\2F;#/.]?%&*R[1-M*N(S3^4C."[G?'&@..8X(WY9PJN%V@IEH+
M%:;:S342)3R2(J/AZE]RXC&"LDCIY(C4 X!&#C;O?-N?$./#B''Q?9X_%^_U
M:.<7QAU>'K#JU &1VS9[9[@9G(E-S<M"8XM68X/)4Y4CSUZ%RW8L:]A^'FHP
ML4#MS7)]O.Q>.K934Z[)&8U:$B\B'NL<T"Y52,([3<_M:W6K6>Y62M;K;'')
M6 <CF80#^<O#N$8)6BQ94D:]&,F1WKAK7DXBOSF+:NA,5]HA*5T*?+SM:!*3
MDAZ7H"EIR%)KH5W1HQ#1S95V&60[58>0<@D$YQG: 1F2$:''PR#*@D$-T)QD
M= >SKGZ.S5D//( @43EYP@(@'.#B(!S0'@''B/#G%X\ ZN(<?"''WB'C#\^J
MD9S9IO1DDY"2:;J$VEM;UE]#U6?4G\C.'T-#S\UCF5D,<(/G .!CF,*WI+R,
M#,K5DZR?D DFD[N3)(S8S<VY>MDV[.XQ!X)WN[LC^/L,9EAA?"/K!?6#.=2N
M$/*PE48,H6$=MF$-&0S5:%=.DH,\*=I)1TFYBP5&>4*RR>)4N4S<J<!BP;$4
MY*;1NSC8 P8=%\H'?Y)  +"[E1],U"=>W"N<=,^@9] [.O0@#)%L7$/&'YPT
M<XOO@_.&JP0V\;U8+'-^@GF>Y#)-EMN:,635?5:76T4-.M8SC;4#J_1HV-DB
MWM%=9R-<<)0[R'J#Q\X59P)).',G-S\BU+XOM8WJ)(69LGNXD)LDNMC15LYE
M):YP;XKROT2=K%HE6"M8(V1J; MJDH/(C:FQ2,FROLQ5BP5YL"-<L,BQ;6>)
MP>5_?"FP&PI"S>6/@LE1L#+CF,/A%C!,;8)&YEIRDZ_#1]O3H_4>3U'DY'V1
MZ-M^Q/F!(L][(03"0#EYP !A+SB\X"B)@ 1#CQ !$I@ 1#@(@( /$!X>\\G.
M$O/+S@*!Q+S@X\T1$.=PX\>;Q 0X\.''JX\0'561-F^[&+FZ!8(?=A)N)M@:
M@*Y-GY1U;!D[HM5,C9%MDNT22!9ZS3I\M7K@PKC#'SLH5^&41=O6:B22*3=]
MS6&S7>"R*\E!W4KK6E.<J18>><RER=S"E1KU_N-J=05QGBMF<A:(Q\QLK9(]
M8B4:=%J]KF\*:0;M4599_=XG2_C*G[0!\%/UZX)_Q?11VC/4CM4' U7E1_A"
M>;[5_P Y[.P=OIQYL]-6P%,4P 8H@8I@X@(#Q 0'P" ^Z ^X/NZ]TR6W6EVK
M'^'JG5+FH09U@I971V*3LKY*OQ4U;I^=KE12>)G40<HTRMR<34T5VRBC51.%
M*9HH=MV$PO;K0=0KNJL'5690X[' ) 8=O1@,CKV'6$C!(!R 2 1V'![?SZ-&
MC1JW5-?*9DO_ &/3E?V<V$V'<Y8Y'&ZKXR]5;Y)8VQ.Z1\<J4#%C9US6X=W"
MRKIB?G(EF&2<<622 BZD2P5YZ9D+_M>K='\M^ /X#)'W;U]=?/)[XOT@^W1S
MR>^+](/MURM.->($14\:B;:H7<]+3L[8&,LQCRS'&23U)ZGKJ0%TK  -ZG'G
M,:$GL[3CN_:?3KY%/]KU;H_EOP!_ 9(^[>C_ &O5NC^6_ '\!DC[MZ^NOGD]
M\7Z0?;HYY/?%^D'VZN]V_$'X3!^B4_\ ^&J^VM9]^G_5IW=W=^T^G7R*?[7J
MW1_+?@#^ R1]V]'^UZMT?RWX _@,D?=O7UU\\GOB_2#[='/)[XOT@^W3W;\0
M?A,'Z)3_ /X:>VM9]^G_ %:=W=W?M/IU\BG^UZMT?RW8 _@<D!_I]C8\/W^
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M^D'VZA3(Y[7<]G:Q^U "^?[4  >@  = -:NYO2?-YSYNSU>;T:0*.)\7-@>
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MWJ)A(:YR+"*C&;J+*U8,TD6HIMFY5(E10$B&.<2@=0Y@$P_A#JO5=RV[ O\
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M"?PL^$^HGFJ)/"!Q@LDTKRNL'$-TIH0\C;V$5/3U,5/!&#T2&&*.*-0$C15
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MXZPI*0UOE0@R3I D1W[1S=SEV0D<N-6:4I@XL&[F&-_B!2?-.O>K='<PQO\
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M5$D(D)F68 8(?)CY>S S1U,<DW-%UO\ )#'+">0U#)&"&J'E7)2DBG:(+3M
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ML5":OV<B\J]B?OY&S-H_D89S_N8G,Q%KM^KS%U$OG#%U+T")Q99H"8I-.D<
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M*!E3$(5,IE#  "H8J9"D QQ,($*4H#S2@ 9\ \0?FT:---' /$'5X.KP>#[
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M&" 01@@C((]&.S&MDB2:9$TTR FFD0J:::8<PA"%*!2E*0G-*!2%  ( !P(
M!S0#@&L^:'[OB_9&]S_'_I\(^[HT::KH$H#X_=\!C!X0X>X(?XO$/6' =><T
M/#U]75^R-]O^GP]8^,=&C337HE 0X#Q_./\ 'QX_O^,.H>K1P#]WW?='W?\
M'UZ-&FFC@''CU^#AX1X?FX\./[O#CHYH=7AZAX_LC?Z>OK#]P>K\P:-&FFO.
M:'#AQ-X_V1N/Y^/'_%X->\T/W?%X1_T]?7P]P1ZP'K#KZ]&C331P#J\/4'#P
MC_IZ^L?W1Z_W= E >/'CU_\ WC!^8 '@ _NAP'W=&C337G- ??>#A^R-]OA_
1=\/'KX\=9?S\?\>C1IIK_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g312628.jpg
<TEXT>
begin 644 g312628.jpg
M_]C_X  02D9)1@ ! 0$!&0$9  #__@ Z1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?04Q47TM?3$E.12Y%4%/_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_P  +" %$ ;\! 1$ _\0 'P !  (" P$! 0$
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M9?8N ]1Q[G#0'S,:R^Q<!ZCCW.&@/F8UE]BX#U''N<- ?,QK+[%P'J./<X:
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MN<- ?,QK+[%P'J./<X: ^9C67V+@/4<>YPT!\S&LOL7 >HX]SAH#YF-9?8N
M]1Q[G#0'S,:R^Q<!ZCCW.&@/F8UE]BX#U''N<- ?,QK+[%P'J.1%O;0FDH;5
MEJD(G4NNXY^@2%!!XSJ,&W=(^-LT(BJ**Z;(JB0J(J*(G,F8IC)**)&$2*'*
M:7>.'O :8^C*E_V QR:<8QC&,8QC&,8QC&,8QC&,8RH/KI<IK/Q5Z;.]9?68
M33K>V[TX'BWQYA*O'OI:X3NX>04A[0X=&EQ46V?2LM;(&MO+5<86+B6#^4?/
M*XDW8,W#M1%,WE@2WA(ZNZ*75'X(.9?D;65>%_)[A_?M*ON4-$O6B-Y^Y-Y
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M*8.Y3 8._;N @(=_B[A\.1"O[^\;]$TS]]H#)?QC&,94,M:-BDZX#.MHZO\
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MR'A=I+TVV;8U3K39RR;O6C+6[26CXI=U3U6S]XW43<+OYE U\H    !Y@
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M>@MWZL#]ZH'*VN4?'.Y<BN&?%.(U_P 5M$\H+;56-.G&*6YM^;-XS2VL&RM
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M+]C%(Y9N5DO#(HD82JIJ$+W3*T?\;Y_V</\ XJLLNQF!,!0[B/;S]@^,1^
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M(BD*24Q!#+M'+BOSC4IO"8SL"O&S#!4"+LGR"Y"*%TC/PDY%\?P,^X,\O[G
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MQ['N*O%V2I=%H>D5K',.I6 U :YTZ2D?'6+R@T]88=^P=P[#V#N #W ![><
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M]N8R)-0\CM#[347("B*>NMP:[NJJA1*)NY4*Y8Y%?N4 'PBBF!B"4P&* E,
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M],)F$'!.1!8 FFPL9MH" )D7*67)L+R!XPH%+&EI8'*$L'M)!(@  "4IA
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MZ#=,B*"1$44R FFBD'BT4R%#L!"(D\%(A0#S 4I * >;MG]2E*4.Q2E*'Q%
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M0VFJNJ8%7!-KZINZ;@Y"BJ CW$>MN(KJD\?DRJP%CT)U Z0S%8ZD/>V?N/\
MDJ#,RH%3]CW>G1U\XX[(G4T0 R;)[K;CS&.U?"!>=8E$% ^LPZHO'NJ3,94N
M5-?VSP4N<M(^1XYERYI)*#KJ9E"D)X32L<DJQ+7?B]:%E53E(S9Q>YAF7(*)
M":'0.H"1=1=;\_>&%TZWNSM,5/DAJZQ;*F>%FG-3PM=A[$202F]FT7<W(395
MOH,)/-DU*Q,VZOT:VP5@D(&,F7<DDV</&R;=1]$3+5A>\ @( (" @(=P$/.
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MPBI"7Q"9UN_BR&,%G^,8QC*XJ]^-KW!_F[.-W^T]RIRQW&,8QE<5>_&U[?\
M\W9QN_VGN5&6.XQC&<3$*;L)BE$0$!*(@ B40'N @(@/80$ $/SYYO-#]'CI
M]TCK6\GMXPFB8TUGJNB./_(6I0,I+2DQ0*ON/D;L;EO6-IW6&H\DLXA$G,DP
MUI#.8*+=).X&HRLA-2=8BHMTX8&C+Q;!Q/XO6U<'-JXXZ&LK@&8QP+V#3FMY
MI;R>(K"+'QLE6'*GL,1<+B+;PO$B*RP^!W4/X40R/3.Z<\L5 DCP+X;.2MA.
M*!1XRZ82!,3E*4_8&],1 P&*0H"4_A%     //WZ [Z1G3>7,HHQXB:EK*ZB
MIE!=T5E/:]?)IG,8QF2#^BSU<>-HLPF #0[==**$B3<@LO :MBI?U:=*CAC$
M"F>LUO>-(4;%4+&C0>8_,NCHP@JE.10T QK._HZ-@S'!58QO)C)L4RCARL8H
MK.%E#\W/33U2D;M6^074 J"'@"8&L-U">74DW]F^?P9 Q+EM2V&57*!4 %JL
MHI$JE;ID7C52*.BN/QMNGI9HTWA074.ZC4.)SI'=>R-VZNNA78HG R7\GLG0
MUR38 GW4[IPY8U)WXP"ORNB(-2H>.3@%T'>HGJSKB[FN)N6Z=%;:'FG>X;SR
M:JDO$W/:FS:GR;;[>"AL5Z/>:@_K4S:[RI69D^TXV]P[ZI5Y9DZ?Q1[&Z"M"
M?V+(<;NHM%F.$3U(ZK,$,'B"_A%X-:SG%4VZ8CXE<BNOMKZI*:74 "@_=+(J
M1;@?#,R@HSPB@G])>C]5>*(D6-Y*<#K=X?\ )*&G^'&_*DJW31* )N@-7^:5
M@2?.7?<3.D?8\:V;J$\)KX2:OB4?G(2'5SCQ.#BH].>W@H( 4Z6Q>4>MQ:@F
M(@)Q25U?M,) 7H"!@3*M&!&"F*8JRP+ HW^@YW%U.H@2@]X.\6+)XTICE-3>
M?=O1]C%2[ =-R2Y\*:Z)W#GPO"9%:G5;?Q#E>NFO<AA^>ARNYT,2G//]+K9S
MT $JI0U]RLXD642M2?\ /IKEN5^U@J$H;^,+)FU3>LG( 4%Y9B<W@!^]YSNV
MQ!E$UHZ9_4"B2%3,Z,K#0W$_8A$X],1!5R='7/+*S/U72?@*B2$8LGTZ[\$@
M,(YV=PW(IY7>D5_"#KYRJZV6WM13?&UC4-?<V[ VK5=(T?3BVR=4.N-.K+XG
M4I"[I.S#$RZ4]6X!VROS!I%P1JS87B+Y@\<L(URP?^[<![@ ]A#N #V'TAW#
MOV'\^:J\I+7RUK%;,KQ>U+IS92ZE6N[B?>;,WC=-33=?E6<0"E5&G0M4X];P
M0NCMXX,]46:R;NK%0>,XUDF9XE*.'<9XN>A_SE_A%FWN9LG4^1]1VYM#7Z6C
M[_+HUKEU2K#Q-U6G96$O248N3;[0J?$VY2CFW-$W;]"(J9XDK28:.Y=RXD69
MHM,ZMD?.BP=2-]U*]&SU$K6YJI=8/7/%5G4=6:KDN0U_T;9[A9G_ "2+R)<4
M7;D?7-><5T]<4LLCJ(W(![S!ULUO]GKD!!-=1'UNZ4BI"P3?TK;)R7K&C^9-
MH8(<MGK6N\+^+\_'AR?BMUS%P>=1^%T1MY[S.;TN%WTW=VB5;+;!9ZB]L,?4
M&#K3$E=U7S;6*3E@O))'Z-H/E!UAF^WN/Y]FV:V["H]BL_ #\(-0E>(<%06+
MUARZX?[>V!O&'D[C!P3*0J49QYW7K.H1S&6*X8NZE)[#D:[MF1FVSBL1T5/_
M $=N;?*SDENW8VO>2.T+%='\5PTXK;VM-*M'&I+CLMIO?.W=A;[KFXM55 [N
MM0<SL_6]$=:\AZU3MBF?V6(GF[!RJTM-F?IR4V[NMY$^]!;OU8'[U0.:\VEQ
MHUKTY))QR8M2U)X^I<7/"W+:6UIL]+=PVN/:.B6UNF=FI3IE<HEZ:*%=NS6J
M;E.S*N5TFD$"DHX:I'U\Z5E[Z64C7+A0>G)KFJZI7AH"MVF_5P^F+KJ39T]
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M5KYVS AJ^K8+N>(%F%SL!7MLV,8QG$2$$0$2E$0\X")0[@(#W 0'MYNP^?\
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M)ZYM3:\H,)2H6^EN&J,40DG[-=7"Y@3  @ ^D?S"(!^D0#L'?X.XAW\_;T8
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MK'KYJTMC>L(VRLV>:MI[''2DNYUHUUBS5V(G;7C&,9@1[ (]A'L CV#TCV^
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M^<(%?RL>U%5VE2?;NLS:8/AU6^:45PHV!^#=LIR?D=T,[WN;66OW.G8KC/R
MEN/BM"&75;V&#V!R6VQ:(M4FJ=&5-T,=:)AK*5MILY9VC#/9^\2+?EE8UA)$
M;/61)!DT>E:2315A(M2NVZ3DK=^Q7 JS-Z@54$G;18 5;."*(*!X:8Y^_&,9
MU&^VAY2:79[;'4ZV;"?UV%?RS.C41&!<7*V.6:)E4*_6$;1/U6N*3<HH!6L<
M6<LL%%"X4(+Z68MP4<$IWLG6IH5<X0Z"Y>.-#WD]GY ;"E:E#Z"&TPI[92ZO
M4.1:7'[9.Q+Y:8Z+E(*)KNNY.0K9YX\>SE&KNZ72FZ[AY1^ZL+2PA:1R&-X6
MG[>/;MV\B%_[EL@R]_Y^W?/Z\</> TQ]&5+_ + 8Y-.,8ROR^]-7CGL3E?#\
MN9UQLE&W-+;J?95DUQ%W8S+3>PMO:$@;-6-'[=O%/-%KRK^]ZL@;2\CZXI#V
MB"K<@$=6W=MK=E?U>!=,; @    #T   'P^8/SCY\SC&,9H$OT]Z*/."8YZL
MMV\AHW:L_7:?1Y:G$LVN);5PZWIC$Z;364%%6;5,[=*11)V?67O-RA:#?:L>
MXW=4L[8';X6K%LUW] .P '<1[!V[CZ1_./;L'?\ FQC&," " @/G 0["'Q@.
M:%V;II<.K1R\UOSC7U%7XKD1K>7NUD0M\''Q4?[<;3=:?6Z(>U7Y,8U=W9+'
M5ZU5XYA3I4'[%:%(HZ\8#XAVY&V^@    !Y@ .P!\0!C&,9@0 P"40[@(" A
M\8"'80_HRON"Z:W'JN<N#\P8J2VBC; V)<MV,M7'NY5-(1._MB:D::(O.]HR
MDFAO*B&Q;1J5H6G28*VI>FE2</IYE4&EK?NIU2P7T8QC&8$ , E$.X& 0$/C
M 0["'F\_H^+*]:UTT>/M5Y:N>7D7-[:/9S[1O6^8W5KZ]IO=*U_?VS=01NAK
M]NN&JJL%[8R7:R:HC@J*K*0N<C1XEN]D9*O4^(F7AI EA?HQC&,#Y_\ 5_J'
MOE4^TNCWQ:VK4"5%_9M[5,#[&YBW>4L=#V6VK5FGJOSXM[ZY<J]*R[TM8>,5
MM0[1?.(]DO&-HQI<ZZSKU?=5:\PT['GF7%GM:K<'3J[ U.LQK:&KE8AHNO0$
M0S*8C2*A(1@WBXF-:D.8YBMF$>T;-$"F.8P)(D QC&[F'[>,8S @ AV'XP'^
M<H@8/]894Y>.C]H>VQN@8Z$W/R:UN3C5MOD9O;5PTJYZT>,V6W>3&S[;M6W[
M!EZ[L+3]]J,S;:7,WFU0^HK"XKI9G6T!,ODX-^$VZ<SBUK3%L9FS:-#NG+T[
M9L@W,\>F2.\=F12(D9RZ.BBW1.Y<"05G!DD$4S+'.9-),@@0OZL8QF#% P=A
M] &*;^<A@,'^L RJ+871;X%[6XW4[C+L?6CJY5?7SZYNJ3?)]Q"/MLU=GL3>
MY>0MX@86YGKQ4F5?M-V33C9J,3AO >U5)**45]F)IRI=XMY14=!:,G86'9-H
MV)B(^K1D9',D2-V;".C[#76;%DT03 "(MFC5%%NW2( %312(0/,7/I\</> T
MQ]&5+_L!CDTXQC&,8QC&,8QC&,8QC&,8S^+ERW9MUW;M=%JU:HJN'+EPJF@W
M;MT$S*K+KK*F(FDBBD0ZBJJABD33*8YS 4HB$)L.3O&V5@M?VB+Y!:0DJSMB
MT&I&K+$PVQ07D%LJZ$=JL#5&@2[>P*1]RLY7R*[,8"N.)*6!VBLV%H"R9R!.
M'A%'N &*(AW[^</-V'L/?S^;L/F'XA].?B>2L9'F8D?2#%F>2>IQL<1V\;-C
M/I!9)5=)BS*NJF+IXHB@NJFU;@HX.FBJH1,2)G,7X]1NU,V!!HV>AVVL76M.
M'LQ'-[#4I^)LD&O(5V7>U^?8HRT,[>QZKR#G8R1A9AJ1P9>,EF#V->IH/6BZ
M"?9@$!] @/;T]A >W]&9QC&,8QC&,8QC&,8QC&0GR)]Z"W?JP/WJ@<Y\</>
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M8'[U0.='X_6B0;:*T\BFBS$B>MJ@0HG36$P@2%:$#N)7!0[B!0$>P '?OV
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M+Y!C]4X]9R(=\V9^ZU+<4U$6A0*A!G 2)K /<+;72]A\)P8.W8X_!W[]O/\
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g347371.jpg
<TEXT>
begin 644 g347371.jpg
M_]C_X  02D9)1@ ! 0$! P$#  #__@ [1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?2$)!,4-?2U]"05(N15!3_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_\  "P@!' &< 0$1 /_$ !\  0 " 04! 0$
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M#;';VO=5N?$9,^PJ-V*TL[KZ>F(+U5KH5+XU(B?4^Z@KU [I,[FZ'Y,)+ZQ
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MG.-<[X*4;9UQMG&<:YVZ8SG&<8\F1^KONU_PB@_MJ7_K!WW:_P"$4']M2_\
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M\$S-^>T@$O@     #@)7^YB1?S$\?-JH5PX'?8.\-?O4^._Z((<+7
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M50KAP.^P=X:_>I\=_P!$$.%K@          'A%]'"^:WL\?A Y(?FK4(^>"
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MY-C51O.(      X"5_N8D7\Q/'S:J%<.!WV#O#7[U/CO^B"'"UP
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MZ_@SG&?P9QG&<?@R-.YQUZ_Z7B_]VW3^CKTZ?<Z=!$1'GW<O@F9OSV?Q+X
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MJ?.NAA>QF.[S.0      X"5_N8D7\Q/'S:J%<.!WV#O#7[U/CO\ H@APM<
M         \(OHX7S6]GC\(')#\U:A'SP0    &;_ -#>_OV/ GX0Y[^A"TA]
MC8O]K+_D:_W<#>   #'IRO\ .(S>\Q!\_P E$P0HYT3\+X^H8Y.QPEY(XZZG
M-,QDR@M)'8HYE5V=NWR5^5'$J"DS*PJ]279U4&$'%DMZ-09N4;KKDO;SY]@S
M ;[;Y^XR2N+EJQ7QG3,I6UW5="=JA6LTCM>4UG%%*:YHRMJ3AUQL:EA=@3MI
M>W2#+,/D@5LU5-JIMEJ39;(8BEC_ *MPZ8]C B CS[N7P3,WY[/XE\
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MFSJGTG       <!*_P!S$B_F)X^;50KAP.^P=X:_>I\=_P!$$.%K@
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M)V2*14AR=731@8$YAN4+>F/?'%U=L-J3&^R9N+4K3B$B4LE BR4D3)TY4C@
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MCSX\_P >?*-0            &F?)^'7\N!33@5]CVM^^.YK_ .-+D"+F
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MUQC/7&.O3&?9QCKGIC/DZY&G<Z]UW7<Z]UY.ZZ8[KI['7IU_WC<
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M?Q+X                     -,^3\.OY<"FG K['M;]\=S7_P :7($7,
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M(\B);ZUL&>15:H@RR=NLC/F,[D)!/H6 1 1Y]W+X)F;\]G\2^
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MIC.2\3D                     #3/D_#K^7 IIP*^Q[6_?'<U_\:7($7,
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M7MN5UQ(]#T[$W01L2)5*4XY"ZGK]>]&=,!$!'GW<O@F9OSV?Q+X
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M=5;*TN+TSH'-U3I#$"!:[-B16H*4+TI9L?D>?=R^"9F_/:0"7P
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M-_:X<$'.Q*E@2:[X\6AO*'[RBL+"7G%M4#DCH3<!%&*H!NK=3$3^PSU!8BM
MQN;/)X\R)&M<Z-+8XN25Z=FUL56<H7EYQIY0+Y\UT!<\%M9PK!U3-,X2Q%UV
M7',AJ]4[H6QPSJ<0FPY1UY71Z0(6.5LV7&+/BU@?$C0\K5#.XEIK'@
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MV3L;(H05_$GF?R=2U[24^4S$\E4B;W66N3:S,R1!>0
&    ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g363639.jpg
<TEXT>
begin 644 g363639.jpg
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MO_ G_;CU+7]$W_@3_MQC*<_E9MI_@<?%X_,YUC_>RX^5FVG^!Q\7C\SG6/\
M>RY<7EIG&//+;6,8^?.4(QC']N<<_/HQOYD-*S]Q*$JS_<G&<_\ 3C&4[?*S
M;3_ X^+Q^9SK'^]EQ\K-M/\  X^+Q^9SK'^]ERV2UW&E402H]=K)6J>#3(8A
MJ,VHN*K8E,N5E28T91(W)@0L2)"D*2PQE_UKV4JPVA64Y\H[WCO%T_UY@(FR
M=@-4JE62;-'@A=<LL&]&RDD8.=+D_9 -"Q9S;D<:-97,(35#TP8+&6U2I+67
MF4N,9"/Y6;:?X''Q>/S.=8_WLN/E9MI_@<?%X_,YUC_>RY))_P 1?KV6-B:S
MJD)N/?-B)0BY24)TWI#8%D<KH8*X*8E%K--.AZF)$17Y)F%%&,+(O$2\C$M
MZ#(2/G.,8<*LOB5;HI9*R5JC]=.K<:Y22B*0#V_'O>R=R:_JCLY$4%8[_6ZC
M/@ZV=ODD4B0<D:_B6"6'!2Y$ (6L9!V.15B.8_\ KQ^'^_\ .3Q]?'R\OZ\_
MEFGOE9MI_@<?%X_,YUC_ 'LN>%>+1M).///@X>+S_P#;IKK*K/\ <GMCG/\
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M\,MV.DV*JPE-AJNGTWLQ[0[*M.WV+:6AT*7"%G87N(:<"U8MK:JDH[5O;78
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M=3YXC#X2%9B 0<=6!X,:EN)%1E>7WW]M\<<]Q''A&>9F9GF?&?KZX],<IO\
M'L^C0V+]8;H/^OOUJY<ARF_Q[/HT-B_6&Z#_ *^_6KC(RXQK[7/XQ[]*OCAK
M[7/XQ[]*OCC&>SCCCC&....,8Y37U0^F?\7'ZNOA<?Z%VTY<IRFOJA],_P"+
MC]77PN/]"[:<8RY3CCCC&....,8XXXXQCCCCC&....,8XXXXQCCCCC&....,
M8XY^%.(1\,YSYXQYYPE*E*QC[N4IQG.,?UYQY>?P\_/D [SWW"JM=ZUIUTTC
MNKM'LB@D9-9L;>O*NBLZNK-VB7!^E$*K;=S[!>KU/@$ ). 8F6A%69O$NO#
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M;;3A*&VT(QA*$(3C"4H3C"4IQC"<8QC&.:)[.P9=.LDM7K8#I#I0F-K=GMJ
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MQS39LS:H*U#7JH4YMA9.Q:<RSL[$53$ZA2HD)KU#ARX=!#!,6MKE#"Y:71J
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MT$GKT,K@);#8LJ17V6UL X"?-=\BL=<NQ*FJ6+F34K2^1+J 0$/60@>M@(#
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M;$#E#9;,M#(<:W'5[[5N77NN0&N!,D>(<(DR)2:X5LEH/RL$K1:C+V,(=+6
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MCKWCP\*%U[V7([!=AJ=MNVX[X@IS58);LZ427K1M@-1=7T[6[$QBL3T5VOT
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MUGPCRF8\ZEU*B@I,66R%E7+:ES4Q+O=[E,88<GN,8SF&  0\Y7@#3 "5JB@
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MU=?"X_T+MIRY3E-?5#Z9_P 7'ZNOA<?Z%VTXQERG'''&,<<<<8Q\WS\JHO\
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MU0^F?\7'ZNOA<?Z%VTY<IRFOJA],_P"+C]77PN/]"[:<8RY3CCCC&.,Y\O\
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MJ"E(/372%ML=BE6JW[KKLWLG>3<H8*"-OWKLJ;);UN,,:'"L,0!H,18;]/$
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M6<P)3$#/:[<V,3UR$K\P)7(EH,V:\5.CBQI(^Y5QC<JT$%1/>!$TT#L;T6%
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M6W5B!T6,:M RF[1IUNHQ(X"41 _9& ,0(1*2Y$?]&ROD.>BN?/1]E\\YS_\
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MDAX%]^6+K-)IU)I^F=1UAF<\U%Q/(LZXUR$LMJE(A,-(NEJL@Z$].%CQ\Z1
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M-W7_ +"5AF;<:OL1;\ +=B<9ZR!@=_6*Q6\0@PW $+@?6Y$.4 @X%#\1 4F
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5<8QQQQQC''''&,<<<<8QQQQQC/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g388375.jpg
<TEXT>
begin 644 g388375.jpg
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MMF:+-&+2N[G>HWJ]8<%,=Y5ZH,-5*T*8%,91L5],%@(UP5,HB3]=KL@L<!Z
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MB-[K\CHR24I H9,<4"FN&PF[E[#,81<=0X$S,@B($2>A!NY=7IY%4>2;I8
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MJVV:ZRYDH-(D+;I-)]+,V*J2F*<!$IR*  B43IG*<@B'I$IBB(" ^D/'F("
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M4]':N+M0AH8>-ITVW LQ<MK9?SFUV%4=E6'7#07M\4-FG3-")!\!$/@T:/4
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M1CZP+,4GC-JX6CD%6A9-TG%E<&?)N44(WOE:0@-"V/" \P]G6=?A](57'8"
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MR#--]YCX!_O#9@^BFF:/*S@ ,F[)1 .7.A9X'^&SXN-_*81]/(.8\M1%$_\
M")_NR_[0:D_#^V''>0\<S->X_659N ^6A7LUA3!)M/KQ("RD9C!"F"D9,O$D
M404Q$>(=S;NWR;C?*-/$IU\AM:FRO"F6*UHG2+ZM>SX.5W5@4A+9")@!\Q$3
M,1,SYVND9Q$-L$GLWDM^@6FSQ^VB-CW\K[,YB@6^*E9",8VU.C ]BJ<[BR6F
M10D+2H$5$"A&":54#MV156HD6,@PWE'/"D(82&S9>@,41 0'!.7O 0_\*_P?
M#X"'I#5Y\-#;_AW<MP>-E6+LZ4.&R5CQWBBB6!_3[">0- R<G6+1*S,&I+,6
M#YBG+-&4H@@^\V20NHMTNBB9XR< DF!5CQW#9X?$.S:L6.R+:B1LS$ 0(O@/
M&3TX 9<5C HL^KCE=<!.<W@NHJ'2()\NS I 64JXCGV]6GIUM^PVKJWJU::5
MR@A8TZ[OB3\QOJ.)MF9 Y80+2OQ(^H1/F.FW+>9Z-/(N9-KCU=5K(HV;7W]3
M0<P[MA0N=*01:6*J\"8PL#8YGF"]C\3'E WU1QPIA]&:;[^0;,'T4UP/E'/"
MF .8YJO@ 'I$<#Y@  ^4:IK7\[KX:(KFZ;<Q7J_%Q\' P.X?-\+"0L2S0CXJ
M'AXG*-KCXN*C&#5-)JQCHYBW;LV+)LDFW:-4$6Z"9$DR%!0_"EIU1R!Q&]G5
M+OE6KMVIUDS/%QMBJ=MA8VQUJ>CC0-A7-'S4%,-GD7*,3K((JG:/FJ[<YTDS
M'3,) Y.)W:?B*,ENM+]XEJSST)3%RC!D 5ILRN"_'^L%(QZ^WCQ$SY\>/'2.
MJ]X^9V=I.*-?CXM=I#FP^:=Z5B96(K_+(QH>TCYCV]?/GQ^OY\^9OH^4=\*0
M"G,&:KZ?LTSJ&*3 ^8#FZ4RB8W(I:H(B/(.0!Z1$0 /$0TH7]6EX<7^<(P_U
M2NG]@ZS1,\,CAW62/382VR#:NJWY@J -<&X]C%@4%!1$3 ZBH-B[ 0(L?D +
M@!3B54H J1,Y<(_J(?"L_P S/&7_ *E?_III/$S@)Q'K7Y8B8_RC[C)M07^/
M\3*JOIX\%_V/V]O_ !]?V[P7W&#^;7#WQ/B8F:VQ7]?U^_U#K/MY_P"9D?$Q
MY\3YGIC+RI#8Z]<H8TW[T:'*HSA6$?AO/:C1(""RCU9!9;%%XD3 H!1:(2,E
M*T.6?JD**!I*F(J*"@0!1AB=Z:?LUE_'&W];K<AV6'KD]!2D3;HR%F*T[:*!
M,QMB9,)&#<L4>3E4)-G*)+1Z[1+L2KJ \2.B3L@5, = &!/?M<[-^8<Z+MIY
MF\0_N7Q)S'U\P_W!X^'CS^74JXSWC1Q7&JX^I47:FL31J//153+[63@A3(-4
MR3^$C,1,2B(5*P]8])(HAROL<WF&Y;V\FTZK%H4S<0K.;;"+0C\9.@U&'I\X
M !F)1,RR&G[3!>(U('>F?[-9?QQM_6Z^BO6Q# 8C]H0Q1 0,5\W*8! 0$! Q
M5@, @( (" @(" " @(:V\$5@C;%.M1>PN'\$R[,JQVYG47CS'$@V*NF!#*(B
MNSA5T053*<@G3$_60#E$Q0 P<ZE[F_;S]PO#7Y+J']']2D.^M)H"Q?'VL6<0
M0F&FH@(9\?L2BG,3$_OQ,3,?Q_[ZAY_3U;49+9R$5, O4P/-8!@4?S!"5F"$
MHG^8F(F/$_\ KSJ^-C&&LD;R\[XHP%'Y>NE4J6/VUKO4?-, N%YB</P+!<M@
ML\K5:_%V&%K>/E[1-+-VKJSS%IQE3?/4D1Y;+O&JJHF=;#+#5<JM*Q^R@DFE
M2JL!385Q7R-T(6L56 @J<";=\Y8)Q,9 UNL5VL+&34EY6OQU;KE6!1<K^?@[
M@LX8Y.EE[5[#6(JDX7=57%V.JT[<E:$<N*_1ZM"N'!(]^WE&)5UHR):JK%92
M;5K(M"JF,#9^W0>( FY125+>!JY7C)+(F@X8R#E(Z+A(T8Q,DNBHZ=/5$EB&
M0$BJ9WCYZ[.F<#$.Z>.G!@%9PL<ZG[D\GGGR5UUTPSJ];U=40R5V "[)DQUE
MI*578?S24@0^_D(]C H-C/9Q=L>(?[>O.R=]NE8L^4W'#\B6'2@%K555#76%
M!"87["7Q^"F1 Q(%K]8F.?;I5[OF3(=IK)XQ&"EK$X/'J,W34[:13;(H,E9I
M,Z2;?M"SCANK+=HL15T?OG4Z=O5Q.Z5Q!WIK^RFW\81_^^IAXXSQSZZ'2_EJ
ME?\ [.T>UGCG_(.E_P"JE?\ [.USJU/I!V]?3T=6SS[,&SIWK>A8%/&GK4+K
ME@[#14$;,P"Q-I0 QY]1B(_?B//5'$^NCCV%C9&'3[9ZYU,;,H954W\OK->5
M?/JIJ))S)X_Y8TEJB6'/^1^9\1Y\=,:<,+!ZUVRB^S+*-05JN,DEV4&X. ';
MR%\EF8H)@@/29-;V.P;IT]<B0X';/I*('^_ P%D!@'(.0>@/ -4N)AX:!:]Q
MA(R-AV7:J+=TBV+2.:]LKR%57N[-)!'M5.DO:*='6?I+U&'D'*J<PY<^8<OA
M]6K0=J>W-+M?Q&MQNM9B_:*S8T-32A'VTW[]F1&6PGY'2I::RJU1(2UD_&B#
M(I,RGJGG>GNKH=X><W.6VZA9M.*M7,QLF;'W7XS,J09BB;$*1#FOMNMW7LA*
MXEUHP 86 1#8'&8P=DS<5PUMS^*L/UIY<LA2M=J-@@:I&$[67L1*'D:H7J7B
M(-J @=_.NX.O21(6+2YN)62!M&M2F<ND2FU?-AAI>IS,A7[7%256GXIP=K)P
M5G8/*[-QKH@_7MI"(FT6$DQ<%_Y2#IJBJ'K(&MR)S*/AS >?JYAXZL.TXMQG
M=U2KW3'U'MJY#$.1:T5*O6%8ITDC()G*K,QSU0#)HG,B0P&YD2,9,H@0PE&R
MO!^XS.'TK6<S,&_5L6RN"06?MG*<:DI.)F4N!@$"%R(^%D)>T^Q041%3^X/:
M]/-[U32#4/.MUJHTB$JT64M0#G."8B&I)3!-[/)?W((?$>L3'F=?_P "GBR[
M9>&_#;D*_N"C<DOT\MS.-IZL2>-X.NVI!N:G1=JBI./F6C^V5UXS6<>?FCI@
MY;IOFJJ:+M)P=HJ1N#E07&JXV^T/?]M0KN \"PV7$;,CF.G9#E)C(-:K%3@6
M$+5(>ULE6B)VMTGY&0E)!W/M0;H),$6B+=!TNX?$4*@V<340VW[>?5@O#7C\
M&+J']']<CMNV]CZ<%X;']O%U$^C^LAW-^,/Y&/*&<;T_R8V$6HB-I<5OFKJ6
MI92K\?[>(%8S(_)ZD4?N/$S$_!' N55N,3Q)7)LV,J:SJGDL4ILPE[B<P8=]
M[ ^WLPX@I7,Q$_K]Q$SJ">],_P!FLOXXV_K=3X/)5;% /MC><*XRF8MY/0NZ
M>?E9>':OFSB1C8RP8RQ>E!OWK1)0ZS9G++0DPC'N%2%1=K1<@FB<ZC1P5-^Z
M4Q'M*A'AH^9QIMWBGQ$TUCLI*EXM8.RI+ (I*&;.XM%<J:H%,*9Q3 IP 1*(
M\AU>>/*S@F">RI,5P&)H>0D&*2<T6@1-*CWCV-;K*=@24+66Z*[EBBNZ5[(K
MP#MTU7"G0!3JFZCF'=O+Y9E-P0I!3M%90T9G3KV#AE<O8E$B$K9YD9./U,$,
MQ'F)B"CKSPCLOJ\-UU<B*XZY4"J]1><RPA4KL@(BT;$L-?B"D/$S_243/@OW
M$SJA-W4Q#R>[#=%)1TO$OX^1W(9X?,'S.38NF;UD[RO;UVKMHY17.BX;.43D
M6072.=)9(Y%$S&(8HC=6Q;,^)\";O]O69<S,BV+%F.<C,;+>H-A&0UI>R<"A
M%R[15JVKLH]:Q\NJ+IXU4!H[<))""8J]76D4!VHGN;]O(>'M%X:#_1=0_P!O
M_)_Y=<^YOV\^GVB\-?M^U=0_H_J2SWCHGFSF-X_:E)T?L&,#36MDK)$5S,)B
MF7H<C)2,_P!7J7C^?$^8N'8^XK6C75R&M#PO_D%K9G$Q4,^?[@0.)LC[A!3Z
ME'Z]HB?X\QU' )Y0!P32D* [>+CS I0$?<MX;](  #_TNUX$^/KP96-JK%QH
M&TF]3^6X231;X^?UW;/@V N[*=DVSZ$CT*W:%;HS?Q;J1-,N(,@,78+J)S;E
M$J"R2[@AI)WN<-O7W#,-_DOH?]@:]+/;Y@6.>-)!AA;$;%^P=-WK%ZTQK2&K
MMF]9K$<-7;5RA!)KMG35PDFNW<(J$6063(JD<BA"F!?_ )KB,1/C%Y%/D2&1
M/DH^A00P,B<#FB4@4>8(8F/(SX__ !D1@\PF1\[7'!]2 H,.,Q[A(R,P:Y.^
M8PP9B2 I&?4OWXGQ'F(?Y6'9(]ZKL&CWJ[*'LHP&>K!*59W*1JDQ"-);VGFR
M/?4FSE1,R)9)C)1:;Y QV3MY&O"-%E01/TNW^3>2<7)<*O$[=A(L'ZT1DK.L
M=*I,GK9VI&2"N49Z628ORMU5#,GIXR2CI)-NX!)<S%\R>$(+=R@J=YVUXBQ3
M>Y(DU=<:8^M\NDS2CTY6T4NL6&138H*KKHLB/YB+>NB-$5G+A5)L58$$U5UE
M")E.JH8U6J%!HE :O&-%IM3IC.0=%>OVE3KD+6VSUX1!-L1T[;PK%BBY<E;I
M)-RKKD45*BFFD!P3(4H>+O+$VN%9G$QHM6S/O'=^]EXDMLFV\R50CXX(!&+L
MQ!2XYGXHF8_KF!]4>&NJ<[U>9%>6P-.BNC-+X2$UBI-!0M^;W]2(IHC)#\0C
M$,*(_P 8F8FO'?X(J%M:W??%L^J:H79(7=IS_A.LQJB_LY2,<7$WE;'L0P3,
M=.[-BF5E+Y6&2(I7)HF\LT4B2W(2+6U0FBO&I1 Q7S,! 0$!!ZW(8! 0, @8
MJQ3D,40 2F 2G(8 $HE, "&Y='I'P$0_A^4!^\(#X@/I ?$-8:5VZ;?G*RSA
M?!^'EUUU55UUE<8T5559==0RJRRJAX QU%5E3G454.8QU%#&.<PF,(C*N*=V
MKN%FCF:=)FN%?U"D_P"ZA#U5XCQ]NTC2[Y@7$1"2F8, _MS) (0,0YAV9S^0
MZQ:V7>#%99\G=0-;Y4-L^T3]RH1:KX6,\S+A&)$SB&1$&1^VL,W0<2'+N\';
M3MMP1G:40N-IVT62]*5S+;^:;KV2X4BV5VKP\3!W<BO-66L]66KIT"7$SH75
MBAW+,LXW5G6#R:FII?DT:R/ZEY75NV1%%/.6<#G6*JF9(A$[0Q,H8ZA3"0I4
MRE,8XB8 *4!,;D <]/2>YNV]?<*PW^2VA_1_5XTZOXXBH%[7*%"TJ.K*#V29
MR,'48VOLX)&1<\@EVKR+@T$HY-ZOU@$D@N@5PKUAWHANH.>JY1S[*VL)?'\_
M$C'7.D6B #<6Q<F4O99%*(0J1@FV29ZA/QKB?40$9B(W7$NW>MA[S>1:.Z6R
MV,Q689E3)9B"QKJK$Y_RL]BA585^S/)LD?,D4^9G45YRF8>4S;F>4C9>*?1T
MGE_*<C'OFDBS7:O6#[(%C=,GC5=-8R:[9TV62<-UDS&3514(H0QB& 16UP=7
MM _5-]G+7()ZL^JLOE)W7GC"R$B).%D)"R46XP-<CWC&1!PR<&?V61AV;,BZ
M1P\X+M!2#O (ZV6RN!ML32190BV'<$MI5\BJI'12N.L<HOW:#4HBL=DP/"%<
MN$6Y"&[0[=%0B)2#UB4"CRK+;;Q@)BZ;/&>$L0M'C-RW>-'3;&=';N6KMHLF
MY:NFZZ4"15!PV<))+MUTCD5163352.50A3!*;7>6G=RKN4&*\9;1=FDX-)1&
M@VU85!R,58\, &"V F1F8D)\Q$Q/40J]C;E':I;3-M12O03J@AF<P5O%5N'2
M E-C^I1&LU2<04>1./W,3'703;?M\Z"\\%X=Y](<^>+J)SY\O'G_ '/^GGZ?
MOZ(?;9MWKUQA,B0.",-PE_K7>@KUWA\84B*MT&5]'/H=Z6)L<=!M9B/([BI*
M1C7)&SQ,BS%\[:J%,BX5(;-0"'J$/A'ER]?B(_\ OHZB_"'\(:27W5KP4?<O
M\$) 4?,SP0%'J0E'MXD2'^DAG]3'ZF)CI\Q2I^1F*E;V$A,)^!?D3"8("&?7
MS!"400E'[$H\Q,3^^H/_ )698((^:-FE<++QP3L5B[,$U(Q)WB";YG$S]PH[
M*%D%T%#E,1K)NZY.H,E1^M74BGP$Y]@8=1)$W;,%""+UERZR_P#/&OPA_P![
MK<*6C#N);O*C.7/&&.[9-&;(,AE[-2*M/R8M&PJBV:C(2\2\>"W;BLL*"';=
MDD*J@ID*)S\[<]S?MY#TX+PT'^BZA_1_3AXOW7K\<PJ&-.*^U-('05B+RU0P
MG66V)F%_;'(P,MD(B3F9@8F9\S,0DN6]G'\GY#H;D;:JD731(U_LS;\8HKIK
M#Y/YP]I(4P9>!B(*9B/UXZ0OP2)N&GN%?LN<0DK'RR##$:$$^5CG:#Q-I,P5
MCL$9,Q;DR!S@B_C)!!9H];*=*K==,2'*'AS=04,4A!,80*4HE,8PCR I2F 3
M&,(^ %* "8QAY 4H"(B  (ZM^KU&ITF*+!4RM5ZIPI'#AV6(K,+%P$85T[."
MCMR6/B&K-F5PY4 #N%@1!18X 94QC>.J\N@@Z06;.4DG#==)1!P@NF19%9%4
MADU45DE ,FHDHF8Q%$SE,0Y#&*8HE$0%2Z5H+VC?N@!*"Y=M6A6109+&P\W0
M!%$#!2$'ZR4",%X\^!\^(<^94.AF9]$S%C*5&K4)@C( PJZ 3)P,D4C!R'MZ
MR13'GQ[3X\]:AW=/:*]:MS^Y.SP,U&24%8]P>;9Z%D6[YJ9O(1,OE"UR$:^;
MG!80.@[9N$7")P$2G24(<HB4P"*H>$3/04/Q-MD+^6FX>-9%SY6VAG;Z38MF
MX.I2,G(F-;BLJN4@+/Y1\RCF:8FZG#UVV;) 959,IMFV&VW;R  !<$X: I0
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0H.V;[>@TQ8\U*%=<%*#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g426701.jpg
<TEXT>
begin 644 g426701.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@ _1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?3D%32%]&4$]?-$-?4$A4+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 1,!M ,!(@ "$0$#$0'_Q  ?  $  @(" P$!            " D&!P4*
M 0,$ @O_Q !&$   !@(" 0,"! 0#!@0#" ,! @,$!08 !P@1$@D3(10Q%2)!
M419A<9$7,H$*(R1"H? 84K'!&271)B<S-%-B<N$UTO'_Q  = 0$  04! 0$
M            ! (#!08' 0@)_\0 /Q$  @(! P,$ 0($ P8% P4  0(#! 4
M$1(&$R$'%"(Q0151"",R819QD20S0U*!\"5"H;'!%V+Q&%-C<I/_V@ , P$
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M ,P? @1W&O$%UD52$(?HYO$3$$AB^!_S$*8H!XB!ODP=B "'Z@&?YXZ >^P
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M-7CN3,59HT6-X%W:55#*#(8CMJ<0*1RW.(AV $63,(A^X !A$0_IGO[#^?\
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M+XX"/7<<^=E-_P O?>;Y*8#?;O\ K^G_ '_Z_</CYR*\;QL4D1T8?:NI4C<
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M^3,IV (=-R/R-1[TUR6UUN5$C6+>&@[0"8'6JLRJ@F_4Z*)E%8A<IBMYML0
M$3*,P!PD4!,Y:H!T(R&[#]\AWNKB+4[^HI:*,JG0K\BI]8D]C$SLX>4>I"!T
ME9!LQ]M:/>^90\)>)%%T4QA4<(N^S=:SUGR9M^M+ CJCDDQ>1DB@LFVC;NY
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M>F7J7#)$)ZD3K+E^B\UA<;LEF>$N+&5OT:?<C#1UY+,<EEX(.4J]MXG^0O\
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M?'6[&YV93+%C:ID1BQ,PDE_JE<F=N,8S7M?$6F,8QIIG@1 H=C\!]OL(_?\
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M2P;1K%%;C"J?;<F#M=L3.9#(QE?<,%'#4*;UPZKLS1V9\9TU+8[UNQ:D:A>
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M\O7R/R/?S]_@!$1'[_'8YQL)#QL!$1L'$,D&$5$,V\=&LFY?%%JR:)%0;HD
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M4BM7:A,6>D/[%#MK39)*V+VH9=A*W&ZV*U)'EHFIMP>.ZJ>RLI)!V!,A5DV
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MZ-=5>4EUHIU/D&/D]ETR,0(A#6*81E7B#4-:5+_:$KM S>OJ=:^'T_=*=$;
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M:\--C(.6[ILK_P"*+:R@$=-'30PD"L:[1,(%=(HF$"JIG2,8"B43IG(4W9#
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MP@/EXKLXY!BY((_^9-RU6(<!^2G*)1^0R=)YQ];8'9;-D.?P&=(2H_SXH?\
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M/SO6E>O2LQ5\?2C5'GKU"Q%NRBA3+,[;$1 @-%74<4;Y.TCJK#\@0"@ !UT
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MFPF*ZT+7ND!4QN=D!DR'0TMCLF2<\><W1D]N4_J=25B6BZ>FL/GZC,*]!<Y
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MNC)IID.U;R"<?[_XM/N%%T_PNO#*N(:O!(  ]3-@BFPI B9TLWE 4#%*8
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MNPX),D^/S]>S9,>1L5K&3E5C8EAIA4GF+M&\F&XB*)!$QC]]_F/\F$/(?O\
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M_4/]<\Y UG=,_!E"D'\W8?;L>AZ ![^1'KKH.OG]NP_<,\F-XAWUV  (C^@
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M<[_BB7BH_P#*\Q.Y)#[;*(%2/J'Z0;$\F=)Y1SBA"#_PL'Q4W\\644\#'(B
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M9U=&+PFLY-K2:XA(Z\A7+91BYB:0_3CB.ZK&.&*JK->.A%6;-1LJLB*7MK*
M>U#@LFO:,V6E9UM+//+ )8I)T6.G$8VD63DP"0N-I.22DJ\R.RAAD;?JIT8U
M>U4I=!P1UFQ7L:,%U,?<J5;)?J6Y):3'R0^U@:?(9FLW=K<+="M%-!0L1Q]J
M,1-X/<OK+S#+>;PU@8:(U?7HO4$!"K-$),DRIMJ4HR=GWG77[M\N#-U&Z[GY
MB'I30C)H1R65830O7"QRHD3L*S0_'SC[3N.- +KZEN9:28K6^\WN6F;"JQ7F
MYVU;#M,E;;#+2)HMA%1B2AGTF=HR;1\<S:,XUJS;$1$4C'/OC-@Q<=Z*A63)
M3)/?X%K4D8"QF5V+%(@ H$48(2/<<BJ@L2Q)URGK&YT]>ZERMCI3'R8OIP31
MP8BI,S/8]G5KQ5DLVG8LS6[S0M=M>0JSV)$14154,8QD_6LZ8QC&FF,8QIIC
M&,::8QC&FF,8QIIC&,::8QC&FF,8QIKP( /W[Z^/Y==?TZ'^?W^_VR#F].++
MJ0FQVOI)VI5-D,G0R;B.8+IQS*<=]G,N]CUA\4(J<=%,)70J@:*F2@"3Y))5
M11=2<F,NPS20.'CVW^F5ARC=?RKI],"/'GR/P0?.HERE!>B[4ZD@'E'(A*2Q
M./J2*1=F1@=CX\'Z8$;C4%M0\NVRCX*!O1I_ 5XCW!8]>6D6YHR(?. +^4)9
M%<2_PX^5#PZ.J8\.]$P+-'+<JI&Y9QHN$7*22R"J:Z*Y"JI+(G*JDHF8 ,11
M-0@B11,X" E.03%, @("(?.:AVSHS7>X(\$K9$!^)M4%$HVQ1PE;3D<"G794
MG/@H1TV'_G9/DG+40[$J:9Q!0L.FNL>47'.0;):NF"[/HJSLB9:\\+YI,_J5
M2(E%W#KN2O8M(!.0Z\A6GYFR8%57<LDDRF*>28ZM@EXF%64@DUY"3"S #Q#+
MY(+'PJ2*H4;#F?LXI)\GB^,5N&3)U >*7:R@VHD) 46JQ;E)P7<O/$6Y?90'
M<:L@<',7P*'7BH(D,(]]@ B4!$ ^PB!1,/0_'[]!WG6)U1L]/:7)SF%NNRK5
MN3GU=M2NO(5W7037KYZ1JU9W2*:I&28&5/+(K0T65XYE"G]E[).WAT4TDR)$
M)V;"G<'9L_KR(IO%$4/JDT/)1L5R9-,KE-,5.CG;@J<Y2&,'D9+H1Z,.='#6
M5O<Z5OV]=<2"D>U>5C=6SJM*)Q1E$8M)2'O$XE[<>DL85R,$Q$2,TE/)4&Q#
M$.8QQ*)OFK^(:W9KX7 11E_;29:66R ?Y;M!6'85E^F8%Y&3?P/)W_;[(_AF
MZ6CZHA]25KC?+PX/!PU%53WS0M9<SY3MD'D$84:44R[?/N*I(&X,_P#<U\9/
M4W(@"?:QBIG W8&3(BK[I0'HO^5(#>*GB ^Z0G0@8Q@ZJ@VX^8/OJR(B45#*
M"9(3#XBD3P/[I1,  40(4G0F\C  E^1-Y%'-J;*V@HLHX3!<O^]34%0!.  B
M=,BAO; 1$3%,/9A$OZF$$Q$!+D)]D[#AZO6I>YVAU])#L ( "!/,73DY#IMV
MJ"?R)Q7,3\Y@#R\2G4Z\A[SY%"S79XXH4:2:66..*.-2[N[, J@;'=F.WV06
M._Y\G]%_37HU.EL>+MF0588(WDD:9ECC2*-.3/+)*1'$BH-S)))&B[?.1?&O
MT>Y,:O2UGPNT8@U6E)*Q2,HJZ1036KDPTBH\/8%PNC]29E)1J)SL6_NN5R."
MN$$U 26*70=HY72#YFH,(F)&[DXI-9FP J@S*"G::8MXH0*O(*F.<A&[4I_?
M<JF(0B1_+P-SWIN<-K[ZLG*)G5; O:JGI:&<+VS8]GKS!!=U4Z7%E,BPCDI>
M10=1D'<KW(E+"U!HL@Y*U:)R\Z:+>(1*HCWS.*_I6\'.(4BPL>H=&0R=]90Z
MT*;95WDI:_WURT<.FSIQY3%F=/&4>HJNT;B)H*,B? B"9$RD3,<IOH?I'T4?
M*PBY?GA4+8*3"42NJ2*(S-'"B$+::&5F1Y'E2%7#1B-N#;<B]2OXK^D.A[UF
MIB\18SMO(UQEZ A=8FXY EDLW+UB:9Z52^L:WL?7CH-<]A8KV-X4GA9^M/Z:
M'HH[(Y4VISOOGC ;(H>K&!8X:9KJ0![0;IMYN]9)/TY%^5F^1L-%UI&I*II#
M$?0Q=BM;IP'M.HF.:N#/^YMKK7=)U32*OK?75;BZ?1J/"1M8JE8A6_TT3!04
M0W3;1\9'H',H8C9LB0"D,<ZBRAQ.LLJJLH<YLS!),@" =AY")A'R-Y"8?N;O
MOL3?S^_]Q[Q:T7NFT9DK(6ZSPU>:IIF6$\J_0:JJ$* ]@@V,?ZIT?\H@4C9%
M90PAT4IAZ ?ISI[IK'=.4XZ6.@'+BJRS]M1-.5_I![:@)&IWX0H!&FYV'(L6
M_./U-]5NJ/4[,2Y;J2\8J:2&2AAXK,PQ>,!0(S0Q32,'LNH_G79BUF7D59Q&
MJ1KEI2^( 'WZ[_0 _7O[!\9P-DL\!4(AW/V:9CH.'9$\W,A).$VK9/O_ "I@
M=0X>XNJ/Y$&Z0'774$$T4SG'K(1W;F]'NGYZUI*HS.P)]R8J3*17C9%.,\U!
M I%6L.V1"<D$P$0$%%BQ38!_,=84P,(XS \:=N[OEVUOY&VI_&QR2IE&-*C5
M6P/443G X(D3;>[#5Y$X"!5 23D9A0H>*SM!8H'':EI\ 'M2"M'MX78/,P_^
MR)6''8;$]QH_L;?1VX])F%FD]OC(),A,#Q>5=XZ4)! )FM,.+;>3PA$K$>"!
MNN_QWG>6R^1LZ[UIQ_C7\=6% *WL-T<>['K*L5PZ6,[<&(4U<BEDO<(5N4QI
MZ93[22101.)32ST9H"IZ0A#MHON4LDBDD6>LSI$A'3T$Q\RL627D?\-AT51%
M1!BFH8RJH X>JN''B8NT*?2:K085M7:?",H*(:]BFT9D,'N*F^#N'2ZAE'#Q
MVH'7NNG:JSA0  #*>)2@&4]!WW^O77?\OO\ ^V>3V59/;UD,-;[*D[RS, !R
MF<;;CP2(Q\%WV^1^6KE+&/',;M^?WE]M^+[%8*R'_AU822%&WAI2.X^VY"[D
M'S_J(_UZ_P#8 QC&1-9?3&::W=O#77'JAR>R-J6C^'*NP>1T6B=**DIV6EYR
M=>DCX&MUNO03-_.6.R33U0C*'@X9B]D7RXG$B II+JIZ]UYROI&RIB"B(NK;
M?K2DI%7F4DW&Q-5V37+2I&U\O )S<;<%+DA%+P[MXC8XYY K(MWT7+,P>*I2
MJ9V:Z1(SW*D<XK/8A6PP5A 7'=XN2J-VQNP5BK\6("G@YW^#;9BOT_G+6.?,
M5\3?EQ2335VR*UI/9=^O7]U8A%@J(FE@KE)945BT:RP\@#-$'E/C-;RNTJ1&
MQ+V3_BRONB-F\JH@DQG(1R\?N8=-Z9W'1Z";\1>R)5X]TR^B;^2Q7J2C54$E
M2' F(Z3WW2-[:PI^SZE*(MXRVT>LWY:&E'\)_$=2B;9#HSL6TMS&+DGZ4)($
M8*F,Z!=<[8#(+F1<J))F4#TVJXF2OWHS-)&\J1AU+-'&8Q(X /\ 2AE3E^1R
M!VV\ZCC$Y,T9\E[&R*-:S!3L6C$_:BM618,$#MMX>7VED(-MBT+IOS 4[VQF
M FV90!KJEL)>J>:L).B,E;,G:*^->*Z,<$OIAFC2(19' JF*D#<[L%Q5,5,$
M_(Q0'%&.[Z:O.[&C)%T[J\7K>2JL=)VZY$CJY2II2W5QG9(M6GV=](IQ\^U3
M:.TFK]8#-?II,_TJ8."B10]1L0CCO*@#;\6++Q.P=B=P2 .,;L"=@0C$?1U2
MF-R$@G*4K+>V [X[+AHR9Z]7B58 EQ8MUHFC +JTR<E .^MTXS@5)MJ0C)11
MXT03D544HXQW;4 D57")ET$F?F?_ (M19!-1PDDT]Q55),ZB93)E,(?#+7:J
MPDC&0\O98**F)HYTX:'DYF*82DR*9RD4&*CG;I%[)"0P^)@8HKB!OR]"/QEP
MLH^V ^OR-MVVXC[^VW\#\ZBI#-(P2.&61B'8*B,[%8]^XX"@DK'Q;FVVR@$G
MP-]99C,/:W:L/90(5C98%],F3=K!#-)F*<ROT[!PHT?."Q:#D\B!&3LHM'IE
M&PE;."BW7!)8IB!C+?;$$>]7*C/FTU#+4V+ITHZL,]'(1%/DPNZDDC%1T#97
M3PC64EFZT8JC)1P(MUV:KAHF071ER@6DS1#;>1=F8H"#N.81I&4D;[%45F.^
MVP'^6]V.G:E$AC@E;LP+9D^.Q6!YX:J2A3LS*]BQ#$O$,2[@ >&VVMC,&4V%
M2B0B%D&Y5?\ AUZY29L9_P#B"$+#.WBRJB"3-G+B^"-=NE%TE4$FR#A1=1<A
MT2D$Y#E+K#3/)/7&Y=2ZKW)'2W\*5[<$6G)4N'O+R#K]C?F5<N&R<<# 91RB
M[EA,W,8S&+=OE?%1+H/(PE"CW-?N+%WH^X\;3*G,<C$CQHT@&_\ 1SEC4-],
M7''?5Y,5DGJ2WTHVFIP6HJ,TXA<QQW)X;=B*LQ .TS04;DO#[5*TQ;;CYD1C
M,/\ XUK1IA&OA9J^6><BZ2;PAIF+"76<,B)KOD48DSC\1469-ED57:143*-D
MU4E5TTTU"'-X+>*HJO-M$K76SNJKX&M#<L[$'<0!5 /[9IU KSW84IQ3.!!D
MR-0-XFZ$1*;QN=Q/^=?LK_4/Z@-R/O[ \D?8'D@#SJ-[:QMOV)MNVDN_;<_R
MI'$:2>!MP>0A%;^EG(4$GQK,<9@XWVIJ1,G.HVZL&A(-RZ9S<R%@A3Q42]0$
MB2C*3DR/!81SINLLB5PW>K(K(@H0%" 8Y '46I^3>M]GU2WW9O/(5ZL4O;%]
MTP]F;>_@(&/EK7KNP+5N3?P[\\LI'.86:=MS.ZZJ+E-[(,3 L9FB8P)A::U7
M62.$S1]R6-Y47FN[1QE0[#S_ $J64%OH;^3J7'B,K-7LVX\?;>O3GKU;4JPL
M5@LVN?MH' '(2S=J3@@!;X'<#==Y*XS$'=VJL>_;Q<A:J\PDG[EFTCH][-Q#
M1\]<R*:BL<U9LEW:;ITX?I(JJ,T$4CK.TTE#MRJ%(<0Q.A;NU?L^P[$J="O,
M)9[)J:V'HNQ(6/44^NJ]J2BXB:5C7:2Z*(N")QT]%G/)1XO8DKM=6-%\,FR?
MLVUSNQ\E0R('8E50LH8LJ\BH7?<L%^1 \A=R1L#JP*-UH9;"T[35X$66:=8)
M3###)(L,<TLH4I'$\SI"LCLJF5U3?DP!VWC&,N:BZ8QC&FF,8QIIC&,::8QC
M&FF,8QIIC&,::8QC&FF?A4?%,QNQ#Q#OL/@?@>_^OV_GG[P(=_'_ /?Q^H?Z
MA\8TUUW=G\Z_4$V_RJYE:PX>O>*&L=9\"%:TC?GO)E>Q%<[7EY6-/+2*3BU,
MI%I$:VJ**3!^V)/K((IQ[=(CYY)+*.P1C\VY#^KUL30H\IH]UI+7EIE^-7'+
MB+N=1W";<F7%5M]CY(7&N4ZP0<?/,:DX(%0J:\XO(UVVLDGRMF8M4E7$?'$<
M"<LI.37I"\->4VWI;=5_KNR8.WW5C#0^UVVL]HV?7U9W)"UX&Q(F*VG7HA46
M5D:HMVB#-15O^%OW3=-$'CQ=5HS5;\KL;THN*.S#[;)(1M_KD9N/5O'_ $W/
MP%0N)(.$@*'QHLD+9]7Q5-9FB'QH0S-[7XMI++JKR R4:BHV*FV,NJL.Z19'
MI%OTQ;6.EDCAKTTMQQ5'AE,R6\2<B\MV.^C77L5H<H:_**-(A8C13&R;+SB3
M%]<K^LFKDHEGL6;SXZQ+>[T"02093]-B3'2XTQT5IM+BXYC'-.UEX)I7W4A=
M5OG]=#8R''J];5-H/3KB4I'*;4_'1.Y1?(B?E>,=F:;5JMDL:]NB-XCK5L[*
MGKQ6OILKXB%8<Q\,A($>&>"JD9F?8E"];]H^HW&'8FW]75?6-%W'R,W[HJ^;
M$AM@VS8%!B8;3-296"+VAJ>7B:"UE=F5"YS$HSK#9TK#12;1ZUE'"*CINU$Q
M9P27I7\8G=PM-G:$V7$1MNY-:NY=2&OHBZ)):T8;PU<G+$:6."J3J#>-XB/N
M)Y=RKL.#;. CK,J1HK[;$S<O?,:X],;CCJBSZQL=*=;/C66F-[[:Y!:LIKB[
MB_IE(MNZ:VO7+M7(6(7AQ>H:].DY<24+4 E!;0TPX<O6CH".G#=5+<Z+:%U3
M%W%E<2%72:=.V6Q)C1!RL2KR3*;S<V1T*';RJJC6Z^-]1TL0F7.8]X5C2)PU
M>NW-QEWE:PT<=6!S$,64A[*SQ3RNHY31,[2QP6U[ZQ>V-]US4-9XX\7J[L[?
M6[[MR9&GU67VZ\HVM8[3?&^X#67&PK%>)>G+3*$]=1<1)86GM*PK],\?*$?R
M"*3<HK8K>/7-FTM2\<-N:\XQ,48+;$;L<^Q)W=FV%]8ZWUU?-5VX:3:].QVU
M(RB6VLO;XYDF[Z6A)&W!2ZD]KA&T@O*HKG>MF4VI7TB>*<G2ZO6(U]N^EV*C
M;)W'LJD[<H&V)JD;BJTEON:=SFTJ]%76OLV0FI5D<NC(J5Z1C'Z+9!- 6KHC
MDIW)^)M7HT<+I^EZZH->B=NZHKFO=>3^H7*.H]QW.E.=E:NMDPM8+;2=NN4'
M#W^/XBT3KN1E9MS()HS3EQ)O4RRB;06S9O[';Z([D7<QMY(S:D=UY2R.*^^4
MXK))^H+S3A)AUC$<2R1SU[<DCF.=55/0]2&CL+%EJ(E:M&(G"U5C6=6QFYBA
M?%S-"Y9,JTKS6;"-!8J1QJ)89&.I=H>JW>:K8.:D#5^.!]@K<6-:\4[U74:S
M>G<Q_%AN2\;%2<A)6F0J]8L#>(H.JVC]24L-II*-S4EH1@O*1K(&QP5+U@-Y
MW&R6#:EIWX[C*A$1'(>W;#O[0^N]FQ.UZ0VN+">;A?H2*LK&,KT^S-&+R</*
M%KU\J-4M\<UG$2O(E1$&[U7N%V/TH^*%I<;@=N(K8M?5V_6M!UIR6I[$EZTK
M04>,D:E%Z9FM72<0BWF:K8ZNU;-0._<24P2241$T@T6*X=$5U-M#T9.-UQXW
MVK3=7>VR-V;-WRQ[?9<C]B3,IM/;CG;-J&-3L-INLY)/8E:VL;'%1;2OSL&8
M8YJO&H-W3<J,RV)(*<M]4^E^G.M.B[.*QM.9,["^-N8RQ/W(XO<5Z%:/(PMR
MM2Q1I=L>[:-W1C#_ "4'P8M%]'?PS>I/5/I)ZP8S/]37H9^A,E3RF$ZGK5$B
MGL+2N9">?%WXHACX)7EQ3C&2ND+1R25Z]H*KS.T5KI]RMV;-Z[*6*87*9I%,
MG3TQ55O9*N*)!]ML"AQ,8#.W1Q**H )OS%$OP4>Y0<1_1;Y->IE$4?>VY]C1
M^AN*KQRY?5NJQ\0]DMF7EBQ=NFJUAJ\ \;(0<;$R!D%&,!8[4[>*/TQ4EXVN
MN6!F2KBX#C1_L^PQETCIOE]LJL;%I%4GF,Y"ZRUHSG8F(M\M!3;.4A'M\FYH
M$WBM9#Z,JDA1XUF0L@HH+20GW+ BS=UV:&C5NR;(-&B"35LV12;MVS=,B+=L
M@@F5)%!NBF4J2*"*92IHHIE*FFF4I"%*4H '#_3'T@.+:?+=2U>S;[DD=&D7
MC>2&$H%,S2QLW;9N3A>VRS ;$NFVS_7_ /$S_$[A>HL4O0WI?D9Y\;;6&;.9
M^JEK'PR1!Q,,32258;$T;<8EN22*( @EJHDKMWH:/-5NM.^GOK9/C7P^TD[U
MM#Q"JCR>M6RB.7M^M-B4*1):U6DSH0?V2863("*+^7=%CV;3V6<3%LX\B;4-
MW:RY#<J9:MNB5F@OMBK/Y>0<?QK(1LD\0046!%/\,:H-EXJ#;LXTY! K=-<"
M)F5-[I"B(B>Q78^I*%M:+_"[K MY/VB* QD2"9K+Q:BH"'NQLFD .&QBF$#^
MT(JM3F  6;J%#QSY=0:N8:@IZ=,C))Y+L&\I+2+9W()()O 3E'8N2MW MP*D
MLHW+XI"X*FE[P%]PR9#"(9]-P2XVM2CKU\=#&Z< %*GM$+Y++Q*\06))0#RS
M%BY\#7YMVZG4>1S4MZ_G;4T4R2DSQL!/S;MJJ/'.LR;JBA$F0F140*"JGB(;
M?PSSLV&"1)>T1.NX]80,8K1W&PKM%,1$#@*4"WE98Y@+]BJOTOGX[_4,FK?!
M>MN'Q9O:5[LM\E52^3E)-PO&MSJB(B<#R3AR_G7!![^3%=LA-\CX%'H<GMC/
M#?G XQ"* ?\ \$*1M_\ Z;&3S^?GY_/@#4A,#2+![3VL@X_-ZS),N_CR(04A
M'UX';\>?R23@]+UO1=>,?H*;5H:OHG*!5U&#1,KMUX@  +Q^<#O7AN@#LSE=
M01'L0Z[S-P*4/L !]OT#]/M_;],\XR&S,S%F)9F))8DDDG[))\DZR\<<<2+'
M$B1HHV5$4*JC]@H  TQC&>:KTQC&--08YTZ3V'NF@:[=:D6KBVR-';\U3R$J
MM<N,B[A:K>7VLY-ZNXI$S/LV[UQ H3T=*/2M98L<^18R39F9=L=%4ZB,2]V\
M?>6/)&8LUVLFL==ZU?R/#'E[H"%J*&WT[JLVM>V5=>.M<N)F>3J<*P*1ZZ@K
M",P\CT7;&%;(QHKB[6<'1:W-XS"V\%4N36)9);2BVE9;4,<D0AG>F_*O,_*%
MI5DC'P/;E1'7^M&8*R[[@/4/,=.U<3!4HX>Q/@K&4FQ.0MP7FNTH<S"D61I(
M*^0K4IJMAXUL;VJ<]F*<OV;$<3F+52%9X"P=;W'K.UL-2ZHC:GK?A5.ZVK*#
M1K%E-7>2%@MK.8E+;%QI(S_\_(M5)9R^V$!SR2[]XX<'[>/%'(Q9:>F3M^#T
ML]HVO(+7&M[!;_3RUMI38J\'82Q;"_[_ *IM",M]LC[F^A8LK^:@;K5T)NGO
M+^<KETG'6!TV39"P\FV=A01 H=B/0=]?ZC]LB/=>8>JHVPUZH:[L^OMI6Q;=
M-"T_>:Y#[3H\)+:]7N\W8X$9*5;3;X@R4U'255EFK:@1W_VOL*S-ZG#,U3,5
MN\?8Z=P497NE())$LPH1)'#(\=F*O!*L9V#@I7KK&#&=T1G)^/C6WX7U7]4+
M<LAQKR9-89,59MK9BNWJ"-C,ED<E2DR0L7&J=F3)Y2U8?WI$<UIPRD2L>56M
MLX&;ALE*W1,Q/'BAZO>WW=FKMC:BT3K?9FM#T?5$WK;3<W0C["M,3:M;R&H]
M@)W.=E_IK?0%*N"2E;09S;&4-:62!$OMV;P6Y 6BL[D>3='H%KV7:+]Q@V/K
MT*+;J14J+"["U/Q4::DG9N4H6Q:5;*;/ZR:7?Z^#3UI-Q8*NZ2Y;2T&LRE(Y
MB@2QJ]<X-31#[5;/7L[5ML)WOD13M!6)Y5[6P%I0W-JA+W+J6=^Y!J[;2;.,
M&A2S-1JT631743?=22)HURF/W<@>9&K](<9[!RA92L%L"G-8Y,U*&!LT:QAM
M@SDK(IPT)$PMI62>1GLOY%)ZH>51;R#="/CGSU!)T"9$U(IPW3H2V3=D5*T%
MBQ;>.>)$6%X[TDE@".'MD11Y&<!H1QA98DXAD4'9*WJ!ZO29#!5H.EZIO9O)
M4</A8+=3,26IK8N]-P4L3)/?S#7(!8FZ6Q8F6]8B?*0^_MY*>U[NW;'(6;7=
MRDJUQ/1GM6ZIO]GUW==<S=XD!EG=7@M6RD-KJ=AI_86HH9O&. EI&)EWRD'6
M*LY3CD!K<VY'WVXL2HY!SG]Q-Y$<AMGMY'7M,U9)5YI2=7!3[H\4U]7-AUB[
M4W;1;A9"S%OL--LFPBP:U?12+38G74_4&3:97F%K(Y=D=$35GIJ3E_I78ZM=
MISW9NHXO<KZH-[+8]75G9\'=G%?53@VL]-,V$XT;1*-@9P48Z2DG<BE&QRJ,
M.HE*OXV.:F,)<(G?45X<0<A14$M]Z[L;6^;#7UFSE*K98B=B8&Q-ZY)V475K
MD&KX&\'!+-(]%BTFUO>:OI:8AF;,RQ7X+IY*_#B+](P6LDB02-$ID%JO')R2
M.. (7=6(<F:(N'!=9)(R.![>VG=+Y'U$Z;ZBK9/#=(3V\KBX;LD,,N'S-VG%
M%?MVLF;<$%>U'6B@/L[@J/2:*I;KP6"RVW[LC1*UCP7O-,Y$ZVWHG2M>QDRU
MYF\R]K[$MS*28I7&;TKN*.N0:HBG+Y*+(_FBLGDG#K.J8Y=E;5MT9R\)[SH'
M*[GV\I.%&U]T;%Y$S$3!4R8J>V;+Z>;R+:SEB(U,^KW'G:LS9=NM9-@>/7^C
M]NMO_"';F4,%C5668)+,CE]TUC[#D[QWE-E2>G8[=>LGNTH8DL:4H3:Y0BUH
M9G@&8R$^U4BTW9EC/H%@ O9N/3\WT0T*9S(MFR)1.',4/?ND]H5ZQVW7>U:#
M=:K45U6UHLM:M$5+P$ LA"M[&X++3#1P>.8E;03MO*.5%W!$VS-0%ESI@4X%
MLIA<$]>2C%80QRRRR/'':B+-*N/;&3,57P6%:8=\%=S*4=]MP#(E]1?4VOE*
M?4MG&S);H8G$T:MJUA\D((<9)UA%UIAS&\LH,<5C-TA%CI%F$4M&.2I6#%3(
MM.TWP"VG7E(,L%I+2>TM:TKFORBVY \=++:XZK:W=:LW52"5K7<TW:'JDQ7X
M64U_.+/)L:D-?<G8(NGJL$H2242$=9N/38WB:A<?:G<:+ ;%A:AQ,8<?K17Z
MAL^CU61US=6>TI:XN[C2;/L/6ER!I'2,2]B@3LE$3K6Q8N3KD:D5VZ:HMV[:
MR;>?J-\==<\?[]OC6VPM>;L+3I:K55K6ZGL:OM$Y&WW*0!I7HJ1G#(R:==:+
M1Z<K9E)9S'NTCUV!F)%@@^*T$HR$G.16M=::QH=_W;=]>:J)<HV%,U)-7N'<
MPCV>DX@LPK"UFS+)1;>U-TD3'6;3+"/;MW<:4DJJW9-E?$F/_1NFII96COG:
M&O!8<I9@-6."9XZZ'F8S$893B^T87D>)0)'1(WE,AVW_ .I/K)3JXR2QTW&7
MN9J[CJ2ST<PF8OY>A5M9&RD>.BR\.0BMU4ZP:[)E*="K;M/8JP6\A;KU(ZD=
M,M9XQ[1V3S-W19*WJBG1$;0?4*UOLA]R9L%B<--IP=-UYI^BJ6+7U.@E:V5[
M8X38AG"<6]DV=B0AGRKZTGLD8Z58QA@XV']-K>#34'(.@3E$CWFT[+Q\Y&:C
M@]IH[<HZ%+V[([<V TMD.ZMM:8:XC=@KR3H&S>77L.T[=:UZ7,)R36!.^9RP
M';VH:BYUZ,NNE=([;V7;Z/H^2W=5T;5 4JXWZ%4D&D>K.G@RK?B9RQ[=S%C)
M"P:&G3M640$A(-8\'0N54BJ[6L7+/C7 VFW:_E-W:R;7JD0\_.V>HJVR*&?A
MF-4B2V"PF=QA5Q7*ZA(<22<BP)Y/V30R;EPW21-Y@AP'3SPO,V0,RW&LSAA9
MB@4QY9A8A58@O,.(TC,#MO-)P/DQ,8AY<]3_ %6JVH\57Z3>N<-6PF--4T,U
MDI3/T#_X7/.]^"V@GIK:>:"]CX&&!A[L/^R>]!O3U66ST^=E0AMPH:TU;J*0
MUY-;8X-;1:Z.6GX^L4O;3?2%,=Q&YJ[:&X03J(AG]DG%(V6:2<W'RK:X/89D
M[G"G3*8P8<X]/S?*5"UJV=:GUT^A*OO'EK=Y[CQ1KG0&]>B:OO\ _#34%6GR
M^T=9V'7YY"A1C>2JRK>2IL7(-(N7>NZH_BC +9U.1KZGW&MROH&PI6NN0VIM
M\TK:=G/LRY6:,JB-!F=9!1R!2;3"OBKF+:9=2Y^VM'%DD740:.,)V[U)R"J5
MC$).1-CBX^<@I)C,0LO'L92)EXMTB^C92-D6Y';&0CWC<ZC=VQ>M547+1V@<
MZ#E!5-5(YR&*8:H>GNF\@\AJ67<1QJC0U[$)C1;-F',K(JB)F,4QEA[?S:L:
M["-%W)<Q<KZH^KW2T-$=18..F;-J66.UEJ.8AGNV<)BK'0-R&S)'EH8UR=9:
M%P7;02'/)?XV&NI56C"E#&P_35OUD#8LG&TRH25BC]&^G[2=$V*\WIK:;M2+
M9Q_V+^.[5+_'*E=9.&,BWJP)1$;<6;)@I<0(9BDUBVJAV^3MXRZ"L6E>1O+>
MQ/-1:ZA:EM[8Y-C:_P!MUF0A$;A*Q4S7JHRF=93E7;0#:9B8V'M$-/7'ZM:>
M=Q,I)SZ[I&+1D%UW!K$,9EZW3F-J6X;D*R+-#,\Z^4"M(_OPQ<!-V^.1G0$$
M-P6%"2L0&M%R_JYU?G<+;P.2GKSXZW0CQQCY9!6AKQ#I;MF)AD-BRMTG3F*3
MK-7DLWLK9F@DGM*\+&,9G]<PTQC&--,8QC33&,8TTQC&--,8QC33&,8TTQC&
M--,8QC33&,8TTQC&--,8QC33&,8TTQC&--,8QC33&,8TTQC&--,8QC33&,8T
MTQC&-->E8AE"D HF 2JIJ?E-X=@0P")1'H>RC]A#]<K#:\#;@TK];B4K;22/
M8WU&WW-B6D4X>4(K)5-6]V2ULZ2LJ4H+NK*U83C:,))NCFB4Q8B"92MCI)DM
M"QD*WCZMUHVL(7:)9$C(8J565HF?;;\L88_)\@ @; G?8<%U3FNFQ97$64KB
MW-4GGY00S%Y**VEK'>5&(5!<GW0?!RRE@2B$4@2?I7; NU;D-;6_9%<K.E%]
M\TS9L)J'7\]M9W"4F!85?:T'L(=<S]PFGEFH<Q>I+8,;.I5:%D0HE?>0\A]"
M@)9MT7):7?BEMO8O 8_%&U7;7R^R$:=4*,C?8V DXBG/XV@W"N/("7=5=D1-
M:)DY"I5EFC+Q\.4L2UL+AV:)30AS)-TK"\9CZ_3>*K).D4,H%FG+1GY3ROSK
M3%F,?%F*($YN(NVJ=M795\; ;3DO5OK?*V,59N9"JTF$SN/ZEQA3'4E:MFL<
MD2)>,G:,UB:X8*\N4:U+.V4L016;QGG4R&I"Z^G_ +JV9OR9OUZW<R?Z\4M>
M_G57C&+R[,Y^J4?=VF)353&K0=;2?I:[A7]'7?FFS6B.CC6*YG653FI1N9!!
M,_VQ_#;D^CKWC-%.[CQK+=N)6R]?3FMUXRAW]E6;;2*=IZX:?>H7P33JDPE;
M)!C;/Q^,5@2(PT-(1_TG@\2?*+HVQ8RD=-8P233*+0EL222S2&Y8=G=_;%2Q
MDD?<0FG7[*_2!..Q5F!JE]6NL)ZN.I328J2IBJ53'T:YPV/6."K6CRD,D:!(
M4(%Z/,Y%+X!"SK.H C[,/"I&J>GUM:"V#$-)+8VO9#35%Y#;^Y,4E=*N3X[F
MDKGN^+M[9*K6FQ.GAX%K6*R\NTF1X_AT5I:U0\9#QSU)D8BZYMSUKA.[;>GR
MWX13MM9LWSCCVIIJ;OM1CSL&CJ9<Q#AB[LR<0Y%-R[;NGJA7#]H^<@XD&Z[U
M!=?S<G4&P?&7J^ QE;N\(7;NP3UF,L\LC"O8CJPR0JQ?DJ=FE6C78\@L>_(N
MS,8F1]4.LLG[+OY"",T,GB<U :V/HP;Y?"V<Q=IY*<) %LV3<SV4LV#.LB3R
M6%$B%(8$CI[>\ -\WVK;M?;-O^F8[8NT:QQ<U[#L=;U:U1FO(*G<;=A-[H5_
M(!,KK6&3LUJ1,]9(D3(C%5]F5C#I?6L4UG)Y0\J>-VS-KW?0NT=26+6T/<=*
M2FTFQ(O:U9F;)4):L;@I*5%L:B;6NO8Z00GH)@@D_A$S+?AL@H=S'R9D6JYE
M2SCQB+ X^&*2*-9AW3 TDG?D$KR5K<MZ&5I 02ZVIGE_Y3N$*F,<=>6O4SJN
MYD*.0L6*#MC4R$-.K^F4A1BK93IS&])W:IK"'@\$N!Q-*D!(6>,QO8C=;,LD
MK4:+^E+>F=6T[7 M^O-@QM3XS,>,>Q*Q;YC<U%JUD@(;9DO?XNQLB:HLD!)2
MR2WXNHC)4>S+'@5)!G&OVKU%1DF8V]'O!C=L_P IH#<MNV] V.@4W;.S;Q4(
M%VXNX2T)3=D:HF=9MJ+&5,KXFM(=U3229GW\9-(QU9;V"[G^)WZ9TR$7M7QD
M>+I?$0A%CAE14FI3<5L2@.^/7C6$A#!I$0@2%&8J9!RV + Y>SZT]?W&E>SD
M:<TDN.ZAQ89\92XPUNJ&WS!JP"(5:D]B+:L9ZT$4AKI#'(9#7KM%3G3?3HV\
MSU]HBEW78.JI!;1/'7E/QUA7T!6+.BC+Q.Y:Q6:QKVX/&\NZ=G:V.&;0T@K=
M$VBA6SS\0!&"$A!="M9'QTUE)Z8T3IG4LS)LYF3UCJ36VNI"6C4UV\;*/Z34
M8RNO9&/:NNW35F^<L%'+9%R<[@B"B9%C"J4XCNG&3J6(HX]Q)6C99!!'7YO(
MSL8HHJ\"!BQ)8B.M"O([GX[_ ).M<ZEZ_P"INK:RU,U;@FK+D+>46*&G6K*E
MR]D,OE+4B]F-2JRWL[DIC&I"#OJH 6.,*QC&9/6EZ8QC&FF,8QIIC&,::8QC
M&FF,8QIIC&,::8QC&FF,8QIIC&,::8QC&FF,8QIIC&,::8QC&FF,8QIIC&,:
M:8QC&FF,8QIIC&,::8QC&FF,8QIIC&,::8QC&FF,8QIIC&,::8QC&FF,8QII
MC&,::8QC&FOF>O&D<S=/W[ILR9,FZ[MX\>+IMFC1JV2.LX=.G*QB)-VS=$AU
MG"ZIRIHHD.HH8I"F$*S;1ZC]2G*6ML70#6N[/J#6$C+221DY"6KY9ZKR#Q5L
M2;KRGT2Q7;1RFD=S'&43\G#4HN5$T2'2(I*/F=KFZ[?XD\E]6:X?J1M\V)HK
M:5-J#E-4J!AL5AILO&Q385S&(5N1^[<)QYUS& $2.C*"/11SI+^F5Q)]0&D7
MEKI_?O%SFBTTY/HQS2G03J&>5O55#N"<NC(2%BN<VXDFSR)J[./8';BT@#2+
M:3.Z=MEJ])FD$TU:LYTI<S_I[UC>P75?^&^J,/2EM89(TI2SVY8J=J6.(078
MYEL1SV5@AD6*%I8D#R#=BB-C\;UA6Z;]1.B:F=Z4/472.2R5.'/NSWHXH:LV
M1JP6 9J,U:2"2*F;$JL]A$=F0%HPK..ZSQ@Y45#DQ7I-_$LU*Y9JZH@E9*B]
M=I/'D>1X)OH)%D\2(B24AWPI+$1>)H(J(.$E&CU!%P4 -*</D ']\HZX&Z-W
MMJ78NV+G-:\L<,A#:NL<3",IIHYB&=XLWXDW>P<?%*N@05<-5%H8Y@=JHI>P
ME(MU/%%18R9>$X\\Z_45L\=QZ=[]X<;2K5OVENR7H6SZ)1N/MJCZSH_7S.:A
M6$-L2[;)NUZ!NK"S3&4>O5'E>83B[!."?+KQA$E&Y5>;>AF3ZQZW].Z6;ZJI
MK3S=6S:H7C>]OB+-_P!N]HPWTQMAJ[QB6O5<3-%!'6-A (E3W5:-^K^OF,Z(
MZ ]3,E@.C<BV7Z=GK4<CCIL;)+FZE'WE:B]C'')P&QWO;6KBI )9IK:UV5+4
MDD\%B35\&,HGT1S$]3R[Z\VI:]N\8PUW>JHXW<A0-:I:7VBW5O;>FU";E=8.
MRRCY^_9)!=K"UCXLWG-,2O/,R3--JH[:G-E--Y@^I7"[2BM(;AX?J2KZ8V/J
MZ0@N0NHJ%=)#1$AHZV04E(7M*VA,65>:USMJA22<:P7C9):4AGJRC]L0>T8U
MQ+]ADP5M'L1B?'R/6&\BI>@\H$$CO"S,L=A(E(,A@>0C?9 _%^/$TZIH.(6-
M7*HD\AB1VQTY E)81I(L8>2(S%6[32HB$ %F4,O*Z_&4:Z$Y1^K%?N)FT-\[
M3XNU?7^VZG6]OJT[0:U#N4=;+;9JG")+:Y;M:U(61S8GC&X3"PHG%H]3,Y0;
MJE9J(F_-GTV[E)ZIC#3G!:_5OCK$/;]R'L]3JW);6JFE;X]=<9(U\Z(WLMVD
MCM]A-7[=HS(L+I".LJ"#=HDW.1R_7$3*95^@6NZT/NL472U+48C)TRG=BKO9
M8B02E&A,<;!)U)B>;C KF9T1O1U12[(G-+,JIJ17 K8JT)3%+;CIHO;*\N\9
M95<P[=Q8 TY B4MJ\'&<!"IS;.'C&L]*LIJ:09HI2DNPB30K*2>$ 2K/&L0>
M2EC1J*Y@\R,S2;X40'Q^I5#HPLP?G?QL1OX.X\CQY\[';R?]-;%R ^_!_;]O
M]-Q_H=<_C&,:JTQC&--,8QC33&,8TTQC&--,8QC33&,8TTQC&--,8QC33&,8
MTTQC&--,8QC33&,8TTQC&--,8QC33&,8TTQC&--,8QC33&,8TTQC&--,8QC3
M3&,8TTQC&--?A3_(;[#\?J "']A[ <T(_P!;TPCYVBWB56"2J)E#IQ<O-11?
M-Q/+/5SD"-D6OMF6<JJ'5%/Q%0IA2-VD $!C-;ZCJU;,57W-:"QQED"]^&.7
MB#&=P.XK;;[#?;[_ #K*8JS9KRS^WL3P<HDY=F62+EQD!7EP9=]CY&_T?K7Y
M?:YJ8JO'1FDF=8R;L@BK9K.J0"2#])\Z(1%29.BF4[HH*)E33*#<H>TW!)'M
M//MDJ#5'-<7AG$:LO'%NJ<\5!:5F5#DE4P3 CDCD\@+HI2]=@V*L#7R_/['E
M\XQFJMBL7QN_^&T/E&RM_L=?Y*UA.2M_+\@[#<'<'8;_ %K+)D<AQJGWUS>.
MQ$\9]S/NCCM$,GS^+ DD,NQ!)(/G7V(:\IZL045(DYCIIN$R+?B<N#@I4SSY
MTQ^H!^"XG(:3>&*J*@J )T1 _P#PC3V/4PH%4"(F&/X>Y%M-H5X)%,TQ-F,I
M^#MBA'F;JFD168'0%%(YE&"C4[A0A57)EE/SXQDW]+QF\9_3J.YHS*3[2ON5
M./L(5)[>^Q1F4CZ*DK]$C5ALA?\ YX]]<V]W VWN9OZEM0.K?U_U*ZJZG[#*
MK @@'7&,M<5"/=MD64<\;I(NU3I$)/6#I/N$CVG@3RE3"5(K=DW(1 !]D@E4
M4(F55=P=7\*Z[J;B);)J,Y(")+.T2E2LEE;@9)R1V1<BOL2Z?O@H  8?>]P0
M4*54H@J4#@QD),3BQS48W'A2R@J*=< @)!L".WML-AM^VP_8:E#(7S)"3>N$
M\8QN;,Q.WS\;E_KR?'UY/[G6[8IJ@G&1Z1"=$29-DDP\SCXIII$(0O9C"8?$
MH '9A$1Z[$1'YQC&=)A1%BB54556- JJH  "@   ;  > !X&M5E),LA)W)=R
(2?LGD?)U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g498650.jpg
<TEXT>
begin 644 g498650.jpg
M_]C_X  02D9)1@ ! 0$! P$#  #__@ \1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?149&14-47TM?0D%2+D504__; $,  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_   L( 28!G $!$0#_Q  ?  $  @(" P$!
M        " D!!P8*! 4+ @/_Q !E$   !00  @,%$@D&"@@#"0 #! 4&!P !
M @@)$1(A,1,4%18W"A<X.4%15V%Q=G=X@9>QM;?6(C)6D9:SMKC4)C,V<G.A
M&!D:(S1T=;*T\"0E*%AF>9774F*'-4)'28B2P<+(_]H " $!   _ .[!KU'[
M$.P1#ILXRVJ:-&(V9PQ@R8;Z4,..,*ADA!!1AA"F0@HHF>6668@F66>65[WR
MO>];B\[6._R$9_Z-H_\ !T\[6._R$9_Z-H_\'3SM8[_(1G_HVC_P=/.UCO\
M(1G_ *-H_P#!T\[6._R$9_Z-H_\ !T\[6._R$9_Z-H_\'3SM8[_(1G_HVC_P
M=/.UCO\ (1G_ *-H_P#!T\[6._R$9_Z-H_\ !T\[6._R$9_Z-H_\'3SM8[_(
M1G_HVC_P=/.UCO\ (1G_ *-H_P#!T\[6._R$9_Z-H_\ !T\[6._R$9_Z-H_\
M'6O924-9X.9*Q)<SGH2B2.F[B7S7WY)9MCL5FHF)LP&4*9*SF<XB6C$.^C8H
M14M8R<#R,&10P <1!<\<+\*9<LZ320GQ>K1Y(VLK[2IN4G*C0VILUVQDZ$^5
MU=FI"BONY*CDXAGSQ=Z*360T=75W$0;PA\VBIJ6H'%($L 3,9A[U\[>.>WQ$
M:'9:]OY,I/7SZ[6M_P!"Z[__ "V_"MZMJ>=O'/5_(1G]?_AI(ZOZW_0OP>R_
M/I<N5[7M?KM>GG;QSU_R$9_5VW\6DCE[?X7>?*][>K:U^=O6KCSN18/8+4<S
M[?*1&3-9++0%AU.]W.D@VD!MM9LM]/,*JZX7"MJH)5.1D1&2RIE15%10,%R1
M B7'-&A@@ L\\?8)#.B1P)*:O(378"RB+*>15DA72D5!/IJJEJ94(\G**:>*
MEA2QXB?)#@FR9LL(* 9+BAC YYAYXY7]CYW$<]7\A&AU_P#AE)]R]K_]"ZKV
M]6U^5[==[VM:UZ>=Q'/+GXB-"_N-E)O>_MVM8ESO;V[6O;EU\^5/.WCGG:WB
M*S^OU;-M(O:WK<[V)\K<_4YWMS]3G7&G<EP3'Z$.Z'VGQ6RFT6.HZ:8<+M+M
M1MH8"BX5<BWT B*KK6))/#.+B\IIJ(CELC%AU-842*82P'/'"X G);1Q'-^?
M\A6?RMSYW\6DBUNJ][7MSN3Y<[7M>U\>?.U[7M>UKVO7!'6/KLQ5^/6L\@(K
M:[BEASG&5&J*ND&\F*3Y=I!LK3R.-QL%318,1762[6;BZOB$"MLS%DM)/F[8
M7#+YWMS$ZQ8M3B)M2/LUDDR! J8.G#9EO(X(!8H5!$,&#(PF9.UL  0 A!1!
M+_@XAX99<^5KUQB/08!EACM*2XT(1B^H_?C>2G8S'DUDQOK+<<S;7"@9Y(6T
M56)EA"AY-4"@H8Y4T")<,4/.U[7M?JKR'R0@6,&>YI"D<E%3"8;+1%%RN]Z/
M$LUFVU6LW4DOF;5%UQ+ZN&42T9'3BH8A@\I*!HN4*@89BC"X88WO;U+,.:XR
M(J/I$8F,3N]7C)R$FA(*:W2;<5CC.<RFUD![IR(X0"9<41-4#[0=+=<A, >V
M-S**LIR@#?,N9#SOYJ!AKTZG.^62V XC<+QC%21$:2&JB8--4<+!5W*WR3L;
MR8\T8EB,H-D^NM=23W$CE%D F.I(AXFJ$PQB1D$;/S'>EP1'Z$.Z'X0BMDMD
MJ=2$XRXG<7:C:0@%!P*Y%OH)$976L22>&<6UY3341(+9F;#*:NH$4PE@.=.%
MP!/3,(YKC*5GE>.<(H>_G>/]S16^K-<DW%F[1D=FB% G6R'#B2+BY)3G;V9\
ME962#=@S9+OLMD,'CB.'?+G]XWCFUK7NQ&AROV<FTD9<_P#]I*_;ZGK^I3SN
M(YZOY"L_K]6S:2;VZ^RU[V)7M:]^KE:]^=[WM:UKWO:M-M.0-07ZZV\QV,Z(
M#>;L=K$<4GM9!::BQW(H../&B[R3 =+S0L$7,\&K-MNO=1(M-;52 HY5,<)H
M%(.9@G<^XVW)YW$<]OB(T/D;*3>_J=5[6)<[7Z^?*]N?+KY<K7KC"6FP.N.-
MTLY%(14L.UC> _'5KI0#347&T?&8@(JMOQG0R>(RH@>,"6",I(?A8J4\+IX0
MIU/[X+!YBX\IM&L=7Z[,1G_HVC_P?5>WJV[;7IYVL=_D(S_T;1_X.GG:QW^0
MC/\ T;1_X.GG:QW^0C/_ $;1_P"#IYVL=_D(S_T;1_X.GG:QW^0C/_1M'_@Z
M>=K'?Y",_P#1M'_@Z>=K'?Y",_\ 1M'_ (.GG:QW^0C/_1M'_@Z>=K'?Y",_
M]&T?^#IYVL=_D(S_ -&T?^#J ^TC.:1!_HP!%L-\D#=G$A+A%$=/+AW$R7G)
M;+.^ )?#&^=\<<<;YWM?*^...//EC:UIBZX>0"&/@R9?U 1K=-*4I2E*4I2E
M*J(XJ$"RW([DT4G!@P8)MDR=2MHC\P2WJN34&$37I*;BY#<A1F@/1EE)37&W
M';A?,*NEVI\@-UM.1?0KJ=P#HB,L%EHF3 -TFM'2#B2/Y415DSKHLQ L$-KN
M)3(\?NN[8U8U_?9% V2X33NA^'98E<GJNZ1V$1E)5GQ<1&2LN9!4%UU(2JF$
M3B\NG04@1QY?D2(.+U)*4TE5X:][O-6)&7#G"IBW9"&4G9Q@-"<MBFQ @,])
MFX]X0>K%V(!#0UMZNY<C)><2H?DV(Y"ER.4,0H<7T<XJ!)H'N9YU4XJ2FT8]
M3V/&?$)NHA:EI34TW*)O$)9ZHOZ>[;"[$OUQ'GUNR^4Z1HR+3NWP85.QHD$#
MB@B;#(J T&^X8F,)KB<IL:1E'^$P:P<;,[N5O6XX-)[#!82K$NT2+&DI/O8H
MNT(N9*BM1<V$F($V#2#:V(<;%74Y2<R.MEXJ173J]"\BPHO.K)YO.750VC9G
M+RBUMU:WM,<)KBJP?)31GPTZ)LAJ<VKJO"<]N1.7'^GK+OU9NSE=LH2XYMLM
MNEPLTGI+PATPC R!/%PLE@\OKJ>WF8U%I.32\?C&C'$?B!!?L<L)-W'>^KES
MO"9=\KQ0WMM5C";I@9K3BN:$7?B/8!DE\32@JL9+YQ\ P4?>#/9\BPPV7$U4
M(XRXL5F\GCXE0N$N/1GBMOR(E7%<RW*;JBQ=$N("NZNM4GN(Z"DFLN:CVWK)
M>F@443@]V7,P)>5Y<8T*66\3"HZ'&]&AB23$]O.IT* Y#P77\]F]&^*NV%*0
MH[APUN0^=24O:1FO_%L)FR#U?4WNQ)?F@S,).1S-5RK>X&N$CKC+8VZ0CS6U
MQA&]BV0A(SL,(SK2V,]64D'40?8BCK#QBPY8B$^Z@MKG_."<D<-+&$=A4;9Q
MJ,W6F$&M&R0TL^($U-NH8;,REDN3Y!E$^4>V"\KEXTG@A((BZW@60ZD8FVAB
MBK#=[\/3BFRO&._+"E6#-MI:;#B=$+2PR,I6V<!+/]Z/5C;YM&0UQJL9K-_;
MA\PN]3Q'60R^"39D=L(VK:$E H;00R\?9O4)&<"+(MV:Z\7M2W4GB36$QMXV
M!&[U;>^T;(1%*V0;Z@"58+KUW1DK2HZRU)[[1+D9ISS1'6E'%%)* 0=%XD0R
M(:'3GM.4FJRN5D1(Y+K/JUQ5DF#X 0W5&NQJ"M1SO'.+Z35)P3STI2&B=R</
M"6HZ07,<198V.VB2(P"!V+5$'!J-I0F60V>:?ZGE(P[29;;$$L)-7@IP9O[$
M<$[=,;:YGSDE9*9=GAPRY)TEY9=DD/MS6BM91I%5##&4]DMH4F/C SM#1CI]
MTM:4T1JR.X%,ZM(L:L0BD!@#U^0%H-Q1&ZUF6_79AMFARG#V' \28M;17:!R
M$6453&2E-9N\1 =<CM%EG&/WH.7;]EI)D#Q\1EX%=+X&S+3+*:B>.GCTI..[
MJAN_LF_)(18PB'9J?H*>_#Z?L3PJR]?-AT>(VC'>Y*Q)*@H+K]V)8BM+\4%)
M.8#JAO-*:B$64RDH(@0A!>;@K!*J;B(N1/C5O)J'Q4G8J[&M6&(XV5#9\B;!
MO-XL!SQ1/ C2&3C"%PV]=XTA6X[6;VQNOJB$S =B$%\=P<RM(2FSXX=;9-.)
MR09+))PIX 7JX^T\XGA;;\:62D-;9M:691EWA'O\78V^Q;6;T!)+=AG42$(]
MW]([&Q"FR^649/=#N,MQXL1..K$3R)FOK%[7::\S P3AQW1I7N&UQ<I4U^VE
M9^PK*VGEAU7"BAWO%E*\UEC;+GJ96#OU'\B"/Z!%Y7W6>(.:B!JS:2DE#)),
M6ZGL!,3\F8BCLLQ)[3;#I)3&?NI_$9LJOTRXH0WLDC7AT;C\1Y](4+:[[EHF
MOTWX&Y3:$"%]%)*7I$-S<WNC&D<C(<DIIU./.MTDF8]Q[O=UQK(R<$&G+4FN
M*]C,&$P\':&C*!MQ)P3R8>XY*;8/UNVA%C"99;4&+JLQCP *E+".\M>D!^*+
M3>]\70HG,51BV<N9574T)&QP4164L0F9.J_&O%V6T16IM(;.JGG4G= F7/3[
M:FQ1Y;C%XPH/'CG;>V63A*HNPS'1"KF(+#G04&2T@'7:59#?BVT3<P-R>DM,
MR 1%'1L8\.'BSQ)J^QXI@&+IZAISQOJ)LC%LA$,9P3"^;X=B]Q+H-EM938>6
MT^=B@B6L2GJ@ENU*9*T0=\3F,Q23X2,7.Q5YV@N-;D\DZ#\2J18K:#:?2CNT
MF-II:S\559B]LY[%NR(GZW)*<ZY$2[HC&D@GV-MS,SM<.+><2>]5F-4Z0-@9
M4-HJ&FI+;DUW&D7$P@']62!H1Q(B:CMH^4R)]PR\R;)QGPH7B])1B68&P:\>
ME"'H(2V_MU&+];^>UT%.59.*DR )V2\@1L^XR< S5)+9A@R,2;0ZDU'=V?\
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MG$E'5T5+->YA:/..:,EL8W(\BS(0-Q@ZDA1#2U=1U'[I,S=/;F10,<2)6LE
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M_-6>5O6_Y_YO?\]8Y6]:WYJ<K>M;\U9Y6];V_E]>E*5CE;UK?FIRMZUOS?\
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M8_?<<(Y1P/QF.AIHA]S,UF$E-91#P!0RZY"=:.Q6.WPLPPALLE)TO%P(;;2
MKX6#'554F"**"&)D+A'#B!PC,*5HCN@I*<9/5/3D_5>>SAX\;0S !0H4*1HX
MQS)DP/G>V 0  (8@HHF5^C@'AEE>_*UZ^67</+ESYX<NCC?^=#Y_BVOV=/GS
M]KES]3ESK]AAY6RROSPY6"&OU"AWO_,Y]EK9\[W]JUN?J<N=?=MU+]"UK=\
M<,^W_P#AJU_6J0E*I7W=\OJI[TVG^I4*B/74/\U ?TUTU]X\S_M6R:ZJ]=GW
MS(IZ<0R_@ G[]G4>OJ]TK@LH>360O>.[?V?4:ZZP?\T%_9!?J\:\LG_IA/\
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MCZ^P@E*J5J'LLH)BFFQ)'I!03CY.%7N.3.D#I-N &B9LH8##'*F2XP8P P>
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M7Q0]:?L59%3 JO3:_P HB-[S"'U^Y:TSN66BPWP;94+37=\XQ@-J8F8.W..
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MEM.]H?!R Z'4IG(!EQ'2FVRVXK.QTK:NOL-=0$E,16\B%C:DI'#:FIE NY@
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MHK\MX(30CB '?&+Q;"\;?"5':CGGD"NM-,76LNFU["]2U^?7[=[=?M7O;_\
MCJ]KUJKVDCTT?47XD.^GVTZ!5852E*C1N?Z$':?XN$Z_94[::8>A!U8^+A!7
M]T5M+E^:O?J&K>M*JH'594UZ@Y25%,^94U)1/Q''AP\H*!XUF;.GCQTPVQ#1
MLX<-"BF31H<80P8'%$&%%S%SRSO7YPX-8]<%N 'X;68!A-6-@;H<0Y,!-*<3
MQ^?,A)J/O7L(D)">&,;;HP@9%*2R)--3BF&6(!$@5+DBP814N"$':JT66SV
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M5BARP4^5AR@F,T9\/8)?C1<DH9;;)RY+P:31'XF-:P1,$V=:ZDJ AFZHL>O
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MQT=AX'6U!QX2(6='L[S-/K7:[6'PBXHH*HJ<\)T>(95ZK1\61TXJ1;1A+=Q
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*I2E*4I2E*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g581856.jpg
<TEXT>
begin 644 g581856.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@ _1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?1DE"4D]325-?-$-?0D%2+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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MRATA^TK;^2^%\-?G _7#D0>$_N<6;]*'2'[2UOX!,#&,8!KA?5*=(W->?+U
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M&A8&V*( 5)%"&R-,]%/W,K4Q-"(!J5K:&ZB)/(98_5FC1-:=,F3QQRDKV>$
M=+_G-44O ;N/MX^%GQT]$]"3CJFSJ9FAU^607'2IG8T&Z-Z5J1U>RHI&F:(,
M))J6J+;A;6F)0Q^/M"'W*-$G*4"2:5J@'K33E!E@]/5)"*)K.&U%7"1\0P>
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MH?J?GJ?U/]E&"*9BF3V3#^J=E2-^:)$$.Q5S/H<B*A\J;69\4HU*H8 :(S!
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M:H^X(HRZZE?R!^5H7]^8V-8F:E"L]*\/+4VGEEK'%&2=V5UZ=YM8GRP(R^=
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MP"WK&,8 QC& ,8Q@#.E32O8+8*= DG$28)8F;5!JMO(?FU,Y%(U1I/R<U0F
MH /11IA&]E#&'T$(O?L[WZ?1C& 1KZ&X@J7HEHI!O5R*T:<7\Z39SGU/2>@9
MGJM)+#GQZ@<MK-W+0+R&MT(^;'*&3B2M"I )'L RW$8PB ,(=Y$.U_"#QO>2
M9]%;4AZ#GDAEZ(#?.IK([;-<Y5.DXJ(+YR7'2A0J8#6I6\.59ITB,V3HVA!*
M6YU3C<H^],PG)Y)<F, [M8OATXRM)%.$,M;+,/+L)WOE]DIK=8;@U*37/H^&
MTE!+,4(3T20H;:-2Q\_UX)B$C]T-@<"'9>@$$YQ_YCEHEXD^3(J*REXS;FE4
MKN6J^F*AMRPYC<4N?+$L2/=8?8L3VH[R"8"4)W8B5IF*EZUBD(>V,UGW#(W&
M4R)H3%J#U:P]C .D0OPH\40>-6!%VY-:BU)9U9]*51+U2Z=D)E2N,=8U325-
M7"8WIV%@96AD<G"$\^5L0P&,[6A0QQR1.CBW-X#794'/,G\*?#\O76&8]MUO
M*8]8)-AC20 5ORLVNZSDMP'1M1=$]J6(*35#7!YM;JF)HU$V=T9:@C9KM*Q1
MU#'M2^2:<F, L&O"@Z]Z%CT/C%CIG14TP:XJ:O-B*:G(QL-U.Z(LJ/6M C5A
MI99FU;05+8PUC>&L>@E.K;I0@-&66>(6H"JO#ES(M=KM>5EC=.'K+UMU)T&^
M'?9G4$+H?T QSUAL*$W37K\D8$\F8IW7"^-ML;KXY>]O3#&(!\K@B1B%&5A[
M<-C )$,OCYYJCM4<OTPPQ^2-<%Y$F;K8%2)BI8[*G4R9/]<VW64ED4T>W$:U
MSE[I)VF[[&?I"L<U&U#G,'KZX3C/E!(2Q:ZOFMYFIWQR<T4%)><&22MLL53^
MOJS:9B[679K;+HG$Z"\?L^YRCB&,R6O9A GA(&74W$FZ'60G7*W)NEA1REU&
MA1/9;<XM[& 7&<_<"T!>O"OC\9[$(F+B15WCL!SU&3V^3"9U(J\Z4YAKJKK0
M+<OF]"0F5/2N*LB$ME<RDR;3*OT:L3)]B,]@/H_>$7AF3DSIJ>6ZX5<0GD6G
M;!NO!7#*OL>0Z56A5*&E+/N*!0_8]M$;N"P*X;AL4BEQ9"DC1SS)GEH:6IZD
M[ZX+V, DK,O'-RE/V/J9EE]?E/JCKQULAXLR4.6VY=-(\MMBCH7SS-]U7+%K
M8H>:X+=JV@4?2#+CZDK6W0"MR.V<-4(H.-)AXF^2YG<TLO-8&W6.83F#(X7+
M4T.MN5P]I>7)KIK?/S#8XAQ\]"_MMCQVHO<1)G>F5^;&HGY V/JEB5R5M1/!
M#& 56V1XE>6X%V%Q9QQ$7R]8Y4UK\_>4JP;661JX'Z(R^Q5LX<."X;.HV^ND
M0(8&IN@\UAR4B.R6)1-BC;2O" 4B"43,S3I,98=(?"3PE)C9\F5Q^TDD-G2*
M?DLM6-]LRHNJZ@=K;%&C+<E5*PA2<K:Z_D]F!B3<3)W%)I6242NDH(\D8MRR
M2"=&, Y&Y?#!QK=SS:$AD!]XQ9\NE\NARM9SKBY9-"%$]CM^_8Y56+6LF TA
M"G=*V6OU30>4-L94D#^;'MM7>Y6B:7Y^:G+F&#P]<91J?2:P&9ILA$HD5TPB
M_FZ+ L-T%"H58D*Z!8^GU"N&L TX@HFR:71'VZ3S!N=E3T U'I3&HX;&XTK4
M-)C& 9+J'QI\S4MT?=W5,=)L>06O?D?F$.F:F=6(^2EH31&P)@FG$LC36D5[
M+7K&M9(4B0;+]=CI*%D(9B Q6 JXM%#5#*=!?Q\<)41='(,&73TJ9N*^'H(-
MR(UK$TJ4HSCJB\57D)N.7\G 7A*3[(.DC<\Q9HW.W8DE.1+D!(VWYN;$6P$E
ML8!+65>)GCV2I5HV5'>=>3 4[9+,8+/AG3=_J+$@<\8397I/):[>)S8<U;H4
MO7-4YF49>@,3.E2O,4DKE'7%.>UZ1ITL?>Y^1J0Y.X6OZTJ&C[E!Y%2'C&LW
MB2KTQ#^ZKVB+4B\?,YX0$IW%0I5N,S:U[<A<V^6.Z]P6&.! CW4IS"I5EJ&,
7 ZY_R>'QN?\ LG9W]X&O_P 'C&, _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g601849.jpg
<TEXT>
begin 644 g601849.jpg
M_]C_X  02D9)1@ ! 0$!]P'W  #__@ _1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?3D%32%]&1$%?-$-?5$),+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( /\"K ,!(@ "$0$#$0'_Q  >  $  @(" P$             !P@&"0$%
M @,$"O_$ &P0   & 0(! @\'#@@+!@,&!P(#! 4&!P$ "!$2%PD3%!46(3%1
M5UB1E9;5UA@X5I>8I]09*3=!4FAQ=Y*QMK?1TR(C*#)A9X&')#9(<G-U=GBA
MM<<E)S-"1_ F-48T0T139K1%=(6&H\'Q_\0 ' $!  (# 0$!
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ME,W_ ,3);_LR_P#_ "A9K%J/^PQ4OXMH1^C3;JMXL^)1TTTTPPU6V^ML$+W
M/-=R9]EMK064U>*78B4GJ2Q'BNGY*GG"!J;9*B5.+.6,U8B<$K*WARG-Q@)8
MR<F!SRA<<62TUGKV7U'"^LTDN"#$6!.Q0+5DI@^(L69K,9[B B&8F)G&"S6K
MW$E7LJ!R3)9$LXW&24P'*+\$P2VK!@%$Q(F(E$Q,1BH;'LWA*!E-8I-9NX*T
M$.+#J.SF[-JW+))TH8I32\P*G$3,85#H7@;6WJWY,C,DS<1_$2%*A1I%F0EI
MP9U"%S;"=N@XQ<CY9-VW=7E-RB2R*XY3&<WGB%5!7=@.DG2SMQM1H*6MI1#4
MO139..8)FR5/#] D<D6'.08H)3A#A+LKUKPZ)44N<*8K".QII2R6QI+N@V])
M*IAT@+(,KN8V"P3@N<-K!; CS B3UJ-HBCXYR):B3N+NB-;&Y4R-+L\$HD!^
M[RG,,SLYG52.8V*_:;2>HY9"/1D95O9CFB%I-0)$IL;#T@ B(N3GB=%F^6Y5
M6RNV\LLKV>S56]-)B12[FAG+6GEF6-%K'$,(B2AIG B//(3':L%>;/[O@EKV
MK'K9:[%@\\E-,SFT;(:+5:E;(GD>U\$/=HLO>7EM&G:8H-M#"V-UFJ%06V$+
MB#%:E>F1HU^.$1Q#:/LFW0 LB=5)>4RGU66K:3I-KZK^JKYP\4S;$\5/"61+
M$5E,#:!>>G)-2%LS<K861VBR>0PY&RMSZ2]M($YAM.K/13I3+=WD8W$Q6"0N
M7V]<W0RR[%B]8/ Y)4<DVP/VX$FO")"ND3TRQF1O4LE+NEF$#M0Z81%F(41)
M#"V!N1N#$,Y09+>]N4RBA[KW-32B'8FNIBX]#[BLA>'EC:6H:=)+H?N*20JJ
M9&YM)Z0QM<5J:,R.=Q],)<F/-4,#.!J)/1D-J?DV--&Z#@K4<XN*L6YK]C/M
M(,I)$:F0&(.=7 H=*8MH57M5@"%EEU9BD<SE]EK#;]$TG:OY+1;6IQ8[</9F
M*NM(KF?A+$IL&/1AQ57-L5;+&=0<RM@U\ EDV]EDJVJT[,H[N+B[\WO!S/N?
M4-:NSBDTB7H30KF.!16NV17%%*011T54M#)"XZJ;A-P^"=Y08<N0(9AA686(
MZ'E5YTB%+Y;;FY&Q)6X5A9U*R-_GUMB>5,LJJU&4MI=X0ZH$\?;V1O;F=845
M)F%=%&J./N9020[/[K(.IR$Y59)36^X)'N%M.ADV^'<B5$DFUPC<>F? $U("
M;(+2S,9A"RD32^EUL4E;:OQUA(?5%=$M625+ETE)U\*90*FU;Q5DVW%[RWVG
MXR'<5+Z&01+8WM7W$2YTJ=H@A4ELNZMP2&2JDZQ]3S&+RI%S6Q0N"KQ.4,:$
M[4&1.<B,2+'=,E0HRP:]=3,T5R:C4*1IC72ZPV(OQ%>O8JJK5MP*G+3EP+33
ME=<3Y937)NP*!BMBRYE=BR"7:;<5TK#DU4R67S-BQ7MMLV=C&Y"1A#&OM]2P
M0\W6LBK<VF#=D3AMRJ]W54HJ<VU>XAH5FD+!!4:QS-4MQK5)Z\,JYZ1R5":
M1$C*51(TU(("X/)PI,&JR'(Q9#J&:HV$U#4DQ@,G;99<DM9*=P]!HVL[!L=;
M*JSI(+VUJX\+F]CI[>F6 ,:(LX+HE&%,I=Y0JBL96JVF/GMY*@W(_MZ'K8EA
MVOM"J6=VO*B9M83P.PDTGE21,@1H'I:PVI.(Z2J;$K80G1$-.$+2D(:2R@#$
M%M)2].4*S\FJCKH:T5JUFF7/OY85]I0AMF@_IM,DLA3[0-Z7.(G -*Q;]URK
M,UVG@<0+FA-@J5,JS*OE^:CEZAEZ:N8(ZJ@ARY:BFQ,,Z9$$FH*M..7F8 ,J
M(,)DDK.(SIVIHA1E:Q.J(&4XD1*%MYS8R%.SD>[N($IS@M<AX5.*G 3E0^J5
MZC.!F8QD)>0%X_@@QJ3---:IK&.8QS3)C6F;&L.9(S8PI(S(I[Y(BF2*9[YF
M9F<;92EH4M*0%:DK!2EA$""UK&   &.X1 8@1B.Z(B(C#3337C&3$#[E/L2.
M?^U5:?K*B6IWQW/[1?GSJ"-RGV)'/_:JM/UE1+4[X[G]HOSYTPQSIIIIAAJH
M5G[-839=HO-O$6=N"K*8R.*Q2'2(ZGKEDE<MKZS0E7)%L:"ZMC.6(A6J;#I8
M_=)5&9Z9@"X8.&,8[=O=-2:UNS3,F5G&DS"5G([;&N2$Y XF)@AYP MIB=B
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M9$+,N;27<NR]-K* C+*;1L7I0;C(Q<DD4#LUF@(A,/8)Y54$2:T)1T5-5S,
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MX\G_ .#+3SC.<<>UV\<>WCMYQQ[?#7;;+CSF\S=3 $AF3(C6.[JT8[!"BPE
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M0H\9QG"5-C.,\K&<)R,9P+CQXXS@OM9X]OCW>/;[NM?,:O'<;55ZN%<;AU4
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M4IDN:A2-BNXFL7 "8Q+60&>:_*7T4GWYMA_ZAK[]"&37ZM-?E+Z*3[\VP_\
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MVB")4I9T;O&[2E=>RAW<>R%E6-LH:'1$.ODB!$<RN2$S!#DK.ZH+4$IQ8Q&
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M0H0NC"[-CTVC.5)@+VA>D<T0U"%2:C6D 5H3CTXCDBLDY*J*"9DQ.I*-3G!
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M]^O\&/?IIIIC[AIIIIAAIIIIABA5_P#OU]AWX=Q_ZNFW5] ]S'X,?FU0N_\
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M/;ZLC1(C\B.ZV1ZTHC9@&4G)@BFUB<6MD2@)2-:8H-R=5ZU7FJ[I24'$JKO
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MS-SRW)8M;L[O;G6-;6YV3JBL8EI\1B[%)%J,LKJY$R-;2M$8%*4'%!IU"";
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M/K/S9]AO4W6:*]<>NG99U\Z=TKLPZGZAZB_@=.ZIZ?U3_%]3=+_CM,,7$TU
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ME?&-PP?E"Z(&6*"2JL)E!J0_)639D29G!2D@X@7*+#_#+%R>(<8%GN^>QZ\
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M73(!*3<LI 2Q)U/2:@K!*<"P8I9C!U'6%DX&&*F4TV3N1<"%\KLO"NRZ)D,
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M'E4H"GRB3E+7E&K1I$QRD"Q1A,H4$IQI23#@^Q58L'1V*S5,H?$8+#?H;(;
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M0-X/;VX)9YB0@HU8K&=NLCN)HV7/:[I3"(A8RN36\XL(9T'D*FM"L8@7:!3
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MO/'2&B<(X"4SRQ[3ESA%)=#4\A2+'>++8C;4G@+L:U25F=QA-)D[4H;5R<A
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M7.W[X=&>BLQ]G]/=<[?N/'LZ,]%IE^;K!PX_T]W4U6I+X/LV#Y".PIHQ "
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MC?H:]:C39'[T;;C^)R"?\E(U2^TNBG;2YC65BQ)F?9J8\2F"2^.-)9\'<4Y
MW-[CKDV( ''C4""24-6J)"8:+')+!G(Q?P0YUANVWHF.UJJ:#I^MI:]S B3P
M>O(O&7\E%#'!<D*=FAN*2+2TRPL\):DD!P!8+/!CDFAX#QC''DXI;.*'#J=<
M5;\:VTSV,=*7ZA6?MQ2Z(VF9OEK@1+.MRPTE+8R WYI "*(F(QT-7 _C#'#2
M[ED\--:QF+-<Y5?"E.G<S[25)>09O7;:A/9^>4+>Y*C9MR"QJPF>8AB=T^FM
M8OU7+9S\()UZ N?TG3ZKELY^$$Z] 7/Z3JU>=OAC_K[I3]MT/^][;3X;T;S
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g770745.jpg
<TEXT>
begin 644 g770745.jpg
M_]C_X  02D9)1@ ! 0$!&0$9  #__@ _1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?04Q+04Q)3D5?2U],24Y%+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_   L( 20!OP$!$0#_Q  >  $  @$% 0$
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MC&,8QC&,9"?(GWH+=^C _M5 YOXX>\!IC^C*E_V QR:<9H( /K]/_G_SZ<U
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M^C _M5 YOXX>\!IC^C*E_P!@,<FG&:"(% 1,(  >L1$  /SB/HS7N @ @("
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M TR5IY-Y!%PS6/M$QC&,8QC&:"(  B(@ !ZQ$>P!^<1S'SD3RQXT<2:<>_\
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M:_D4M_/K;']Z]VR5,9@=U+.&C/GAPXVUQ_;2PU78;YC'7G1>P4%EFDAK/?\
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MKS"%KU/=O*NC"/M=[?I,RR4A%@:)J2#EBJD@\9.$BYM&,4H"8Q@*4 [B8P@
M 'QB(]@ /SYBY>N;'%#6SW=,9<=]:WBY3CI4:U>=Y12,\G,RFK:W<9E_7ZJ[
MN<; I2CZ&>6"8C7;*(@UT/.!\H"!T8HR+UBJYEW4VV:%O"A0FS-9S:MAIEA/
M*I1,JO"V&NK+JPDP^@9-):&M43!SS%5I+1KUH=.0BFASF1%5$JC=1)93\6FO
M32EA#U>?6V/[U[MDJ8QF W4QX>+<W^(.QM.UJ8"H[CA5X';?&S8R1R(/]8\D
M]2R:=STS=X]\H!_8X&MLCT(2:=)D.H:KSLZV I@7$!K7M9[/UE^EKIODWI1)
MIJSJ&<9[63:VL&Z_BV;O3_/#CD_=UK:^D+05P9%PG0]C3,98*#.0\LLG&R]*
MMU5L<DT=M6C9,]JO 'F/3^=_%;6/(NK1SFL2MC8/(#9VN9--=M8=2;EISM2N
M[5U59(]XFWD6,M2;@RD8U()%HS<2,,,1-IMP:2C8Y\RP'OZN_P"L!#_> 9KC
M&,8QW ?4(#C&,8QC&,8QC&,8QC&,8QC&,8QZO7G7IJS56!=UYE89^ AGMMFP
MK-4:3,K&QSJRV,8J3G0K]?0?.$5IF:&$A)J9")C2.7XQ41*2/D_D<>[61BCD
M)R5TIQ<H\=L/>5N6JE5F;G4M=PBT?4[I>Y>=O%[D1B:?5H*J:]KELM<W-6"3
M*+.-91<&[467[%$"]P$>JZ/YG<7N1Z[-'2>W:W?'#W5=6W.F2.:3L>=OKBY7
MC8&M(*:D1G8>)]B'IK_JO85.EJM*BRMM:L-3EHNRP,0Z22(KDR*S7Q@I"='Q
MOBA7%(1)XSQ F]*PI_\ '\4)P !5\'Q8G#L)O#]&0O&[)T3"[M<:=B)2JQN[
M;IKIUNM] 1<(+28LFOH:VQE!7N,C/,HI.,E4VELL$;!HIOIE>8.O( =HS4:"
MNN5R&714U)<TB*IG50"O@LF4Y3'2$]H@3$!4@")DQ.7[XGA@7PR??$\(OIRK
M'J*U:]7?H\,ZC1=:(;7-9*[Q?A;K6%]$R')86.K)+8^NFFT;PSTC7Y.(N=]E
MM:TA68V!"QU!?M;TSF*VQDZPZ9R#,KYKB1T*VG*72NR[OQO#4S>$X'*U_=%Y
MTUL#W%=[X;R\Y.5._:>J]3V'8J_LBS3>QWDUOEE9]I-1K^V6+2\1T#H.OVF%
M50H5H@XUKZ,=M:\':^NK3KT+QL/6XVABDQ"[ZHL_F;L.O>*?-7OE=7LP,)/V
M(?*>2^2*N/(7/ALG+IOX >.\,M5')#I;S6V;3R;L5:LVMYMOO#B1P\T(WB-S
M16P)?SJNW%OD/L7=<G<]O6+5EGUO;YAUL6,M$# KVNM6"/M,+/1JME6:3+!J
MVK;W,?A-QJV/QXXJUG1FV]N2VQ[@SF=CS#JS0<Y>SM*=#7K8UENU:UAK^Q[#
MLEOV:[I&HJ]-QNN*1*W:U3-G=5NNL5'JS-,Z$6PG713,(_7B+ KAX[*RN&T6
MH.I!RH\?.00VE=$@7>.U?\JZ=*@7PUW"GWZRIC*&^^,.3!C&:"'<!#X_B] _
MJ'X!^(?@RANJ(I].OJ]V>DBBG#\6>K_[)[+IRB:96T)0>H=JBMH$V57C'3(5
MO'!R9U*Q8W1FZE'WE4[L6F2,9#LQ.LH _&N/;I<]4)AL<I#1O!;JV7F&I>SD
MDRIHU?1G46)&>04?8;SQH@TBZ]RTJ49YFV51! !=[1@(Z;FI%)LJW3'+OI'Z
MQH>K.,VR82@5.*J,:XYM\_$73"+040(<M-YB[FUI66ZH+**J 2OT2D52HQC?
MPP38PE?C8]$A$FI0RT/&,8S8H(E(<P>LI1-\'I\$/"[>D!] ]NP_#V$>P@/8
M0KEZ>%MV_;C\R2[;W;>MRA0N;F\=2:_\\X+54'YFZ[U^-<+7J]'^UCKF@>RA
MP]GG(OY:R>S4JZ%LR\!TW CD'5CN,8QFTX^"4QO^2 F_/V]/;X?7V[=_@[Y7
MGP5NN[+E?^>K#;FY9C:<-JOF59M0:IBI.E:WJ2='H,1JS5>RFD61Y0ZK7'UE
M=B[VRM#+2UG<2;Y2-J\*J4R3]U,NI&P[&,8QC&,8QC'?\_\ 4.,8QC&1##\@
M-%V';]IX^P.X]836]J/!-;1<]-1=ZK3_ &C5*V]3AUF<_8Z(UDE;-"PSM*P0
M2C:3D(UNS7),1ADEC ];BI+V=0V#4?/^B72BA9[?2O/.IV&J^>.OYKS;O=4\
MX(EW%><E+L/DKWV"M<)Y5[)5Z8\C=^QDLV://)E_$^+-YC>3O1:YI2EXN9]-
M<D=P<CX!CHV/;\8MF<SNH;MMGM?BGRY&V/9E[R,UPPIG%6XQ23Z-KL)2:5$B
MPGH><<UJ7VE&NI)LTM@-B9G6CH[6^R:IH5)EN;O,G8LP/(SB+O6]O-]\F;CM
M%[0FO'VTS-LMT)QQN\!5==VS7=DM:]@<1;:[$!J_<MH.N/'*,4X9G(:$N4G0
MC6ORS^J<>KM0:=I63U?QYUW/Z]VPC=]D6&YN]9;:YE[DV'<[;L2Q'N$Q+W&[
M[)Y21FR'MJF6<_8IVS5FP-W,E6G,_%6F!B6)Z!&\BU&Z4Z9Y"Z67L=MXM5K4
M<;R;#7>W7O*>A6*%X=ZXXJO]54^]H;6K\.'%F9?467V1)TN=BIB7='V!:X1&
M+86<[78Z73YS[GFW!,0E"CFFR>,\(JTHFW*2HF[I.V[8AQK>[8Y+:ZWLCL+B
M&LYLT$-,V!KMOK]8M/?>1TNO-K1;["]BZU6HEU+M;#E7I7I:[(XG;BV[R0NV
MT];79J-:W=5D;+6J9;H?>')9/D%R@IFZ8>T\R[E/6N8@[[:./\=%'UKJ0]:B
MT$6T!+23M!U6X@K*EMY;ZC+!P^Z/D08-Q:YTA#QL7Q1G+;;MM[HV?H'7,U2H
M+:&MI:VZTM6S-+5>V[9B([;,(T=ZX\DU_&)6657LJ+)D_9E.JH/>>BA:-16K
MC+L=YIE'0I*XUWW96DFKQUY(\IN4U$6L T77CMSY?LSEIK_75];VI&.=1B4K
M5H"(=T^*9%BGK60&:E9IBSN+QC(KTU_(I;^?6V/[U[MDJ8QC*Y^JEQ"L/,_A
MK?\ 7FM9(E:Y"Z^E:QOWBM>2&;HOJ-R6TI*IW75,RP?NB*HQ?LS*,7%(EY$4
M5A;UZV2X^*4#[P<&]^[IHG5#^Y^>06Z96D ]M%@X<[=MUCUT#*2+8]4<K] U
MJ;EI6O,H\ +8XBW:JWW1/**X8Z#:542CXEZ5 [22!->BK[G>ZRG.YUIS=&M-
MJ\*.27,BJ:WO25E:7?C90:"39,?<-X[&W+LC;,SM<NS=JZ]9V^4L=R</U(7S
M-BF:$,O&RS&T+M7LA%J.O0XTZW=*8>"&R>G+U?\ 4'@I,E7+BW]/S8EEBVHO
MWQV2""DUJB;V'%F7#P/*#)$<&.*1R))%5>G*U-R+_="_2J@C>)V)O#9^GW14
MGJZR.X>)/+C7"39%B])'JJ+R=@TBE"D\-T<B2:828J@J(H+)HN2'0+,U0ZW'
M2.NP ,1U%>([$!463_TLW-5J"8#(($<'$2WQS6C%3%,X%25, )+K@=L@=1RF
MHB7+"C\U.'>SO)O:VY6\;-@^6';)-0I.]=66DSA5XW\J:(HDA+8]446=-O\
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MOAK//VUHUL-G7>RGI= Y1'L &_/X!P#X_6)>W^W\GKS7QA._;PR=_B\(._\
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M3[T%N_1@?VJ@<UXY% V@-,=^_O94OT@8Q1#_ - ,?4)1 0[_  ]A]/PY-0
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M%T3_ /IXT/\ ^'6]O_"G'^,A=$__ *>-#_\ AUO;_P *<?XR%T3_ /IXT/\
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MSAWIJTO!F)2/8MWTF+NS6">L;D7RZ_CYV;EY=3PI"2>N%[3L8QC&5H\8>_\
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M*"Q"',D)RD,(<GM\ZC_#F(^8_P#L6/;YU'^',1\Q_P#8L>WSJ/\ #F(^8_\
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BQ341:% J$&<!(FL ]PMM=+V'PG!@[=CC\'?OV]/Q_P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g780818.jpg
<TEXT>
begin 644 g780818.jpg
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MMQDC)'*9H;C1)4)26&)YDL'6V#53=8*RM/ G*#1#1FATDYC_V@ ( 0$  #\
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M[!_!V[=R'X->WN0'^4  ?OY@--0\W=>?M[1WW$?)][M'81[/^CV]R/WPS(Z
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M8JY:%]G=[H9#&5[HT*@U[0[KO2S8=1\FP /DSLSZ("QNX@(" M;CV"'E ?\
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MO6FP,=X6>]R)YGS-)H=,:BBPP^!-S@BEGT<             '8  'D   /(
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M%)$^GC5"0[?80W73SDS?BU"4=V;::FHT-?<=D2\]O[@2S-2G1$2["H[\6:T
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MWQ1=2D*MKD,8E,WJ<ET@R9^8*]N5 0$ $! 0$.T!#R@(#YA ?O@.,9C;S#^
M?U97OPS_ (Q/5)_GOP?[W_[ ^%(?]V6$XQC&8V#MU$ ^^ A_7Y/ZO?RM/IC>
M&Y=?<DPG50VS3ZQZYQ\N;#CS5;41"(N<A@]M7"_V1"Y,S)M7%RU5MBU@D"0A
M29N80<C=B%K><G#9-WPRRW&,8QC&,8QG3K#DL=AD"FLOESZT1B*Q>)R.0R22
M/[BD:&-@8F=G6+W9Y>'5<:0B;6MM0D'*URY6<4F2IBC#CC-"]-M@A)TE9"PR
MCIA\ 7:-O+6_-8<1:%:A<6=<F<40.<>KMBC[ZWBI2F&D@M9GUK<F9T2CMWY
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MG>[3"DQZIOX[<BG!*0C9X]R[CS0D/VC<EU(;(URHC38IE$73-EIMDVA.OHX
MV2WS7E'U;F1'&+$8CHQSAA>IZ^8U]*8BS.W>N&?&"&#M&WA];D:"0Z[JX*L?
M"A;#CQ-B$@A,LT 629,*I7:=C&,P.VH>4=@ /?$0SCW-T;6EM<'5T<$+:V-B
M%6XN+BO5IT:% @0IS%2Q:M6*3"DR1(D3%&J%*E0:60G(+,..,T+TVV"L'I8V
M/7DSA/*I'$)W#)4K3=0#G8_*$T;E#$^J"&*1<FIZJCST<0UKU9I32_)@%0S.
M)FFJ1T(U$Y$<>6'=9:7WXK_UI?\ V]?]^9 S0?*&^@A[X; /_?F>[T_Y6O\
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MY,KB=S)V5Z&+.J+?PH=U'=JD:#CIPB1&>Q=S!$U,A6GT"XG)-M"]A+2*3]'
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ML^!)&^!Z%'49C$EL\F::0"82$";(GE9F0R329I94ZIL0ZWQ8QF@Z^^W;?O\
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M=U0,Z*VU0L2I"^^JE!*4H=@T Q29HG+'?;M'74##MB]!V$ $0U#;NA !$ $
M'LZ@]6974;.(3R&>0MB/5%;GIB7F5Q]K-4$E[]ZW.(+7N*?<XK0S_%[&%Z[:
M:[_4#L&WDS63KRWXKL3@>T/?).@6=U2B7JI;'6YZT;W!/L<7H<3J>B62@E24
M)I1A9I8&%:B869IOIVZ[ZB.MUG4;Z?+?HKW6\Z.'B8$('BLU,Y,TKWU,*4=P
M4ZFDZ3?8[7<C8O?4TL"Q,TVTVU'7NM1#.FKNJOTUD*7=6'.SBFYEEF$EFEQZ
M[X')U97?QWU*-.01MX=EQ*?;?02Q5&IM4NA@Z%[G:[F%Z[:^FO5QZ<VD/DRI
M+R69)NWDQF5K%I%1%V!(GHU,RL"QU=6YLD4':22HU)C6HHXQC/5R:-+B50IU
MZ%Q1[$Z+2:J.B?S;<YYT^*JK+IY\<;CY!K(I++48IG:/(^WC:SI.N)&[V"_R
MDA%)Y[,I1=EP/)X1^2L#LDA=15C,$9>IJQ0YN$76NQZQ3:P3PGY'7YMHX<X^
M8,T?(\K#4Q5QMX<>$G%2B=23DQB=6S2ZQ&62._*>UR-M-P)6;++AKR&/A7??
M9E8)B3Q2ES:I+CO1/&V(A!*"J&NJ>B.Q^JQ4Q5S$62)HG1R H"37A\%H2)E$
M@?%6NO=+GU]/<GA><.YZU<H/,W,VW*   =@!V 'D  \P![V,9TNQU$E25_.%
M4,:F9]ER:(24^+LLB?%D98'>0E,RW=G;'N1M[%*%["TKG#4A,X/"*-OZIN2F
M&JT[,Y&E:I#82=)$^1*>F#P!-E+8TM#O[D:ARO83(\JWY![5D5ZR$1]9[8+6
M9@/!<Y1\MK<G9O\ :X2&=V5K6=(X/*5 2\K[#\8QC(:=1G[GSSJ_F<<G_P"X
M^=9OFC_M,U-^;. ?L@S9M+&! !\X /X?+G@!98>4-- $?OAJ #_6 =N!TU$>
MWMW]_P AA@!_4&P!^CL[,J*ZVU*4]:G3ZN(VSJQA<_"+NM:2!BTE#*0O%N>5
M5KP6.'.!!^FR=6!IC.^.23?45 E& ?H887N8G(V+M*@$&B%90F*UW (ZUQ*#
MP9A;(G$8PRIP2-3!'&!,6V,[2@( =A+2H4*8D@H-MM]]@T[LS?<S;;8>W8QC
M&,P/F_3K^L,^<2>_9U-/RLD?RPLR9NO!F%\O>,_"V6F6]?G'6WZ3K8?%K>G&
MB<L\&LUA8+$CS$@L.$+#)1%)U#I+")N5'(RI?8])HBZDZNL9C[TV&M[JU)E0
M2ZX?<.:[X:0.612'2VTK2EME6 [6K;]UWG,=9_<EO6*[M;/'MY1.9.0UL36.
MS9%HY'(G'6"-Q^/1:-1MA;6ME9$FFB@U1O.UITX5I7TGG+77=@6ROCJ$I8FK
MRJT4:<; E&YBU*DV0QE%,)1"XTH7$EJ=UQFCM*&A."-(JWU4;GZE)SOGPXK=
M2FY7CGQ8\/O.]4:.N]Y3S-B5D\<IO$:[A <-E%>\I./U&< TSC,F1D)E6\EY
M@,5JN.B8J>3.9M%C2XXA94FR1D9]R3]B]#;G-R;Y<*+^:N4,O/F4\8XW4=C.
MC)'"*\507C]*9_)+DCTPXVNN\1K"N)97=K5ZL@* R4TC:;M;\XAL;4Q:2.-L
MO2B9*VIKMUIYV7O-NW\M<8V\Q52"JKD_M2^GL*A>)1,.6 6M R-O3^V>Q5@;
M#NFT%P!;IIJ(+4:,[M)"2^,8QF-O,/X!_5E>_#/^,3U2?Y[\&_V N%.6$XSP
M$O01[1TT$?/VCJ CVAYA[>S[V!TU'R?5 'O:[[ZA_5KL&=-F%;5[82$ULGD&
MATV;3]#2SF^7Q=BDR(XL\GV,>6:E?&]>09H<G_Q!NFY>VIA/^*W 2_J<BA*N
MF?T]Y:>:Y.O"OB^2^";[,+DS'1]<QF5)EVIVJK5>EDL;CS4])UVJG311[)T6
M=WN;IH)O?- '0:@>E+T:>GW#ZVY+-Y]2/5A-Z+G!RH@Y:&TIU(90@V:Z@LF2
M5"SZJ&MK.C+.[$.L?9RE;LDD;<^EFN)@'ZF=V049EK+;TGNFLV;'[:<'>,SA
MHH+++-3/]41J3HA[T8!I1NB"2I7=$4I+W >]JRDY:K37;<O4X"S#--NW-O33
MZ=;03NG;N!W#A,28:)^Y8<9J8- 31TT+'<!40L[;41T+TU$-1U >Y >SM\H]
M[1<(^&C8E3(&WB9QF;D*(O4E&B0T'4R1(D)T$=M"4J<B'Z%$%:;".VI96FNN
MHB(@ "(YMEOIVIFE8E<&NLJ];ER$S0Y$M00B+(U:0W34=-#$JE,TE'IS--1'
M77<DS3;741 ! !$,[RF;&Y'OMND0I$N^VO<;;I4Q";?;3M >XVW(++VVU[0
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MP[^UWSV8QC&,P/F_3K^L,^<2>_9U-/RLD?RPLRZGAW_%:H+\UD1^3"LDGF!
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M::8=!8.PML8B,584NJ%ECT>9TVB-K9VI%H(Z)4"!*66G2I]![@DG3737LUU
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MZ3QXU:R](D%]<(Y])X\:M9>D2"^N$<^D\R%J5F(@ 6'!A$1   )?'!$1'R
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M+'DG&"ADZI]9DR@FKXF6:0H=4!)Q6^C<7IOH84:HTWTWUVU'7;7;4!UV 0$
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MZQX6Q;X2,'QRV?.L>%L6^$C!\<MGSK'A;%OA(P?'+9\ZQX6181  DC (CMJ
M #RVB(B.P    *A$1_D#RY\\4YWT.FLP.)VU-*-E,@,*-+V PLPLQV5[:&%[
5Z".N^F^HAMKOJ(Z[:B ZB(" Y__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g849928.jpg
<TEXT>
begin 644 g849928.jpg
M_]C_X  02D9)1@ ! 0$!F@&:  #__@ _1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?1$5614Q/4%\T0U]&3$]7+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 24"F@,!(@ "$0$#$0'_Q  ?  $  00" P$             !P,&" D!
M!00*"P+_Q !R$  !! (! 0$'#0H'" H0 0T% @,$!@$'  @1"1(3%"%6EA46
M%Q@9,5%45Y?2U=9!69&2DY69T=/7(E)387&4U"-5=H&8H;'!,C<X.75WIK:W
M\"0E)B<H,S4V0D5&<GBRM;@T0V(I1$=E=+3A\8*'L__$ !X! 0  !P$! 0
M           ! @,$!08'"0@*_\0 9!$  @$"! (""@D-"@L' P4  0(#!!$
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M>"?.\SEAFAD79)%+%)4LDD<B$HZ.I5U)5@02#)_A6<>\XW^.G]?'AFOY5O\
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MKU:89;CM G,M,IPH6F.RS&S#SCP*HT>-'6E3,9A#?6^PCJ/Y.:A^9(OW?_\
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MC8NSQJJQRL1$^3R=,IDS"-<\FK(,M$-:\ST"QM5F6.BJ)**&$2QR1 U%<E-
M[2*$6.1V9XP#(GD0-RZU)DGAD&SLONLNDH^)V!QEL#*DAPZ+"3B#;*Z-;KI:
M;"!+R7?AC"DN4@:V_,PUEB-(6U1?W9K)@8#-8LBI8BQ5O-P&DQ@2QEX":NAR
M,RZ?*2Q8B8P!$QG9;*)<TZL:S#SX7QI37B\GP,?/=-==>'7*'@I+C2+79S!&
M+)AK*1XU7K5A;$BC@&LA,&% @I2;5(,VL-VH8-ADH\$F[E*%MH6P_P!1.Z60
MI"*3&R[2:>'-!KZ+J*,3#L28!=O!F+97'B\H8?@(M\098,$)3(HW&<'RX4U
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M*?)FMR*R4MX-F$2A#R9L;9XQ0!"DES59.)PZ&CIQ+3R0$01E.3R!VD(OM=K
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M'(H]B %YR[-^=*]_7?'L0 O.79OSI7OZ[XPQ*_'(H]B %YR[-^=*]_7?'L0
MO.79OSI7OZ[XPQ*_'(H]B %YR[-^=*]_7?'L0 O.79OSI7OZ[XPQ*_'(H]B
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M)P1J9+R<)SEJ.J;(8P^[C"DYRVUE:\84G.<=F<=O<<@7;&I9VR[?1)OJEZE
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M8E.% L%P:B?@1Z_#DF7/EE36S:@R^*J2)Y*6@4N\TS10M-)%+R!BD=F@IJ<
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M_*/DWUH3'%M1P4 @;?@DG8A9H./(%%CDP8,I]K#-35-V)IIU%R;<&0 #D?N
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M/4C.M?IJG,;!5-V<#KL[5]A-5JY@["[F%8!L\/L(OK!I<</'Q-F%F3EN#NP
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M;R;A#D!J_*E L%"QZC55%U8!57( JJIL0J@!=ME  &'MBS;E;2NI1;HM4:6
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M4U(5L!8SZ6Z.5O\ :7E;P>*[>-L9&ZMZ"]2:EL]"L%?L^S"4#7BZR5#5*PV
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MQ02IK!0@CQ?L=@0Y+:GXJ5JE,W[R/MG(CN55*9+)I]KUS4=7@Z_E&"/A$W0
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M]KN/4ONY7GAW*_T%ZL/M=RIW%3X9R3TN?Z+CK*Y^R*J+IW4*JH"JHH*8*J@
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MQAAQQQQAAQQQQAARQ-CRUPJRF0@YZWE>N.F,^J7B;L_^#)MX.,H?XNRVZO\
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MQQ[;-)1U.Y'E,AD5FW"-%6-U:4M%=.]^LO4.@)=K"V5NXV*V5*A,[#(52D5
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M1XP)FO"?7.'%9L(TSAH3*K@^2D8'426(K2"46JM$\11"R\]T/;<S,[3$O/\
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M!C/K8;;:"_P;(83CQ9#24(P[V8QX_G"<942\<4K.59SG,@\M>F G:U788=]
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M"H6$M%-<&KDX:WR<X[,=O;V>7_\ IV=O]/9Y.WW^SR>]RY3-Y1Q-]/2.)!(
M#"!L9T" K8GDI&\CID8GB,RV J+4L+W2-KWY%18$@#S"UR.ECTD\K:9+%TJ=
M=8T_LF-4M\;,(UJ;46HE7F2][2_5*<.E!*)XU4E-V.NF71ML&W.!L(VF[#I%
M4F%0%@A@(UW QY<:)2Y5T/ICK<K.\].VG:5V06H ;446N[%$9V[:;("]6(H
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MIL/*VE%GCK%:#Y:XG)@$];:[19%+K)(34XT&!%KP9F4[&M9P&]--R9Q<?$@
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M7GEN/TAJ7V)X]R,Z<O/+<?I#4OL3S8H(V;03Q&QBQ%J#SY52"5NRV%;$G&8
MZOVX<1+5LRLLI*1+XPL,$D)\>;$G2(Z8L9;S[C2%-Y7V46\4R<H2B%;*U,6>
M&.&@:(I\3)69#LMK>>*BD,S'%$AK33;CKD^%A^(AM"W%/80E2L0,<@-C&X(
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M]H%8+,ZB+$9PX\B,V#JM@GN$9*&!J$#'F52\2EL,.TYVS:! &QRSMN R(<X
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MB-;S91&N14>PD)=%UGL\96X<_&SI$" ;(:YVS3[;G)N2+$C8K\\*6*0K2/=
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MNQ(S+-RCBH\%;%B9\6P!8O)I(21COIT)]D(15+?*U\1.B5+GT):7L^N;#K6
M/>%B]@GM:D]KG"<LY9[5L*'KW99K:SRB)L@?CN1;;:[39+'FP793,XC*'GR<
M%V%(8:#($0/M?)C"'-$(,:M*W:X NXXDVU=['8A8I$I4NR(I=-SN)E]M@$K2
MC)9 1(Z0H*DD@):.GWNT2CBNH#S/O$8DE81R;(XC?EOZNM%4655XMELA6 NU
M:QF[CB9Q3K9(=':\AAB!U=A/P6 ZR05#D$44QF'.A(GQ9<-V$2CP)+T1N581
MKKNTM7=U6?4AE-HC#*>!J\VR[-8JEFGT.N6BTVXO4H--M!6"#?:K$MZ9$"K'
MG3#T:N&I5F'"1I!XE'(-,2=M_I8TUO8\ .;0!%;(BO#)PJ-7UVBQ0JG*8F1"
M\%N1,K<$E'&9)P(M@-,0B\-J$3\7GJB39<V'$'QX<?0>@GIPA$G2WJ!<YTXM
M)CS;HLOM/9!AG9$N"1EG1;^Q(A.S28EM6(LTO-H%>J#'>03T:#,82EJ%'C(I
M0G)!&#.,Q,IB8,J< HLO%!5D<E";0AELT94NRDBP8BO4#4IF84QRD0+,A1Y>
MV1(\0ALR/&%=1NG96+)*K"-) IW%+]$WW0[IJGL.>IECL,:2U&"DL,W+7>S*
M!&?#$2FID3I,.79:2QXZ2%U7=FM+PY7X<=\LNN7 !-D,P(\N5)'=PKKOZ?I
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MJ#4L?1!%')#084FX;KSL>\7A1FN'$U8%311D$>D6!\L.)UNOU>M1:Q,:E9=
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MU:C/; >@5'9@RZ!QIH1?JU$&6D7F-ZFPR;0=Y\>[YU9[GCTJ4VY4'8%6I-L
M6W6U;KU1K941N'<(QM^N5RQDK@P(M(N!>8P>[03-M-&;-<8MP@&X]X.EB!*W
M-&9,IQ?-^;..QIVHR+D%<:L+99>UYDCD/<HP$;#J:0TRMF12=6+5LD5/'(=\
MM54":#G*Y'V5^W$=M1T':A8%X35P.\8[L)4 E_:I'VRT>5K+"R*M#%-4S1*!
M#24Q@J(]Z%^MJX=4I,Z(ONO:S19A+3FE^I+76*G9C-F:D:AWQ)O42IA[BX9
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?&&''''&&''''&&''''&&''''&&''''&&''''&&/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g861211.jpg
<TEXT>
begin 644 g861211.jpg
M_]C_X  02D9)1@ ! 0$!&0$9  #__@ ^1$E32S$R-#I;,3A:1D$Q+C$X6D9!
M,3 W,#$N3U544%54730P,# W7S%?1T%-34%'5%]+7TQ)3D4N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@!1 &_ 0$1 /_$ !\  0 " 04! 0$
M           '"0@! @4&"@0#"__$ &<0   & @$" 04)"P4*!PL- 0$" P0%
M!@ '" D1$A,5%B$Q%!<W459A=[;4(CE!4W%RDY:7L=<8&8&1M0HD)2E)>8FA
MN,@C,CAXM]+P)B@S-#4V0D=2DL$G14955UAG:8*8LM'8X?_:  @! 0  /P#V
MP<>M?T1[HC3KMY2ZJZ=.-;4Y9PY<5^*67765@V2BBJRRC0RBJJAS&,=10QCF
M,(B81')B][77?R$I_P"K</\ 8\>]KKOY"4_]6X?['CWM==_(2G_JW#_8\>]K
MKOY"4_\ 5N'^QX][77?R$I_ZMP_V/'O:Z[^0E/\ U;A_L>/>UUW\A*?^K</]
MCQ[VNN_D)3_U;A_L>/>UUW\A*?\ JW#_ &/'O:Z[^0E/_5N'^QX][77?R$I_
MZMP_V/'O:Z[^0E/_ %;A_L>/>UUW\A*?^K</]CQ[VNN_D)3_ -6X?['CWM==
M_(2G_JW#_8\>]KKOY"4_]6X?['CWM==_(2G_ *MP_P!CQ[VNN_D)3_U;A_L>
M/>UUW\A*?^K</]CQ[VNN_D)3_P!6X?['CWM==_(2G_JW#_8\>]KKOY"4_P#5
MN'^QX][77?R$I_ZMP_V/.'FJKIZN-2/K!7-=0C(ZZ;8CN8C*U%M3.50.9)N5
MR_2;H&74*F<4T04%4X$.)2"!3"'+%UQK@Y"G+1J<)#@!BF"N0_8P&#N @/N/
ML(" @("'J$! 0$0$!S=[VNNOD)3_ -6X?['CWM==?(2G_JW#_8\>]KKKY"4_
MX_\ S;A_9\?_ (GF@ZVUT "/H)3^P?%6X@1[_%V!F(B/S!Z\X2+K>F)Q)XO#
M0.MI9&/<&:/UHQA6)!)D[)V\;5VJS(LFU<E[AXD%S)K 'K$F<DC0M7N#"1"G
M498X>+N5*"@E3!X1 #=RIMC"'A$0 W</4(@ ]NX9]7O:Z[^0E/\ U;A_L>/>
MUUW\A*?^K</]CQ[VNN_D)3_U;A_L>/>UUW\A*?\ JW#_ &/'O:Z[^0E/_5N'
M^QX][77?R$I_ZMP_V/'O:Z[^0E/_ %;A_L>/>UUW\A*?^K</]CQ[VNN_D)3_
M -6X?['CWM==_(2G_JW#_8\>]KKOY"4_]6X?['CWM==_(2G_ *MP_P!CQ[VN
MN_D)3_U;A_L>/>UUW\A*?^K</]CQ[VNN_D)3_P!6X?['CWM==_(2G_JW#_8\
M>]KKOY"4_P#5N'^QX][77?R$I_ZMP_V/'O:Z[^0E/_5N'^QX][77?R$I_P"K
M</\ 8\>]KKOY"4_]6X?['CWM==_(2G_JW#_8\>]KKOY"4_\ 5N'^QY#>_P"@
M45EJ:V.&=,JS1P0D&!%VT!%(K$ UH@BF\"J;4IR^(HF(;PF#N4QBCW*80'N/
M'#X -,?1E2_[ 8Y-.,8QC&,8QC&,8QC&,8QGDNZC:W'BU=5?=E>ZBE?TOL+7
M5"Z=U<MW3OTKRZV]$Z"XL;)VE+6RW,^0[TFR[@9;7\1MUF5M4X9S87L7/VRF
MTH[2PQ<*F2,BGXX%QO4KV7K#IW\+J/PJWYL;BXR]&.H1=6=8L^P^,?)J19ZT
MXS;/DZ%0VQ>7O,B.TU05M%0=I<&8UC7E4U%>.0$Q225R#K3M.-AT9"9[3M[J
MW=4":X\[1Y4Z_P"3=.ULAQEZ<72YYGSVI6_'W5]IJ.YMB<H9E:L[2JEBL,XB
M%RJ5"F5$W$LK'56;:3S%V2/:5ZPUUHU>I2N35PYR=2_6]NM'#IQS+C+1LV,Z
MV/$W@FUY12/'#33*R%TER?XHW'<\\T-JQDP)KX92DV9C&^ATF5()<R3$$;!*
M3C)=PP/$VC>J7U#=6;2T5;.27,>M['TO-W;K \<MDPSWBY1HY".#IIZ>NNQJ
MIR3=M]9+1M\LU^M\I7R'NNNZC*5NG/Z\V2@*U"0\LNM9U,)[/U1.H=NOCESA
MT[;N1^P=K4V4X+<5.4MBNM6K/%J*W?JK4NS>3FMZ7R0]%HSAA:+DQH=;=\>K
M5-V-77VS;/9=X46FKDF;0[@S.EE5+!- ZXZ2][ZHM?X6<:..G'>P<8^0/$"Y
M0\Y+<9.:\%LG4F^M<ZY8:PV#!K\KN+5>HDDY@]I0%V=NBZWOTENECL202A)F
MPV)K)-7Y(]GE_P#W/IPHXL:RL/4&W/1-)TRL[2UIU-.?O&"B7:-2D?/59T!4
MMA4U*L:LC%5Y)P@E5H1..:$8M5D%G2!42A[I]:GE/3AC&,8QC&,8QC&,8QC&
M,9"?(GX(+=^; _6J!S?QP^ #3'T94O\ L!CDTXS01 ! !$ $?8 CZQ_)\> $
M![]A >P]A[#W[#\0_$.:XQC&,8QC&,8QC&,9&&T-)::W?&Q<-N?4VL]MP\'*
M)3D+$[.H54O\9$3:!? A,Q;"V1$NUCY5 OW*4BS21=IE^Y*L   !Q=GX[Z"N
MP5CTRTCJ&V^A5DE;E31LVLZ1/#4K?.*"K,VJL^=8)V$#9)90QCR<[% TE) Y
MC'>.EC#XLY$FCM,)Q4C!)ZDUD2$EZ]7ZE*PY-?U L7)5:J+JNJO6Y".+# S>
MP%<<KK.(&%=(JQD.NLJM&M6JBAS&Y9?5NM74JO..=?4=Q-.;9$7QQ+KU&NJR
M:]W@(H8.#N"T@I&F>*VF&A3&B8JQ*+&F8Z,,,>R>H,Q%'/Q;:DU8R78NF>MJ
M"U<Q<I;9R-<-J96D%X^:OJ"[:\2[%5*+(HTD[BW<N4+5(-S)N[$BX72F5GR:
MJA3=?UWQXT'J%%1MJ?26HM8-E(Z2B%&^O-:4FDH'BIF3--3$:9*LP460T?*S
M!SRTDR, M7\D<SYTBJZ,*HM=<>=!Z@$1U-I'4.L.\M+3QO>\UG2:3XIV>:MV
M,Y-"-9@HL1EIEDT:M)61[^[)%JV0;O%ED44R%D2!JU:JQ)5.LUZ#KR<Y.2=F
MFDX*(CH@DO8YI4JTO/R98YLV+(34JL0BLE+/ 6D'RA"J.W*QR@(<]C&,8QC&
M,8QC&,8QC&,9"?(GX(+=^; _6J!S?QP^ #3'T94O^P&.33C//5U9.8.T^-?*
M/C.UU9RTD:_.+WKB:TD.&4'7=9,9+86NMI\FU];[7V>JVOL%(7[E,K,U\8_5
M-<T7QULM$V!IV9<J;MLTK,0CN/C"\/T:>9_(;D?M^SU_9>])/?C&=XAZGWQN
MV&>P-)9-N(O+BT[XWGKZ]\68_P!!JM675+:P5+I4%X-7;16GME0ZM37N3Z4,
MTNA_*7X1UZ%W=Y&C/JU.0SUK$KSL;)O5X%S%ST2VE$8A9VQ&+F7\@T,5RY;F
M!M,,(UP9%7Q%3$R:I"=]QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MR$^1/P06[\V!^M4#F_CA\ &F/HRI?]@,<FG&<0^K\%*2$5+24-%/Y2"4<+0D
MB]CF;M_#JNDP1=*Q;QP@HYCE'*( DX49*H'72 $U3'( %#=&P4+#K23B)B8V
M,7F7YY276CV#1DK*2:I")*R,BHV12._?J)IIIJ/79EG)R)D(=42D* 1JO\.\
M;]$TS]=H#)?QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8R$^1/P06[
M\V!^M4#F_CA\ &F/HRI?]@,<FG&,9$"_P[QOT33/UV@,E_&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC(3Y$_!!;OS8'ZU0.;^.'P :8^C*E_V QR:
M<8QD0+_#O&_1-,_7: R7\8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,A/D3\$%N_-@?K5 YOXX? !ICZ,J7_8#')IQF)FZ.<_%#CSM>@Z1W'N:NTC9
MVRD:Z\K59?1]FD/<\9<+JVUM3YRXS4)!2E=UO7+AL-VA1*C9-C2]4@;1<3&K
M4%(OYA)9FGRF@>9_&+E%8=AU70NWJ[L>>U:Y:)7!C$M9YB"+&1F+'7HVS5YW
M.P\2RO%&E+#3K;7HO8-&<V2C2=@JUCA&-B<2D))-6\@+B [WCNP_^J:9^NT
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M-EF#2(R#AM$+L+&<8QC&,A/D3\$%N_-@?K5 YOXX? !ICZ,J7_8#')IQC&1
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M:/0;J:FH,9)6O.MA:,M-=O\ KR7>MU%@@+HVC[Q#0DH1!2P:_M<4JX:)8%<
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M 1G&O^%>]ZRR%<RZ'B<.)2-YQS[P"(M@< 1NE'&!98Z?C61(0PCQ?H]U:_\
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M#U /X ]0>K+'\8QC&5PZ'+_C+NH('<W8NA>GV( )SB'?_ONR^O[KU]P]H#W
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M XZ=SJ*G,5-,@>LYS%*'K$,^_P#G,N/'?L.ON;I>P]C>+IP<_/N?7V'Q ''
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MUD;QLV#-J<2>3%1LV0;J"3N41(*B*9#F*(E*(E$P@(E*(@(@ A]@D ?5W/\
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M&D0LY,NM,2#UJ-F:LD6RK:2]DI-E=4RE,?%9N+'$'=/DP+Y1WJ/EALC64XY
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ML=QC&,8R$^1/P06[\V!^M4#F_CA\ &F/HRI?]@,<FG-!$  1$0   1$1'L
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MWYL#]:H'-_'#X -,?1E2_P"P&.33FTXG AQ3*!S@4PD(8W@ Q@ 1*43^$WA
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M2*%:3I]QC(ULK"Q]Q082T^G+6[$(1,I2$*4A" !2$* %*4I0[%*4H  %*4H
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MVF_]+X_PX]+) 0$!;1X@(  AY%?L(![ '^^?8'X ]@?@S4+=(E  *W8  >P
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(!W[]O7\?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g963328.jpg
<TEXT>
begin 644 g963328.jpg
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MR/+K5T<&=63;,\ 8Z6OS*5<AO2]H7NRQ4-S&$$+68S6^X98IZF!#;CJ%F2
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MN<K1^[YG![[$;W;',U%4!GM[JO\ ,1%5.[51S>Z]- QHUI+>=X$*)2?<T8O
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MO?1U_5RHK#>VQ[FQGI+\"+W<]7O<O9A5(UK>R(J6ZSO*P3(\4518T<J8\CF
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M-2B*"5@!Y<L@D\\@D'B&5LMEK/D_F-C8=TN[?X_;NU]H@N0QWXKT$-?<8]O
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M'56)S\,Q3&IT:VP')'X_.CT]UD2.SO"3XOLF(7([@=-F-3!-'A1?@_/]S_T
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M##**Q%E'?[A%:[Q?W3LK!O?W[O&GDY51RN1RK^43KK**E %\228)4(G9ZI^
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M"&(O=SGM5$["3LUS57Q:JKW5%[^*.:B>77?YWE<K/,KG7\N6XJR9,D<=51?
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M2*]>[G-\AHK:+;EY[>[@P22&+ 3W)#X<-$K K+:5018KGQW-=8B BM54<X9
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MV3=D82+CF.Q/?B5D%)(@GOLKMY#A4V(XQ7(=A+*_R.7"@"'V0!#27! 3=/\
M3>_AZ-1<>Y>,[GYA%QWD!O*&L"ZJL#;!=-T;K&X8OU#$C5=J-A-H9#4G5CHF
M29170J&#-%]?1XD"6R/:)G"XR<0^./#K 4UKQPU-B>KL7*4$NV;10GDNLHLX
MX4 RYS+)K$LS(<NNE'W;^J7]E.DC:]PXRQPJ@FR2ZR5/;JM) L4:\@23(1]Y
MS^,Y/7[#OOO.N8_-_5[?_*3+4HRS[7M,@XO$L@-NROPWO3(%]I'&0T,) (8K
M))*O6OF,31M:B(B*B(G=/RO9$:G?_%$:B(B+\-1$1/PG7TZ=.K[6HO\ SUK!
M_P 1"V*_8GI_LE3HD%JRN5+@K,\$9)DBQC3!011O>J($Q%8JL,BHHT8Y?QWZ
MUU<@LXX2DO)<^2'Z<+&3''8V?V%#0K@C 5J*K'2/>^]'*OO!:HW$3Q1[=@'^
M)06O7+> @[!P5:^1RN>$1CMCH4@<1TX1Z->JM>KV!0KD:)4(WM[J*C1NZU4]
MV[,B#(W&\:]^7/DA%"AUD=/J)4F>7P1BPP0W/<J-8]!,:B/8H5^51?QJ+RZH
M]GR/D,*L5.!N1957(8'E(6P.*_\ B)&!R^X?CN[T"\FVKQ[TJLWMUO5*=3;]
MWW:>U-8E5%KPA:CL[_>.!(()R Q4(0&&,_7;^[HT:H>H9;WRXS& 9&@O-$(C
M']@N"R&C@C:BR1M8V,)'*BO[*YY$>COG33JZ/;:VQ9LJ_#D.=ZDH=ETM[:6$
M9U%?3\CDV=9DF-5D%( $QB;B-U6VN-_J(YMNCY4<![=M<.6DF%8&1A@L."/)
M=AO8?)3D?)I\94R2!U#U&X3#SAN5S$F-12-&-4>P3O/[F]OFJM0[;KK"ZQS%
M,NA7A?VME9LVU7D^.UL:[RG7.3V;@1\GB@J#NC_N# L]C!BCRB@+-BOJK.'$
MRNE1]@.;"L+*M<KL'%7,]=(V6>WCC#+. 0%B7&9:\;?9(Y)#_=[62B<^:/4/
M^*OR#?O-]NK> 6[>W[-MMI%CL)"91O-LR)&L;47A>>;;Y4/M"+@EB21Q.@B]
MN$M.C "Q:H3\BO+:2&51N6,&(^5'AE28 2A.A -:089+I+F!(BN5R'8]R%:O
M56!@7.12PY!CP;%DQ".7(HSI+Y!8RD(;QDR"N.<$DLT#6!:KWH]B,:KWL<]B
M+UE2 =AD]MD3*PDBAL#N*4UG&:.):F;"'$EQ1?5#AR(K9<J.I98715*Y$$=X
M_<DD8RZTRPAY#&C)4RR4)OJ$B.K88S- CE5R1RD^@AM;&#'9X^SYM*]&(C2E
M3NJMB>[S<0%C!<L6(4, K 9(R3A?U!<D_C.,'&NV=B\]W?>Z]"Q)4DV^::A4
MFLP,N#2FDCB::!\EBKH3(A&<\E ))^:&%8'.HRD5C:\4A\.-#!/CCM)-@Q7=
MV3(0FE;7Q$1ST<\2D"]J*\SO)R=7BE3(-)CKKZVR>]9#DB GZ4&0,Q9KVHT?
ML# 5LD+8M<%CO![1*%[&K(=\HUCJ<O: ,2+6P*"5:VA@E)&D6,:"%54AW-=)
M>64]RG?'&!"B:1D9$;V$KFN(T?GU-U44>6,J(KCV()S2_1@#02I7O@%$D*(1
M[,/E'9$\D$&8BLBO*9GN*X*#?YI'@UM5(,:*'"D*K]$$_=R'+!Z _;/[=8$R
M6Y+N92-YV]M"V<(H) 5<@EU)48QAEPP8D@CO71PIV-V$.Z-&?*844IL\=#5S
M&OL+-AF*@SN4,0K9I!.1'O:C(81L=V3Y3NG5X=D.45CQU]=46-%#-!\G2);/
MKX79#$:"-)B/&%(\CWVO>I89C2'(YS"HBN1%K$U3&I9/T3*6/*OYD9\=+A\=
M"2QJT:M$KF ]XGOAD(UYY;D1Q!O]IXF/8BNZO*J^=2SZ66L^PE,L*MH;5X5E
M6,$,HKV*85>^,QXQ1H\AC6%&T3&M,\K7.<WR<EP*]I@I>*:)@P)X<@, C]1'
M^$_)!QC&2 !K)B3DWMR2&9)F^V.4!U!1"&XE@2 RY)_#$_!.JC=$_4HAHM?.
M,ZUM@F#>08U@Z."2.4T2SH9'1Q.+. UW@4T!APM%V5"^;D9VH?$IMC1R;&OH
M:Z!1TM7)^@]MTY&64F4%%!.FM$SW(IVN>QK4;8%"/VVL8Y?)JJO*IK&KHYDS
M)<@*XSH* ()I8 AODO4SO&N ,;@QTD>;/](.IQ/ SQ:9SE5&]=\EU0NES,GC
M8X@I5A'-+?%CRIQH9PO?[KG*5!#<.:WNY'L<"1'DC:K!.8J>XM]!%R:,2.V3
M*H*\B5Q]O$_G[LEA_;H]=ZRW%*D3F2N)C[22Y8KRA('2IGY4($( !P>NCUJA
MKX^-U@C4Y&28%F:<1\Z+/^DM;2:>R57NL8OT9?8CQ -:IDK'^Z%XWJ[R5R-<
MM"9;:@IXP+@$N22-#B&B1"#2/!&*0@"J,Z1XZ>3FL0:O("04S7JC48+VT>J=
MO>W4"SF%MKB#%L(K?;&.6=KB2JI@6M,($-I C'):-'*HE.)QGHTB/<Q1Q_*+
M>8W60;'M&81A,QQY4MB-E6@&*6LJ*SW'MFW-RJ,;VA!&95<4R^<@CFPXL8A"
M-:R0PUZJ+[LQCCB@*R32RLH18XAR>1S)D# !.%QDX"J20-0'R_R^OX[L^Y[K
MN%V*G7K036%DL.(U54(8QACQ#R$'C'G)+XQDD#73/V$VGQJ+GLF=DLG$['([
MG',MR6IQL&45F%+$G@%7"S:(>U@3H8LE#)?/@SHP8=1[8R0V3S60BL!.?7.4
M$Q>#63VU50=MK7AG RN J%@V\6R0;H:UJ@,,D16C5CS"G-EFCO:K5<0:H]V.
M;/\ .O[,[&MQW5U[;44JAKW5*WU+./&L):G<PDXD\T55^K;;RA))GQ922(LE
M[AC(!Z!&U)4:=K"VN)4S]AW_ -4?W94]T)M/5P8,4MBYB&%(%0P:J,4[8CNY
MI1Q/FK/D26,*YSGLZ^6[T4E)+BUV@>9W%97+8DK@N8F,0CC,;%2A;F<\2!A3
M\\?^@'JQY_ZC^I6]56E-WPZO)>O75M0P)6V_;9+$D6TQ5)JU:M,;UG^BIALF
M?W8:UZ>/V"DL@EOL*SF9#6Q;<T&H4H%ACF18?MO&\83>ZQYTK&.L R%56M9&
M< 97$[M.9 JB+:8EU9Y?]%CT4EIC.-N(D>>;ZA\!DTBN>;Z4 SL^H>P(W*1@
MXZB0?WJ]2(OMK4L.')K\MGG:568['J9:P&#3VQMDOC-9#*CAN\C$"YK'S&.C
MHY$;_P!V/[L1.B/>3;G*ZF'/N52HCQ2 CU/G#BS94U@G)]0Q2-D_4",-Z*@W
M/"5#,1SS$:US&8N*&27,A/+ RI8Y#,N $;/>/P3\=8SKNN7?(-OBCK) %6+B
MJ*BD"-,901\F)7@,8/+/7Y.NUN]H8S0VM#@Q8)+"FJ8AHEQ)>+WVO H41)8P
M,BED%\SJT1VJ\(T1KE(YC%1W4]/2GDRY/J@\6'.@K KF8KR=?6PWQEAK5AD:
MB4HX XPVMC-&]B?5*H_)RJYCD<K7JG6/R>.CRB1/D%Q^?51X=6$++4[VQ8PB
M02JAVS90Y!X[#$8]2,0L-S2K_HZ=F$5RY /2;M(MWZEW%*4.1+*6NQKDW4B8
M=P7M^C33:R%*]6JTQ'$,B/ ]6*-H7N"JC>QK%DGBX;^?;<LD,2?U'92BC.5C
M*]?..F[_ "/COX&O/6*=K'I'YK(05!V^G@9[R=UVYCDY(/1!R#@_'8&-;RO3
MITZWCK\RM.G3ITTTZ=.G333ITZ=--.G3ITTTZ=.G333ITZ=--.G3ITTTZ=.G
M333ITZ=--.K/[/X_:-W:*&#<FG-6[7#6$$6J%L? ,5S5E:0,A)05@KD-5/)$
M:.2B&\([QL4G=RHO=>]X.G37N.22)Q)$[QNN>+QLR.,]'#*01G\]ZI##L!PC
M7U8E+@N&XKA5,/M[=3B..TN,U;4;W[>%?1P8$5J)Y+V11+V[JO\ 7JKD1$3L
MB(B)^$1.R)_N3KSTZ:^,S.Q9V9V/RS,68_C)8DDG^Y.G3ITZ:\Z=.G3IIK3L
M_BS;-::/Z>5FATC+!S;DI)4RKX]ABPG6"F8BJBIV>%2-<U>R.153NB]N^LYJ
M&F%B.&V&]<Q&Y;BXBRZ[ P3&]DKJ)0O?(N!?4,57S)WD@0$:/N-RN3WF$$U>
MMPS^(.X_8MR/V-P.PO-LAD8YBN/PN7&?W<J,(#R3H.-8OI,)*E2G[MB,G+:-
M1\IK7D&@D:UCO->VG]R.RH>Q<\%@.L:U&T, T?'L=HH+FN#%I:QA6M*]!.4;
M0/" LR7)17*Y&$<XG=>R:I\XY3WA0#A([<,!LE20PKHSELX'2-Q*'!.6*#X)
M(B/D?D/DC5Y/!=I>U+4\@W/:[1VZLK2R7[R@5:M6.%?UB:<PM+$0??DK5H\,
M,J;,T&+YOO#)YTR%$DO@..SZR>6*Z6&J^M[EAB"T:=C3RL\B(%6J((5205%1
MXQOGGI[5U+KN17R8D*/9F2:T,N4A1C.TS'(C/U:4;Q.5XC$^R,)8[2N1\404
M\/NZK7^(EP+#:B!C%@2 X##ER"?]7(K%FS3!:IYDI0#<(SU?[3(K7O1T:.%C
M!M:,7D^Z[;NZB#!"JT?F1)4BO9<R8)4JVRGD\I#63EF*]%8TJ>+YSD[PVH0R
MG<5[(Y(N6 "QQ@)#& L<:C"A% 49'Y.!^?\ +]R>Y_1[T-VSP79*-O<*%2?S
M.] )MRW25&LS;=)9C4G;J$K&2.".LK^W/:K".>]()/<G>FY@-\<LR"H'0RX,
M2JCV-E"<[V)DN.D-+.<]RE-*#7 8Z+"='B^8X9'O:1SAM,XB.=X+1L&RHOT:
M)&BV<UPX9E&5Z'_4B)*(-LH\@\HI'$G#&A?",.(50QF-<[Z5WMJO7$Q?&;:O
M+>2+"SBQ1V,80)P#,6X; (]_NO3ZE7QZ]&":J*Z4 ;%</Q&K0.1Q.JFA8[6F
M$C(/:SM/?-*I:52+' T@2.%.,(9FD <)E7Z@[X8)CHK?L4:]OFB]$3'W#@%@
MOPQ'P ,X*G'7]S_TUT#2H4]H4PI&6(XR"0L[L<IR8DR/P0A6^Y44(I&"/@&V
MU]/L[1*QN)7EX/\ 39)WVDLD,, ]@ONM<%7QXZF-.A!(%H1!07>2J-<CA=E[
M]Q32;B;=P7W<=L<D4:M;?,BM_5"'>\IU<D@@8C8I/=$H%$21(1HGHC3,\/YO
M=/J#XY$-YQ:_]3D1)LZ5,BC24PLUQF^Q3L.C&+X^+4^K1B,)&0;?%@%56]58
M.X"^!7Q[@H+"T=#?:!/.&Z7'JR,*QH8P3 0:+!*[Q/\ 33C-;]9X#<A?;=WN
MA6BX@?L ,GC\ #XRO]Q\CY_\[L;C5K O&3/R)+'F.3,X ')LC) P!@$%0N<X
MU;>Q2^D0(V6UC+(" =)KCSV,DQRR"RI2N<4R,=*1YD((0XQ7 &AG%&5'N:U6
MD[BLK,YC3"CL!79:RVKRO6;:0F4[:^*V/Y@B >9Y Q?<*YKID@Z#D36N4#6C
M(_NG/JN0UY%LIU;* J0G%>P!UAQ4ARV>8P 6<8C7*9$5D@@V &-PR-]H2-14
M<EM<ZV5,C3Y<X<UD^/*>PKD,P7Z22.X[71WS)17H<L^.P;9#/Y8XH%,QI%<9
M!H3PWTRJ$64RRD_'% O$_I.0V"<X& #G_,=V8WC<+#JJU(4"R QD/)-S53T#
MR]@(RCY*^[UEBG[=ADF)6N8 9%2?(<SP*X,R.Z%CD8SA*%4AK&_GOE5RD$X4
MF4UY7G<J.<K$3LE,'KY.%!&_*+7ZZ<Z/(?7 @>W])7L\T61%.<B]CC9YC0*D
M&]#,=XB:G9ZDZ[)-EPYM15%CQXL2:\#7/-(L8AA0(S #D._3B&&\,,=B]%D-
M&U4(94*D8<AS7^-ELFVS45JM#>&CEB@$YY 2#R4B$-'\!,094<$A'L0A&(]>
M[1J1!I&1[3*ZV%7E)S5'9^0;@H![. !W@8Z_<?D9QJM+N^X0H[6+$=>)$S*I
M8+P15#'+EE487[R3\ ]_G/IN?,:FGQ961B1+6V& XJX+4D>P9LD2?>,Z*C52
M(C6"B.0(FD&7Q<]SP>#>%LR,3CUI7%<5C1TB["V'3QK_ #*X&B)+-)LX_P!1
M[0S?<6+#JH) 5]7'1Z#$QYSM5Q915ZN-PMXU;(YW[NQZ)3UA8&F<'N0WF>92
M: 0,&2&'(<2NQ^$\S!AG6$_V&(D02(D>.Q5E._EIYUMZRN&#P;D568_&C_25
M#<9C!IQ*)0@4 ((0>Y[ZE5%8BC"U7M3Y>B^:IXKU4W/;9[,FT03)BC#;]^X
M<K:G2%WJPL,<7CKM&7=<]NXR"H##\[_XEO4Q?);J[)LVYO=V;;95>Y)7D+U[
M>Y/^A!-'E)A3K^Y]BN5CEL+S*R*ZK"'CEK(67Y$'+LF89]-1%8:,4<*58*:X
M(4:QK&3%BJ.5-K8!'+X!CM,IIHT*]JCB,]Z?.089)CR/HJZ7&L:V/9@>"Z+$
M"A?99[;S%E1S''91YIW/=[3#@[#"%'/<57JC;/:UV#30\'QYN/S/H9 J^M=)
M+_(: ;&P_ D%D!6"=((- O8G9SWL\3O1['L[.K^-G-1)G*U9T5@RS(Q H:20
MT>4= HCWR(PVC0CAC)'5#=R,;W<-!_**^E<]MV$DGN?X45$('%0200".L=Y(
M.#GXZSKM_P!#O3'8?!O"-F@VB_7G_G-"KO&YWHY(F.ZW;,(>.R2,LM>&.1X:
M4/,K# [,5]Z:5C7"SH<",6CFOD6C9P7^%E)EL*:)*\W.1HT:X0QPNW@UR2"M
M8%40A$1W9B<F19SHY0"J(P',>V2Q%.R$L6MC1F!:Z5',&-%49GN>HRC*\[I"
MN<8+G]4?DF0X[(DBNV6<6L1\=T#]*AAC5\!/IA'9(CQA_4R0#>K6^XLV0U%(
M9[&JSS5SG6\!O>/:W$7":>31QP#AVEA.M;B4@:NMI,;AR;>SN[27"CE<&OKH
M83F,1L8QU8Y@X["O<A4N$1W&(EYX[ZP,_N?VS^_]AGX&MD>1^1^+^*4Q=WN_
M1JJK*KS6K$<<<<K F,&20JO-V'&-%+,?_#UJ_=9FRSL=N*JS@Q(=8L98*RAQ
MF17RY2RGJ!/ 'OG43.ZN]P@G1Y'BYI%8Q7=3E])3'0T?J2<5C ([VIE-R@:$
M1(H89' %IMZM.T("&&T1%<GC[;V#\E54"CG.5,>57FD*&*/!6JA9 21[1*P=
M,81\:M*^:%LJ!<UEK[+7%AV 1J:+/,BD:]7B.T,IKH[,C_I1Y-%OO4KXK1V0
M1P31*'DP3VVG4J#8_3+V%BB5Z(\HHY?L,9$1B';XIW[_ &Y?Q]&7?MM++Q*O
M(I&03EUR#UT1A6S\8(_MJ#^I^ZU=W]&O*[^W2Q6:-_:]OM5[,)$L,L<VX4)$
M>.5?M*M&H(ZRK,JD#\;PG3ITZW1K\X=.G3ITTTZ=.G333ITZ=--.G3ITTTZ=
M.G333ITZ=--.G3ITTTZ=.G333ITZ=--.G3ITTTZ=.G333ITZ=--.G3ITTUJA
M?Q.^P+'72<++*LDDBENX7*W&)#QJY%)"LL>TE)D1U[?EIEKQ-<BJB*GQ\_A=
M3/CA70;FWRC+;Q&DD0&1X<.4]_@R"PQ"2IKD'[C?>*Y?HQB<Y5\&C<P2=R+Y
M;.?\6J9X:K@"K.WWY;R5&[R5416NP[5?Y1$7NGDC5[+V1%1'=^Z(BZW/&F.:
M#A9;=&@7W<CL7E85SG-(L4,:.%C6IW>9_=C_ !*QB_3*W[NR/1W6J_,46/<I
MK'1=X*D7>,A S'B/V')F8]]]#&IEZ"[)5WK^(38S=B66':-AW+>(A(%9$MUZ
MEBM3D ;_ !PV[D,T;*1(DL:/&5<*PEI,H:N]0GU5FL6M@L_6)A0E<T]G!50Q
M$2(L@C$7W9)1I(4:^?TR':C&/:JMYA;B'6T,,=:'ZU[R%_0Y;I;!.D2@L,UH
M9/FPEC. -PW_ .CA(P9F,<CV+Y*]UNC6-M)GJCGE#[J>R$I"H@0!D/#'*9LB
M2&$]SGJOVN&=BL\!N(V.-7E)2DN168_8K.N[8YU X*Q(S'$9X2&(PR$]TY6I
M](\ W/8R.X@RN50JXB.)WBP"F/B%=I?<9F;.5]LJ@1 H'6&#L6))/+&<  ?I
M99A2K8,DDZ0P$1!86.'0C(=LLW-PYP5 S@@@?.KXSVW4<$:M-!?((>*&79QA
MD/: (3L0Q%BB^F)-A- 0:E*-AXZ"&]!M&Y7.<O@>U*:I6&:*8@7U3G*MD\LD
M2(6=W81M0=1O8"4!SE(A!IXO>QHD=\O58GY;R9D5DMM32S99YDASA1 -:6=/
MD_Z@V(_Z)@%]^0Q[4>)HV.*BC[^RK"H^X.L>%G,7E%)#?DH8NK<*E$:YV2YF
M^53O?&7S.DNLIRO;/E-[=RI[8!B54?W<U$\5NQ6F"8EE:#K(7V^4G$8+<493
MG &#]I &2#^=:.\]]:? _$C)!N6[1RW@IX;9MJM=W"4, ^):T#NT(= <23"&
M!@?U 'JJ=B<HZ:0\$&3,K2AA/+82"F,%94R8:.H%9/%%]F))DN8HF#(*($GP
MA"O.KFJZ*V2\FYF0B%68S66LN6LH;1UE3&GE8].[%:UB>^0ONM&KW,<]7,8J
MHY&J]RM3,+K[TO.(^I@"O-Y[)L=GV[!L67%D3AT.-*<;T,H0!&\LXPT5G9R/
MG#:K4:Y6M<K>K[BY)\(..D3]+UIK_!:\\#Q8(M9319L]/%/)"%L)<:7-<3R7
M_6<7NB.1R/5.K>7<MJIL89K*/-]I,>'EF!;CT]>JCE%."03UW@G((7E?R#^)
M_>YI)%\<\>VW::BDI%;WJ=[=IQD$LM&I+#74HO'C&+C@DG)Q]@P0T6'\MLT(
M27AFE-GO'**U8LI:B>".1C1HYLCW30V(CVN<8XC,(Y&=QB1$8)&I=6MX;\]\
MD<>2FMI%"Z6)0F==W-96M<.6B/[2?J)#2JYK4]USB,8]KE*U&HUS6-R0YSZM
M501#@QJID#"U7HQJ*T/^H]J?+FL&B-\.[E]L*M:J]E\NW4,L^]3O9-N4D:H%
M]"SS>T;U&I2O1S57NQOB$;E&]%1GPY7HK7HJ+Y(MD=X=_P"G1V:S*N/F2O%5
M7L#LO.[2#!^T\8\]EU.%UJW<?XA_4RQ)Q_TU%)''<>S;31A6/)4!5DGK3S*6
M&?N$H(/^$XZ8OZ8'*6[$P>>[2U[@M6JH9_MVGZI*9V*XA2]X"#"1_N$56>4A
MR,\VHQ/!GVRTU-Z87#S"YD6XW;MJWVA81"!?+J9-K!Q^@,1SVN]HD9JOFFC?
MZS4#]6-9#55SU1$1'XILFY@;KSI7QPW]U-,J]UCUQ9+U3R=]_OCC-<UGDY$5
M5<U$3_BL5.R=4A!F[WRHZJ1;(#" 1[S6EJ42"$YRN'[@QB.<B$\O(8V-1SGJ
MC7,%X]V_3?WYU!:+;J:(3_2EL32E5^TC"I[:@D]ODLA.,8P,X.O:]4_4L/%5
MK^H?F\!?[XE>_9VM74 M[L5=$VY5",&99U7BIY$A#WN$ZXY+\7M'X_%PK7'[
M-Q3':H;@P:FE6NKP+W5&-?[(R?Z017-1"D.\SR^*J]ZKU#CFWC'&+G94UD>U
MR$.-YSCKS'Q_,*!]>69$"1R(:OL(Z^X*QK#$1J^+T'[96JUKQN5$=KH2=>;E
M$-3FD1YJ,>Y'BBSCD<]KFHO<:^VUSGM54"Y@Q.($B]R#:U%3JB:K/\VQ:^!%
MDSK2LM7'3Z<C)GNQ2N1R.0#"A]MJO1&JT@RHU_CV5Z*U%ZLK/^D5J("#<Z*1
M0D2^S!5'15\J1([,R?J*EU!Y*P# CH4_)O!O4+Q#:OJ_)O3O<=KV8\%>Y-'&
M]6OS8",RFB9HZ3N1E/>]DEEXKR(($F-I\2<'TLX8'\B)4HIE8<L&NHD"3VE<
M]BF:T\@@@E1R*K"#[=^Z+_BJVEABTI7)[/[LV5.F*4BFD-O*V,$O?Q*KF 97
M^+/(B>36JJJUZ*].W=>UK-WY'>WEL.TFF.U+*$%Z(8W=5,)C&2!C:CG.\&$1
M7#&BHKT\G,5/RO88MH6TS"KAV]-D0'-D-:@9<R  ,-2*KA?3C*^V$\KE5%9V
M1//Y<Y6>**J7-.KN%BM'+<WFTK298)52"%%(."&9(V9B,%6^_'7Z01W[]/Z/
MJ_YK':VGT]W/?9*VS+'(^V0>724%J0RL5B>.K/NM$-&&7ARKQ,D7V1L5Y(#<
M#(K#4,> [Z61G5HYO?V(EGDL9:_NU'/$TL:)! 0OM(GV(X_97_\ ;4=_+3JA
M=77>)2]EUE'9"C8Y1YY29GJVRM0N1&U$?:&,V6%1;J8>056DBT5Q;5EG-5Q&
M*L*+(5KVJB.;4\'B3L:RE.$VWKV16E>ULIL.R/&(B]T7W2!5([?%7*UJH=&K
MXH97^TJ/==+&.'-$RQ=$R?)K6='CL V6.J'!4!"*5!&",3"$FG J.5'(.2%S
M&E;[AD[N(W(UU6%Q*]ZS:DSR1IG/%"  I$>%C7'R2$R3^HYSK8"^@W\2'FEZ
M [_MNZ2G;Y(C'/Y'O\#58@'/)HU^NO32@'+-[4$K,'+ DL ;\:3P;)Z/3VG0
M9&,P\LI9.0X;E\0KPQX]'+I[.SBG>3S:PS&LE4TR8",8R#D_J#Y2(YAT5<I'
MI11VL]2;B\]_M>ZR#R?0;TDI((2*;2ODPKNXF*T3W#\F>"J)'>3.[U1"/A0"
MKMJ7"8BV=PZSJX4Q\6KDO0I[0H0A%$&"=)<KSR2!   G3)9I\D+0,0\Q[W-3
MJ;'I3 @-]2;BL^*TX3 J>3<,XB$<Y"^>E725E()Y3O&CGN5@E:5K"#:CT$U5
MZS6QRA]^H-A%$DLQ$2'D(\M(Z\2<MA5<*0?R<YUVW?\ $MW\(_ALWSQW>K%.
MQ>HT?ZQV][,M2)9_(*\T-:*6W7JS,((IH$P8551$54D'6\!TZ=.MOZX.TZ=.
MG333ITZ=--.G3ITTTZ=.G333ITZ=--.G3ITTTZ=.G334*N??,1W!KCY(WL+4
M68[TDAV+JG HVL]?3 1LVOEV3GE/B,D^+19$"P9>WM+7V$VZK<78R*?*)< 5
M!&LJV18#F@^.7\Y=:5]7P4RS7 8VV=><\MR8YJ_6^=X[>AA5%=1Y5H+;V^Z7
M/5%(KI1KF%(J-4OHRT3754^+.O6EE20EJ94 ]#^I-B^2Y5K?C9%QC'[W(I55
MZAOIY9/9QZ"IL+B168WC/+76-UDF0SPUT:22'28_3Q)=K>6LE@Z^JK(TB=8'
M!#"4K<5NU.->[>,GJ&<$-#:NUKE66<%LSY_9)S*U=>8Q33Y^-<0LUD\:>4N,
M\A-'Y RO:>#B.HMD9QM?']QZ3*\%;44>3W^U\#C-# CXT!C36=FWY?\ %+']
MQP..]_R5T+2;]M)M165VD[;;N UVUYMI?P5LZ*JBX!,OPY0:TNJUKK"HK65B
MSK."GU<&.<"M([L<GY4\9L*SVNU7F'(32F+;,N,VQ?6M3KW(=H873YO9[#S:
MIA7V'X-7XK/N07LW+<HH[.MN*#'XT$MG:U=A!GPXQ8TR,0NM%L?'I57P#YP^
MG5D7'S<^5>H=NGE'RGR'6]E5\=MI7F/;/V1NODUD>S.,G+>LY*0L+G:EJ,7U
M=KZTUU<V6Q<MV5CN0ZC'J.=A\J%6V^.4-1/RG\/]#%I_4V]4W=V<Z^)*R_(3
M\&L&Q#;MUAAH(\EQ;$^,>.2\JC8#>6$%8OZ,FP2RI&3@QF<0"7E?50;LA)5!
M6BB--38@\\N$=GF-5KROY?<8YN>7D:XF4V&1=[ZP-D]K%QY+];T]?1LR=;&6
M.F9BF3DM/:CN=!#CMX:2T8:N:0-9:JY6\8=Z8KF&<Z6Y$Z/VSA>O5*F>Y;KG
M:F#YGC>$^S4OOBKEMW07D^NQMC*)C[I27,B$+](:ZR1ZPFO,W7(P_B0^Q]'W
MB?K3(N.UG-R+)_5@U#LC;6&W&K[,^3SZ:\]6&VD9KFV8U$RD=>AIBZ;,S]6R
M&R"&OBZM]IA9@<0\466'+Z=OSC]RR]2/>_&_C[*V/D$CTP.&-;C=4FK,ES+"
MLWRVGY*\L\?S1\O%\3'62=O7^K=2Y,#+K'5U%:+F&28U I<0@NA!R.I4C361
M/,?4'XXWW&SE/N_B[O+0?):YXUZ)V-MVVQ_6.VL1SZ%%E8MK[*\SQ>#E9<&N
MK>?15.5'QB1%AV!!B^MC!G%K"')%>C.PF<KLBC>FW+YP-Q.F?E<;A"?E4W!O
MKK!<>?D(M!.W F*?J2-_5?T9UDB4_P!<C/U#Z'_2$;]3\=:]S\7VEM3</.'/
ML:RCD1R7P[(?0HY9Z:QK:F6\*Y7%?&K79S<RB3ZW2^J<(C:FUME^3&KX=NV5
M45F35V63HI[B31X=E.02XN91JS,9+PK-"^AE+UW'QK) [#)Z4)L+!AZTEJ/+
MA9F_ARM$+&EQSZ3];9D;+Q4JEI?H?U5MHGT'TGUB>STTU)KB[SIXX<FZO"\=
MP[>VA\DWM8ZOQ+8&>:4P7;6&93G>#FML=QVSR6)9XC NY>4PHF,6V0 I[$UA
M7")7RB18EHL68=HULE2\],TMMI\%=?S=?ZOB"Y9;9YJ:XR:7@VYJS<]3AT3B
MU0[-M:"=19OA];5XW<7V3OP.&+.<6F0Q3=;7L^\P6R+)R+%IT@N,S54O'=QK
MZ)>BN/\ QXW)JC='#'-]>9EOR3E?'':6GZ3C-J/#N)6?:TW5K>]V3EV"X]@V
M52]Q9IE&*8368W@&59A'ST_;8;"RZ?&EO \/B/J+;5/EWI$%L]<Y_1KA7,WU
MO[O+YMKA61P08=4[ R_EN7 ;_*'S*L0J*IS-EU2R<3L+?Z6%DH;6M?3&G#GQ
M5-\SWC^Q/_+'_OIK/Q0\LN+V4[CMN.^-<B]&Y!ORB);!N]*TNU\%M-K5)Z&*
M"=>Q[' (5Z?*(DFDA2HTRYBFK&R:J)(#)GBCA(C^I!=:9?!7C-G8W\'^.?)C
ME%RNP#>'&#E?4[/G<<8_IJI^W6[NPW+\SR#-<\'S9Q/3,JIRK5.]J.XRJTR7
M>%MMV0;86+;!DPLXF,RF=,H ;F3>R-:B)V3LG9%145$_HBHORG9/CLOS_CU]
MTUIS_P 6RB+3\ NZ=^V6<E7(G].Z8;JOLJ_<W\?E$[]E_K\=:S&A-@4M!B-K
M"N9(&-BS9KQ-5K3.CH=0R6$4'FOOC(YY$0:(-@WJ]7$0GBH]XKUC^-> \K]Y
M\*M1;('(_;TS .9]X.5#,L>=66E72\?!0K.";LYHY<1DZ0HE(,HG(]S"">QR
MIU@XN?1"XP898I/RG=.P)]?%(Y'UPOT"I><#7>:#)+##:5C2*K%(1J-<K?-!
M.8Y$ZU?YE[ O,UM_:@]NN5?W%0.X#MP[).<*3@CO (SC&O'BGF6Z>G/J''Y;
M1V\;C&-EL;;-"+$$#E+7%AQ:?H<):\3L5!)3D ,]:PM93OF/;R(^.8I%F7MG
M*($%364\!]M.>9R-8@F!B@D-D>Z7VV#8I'%$C6HG9K4\9):+],[EYR3^GO\
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MU9@ ;%M9LB4T0940L<;2#KV*[V!QCC<J-(4G<BM"TR2D$]JN8J.3KX.!?1C
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MEN,YQL[5]UEV(5LLDVKQ?/Y6J<VP==B8]42#25J*?.FY# J0SK&+7!BQ;&:
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M97([JJ'^'QS[&; -A2\Q\&@(Q>TF%&XU9 R%8L^?Y<\2<B54O97/[&&X)O\
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M8B\?U*,\M_MHD9W\I'.<)2L<QW5E,3VXF.'KY8L:I[^[F27%@-?$9*(.61I
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M#0<IDHK1*OB].ZJ),G-OOG=96EE\FWI4R3CZMR !V>RHZ7H']AT<]ZPM3;/
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M>=1(<XB,]OVU&J.I&PSNHU5DQLIRQFHL<@EI8T*18R=IUX*L%A'[,+(HZN=
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M%M-RU^WJ>9M2JPL.)8=@>I8V26%%J?*(!ZN&69\,3]/WFEJK6O#C8N/6FO\
M9.WN'_+S?.\L XX;&Y!;5RG#\2XX;UU/LS3=?QEQWE?G>O\ *-DYA>:=QK/H
MMQB&<Y[KU*VRD096#>-1C$.CM!--9 -E>H_HC54[EM5Y/2[+D6W$3*N/^O\
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M]IQUW#D&Y\TSMM=:V=Q<1LDN;716FH>/X-6SY$69B=2(E[:S;"39SK:+2.&
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M>@DC]Z*$/%+(XL;;92N\DTT3!Z\BQ32(73@XK_ -OB+"E5\[&JV\L;5\J-2
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MDH7Q,2RZDMGZV>O6:8F>F-"X8X'I7(L?]4//>7N8;,U!1%X_YO0[:-G_ /\
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M(YI4)[461V_[8,;FO5SO GMN&CR)H#U&I02>6PV3 LUH[932(N W!([%IF8
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M53Y_IW_/;X_'QU[=.FFO';Y5?GY[?U7M\?X)W[)_GV1._P#7KSTZ=--:OO\
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?DZ=.G6Z-:4TZ=.G333ITZ=--.G3ITTTZ=.G337__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
